data_2kcw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kcw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.267 4.3 t . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -135.2 141.84 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.88 1.672 . . . . 0.0 106.676 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -136.32 166.17 24.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mm -123.08 142.16 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -150.52 172.02 16.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.784 0.834 . . . . 0.0 109.76 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -61.67 148.39 42.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.492 -0.755 . . . . 0.0 110.488 166.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.722 ' HG ' ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -70.84 160.76 32.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.735 1.214 . . . . 0.0 110.26 176.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -103.11 161.72 13.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.146 163.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -62.82 -51.76 65.79 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -24.9 62.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.754 -162.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.35 -0.61 46.61 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.404 -0.185 . . . . 0.0 111.1 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 -39.43 53.22 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.137 -0.977 . . . . 0.0 112.752 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -65.56 -28.56 69.25 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.616 1.208 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.19 -32.78 73.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.209 0.528 . . . . 0.0 109.644 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.88 -38.82 64.29 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 120.901 -1.125 . . . . 0.0 109.63 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.28 -46.46 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -47.15 87.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.06 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.84 -50.36 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.996 1.319 . . . . 0.0 109.52 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -53.76 -47.15 70.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.0 t -59.13 -47.32 85.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.279 0.632 . . . . 0.0 110.683 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.306 -0.871 . . . . 0.0 112.811 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.1 m -60.17 -38.06 82.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.342 0.974 . . . . 0.0 109.516 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -70.44 -42.74 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.077 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.41 -34.99 78.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.392 0.542 . . . . 0.0 111.094 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.78 -33.91 30.62 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.283 -0.886 . . . . 0.0 112.309 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.511 ' CG2' HH12 ' A' ' 83' ' ' ARG . 19.9 p -139.1 -5.12 1.47 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -167.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -126.61 30.06 5.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.697 1.59 . . . . 0.0 110.454 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -60.8 -18.94 58.36 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.962 0.887 . . . . 0.0 112.849 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.11 -23.52 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.212 1.405 . . . . 0.0 112.517 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 106.02 0.53 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.418 1.087 . . . . 0.0 111.591 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 m -56.25 151.09 13.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.056 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.06 -34.41 68.24 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 123.077 0.551 . . . . 0.0 112.351 -172.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -68.07 -47.91 67.01 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.714 1.245 . . . . 0.0 109.358 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -68.66 -34.98 76.63 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.574 -1.193 . . . . 0.0 112.02 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -53.86 -49.35 68.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.754 0.822 . . . . 0.0 110.773 170.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 m -62.91 -47.08 84.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 124.349 1.031 . . . . 0.0 109.16 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.37 -36.54 74.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.457 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.54 -50.77 70.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.414 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.69 -39.06 79.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.081 0.855 . . . . 0.0 111.237 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -51.07 69.46 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.06 0.544 . . . . 0.0 110.326 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -37.21 79.01 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.478 -0.764 . . . . 0.0 110.134 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.8 t -58.5 -46.99 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.51 1.524 . . . . 0.0 109.026 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -67.74 -18.04 64.76 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.913 -1.117 . . . . 0.0 113.034 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.3 m -95.02 10.61 35.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -140.09 -56.29 0.55 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 119.473 1.033 . . . . 0.0 111.796 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -55.81 -40.24 83.22 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 116.888 -1.53 . . . . 0.0 112.659 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.73 -11.63 18.36 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.315 2.01 . . . . 0.0 116.209 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.99 -15.35 3.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.14 1.336 . . . . 0.0 112.461 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.02 148.24 98.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 123.784 0.833 . . . . 0.0 110.124 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.84 65.23 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.347 3.365 . . . . 0.0 108.844 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.722 ' HB2' ' HG ' ' A' ' 8' ' ' SER . 64.1 mt -83.9 170.89 13.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.033 0.933 . . . . 0.0 110.651 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -122.75 138.88 54.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 166.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.54 135.57 56.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.615 1.166 . . . . 0.0 108.811 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.28 133.0 41.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 160.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.4 140.65 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -79.22 -174.58 4.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.078 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.48 -19.53 9.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.537 1.535 . . . . 0.0 114.885 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.36 4.93 44.4 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.769 -1.207 . . . . 0.0 113.203 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.3 t0 52.24 52.45 14.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.27 1.509 . . . . 0.0 110.897 -169.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -131.7 124.57 19.96 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.23 137.83 45.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.113 1.875 . . . . 0.0 111.743 -169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.86 -11.06 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.397 1.079 . . . . 0.0 111.38 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.93 171.49 41.07 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 169.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.66 161.96 39.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 111.704 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.31 138.92 24.05 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.674 1.59 . . . . 0.0 106.942 -175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tp -112.6 121.34 44.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.5 tp -141.56 133.25 27.13 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.573 1.171 . . . . 0.0 108.424 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.5 m -147.27 160.2 42.76 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.761 2.024 . . . . 0.0 106.979 164.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.0 -115.01 6.68 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -170.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -135.46 32.71 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.567 1.183 . . . . 0.0 109.637 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -128.2 103.13 7.02 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.113 0.965 . . . . 0.0 109.216 -165.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -81.08 87.14 6.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -60.26 -36.32 77.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.932 0.893 . . . . 0.0 111.181 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.81 146.46 41.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.546 -1.346 . . . . 0.0 110.685 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.97 118.25 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.37 143.14 30.8 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -150.74 141.23 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -53.46 122.93 34.32 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 125.374 1.671 . . . . 0.0 108.929 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -51.84 -27.17 26.43 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.186 1.924 . . . . 0.0 114.39 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.3 -28.28 69.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.112 1.324 . . . . 0.0 111.89 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.66 2.04 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.867 -1.145 . . . . 0.0 112.262 -171.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.511 HH12 ' CG2' ' A' ' 27' ' ' THR . 46.2 mtt180 -53.36 -44.82 68.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.095 -1.003 . . . . 0.0 111.958 170.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.31 -22.95 67.85 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.369 1.043 . . . . 0.0 111.596 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.0 -7.41 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.696 1.248 . . . . 0.0 113.084 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.21 1.25 51.08 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-O 118.699 -1.056 . . . . 0.0 112.606 172.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.6 t -55.68 -31.35 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 118.725 1.263 . . . . 0.0 110.019 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.86 -49.8 34.14 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.003 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -64.62 -47.01 80.15 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.734 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.86 -43.41 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.558 1.072 . . . . 0.0 110.085 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.2 mt -69.34 -42.15 75.69 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.628 -0.67 . . . . 0.0 111.017 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.51 -41.25 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.813 0.733 . . . . 0.0 110.432 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.38 -38.69 90.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -59.32 -46.07 89.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.381 0.537 . . . . 0.0 110.605 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.93 91.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.989 0.516 . . . . 0.0 110.609 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 144' ' ' TYR . 32.6 mt -62.59 -34.58 77.29 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.9 m -62.71 -33.97 76.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.536 0.523 . . . . 0.0 110.695 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.8 mtm -87.59 -22.52 24.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.626 0.648 . . . . 0.0 112.061 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.78 93.16 6.25 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.775 1.23 . . . . 0.0 108.237 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 -23.65 57.24 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.738 1.625 . . . . 0.0 113.266 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.32 31.18 4.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.379 1.471 . . . . 0.0 109.368 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.8 tp -49.86 144.64 6.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.529 1.932 . . . . 0.0 113.04 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -127.48 162.0 27.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.778 1.631 . . . . 0.0 108.751 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -153.35 -179.68 7.96 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -141.56 165.51 27.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.063 0.945 . . . . 0.0 109.856 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.72 145.63 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -71.29 131.85 44.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -58.35 -33.09 69.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.519 1.128 . . . . 0.0 111.534 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.167 0.587 . . . . 0.0 111.523 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -85.81 68.62 10.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.291 0.567 . . . . 0.0 109.886 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.35 -26.07 62.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 111.018 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -61.47 -49.16 77.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.67 -0.644 . . . . 0.0 109.61 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.65 76.57 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.411 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.04 -48.32 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.058 . . . . 0.0 108.46 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.83 -47.15 92.67 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.525 0.602 . . . . 0.0 111.793 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.26 -51.04 70.96 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.91 0.884 . . . . 0.0 109.116 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.66 -35.39 80.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -42.69 99.12 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.738 1.154 . . . . 0.0 112.584 171.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -59.57 -41.01 89.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.052 0.842 . . . . 0.0 111.306 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.05 -37.82 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 123.998 0.812 . . . . 0.0 109.648 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.38 5.35 0.97 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-O 122.182 0.879 . . . . 0.0 115.003 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -73.9 159.09 33.31 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 118.294 -2.886 . . . . 0.0 111.475 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -142.59 139.36 31.32 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.5 t -71.69 136.28 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -130.28 -8.63 4.25 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.26 1.824 . . . . 0.0 110.922 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.36 178.1 42.65 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -157.32 178.69 10.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.122 -0.634 . . . . 0.0 109.62 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.671 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 N--CA 1.451 -1.022 0 N-CA-C 115.809 1.427 . . . . 0.0 115.809 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.7 tp -104.39 146.77 28.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.8 mt -114.57 145.93 41.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.68 138.08 51.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.654 1.182 . . . . 0.0 107.986 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.87 157.85 45.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -169.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.24 50.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -73.21 116.7 14.06 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 74.7 t . . . . . 0 N--CA 1.411 -2.403 1 CA-C-O 100.815 -9.183 . . . . 0.0 110.44 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.5 t . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 mm -126.76 144.45 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.7 m -141.65 167.59 21.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.45 142.83 36.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -148.72 173.51 13.16 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.539 0.736 . . . . 0.0 110.214 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -66.03 147.87 52.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.573 0.701 . . . . 0.0 109.11 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -77.71 147.17 35.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.854 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -85.99 175.85 8.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.803 0.841 . . . . 0.0 108.746 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -82.35 -49.06 10.44 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.43 -26.54 61.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.81 0.732 . . . . 0.0 112.203 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -72.77 -5.2 36.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.031 -0.418 . . . . 0.0 111.841 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.66 -38.64 29.43 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.487 1.041 . . . . 0.0 113.178 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.78 -28.61 69.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.926 1.363 . . . . 0.0 111.795 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.71 -31.28 70.26 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.401 -0.812 . . . . 0.0 109.578 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -75.49 -39.67 58.23 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -56.29 -44.82 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.497 0.719 . . . . 0.0 109.084 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.45 96.18 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.883 -0.51 . . . . 0.0 111.436 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.0 mt -59.8 -48.89 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.512 0.725 . . . . 0.0 109.705 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -54.19 -45.7 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.269 0.628 . . . . 0.0 110.111 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 t -60.54 -44.24 96.32 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.607 -0.683 . . . . 0.0 110.518 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -63.11 -42.69 99.6 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.658 -0.651 . . . . 0.0 110.833 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.7 m -59.6 -38.09 80.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.514 0.726 . . . . 0.0 110.876 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.44 -45.52 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.273 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.02 -37.39 76.83 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.153 0.888 . . . . 0.0 111.83 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.6 26.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.147 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.5 p -135.44 -5.78 2.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.448 ' CE1' HD21 ' A' ' 110' ' ' ASN . 12.7 m80 -128.52 26.89 5.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.009 1.277 . . . . 0.0 110.632 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.5 -14.41 28.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.323 -0.861 . . . . 0.0 113.293 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -53.38 -22.79 8.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.737 2.015 . . . . 0.0 112.988 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.01 100.29 0.41 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.057 1.343 . . . . 0.0 108.529 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -56.32 157.33 5.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.527 1.531 . . . . 0.0 111.109 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.32 -36.98 66.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -67.14 -48.56 67.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.888 0.767 . . . . 0.0 109.783 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.52 -40.27 96.61 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.663 0.785 . . . . 0.0 109.796 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 -55.54 -48.45 74.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.932 1.293 . . . . 0.0 110.168 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -65.42 -49.53 68.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.0 0.92 . . . . 0.0 110.05 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.83 -38.13 88.08 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.861 0.3 . . . . 0.0 110.66 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 mt -62.79 -53.74 49.72 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.565 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.53 -38.22 74.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.442 1.019 . . . . 0.0 110.701 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.9 -49.09 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.221 0.609 . . . . 0.0 111.854 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -36.45 74.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.201 0.455 . . . . 0.0 110.296 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.02 -48.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 126.211 1.805 . . . . 0.0 109.038 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -70.41 -10.76 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.987 -1.071 . . . . 0.0 112.679 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.7 m -96.05 4.7 52.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 110.681 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.24 -56.45 0.8 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.158 -169.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.81 -38.47 68.4 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 120.466 1.485 . . . . 0.0 112.91 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.19 -13.01 29.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.945 1.764 . . . . 0.0 115.362 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -128.95 -14.7 4.41 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.63 1.559 . . . . 0.0 113.196 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 152.19 95.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.792 1.237 . . . . 0.0 111.999 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.19 62.71 7.61 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.98 3.787 . . . . 0.0 111.65 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.8 173.73 8.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.185 1.794 . . . . 0.0 112.374 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -133.07 146.15 51.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.45 137.87 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 110.487 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.87 35.74 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.01 140.89 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -76.67 -174.83 3.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.609 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.08 -15.56 34.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.821 1.648 . . . . 0.0 113.118 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -87.74 3.73 46.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.037 1.335 . . . . 0.0 111.713 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.14 33.28 21.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.675 1.59 . . . . 0.0 111.412 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -117.79 133.49 23.33 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.26 138.18 46.04 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.703 2.268 . . . . 0.0 112.4 -169.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.76 -9.64 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.601 1.16 . . . . 0.0 112.348 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.96 170.43 37.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.08 158.56 43.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.882 0.841 . . . . 0.0 110.7 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.92 153.34 48.24 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.948 0.899 . . . . 0.0 109.54 169.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.35 120.62 38.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.1 tp -145.45 140.26 27.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 m -154.4 155.97 35.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.985 2.114 . . . . 0.0 105.334 169.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.39 -114.56 5.63 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -130.96 13.99 5.25 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.785 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -114.74 106.21 13.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.491 1.041 . . . . 0.0 110.407 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.7 ttp -79.16 82.56 5.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.5 -19.52 62.16 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.01 148.54 30.83 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.247 0.93 . . . . 0.0 110.573 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.9 tp -156.63 119.88 4.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.525 1.93 . . . . 0.0 105.932 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -146.03 145.08 30.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mt -151.34 142.07 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -55.55 120.03 28.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.03 -30.76 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 114.471 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.98 -24.16 67.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.9 0.33 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 118.701 0.682 . . . . 0.0 112.408 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -60.59 -38.27 84.06 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.293 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.22 -27.73 71.08 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.589 0.614 . . . . 0.0 112.742 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.35 -6.2 48.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.236 1.018 . . . . 0.0 112.14 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.61 16.1 64.59 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.292 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.38 -31.74 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.134 1.467 . . . . 0.0 111.094 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.86 -52.82 15.32 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.388 -0.674 . . . . 0.0 111.921 170.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.49 -42.92 98.53 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 117.327 -1.321 . . . . 0.0 110.291 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.6 t -58.1 -45.62 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.297 1.408 . . . . 0.0 110.011 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.3 mt -68.59 -42.23 78.53 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.855 -0.528 . . . . 0.0 110.81 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.65 -41.56 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.041 0.536 . . . . 0.0 110.024 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.2 -33.19 73.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.317 -0.864 . . . . 0.0 110.121 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.93 -46.55 88.85 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.317 0.508 . . . . 0.0 110.382 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.89 82.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.083 0.553 . . . . 0.0 111.019 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 mt -58.98 -34.82 72.26 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.102 0.961 . . . . 0.0 111.303 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.81 -32.81 74.07 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.13 0.423 . . . . 0.0 111.784 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mtm -91.45 -23.21 20.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.237 0.615 . . . . 0.0 112.148 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.53 92.47 8.12 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.548 1.539 . . . . 0.0 108.339 -172.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.49 -22.75 65.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.474 1.449 . . . . 0.0 112.35 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.22 31.69 4.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.862 1.665 . . . . 0.0 110.039 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -48.33 143.3 4.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.254 2.222 . . . . 0.0 112.843 -171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -130.49 159.18 37.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.56 1.544 . . . . 0.0 108.01 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 t -154.17 -175.41 5.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.157 0.503 . . . . 0.0 109.792 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -148.48 160.38 43.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.135 0.974 . . . . 0.0 110.609 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -157.11 147.94 10.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -72.51 132.57 44.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.98 -35.13 63.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.963 1.305 . . . . 0.0 111.939 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.11 -30.84 71.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.419 0.554 . . . . 0.0 111.771 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.448 HD21 ' CE1' ' A' ' 28' ' ' HIS . 58.9 t-20 -80.47 63.37 4.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.953 0.901 . . . . 0.0 109.374 176.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.27 -26.62 52.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.3 1.04 . . . . 0.0 111.151 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -47.44 83.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.688 0.795 . . . . 0.0 109.833 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.53 -35.01 75.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.856 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.45 -47.93 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.47 1.032 . . . . 0.0 108.444 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.07 -46.44 94.55 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.544 0.592 . . . . 0.0 111.817 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -55.14 -51.33 66.82 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 117.762 0.781 . . . . 0.0 110.008 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.23 -33.7 75.91 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.926 -0.484 . . . . 0.0 109.917 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -58.48 -47.48 83.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.433 1.015 . . . . 0.0 110.852 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.44 -42.88 88.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.951 0.796 . . . . 0.0 110.463 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.76 -37.76 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.945 0.898 . . . . 0.0 110.776 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.85 1.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.28 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -79.71 154.94 28.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.596 1.698 . . . . 0.0 111.248 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -140.79 138.51 34.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.267 1.827 . . . . 0.0 106.39 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.41 134.39 30.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.935 0.894 . . . . 0.0 109.75 -171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 p -125.34 -9.99 6.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.453 1.901 . . . . 0.0 111.364 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.88 42.12 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 118.822 0.737 . . . . 0.0 111.565 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -152.65 -176.43 5.72 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.124 0.969 . . . . 0.0 108.839 169.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 125.329 1.452 . . . . 0.0 108.59 174.463 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 118.344 2.401 . . . . 0.0 118.344 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.7 148.44 23.33 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 168.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.16 148.16 41.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -120.65 138.64 53.82 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.609 1.164 . . . . 0.0 108.131 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.88 160.75 38.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.343 1.057 . . . . 0.0 108.288 -169.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.26 150.1 52.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.567 1.547 . . . . 0.0 108.536 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -75.67 124.01 26.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 124.468 1.107 . . . . 0.0 110.336 -177.338 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.234 0.266 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mm -132.69 140.79 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -135.58 164.16 28.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.5 mm -127.16 143.21 41.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -154.99 171.94 18.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.798 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -60.59 148.98 36.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.884 0.765 . . . . 0.0 109.082 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 p -62.84 161.62 12.41 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.764 1.626 . . . . 0.0 112.27 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -112.24 160.47 17.59 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.691 1.596 . . . . 0.0 107.251 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -69.84 -45.46 67.75 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.094 -0.378 . . . . 0.0 111.031 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.47 -27.21 65.03 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -82.82 -2.36 54.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.021 0.528 . . . . 0.0 111.483 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.34 -40.19 60.46 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.201 0.909 . . . . 0.0 112.766 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.34 -28.54 69.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.551 1.175 . . . . 0.0 111.766 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.65 -32.52 69.84 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.346 -0.846 . . . . 0.0 109.711 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.6 mt -72.81 -39.44 66.65 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.728 -0.607 . . . . 0.0 109.592 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.74 -44.78 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.205 170.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.21 93.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.363 0.665 . . . . 0.0 112.258 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.22 -48.94 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.398 1.079 . . . . 0.0 109.505 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 60.3 t90 -54.7 -44.92 73.84 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.885 -0.509 . . . . 0.0 110.396 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.84 -50.28 74.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.991 0.814 . . . . 0.0 110.832 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -68.98 -25.19 64.4 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.273 -0.892 . . . . 0.0 111.94 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.6 m -69.58 -31.89 70.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.94 0.791 . . . . 0.0 111.085 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.87 -47.16 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -58.92 -39.33 81.23 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.15 -34.23 20.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.706 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.0 p -138.41 -0.43 1.99 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -133.57 33.45 3.52 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.324 1.42 . . . . 0.0 110.812 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.06 -14.19 9.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 113.534 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.02 -27.81 63.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.222 1.809 . . . . 0.0 112.709 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.21 129.52 42.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.499 1.12 . . . . 0.0 108.917 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 p -61.85 161.97 9.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.375 0.67 . . . . 0.0 110.41 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.49 78.11 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.9 -0.5 . . . . 0.0 110.647 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.32 -50.76 68.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.398 0.679 . . . . 0.0 109.97 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -67.89 -36.93 81.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.145 -0.347 . . . . 0.0 110.103 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -55.25 -42.3 73.31 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.707 1.203 . . . . 0.0 110.732 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -72.55 -50.83 22.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 118.587 0.631 . . . . 0.0 109.658 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -69.34 -35.14 75.6 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.125 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.38 -51.47 67.43 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.121 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.48 -37.94 76.58 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.554 1.07 . . . . 0.0 110.843 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.49 -48.07 81.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.653 0.66 . . . . 0.0 111.807 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -38.11 72.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.47 -46.37 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 126.236 1.814 . . . . 0.0 109.291 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.6 ttp85 -72.34 -10.29 59.6 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 120.753 -1.217 . . . . 0.0 112.23 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -98.0 5.71 48.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 110.696 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -136.09 -56.77 0.76 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.617 -1.183 . . . . 0.0 112.724 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.39 -38.83 69.82 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 121.019 1.736 . . . . 0.0 113.246 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -61.09 -13.55 28.48 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.409 2.072 . . . . 0.0 114.845 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.38 -12.61 3.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.772 1.624 . . . . 0.0 113.272 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 153.21 91.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.227 1.411 . . . . 0.0 111.626 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 66.29 7.33 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 110.136 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.3 mt -87.58 179.08 6.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.336 1.065 . . . . 0.0 109.907 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -137.37 127.67 26.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.63 141.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.026 0.83 . . . . 0.0 110.237 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.05 134.77 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.94 142.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.516 HD21 ' CG1' ' A' ' 63' ' ' VAL . 16.4 p30 -85.08 -178.31 6.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.251 169.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.6 -26.38 8.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.805 1.642 . . . . 0.0 114.18 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -76.64 -3.07 35.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.31 1.044 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t0 51.48 57.98 5.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.729 1.728 . . . . 0.0 109.358 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -138.58 127.15 14.09 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.64 142.64 49.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.634 2.222 . . . . 0.0 112.396 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 57' ' ' ASN . 32.3 m -124.96 -11.92 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.111 0.964 . . . . 0.0 112.596 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.22 172.13 41.46 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -148.51 159.58 43.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.331 0.566 . . . . 0.0 110.479 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.18 140.47 45.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.539 1.136 . . . . 0.0 108.125 169.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.85 113.92 25.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 tp -149.9 138.57 20.82 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.571 0.7 . . . . 0.0 109.531 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.9 m -158.5 153.7 25.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.83 23.31 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -128.93 20.53 5.93 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.49 1.116 . . . . 0.0 111.382 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -123.46 103.64 8.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.535 0.734 . . . . 0.0 109.565 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.1 ttp -85.39 80.84 8.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.95 -32.51 63.9 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -172.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.53 157.09 43.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.241 0.616 . . . . 0.0 111.037 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -155.13 123.47 5.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.064 2.146 . . . . 0.0 105.418 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -145.46 141.82 28.7 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -149.37 146.69 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -60.06 122.15 64.1 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.45 -29.8 7.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.069 3.18 . . . . 0.0 114.665 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.06 -23.86 67.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.998 0.919 . . . . 0.0 113.392 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 m -117.86 -0.27 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 118.716 0.689 . . . . 0.0 112.669 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.35 -37.03 76.83 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.918 -1.114 . . . . 0.0 110.539 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.92 68.73 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.719 0.676 . . . . 0.0 113.004 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.3 m -74.96 -6.71 50.78 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.486 1.143 . . . . 0.0 112.119 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.85 14.18 63.4 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.841 -0.977 . . . . 0.0 113.345 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.21 -31.58 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.185 1.492 . . . . 0.0 110.996 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.12 -53.44 14.98 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.881 0.753 . . . . 0.0 111.838 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.47 -41.25 96.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.138 -1.41 . . . . 0.0 110.365 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.43 -46.52 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 120.693 1.588 . . . . 0.0 110.011 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.5 -41.91 83.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.963 -0.461 . . . . 0.0 110.602 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.63 -43.24 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 118.489 0.586 . . . . 0.0 110.407 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.58 -32.51 73.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.796 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -59.59 -49.07 79.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.131 0.423 . . . . 0.0 109.991 171.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.21 81.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.878 0.471 . . . . 0.0 111.265 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.67 -35.03 75.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.802 0.841 . . . . 0.0 111.356 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.28 -35.21 79.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.29 0.495 . . . . 0.0 111.523 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtm -87.78 -24.07 23.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.421 0.688 . . . . 0.0 112.062 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.43 96.18 5.32 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.55 1.54 . . . . 0.0 108.305 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -23.72 53.11 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.198 1.265 . . . . 0.0 112.084 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.68 28.35 4.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.754 1.622 . . . . 0.0 110.654 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.3 tp -51.84 144.24 11.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 112.906 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.2 p -129.17 159.4 36.17 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 108.811 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -153.42 -179.68 7.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.865 0.466 . . . . 0.0 110.271 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -138.26 160.0 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.088 1.355 . . . . 0.0 109.185 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.84 145.89 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -70.66 131.51 44.02 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.49 -32.74 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.96 0.904 . . . . 0.0 111.583 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -66.88 -30.27 70.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.015 0.526 . . . . 0.0 111.691 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -79.65 64.19 4.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 108.795 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.83 -25.97 44.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.565 1.146 . . . . 0.0 111.151 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -49.46 75.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.465 0.706 . . . . 0.0 109.864 176.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.81 76.14 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.775 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.02 -49.09 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.415 1.007 . . . . 0.0 108.471 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.81 -47.44 91.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -54.13 -52.08 62.2 Favored 'General case' 0 C--N 1.338 0.065 0 C-N-CA 123.976 0.911 . . . . 0.0 110.124 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.65 -34.39 76.85 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.775 -0.578 . . . . 0.0 109.975 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -60.03 -46.51 89.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.52 1.055 . . . . 0.0 110.806 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.1 -43.05 86.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.093 0.86 . . . . 0.0 110.427 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.41 -34.4 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.15 0.98 . . . . 0.0 110.963 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.41 10.04 1.73 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.282 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.17 158.04 26.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.726 1.763 . . . . 0.0 111.28 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -143.04 136.22 28.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.868 1.667 . . . . 0.0 106.606 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.63 134.94 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.909 0.883 . . . . 0.0 110.353 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -128.17 -9.45 5.32 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.927 2.091 . . . . 0.0 111.578 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.86 174.52 42.83 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 170.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -159.68 -173.66 4.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.722 0.761 . . . . 0.0 110.884 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 126.911 2.084 . . . . 0.0 108.315 172.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 N-CA-C 115.684 1.378 . . . . 0.0 115.684 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 tp -110.04 151.02 27.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.528 1.931 . . . . 0.0 107.141 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.35 151.63 32.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -119.86 139.62 52.1 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.756 1.222 . . . . 0.0 107.844 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.75 161.56 36.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.706 1.203 . . . . 0.0 108.529 -171.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.92 149.32 52.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 108.396 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -73.76 132.38 42.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.6 t . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 125.317 1.447 . . . . 0.0 109.912 176.384 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.26 144.52 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -141.92 165.78 26.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.56 142.99 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -151.21 173.52 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.636 0.774 . . . . 0.0 110.167 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -65.73 148.75 51.25 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -73.94 146.45 43.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.242 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.16 131.88 35.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -33.32 70.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.399 0.545 . . . . 0.0 112.198 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.88 -16.66 60.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.513 0.725 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -86.85 -2.57 58.68 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.379 0.99 . . . . 0.0 111.217 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.59 -38.28 28.23 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.79 1.185 . . . . 0.0 114.186 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.91 -28.5 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.769 1.285 . . . . 0.0 111.818 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -69.11 -31.53 70.29 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.465 -0.772 . . . . 0.0 109.702 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.7 -38.86 64.73 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.8 -47.16 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.42 83.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.556 0.616 . . . . 0.0 111.721 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.2 mt -65.16 -50.87 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.406 1.082 . . . . 0.0 109.449 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -57.13 -46.89 82.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.702 0.683 . . . . 0.0 110.49 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.3 m -55.32 -52.76 62.43 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.745 1.218 . . . . 0.0 111.005 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -69.97 -29.17 66.22 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.473 -0.767 . . . . 0.0 112.041 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -63.07 -42.46 99.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.962 0.801 . . . . 0.0 110.117 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.9 t -70.27 -42.93 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -34.49 73.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.902 0.773 . . . . 0.0 112.306 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.74 -34.47 21.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.992 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -137.13 -0.14 2.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -130.67 22.57 5.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.403 1.456 . . . . 0.0 110.63 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.67 -10.89 14.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -169.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -29.8 65.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.942 1.297 . . . . 0.0 111.618 169.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.5 tp -53.22 125.35 17.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.125 2.17 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -53.09 140.0 26.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.01 1.324 . . . . 0.0 110.704 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.17 76.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.92 -49.87 64.18 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.48 -35.31 77.35 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 122.081 -0.387 . . . . 0.0 110.404 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -57.19 -44.65 83.8 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.5 m -64.69 -48.64 73.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.711 0.687 . . . . 0.0 110.145 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.17 -37.3 83.51 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.009 -0.432 . . . . 0.0 110.819 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.41 -51.27 69.46 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.258 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.59 -41.07 76.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.688 1.131 . . . . 0.0 110.659 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.74 -47.45 81.0 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.775 0.43 . . . . 0.0 111.824 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -36.59 72.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.949 0.34 . . . . 0.0 110.323 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 t -58.26 -48.69 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.257 1.823 . . . . 0.0 109.064 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -69.76 -10.33 57.95 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.095 -1.003 . . . . 0.0 112.639 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -99.5 5.94 46.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.79 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -136.06 -56.28 0.77 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.451 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.73 -39.34 75.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 120.643 1.565 . . . . 0.0 112.844 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -61.63 -15.51 42.29 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.065 1.844 . . . . 0.0 115.073 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -127.6 -14.24 5.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.45 1.477 . . . . 0.0 112.852 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.85 153.39 88.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.128 1.371 . . . . 0.0 111.475 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -77.54 62.51 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.743 3.629 . . . . 0.0 110.972 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.18 176.74 7.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.098 1.359 . . . . 0.0 111.462 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.02 150.84 50.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.124 2.57 . . . . 0.0 104.868 168.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.69 140.48 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 123.942 0.897 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.36 132.7 35.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.88 142.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -82.87 -177.26 6.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.442 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -49.74 -24.27 2.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.488 1.915 . . . . 0.0 114.488 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -84.41 2.19 41.84 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t0 50.46 58.21 5.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 123.512 1.625 . . . . 0.0 108.77 -169.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.08 124.52 15.35 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.48 138.63 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.65 2.233 . . . . 0.0 109.727 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.36 -12.11 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.27 1.028 . . . . 0.0 112.289 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.03 170.15 40.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.83 159.01 43.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.027 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -140.8 126.78 19.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.302 2.241 . . . . 0.0 105.717 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.7 tp -105.27 124.65 49.9 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -145.95 139.67 26.36 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -153.44 154.57 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.79 5.87 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -132.27 29.07 4.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.609 1.164 . . . . 0.0 110.455 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -125.5 112.03 15.75 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.425 -0.797 . . . . 0.0 110.601 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.5 ttp -85.09 86.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.48 -28.91 70.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.45 144.58 31.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.008 0.523 . . . . 0.0 110.217 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 tp -153.66 114.58 4.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -142.36 141.05 32.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.5 mt -148.43 145.43 18.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -58.23 122.24 57.6 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.154 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.2 -29.81 7.05 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.192 3.262 . . . . 0.0 114.723 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.74 -23.41 67.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.122 0.969 . . . . 0.0 113.537 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.45 2.73 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.788 0.722 . . . . 0.0 112.827 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -58.99 -37.6 77.21 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.897 -1.127 . . . . 0.0 110.506 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.99 -25.59 69.51 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.71 0.671 . . . . 0.0 113.039 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.9 m -74.79 -7.34 53.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.515 1.158 . . . . 0.0 112.03 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.91 13.97 63.62 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.335 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.72 -31.69 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.288 1.544 . . . . 0.0 110.925 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.47 -52.85 18.13 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 123.819 0.723 . . . . 0.0 111.754 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -62.94 -42.38 99.79 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.356 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 t -58.55 -46.29 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.055 1.298 . . . . 0.0 109.82 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.9 mt -70.4 -39.33 74.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.215 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.15 -40.69 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.83 0.741 . . . . 0.0 109.925 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.04 -37.7 88.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.195 0.907 . . . . 0.0 109.71 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -61.05 -47.94 84.05 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.819 0.448 . . . . 0.0 110.439 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.93 -49.07 77.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.583 0.753 . . . . 0.0 110.739 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -60.09 -33.06 71.57 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.401 1.08 . . . . 0.0 111.734 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.5 -32.71 73.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.475 0.58 . . . . 0.0 111.625 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -90.06 -24.82 21.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.435 0.561 . . . . 0.0 112.074 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.06 93.35 9.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.287 1.435 . . . . 0.0 108.713 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.46 -23.39 50.68 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.342 1.361 . . . . 0.0 112.654 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.61 30.39 4.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.67 1.588 . . . . 0.0 110.219 -174.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.3 tp -51.42 145.76 8.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.195 2.198 . . . . 0.0 113.185 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -128.53 163.9 23.97 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.511 1.524 . . . . 0.0 108.912 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -153.75 -175.15 5.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 110.149 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -146.75 161.12 41.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.158 0.983 . . . . 0.0 109.824 172.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.0 p -156.21 149.06 11.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -80.04 129.72 34.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.2 -27.01 53.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.806 2.043 . . . . 0.0 111.974 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . 0.251 1.2 pt20 -51.48 -33.36 31.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.113 0.965 . . . . 0.0 112.651 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -105.71 69.51 0.83 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.132 1.373 . . . . 0.0 109.621 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.76 -23.99 32.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.894 0.877 . . . . 0.0 111.987 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -63.43 -43.93 96.04 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.454 0.702 . . . . 0.0 109.662 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.669 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.03 -45.81 84.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 119.206 0.912 . . . . 0.0 108.945 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.25 59.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.05 -50.73 66.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 117.811 0.805 . . . . 0.0 110.601 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.22 -39.07 93.58 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.84 -33.94 76.29 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.631 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.85 -40.24 94.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.022 1.283 . . . . 0.0 110.919 174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.8 -39.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.9 11.81 0.69 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-O 118.825 -0.986 . . . . 0.0 114.112 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -72.97 160.83 31.49 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.635 1.718 . . . . 0.0 111.189 172.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -149.72 141.18 23.34 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.884 1.674 . . . . 0.0 106.884 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.43 133.05 32.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.972 0.909 . . . . 0.0 109.436 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 p -127.11 -8.1 5.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.671 1.989 . . . . 0.0 111.492 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.82 170.71 40.73 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 111.761 171.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -142.62 164.53 29.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.815 1.246 . . . . 0.0 111.279 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.141 169.197 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.458 -0.602 0 N-CA-C 115.625 1.356 . . . . 0.0 115.625 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.45 145.56 26.08 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.0 mt -114.68 144.66 43.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -113.91 139.09 49.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.99 161.54 35.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -134.07 147.52 50.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.673 1.589 . . . . 0.0 108.292 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -75.8 125.91 29.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 111.389 -178.418 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -136.48 141.16 41.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.354 1.061 . . . . 0.0 108.232 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -141.63 163.38 33.09 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -124.64 144.25 35.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -150.46 170.98 17.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.414 1.086 . . . . 0.0 109.272 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -65.35 148.69 51.27 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 m -72.73 152.48 41.62 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.049 0.94 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -98.24 164.09 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 107.919 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -66.99 -39.4 87.14 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.158 -0.339 . . . . 0.0 111.048 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.99 -26.78 66.08 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.72 -0.32 56.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.212 0.46 . . . . 0.0 112.073 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.45 27.67 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.014 0.816 . . . . 0.0 113.455 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.35 -27.18 67.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.261 1.031 . . . . 0.0 112.119 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -68.04 -33.08 73.9 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.394 -0.816 . . . . 0.0 109.572 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.56 -38.54 62.68 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.03 -46.6 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.78 98.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.374 0.67 . . . . 0.0 112.076 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.6 mt -65.41 -49.7 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.285 1.034 . . . . 0.0 109.574 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -52.02 -48.45 64.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.96 0.504 . . . . 0.0 110.004 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 t -61.18 -50.83 71.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.036 0.534 . . . . 0.0 110.16 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -67.63 -28.78 68.02 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.956 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -68.39 -35.87 78.31 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.511 1.05 . . . . 0.0 110.689 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.88 -43.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.28 -26.88 63.07 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 113.345 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.28 16.56 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.984 0.914 . . . . 0.0 111.931 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -133.42 -7.14 2.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -169.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.3 30.26 5.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.225 1.375 . . . . 0.0 109.512 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.51 -18.16 50.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -51.22 -27.37 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.306 1.842 . . . . 0.0 112.303 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 102.89 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.087 1.755 . . . . 0.0 108.912 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -57.02 149.08 19.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.078 1.751 . . . . 0.0 112.546 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.54 70.69 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.61 -45.76 85.5 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.915 -0.491 . . . . 0.0 109.83 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.81 -32.95 62.12 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.944 -0.472 . . . . 0.0 110.241 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -53.94 -43.0 69.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.144 0.977 . . . . 0.0 110.235 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.6 m -62.31 -50.68 70.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.504 1.121 . . . . 0.0 110.153 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -65.03 -39.31 93.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.445 0.298 . . . . 0.0 110.373 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.27 -53.13 59.56 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.462 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -57.08 -39.99 76.05 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.683 1.129 . . . . 0.0 110.484 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.34 -48.92 73.73 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.124 0.569 . . . . 0.0 112.012 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -36.76 75.11 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.076 0.398 . . . . 0.0 110.296 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -58.64 -48.63 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 126.29 1.836 . . . . 0.0 109.023 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.54 -11.59 60.95 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.978 -1.076 . . . . 0.0 112.679 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -97.17 5.64 49.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.742 0.817 . . . . 0.0 110.652 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.4 -54.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.86 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.61 -38.65 69.8 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 120.674 1.579 . . . . 0.0 112.938 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.23 -13.34 31.66 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.407 2.072 . . . . 0.0 115.02 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -125.82 -20.71 4.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.946 1.703 . . . . 0.0 112.393 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.19 148.72 97.72 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.516 1.127 . . . . 0.0 110.69 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.17 45.51 1.99 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.727 3.618 . . . . 0.0 112.091 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.81 171.05 4.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.457 1.503 . . . . 0.0 112.187 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -119.44 148.52 43.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.541 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.67 137.69 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.351 1.06 . . . . 0.0 110.122 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.41 133.99 35.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.63 145.4 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -88.03 -171.67 3.49 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.479 169.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.73 -23.57 29.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.926 1.29 . . . . 0.0 113.47 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -82.93 5.33 22.28 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.679 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 53.9 30.47 11.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.934 1.693 . . . . 0.0 111.112 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.49 128.06 27.73 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 126.927 2.091 . . . . 0.0 106.22 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.62 136.19 35.44 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.727 1.618 . . . . 0.0 109.52 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.15 -14.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.354 1.062 . . . . 0.0 111.185 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.72 170.81 42.99 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.14 160.28 40.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.741 0.816 . . . . 0.0 111.257 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -139.83 132.23 28.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.574 2.35 . . . . 0.0 105.967 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.0 tp -112.19 124.2 51.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.74 133.02 23.17 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 m -142.23 150.7 41.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.08 -113.64 4.24 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.4 29.75 4.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.781 1.232 . . . . 0.0 110.596 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -126.82 111.87 14.69 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.591 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.2 ttp -82.74 88.81 6.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.06 -29.52 69.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.68 145.43 32.44 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.851 0.46 . . . . 0.0 110.667 -172.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.72 115.55 3.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.11 139.4 28.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.8 mt -150.02 144.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -170.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.29 123.61 76.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 108.826 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.8 -19.08 66.44 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.005 2.47 . . . . 0.0 113.832 -171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.5 -21.06 63.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.801 1.182 . . . . 0.0 112.299 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.68 3.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.807 0.843 . . . . 0.0 112.841 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.24 -29.86 58.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.122 -0.986 . . . . 0.0 111.756 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.85 -21.0 50.62 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.316 0.96 . . . . 0.0 113.823 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 66.8 m -73.74 -3.77 30.44 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.023 1.412 . . . . 0.0 112.266 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.01 12.96 75.76 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.276 0.941 . . . . 0.0 112.869 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.85 -33.03 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.485 1.143 . . . . 0.0 111.579 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.53 -50.52 47.96 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -38.7 88.65 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.295 1.047 . . . . 0.0 109.87 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -58.43 -49.59 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.624 1.102 . . . . 0.0 109.916 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.1 mt -67.76 -39.35 84.18 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.849 -0.532 . . . . 0.0 110.707 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.93 -39.74 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.933 -0.556 . . . . 0.0 109.8 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.67 -35.66 81.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.789 1.177 . . . . 0.0 110.388 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -61.23 -45.72 93.37 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.195 0.452 . . . . 0.0 110.3 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.17 74.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.846 0.858 . . . . 0.0 110.744 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.3 -33.29 69.29 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.77 1.228 . . . . 0.0 111.697 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.39 -31.9 72.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.361 0.528 . . . . 0.0 111.637 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 mtm -90.39 -25.51 20.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.157 0.583 . . . . 0.0 112.091 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.97 91.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 125.276 1.43 . . . . 0.0 108.863 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.09 -23.25 53.59 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.362 1.375 . . . . 0.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.48 29.46 4.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.595 1.558 . . . . 0.0 110.444 -174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.37 145.37 8.49 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.03 2.132 . . . . 0.0 113.327 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.9 p -128.03 164.77 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.545 1.538 . . . . 0.0 108.937 170.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.1 t -154.99 -174.15 4.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 110.354 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -146.96 161.97 39.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 109.799 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.4 p -156.13 146.22 12.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.59 133.93 47.16 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.0 -36.17 83.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 112.514 -172.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -35.5 77.42 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.196 0.907 . . . . 0.0 110.914 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.49 70.51 7.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.617 0.722 . . . . 0.0 111.037 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.43 -23.04 35.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.756 0.822 . . . . 0.0 112.074 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -63.61 -45.66 89.31 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.794 0.724 . . . . 0.0 109.593 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.11 -34.58 75.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.878 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.26 -46.06 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.374 0.988 . . . . 0.0 108.895 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.4 -48.16 84.26 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.649 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -54.18 -51.94 62.77 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.128 0.971 . . . . 0.0 110.144 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -64.94 -36.67 85.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -64.36 -40.82 96.6 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.063 -1.023 . . . . 0.0 112.718 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.75 -42.87 89.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.742 1.155 . . . . 0.0 110.255 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.31 -35.19 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.67 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.89 7.82 1.31 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.701 1.143 . . . . 0.0 114.904 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -77.1 164.78 25.38 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.132 1.966 . . . . 0.0 111.72 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -147.59 139.58 24.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.414 1.885 . . . . 0.0 106.218 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.0 t -72.88 132.98 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.23 -10.05 7.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.728 2.011 . . . . 0.0 111.417 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.87 178.99 42.5 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.786 0.721 . . . . 0.0 111.44 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -155.82 -178.02 6.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.129 0.971 . . . . 0.0 109.214 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.325 -0.479 0 C-N-CA 125.144 1.378 . . . . 0.0 108.892 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 N--CA 1.46 -0.486 0 N-CA-C 118.223 2.355 . . . . 0.0 118.223 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.56 144.49 36.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.1 151.55 27.09 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -119.63 139.52 52.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.23 160.78 38.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.852 0.861 . . . . 0.0 108.733 -172.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.7 149.95 51.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.555 1.542 . . . . 0.0 108.575 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.44 133.89 39.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.97 178.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -135.96 146.4 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.899 1.28 . . . . 0.0 107.603 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -142.92 165.03 28.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 mm -121.67 142.46 37.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -150.19 172.8 14.73 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.876 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -65.5 147.77 52.85 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -73.89 146.74 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.004 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -84.8 160.21 20.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -66.87 -45.48 77.96 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.232 -0.293 . . . . 0.0 110.283 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.34 -28.54 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -83.07 0.93 42.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.915 0.486 . . . . 0.0 111.387 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.07 -45.19 33.37 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.298 0.951 . . . . 0.0 113.617 -176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.69 -21.83 63.47 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.499 1.15 . . . . 0.0 112.565 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -66.29 -33.33 75.5 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.757 1.162 . . . . 0.0 109.564 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.87 -39.49 56.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.45 -45.52 85.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.54 -44.71 95.67 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.142 0.577 . . . . 0.0 111.336 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.86 -52.56 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.47 1.108 . . . . 0.0 108.607 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -53.03 -48.79 67.33 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.589 0.756 . . . . 0.0 110.149 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.8 t -60.16 -50.17 74.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.283 0.633 . . . . 0.0 110.434 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -72.85 -31.39 64.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.154 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -61.19 -43.75 98.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.458 1.026 . . . . 0.0 110.372 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.39 -48.48 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.901 0.88 . . . . 0.0 109.053 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.02 -32.94 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 112.269 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.99 58.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.29 1.036 . . . . 0.0 113.341 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -134.81 -25.55 1.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -169.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.444 ' CD2' HD21 ' A' ' 110' ' ' ASN . 38.5 m-70 -104.09 35.84 2.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.846 1.258 . . . . 0.0 108.476 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.4 -26.81 63.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.805 -1.184 . . . . 0.0 112.428 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -56.49 -24.14 44.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.288 2.235 . . . . 0.0 113.515 173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.79 109.4 1.72 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.012 1.325 . . . . 0.0 107.934 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -58.1 141.84 48.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 111.173 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.72 65.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.932 0.893 . . . . 0.0 113.006 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.57 -45.0 96.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.389 0.676 . . . . 0.0 109.907 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -77.9 -29.09 50.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.531 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -56.74 -42.9 80.08 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.491 1.496 . . . . 0.0 110.318 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -63.93 -49.61 71.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.859 0.864 . . . . 0.0 109.862 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -67.33 -36.11 80.78 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.017 -0.427 . . . . 0.0 110.986 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.0 mt -63.52 -49.63 72.75 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.446 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.91 -42.24 75.73 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 119.957 1.253 . . . . 0.0 109.769 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.85 -48.34 82.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.584 1.084 . . . . 0.0 112.446 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.52 74.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.81 -44.43 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.185 1.794 . . . . 0.0 110.117 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -62.94 -24.02 67.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.602 1.161 . . . . 0.0 111.134 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -97.93 7.79 45.79 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.549 1.14 . . . . 0.0 110.662 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -138.12 -59.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.547 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.6 -36.52 46.47 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 121.228 1.831 . . . . 0.0 113.113 -175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 -15.03 34.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 121.942 1.762 . . . . 0.0 115.419 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.61 -11.79 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.938 1.699 . . . . 0.0 113.455 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.8 154.85 88.02 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.408 1.483 . . . . 0.0 111.988 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.86 60.67 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.961 3.774 . . . . 0.0 111.733 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -87.24 172.99 9.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.434 1.893 . . . . 0.0 112.213 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -135.2 145.83 48.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.14 140.21 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.825 0.85 . . . . 0.0 110.41 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.88 134.42 35.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.31 144.09 38.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -83.77 -172.95 4.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -55.2 -24.36 26.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.033 1.333 . . . . 0.0 113.311 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -84.2 0.8 47.34 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.479 1.111 . . . . 0.0 111.831 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t0 52.24 53.87 11.7 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.013 1.387 . . . . 0.0 109.524 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.05 125.28 22.75 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.71 134.25 37.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.545 2.163 . . . . 0.0 110.881 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.39 -11.46 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.192 0.997 . . . . 0.0 111.981 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.65 169.25 41.94 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -139.79 160.92 38.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.709 0.754 . . . . 0.0 111.603 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -139.85 131.34 27.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.593 2.357 . . . . 0.0 105.949 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.84 116.46 28.04 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -144.04 132.97 22.68 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.4 m -141.97 152.97 43.96 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.8 -118.62 11.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -129.28 30.94 4.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.159 0.984 . . . . 0.0 111.022 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -122.87 112.74 18.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.253 0.621 . . . . 0.0 110.153 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -85.1 90.75 7.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.68 -26.42 67.78 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.32 144.99 30.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.043 0.537 . . . . 0.0 110.734 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -153.54 119.4 5.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -145.09 143.23 30.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -143.96 143.66 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -54.31 120.95 28.7 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.088 1.755 . . . . 0.0 109.407 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.03 -24.89 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.215 3.277 . . . . 0.0 114.919 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.11 -26.97 68.03 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.57 9.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.429 . . . . 0.0 112.54 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.88 -34.83 63.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.667 -1.271 . . . . 0.0 112.392 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.17 -13.59 81.73 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.165 -0.797 . . . . 0.0 113.244 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.14 173.68 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 0.0 110.08 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.51 -11.09 39.78 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.959 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -51.47 -34.42 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.601 1.701 . . . . 0.0 112.01 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.42 -54.64 19.59 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -65.54 -40.37 92.81 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.455 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.66 -48.39 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 121.186 1.812 . . . . 0.0 109.977 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -68.05 -40.99 82.68 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.973 -0.455 . . . . 0.0 110.701 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.296 0.498 . . . . 0.0 110.205 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.52 -34.07 75.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.325 0.966 . . . . 0.0 110.1 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.6 -46.33 90.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.338 0.517 . . . . 0.0 110.198 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.94 72.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.377 0.671 . . . . 0.0 110.822 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -58.77 -33.34 70.19 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.359 1.064 . . . . 0.0 111.734 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.1 m -62.95 -35.45 80.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.585 0.63 . . . . 0.0 111.503 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.41 -26.46 26.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.26 0.482 . . . . 0.0 111.86 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 89.91 12.08 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 125.101 1.36 . . . . 0.0 109.294 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.47 -22.78 58.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.468 1.446 . . . . 0.0 113.059 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.02 31.49 4.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.441 1.496 . . . . 0.0 110.095 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -50.3 143.99 7.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.232 2.213 . . . . 0.0 112.9 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.7 p -129.62 163.25 26.45 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.404 1.482 . . . . 0.0 108.778 171.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -154.78 -174.46 4.99 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.166 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.57 161.45 41.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 110.018 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.7 p -157.17 145.44 10.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.0 129.29 39.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -58.39 -30.88 67.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.18 1.392 . . . . 0.0 111.941 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.51 -35.28 78.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.203 0.456 . . . . 0.0 111.224 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.444 HD21 ' CD2' ' A' ' 28' ' ' HIS . 61.6 t-20 -78.6 63.8 3.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.039 1.336 . . . . 0.0 109.882 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.74 -26.8 47.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 111.394 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -45.25 94.3 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.94 73.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.88 -45.96 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.396 0.998 . . . . 0.0 108.828 171.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.8 83.07 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.58 -51.59 64.8 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.022 0.911 . . . . 0.0 110.379 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.53 -35.02 79.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -64.91 -38.95 92.66 Favored 'General case' 0 C--N 1.341 0.205 0 O-C-N 120.916 -1.115 . . . . 0.0 112.632 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.28 -41.37 88.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.956 1.253 . . . . 0.0 110.329 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.78 -39.36 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.794 . . . . 0.0 110.309 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.41 5.18 0.98 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.542 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.99 162.92 28.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.355 1.577 . . . . 0.0 111.169 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.77 140.01 25.53 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.11 129.31 36.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.984 0.914 . . . . 0.0 109.16 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 p -119.54 -9.88 9.74 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.599 1.959 . . . . 0.0 111.397 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -170.87 -179.29 42.01 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 171.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.31 179.08 8.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.679 0.792 . . . . 0.0 109.271 170.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 0.0 106.893 -179.883 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 CA--C 1.536 0.613 0 N-CA-C 119.09 2.689 . . . . 0.0 119.09 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.0 tp -102.18 147.62 26.42 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.9 mt -110.85 150.49 29.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -116.88 139.08 51.04 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.94 160.57 38.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.3 150.56 52.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.431 1.492 . . . . 0.0 108.195 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -75.12 128.26 35.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 124.664 1.186 . . . . 0.0 109.925 -178.145 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 mm -132.96 144.34 36.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.621 0.768 . . . . 0.0 109.348 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -141.6 164.49 30.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 mm -124.33 143.77 36.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -151.91 172.39 16.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.68 1.192 . . . . 0.0 109.162 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -66.68 149.82 49.96 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -71.34 154.11 41.83 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.482 1.113 . . . . 0.0 111.721 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -97.66 163.68 12.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.816 1.646 . . . . 0.0 108.258 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -69.17 -48.31 62.6 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.282 -0.261 . . . . 0.0 110.742 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.52 -28.62 67.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.79 -1.91 40.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.86 -38.19 37.04 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.25 0.929 . . . . 0.0 113.503 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.76 -28.44 67.62 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.58 1.19 . . . . 0.0 111.919 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.4 -30.73 69.71 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.89 -39.36 61.54 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -56.88 -45.64 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.34 98.01 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.884 0.474 . . . . 0.0 111.884 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mt -62.41 -48.45 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.345 0.658 . . . . 0.0 109.678 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -54.49 -48.42 71.88 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -59.29 -42.08 90.46 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.866 -0.521 . . . . 0.0 110.596 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -62.63 -39.79 94.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.47 1.108 . . . . 0.0 111.718 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -65.78 -36.52 83.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.572 0.749 . . . . 0.0 109.969 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.59 -45.81 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.254 -0.903 . . . . 0.0 109.127 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.26 -33.8 65.8 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.948 1.299 . . . . 0.0 113.004 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.11 -29.48 12.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -139.28 0.6 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -168.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -135.17 25.79 3.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.429 1.468 . . . . 0.0 110.963 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.58 -12.8 17.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.874 -1.141 . . . . 0.0 113.196 -174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -56.21 -20.34 17.74 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.325 1.85 . . . . 0.0 112.904 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.94 101.84 0.42 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.08 1.352 . . . . 0.0 108.8 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -56.69 157.71 5.18 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.342 1.457 . . . . 0.0 110.729 170.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 -37.9 63.59 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.88 -49.75 64.66 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.905 0.775 . . . . 0.0 109.701 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -63.72 -40.19 96.13 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.233 1.013 . . . . 0.0 109.956 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -55.58 -50.23 70.64 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.838 1.255 . . . . 0.0 109.614 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.1 m -64.1 -48.33 76.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.303 1.041 . . . . 0.0 110.274 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.46 -41.31 93.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.188 0.449 . . . . 0.0 110.723 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.99 -50.53 65.95 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.595 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.36 -41.94 76.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.061 0.846 . . . . 0.0 110.684 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.34 -44.51 83.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.452 0.701 . . . . 0.0 112.225 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.32 -38.24 74.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -56.8 -49.41 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.493 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -58.39 -24.27 59.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.646 1.178 . . . . 0.0 111.674 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -101.46 6.49 42.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.179 0.992 . . . . 0.0 110.959 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -136.89 -52.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.306 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -58.36 -37.89 59.78 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.265 1.393 . . . . 0.0 113.001 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -63.42 -14.01 39.68 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.129 1.886 . . . . 0.0 115.426 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -127.98 -19.01 4.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.042 1.746 . . . . 0.0 112.463 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.38 148.43 96.17 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.256 1.022 . . . . 0.0 110.416 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.43 43.74 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.748 3.632 . . . . 0.0 112.102 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.83 169.96 7.27 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.52 1.528 . . . . 0.0 112.07 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -113.27 149.54 33.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 138.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 110.238 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.93 132.35 35.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.64 141.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.59 -179.51 7.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.342 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -51.26 -25.67 6.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.594 1.558 . . . . 0.0 114.22 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -79.39 0.14 30.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.171 0.989 . . . . 0.0 111.773 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t0 52.01 56.97 7.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 123.34 1.543 . . . . 0.0 109.216 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -136.95 126.75 15.72 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.8 137.3 38.0 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.904 2.403 . . . . 0.0 111.695 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.6 m -113.82 -21.36 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.115 0.966 . . . . 0.0 111.68 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.84 170.61 39.2 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -141.44 157.43 45.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.855 0.862 . . . . 0.0 110.686 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -141.38 134.29 28.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.788 2.035 . . . . 0.0 106.668 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 tp -115.91 118.2 32.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 173.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.8 tp -142.07 133.49 26.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.215 1.006 . . . . 0.0 108.298 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -143.45 153.87 43.09 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.25 -119.48 13.58 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.52 37.12 4.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.194 0.998 . . . . 0.0 110.478 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -127.27 109.1 11.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.824 0.85 . . . . 0.0 110.066 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -85.45 97.41 10.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.47 -31.73 67.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.9 23.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.689 0.796 . . . . 0.0 110.282 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 tp -148.08 122.85 9.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 173.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.38 142.63 30.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 mt -148.55 144.37 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -61.07 115.33 13.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.19 -15.03 26.59 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.785 2.323 . . . . 0.0 114.364 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.83 -24.37 67.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.821 0.737 . . . . 0.0 112.554 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.32 -9.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 112.928 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -47.24 -46.43 24.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.581 1.152 . . . . 0.0 111.237 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.26 -14.52 71.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.884 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 72.0 m -68.91 -14.39 63.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.246 1.523 . . . . 0.0 112.062 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.52 -7.76 7.9 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.309 0.956 . . . . 0.0 112.589 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.73 -31.52 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.744 1.272 . . . . 0.0 111.059 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.74 -50.45 37.2 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.573 0.606 . . . . 0.0 111.895 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.22 -46.83 79.07 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.842 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.71 -49.28 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.646 1.112 . . . . 0.0 110.288 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.24 -36.81 74.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.118 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.98 -40.56 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.03 0.832 . . . . 0.0 109.789 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.67 -36.11 83.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.409 1.004 . . . . 0.0 110.02 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -61.5 -48.24 81.97 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.871 0.469 . . . . 0.0 110.3 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.59 76.03 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.511 0.724 . . . . 0.0 110.87 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.67 -33.37 70.04 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.697 1.199 . . . . 0.0 111.696 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -62.84 -35.03 78.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.583 0.629 . . . . 0.0 111.465 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.8 mtm -86.13 -24.39 26.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.381 0.537 . . . . 0.0 112.013 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.77 91.05 9.42 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.866 1.266 . . . . 0.0 109.899 -171.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.65 -23.86 48.74 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.341 1.361 . . . . 0.0 113.273 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -103.39 30.92 4.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.428 1.491 . . . . 0.0 110.292 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.3 tp -50.86 146.57 5.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.559 2.343 . . . . 0.0 113.673 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.7 p -128.32 162.23 27.55 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 108.92 169.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -155.31 -179.29 7.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.788 0.435 . . . . 0.0 111.108 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -137.19 155.14 49.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.3 p -155.41 148.61 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -74.54 134.09 42.22 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.88 -35.31 68.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.682 1.193 . . . . 0.0 112.069 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -64.11 -29.69 70.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.415 0.552 . . . . 0.0 111.873 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -79.78 65.81 5.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.69 -25.68 60.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.746 0.818 . . . . 0.0 111.342 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.58 -47.71 82.63 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.006 0.522 . . . . 0.0 109.897 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.85 80.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.592 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.0 -46.28 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 119.179 0.9 . . . . 0.0 108.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.18 -49.88 67.64 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -55.25 -49.76 71.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.932 0.893 . . . . 0.0 110.524 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.45 -36.1 81.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.56 -39.23 93.37 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.83 -1.169 . . . . 0.0 112.526 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.32 -42.94 92.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.863 1.21 . . . . 0.0 110.218 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.68 -34.32 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.847 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.53 7.53 1.88 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.394 0.997 . . . . 0.0 114.361 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -73.39 166.39 23.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.779 1.79 . . . . 0.0 111.518 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -143.42 140.57 30.48 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.142 2.177 . . . . 0.0 105.969 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.3 t -72.44 129.54 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.6 p -130.85 -6.64 4.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.054 1.742 . . . . 0.0 111.338 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.34 178.57 38.08 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -157.78 -172.33 3.9 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.733 0.813 . . . . 0.0 109.918 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.315 1.846 . . . . 0.0 108.94 176.046 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo . . . . . 0 N--CA 1.458 -0.562 0 N-CA-C 118.829 2.588 . . . . 0.0 118.829 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -97.45 149.42 22.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.0 mt -116.64 152.92 33.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.99 139.78 52.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.704 1.202 . . . . 0.0 107.874 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.35 157.71 46.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -170.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.34 150.87 52.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.988 1.315 . . . . 0.0 108.41 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.13 130.69 37.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.486 1.515 . . . . 0.0 109.823 -176.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -138.63 144.98 28.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.636 1.174 . . . . 0.0 107.848 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -141.68 165.03 28.6 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 mm -127.06 144.06 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -154.24 169.99 22.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.13 1.372 . . . . 0.0 109.037 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -68.35 156.8 37.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -83.48 151.78 25.27 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.531 1.532 . . . . 0.0 112.103 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -84.72 161.11 20.16 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 168.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -70.61 -43.44 69.31 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.995 -0.441 . . . . 0.0 110.739 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.87 -28.31 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.07 -0.98 42.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.872 0.469 . . . . 0.0 111.621 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.84 52.58 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.02 0.827 . . . . 0.0 112.678 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -60.51 -34.04 73.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.418 1.109 . . . . 0.0 111.547 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -71.61 -32.68 68.26 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.261 0.624 . . . . 0.0 109.982 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.41 -39.88 67.59 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.768 -0.582 . . . . 0.0 109.437 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.62 -43.99 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.407 1.083 . . . . 0.0 109.231 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.54 89.47 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.048 0.539 . . . . 0.0 111.298 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.9 mt -58.46 -50.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.485 1.114 . . . . 0.0 109.167 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -53.35 -47.26 69.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.307 0.643 . . . . 0.0 110.299 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.8 t -60.05 -50.81 72.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.534 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -69.75 -29.75 67.18 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.44 -0.788 . . . . 0.0 112.281 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -63.23 -34.95 78.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.636 0.653 . . . . 0.0 110.909 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.99 -44.21 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.67 -35.36 72.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.766 0.712 . . . . 0.0 112.326 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -44.88 17.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.787 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 p -131.79 -2.12 3.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -168.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -129.5 26.45 5.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.57 1.077 . . . . 0.0 110.502 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.89 -15.76 34.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.969 0.908 . . . . 0.0 113.246 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -55.51 -18.7 7.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.895 2.078 . . . . 0.0 112.955 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.09 99.54 0.67 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -53.53 152.6 4.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.331 1.852 . . . . 0.0 111.162 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.38 68.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.26 -49.0 68.65 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.698 -0.626 . . . . 0.0 109.513 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -66.74 -36.53 82.66 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.126 -0.359 . . . . 0.0 110.574 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.55 -47.31 73.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.82 1.248 . . . . 0.0 109.839 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.4 m -65.03 -49.4 70.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.221 1.008 . . . . 0.0 110.053 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -65.12 -39.85 93.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.508 0.323 . . . . 0.0 110.631 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 mt -63.03 -52.0 64.58 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.308 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.91 -40.53 73.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.569 1.077 . . . . 0.0 110.592 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.59 -49.32 73.81 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.094 0.558 . . . . 0.0 111.954 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -37.44 76.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.998 0.363 . . . . 0.0 110.065 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.64 -48.85 84.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.412 1.885 . . . . 0.0 109.161 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -69.58 -11.67 61.02 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.241 -0.912 . . . . 0.0 112.304 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -99.03 6.09 46.78 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.098 0.959 . . . . 0.0 110.818 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.98 -53.98 0.71 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.744 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.36 -38.03 63.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.73 1.605 . . . . 0.0 112.948 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.67 -14.25 34.8 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.378 2.052 . . . . 0.0 115.223 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.55 -20.01 5.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.591 1.541 . . . . 0.0 112.03 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.19 146.49 97.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.437 1.095 . . . . 0.0 110.107 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.17 46.27 2.19 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.325 3.35 . . . . 0.0 111.421 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.67 157.28 30.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.948 -1.095 . . . . 0.0 110.154 -172.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -101.06 144.35 30.08 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.84 136.7 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.684 0.794 . . . . 0.0 110.166 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 168.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.46 141.51 45.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.437 ' ND2' HH21 ' A' ' 59' ' ' ARG . 20.1 p30 -82.22 -178.12 6.91 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.135 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -54.85 -23.78 20.06 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.441 1.497 . . . . 0.0 113.712 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.437 HH21 ' ND2' ' A' ' 57' ' ' ASN . 84.4 mtm180 -78.14 -1.83 34.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.345 1.058 . . . . 0.0 111.685 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 t0 52.19 58.31 5.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.577 1.656 . . . . 0.0 108.967 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -139.13 127.95 13.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 140.85 47.94 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.956 2.437 . . . . 0.0 112.527 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.424 ' CG1' HD21 ' A' ' 57' ' ' ASN . 27.2 m -118.94 -15.79 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.373 1.069 . . . . 0.0 112.294 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.71 168.81 40.38 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -141.7 156.33 45.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.347 0.659 . . . . 0.0 110.749 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.39 141.21 39.62 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.356 1.062 . . . . 0.0 108.522 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.56 117.98 31.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -148.88 134.99 19.18 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.125 0.875 . . . . 0.0 109.798 171.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.5 m -152.66 151.5 30.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 167.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.56 -122.9 26.0 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -129.67 22.16 5.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.517 1.127 . . . . 0.0 111.482 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -123.35 104.8 9.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.679 0.792 . . . . 0.0 109.548 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -83.21 82.0 8.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.18 -32.6 62.3 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.98 157.06 42.41 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 tp -154.94 126.44 7.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.916 2.086 . . . . 0.0 106.508 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.73 144.44 29.42 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.062 1.345 . . . . 0.0 107.959 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -149.9 146.01 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -53.48 116.51 9.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.702 1.201 . . . . 0.0 108.84 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.54 -18.65 60.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.317 2.678 . . . . 0.0 113.352 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.92 -20.86 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.222 0.919 . . . . 0.0 112.423 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.46 4.16 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.56 -45.31 66.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.065 -1.022 . . . . 0.0 110.469 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.49 -19.13 68.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.225 0.917 . . . . 0.0 113.632 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.81 -16.51 63.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.052 1.426 . . . . 0.0 111.749 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.99 -15.05 5.91 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.263 0.935 . . . . 0.0 112.637 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.15 -31.96 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.997 1.399 . . . . 0.0 111.656 -171.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.87 36.16 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.614 1.102 . . . . 0.0 113.693 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.72 -42.88 8.52 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 116.933 -1.508 . . . . 0.0 110.08 169.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.73 -45.13 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.58 1.537 . . . . 0.0 111.215 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.77 -38.53 83.54 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.94 0.791 . . . . 0.0 111.517 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.55 -42.94 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -64.39 -34.62 78.6 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.794 -0.566 . . . . 0.0 109.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -60.38 -49.03 79.2 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.09 0.404 . . . . 0.0 110.042 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.24 86.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.09 -34.67 75.29 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.918 0.887 . . . . 0.0 111.404 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -63.44 -37.35 86.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.271 0.487 . . . . 0.0 111.331 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.3 mtm -85.65 -24.1 27.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.101 0.56 . . . . 0.0 112.272 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.99 96.55 5.46 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.482 1.513 . . . . 0.0 108.342 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.77 -23.9 47.8 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.149 1.233 . . . . 0.0 112.225 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.77 28.49 4.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.77 1.628 . . . . 0.0 110.602 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 tp -52.2 145.86 10.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.155 2.182 . . . . 0.0 113.438 -169.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -128.11 158.0 39.21 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.069 1.348 . . . . 0.0 107.842 169.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -153.28 -173.72 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.773 0.429 . . . . 0.0 109.905 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.75 162.18 36.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.686 1.194 . . . . 0.0 109.552 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.3 p -154.55 143.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.69 125.58 27.23 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.37 -36.36 73.36 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.853 0.461 . . . . 0.0 111.957 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.47 -32.34 71.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.809 0.444 . . . . 0.0 110.851 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -77.3 65.98 2.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.646 1.179 . . . . 0.0 109.189 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.22 -26.49 60.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.332 1.053 . . . . 0.0 111.113 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -45.92 92.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.253 0.621 . . . . 0.0 109.791 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.79 -34.21 73.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.936 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.69 -46.72 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.464 1.029 . . . . 0.0 108.791 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.04 -49.96 70.1 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -54.99 -50.57 68.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.667 0.787 . . . . 0.0 110.873 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.9 -34.92 78.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -65.84 -38.61 89.33 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 120.99 -1.068 . . . . 0.0 112.296 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.85 -42.84 90.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.909 1.231 . . . . 0.0 110.191 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.93 -34.27 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.299 1.04 . . . . 0.0 110.787 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.87 0.89 2.16 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.323 0.963 . . . . 0.0 114.853 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -72.93 161.76 30.31 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.466 1.633 . . . . 0.0 111.688 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 141.81 27.19 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.82 1.648 . . . . 0.0 106.609 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.9 t -72.02 132.47 33.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.327 1.051 . . . . 0.0 109.863 -172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.4 p -127.58 -8.81 5.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.754 2.022 . . . . 0.0 111.707 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.62 40.78 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -161.13 -174.84 4.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.919 0.86 . . . . 0.0 111.008 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 127.398 2.279 . . . . 0.0 107.121 169.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 115.71 1.388 . . . . 0.0 115.71 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.75 148.21 44.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.228 2.211 . . . . 0.0 106.268 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.8 mt -111.82 150.97 29.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -118.4 140.07 50.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.86 160.47 39.21 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.748 1.219 . . . . 0.0 108.399 -169.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.43 151.88 51.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.268 1.427 . . . . 0.0 108.781 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -80.54 72.61 7.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.832 0.825 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 123.681 0.792 . . . . 0.0 110.582 179.891 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 mm -133.36 144.71 35.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -141.34 165.04 28.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.98 142.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -154.01 170.98 19.8 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.044 0.938 . . . . 0.0 109.779 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -62.24 148.68 44.02 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 p -61.29 168.18 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.461 1.904 . . . . 0.0 113.166 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -118.93 157.89 26.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.356 1.862 . . . . 0.0 106.792 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.16 -43.33 74.49 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.915 -0.491 . . . . 0.0 110.842 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.11 -25.73 64.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -85.2 0.34 52.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.264 0.625 . . . . 0.0 111.533 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.81 -41.12 57.84 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.931 0.787 . . . . 0.0 113.41 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.29 -24.79 64.9 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.674 1.237 . . . . 0.0 111.771 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.3 -30.96 65.29 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.6 -38.97 67.66 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.58 -46.34 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.29 95.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.731 0.696 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.25 -50.98 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.628 0.771 . . . . 0.0 109.398 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -60.09 -46.93 87.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.715 0.406 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.38 -43.13 83.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.326 1.05 . . . . 0.0 111.148 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -66.29 -41.5 89.73 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.761 0.824 . . . . 0.0 111.083 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -41.53 88.48 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 110.328 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.56 -46.15 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.702 0.801 . . . . 0.0 109.397 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.5 -37.49 81.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.753 0.706 . . . . 0.0 112.17 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.29 -35.24 20.05 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.554 0.742 . . . . 0.0 112.843 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.9 p -137.43 2.98 2.53 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -128.75 31.56 4.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.626 1.103 . . . . 0.0 109.239 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.44 -24.03 42.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 0.0 113.314 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -24.32 58.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.973 2.109 . . . . 0.0 113.019 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.44 127.15 30.09 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.528 1.531 . . . . 0.0 111.386 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 m -55.83 141.59 38.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.767 1.227 . . . . 0.0 110.373 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -32.38 70.2 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.588 0.355 . . . . 0.0 111.891 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.61 -47.56 75.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.77 -40.94 88.42 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.575 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.03 -54.5 29.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.493 1.117 . . . . 0.0 109.373 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.2 m -64.95 -47.98 75.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.541 1.136 . . . . 0.0 111.409 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.19 -36.13 74.4 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.219 0.463 . . . . 0.0 110.654 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.0 mt -63.23 -50.78 68.88 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.887 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -40.52 69.74 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.498 1.044 . . . . 0.0 110.64 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.56 -44.72 81.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -35.79 68.02 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.084 -0.385 . . . . 0.0 110.437 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 t -59.65 -47.51 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 126.08 1.752 . . . . 0.0 109.128 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -70.01 -10.41 58.55 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.738 -1.226 . . . . 0.0 112.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -95.7 5.7 50.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.476 0.71 . . . . 0.0 110.777 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.39 -55.86 0.75 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.697 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.21 -39.1 75.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 120.635 1.561 . . . . 0.0 112.732 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -63.35 -11.57 26.27 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.423 2.082 . . . . 0.0 115.068 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.44 -20.55 5.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.704 1.593 . . . . 0.0 112.104 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 140.24 97.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.171 0.989 . . . . 0.0 110.068 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.26 50.05 3.41 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.635 3.557 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.86 164.07 4.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.364 1.466 . . . . 0.0 110.578 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -107.87 109.36 20.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.42 139.46 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 118.478 0.581 . . . . 0.0 109.946 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.98 133.28 35.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 103.714 -2.699 . . . . 0.0 103.714 167.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.54 141.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -80.56 -177.05 6.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.393 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -55.2 -23.62 22.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.299 1.439 . . . . 0.0 113.497 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.59 -0.43 42.27 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.394 1.078 . . . . 0.0 111.657 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t0 52.09 56.87 7.13 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.837 1.78 . . . . 0.0 109.522 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -137.09 126.15 15.2 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -171.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.36 142.53 55.01 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.592 2.195 . . . . 0.0 111.724 -169.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.51 -11.06 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 112.522 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.61 172.56 37.84 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.04 156.75 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.8 0.8 . . . . 0.0 110.369 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.43 162.1 36.12 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 108.758 169.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.38 130.38 52.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -146.26 135.07 22.38 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.2 m -161.64 156.18 22.79 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.025 2.53 . . . . 0.0 105.298 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.28 33.6 61.77 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.425 -0.797 . . . . 0.0 113.902 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 56.0 24.56 7.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.167 1.787 . . . . 0.0 114.148 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -124.02 110.74 15.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.102 0.961 . . . . 0.0 109.707 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.7 ttp -85.86 89.44 7.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.58 -27.14 68.98 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.633 1.173 . . . . 0.0 113.525 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.83 150.35 31.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.362 1.065 . . . . 0.0 109.443 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.2 tp -157.86 120.52 3.84 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.481 1.912 . . . . 0.0 106.432 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -145.88 145.88 30.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 108.107 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -149.98 143.6 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.81 134.01 95.1 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.498 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 -28.85 31.89 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.162 2.575 . . . . 0.0 114.849 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.62 -26.46 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.094 0.861 . . . . 0.0 112.851 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.1 m -111.93 -2.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.88 -39.71 82.22 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.252 -0.905 . . . . 0.0 110.09 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.37 -28.42 73.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.605 0.621 . . . . 0.0 112.838 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -74.01 -8.42 56.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.334 1.067 . . . . 0.0 112.293 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.49 9.38 61.63 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.523 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.63 -29.46 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.455 1.627 . . . . 0.0 110.68 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.97 -39.33 25.66 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.892 1.234 . . . . 0.0 113.455 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.42 -47.27 17.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.372 1.586 . . . . 0.0 109.869 169.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -52.87 -45.34 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.168 1.349 . . . . 0.0 111.428 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -68.03 -38.37 82.45 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.008 0.822 . . . . 0.0 111.422 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -41.47 90.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-N 118.446 0.566 . . . . 0.0 109.633 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.21 -36.27 83.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.62 -0.675 . . . . 0.0 109.718 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -60.51 -47.75 84.77 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.775 0.43 . . . . 0.0 110.203 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.76 74.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 122.823 0.449 . . . . 0.0 111.159 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.26 -34.25 72.01 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.385 1.074 . . . . 0.0 111.338 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.7 m -62.44 -37.51 86.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.331 0.514 . . . . 0.0 111.434 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.1 mtm -86.57 -21.06 27.08 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.306 0.503 . . . . 0.0 112.263 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.52 93.22 5.37 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.833 1.253 . . . . 0.0 109.872 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -22.84 53.97 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.345 1.363 . . . . 0.0 113.108 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -104.39 31.01 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.403 1.481 . . . . 0.0 110.335 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.7 tp -51.68 146.11 8.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.655 2.382 . . . . 0.0 113.126 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 p -129.97 160.49 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.293 1.437 . . . . 0.0 108.63 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -155.03 -176.75 6.1 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 172.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.0 156.04 41.0 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.132 0.973 . . . . 0.0 109.588 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.9 p -150.25 149.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.75 123.99 23.23 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.71 -32.28 67.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.639 1.175 . . . . 0.0 112.638 -170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -57.68 -34.08 69.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.234 0.614 . . . . 0.0 110.963 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -77.43 65.62 3.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.682 1.193 . . . . 0.0 110.465 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.86 -26.09 61.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.582 0.753 . . . . 0.0 111.448 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.48 -47.46 85.57 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.815 0.446 . . . . 0.0 110.109 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.92 -37.3 84.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.354 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.56 -46.29 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.9 0.773 . . . . 0.0 109.168 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.35 -50.08 68.2 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -56.28 -49.54 73.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.796 0.838 . . . . 0.0 110.662 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.71 -34.81 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -66.28 -38.08 86.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.931 -1.106 . . . . 0.0 112.532 172.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.66 -42.47 88.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.95 1.25 . . . . 0.0 110.142 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.97 -35.44 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.253 1.021 . . . . 0.0 110.741 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.22 4.52 1.98 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.499 -1.167 . . . . 0.0 115.067 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.68 161.3 31.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.584 1.692 . . . . 0.0 111.392 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 139.93 25.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.74 131.23 35.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.137 0.975 . . . . 0.0 109.502 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.7 p -119.99 -11.41 9.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.638 1.975 . . . . 0.0 111.419 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.32 173.24 41.79 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -155.3 176.59 12.38 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 122.009 -0.7 . . . . 0.0 109.82 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.523 -179.649 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.451 -1.004 0 N-CA-C 110.435 -0.64 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.86 144.34 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.08 148.23 33.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -119.67 140.38 50.74 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.56 160.22 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.579 1.152 . . . . 0.0 108.703 -169.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.49 151.47 50.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.386 1.475 . . . . 0.0 108.208 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -76.45 127.64 33.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.572 1.149 . . . . 0.0 109.959 -177.235 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -137.27 147.77 26.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -141.82 165.41 27.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 mm -123.14 142.43 39.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -151.48 174.72 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.907 0.883 . . . . 0.0 109.868 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -69.07 147.53 51.35 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 m -73.51 146.53 44.78 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.787 0.835 . . . . 0.0 111.91 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -81.73 158.73 24.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -67.77 -47.72 68.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.13 -27.43 67.31 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.03 1.8 34.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.846 0.458 . . . . 0.0 111.651 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.27 -38.71 33.96 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.962 0.792 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.73 -33.51 75.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.404 1.102 . . . . 0.0 111.516 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.94 -33.77 76.31 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 118.664 0.666 . . . . 0.0 109.583 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.47 -40.12 57.77 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.46 -47.35 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.76 90.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.122 0.569 . . . . 0.0 111.86 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.7 mt -59.59 -51.19 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 124.745 1.218 . . . . 0.0 108.776 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -53.07 -49.59 66.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.603 0.761 . . . . 0.0 110.079 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.4 t -59.42 -49.94 75.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.716 0.406 . . . . 0.0 110.196 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -75.17 -28.16 59.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.46 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.9 m -60.78 -40.26 91.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.224 0.92 . . . . 0.0 110.779 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -70.11 -45.9 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.3 -24.42 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.25 -47.08 10.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.237 1.015 . . . . 0.0 112.255 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -129.37 1.54 5.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -129.54 23.17 5.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.499 1.12 . . . . 0.0 109.508 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.2 -21.51 47.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.03 -25.8 13.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.183 1.793 . . . . 0.0 112.254 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.85 103.16 0.41 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 108.763 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 m -59.72 150.68 27.12 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.799 1.64 . . . . 0.0 112.444 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.81 -33.31 70.22 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.45 -48.17 76.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -74.45 -29.94 61.67 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.902 -0.499 . . . . 0.0 110.517 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -54.91 -44.75 74.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.318 0.963 . . . . 0.0 110.119 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.0 m -64.26 -48.79 74.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.304 1.042 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.14 -34.84 77.09 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.054 -0.404 . . . . 0.0 111.023 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.83 -48.29 77.42 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 117.532 -1.223 . . . . 0.0 109.462 172.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.57 -40.63 75.53 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.964 1.257 . . . . 0.0 109.813 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.82 -47.85 84.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.415 1.007 . . . . 0.0 112.37 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -37.92 75.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.848 1.659 . . . . 0.0 109.877 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -61.08 -24.79 66.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.866 1.266 . . . . 0.0 111.455 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -98.21 7.37 46.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.39 1.076 . . . . 0.0 110.631 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -137.96 -59.21 0.65 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.6 -169.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.71 -36.42 45.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 121.01 1.732 . . . . 0.0 113.192 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -60.36 -18.49 53.33 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.899 1.733 . . . . 0.0 115.266 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -127.29 -13.78 5.49 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.313 1.415 . . . . 0.0 113.032 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.09 90.1 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.017 1.327 . . . . 0.0 111.516 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.37 58.93 6.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 112.064 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 mt -88.83 167.68 13.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.898 1.679 . . . . 0.0 112.921 -170.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -126.94 144.72 50.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.28 140.36 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.245 1.018 . . . . 0.0 110.524 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.25 134.19 35.28 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 167.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.72 142.74 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.64 179.24 7.41 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.43 -25.89 4.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.751 1.62 . . . . 0.0 114.039 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -77.0 -2.3 33.18 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.516 1.527 . . . . 0.0 112.014 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.3 57.24 6.83 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 124.294 1.997 . . . . 0.0 109.855 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -132.31 122.57 18.18 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.24 141.55 82.74 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.84 1.693 . . . . 0.0 109.906 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.2 -11.32 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.042 1.337 . . . . 0.0 112.042 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.25 168.76 41.09 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -142.71 159.16 42.78 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.489 0.716 . . . . 0.0 110.99 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.77 152.47 47.95 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.173 0.989 . . . . 0.0 109.726 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.59 119.53 34.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tt -143.13 137.41 29.09 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.7 m -150.74 155.55 39.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.87 -108.04 1.56 Allowed Glycine 0 CA--C 1.53 0.981 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -131.48 6.52 4.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.608 1.163 . . . . 0.0 111.988 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -105.42 124.97 50.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.558 1.072 . . . . 0.0 109.766 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.2 ttp -93.16 86.11 5.26 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.53 -26.61 68.78 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.41 147.51 34.73 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.53 0.732 . . . . 0.0 110.165 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.2 tp -155.59 122.29 5.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.868 2.067 . . . . 0.0 105.501 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.82 142.43 29.95 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.38 144.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -57.24 114.77 8.81 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 126.142 1.777 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.57 -29.88 11.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.087 3.192 . . . . 0.0 114.492 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.38 -21.84 66.76 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.37 10.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.143 0.977 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.03 -35.28 64.28 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.703 -1.248 . . . . 0.0 111.085 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.94 57.09 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.256 0.931 . . . . 0.0 113.613 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -72.69 -5.0 34.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.949 1.375 . . . . 0.0 112.456 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.69 69.41 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 119.08 0.854 . . . . 0.0 113.053 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.5 t -55.54 -31.07 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.357 1.079 . . . . 0.0 111.169 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.8 -53.04 14.56 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.048 0.832 . . . . 0.0 111.676 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.93 -42.29 97.4 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.381 -1.295 . . . . 0.0 110.206 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -58.6 -46.28 90.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.251 1.387 . . . . 0.0 110.052 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.23 -40.27 78.04 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.872 -0.518 . . . . 0.0 110.826 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.2 -40.44 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.632 0.651 . . . . 0.0 110.307 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.3 -33.3 72.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.037 -1.039 . . . . 0.0 109.989 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -62.3 -45.75 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.39 0.541 . . . . 0.0 110.383 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.04 83.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.286 0.634 . . . . 0.0 111.064 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.1 -34.27 73.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.114 0.966 . . . . 0.0 111.151 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -63.49 -37.88 88.99 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.219 0.463 . . . . 0.0 111.357 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 mtm -82.53 -28.54 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.371 0.532 . . . . 0.0 112.058 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 93.51 10.13 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.293 1.437 . . . . 0.0 108.613 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.85 -22.36 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 121.417 1.411 . . . . 0.0 112.202 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.68 31.53 4.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.741 . . . . 0.0 110.05 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.7 tp -48.4 141.74 6.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.073 2.149 . . . . 0.0 112.887 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -128.13 158.69 37.34 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 108.163 169.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -151.96 176.82 11.09 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.872 -0.518 . . . . 0.0 110.463 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -134.86 152.11 51.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.407 1.483 . . . . 0.0 108.823 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.0 p -152.95 144.47 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.69 130.09 38.15 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -61.56 -32.59 72.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -33.94 69.91 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.139 0.881 . . . . 0.0 111.321 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -77.72 68.22 3.75 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.168 0.987 . . . . 0.0 110.557 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.79 -24.75 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -62.55 -46.35 88.77 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.84 -0.537 . . . . 0.0 109.878 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.74 79.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.705 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.44 -49.16 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.297 0.953 . . . . 0.0 108.544 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.69 -46.94 93.47 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.83 -51.54 67.13 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 123.884 0.874 . . . . 0.0 110.097 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.62 -33.42 74.95 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.7 -47.92 82.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.174 0.897 . . . . 0.0 110.802 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.41 -42.58 87.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.065 0.848 . . . . 0.0 110.552 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.56 -34.3 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.182 0.993 . . . . 0.0 110.92 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.26 10.48 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.432 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -78.2 155.62 30.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.645 1.723 . . . . 0.0 111.53 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -141.06 138.95 33.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.362 1.865 . . . . 0.0 106.702 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.7 135.97 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.935 0.894 . . . . 0.0 110.057 -170.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.6 p -129.03 -8.72 4.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.468 1.907 . . . . 0.0 111.52 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.48 177.17 44.47 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.782 0.719 . . . . 0.0 111.55 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -157.46 178.0 10.79 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.066 0.946 . . . . 0.0 109.338 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.323 -0.549 0 C-N-CA 126.938 2.095 . . . . 0.0 105.726 178.352 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--O 1.237 0.463 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp -113.18 145.1 41.54 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 mt -116.85 152.05 35.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -125.65 137.84 53.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.852 1.261 . . . . 0.0 108.201 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.12 161.24 36.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.589 1.156 . . . . 0.0 108.162 -171.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.67 149.28 52.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.667 1.587 . . . . 0.0 108.562 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -75.44 129.93 38.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.617 1.167 . . . . 0.0 109.913 177.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 mm -132.1 144.94 35.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -140.59 165.14 28.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.4 mm -128.07 143.22 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -156.45 173.8 16.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.865 0.866 . . . . 0.0 110.537 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -64.54 147.01 53.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -73.53 145.55 45.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.607 1.163 . . . . 0.0 111.928 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -82.25 131.33 35.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -57.51 -39.72 77.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.441 1.019 . . . . 0.0 111.071 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -70.12 -20.67 63.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.955 0.902 . . . . 0.0 113.202 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -84.11 -4.96 59.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.372 0.987 . . . . 0.0 111.042 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.9 -33.25 35.64 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 124.445 1.022 . . . . 0.0 113.355 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.59 -33.33 75.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.536 1.168 . . . . 0.0 111.836 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -65.97 -30.95 71.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.982 -0.449 . . . . 0.0 109.884 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.57 -37.57 56.33 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.05 0.54 . . . . 0.0 109.67 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.92 -46.06 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -44.11 97.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 111.917 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.2 mt -61.88 -50.27 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.34 1.056 . . . . 0.0 109.134 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.7 t90 -51.31 -47.54 62.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.356 0.662 . . . . 0.0 110.127 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.8 t -61.5 -50.44 72.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.105 0.411 . . . . 0.0 110.52 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -68.78 -32.13 71.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.042 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 m -62.15 -47.61 83.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.063 0.847 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.28 -44.45 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.622 0.769 . . . . 0.0 109.519 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.2 -28.56 69.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 0.0 112.064 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.69 -24.55 28.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.653 1.181 . . . . 0.0 113.939 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.8 p -137.34 -21.15 1.19 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.571 ' CE1' HD21 ' A' ' 110' ' ' ASN . 72.8 m80 -124.29 29.84 6.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.671 1.588 . . . . 0.0 109.28 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.28 -18.27 25.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.408 1.083 . . . . 0.0 113.589 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -51.13 -23.84 3.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.116 2.167 . . . . 0.0 113.162 170.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.01 97.84 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.941 1.296 . . . . 0.0 108.003 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.1 m -55.29 153.69 6.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.458 1.503 . . . . 0.0 110.991 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -35.86 63.07 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.07 -49.11 66.15 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.941 0.792 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -65.65 -39.04 90.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.001 0.521 . . . . 0.0 109.998 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -54.48 -46.49 73.4 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.833 1.253 . . . . 0.0 110.018 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.7 m -65.73 -48.04 73.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 110.367 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.77 -36.93 81.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.911 -0.493 . . . . 0.0 110.762 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 -51.51 67.37 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -56.85 -40.69 76.57 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.766 0.712 . . . . 0.0 110.528 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.28 -41.63 89.57 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.806 0.73 . . . . 0.0 112.597 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.45 -38.31 68.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.573 -0.705 . . . . 0.0 109.553 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.91 -47.38 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.814 1.645 . . . . 0.0 109.147 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -57.39 -23.95 52.4 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.36 1.464 . . . . 0.0 111.754 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -102.69 7.7 39.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.426 1.09 . . . . 0.0 111.187 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -136.29 -52.7 0.72 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.905 -169.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.15 -37.14 54.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 120.534 1.515 . . . . 0.0 113.251 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.4 -16.21 33.96 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.433 2.089 . . . . 0.0 115.607 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -126.27 -14.37 5.95 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.32 1.418 . . . . 0.0 112.527 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.75 151.54 92.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.761 1.224 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.38 63.57 7.85 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.693 3.595 . . . . 0.0 110.704 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.5 177.97 7.24 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.785 1.234 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -136.47 141.58 43.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 127.547 2.339 . . . . 0.0 105.244 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.42 141.9 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 119.164 0.893 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.16 134.14 34.58 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 167.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.51 142.31 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -79.33 -178.85 6.44 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.563 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.13 -25.03 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.557 1.543 . . . . 0.0 113.788 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -84.26 3.45 35.41 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.834 1.254 . . . . 0.0 111.999 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.6 t0 52.66 58.25 5.56 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 123.384 1.564 . . . . 0.0 109.79 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.06 124.12 17.29 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 -170.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.49 137.13 45.55 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.975 2.45 . . . . 0.0 111.497 -171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 m -124.17 -13.63 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.282 1.033 . . . . 0.0 112.082 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.9 42.9 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -147.49 160.9 42.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.159 0.584 . . . . 0.0 110.925 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.56 154.07 49.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 108.226 169.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 tp -110.12 118.9 37.63 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.49 132.26 18.98 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.6 m -145.61 153.32 40.92 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 168.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.32 -123.11 32.12 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -129.21 29.05 5.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.214 1.006 . . . . 0.0 111.26 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -122.94 108.59 13.13 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.655 -0.653 . . . . 0.0 110.218 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 ttp -85.59 87.36 7.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.06 -27.82 69.37 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.26 152.79 40.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.716 0.689 . . . . 0.0 110.963 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.9 tp -158.29 119.71 3.51 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.692 1.997 . . . . 0.0 106.38 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -147.04 141.43 26.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.561 1.144 . . . . 0.0 107.949 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.1 mt -150.95 145.71 16.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.29 126.18 77.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.379 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.63 -17.1 52.42 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.587 2.191 . . . . 0.0 113.834 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.18 -21.46 60.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.685 1.13 . . . . 0.0 112.018 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.49 -11.29 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -52.45 -39.71 61.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.892 1.224 . . . . 0.0 112.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.42 84.45 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.359 -176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.59 -18.64 65.07 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.175 1.488 . . . . 0.0 111.561 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.37 -23.16 1.22 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.07 0.843 . . . . 0.0 112.198 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.7 -32.82 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.602 1.201 . . . . 0.0 111.812 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.61 -31.45 37.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.128 0.871 . . . . 0.0 113.37 173.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -87.67 -45.94 9.95 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.01 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t -53.75 -43.85 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 120.364 1.438 . . . . 0.0 111.248 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -66.63 -37.02 83.96 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.872 0.76 . . . . 0.0 111.43 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.27 -42.07 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 118.44 0.563 . . . . 0.0 109.524 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.35 -35.1 79.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.554 0.615 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -61.43 -48.43 81.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.808 0.443 . . . . 0.0 110.382 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.31 82.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.891 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.34 -35.54 75.9 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.224 1.009 . . . . 0.0 111.458 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.82 -36.72 84.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.305 0.502 . . . . 0.0 111.408 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.3 mtm -86.16 -23.42 26.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.993 0.517 . . . . 0.0 112.218 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.15 91.45 7.05 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.267 1.427 . . . . 0.0 108.931 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -22.93 56.92 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.413 1.408 . . . . 0.0 112.788 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -103.81 30.74 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.347 1.459 . . . . 0.0 110.258 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.1 tp -49.61 144.55 5.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.179 2.192 . . . . 0.0 112.961 -171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.9 p -129.08 161.31 30.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.02 1.328 . . . . 0.0 108.796 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -153.09 -173.8 4.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -149.16 161.78 41.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.992 0.917 . . . . 0.0 110.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.25 145.24 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -74.26 128.83 36.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -57.43 -32.37 66.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.862 0.865 . . . . 0.0 113.088 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.47 -34.08 72.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.308 0.503 . . . . 0.0 111.195 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.571 HD21 ' CE1' ' A' ' 28' ' ' HIS . 64.2 t-20 -79.07 65.14 4.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.856 1.262 . . . . 0.0 109.611 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.3 -26.06 60.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.151 0.98 . . . . 0.0 111.1 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.12 84.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.959 0.503 . . . . 0.0 109.861 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.54 77.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.756 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.84 -49.31 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.402 1.001 . . . . 0.0 108.482 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.78 93.76 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -56.14 -50.63 70.59 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.763 0.825 . . . . 0.0 110.194 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -67.24 -33.96 76.43 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -59.46 -46.17 89.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.191 0.905 . . . . 0.0 110.977 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.92 -43.26 91.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.129 0.877 . . . . 0.0 110.384 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.4 t -63.13 -39.63 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.758 0.823 . . . . 0.0 110.365 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.26 11.58 0.89 Allowed Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.4 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.43 155.43 29.93 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.652 1.726 . . . . 0.0 111.479 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.01 139.22 34.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.103 1.761 . . . . 0.0 106.618 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.66 133.81 31.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.978 0.911 . . . . 0.0 109.8 -171.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.75 -9.66 7.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 111.459 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.09 178.31 43.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 118.849 0.75 . . . . 0.0 111.491 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -151.26 174.83 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.49 0.716 . . . . 0.0 109.572 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--N 1.323 -0.574 0 C-N-CA 127.267 2.227 . . . . 0.0 106.289 176.303 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 N-CA-C 114.421 0.893 . . . . 0.0 114.421 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.1 tp -131.69 144.04 50.72 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.2 mt -113.86 141.27 47.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -113.29 138.78 49.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 160.07 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.64 151.37 51.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.639 1.576 . . . . 0.0 108.575 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -75.8 126.37 30.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 68.2 t . . . . . 0 CA--C 1.548 0.891 0 C-N-CA 125.272 1.429 . . . . 0.0 109.89 -178.903 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 CA-C-O 121.354 0.597 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -137.62 144.66 30.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 107.615 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -140.37 163.57 32.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -123.78 143.06 38.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.11 170.93 18.73 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.747 1.219 . . . . 0.0 108.956 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -66.35 148.65 51.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -73.27 148.43 43.62 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.282 1.033 . . . . 0.0 112.237 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -79.76 155.88 27.73 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -68.63 -40.59 80.27 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.909 -0.494 . . . . 0.0 110.269 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.7 -25.82 63.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.82 0.6 46.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.095 0.558 . . . . 0.0 111.394 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.4 -42.91 43.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.536 1.065 . . . . 0.0 113.64 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -72.52 -18.75 61.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.732 1.266 . . . . 0.0 112.066 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.67 -31.29 68.15 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.051 -1.031 . . . . 0.0 109.33 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -73.95 -38.35 64.26 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.57 -45.47 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.46 98.76 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.977 -0.452 . . . . 0.0 111.505 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.52 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.816 0.846 . . . . 0.0 109.466 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -54.26 -47.29 72.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.266 0.627 . . . . 0.0 110.298 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.48 -44.63 95.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.674 -0.642 . . . . 0.0 110.327 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -63.58 -37.04 85.82 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.677 -0.639 . . . . 0.0 110.993 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.2 m -67.87 -35.56 78.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.485 0.714 . . . . 0.0 110.819 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -70.9 -47.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.31 -33.54 69.59 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.559 0.744 . . . . 0.0 112.708 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.35 -35.63 15.11 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 118.344 -0.836 . . . . 0.0 113.17 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -138.63 2.0 2.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -136.44 26.61 3.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.91 -13.77 28.04 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.997 -1.064 . . . . 0.0 113.565 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -52.95 -22.93 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.741 2.017 . . . . 0.0 112.905 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -64.21 97.21 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.36 1.464 . . . . 0.0 108.679 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -56.26 158.81 3.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.57 1.548 . . . . 0.0 111.317 174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.41 65.03 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.37 -46.82 72.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.966 0.803 . . . . 0.0 109.98 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -64.91 -40.25 94.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.488 0.715 . . . . 0.0 109.748 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -55.57 -47.43 76.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.953 1.301 . . . . 0.0 110.097 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -64.94 -49.74 69.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.187 0.995 . . . . 0.0 110.019 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.26 -38.85 91.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.405 . . . . 0.0 110.785 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.86 -50.74 65.42 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.61 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.87 -38.83 79.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.734 1.152 . . . . 0.0 110.093 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.74 -48.22 82.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.98 0.809 . . . . 0.0 112.099 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -37.05 76.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.97 -46.37 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.801 1.641 . . . . 0.0 109.942 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -63.31 -20.57 65.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.515 1.052 . . . . 0.0 111.398 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -97.78 7.15 46.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 110.808 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -137.4 -56.13 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.215 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.99 -37.23 51.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 120.467 1.485 . . . . 0.0 112.708 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -63.94 -11.17 25.8 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.002 1.802 . . . . 0.0 115.706 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -128.06 -19.63 3.94 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.866 1.666 . . . . 0.0 112.746 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.74 149.67 97.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.408 1.083 . . . . 0.0 110.902 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.46 47.9 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.648 3.566 . . . . 0.0 112.305 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.36 165.49 16.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.038 1.735 . . . . 0.0 112.463 -171.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -115.77 147.4 40.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.37 138.58 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.935 . . . . 0.0 110.382 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.54 129.23 34.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 168.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.4 m -124.15 142.02 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -82.85 -179.7 7.52 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.05 -25.45 8.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 0.0 113.97 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -79.24 0.57 28.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.955 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 t0 51.63 55.96 8.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 124.207 1.956 . . . . 0.0 109.661 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.41 119.09 21.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 128.103 2.561 . . . . 0.0 104.333 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.64 138.74 65.98 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.693 1.596 . . . . 0.0 109.924 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.34 -9.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 0.0 112.468 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.46 168.67 40.16 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 171.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -142.46 156.34 45.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.813 0.806 . . . . 0.0 111.249 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -141.75 138.0 32.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.362 2.265 . . . . 0.0 106.037 -173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -124.15 119.57 29.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.7 tp -141.97 134.5 28.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.0 m -159.4 155.87 27.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.131 2.172 . . . . 0.0 105.422 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.14 35.46 59.9 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.564 -0.71 . . . . 0.0 113.774 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 58.14 22.24 8.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 113.697 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -125.47 114.36 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.6 ttp -80.89 87.32 5.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.96 -28.09 69.84 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.768 . . . . 0.0 112.837 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.97 144.63 29.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.755 0.822 . . . . 0.0 110.407 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.1 tp -156.19 117.58 3.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.955 1.702 . . . . 0.0 106.464 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -145.31 143.14 30.01 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -149.62 144.18 17.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.08 125.33 86.63 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.52 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.73 -30.21 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.882 3.055 . . . . 0.0 114.947 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -63.72 -25.18 68.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.94 -3.11 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.641 0.655 . . . . 0.0 112.497 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -59.62 -37.24 78.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.823 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.7 -26.62 68.75 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.859 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.0 m -78.29 -3.55 43.48 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.392 1.096 . . . . 0.0 112.212 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.11 13.15 64.57 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.486 172.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.0 t -57.21 -31.03 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.294 1.547 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.5 -49.85 44.12 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.634 0.635 . . . . 0.0 112.176 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -63.87 -46.85 83.08 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.716 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -54.03 -49.55 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 119.397 0.999 . . . . 0.0 110.152 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.95 -37.52 75.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.039 -174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.58 -39.75 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 119.088 0.858 . . . . 0.0 109.801 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.97 -36.11 82.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.74 1.154 . . . . 0.0 110.066 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.03 -48.33 80.78 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.872 0.469 . . . . 0.0 110.491 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.18 78.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.643 0.777 . . . . 0.0 110.753 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.49 -33.66 71.62 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.702 1.201 . . . . 0.0 111.646 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -62.66 -34.11 76.41 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.5 0.591 . . . . 0.0 111.548 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -87.19 -25.38 24.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 112.091 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.08 94.96 7.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.096 1.359 . . . . 0.0 109.175 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.91 -23.42 47.3 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 121.237 1.291 . . . . 0.0 112.318 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.12 28.87 4.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.789 1.635 . . . . 0.0 110.482 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.3 tp -53.0 146.49 10.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.281 2.232 . . . . 0.0 112.819 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.8 p -131.31 161.68 31.78 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 108.802 170.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 t -155.86 -178.37 7.24 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 122.636 0.374 . . . . 0.0 110.631 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -135.68 156.57 48.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.785 1.634 . . . . 0.0 108.695 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 p -154.39 145.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.53 132.48 42.91 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.17 -30.82 66.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.566 0.747 . . . . 0.0 112.213 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.53 -26.73 68.02 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.367 0.53 . . . . 0.0 112.193 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -79.95 67.84 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.748 0.785 . . . . 0.0 109.806 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.41 -27.7 49.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.446 1.099 . . . . 0.0 111.422 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.25 -50.59 65.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.006 0.523 . . . . 0.0 110.149 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.54 82.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.41 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.5 t -56.45 -49.14 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.92 -48.68 85.07 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.79 -50.88 70.99 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.392 0.677 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -66.94 -35.32 79.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.19 -47.37 85.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.983 0.81 . . . . 0.0 110.876 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -58.87 -42.03 88.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.021 0.828 . . . . 0.0 110.603 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.85 -40.28 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.701 0.8 . . . . 0.0 110.345 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.52 8.13 0.73 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.775 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.53 153.17 40.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.643 1.722 . . . . 0.0 111.142 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -140.5 139.49 35.11 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.126 1.77 . . . . 0.0 106.523 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.9 t -72.08 134.68 29.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.85 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 p -126.0 -8.6 6.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.789 2.036 . . . . 0.0 111.379 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.26 43.95 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 118.779 0.718 . . . . 0.0 111.467 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -154.44 176.91 11.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.83 0.852 . . . . 0.0 109.437 171.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.323 -0.56 0 C-N-CA 126.876 2.071 . . . . 0.0 105.831 176.671 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 N--CA 1.459 -0.513 0 N-CA-C 117.687 2.149 . . . . 0.0 117.687 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.8 tp -103.92 148.09 26.57 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.79 151.61 36.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -122.67 138.51 54.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.878 1.271 . . . . 0.0 107.849 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.03 159.79 41.08 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.435 1.094 . . . . 0.0 108.467 -170.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.18 149.66 51.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.413 1.485 . . . . 0.0 108.417 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -73.9 125.45 28.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 124.63 1.172 . . . . 0.0 110.008 -178.479 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -136.72 146.74 28.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -140.9 164.02 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 168.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.8 mm -124.5 143.59 37.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -152.3 171.3 18.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.73 1.212 . . . . 0.0 109.136 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -65.85 147.47 53.32 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -76.35 148.85 37.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.623 1.169 . . . . 0.0 111.912 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -77.33 162.07 27.57 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -70.16 -46.67 64.21 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.93 -27.61 65.91 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.72 -1.48 47.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.789 0.436 . . . . 0.0 111.334 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.12 -35.96 55.66 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 124.14 0.876 . . . . 0.0 113.461 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.53 -28.14 69.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.979 1.39 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -68.09 -31.73 71.56 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.364 -0.835 . . . . 0.0 109.762 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -76.13 -37.36 58.13 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.11 -46.96 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.119 0.568 . . . . 0.0 112.042 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.18 -50.6 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.24 1.016 . . . . 0.0 109.569 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -51.36 -47.51 62.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.282 0.633 . . . . 0.0 110.005 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -61.51 -49.59 76.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.901 0.48 . . . . 0.0 110.233 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.21 -30.32 68.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.179 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -62.54 -46.15 89.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.628 1.104 . . . . 0.0 109.462 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -66.57 -44.02 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 123.877 0.871 . . . . 0.0 109.305 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.46 -28.62 68.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.361 0.982 . . . . 0.0 112.326 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.71 -33.3 27.61 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.984 0.914 . . . . 0.0 113.301 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.7 p -135.17 -12.17 2.17 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.415 ' CD2' HD21 ' A' ' 110' ' ' ASN . 28.5 m-70 -118.68 24.5 10.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.347 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.19 -19.76 35.96 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -53.41 -28.88 32.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.804 1.641 . . . . 0.0 111.927 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.21 104.98 1.96 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.961 2.104 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -59.87 157.83 11.71 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.557 1.943 . . . . 0.0 113.181 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.04 68.77 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -64.83 -50.18 67.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.631 0.65 . . . . 0.0 109.545 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -64.09 -38.58 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.138 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.18 -46.66 79.28 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.549 0.74 . . . . 0.0 109.917 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -64.81 -51.1 64.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.554 1.142 . . . . 0.0 110.105 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.37 -36.33 76.71 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.998 -0.439 . . . . 0.0 110.835 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.15 -50.97 68.3 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.834 -1.079 . . . . 0.0 109.276 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.822 1.192 . . . . 0.0 110.501 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.9 -44.66 72.75 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.86 -36.02 70.0 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.123 -0.361 . . . . 0.0 110.421 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.35 -47.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 125.992 1.717 . . . . 0.0 108.949 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -69.45 -12.1 61.37 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 120.847 -1.158 . . . . 0.0 112.819 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -95.53 6.05 49.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.715 0.806 . . . . 0.0 110.679 172.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -136.79 -55.32 0.73 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.58 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.09 -40.14 82.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 120.66 1.573 . . . . 0.0 112.632 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.49 -12.26 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.253 1.969 . . . . 0.0 114.853 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.85 -21.36 6.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.79 1.632 . . . . 0.0 111.937 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.55 148.65 97.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 110.778 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.65 48.85 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.653 3.569 . . . . 0.0 111.721 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.09 169.48 5.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.171 1.388 . . . . 0.0 112.272 -172.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -121.66 144.37 48.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.61 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.12 138.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.219 1.008 . . . . 0.0 110.659 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.72 129.48 34.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 103.617 -2.734 . . . . 0.0 103.617 167.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 m -126.86 144.63 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -80.47 -174.56 4.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.807 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.69 -22.43 46.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.476 1.11 . . . . 0.0 113.249 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.88 6.1 29.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.997 1.319 . . . . 0.0 111.682 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 53.01 41.94 32.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.964 1.364 . . . . 0.0 110.467 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 120.33 45.57 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -173.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.86 130.71 28.51 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.281 1.987 . . . . 0.0 110.286 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.32 -16.01 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.144 0.978 . . . . 0.0 111.637 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.97 172.72 42.16 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -147.35 161.73 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.372 0.669 . . . . 0.0 110.881 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.47 158.9 43.3 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.448 1.099 . . . . 0.0 109.717 169.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.5 tp -118.06 128.07 54.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.07 132.16 23.07 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 m -142.95 153.71 43.32 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.5 -118.44 10.54 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -129.07 30.76 5.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.181 0.992 . . . . 0.0 110.826 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -122.58 109.73 14.67 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.398 0.679 . . . . 0.0 110.452 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 ttp -85.78 87.85 7.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.37 -29.06 70.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.38 36.11 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.629 0.771 . . . . 0.0 109.815 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.7 tp -158.73 116.16 2.83 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.548 1.939 . . . . 0.0 105.958 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.97 143.21 29.34 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -149.91 145.44 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -171.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -60.41 121.58 61.19 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.99 -16.28 51.91 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.311 2.007 . . . . 0.0 113.704 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.02 -23.29 64.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.06 -9.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.438 1.095 . . . . 0.0 112.309 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -50.54 -44.18 56.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.341 1.056 . . . . 0.0 110.436 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.67 -18.77 66.42 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.165 0.888 . . . . 0.0 113.842 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.49 -9.11 57.68 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.108 1.454 . . . . 0.0 112.239 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.12 7.96 34.58 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.04 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -55.33 -31.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.053 1.426 . . . . 0.0 110.682 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.6 -51.7 27.0 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 119.377 -0.68 . . . . 0.0 111.706 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -62.24 -42.45 99.33 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.583 -1.198 . . . . 0.0 110.431 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.3 t -58.76 -46.54 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.98 1.264 . . . . 0.0 109.957 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.43 -41.19 80.67 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.949 -0.469 . . . . 0.0 110.806 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.51 -41.75 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.445 0.566 . . . . 0.0 109.943 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.3 -34.88 79.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.125 0.875 . . . . 0.0 110.14 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.38 -45.22 95.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.4 0.545 . . . . 0.0 110.424 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.31 -49.45 73.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.835 0.454 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.35 -33.67 69.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.113 0.965 . . . . 0.0 111.512 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.66 -35.97 81.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.297 0.499 . . . . 0.0 111.558 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.6 mtm -88.63 -23.0 23.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.267 0.485 . . . . 0.0 112.161 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.04 90.05 9.5 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 125.137 1.375 . . . . 0.0 108.914 -170.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -22.05 61.0 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.476 1.45 . . . . 0.0 112.919 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.45 31.93 4.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.535 1.534 . . . . 0.0 109.951 -175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 42.0 tp -49.2 144.81 4.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.238 2.215 . . . . 0.0 113.015 -171.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -129.23 162.25 28.3 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.186 1.395 . . . . 0.0 108.657 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -153.64 -173.72 4.68 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -148.92 161.78 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.481 0.713 . . . . 0.0 110.372 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.3 p -155.2 149.73 11.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -78.11 136.31 37.85 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.13 -26.2 60.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.224 1.41 . . . . 0.0 112.352 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -48.81 -47.45 42.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.056 0.844 . . . . 0.0 111.05 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.415 HD21 ' CD2' ' A' ' 28' ' ' HIS . 59.5 t-20 -85.82 65.3 9.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.327 1.451 . . . . 0.0 110.244 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.22 -29.36 46.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 111.441 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -43.89 97.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.409 0.684 . . . . 0.0 109.966 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.36 -33.99 72.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.148 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.25 -45.34 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 119.505 1.048 . . . . 0.0 108.678 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.39 -50.78 63.15 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -53.29 -50.54 64.68 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.869 0.868 . . . . 0.0 110.797 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -65.25 -38.51 90.57 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.91 -32.95 74.34 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.523 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -60.42 -40.88 92.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.353 1.433 . . . . 0.0 110.766 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.09 -39.13 80.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.05 9.32 0.82 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.841 171.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -69.01 159.58 32.57 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 1.537 . . . . 0.0 111.117 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.82 140.59 25.89 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 t -71.94 129.91 35.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.981 0.912 . . . . 0.0 109.324 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 p -124.93 -7.64 7.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.258 1.823 . . . . 0.0 111.796 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.91 173.06 42.2 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 118.82 0.737 . . . . 0.0 112.218 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -141.98 159.92 41.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.543 1.537 . . . . 0.0 111.061 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.646 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 115.738 1.399 . . . . 0.0 115.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.0 tp -96.74 143.79 27.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.8 mt -114.73 134.72 54.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -102.98 139.73 38.16 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.19 159.94 39.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.24 51.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.538 1.535 . . . . 0.0 107.987 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -75.8 125.7 29.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 124.552 1.141 . . . . 0.0 110.051 -177.259 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 mm -134.66 144.38 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -142.39 166.12 25.54 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.52 142.65 40.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.69 171.17 19.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 109.507 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -64.57 147.73 52.27 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.929 0.786 . . . . 0.0 109.106 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.12 148.28 45.85 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -80.49 158.57 25.82 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -66.57 -48.99 67.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.73 -26.71 65.39 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -169.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.26 -1.97 43.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.161 0.437 . . . . 0.0 111.635 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.53 -39.14 36.7 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 124.185 0.898 . . . . 0.0 113.385 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.77 -26.78 67.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.686 1.243 . . . . 0.0 112.078 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.21 -31.77 71.53 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.15 -40.09 59.91 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.26 -46.01 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.603 0.761 . . . . 0.0 109.289 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -46.92 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.6 mt -57.35 -52.19 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.717 1.207 . . . . 0.0 108.934 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -52.94 -49.91 65.08 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.774 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 t -59.51 -50.49 73.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.109 0.564 . . . . 0.0 110.655 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -68.33 -33.05 73.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.145 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 m -63.34 -46.96 84.19 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.199 0.909 . . . . 0.0 109.688 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.63 -44.14 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.794 0.838 . . . . 0.0 108.912 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.99 -33.58 76.4 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.998 1.272 . . . . 0.0 112.052 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.24 60.9 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.428 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.8 p -135.07 -5.66 2.37 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -121.72 44.39 2.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.633 1.573 . . . . 0.0 108.486 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 -32.29 57.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.048 -1.033 . . . . 0.0 113.051 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.65 -21.72 66.59 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.745 1.218 . . . . 0.0 113.117 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.36 114.23 8.29 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.367 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -61.06 148.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 112.091 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.85 73.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.105 0.562 . . . . 0.0 112.464 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.82 -48.67 73.53 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -68.55 -35.5 77.5 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.137 -0.352 . . . . 0.0 110.381 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -54.87 -45.57 74.63 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.397 1.079 . . . . 0.0 110.313 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.4 m -65.23 -49.8 68.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.339 1.056 . . . . 0.0 110.235 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.01 -35.95 81.06 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.971 -0.456 . . . . 0.0 110.723 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.44 -52.84 62.9 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.345 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.75 -38.01 71.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.475 1.034 . . . . 0.0 110.74 -174.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.99 -48.82 72.6 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.089 0.556 . . . . 0.0 112.094 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.68 -36.03 73.11 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.974 -0.454 . . . . 0.0 110.471 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.49 -47.74 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.231 1.812 . . . . 0.0 109.098 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -69.85 -11.17 60.66 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.924 -1.11 . . . . 0.0 112.676 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m -95.87 5.47 51.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.691 0.796 . . . . 0.0 110.749 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.38 -56.43 0.75 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 117.892 -1.052 . . . . 0.0 112.628 -169.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -56.2 -38.37 67.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.558 . . . . 0.0 112.827 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.07 -14.86 35.72 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.8 1.666 . . . . 0.0 115.209 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.71 -13.57 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.741 1.61 . . . . 0.0 112.772 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.23 152.34 91.94 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.957 1.303 . . . . 0.0 111.321 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.82 56.18 5.86 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.831 3.688 . . . . 0.0 111.932 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.34 159.2 23.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.369 1.468 . . . . 0.0 112.009 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -116.24 142.45 46.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 141.22 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.259 1.024 . . . . 0.0 110.072 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.09 134.83 35.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 168.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -128.71 144.3 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -84.21 -171.77 3.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 110.763 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -62.33 11.04 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.501 2.32 . . . . 0.0 114.182 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -127.97 8.99 6.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.354 1.862 . . . . 0.0 111.314 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.0 t0 50.25 47.26 24.0 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.187 1.47 . . . . 0.0 110.259 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.41 122.99 26.59 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 -172.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.7 135.5 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.24 1.96 . . . . 0.0 110.994 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.93 -13.92 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.179 0.992 . . . . 0.0 112.136 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 170.86 42.61 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.41 159.88 41.23 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.295 1.038 . . . . 0.0 111.962 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -140.0 127.48 21.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.926 2.49 . . . . 0.0 105.999 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.97 116.8 31.17 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tt -146.56 129.29 16.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.348 0.522 . . . . 0.0 109.875 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.7 m -146.04 154.68 42.13 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.58 41.98 65.78 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 118.953 0.797 . . . . 0.0 113.996 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 59.53 21.97 10.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.811 1.644 . . . . 0.0 113.842 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -130.18 108.12 9.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.074 0.95 . . . . 0.0 108.97 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.2 ttp -85.9 86.14 7.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.13 -31.48 71.19 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.85 142.35 31.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.607 0.763 . . . . 0.0 110.296 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 tp -150.85 117.46 5.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -140.93 140.08 34.4 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.68 146.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.97 118.25 9.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.08 -18.6 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.636 2.224 . . . . 0.0 112.638 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.95 -23.52 66.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.1 0.864 . . . . 0.0 112.554 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.55 -2.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.939 1.295 . . . . 0.0 112.487 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -59.89 -27.64 66.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.678 -1.264 . . . . 0.0 111.698 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.97 -16.19 75.48 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.981 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.19 -175.09 2.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.713 1.256 . . . . 0.0 109.293 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.45 -31.58 36.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.632 -1.093 . . . . 0.0 113.612 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.34 -36.66 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.712 1.756 . . . . 0.0 112.733 -170.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.84 -23.04 43.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.873 0.749 . . . . 0.0 113.441 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -41.85 7.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.065 170.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.11 -45.98 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 121.605 2.002 . . . . 0.0 110.662 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.8 mt -68.9 -37.09 78.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.997 0.817 . . . . 0.0 111.641 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.15 -39.58 83.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 118.53 0.604 . . . . 0.0 109.674 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.49 -35.08 79.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.534 -0.729 . . . . 0.0 109.197 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.87 -48.36 79.35 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.574 0.75 . . . . 0.0 110.427 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.89 81.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.584 0.753 . . . . 0.0 110.888 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.11 -33.12 74.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 111.414 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -64.33 -39.06 93.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.491 0.587 . . . . 0.0 111.035 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.9 mtm -77.3 -29.83 53.88 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.438 0.563 . . . . 0.0 111.728 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 96.15 6.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.695 1.198 . . . . 0.0 110.13 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.01 -22.83 62.01 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.33 1.353 . . . . 0.0 112.409 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.55 29.19 4.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.509 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 tp -51.94 144.03 12.48 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.002 2.121 . . . . 0.0 113.589 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.4 p -129.87 161.3 31.13 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.47 1.508 . . . . 0.0 108.612 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -154.51 -179.33 7.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.918 0.487 . . . . 0.0 110.232 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.2 1.4 . . . . 0.0 109.018 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.5 p -153.86 145.3 14.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -75.78 137.71 40.72 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -63.89 -25.52 68.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.281 0.632 . . . . 0.0 111.944 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -71.74 31.57 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 112.415 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -149.7 67.04 1.0 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.946 1.698 . . . . 0.0 107.685 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.56 -26.42 61.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.52 -49.38 75.56 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.854 0.461 . . . . 0.0 110.085 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.27 76.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.673 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.42 -49.74 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.52 -46.32 94.56 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.294 0.497 . . . . 0.0 111.914 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -54.22 -53.17 57.25 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 125.146 1.379 . . . . 0.0 109.852 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -68.32 -33.38 74.21 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.855 -0.528 . . . . 0.0 109.852 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.26 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.418 1.008 . . . . 0.0 110.879 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.64 -43.27 89.69 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.841 0.746 . . . . 0.0 110.438 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.29 -37.61 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 110.607 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.59 10.07 0.83 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.618 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -81.78 155.93 25.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.635 1.717 . . . . 0.0 111.439 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.1 138.24 33.38 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.126 1.77 . . . . 0.0 106.558 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.85 133.67 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.03 0.932 . . . . 0.0 109.692 -172.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.4 p -125.59 -9.69 6.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.588 1.955 . . . . 0.0 111.414 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.61 -176.87 41.6 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.837 0.744 . . . . 0.0 111.758 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -151.54 -174.82 4.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.92 0.888 . . . . 0.0 109.338 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.323 -0.561 0 C-N-CA 126.382 1.873 . . . . 0.0 106.583 169.88 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 N-CA-C 118.25 2.365 . . . . 0.0 118.25 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.22 145.96 24.67 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.36 152.86 33.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -124.61 138.67 54.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 108.206 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 161.19 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.678 1.191 . . . . 0.0 108.456 -170.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.26 150.27 52.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.67 1.588 . . . . 0.0 108.465 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.69 124.76 27.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 -177.35 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.668 0.747 . . . . 0.0 112.018 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 mm -133.25 145.83 33.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -137.35 164.45 28.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -124.99 141.8 43.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.19 170.5 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.075 0.95 . . . . 0.0 109.771 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -61.67 148.97 40.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 p -62.59 167.0 4.74 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.19 1.796 . . . . 0.0 112.858 176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -118.69 135.48 54.46 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -55.72 -39.4 71.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.94 0.791 . . . . 0.0 111.73 -173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.64 -22.46 61.68 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -85.77 -4.18 59.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.829 0.74 . . . . 0.0 110.87 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.54 59.58 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.917 0.77 . . . . 0.0 113.107 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.65 -31.48 72.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.389 1.094 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.56 -30.82 69.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 109.631 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.2 mt -73.51 -39.47 64.8 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.7 -45.93 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 170.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.81 92.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.748 0.419 . . . . 0.0 111.129 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.66 -48.46 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.186 0.994 . . . . 0.0 109.927 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -53.24 -46.91 69.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 t -60.17 -43.93 95.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 110.525 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -63.95 -41.63 97.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.521 -0.737 . . . . 0.0 111.618 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -59.12 -39.78 83.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.553 0.741 . . . . 0.0 109.722 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.54 -45.86 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 123.56 0.744 . . . . 0.0 109.567 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.5 -35.07 73.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.918 0.781 . . . . 0.0 112.11 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.31 -46.41 27.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.76 0.824 . . . . 0.0 112.076 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 p -137.18 3.0 2.59 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -168.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.66 23.05 5.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.656 1.116 . . . . 0.0 110.63 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.99 -14.5 35.81 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.055 -1.028 . . . . 0.0 113.42 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.21 -21.83 15.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.242 1.817 . . . . 0.0 112.787 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.56 97.98 0.16 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.524 1.53 . . . . 0.0 108.27 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -58.84 156.85 10.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.133 0.973 . . . . 0.0 110.796 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.3 57.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -65.21 -51.68 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.495 0.589 . . . . 0.0 109.533 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -70.23 -33.7 71.97 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.864 -0.523 . . . . 0.0 110.553 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -55.14 -46.31 75.66 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.896 0.878 . . . . 0.0 109.566 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 m -64.76 -48.13 75.65 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.158 0.983 . . . . 0.0 110.187 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -62.55 -42.39 99.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.466 0.575 . . . . 0.0 110.775 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.11 -50.24 64.75 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.398 -0.81 . . . . 0.0 109.412 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.03 -39.27 74.49 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.263 0.938 . . . . 0.0 110.271 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.99 -49.89 74.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.723 0.692 . . . . 0.0 111.953 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -38.82 81.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.61 -48.15 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.009 1.723 . . . . 0.0 109.818 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -62.49 -22.08 65.98 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.913 0.885 . . . . 0.0 111.112 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -99.0 6.75 46.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.192 0.997 . . . . 0.0 110.941 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -136.84 -53.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.772 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.8 mt -59.05 -37.01 48.45 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 120.369 1.441 . . . . 0.0 112.73 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.64 -12.62 29.26 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 0.0 115.924 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.98 -21.19 5.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.602 1.546 . . . . 0.0 111.799 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.05 138.24 96.14 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 110.063 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -80.13 51.41 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.669 3.579 . . . . 0.0 110.761 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.47 164.93 3.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.374 1.47 . . . . 0.0 110.513 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -108.11 109.13 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 m -92.34 141.22 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 118.296 0.498 . . . . 0.0 110.015 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.33 133.28 34.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 167.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.89 143.07 42.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.23 -178.56 6.52 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.89 -23.87 8.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.715 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -75.32 -5.19 43.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.361 1.464 . . . . 0.0 111.982 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 t0 50.22 57.45 6.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 123.939 1.828 . . . . 0.0 109.64 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -139.59 128.13 13.48 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.57 139.85 41.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.618 2.212 . . . . 0.0 111.576 -169.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.79 -9.45 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.078 0.951 . . . . 0.0 111.968 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 175.5 42.16 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.63 42.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.628 0.714 . . . . 0.0 111.177 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.51 162.89 33.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 108.777 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 tp -122.99 129.09 51.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 tp -141.17 132.74 27.04 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 p -158.23 155.85 29.7 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.758 2.023 . . . . 0.0 105.837 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.11 36.18 56.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 121.445 -0.785 . . . . 0.0 113.896 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 58.33 21.97 8.87 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.957 1.703 . . . . 0.0 113.687 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -125.3 113.1 17.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.026 0.93 . . . . 0.0 110.296 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.6 ttp -85.5 90.46 7.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.65 -26.98 66.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -173.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.93 147.19 36.64 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.539 0.736 . . . . 0.0 109.67 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.8 tp -159.24 113.24 2.35 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.363 1.865 . . . . 0.0 106.137 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.21 140.74 29.46 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -150.52 148.38 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -62.59 125.94 87.22 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.45 -27.67 19.27 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 124.018 3.145 . . . . 0.0 115.39 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.14 -22.76 67.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.316 0.962 . . . . 0.0 112.57 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.05 -1.79 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.481 0.712 . . . . 0.0 112.753 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -57.11 -43.42 82.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.276 0.943 . . . . 0.0 109.655 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.17 74.63 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.5 0.571 . . . . 0.0 112.777 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -73.44 -8.36 55.59 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.234 1.017 . . . . 0.0 112.542 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.49 19.41 52.34 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.339 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.72 -30.21 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.315 1.557 . . . . 0.0 110.591 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.79 -50.42 20.24 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.95 0.785 . . . . 0.0 112.101 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.21 -44.17 97.18 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 118.658 1.229 . . . . 0.0 110.075 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.02 -45.8 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.924 1.238 . . . . 0.0 109.918 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -67.81 -41.46 83.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.913 -0.492 . . . . 0.0 110.687 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.42 -41.85 94.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.701 0.682 . . . . 0.0 110.234 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.07 -35.96 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.473 -0.767 . . . . 0.0 109.456 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.11 -45.39 94.89 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.719 0.408 . . . . 0.0 110.54 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.8 -48.89 75.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.713 0.405 . . . . 0.0 110.761 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.5 mt -59.98 -32.72 71.09 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.148 0.979 . . . . 0.0 111.437 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.12 -37.31 86.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.373 0.533 . . . . 0.0 111.565 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.2 mtm -86.84 -24.2 25.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.38 0.537 . . . . 0.0 112.288 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.36 94.73 7.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 125.389 1.476 . . . . 0.0 108.493 -172.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.34 -23.8 51.09 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.203 1.269 . . . . 0.0 112.243 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -99.42 28.65 4.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.718 1.607 . . . . 0.0 110.537 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.04 145.33 10.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.956 2.103 . . . . 0.0 113.547 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.7 p -129.25 163.14 26.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.479 1.511 . . . . 0.0 108.44 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.9 t -153.81 -173.5 4.6 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -147.52 161.88 40.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.179 0.992 . . . . 0.0 110.05 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -155.03 143.37 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.09 129.64 39.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.96 -37.38 74.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.512 0.725 . . . . 0.0 112.607 -170.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.23 -28.65 70.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.025 0.375 . . . . 0.0 111.476 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -78.12 66.47 3.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.72 0.772 . . . . 0.0 109.935 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.67 -24.87 62.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.21 -47.5 84.16 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.959 0.504 . . . . 0.0 109.841 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.22 79.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.595 176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.9 t -56.79 -46.2 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.172 0.896 . . . . 0.0 108.972 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.59 62.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.95 -49.66 70.81 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 124.036 0.934 . . . . 0.0 110.612 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -66.81 -35.34 79.83 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -66.18 -37.92 86.79 Favored 'General case' 0 C--N 1.34 0.167 0 O-C-N 120.837 -1.164 . . . . 0.0 112.508 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.19 -43.29 92.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.932 1.242 . . . . 0.0 110.177 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.41 -34.7 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.317 1.047 . . . . 0.0 110.793 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.48 8.8 1.92 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.397 0.998 . . . . 0.0 114.518 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -76.16 162.42 28.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.61 1.705 . . . . 0.0 111.407 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -147.42 140.67 25.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.221 1.808 . . . . 0.0 106.362 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.1 t -72.65 132.5 33.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.061 0.945 . . . . 0.0 109.78 -173.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 p -127.44 -9.3 5.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.741 2.016 . . . . 0.0 111.691 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.13 177.18 41.26 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -158.46 -174.08 4.62 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.05 -0.677 . . . . 0.0 110.576 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.326 -0.423 0 C-N-CA 127.276 2.23 . . . . 0.0 107.495 171.63 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 N--CA 1.457 -0.618 0 N-CA-C 116.16 1.561 . . . . 0.0 116.16 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.0 tp -116.59 147.52 41.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 107.106 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.1 mt -116.01 147.74 40.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -118.75 139.26 51.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.96 160.25 39.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.111 0.964 . . . . 0.0 108.446 -170.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.37 151.78 51.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.63 1.572 . . . . 0.0 108.384 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.51 129.62 36.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 125.18 1.392 . . . . 0.0 110.127 -178.366 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -133.04 141.34 45.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -140.81 164.99 28.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -123.7 143.33 37.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -149.77 173.14 14.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 123.413 0.685 . . . . 0.0 110.376 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -65.26 147.66 53.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -71.99 179.36 3.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.863 1.265 . . . . 0.0 111.44 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -130.22 161.03 32.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.641 1.576 . . . . 0.0 107.131 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -69.15 -39.75 78.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.369 -0.207 . . . . 0.0 110.643 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.1 -37.2 75.31 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.679 0.392 . . . . 0.0 111.729 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.11 -2.95 26.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.172 0.589 . . . . 0.0 112.039 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.68 -39.5 31.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.267 0.937 . . . . 0.0 113.125 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.11 -28.51 68.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 111.969 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.07 -32.0 72.88 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 109.536 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -75.65 -39.22 58.02 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -56.83 -46.87 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.487 0.715 . . . . 0.0 109.203 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.29 95.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.95 0.5 . . . . 0.0 111.043 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.85 -54.08 36.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -51.76 -44.82 63.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.543 0.737 . . . . 0.0 110.255 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t -59.75 -42.28 92.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.635 0.374 . . . . 0.0 110.57 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -66.5 -43.23 85.9 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.611 -0.681 . . . . 0.0 111.006 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -58.92 -39.15 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.543 0.611 . . . . 0.0 110.305 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.61 -46.01 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.871 0.868 . . . . 0.0 109.765 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.16 -34.12 73.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.766 0.712 . . . . 0.0 111.968 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.36 -47.14 24.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.557 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.1 p -137.2 5.23 2.75 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -168.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -129.56 23.65 5.46 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.275 0.943 . . . . 0.0 110.175 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.4 -16.31 34.52 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.432 1.093 . . . . 0.0 113.624 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.77 -23.11 4.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.034 2.133 . . . . 0.0 113.221 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.1 94.37 0.34 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 m -53.9 156.55 2.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.253 1.421 . . . . 0.0 111.163 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.59 62.39 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.68 -48.01 73.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 109.973 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -67.39 -38.52 84.83 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.1 -47.94 71.24 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.628 1.171 . . . . 0.0 109.976 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.06 -49.89 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.113 0.965 . . . . 0.0 110.193 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.43 -37.09 82.5 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.081 -0.387 . . . . 0.0 110.739 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.95 -51.56 63.84 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.354 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -57.68 -37.58 73.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.467 1.03 . . . . 0.0 110.732 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.75 -48.37 74.83 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.139 0.575 . . . . 0.0 111.991 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -36.43 72.8 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -59.34 -47.35 90.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.076 1.75 . . . . 0.0 109.123 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -70.36 -11.06 60.66 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.852 -1.155 . . . . 0.0 112.707 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.2 4.85 52.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.621 0.768 . . . . 0.0 110.724 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -135.26 -54.49 0.8 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.887 -169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.0 -39.23 74.48 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.764 1.62 . . . . 0.0 112.703 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.33 -9.91 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.421 2.081 . . . . 0.0 114.883 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.63 -22.92 4.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.562 1.528 . . . . 0.0 112.332 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.83 152.06 96.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.62 65.91 8.07 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.887 3.724 . . . . 0.0 110.835 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.38 175.44 7.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.143 1.377 . . . . 0.0 112.023 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -133.71 151.0 51.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.6 2.36 . . . . 0.0 105.329 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.49 138.99 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.083 0.953 . . . . 0.0 110.886 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.03 132.65 35.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.72 142.81 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -83.4 -171.25 3.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.586 1.554 . . . . 0.0 110.656 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.39 8.31 0.05 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.215 2.206 . . . . 0.0 113.957 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -122.31 10.2 9.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 119.917 -1.739 . . . . 0.0 111.212 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 53.37 32.08 13.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.832 1.301 . . . . 0.0 111.127 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -116.68 132.4 23.4 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -169.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.59 138.0 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 112.367 -169.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.92 -10.0 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.431 1.093 . . . . 0.0 112.091 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.35 169.76 39.99 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -142.08 159.73 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.613 0.765 . . . . 0.0 111.239 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -139.74 136.0 33.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.569 2.347 . . . . 0.0 105.862 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -117.99 122.42 43.16 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -146.28 131.34 18.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.9 m -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.24 -114.06 4.31 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -129.11 14.82 6.25 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.791 0.836 . . . . 0.0 112.208 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.85 113.62 26.72 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.755 1.161 . . . . 0.0 110.735 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.8 ttp -83.23 85.41 7.21 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.07 -23.64 64.97 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.94 148.08 31.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.486 0.585 . . . . 0.0 110.606 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.3 tp -156.57 114.58 3.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -143.59 141.6 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.54 150.32 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.14 122.33 69.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.97 -27.49 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 124.334 3.356 . . . . 0.0 114.985 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.92 -23.45 65.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 112.856 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.15 -1.27 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.699 0.8 . . . . 0.0 112.782 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -57.12 -39.96 76.15 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.888 -1.133 . . . . 0.0 110.328 169.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.26 -27.96 71.49 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.473 0.559 . . . . 0.0 112.917 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.7 m -76.22 -6.52 51.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 112.34 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.25 60.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.245 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -54.8 -31.81 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.137 1.469 . . . . 0.0 110.74 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.42 -48.11 34.69 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.972 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -65.7 -40.56 92.42 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.483 1.141 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.9 t -58.86 -46.34 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.681 0.673 . . . . 0.0 109.597 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.86 -38.72 79.94 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.786 -0.571 . . . . 0.0 111.032 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.1 -40.13 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.804 0.729 . . . . 0.0 109.783 174.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.96 -37.31 86.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.058 1.299 . . . . 0.0 110.497 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -61.52 -46.97 87.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.113 0.482 . . . . 0.0 110.557 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.67 78.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.685 0.794 . . . . 0.0 110.92 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 mt -58.12 -34.44 70.22 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.053 1.341 . . . . 0.0 111.44 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.4 m -62.4 -32.48 73.31 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.277 0.489 . . . . 0.0 111.68 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.1 mtm -89.93 -25.26 21.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.464 0.574 . . . . 0.0 112.092 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.01 89.94 12.35 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.092 1.357 . . . . 0.0 109.263 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.55 -22.26 58.72 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.502 1.468 . . . . 0.0 113.192 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.38 31.55 5.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.492 1.517 . . . . 0.0 110.008 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.9 tp -48.16 142.68 5.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.507 2.323 . . . . 0.0 112.749 -171.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -126.15 161.05 28.56 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.334 1.453 . . . . 0.0 108.613 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -153.03 -176.23 5.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.723 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -147.17 160.76 42.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.585 1.154 . . . . 0.0 110.422 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.4 144.36 7.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.8 130.24 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.88 -31.61 62.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.585 0.63 . . . . 0.0 111.943 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -60.34 -32.36 71.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.654 0.782 . . . . 0.0 111.857 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -80.76 67.36 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.789 0.804 . . . . 0.0 109.535 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.8 -25.22 60.28 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.78 0.832 . . . . 0.0 111.405 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.64 -49.26 73.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.035 0.534 . . . . 0.0 110.017 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.41 -35.25 77.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.681 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.4 t -57.03 -49.2 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.94 -47.69 90.02 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -55.85 -51.3 68.01 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.578 0.751 . . . . 0.0 109.651 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.59 -34.77 78.62 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.791 -0.568 . . . . 0.0 109.787 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.98 -45.88 91.24 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.062 -1.024 . . . . 0.0 111.167 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -59.06 -39.71 82.89 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.256 0.934 . . . . 0.0 110.881 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.08 -39.07 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.514 0.726 . . . . 0.0 110.407 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.15 13.21 0.69 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.501 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -80.93 156.06 26.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.803 1.801 . . . . 0.0 111.652 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -144.43 140.76 29.18 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.444 1.897 . . . . 0.0 107.261 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.12 137.94 22.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.06 0.944 . . . . 0.0 110.318 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.2 p -131.12 -9.73 3.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.809 2.044 . . . . 0.0 111.59 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.23 173.27 42.41 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.84 -173.63 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.873 0.836 . . . . 0.0 111.259 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 126.488 1.915 . . . . 0.0 108.542 177.618 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.457 -0.651 0 N-CA-C 114.699 1.0 . . . . 0.0 114.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.15 142.98 33.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.39 149.62 29.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -123.01 137.9 54.83 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.65 161.84 35.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -169.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.47 146.54 51.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.662 1.585 . . . . 0.0 108.897 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.04 127.03 31.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 111.943 179.646 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.236 0.391 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 mm -137.36 145.24 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -144.15 166.01 26.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -125.66 141.85 44.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.78 170.31 21.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 109.998 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -59.07 146.94 36.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 109.818 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 p -62.51 157.91 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.961 1.704 . . . . 0.0 112.595 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -106.55 155.18 19.89 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -67.92 -42.09 81.59 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.711 -0.618 . . . . 0.0 110.648 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.45 -25.66 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.07 -0.06 53.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.059 0.544 . . . . 0.0 111.4 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.21 -41.77 47.71 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 118.998 0.817 . . . . 0.0 113.281 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.78 -26.05 65.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.645 1.223 . . . . 0.0 111.901 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.54 -30.73 67.55 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.281 -0.887 . . . . 0.0 109.621 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 mt -73.01 -39.9 65.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.18 -45.02 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 109.456 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.94 98.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.831 0.452 . . . . 0.0 111.635 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.96 -49.56 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.589 0.756 . . . . 0.0 109.401 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -55.01 -47.79 74.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.688 0.395 . . . . 0.0 110.232 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -59.97 -44.52 94.41 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -64.4 -33.37 75.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.614 0.766 . . . . 0.0 111.813 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -68.4 -39.93 81.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.8 t -66.29 -47.25 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.07 -32.36 66.17 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.754 0.821 . . . . 0.0 112.65 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 -43.04 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.024 0.929 . . . . 0.0 112.482 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.7 p -138.76 -1.41 1.82 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -168.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -135.24 17.84 3.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.381 1.446 . . . . 0.0 112.326 -172.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.48 1.34 0.82 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.766 2.027 . . . . 0.0 114.368 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -59.41 -24.24 63.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.322 1.849 . . . . 0.0 112.523 172.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.08 112.21 2.53 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 m -56.91 154.37 9.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.971 1.308 . . . . 0.0 110.766 172.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.28 -36.75 71.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.2 -47.08 71.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.749 0.704 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -64.72 -40.24 95.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.282 0.633 . . . . 0.0 109.821 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -55.36 -48.56 74.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.611 1.164 . . . . 0.0 110.139 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.8 m -65.08 -49.18 71.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.177 0.991 . . . . 0.0 110.041 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -65.95 -38.45 88.65 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.223 -0.298 . . . . 0.0 110.641 -176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.78 -53.58 52.12 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.386 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.78 -38.22 75.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.244 0.929 . . . . 0.0 110.789 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.99 -48.81 72.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 111.857 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -36.54 75.34 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.177 0.444 . . . . 0.0 110.192 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.87 -48.95 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 126.071 1.748 . . . . 0.0 109.091 172.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -70.3 -10.56 59.31 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.001 -1.062 . . . . 0.0 112.742 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.46 4.2 53.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.625 0.77 . . . . 0.0 110.608 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -135.14 -56.58 0.81 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.805 -1.093 . . . . 0.0 112.336 -169.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.89 -38.65 70.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.644 1.565 . . . . 0.0 113.211 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 -14.8 36.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.422 2.081 . . . . 0.0 115.052 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.72 -13.82 5.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.484 1.493 . . . . 0.0 112.73 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.75 150.55 96.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.844 1.257 . . . . 0.0 111.166 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.78 55.94 5.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.663 3.575 . . . . 0.0 111.94 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.98 155.04 26.61 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.349 1.06 . . . . 0.0 111.146 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -111.32 109.7 19.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.66 138.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.44 133.88 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -126.47 141.5 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -83.71 178.74 7.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.05 -23.93 0.95 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.869 2.068 . . . . 0.0 114.661 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -79.27 -3.34 45.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.669 1.588 . . . . 0.0 112.274 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t0 50.76 57.69 6.36 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.929 1.823 . . . . 0.0 109.69 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -140.63 126.35 11.43 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 141.95 54.02 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.468 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.05 -8.67 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.372 1.069 . . . . 0.0 112.304 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.75 171.55 39.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.42 153.06 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.81 0.805 . . . . 0.0 110.667 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -136.91 132.02 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.539 2.336 . . . . 0.0 105.667 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.75 117.37 31.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.78 133.47 25.27 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 m -143.04 152.74 42.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.76 -114.89 5.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -130.68 27.66 4.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 110.679 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -125.58 111.47 15.05 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.53 -0.731 . . . . 0.0 110.458 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -79.39 89.02 4.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.23 -29.26 70.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.924 0.89 . . . . 0.0 112.979 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.95 148.81 29.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.826 0.851 . . . . 0.0 110.488 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 tp -155.36 119.37 4.58 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.0 1.72 . . . . 0.0 106.463 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.12 144.31 30.85 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -151.43 142.93 16.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.9 133.81 95.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.547 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.67 -24.31 70.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.755 2.303 . . . . 0.0 113.729 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.59 -24.2 67.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.416 1.007 . . . . 0.0 112.902 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.42 -1.22 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -59.91 -38.49 82.49 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.978 -1.076 . . . . 0.0 110.223 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.02 72.09 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.563 0.601 . . . . 0.0 112.776 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.1 m -75.03 -6.5 49.75 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.229 1.014 . . . . 0.0 112.214 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.39 13.73 65.1 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.377 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.64 -31.2 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 119.255 1.527 . . . . 0.0 111.088 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.27 -54.38 10.23 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.947 0.784 . . . . 0.0 111.95 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -64.32 -43.76 93.66 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.031 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 t -56.78 -46.66 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 120.453 1.479 . . . . 0.0 110.179 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.15 -40.33 78.29 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.349 0.522 . . . . 0.0 111.147 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.55 -40.94 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.713 0.688 . . . . 0.0 109.883 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.71 -34.45 77.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.21 0.914 . . . . 0.0 109.87 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -61.2 -46.79 88.99 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.404 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.73 80.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.268 0.627 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.97 -33.18 71.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 111.459 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -63.18 -36.61 84.19 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.486 0.584 . . . . 0.0 111.392 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.4 mtm -85.17 -23.95 28.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.32 0.509 . . . . 0.0 112.117 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.42 95.19 6.63 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 125.123 1.369 . . . . 0.0 109.184 -173.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.16 -25.99 50.19 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 121.29 1.326 . . . . 0.0 112.554 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.03 31.52 3.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.822 1.649 . . . . 0.0 110.369 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.9 tp -49.63 146.37 4.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.662 2.385 . . . . 0.0 113.118 -172.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.9 p -129.94 162.91 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.558 1.543 . . . . 0.0 108.969 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 t -155.76 -178.05 7.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.736 0.414 . . . . 0.0 110.548 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.13 155.39 50.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.621 1.569 . . . . 0.0 108.782 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.63 146.44 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -77.52 138.9 39.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -63.13 -24.19 67.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.637 0.375 . . . . 0.0 111.932 -176.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.97 -40.46 70.04 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.398 0.679 . . . . 0.0 111.538 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -86.15 63.81 8.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.551 1.141 . . . . 0.0 109.331 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.73 -28.27 47.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.207 1.003 . . . . 0.0 111.316 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -47.04 83.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.718 0.807 . . . . 0.0 109.802 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.17 78.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.907 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.14 -49.46 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 119.57 1.077 . . . . 0.0 108.476 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.84 93.59 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -56.2 -50.6 70.78 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.536 0.735 . . . . 0.0 110.147 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -67.13 -33.88 76.39 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.88 -0.513 . . . . 0.0 109.822 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -59.29 -47.09 86.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.144 0.884 . . . . 0.0 110.901 170.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -58.81 -42.68 89.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.986 0.812 . . . . 0.0 110.429 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.03 -36.61 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.932 0.893 . . . . 0.0 110.737 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 136.02 9.86 1.42 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.8 -1.0 . . . . 0.0 114.638 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.38 155.49 30.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.87 1.835 . . . . 0.0 111.252 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.49 138.99 33.21 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.147 1.779 . . . . 0.0 106.574 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.9 t -71.73 135.03 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.17 0.988 . . . . 0.0 109.995 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 p -126.77 -8.69 6.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.951 2.1 . . . . 0.0 111.481 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.3 43.94 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.901 0.773 . . . . 0.0 111.735 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -154.66 176.1 12.85 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.653 0.781 . . . . 0.0 110.185 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 127.679 2.392 . . . . 0.0 106.089 176.29 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 115.547 1.326 . . . . 0.0 115.547 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.42 145.64 50.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.2 mt -116.69 150.1 38.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -120.16 138.87 53.35 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.89 160.83 38.25 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.398 1.079 . . . . 0.0 108.591 -170.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.9 150.97 52.11 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.706 1.602 . . . . 0.0 108.569 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -76.46 124.84 28.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.407 1.083 . . . . 0.0 110.434 -177.306 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 121.458 0.647 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 mm -138.14 144.77 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -140.78 165.35 27.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 168.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mm -127.12 143.18 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -155.02 170.63 21.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.041 0.937 . . . . 0.0 109.822 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -59.02 147.8 33.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.489 0.586 . . . . 0.0 109.905 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p -63.4 154.41 32.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.584 1.553 . . . . 0.0 112.6 174.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -100.16 155.28 17.83 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -65.48 -48.51 72.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.852 -0.53 . . . . 0.0 110.278 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.24 -27.33 64.37 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -169.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.5 -5.76 51.18 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.141 0.428 . . . . 0.0 111.497 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.37 -35.64 36.01 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 124.184 0.897 . . . . 0.0 113.355 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -66.72 -31.51 72.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.293 1.047 . . . . 0.0 111.281 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.96 -31.32 70.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.402 0.681 . . . . 0.0 109.587 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.38 -39.74 64.88 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.792 -0.567 . . . . 0.0 109.774 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -57.89 -46.11 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 171.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.13 99.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 111.688 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.3 mt -62.11 -50.27 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 109.432 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -51.98 -47.88 64.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.534 . . . . 0.0 110.269 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 t -58.62 -50.39 74.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.153 0.433 . . . . 0.0 110.747 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -70.74 -28.18 64.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.504 -0.748 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -63.16 -44.92 94.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.081 0.855 . . . . 0.0 109.435 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.89 -42.54 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.772 0.829 . . . . 0.0 109.425 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.37 -35.05 73.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.021 0.828 . . . . 0.0 111.888 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.47 -36.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.111 -0.947 . . . . 0.0 113.1 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -136.58 -13.41 1.74 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -169.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.76 29.64 4.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.129 0.971 . . . . 0.0 110.572 -169.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -12.76 11.4 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.289 1.436 . . . . 0.0 113.495 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -51.61 -23.0 3.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.333 1.853 . . . . 0.0 113.203 169.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.34 97.78 0.43 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.667 1.187 . . . . 0.0 108.741 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -54.35 157.82 2.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.999 1.319 . . . . 0.0 110.712 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.42 64.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -46.81 72.37 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.901 0.773 . . . . 0.0 110.246 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.16 -40.89 97.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.632 0.773 . . . . 0.0 109.715 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -56.65 -47.28 80.09 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 124.256 1.022 . . . . 0.0 109.992 175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 m -65.78 -47.03 76.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.242 1.017 . . . . 0.0 110.393 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.0 -36.97 83.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.228 0.467 . . . . 0.0 110.712 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.91 -49.92 66.3 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.68 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.09 -39.45 72.14 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.126 0.875 . . . . 0.0 110.27 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.92 -48.33 80.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.809 0.731 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.69 -38.9 77.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -58.88 -47.55 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.979 1.711 . . . . 0.0 109.781 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -60.82 -24.22 65.68 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.367 1.067 . . . . 0.0 111.121 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -99.66 7.13 45.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.316 1.046 . . . . 0.0 110.969 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -136.96 -54.08 0.71 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.81 -169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.26 -37.76 60.75 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.642 1.565 . . . . 0.0 113.048 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -61.84 -14.15 34.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.337 2.025 . . . . 0.0 115.479 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.32 -14.6 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.645 1.566 . . . . 0.0 112.48 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 150.15 93.28 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.835 1.254 . . . . 0.0 110.834 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.28 50.83 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.56 3.506 . . . . 0.0 111.675 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.36 162.05 29.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.461 1.104 . . . . 0.0 110.993 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.06 117.03 28.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -99.06 140.08 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.24 0.616 . . . . 0.0 109.992 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.88 137.83 34.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.92 144.52 37.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -85.43 -175.62 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.586 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.79 -25.3 40.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.335 1.454 . . . . 0.0 113.415 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -79.75 -1.66 39.6 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.04 0.936 . . . . 0.0 111.498 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.4 t0 51.98 57.43 6.5 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.558 1.647 . . . . 0.0 109.238 -169.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -136.35 127.59 16.85 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.26 141.34 47.01 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.498 2.132 . . . . 0.0 111.681 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.17 -11.74 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 112.103 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.25 172.69 41.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.5 160.96 40.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.545 0.688 . . . . 0.0 111.494 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -140.29 137.1 33.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.068 2.547 . . . . 0.0 106.1 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.2 tp -115.48 127.52 55.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -144.36 140.87 29.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -154.21 155.81 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.19 -114.24 4.85 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -169.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -133.98 36.81 3.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.641 1.177 . . . . 0.0 110.043 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -134.05 115.38 14.24 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 121.212 -0.93 . . . . 0.0 111.34 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 56.1 ttp -86.2 90.41 8.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.95 -29.31 67.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.75 144.69 35.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.218 0.607 . . . . 0.0 110.799 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.0 tp -157.12 115.47 3.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.451 1.901 . . . . 0.0 106.14 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.69 141.35 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -151.4 146.21 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -59.24 122.13 61.19 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.27 -24.47 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.815 3.01 . . . . 0.0 115.36 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.43 -25.14 67.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.244 0.929 . . . . 0.0 112.75 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.45 -8.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -46.99 -41.61 16.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.005 1.322 . . . . 0.0 111.799 171.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.43 -12.22 65.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.866 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.9 -22.18 62.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.317 1.558 . . . . 0.0 112.109 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 137.18 -9.17 3.83 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.031 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.66 -32.17 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 119.161 1.48 . . . . 0.0 111.278 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.92 -53.92 16.31 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 123.538 0.589 . . . . 0.0 111.656 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -63.57 -42.4 98.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.262 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.72 -46.46 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.593 1.542 . . . . 0.0 109.932 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.4 mt -68.28 -41.81 80.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.982 -0.448 . . . . 0.0 110.77 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.74 -42.87 96.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.535 0.607 . . . . 0.0 110.181 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.52 -36.22 82.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.561 0.745 . . . . 0.0 109.59 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.82 -44.97 93.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.884 0.474 . . . . 0.0 110.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.34 63.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.158 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.72 -31.13 67.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.393 1.077 . . . . 0.0 111.782 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.82 -31.79 72.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.759 0.709 . . . . 0.0 111.969 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.0 mtm -91.77 -20.79 21.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.286 0.635 . . . . 0.0 112.208 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 94.88 6.1 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.532 1.533 . . . . 0.0 108.175 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.99 -21.83 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 CA-C-N 120.738 1.299 . . . . 0.0 112.887 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -104.52 30.28 5.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.721 1.608 . . . . 0.0 110.182 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.93 149.16 12.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.477 2.311 . . . . 0.0 113.56 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p -128.04 162.1 27.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.188 1.395 . . . . 0.0 109.811 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 t -152.72 -174.12 4.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 109.75 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -147.85 162.59 38.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.231 1.012 . . . . 0.0 109.994 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -157.0 143.49 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -71.04 133.74 46.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.88 -31.73 70.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 0.0 111.782 -172.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.17 -32.2 73.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.848 0.459 . . . . 0.0 111.465 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -80.58 61.56 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.865 1.266 . . . . 0.0 109.143 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.92 -26.37 47.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.479 1.112 . . . . 0.0 111.381 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -47.65 81.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.6 75.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.83 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.0 t -57.02 -48.53 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 119.578 1.081 . . . . 0.0 108.484 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.76 93.9 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.92 -51.11 67.09 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 123.633 0.773 . . . . 0.0 110.02 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.76 -34.53 78.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.027 -0.42 . . . . 0.0 109.956 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.28 -47.91 82.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.246 0.93 . . . . 0.0 110.778 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -58.85 -41.6 87.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.051 0.841 . . . . 0.0 110.757 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.77 -36.07 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.091 0.957 . . . . 0.0 110.478 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.91 9.51 1.7 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.338 0.97 . . . . 0.0 114.272 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.92 154.84 35.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.222 1.511 . . . . 0.0 111.449 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -139.62 138.66 36.33 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.637 1.575 . . . . 0.0 106.759 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.64 135.28 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.214 1.006 . . . . 0.0 109.86 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 p -125.12 -9.75 7.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.714 2.006 . . . . 0.0 111.327 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.17 179.77 43.57 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 118.755 0.707 . . . . 0.0 111.43 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -154.8 179.0 9.51 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 109.246 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 107.96 -178.477 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 CA--C 1.537 0.646 0 N-CA-C 118.902 2.616 . . . . 0.0 118.902 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.22 148.27 32.18 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.661 1.584 . . . . 0.0 107.255 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.9 mt -113.77 148.33 36.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -119.09 138.27 53.0 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.756 1.223 . . . . 0.0 107.753 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.14 162.47 33.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 108.525 -171.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.02 51.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.792 1.637 . . . . 0.0 108.134 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -72.48 127.2 31.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.191 -179.086 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.5 t . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -128.46 146.22 34.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.61 167.14 22.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 168.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.5 mm -126.22 142.87 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -154.53 171.56 19.23 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.881 0.872 . . . . 0.0 109.955 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -61.31 150.31 35.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.544 0.611 . . . . 0.0 109.781 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 p -60.11 162.56 5.66 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.037 1.335 . . . . 0.0 112.046 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -120.82 139.18 53.5 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.489 1.916 . . . . 0.0 106.131 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -57.44 -41.45 80.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.474 0.579 . . . . 0.0 111.563 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.53 -19.3 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -88.56 -2.59 58.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.863 0.756 . . . . 0.0 111.33 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.52 -39.17 44.53 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 118.92 0.782 . . . . 0.0 113.467 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.88 -28.94 70.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.195 0.998 . . . . 0.0 112.13 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.33 -35.6 81.48 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 118.868 0.758 . . . . 0.0 109.647 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.3 -39.31 59.75 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.6 t -58.46 -45.58 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.284 0.634 . . . . 0.0 109.411 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.59 91.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.339 0.656 . . . . 0.0 112.176 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.36 -49.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.695 1.198 . . . . 0.0 109.258 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -55.87 -45.72 78.46 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.864 -0.523 . . . . 0.0 110.319 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.3 t -59.91 -49.74 76.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.739 0.816 . . . . 0.0 110.903 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.52 -25.72 64.17 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.018 -1.051 . . . . 0.0 111.976 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 m -68.6 -34.32 75.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.049 0.841 . . . . 0.0 110.595 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.1 -46.48 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.5 -40.67 92.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.38 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.448 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 p -137.9 3.14 2.44 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -168.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.44 ' CE1' HD21 ' A' ' 110' ' ' ASN . 15.9 m80 -126.99 37.53 4.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.324 1.42 . . . . 0.0 109.305 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.25 -27.47 55.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.353 1.061 . . . . 0.0 113.784 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.09 -17.19 64.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.534 0.734 . . . . 0.0 112.957 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.9 127.14 30.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.531 1.132 . . . . 0.0 110.783 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -56.48 138.08 52.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.096 1.358 . . . . 0.0 110.055 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.57 80.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.078 0.399 . . . . 0.0 112.024 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -66.17 -42.86 88.34 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.783 -0.573 . . . . 0.0 109.696 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.66 -38.89 84.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.37 -52.93 57.69 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.887 0.875 . . . . 0.0 109.329 172.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.9 m -59.39 -49.07 79.23 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 110.321 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.12 -35.37 71.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.29 -0.256 . . . . 0.0 111.18 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.81 -49.7 73.9 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.14 -36.59 77.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.052 0.842 . . . . 0.0 110.441 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.08 -47.89 80.97 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.014 0.525 . . . . 0.0 111.907 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -36.56 71.16 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.122 -0.361 . . . . 0.0 110.104 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.46 -46.99 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.111 1.765 . . . . 0.0 109.229 172.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -70.25 -9.05 54.77 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.797 -1.19 . . . . 0.0 112.555 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -101.28 6.68 42.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.174 0.99 . . . . 0.0 110.891 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.99 -55.1 0.72 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.653 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.45 -38.4 68.03 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 120.57 1.532 . . . . 0.0 112.932 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -61.46 -14.18 33.51 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.323 2.015 . . . . 0.0 114.94 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.63 -17.45 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.596 1.544 . . . . 0.0 112.38 -174.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.34 148.37 98.03 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.585 1.154 . . . . 0.0 110.826 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.39 51.48 3.89 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.942 3.762 . . . . 0.0 111.373 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.34 165.48 20.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.595 1.158 . . . . 0.0 110.691 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -118.38 109.77 16.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.04 138.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.191 0.596 . . . . 0.0 109.663 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.9 134.27 35.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 167.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.35 143.86 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -77.04 -177.32 4.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.172 0.987 . . . . 0.0 110.12 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.0 -17.86 20.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.446 1.898 . . . . 0.0 113.552 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.71 4.56 53.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.383 1.473 . . . . 0.0 112.046 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.6 t0 53.27 46.25 26.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.716 1.246 . . . . 0.0 110.235 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 129.19 24.21 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.86 138.96 71.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.85 1.7 . . . . 0.0 110.282 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.7 -8.89 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.714 1.205 . . . . 0.0 112.233 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.83 174.2 40.78 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -148.16 159.49 43.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.804 0.802 . . . . 0.0 111.517 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -136.97 141.25 42.59 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.329 2.652 . . . . 0.0 105.826 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -122.9 127.34 48.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 tp -145.37 139.85 27.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.7 m -153.25 156.3 38.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.2 -116.12 7.0 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -169.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.0 25.78 4.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.874 0.87 . . . . 0.0 111.51 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -110.9 112.36 24.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.306 1.042 . . . . 0.0 110.685 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.6 ttp -80.04 87.27 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 169.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.1 -23.02 65.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.12 146.55 30.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.447 0.567 . . . . 0.0 110.263 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.9 tp -156.08 116.05 3.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.74 141.4 30.45 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -148.11 146.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -59.64 122.76 67.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.06 -29.59 6.46 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.049 3.166 . . . . 0.0 114.638 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.38 -24.53 67.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.187 0.995 . . . . 0.0 113.563 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.77 -1.51 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -58.16 -37.4 74.61 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.905 -1.122 . . . . 0.0 110.67 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.27 -21.58 68.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.824 0.726 . . . . 0.0 113.394 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.7 m -79.36 -3.35 45.84 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.635 1.217 . . . . 0.0 111.846 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.97 68.44 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.359 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.7 -31.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.196 1.498 . . . . 0.0 110.994 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.9 -53.52 13.9 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 123.831 0.729 . . . . 0.0 111.722 170.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -63.25 -43.24 98.57 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.213 -1.375 . . . . 0.0 110.19 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -57.83 -46.27 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 120.356 1.435 . . . . 0.0 110.076 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.36 -40.59 77.39 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.803 -0.561 . . . . 0.0 111.144 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.2 t -62.69 -41.24 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.646 0.657 . . . . 0.0 109.991 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.91 -34.13 76.04 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.124 0.875 . . . . 0.0 109.876 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -60.1 -47.04 87.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.231 0.469 . . . . 0.0 110.261 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.64 75.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.419 0.688 . . . . 0.0 110.785 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.17 -34.07 69.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.532 1.133 . . . . 0.0 111.458 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.72 -34.11 76.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.447 0.567 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 43.5 mtm -90.2 -21.88 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.363 0.529 . . . . 0.0 112.124 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.12 90.63 9.18 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 -172.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -21.99 59.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.513 1.475 . . . . 0.0 113.134 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -107.34 33.02 4.23 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.606 1.562 . . . . 0.0 109.808 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.5 tp -48.58 144.86 3.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.412 2.285 . . . . 0.0 112.951 -171.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.7 p -129.9 161.57 30.56 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.761 1.625 . . . . 0.0 108.102 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 t -153.09 -179.55 7.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.42 0.628 . . . . 0.0 110.555 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -143.07 159.32 42.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.275 1.03 . . . . 0.0 109.758 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.7 p -155.14 142.85 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -71.26 131.54 43.62 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 110' ' ' ASN . 30.8 tt0 -60.62 -22.46 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.563 0.745 . . . . 0.0 112.001 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.61 21.13 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.99 1.716 . . . . 0.0 113.098 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.44 HD21 ' CE1' ' A' ' 28' ' ' HIS . 64.9 t-20 -148.51 66.24 1.07 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.975 1.71 . . . . 0.0 108.143 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.71 -24.77 58.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.513 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -62.71 -48.94 77.07 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.889 0.476 . . . . 0.0 110.105 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.62 82.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.442 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.29 -49.65 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.71 -46.2 94.69 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -56.59 -50.67 71.27 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -67.38 -33.62 75.59 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.907 -0.496 . . . . 0.0 109.665 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.53 -48.39 81.0 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.11 0.868 . . . . 0.0 110.853 170.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.38 -42.67 87.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.905 0.775 . . . . 0.0 110.499 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.53 -34.42 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.206 1.003 . . . . 0.0 111.069 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.64 9.86 1.94 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.297 169.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -77.19 155.22 32.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.737 1.769 . . . . 0.0 111.039 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.63 139.76 33.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.14 1.776 . . . . 0.0 106.58 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.73 135.42 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 123.888 0.875 . . . . 0.0 109.93 -170.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 p -124.2 -10.77 7.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.507 1.923 . . . . 0.0 111.244 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 179.16 45.02 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 118.823 0.738 . . . . 0.0 111.844 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.91 175.74 11.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.217 1.007 . . . . 0.0 108.4 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.532 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 CA--C 1.536 0.601 0 N-CA-C 116.557 1.714 . . . . 0.0 116.557 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.1 tp -136.28 146.34 46.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.424 1.89 . . . . 0.0 106.368 169.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.86 149.18 39.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -126.71 137.28 53.24 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.676 1.19 . . . . 0.0 108.549 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.9 161.99 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.316 1.046 . . . . 0.0 108.583 -169.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.91 150.45 52.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 108.631 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -76.61 126.54 31.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 124.939 1.296 . . . . 0.0 110.431 -177.284 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 mm -127.74 144.16 38.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -142.13 165.38 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mm -124.1 142.71 39.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -151.84 174.24 13.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.814 0.846 . . . . 0.0 110.046 174.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -63.82 152.61 39.07 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -63.52 174.61 1.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.122 1.769 . . . . 0.0 112.326 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -132.06 142.44 49.54 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.168 1.787 . . . . 0.0 106.493 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -57.73 -40.26 79.22 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.205 0.457 . . . . 0.0 110.897 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.07 -13.43 61.58 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.74 -0.84 41.93 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.865 0.757 . . . . 0.0 110.957 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.2 -40.72 60.31 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.587 0.613 . . . . 0.0 113.182 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.82 -28.2 68.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.348 1.074 . . . . 0.0 111.685 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.485 -0.759 . . . . 0.0 109.908 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.15 -38.96 69.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.39 -47.79 83.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.82 89.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.056 0.542 . . . . 0.0 111.699 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.45 -51.25 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.825 1.25 . . . . 0.0 109.782 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -54.55 -50.17 68.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.933 0.493 . . . . 0.0 109.676 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.46 -48.63 68.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.394 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.74 -33.86 64.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.87 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -27.1 63.67 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 120.531 1.514 . . . . 0.0 111.313 172.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.26 -45.74 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 O-C-N 121.269 -0.894 . . . . 0.0 109.068 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.73 -38.01 83.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.004 0.82 . . . . 0.0 111.904 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.83 -36.59 56.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.249 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.0 p -138.94 -4.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CE1' HD21 ' A' ' 110' ' ' ASN . 20.4 m80 -126.96 25.23 6.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.9 1.227 . . . . 0.0 110.458 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.49 -15.9 31.58 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -53.03 -22.64 6.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.812 2.045 . . . . 0.0 113.155 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.94 97.54 0.36 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.876 1.27 . . . . 0.0 108.163 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -54.82 155.69 4.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 111.181 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.28 64.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.19 -48.13 68.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.85 0.75 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.44 -40.0 94.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.192 0.597 . . . . 0.0 109.872 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -55.2 -47.28 75.48 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.781 1.232 . . . . 0.0 110.195 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.5 m -64.97 -49.72 69.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.019 0.928 . . . . 0.0 110.011 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.01 -38.05 87.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.962 0.346 . . . . 0.0 110.725 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 mt -62.39 -53.67 51.6 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.519 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.16 -39.58 75.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.18 0.9 . . . . 0.0 110.54 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.42 -48.58 77.2 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.958 0.503 . . . . 0.0 111.882 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.072 0.396 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.43 -48.09 88.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 109.279 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -69.94 -10.56 58.99 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.013 -1.054 . . . . 0.0 112.498 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -98.21 5.62 48.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 110.702 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.15 -56.97 0.76 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 117.739 -1.124 . . . . 0.0 112.507 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.49 -38.95 73.55 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 120.793 1.633 . . . . 0.0 113.125 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.39 -14.38 34.39 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.266 1.977 . . . . 0.0 114.818 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -129.01 -14.03 4.47 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.862 1.665 . . . . 0.0 113.144 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.11 91.23 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.048 1.339 . . . . 0.0 111.514 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.46 60.25 7.01 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.844 3.696 . . . . 0.0 110.872 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -83.06 179.69 7.68 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.818 1.294 . . . . 0.0 110.831 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -135.38 140.66 45.17 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.58 2.752 . . . . 0.0 103.921 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.77 139.77 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 119.264 0.938 . . . . 0.0 110.063 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.8 132.66 35.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.43 141.78 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -81.74 -179.82 7.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.358 171.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.55 -25.87 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.769 2.028 . . . . 0.0 114.33 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -85.17 3.35 39.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.288 1.435 . . . . 0.0 112.175 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 51.33 59.31 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 123.761 1.743 . . . . 0.0 109.182 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -131.84 119.27 16.93 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.89 139.78 76.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.019 1.813 . . . . 0.0 109.393 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.66 -10.54 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.681 1.193 . . . . 0.0 111.977 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.12 173.03 41.63 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.86 160.94 41.08 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.615 0.722 . . . . 0.0 111.407 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -141.56 129.78 22.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.836 2.454 . . . . 0.0 105.506 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.7 tp -109.06 124.89 51.48 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.7 tp -145.86 134.75 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m -159.72 155.61 26.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.081 2.152 . . . . 0.0 105.281 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.67 57.53 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.862 0.756 . . . . 0.0 113.881 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 58.43 21.77 8.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.992 1.717 . . . . 0.0 113.731 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -124.46 112.87 17.41 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.946 0.899 . . . . 0.0 110.079 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -85.22 85.79 7.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.76 -28.31 69.79 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.26 144.19 31.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.015 0.526 . . . . 0.0 110.094 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.8 tp -153.7 112.07 3.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -142.58 140.88 31.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.07 154.63 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -171.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -65.0 124.17 85.94 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.65 -27.59 8.1 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.147 3.231 . . . . 0.0 114.759 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.59 -24.15 66.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.978 0.911 . . . . 0.0 112.935 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.49 -2.76 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.759 0.824 . . . . 0.0 112.86 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -55.18 -42.91 73.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.553 1.07 . . . . 0.0 109.786 169.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.81 -26.73 72.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.496 -0.613 . . . . 0.0 113.132 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.9 m -74.57 -8.07 55.14 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.497 1.149 . . . . 0.0 112.419 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.02 13.93 56.98 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.399 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -56.01 -30.22 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.403 1.602 . . . . 0.0 110.293 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -46.89 -52.38 11.8 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.221 0.915 . . . . 0.0 111.883 169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.35 -44.58 96.14 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.079 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.45 -46.96 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.835 1.198 . . . . 0.0 109.963 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.0 mt -69.3 -39.72 78.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.281 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.13 -40.27 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.817 0.735 . . . . 0.0 109.939 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.91 -34.68 78.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.375 0.989 . . . . 0.0 109.762 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -60.74 -48.51 81.49 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 122.908 0.483 . . . . 0.0 110.318 173.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.3 77.19 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.612 0.765 . . . . 0.0 110.93 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.46 -33.46 71.32 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.591 1.156 . . . . 0.0 111.546 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 m -62.92 -35.56 80.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.578 0.626 . . . . 0.0 111.547 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -85.73 -25.39 26.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.364 0.529 . . . . 0.0 112.082 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.05 94.29 7.9 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.176 1.391 . . . . 0.0 109.16 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.99 -23.31 46.88 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.24 1.293 . . . . 0.0 112.405 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.77 29.08 4.32 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.753 1.621 . . . . 0.0 110.489 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.7 tp -52.49 144.79 12.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.238 2.215 . . . . 0.0 113.248 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.9 p -129.28 164.57 23.21 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.82 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -154.86 -174.47 5.0 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.236 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -148.28 162.03 40.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 110.001 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.1 p -157.71 148.69 9.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -70.0 130.33 41.88 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.54 -33.23 65.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.038 1.335 . . . . 0.0 111.805 -172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.39 -27.77 68.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 0.0 111.779 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.451 HD21 ' CE1' ' A' ' 28' ' ' HIS . 57.5 t-20 -79.72 64.97 4.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.434 0.694 . . . . 0.0 109.52 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.27 -25.54 59.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.75 0.82 . . . . 0.0 111.388 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.79 -48.28 79.81 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 109.954 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.61 78.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.65 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.21 -45.35 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 119.319 0.963 . . . . 0.0 109.001 173.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.66 -49.59 71.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -54.74 -50.49 68.24 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.912 0.885 . . . . 0.0 110.44 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.02 -35.72 81.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.51 -39.75 94.36 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 120.875 -1.141 . . . . 0.0 112.552 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.18 -41.73 89.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.997 1.271 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.26 -34.18 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.307 1.043 . . . . 0.0 110.634 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.27 4.86 2.47 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.5 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -71.64 165.64 23.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.331 1.565 . . . . 0.0 111.197 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.52 140.78 33.54 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.755 2.022 . . . . 0.0 106.036 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.33 129.52 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.1 p -128.82 -7.2 5.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.012 1.725 . . . . 0.0 111.249 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.46 176.92 39.55 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 169.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -157.04 -178.81 7.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.728 0.811 . . . . 0.0 109.533 171.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 125.565 1.546 . . . . 0.0 108.073 -178.789 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_exo . . . . . 0 CA--C 1.536 0.607 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.4 147.77 27.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 106.886 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.76 148.82 32.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -115.11 139.2 50.1 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.07 157.97 45.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -172.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.94 150.85 52.04 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.053 1.341 . . . . 0.0 108.206 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -76.31 130.87 38.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 124.77 1.228 . . . . 0.0 109.895 -177.418 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 mm -130.95 145.67 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -140.54 162.49 35.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.2 mm -117.76 141.7 35.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.54 177.77 10.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 109.872 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -73.63 150.3 41.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 m -72.69 -177.26 2.23 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.403 1.081 . . . . 0.0 111.154 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.87 161.45 32.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -67.34 -40.11 85.84 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.925 0.33 . . . . 0.0 110.116 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.73 -26.38 64.29 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.7 1.79 52.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.634 0.774 . . . . 0.0 111.301 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.53 -41.67 49.67 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.281 0.946 . . . . 0.0 112.837 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.03 -26.86 68.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.057 0.929 . . . . 0.0 112.228 -178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.88 -34.59 78.12 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.966 0.803 . . . . 0.0 109.598 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.46 -38.16 49.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.43 -45.45 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -45.71 91.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.074 0.55 . . . . 0.0 111.448 178.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.3 mt -59.56 -48.52 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 109.702 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.37 -51.04 66.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.619 0.767 . . . . 0.0 110.204 173.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.05 -40.83 90.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.897 -0.502 . . . . 0.0 110.367 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -66.23 -42.99 87.86 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.327 0.651 . . . . 0.0 111.216 177.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -59.05 -37.06 76.11 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.917 0.487 . . . . 0.0 111.052 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -72.2 -44.32 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.269 0.628 . . . . 0.0 109.319 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -60.27 -37.81 81.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.012 0.824 . . . . 0.0 111.721 174.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.36 61.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.855 -174.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.1 p -139.27 -3.1 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -169.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CE1' HD21 ' A' ' 110' ' ' ASN . 16.3 m80 -126.72 26.28 6.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.686 1.13 . . . . 0.0 110.456 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -13.92 28.99 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.847 -1.158 . . . . 0.0 113.053 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -57.25 -21.1 31.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.063 1.745 . . . . 0.0 112.995 170.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.05 109.69 1.9 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 m -58.05 147.53 29.25 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.533 1.533 . . . . 0.0 110.238 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.34 67.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.88 -52.48 56.35 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -70.79 -31.84 68.74 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.891 -0.506 . . . . 0.0 110.596 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 tpp85 -54.67 -46.38 74.03 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.956 0.902 . . . . 0.0 109.922 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -64.94 -50.04 67.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 109.843 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -63.4 -39.31 94.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.784 0.266 . . . . 0.0 110.545 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -62.34 -54.5 39.62 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.467 175.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -58.61 -37.81 76.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.419 1.009 . . . . 0.0 110.505 -173.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.13 -48.96 71.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.2 0.6 . . . . 0.0 111.919 175.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.47 74.92 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.282 0.492 . . . . 0.0 110.49 -176.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.71 -48.71 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.195 1.798 . . . . 0.0 108.945 171.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttp85 -70.66 -8.4 51.61 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.001 -1.062 . . . . 0.0 112.764 176.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -99.63 5.55 45.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.066 0.947 . . . . 0.0 110.801 172.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -135.45 -55.37 0.79 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.957 -169.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.72 -37.91 61.4 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.411 1.459 . . . . 0.0 112.732 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.4 -9.03 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.235 1.957 . . . . 0.0 115.437 172.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.02 -16.08 3.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.207 1.821 . . . . 0.0 113.466 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.86 152.39 96.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.794 1.238 . . . . 0.0 112.348 -172.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.24 62.38 7.54 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 125.176 3.917 . . . . 0.0 111.616 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.1 mt -83.89 172.77 11.81 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.233 1.813 . . . . 0.0 112.404 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -134.26 145.86 49.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.58 139.63 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.523 1.129 . . . . 0.0 110.262 -176.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.12 130.81 35.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -123.31 142.16 40.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.1 p30 -84.21 -173.48 4.74 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.453 174.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.64 -22.34 22.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.434 1.494 . . . . 0.0 113.657 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -81.79 -2.36 50.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 111.659 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 53.26 56.31 7.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.286 1.517 . . . . 0.0 109.142 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.61 129.19 16.31 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 127.461 2.304 . . . . 0.0 105.465 -169.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.73 136.8 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.027 1.818 . . . . 0.0 110.217 -171.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 -16.08 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.722 1.209 . . . . 0.0 111.842 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.19 173.02 39.31 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.76 161.28 42.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.707 0.753 . . . . 0.0 110.592 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 154.13 47.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.129 0.971 . . . . 0.0 108.937 168.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.78 119.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 176.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 tp -146.28 134.6 21.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.275 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -159.47 156.32 28.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.358 2.263 . . . . 0.0 105.484 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.63 32.94 61.95 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.419 -0.8 . . . . 0.0 113.889 175.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 57.01 22.54 7.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.218 1.807 . . . . 0.0 114.121 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -122.69 111.02 16.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.579 0.751 . . . . 0.0 109.787 175.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 ttp -85.83 88.78 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.77 -23.95 67.4 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.14 144.88 32.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.378 0.671 . . . . 0.0 110.552 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.8 tp -156.87 117.22 3.57 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.69 1.996 . . . . 0.0 106.112 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -147.17 144.92 29.32 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.33 142.73 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -173.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.49 137.68 95.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.281 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.62 -24.53 23.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.803 3.002 . . . . 0.0 115.852 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.34 -21.1 61.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.541 1.064 . . . . 0.0 112.278 175.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.15 24.89 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.529 1.532 . . . . 0.0 110.493 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.91 132.84 54.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.778 -1.201 . . . . 0.0 108.826 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.95 2.65 53.1 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.995 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 98.7 m -70.78 169.23 15.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.654 1.727 . . . . 0.0 109.18 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.05 -28.22 16.95 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.545 1.069 . . . . 0.0 113.863 -177.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.55 -34.81 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 118.989 1.395 . . . . 0.0 112.203 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.15 -29.94 53.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.08 0.848 . . . . 0.0 112.807 175.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -91.95 -42.52 9.97 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 116.498 -1.715 . . . . 0.0 110.248 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.32 -45.56 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 121.56 1.982 . . . . 0.0 110.826 -172.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.2 -39.81 89.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.791 0.723 . . . . 0.0 111.065 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.53 -40.75 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.478 0.711 . . . . 0.0 109.798 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.54 -36.95 85.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.594 0.758 . . . . 0.0 109.544 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.52 -47.03 87.44 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.057 0.543 . . . . 0.0 110.276 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.77 76.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.06 0.544 . . . . 0.0 110.84 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -60.27 -33.72 72.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.191 0.996 . . . . 0.0 111.578 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -37.65 88.11 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.358 0.526 . . . . 0.0 111.414 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -83.92 -26.45 29.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.253 0.479 . . . . 0.0 112.117 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 91.32 10.39 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.143 1.377 . . . . 0.0 109.282 -169.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.96 -22.16 63.06 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.425 1.417 . . . . 0.0 112.822 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.86 30.92 5.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.286 1.434 . . . . 0.0 110.274 -174.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 tp -50.91 143.37 10.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.898 2.079 . . . . 0.0 112.826 -170.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 65.2 p -130.0 162.85 27.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.746 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 t -153.58 -173.58 4.63 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.014 0.526 . . . . 0.0 109.724 175.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -148.68 161.41 41.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.833 0.853 . . . . 0.0 110.631 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -156.07 147.34 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -72.56 132.16 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -58.34 -30.87 67.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.726 0.811 . . . . 0.0 112.33 -173.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.79 -33.16 72.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.506 0.594 . . . . 0.0 111.236 -177.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.451 HD21 ' CE1' ' A' ' 28' ' ' HIS . 54.5 t-20 -80.02 65.8 5.3 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.028 0.931 . . . . 0.0 110.523 176.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.11 -26.11 59.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 111.632 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -62.87 -46.97 85.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.102 0.561 . . . . 0.0 109.752 176.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.72 77.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.606 -0.711 . . . . 0.0 111.786 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.41 -46.21 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.236 0.925 . . . . 0.0 108.963 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.01 -49.59 73.79 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -55.45 -50.88 68.71 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.582 0.753 . . . . 0.0 110.755 -178.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -66.1 -34.41 78.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -174.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.15 -37.88 86.75 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.82 -1.175 . . . . 0.0 112.72 172.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.07 -42.81 91.26 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.877 1.217 . . . . 0.0 110.169 173.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.57 -35.65 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 110.788 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.72 9.08 1.82 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.418 1.008 . . . . 0.0 114.454 169.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.4 162.2 29.08 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.608 1.704 . . . . 0.0 111.107 171.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.92 140.39 25.6 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.9 t -72.26 129.75 35.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.907 0.883 . . . . 0.0 109.336 -174.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.6 p -123.77 -9.15 7.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.421 1.888 . . . . 0.0 111.681 -174.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.55 -179.92 41.12 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -156.36 177.87 10.96 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.804 0.841 . . . . 0.0 109.254 172.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--N 1.322 -0.609 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.53 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 N-CA-C 118.449 2.442 . . . . 0.0 118.449 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.67 146.15 26.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.7 mt -117.26 145.23 44.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -115.71 138.61 50.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.0 158.78 43.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -171.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.56 152.48 51.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.277 1.431 . . . . 0.0 108.348 176.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.5 127.36 32.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.8 t . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 125.136 1.374 . . . . 0.0 110.146 -176.644 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.267 4.3 t -74.74 155.95 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 127.702 2.401 . . . . 0.0 107.874 177.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -135.2 141.84 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.88 1.672 . . . . 0.0 106.676 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -136.32 166.17 24.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mm -123.08 142.16 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -150.52 172.02 16.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.784 0.834 . . . . 0.0 109.76 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -61.67 148.39 42.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.492 -0.755 . . . . 0.0 110.488 166.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.722 ' HG ' ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -70.84 160.76 32.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.735 1.214 . . . . 0.0 110.26 176.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -103.11 161.72 13.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.146 163.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -62.82 -51.76 65.79 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -24.9 62.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.754 -162.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.35 -0.61 46.61 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.404 -0.185 . . . . 0.0 111.1 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 -39.43 53.22 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.137 -0.977 . . . . 0.0 112.752 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -65.56 -28.56 69.25 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.616 1.208 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.19 -32.78 73.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.209 0.528 . . . . 0.0 109.644 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.88 -38.82 64.29 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 120.901 -1.125 . . . . 0.0 109.63 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.28 -46.46 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -47.15 87.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.06 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.84 -50.36 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.996 1.319 . . . . 0.0 109.52 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -53.76 -47.15 70.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.0 t -59.13 -47.32 85.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.279 0.632 . . . . 0.0 110.683 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.306 -0.871 . . . . 0.0 112.811 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.1 m -60.17 -38.06 82.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.342 0.974 . . . . 0.0 109.516 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -70.44 -42.74 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.077 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.41 -34.99 78.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.392 0.542 . . . . 0.0 111.094 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.78 -33.91 30.62 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.283 -0.886 . . . . 0.0 112.309 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.511 ' CG2' HH12 ' A' ' 83' ' ' ARG . 19.9 p -139.1 -5.12 1.47 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -167.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -126.61 30.06 5.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.697 1.59 . . . . 0.0 110.454 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -60.8 -18.94 58.36 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.962 0.887 . . . . 0.0 112.849 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.11 -23.52 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.212 1.405 . . . . 0.0 112.517 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 106.02 0.53 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.418 1.087 . . . . 0.0 111.591 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 m -56.25 151.09 13.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.056 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.06 -34.41 68.24 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 123.077 0.551 . . . . 0.0 112.351 -172.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -68.07 -47.91 67.01 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.714 1.245 . . . . 0.0 109.358 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.784 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 5.9 t80 -68.66 -34.98 76.63 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.574 -1.193 . . . . 0.0 112.02 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -53.86 -49.35 68.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.754 0.822 . . . . 0.0 110.773 170.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 m -62.91 -47.08 84.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 124.349 1.031 . . . . 0.0 109.16 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.37 -36.54 74.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.457 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.54 -50.77 70.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.414 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.69 -39.06 79.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.081 0.855 . . . . 0.0 111.237 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -51.07 69.46 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.06 0.544 . . . . 0.0 110.326 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -37.21 79.01 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.478 -0.764 . . . . 0.0 110.134 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.8 t -58.5 -46.99 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.51 1.524 . . . . 0.0 109.026 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -67.74 -18.04 64.76 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.913 -1.117 . . . . 0.0 113.034 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.3 m -95.02 10.61 35.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -140.09 -56.29 0.55 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 119.473 1.033 . . . . 0.0 111.796 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -55.81 -40.24 83.22 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 116.888 -1.53 . . . . 0.0 112.659 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.73 -11.63 18.36 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.315 2.01 . . . . 0.0 116.209 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.99 -15.35 3.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.14 1.336 . . . . 0.0 112.461 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.02 148.24 98.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 123.784 0.833 . . . . 0.0 110.124 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.84 65.23 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.347 3.365 . . . . 0.0 108.844 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.722 ' HB2' ' HG ' ' A' ' 8' ' ' SER . 64.1 mt -83.9 170.89 13.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.033 0.933 . . . . 0.0 110.651 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -122.75 138.88 54.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 166.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.54 135.57 56.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.615 1.166 . . . . 0.0 108.811 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.28 133.0 41.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 160.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.4 140.65 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -79.22 -174.58 4.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.078 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.48 -19.53 9.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.537 1.535 . . . . 0.0 114.885 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.36 4.93 44.4 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.769 -1.207 . . . . 0.0 113.203 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.3 t0 52.24 52.45 14.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.27 1.509 . . . . 0.0 110.897 -169.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -131.7 124.57 19.96 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.23 137.83 45.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.113 1.875 . . . . 0.0 111.743 -169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.86 -11.06 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.397 1.079 . . . . 0.0 111.38 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.93 171.49 41.07 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 169.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.66 161.96 39.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 111.704 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.31 138.92 24.05 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.674 1.59 . . . . 0.0 106.942 -175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tp -112.6 121.34 44.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.5 tp -141.56 133.25 27.13 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.573 1.171 . . . . 0.0 108.424 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.5 m -147.27 160.2 42.76 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.761 2.024 . . . . 0.0 106.979 164.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.0 -115.01 6.68 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -170.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -135.46 32.71 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.567 1.183 . . . . 0.0 109.637 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -128.2 103.13 7.02 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.113 0.965 . . . . 0.0 109.216 -165.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -81.08 87.14 6.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -60.26 -36.32 77.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.932 0.893 . . . . 0.0 111.181 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.81 146.46 41.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.546 -1.346 . . . . 0.0 110.685 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.97 118.25 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.37 143.14 30.8 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -150.74 141.23 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -53.46 122.93 34.32 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 125.374 1.671 . . . . 0.0 108.929 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -51.84 -27.17 26.43 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.186 1.924 . . . . 0.0 114.39 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.3 -28.28 69.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.112 1.324 . . . . 0.0 111.89 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.66 2.04 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.867 -1.145 . . . . 0.0 112.262 -171.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.511 HH12 ' CG2' ' A' ' 27' ' ' THR . 46.2 mtt180 -53.36 -44.82 68.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.095 -1.003 . . . . 0.0 111.958 170.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.31 -22.95 67.85 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.369 1.043 . . . . 0.0 111.596 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.0 -7.41 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.696 1.248 . . . . 0.0 113.084 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.21 1.25 51.08 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-O 118.699 -1.056 . . . . 0.0 112.606 172.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.6 t -55.68 -31.35 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 118.725 1.263 . . . . 0.0 110.019 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.86 -49.8 34.14 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.003 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -64.62 -47.01 80.15 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.734 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.86 -43.41 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.558 1.072 . . . . 0.0 110.085 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.2 mt -69.34 -42.15 75.69 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.628 -0.67 . . . . 0.0 111.017 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.51 -41.25 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.813 0.733 . . . . 0.0 110.432 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.38 -38.69 90.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -59.32 -46.07 89.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.381 0.537 . . . . 0.0 110.605 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.93 91.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.989 0.516 . . . . 0.0 110.609 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.515 HD13 ' CE2' ' A' ' 144' ' ' TYR . 32.6 mt -62.59 -34.58 77.29 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.9 m -62.71 -33.97 76.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.536 0.523 . . . . 0.0 110.695 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.8 mtm -87.59 -22.52 24.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.626 0.648 . . . . 0.0 112.061 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.78 93.16 6.25 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.775 1.23 . . . . 0.0 108.237 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 -23.65 57.24 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.738 1.625 . . . . 0.0 113.266 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.32 31.18 4.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.379 1.471 . . . . 0.0 109.368 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.8 tp -49.86 144.64 6.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.529 1.932 . . . . 0.0 113.04 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -127.48 162.0 27.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.778 1.631 . . . . 0.0 108.751 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -153.35 -179.68 7.96 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -141.56 165.51 27.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.063 0.945 . . . . 0.0 109.856 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.72 145.63 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -71.29 131.85 44.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -58.35 -33.09 69.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.519 1.128 . . . . 0.0 111.534 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.167 0.587 . . . . 0.0 111.523 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -85.81 68.62 10.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.291 0.567 . . . . 0.0 109.886 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.35 -26.07 62.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 111.018 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -61.47 -49.16 77.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.67 -0.644 . . . . 0.0 109.61 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.65 76.57 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.411 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.04 -48.32 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.058 . . . . 0.0 108.46 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.83 -47.15 92.67 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.525 0.602 . . . . 0.0 111.793 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.26 -51.04 70.96 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.91 0.884 . . . . 0.0 109.116 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.66 -35.39 80.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -42.69 99.12 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.738 1.154 . . . . 0.0 112.584 171.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -59.57 -41.01 89.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.052 0.842 . . . . 0.0 111.306 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.05 -37.82 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 123.998 0.812 . . . . 0.0 109.648 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.458 ' HA3' ' HA3' ' A' ' 146' ' ' GLY . . . 141.38 5.35 0.97 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-O 122.182 0.879 . . . . 0.0 115.003 168.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -73.9 159.09 33.31 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 118.294 -2.886 . . . . 0.0 111.475 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -142.59 139.36 31.32 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.5 t -71.69 136.28 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -130.28 -8.63 4.25 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.26 1.824 . . . . 0.0 110.922 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.36 178.1 42.65 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -157.32 178.69 10.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.122 -0.634 . . . . 0.0 109.62 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -138.09 155.06 49.15 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -91.34 -7.29 51.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.312 1.053 . . . . 0.0 112.093 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -136.18 173.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.9 -62.45 1.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.942 0.776 . . . . 0.0 109.25 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -161.16 -47.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 135' ' ' LYS . 80.5 mt -90.23 23.67 2.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.821 -1.174 . . . . 0.0 110.463 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 4.57 89.28 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.127 -0.983 . . . . 0.0 112.476 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.784 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -67.27 137.73 94.1 Favored Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 117.253 -1.356 . . . . 0.0 109.629 175.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.36 52.24 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.86 3.04 . . . . 0.0 112.404 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.82 76.93 74.95 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.424 1.49 . . . . 0.0 108.813 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -47.84 148.14 6.6 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.705 2.27 . . . . 0.0 115.809 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.7 tp -104.39 146.77 28.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.8 mt -114.57 145.93 41.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.68 138.08 51.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.654 1.182 . . . . 0.0 107.986 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.87 157.85 45.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -169.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.24 50.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.679 ' CE1' ' HA3' ' A' ' 146' ' ' GLY . 0.4 OUTLIER -73.21 116.7 14.06 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 74.7 t -109.36 -30.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 1 CA-C-O 100.815 -9.183 . . . . 0.0 110.44 171.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.679 ' HA3' ' CE1' ' A' ' 144' ' ' TYR . . . -35.19 -16.14 0.0 OUTLIER Glycine 2 N--CA 1.567 7.373 3 C-N-CA 151.441 13.877 . . . . 0.0 132.066 -151.649 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 145' ' ' VAL 0.265 . . . . . . . 0 C--N 1.275 -2.664 1 CA-C-N 100.476 -7.862 . . . . 0.0 117.36 125.994 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.95 149.82 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.685 0.794 . . . . 0.0 109.73 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 mm -126.76 144.45 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.7 m -141.65 167.59 21.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.45 142.83 36.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -148.72 173.51 13.16 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.539 0.736 . . . . 0.0 110.214 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -66.03 147.87 52.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.573 0.701 . . . . 0.0 109.11 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -77.71 147.17 35.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.854 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -85.99 175.85 8.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.803 0.841 . . . . 0.0 108.746 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -82.35 -49.06 10.44 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.43 -26.54 61.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.81 0.732 . . . . 0.0 112.203 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -72.77 -5.2 36.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.031 -0.418 . . . . 0.0 111.841 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.66 -38.64 29.43 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.487 1.041 . . . . 0.0 113.178 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.78 -28.61 69.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.926 1.363 . . . . 0.0 111.795 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.71 -31.28 70.26 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.401 -0.812 . . . . 0.0 109.578 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -75.49 -39.67 58.23 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -56.29 -44.82 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.497 0.719 . . . . 0.0 109.084 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.45 96.18 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.883 -0.51 . . . . 0.0 111.436 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.0 mt -59.8 -48.89 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.512 0.725 . . . . 0.0 109.705 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -54.19 -45.7 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.269 0.628 . . . . 0.0 110.111 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 t -60.54 -44.24 96.32 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.607 -0.683 . . . . 0.0 110.518 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -63.11 -42.69 99.6 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.658 -0.651 . . . . 0.0 110.833 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.7 m -59.6 -38.09 80.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.514 0.726 . . . . 0.0 110.876 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.44 -45.52 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.273 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.02 -37.39 76.83 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.153 0.888 . . . . 0.0 111.83 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.6 26.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.147 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.5 p -135.44 -5.78 2.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.448 ' CE1' HD21 ' A' ' 110' ' ' ASN . 12.7 m80 -128.52 26.89 5.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.009 1.277 . . . . 0.0 110.632 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.5 -14.41 28.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.323 -0.861 . . . . 0.0 113.293 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -53.38 -22.79 8.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.737 2.015 . . . . 0.0 112.988 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.01 100.29 0.41 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.057 1.343 . . . . 0.0 108.529 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -56.32 157.33 5.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.527 1.531 . . . . 0.0 111.109 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.32 -36.98 66.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -67.14 -48.56 67.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.888 0.767 . . . . 0.0 109.783 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.52 -40.27 96.61 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.663 0.785 . . . . 0.0 109.796 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 -55.54 -48.45 74.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.932 1.293 . . . . 0.0 110.168 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -65.42 -49.53 68.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.0 0.92 . . . . 0.0 110.05 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.83 -38.13 88.08 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.861 0.3 . . . . 0.0 110.66 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 mt -62.79 -53.74 49.72 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.565 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.53 -38.22 74.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.442 1.019 . . . . 0.0 110.701 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.9 -49.09 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.221 0.609 . . . . 0.0 111.854 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -36.45 74.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.201 0.455 . . . . 0.0 110.296 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.02 -48.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 126.211 1.805 . . . . 0.0 109.038 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -70.41 -10.76 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.987 -1.071 . . . . 0.0 112.679 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.7 m -96.05 4.7 52.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 110.681 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.24 -56.45 0.8 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.158 -169.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.81 -38.47 68.4 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 120.466 1.485 . . . . 0.0 112.91 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.19 -13.01 29.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.945 1.764 . . . . 0.0 115.362 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -128.95 -14.7 4.41 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.63 1.559 . . . . 0.0 113.196 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 152.19 95.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.792 1.237 . . . . 0.0 111.999 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.19 62.71 7.61 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.98 3.787 . . . . 0.0 111.65 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.8 173.73 8.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.185 1.794 . . . . 0.0 112.374 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -133.07 146.15 51.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.45 137.87 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 110.487 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.87 35.74 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.01 140.89 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -76.67 -174.83 3.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.609 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.08 -15.56 34.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.821 1.648 . . . . 0.0 113.118 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -87.74 3.73 46.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.037 1.335 . . . . 0.0 111.713 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.14 33.28 21.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.675 1.59 . . . . 0.0 111.412 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -117.79 133.49 23.33 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.26 138.18 46.04 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.703 2.268 . . . . 0.0 112.4 -169.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.76 -9.64 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.601 1.16 . . . . 0.0 112.348 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.96 170.43 37.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.08 158.56 43.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.882 0.841 . . . . 0.0 110.7 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.92 153.34 48.24 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.948 0.899 . . . . 0.0 109.54 169.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.35 120.62 38.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.1 tp -145.45 140.26 27.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 m -154.4 155.97 35.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.985 2.114 . . . . 0.0 105.334 169.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.39 -114.56 5.63 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -130.96 13.99 5.25 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.785 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -114.74 106.21 13.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.491 1.041 . . . . 0.0 110.407 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.7 ttp -79.16 82.56 5.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.5 -19.52 62.16 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.01 148.54 30.83 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.247 0.93 . . . . 0.0 110.573 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.9 tp -156.63 119.88 4.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.525 1.93 . . . . 0.0 105.932 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -146.03 145.08 30.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mt -151.34 142.07 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -55.55 120.03 28.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.03 -30.76 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 114.471 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.98 -24.16 67.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.9 0.33 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 118.701 0.682 . . . . 0.0 112.408 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -60.59 -38.27 84.06 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.293 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.22 -27.73 71.08 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.589 0.614 . . . . 0.0 112.742 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.35 -6.2 48.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.236 1.018 . . . . 0.0 112.14 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.61 16.1 64.59 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.292 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.38 -31.74 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.134 1.467 . . . . 0.0 111.094 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.86 -52.82 15.32 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.388 -0.674 . . . . 0.0 111.921 170.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.49 -42.92 98.53 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 117.327 -1.321 . . . . 0.0 110.291 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.6 t -58.1 -45.62 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.297 1.408 . . . . 0.0 110.011 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.3 mt -68.59 -42.23 78.53 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.855 -0.528 . . . . 0.0 110.81 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.65 -41.56 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.041 0.536 . . . . 0.0 110.024 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.2 -33.19 73.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.317 -0.864 . . . . 0.0 110.121 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.93 -46.55 88.85 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.317 0.508 . . . . 0.0 110.382 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.89 82.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.083 0.553 . . . . 0.0 111.019 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 mt -58.98 -34.82 72.26 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.102 0.961 . . . . 0.0 111.303 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.81 -32.81 74.07 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.13 0.423 . . . . 0.0 111.784 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mtm -91.45 -23.21 20.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.237 0.615 . . . . 0.0 112.148 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.53 92.47 8.12 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.548 1.539 . . . . 0.0 108.339 -172.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.49 -22.75 65.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.474 1.449 . . . . 0.0 112.35 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.22 31.69 4.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.862 1.665 . . . . 0.0 110.039 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -48.33 143.3 4.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.254 2.222 . . . . 0.0 112.843 -171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -130.49 159.18 37.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.56 1.544 . . . . 0.0 108.01 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 t -154.17 -175.41 5.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.157 0.503 . . . . 0.0 109.792 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -148.48 160.38 43.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.135 0.974 . . . . 0.0 110.609 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -157.11 147.94 10.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -72.51 132.57 44.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.98 -35.13 63.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.963 1.305 . . . . 0.0 111.939 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.11 -30.84 71.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.419 0.554 . . . . 0.0 111.771 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.448 HD21 ' CE1' ' A' ' 28' ' ' HIS . 58.9 t-20 -80.47 63.37 4.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.953 0.901 . . . . 0.0 109.374 176.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.27 -26.62 52.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.3 1.04 . . . . 0.0 111.151 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -47.44 83.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.688 0.795 . . . . 0.0 109.833 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.53 -35.01 75.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.856 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.45 -47.93 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.47 1.032 . . . . 0.0 108.444 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.07 -46.44 94.55 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.544 0.592 . . . . 0.0 111.817 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -55.14 -51.33 66.82 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 117.762 0.781 . . . . 0.0 110.008 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.23 -33.7 75.91 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.926 -0.484 . . . . 0.0 109.917 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -58.48 -47.48 83.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.433 1.015 . . . . 0.0 110.852 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.44 -42.88 88.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.951 0.796 . . . . 0.0 110.463 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.76 -37.76 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.945 0.898 . . . . 0.0 110.776 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.85 1.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.28 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -79.71 154.94 28.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.596 1.698 . . . . 0.0 111.248 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -140.79 138.51 34.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.267 1.827 . . . . 0.0 106.39 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.41 134.39 30.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.935 0.894 . . . . 0.0 109.75 -171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 p -125.34 -9.99 6.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.453 1.901 . . . . 0.0 111.364 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.88 42.12 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 118.822 0.737 . . . . 0.0 111.565 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -152.65 -176.43 5.72 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.124 0.969 . . . . 0.0 108.839 169.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 m -131.05 162.91 28.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.329 1.452 . . . . 0.0 108.59 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -80.44 -12.41 59.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.695 0.798 . . . . 0.0 111.622 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.14 178.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.286 2.235 . . . . 0.0 106.942 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.47 -61.7 1.92 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.977 0.353 . . . . 0.0 110.175 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -161.81 -46.52 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.587 0.755 . . . . 0.0 112.482 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.72 28.77 1.26 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.661 1.184 . . . . 0.0 110.327 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.12 13.65 81.0 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.786 0.707 . . . . 0.0 113.369 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -67.07 129.79 93.9 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.665 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.11 43.94 1.49 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.817 3.011 . . . . 0.0 112.564 -170.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -138.01 82.31 25.45 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -170.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -43.4 147.58 0.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.112 3.208 . . . . 0.0 118.344 -169.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.7 148.44 23.33 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 168.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.16 148.16 41.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -120.65 138.64 53.82 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.609 1.164 . . . . 0.0 108.131 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.88 160.75 38.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.343 1.057 . . . . 0.0 108.288 -169.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.26 150.1 52.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.567 1.547 . . . . 0.0 108.536 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -75.67 124.01 26.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -130.05 -17.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.468 1.107 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.04 31.56 2.02 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.0 1.286 . . . . 0.0 113.999 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.324 1.05 . . . . 0.0 109.909 174.023 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.96 153.42 8.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 169.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mm -132.69 140.79 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -135.58 164.16 28.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.5 mm -127.16 143.21 41.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -154.99 171.94 18.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.798 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -60.59 148.98 36.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.884 0.765 . . . . 0.0 109.082 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 p -62.84 161.62 12.41 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.764 1.626 . . . . 0.0 112.27 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -112.24 160.47 17.59 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.691 1.596 . . . . 0.0 107.251 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -69.84 -45.46 67.75 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.094 -0.378 . . . . 0.0 111.031 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.47 -27.21 65.03 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -82.82 -2.36 54.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.021 0.528 . . . . 0.0 111.483 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.34 -40.19 60.46 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.201 0.909 . . . . 0.0 112.766 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.34 -28.54 69.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.551 1.175 . . . . 0.0 111.766 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.65 -32.52 69.84 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.346 -0.846 . . . . 0.0 109.711 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.6 mt -72.81 -39.44 66.65 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.728 -0.607 . . . . 0.0 109.592 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.74 -44.78 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.205 170.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.21 93.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.363 0.665 . . . . 0.0 112.258 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.22 -48.94 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.398 1.079 . . . . 0.0 109.505 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 60.3 t90 -54.7 -44.92 73.84 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.885 -0.509 . . . . 0.0 110.396 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.84 -50.28 74.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.991 0.814 . . . . 0.0 110.832 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -68.98 -25.19 64.4 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.273 -0.892 . . . . 0.0 111.94 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.6 m -69.58 -31.89 70.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.94 0.791 . . . . 0.0 111.085 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.87 -47.16 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -58.92 -39.33 81.23 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.15 -34.23 20.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.706 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.0 p -138.41 -0.43 1.99 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -133.57 33.45 3.52 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.324 1.42 . . . . 0.0 110.812 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.06 -14.19 9.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 113.534 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.02 -27.81 63.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.222 1.809 . . . . 0.0 112.709 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.21 129.52 42.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.499 1.12 . . . . 0.0 108.917 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 p -61.85 161.97 9.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.375 0.67 . . . . 0.0 110.41 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.49 78.11 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.9 -0.5 . . . . 0.0 110.647 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.32 -50.76 68.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.398 0.679 . . . . 0.0 109.97 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 6.1 t80 -67.89 -36.93 81.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.145 -0.347 . . . . 0.0 110.103 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -55.25 -42.3 73.31 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.707 1.203 . . . . 0.0 110.732 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -72.55 -50.83 22.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 118.587 0.631 . . . . 0.0 109.658 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -69.34 -35.14 75.6 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.125 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.38 -51.47 67.43 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.121 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.48 -37.94 76.58 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.554 1.07 . . . . 0.0 110.843 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.49 -48.07 81.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.653 0.66 . . . . 0.0 111.807 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -38.11 72.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.47 -46.37 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 126.236 1.814 . . . . 0.0 109.291 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.6 ttp85 -72.34 -10.29 59.6 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 120.753 -1.217 . . . . 0.0 112.23 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -98.0 5.71 48.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 110.696 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -136.09 -56.77 0.76 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.617 -1.183 . . . . 0.0 112.724 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.39 -38.83 69.82 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 121.019 1.736 . . . . 0.0 113.246 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -61.09 -13.55 28.48 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.409 2.072 . . . . 0.0 114.845 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.38 -12.61 3.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.772 1.624 . . . . 0.0 113.272 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 153.21 91.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.227 1.411 . . . . 0.0 111.626 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 66.29 7.33 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 110.136 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.3 mt -87.58 179.08 6.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.336 1.065 . . . . 0.0 109.907 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -137.37 127.67 26.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.63 141.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.026 0.83 . . . . 0.0 110.237 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.05 134.77 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.94 142.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.516 HD21 ' CG1' ' A' ' 63' ' ' VAL . 16.4 p30 -85.08 -178.31 6.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.251 169.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.6 -26.38 8.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.805 1.642 . . . . 0.0 114.18 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -76.64 -3.07 35.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.31 1.044 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t0 51.48 57.98 5.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.729 1.728 . . . . 0.0 109.358 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -138.58 127.15 14.09 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.64 142.64 49.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.634 2.222 . . . . 0.0 112.396 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 57' ' ' ASN . 32.3 m -124.96 -11.92 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.111 0.964 . . . . 0.0 112.596 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.22 172.13 41.46 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -148.51 159.58 43.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.331 0.566 . . . . 0.0 110.479 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.18 140.47 45.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.539 1.136 . . . . 0.0 108.125 169.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.85 113.92 25.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 tp -149.9 138.57 20.82 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.571 0.7 . . . . 0.0 109.531 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.9 m -158.5 153.7 25.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.83 23.31 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -128.93 20.53 5.93 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.49 1.116 . . . . 0.0 111.382 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -123.46 103.64 8.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.535 0.734 . . . . 0.0 109.565 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.1 ttp -85.39 80.84 8.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.95 -32.51 63.9 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -172.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.53 157.09 43.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.241 0.616 . . . . 0.0 111.037 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -155.13 123.47 5.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.064 2.146 . . . . 0.0 105.418 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -145.46 141.82 28.7 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -149.37 146.69 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -60.06 122.15 64.1 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.45 -29.8 7.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.069 3.18 . . . . 0.0 114.665 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.06 -23.86 67.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.998 0.919 . . . . 0.0 113.392 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 m -117.86 -0.27 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 118.716 0.689 . . . . 0.0 112.669 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.35 -37.03 76.83 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.918 -1.114 . . . . 0.0 110.539 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.92 68.73 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.719 0.676 . . . . 0.0 113.004 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.3 m -74.96 -6.71 50.78 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.486 1.143 . . . . 0.0 112.119 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.85 14.18 63.4 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.841 -0.977 . . . . 0.0 113.345 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.21 -31.58 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.185 1.492 . . . . 0.0 110.996 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.12 -53.44 14.98 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.881 0.753 . . . . 0.0 111.838 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.47 -41.25 96.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.138 -1.41 . . . . 0.0 110.365 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.43 -46.52 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 120.693 1.588 . . . . 0.0 110.011 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.5 -41.91 83.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.963 -0.461 . . . . 0.0 110.602 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.63 -43.24 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 118.489 0.586 . . . . 0.0 110.407 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.58 -32.51 73.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.796 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -59.59 -49.07 79.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.131 0.423 . . . . 0.0 109.991 171.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.21 81.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.878 0.471 . . . . 0.0 111.265 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.67 -35.03 75.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.802 0.841 . . . . 0.0 111.356 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.28 -35.21 79.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.29 0.495 . . . . 0.0 111.523 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtm -87.78 -24.07 23.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.421 0.688 . . . . 0.0 112.062 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.43 96.18 5.32 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.55 1.54 . . . . 0.0 108.305 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -23.72 53.11 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.198 1.265 . . . . 0.0 112.084 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.68 28.35 4.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.754 1.622 . . . . 0.0 110.654 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.3 tp -51.84 144.24 11.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 112.906 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.2 p -129.17 159.4 36.17 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 108.811 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -153.42 -179.68 7.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.865 0.466 . . . . 0.0 110.271 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -138.26 160.0 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.088 1.355 . . . . 0.0 109.185 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.84 145.89 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -70.66 131.51 44.02 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.49 -32.74 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.96 0.904 . . . . 0.0 111.583 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -66.88 -30.27 70.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.015 0.526 . . . . 0.0 111.691 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -79.65 64.19 4.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 108.795 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.83 -25.97 44.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.565 1.146 . . . . 0.0 111.151 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -49.46 75.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.465 0.706 . . . . 0.0 109.864 176.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.81 76.14 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.775 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.02 -49.09 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.415 1.007 . . . . 0.0 108.471 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.81 -47.44 91.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -54.13 -52.08 62.2 Favored 'General case' 0 C--N 1.338 0.065 0 C-N-CA 123.976 0.911 . . . . 0.0 110.124 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.65 -34.39 76.85 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.775 -0.578 . . . . 0.0 109.975 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -60.03 -46.51 89.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.52 1.055 . . . . 0.0 110.806 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.1 -43.05 86.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.093 0.86 . . . . 0.0 110.427 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.41 -34.4 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.15 0.98 . . . . 0.0 110.963 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.41 10.04 1.73 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.282 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.17 158.04 26.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.726 1.763 . . . . 0.0 111.28 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -143.04 136.22 28.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.868 1.667 . . . . 0.0 106.606 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.63 134.94 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.909 0.883 . . . . 0.0 110.353 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -128.17 -9.45 5.32 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.927 2.091 . . . . 0.0 111.578 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.86 174.52 42.83 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 170.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -159.68 -173.66 4.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.722 0.761 . . . . 0.0 110.884 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -138.15 171.78 13.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.911 2.084 . . . . 0.0 108.315 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.77 -8.02 11.43 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.998 0.919 . . . . 0.0 111.502 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 m -143.88 178.08 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.314 2.246 . . . . 0.0 106.763 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.45 -73.39 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -165.04 -40.82 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.83 1.252 . . . . 0.0 111.273 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.69 22.7 1.06 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.978 1.311 . . . . 0.0 110.65 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.46 11.03 82.69 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.55 1.072 . . . . 0.0 113.507 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 12.4 mtpp -67.92 131.06 92.54 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-O 116.427 -1.749 . . . . 0.0 108.458 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -64.73 42.38 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.986 3.79 . . . . 0.0 115.795 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.04 56.26 20.31 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.599 1.56 . . . . 0.0 110.353 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.83 161.68 24.56 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.251 2.634 . . . . 0.0 115.684 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 tp -110.04 151.02 27.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.528 1.931 . . . . 0.0 107.141 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.35 151.63 32.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -119.86 139.62 52.1 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.756 1.222 . . . . 0.0 107.844 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.75 161.56 36.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.706 1.203 . . . . 0.0 108.529 -171.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.92 149.32 52.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 108.396 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -73.76 132.38 42.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.52 -23.95 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.317 1.447 . . . . 0.0 109.912 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.21 -172.92 55.09 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 C-N-CA 123.942 0.897 . . . . 0.0 110.013 176.701 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.94 -179.48 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.906 1.682 . . . . 0.0 107.092 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.26 144.52 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -141.92 165.78 26.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.56 142.99 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -151.21 173.52 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.636 0.774 . . . . 0.0 110.167 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -65.73 148.75 51.25 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -73.94 146.45 43.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.242 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.16 131.88 35.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -33.32 70.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.399 0.545 . . . . 0.0 112.198 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.88 -16.66 60.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.513 0.725 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -86.85 -2.57 58.68 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.379 0.99 . . . . 0.0 111.217 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.59 -38.28 28.23 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.79 1.185 . . . . 0.0 114.186 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.91 -28.5 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.769 1.285 . . . . 0.0 111.818 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -69.11 -31.53 70.29 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.465 -0.772 . . . . 0.0 109.702 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.7 -38.86 64.73 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.8 -47.16 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.42 83.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.556 0.616 . . . . 0.0 111.721 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.2 mt -65.16 -50.87 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.406 1.082 . . . . 0.0 109.449 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -57.13 -46.89 82.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.702 0.683 . . . . 0.0 110.49 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.3 m -55.32 -52.76 62.43 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.745 1.218 . . . . 0.0 111.005 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -69.97 -29.17 66.22 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.473 -0.767 . . . . 0.0 112.041 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -63.07 -42.46 99.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.962 0.801 . . . . 0.0 110.117 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.9 t -70.27 -42.93 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -34.49 73.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.902 0.773 . . . . 0.0 112.306 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.74 -34.47 21.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.992 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -137.13 -0.14 2.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -130.67 22.57 5.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.403 1.456 . . . . 0.0 110.63 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.67 -10.89 14.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -169.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -29.8 65.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.942 1.297 . . . . 0.0 111.618 169.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.5 tp -53.22 125.35 17.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.125 2.17 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -53.09 140.0 26.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.01 1.324 . . . . 0.0 110.704 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.17 76.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.92 -49.87 64.18 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.48 -35.31 77.35 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 122.081 -0.387 . . . . 0.0 110.404 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -57.19 -44.65 83.8 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.5 m -64.69 -48.64 73.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.711 0.687 . . . . 0.0 110.145 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.17 -37.3 83.51 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.009 -0.432 . . . . 0.0 110.819 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.41 -51.27 69.46 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.258 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.59 -41.07 76.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.688 1.131 . . . . 0.0 110.659 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.74 -47.45 81.0 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.775 0.43 . . . . 0.0 111.824 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -36.59 72.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.949 0.34 . . . . 0.0 110.323 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 t -58.26 -48.69 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.257 1.823 . . . . 0.0 109.064 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -69.76 -10.33 57.95 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.095 -1.003 . . . . 0.0 112.639 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -99.5 5.94 46.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.79 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -136.06 -56.28 0.77 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.451 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.73 -39.34 75.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 120.643 1.565 . . . . 0.0 112.844 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -61.63 -15.51 42.29 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.065 1.844 . . . . 0.0 115.073 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -127.6 -14.24 5.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.45 1.477 . . . . 0.0 112.852 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.85 153.39 88.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.128 1.371 . . . . 0.0 111.475 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -77.54 62.51 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.743 3.629 . . . . 0.0 110.972 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.18 176.74 7.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.098 1.359 . . . . 0.0 111.462 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.02 150.84 50.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.124 2.57 . . . . 0.0 104.868 168.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.69 140.48 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 123.942 0.897 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.36 132.7 35.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.88 142.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -82.87 -177.26 6.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.442 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -49.74 -24.27 2.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.488 1.915 . . . . 0.0 114.488 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -84.41 2.19 41.84 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t0 50.46 58.21 5.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 123.512 1.625 . . . . 0.0 108.77 -169.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.08 124.52 15.35 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.48 138.63 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.65 2.233 . . . . 0.0 109.727 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.36 -12.11 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.27 1.028 . . . . 0.0 112.289 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.03 170.15 40.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.83 159.01 43.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.027 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -140.8 126.78 19.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.302 2.241 . . . . 0.0 105.717 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.7 tp -105.27 124.65 49.9 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -145.95 139.67 26.36 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -153.44 154.57 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.79 5.87 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -132.27 29.07 4.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.609 1.164 . . . . 0.0 110.455 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -125.5 112.03 15.75 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.425 -0.797 . . . . 0.0 110.601 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.5 ttp -85.09 86.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.48 -28.91 70.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.45 144.58 31.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.008 0.523 . . . . 0.0 110.217 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 tp -153.66 114.58 4.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -142.36 141.05 32.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.5 mt -148.43 145.43 18.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -58.23 122.24 57.6 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.154 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.2 -29.81 7.05 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.192 3.262 . . . . 0.0 114.723 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.74 -23.41 67.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.122 0.969 . . . . 0.0 113.537 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.45 2.73 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.788 0.722 . . . . 0.0 112.827 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -58.99 -37.6 77.21 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.897 -1.127 . . . . 0.0 110.506 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.99 -25.59 69.51 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.71 0.671 . . . . 0.0 113.039 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.9 m -74.79 -7.34 53.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.515 1.158 . . . . 0.0 112.03 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.91 13.97 63.62 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.335 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.72 -31.69 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.288 1.544 . . . . 0.0 110.925 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.47 -52.85 18.13 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 123.819 0.723 . . . . 0.0 111.754 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -62.94 -42.38 99.79 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.356 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 t -58.55 -46.29 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.055 1.298 . . . . 0.0 109.82 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.9 mt -70.4 -39.33 74.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.215 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.15 -40.69 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.83 0.741 . . . . 0.0 109.925 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.04 -37.7 88.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.195 0.907 . . . . 0.0 109.71 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -61.05 -47.94 84.05 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.819 0.448 . . . . 0.0 110.439 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.93 -49.07 77.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.583 0.753 . . . . 0.0 110.739 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -60.09 -33.06 71.57 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.401 1.08 . . . . 0.0 111.734 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.5 -32.71 73.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.475 0.58 . . . . 0.0 111.625 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -90.06 -24.82 21.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.435 0.561 . . . . 0.0 112.074 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.06 93.35 9.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.287 1.435 . . . . 0.0 108.713 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.46 -23.39 50.68 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.342 1.361 . . . . 0.0 112.654 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.61 30.39 4.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.67 1.588 . . . . 0.0 110.219 -174.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.3 tp -51.42 145.76 8.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.195 2.198 . . . . 0.0 113.185 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -128.53 163.9 23.97 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.511 1.524 . . . . 0.0 108.912 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -153.75 -175.15 5.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 110.149 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -146.75 161.12 41.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.158 0.983 . . . . 0.0 109.824 172.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.0 p -156.21 149.06 11.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -80.04 129.72 34.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.2 -27.01 53.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.806 2.043 . . . . 0.0 111.974 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . 0.251 1.2 pt20 -51.48 -33.36 31.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.113 0.965 . . . . 0.0 112.651 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -105.71 69.51 0.83 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.132 1.373 . . . . 0.0 109.621 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.76 -23.99 32.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.894 0.877 . . . . 0.0 111.987 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -63.43 -43.93 96.04 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.454 0.702 . . . . 0.0 109.662 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.669 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.03 -45.81 84.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 119.206 0.912 . . . . 0.0 108.945 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.25 59.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.05 -50.73 66.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 117.811 0.805 . . . . 0.0 110.601 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.22 -39.07 93.58 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.84 -33.94 76.29 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.631 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.85 -40.24 94.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.022 1.283 . . . . 0.0 110.919 174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.8 -39.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.9 11.81 0.69 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-O 118.825 -0.986 . . . . 0.0 114.112 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -72.97 160.83 31.49 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.635 1.718 . . . . 0.0 111.189 172.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -149.72 141.18 23.34 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.884 1.674 . . . . 0.0 106.884 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.43 133.05 32.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.972 0.909 . . . . 0.0 109.436 -173.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 p -127.11 -8.1 5.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.671 1.989 . . . . 0.0 111.492 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.82 170.71 40.73 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 111.761 171.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -142.62 164.53 29.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.815 1.246 . . . . 0.0 111.279 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -124.15 167.92 13.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.141 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.64 -10.93 24.2 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.754 -0.591 . . . . 0.0 111.296 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.6 m -149.91 177.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 127.794 2.438 . . . . 0.0 106.918 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.94 -60.6 2.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.876 -0.106 . . . . 0.0 110.938 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -160.4 -38.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 98.0 mt -109.37 32.97 4.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.851 1.26 . . . . 0.0 110.501 -172.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.85 11.74 84.9 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.511 0.577 . . . . 0.0 113.096 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -75.37 134.25 73.66 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-O 117.563 -1.208 . . . . 0.0 108.366 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.71 50.12 3.33 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.87 3.047 . . . . 0.0 112.342 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.49 83.04 26.59 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.58 154.96 18.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.793 1.662 . . . . 0.0 115.625 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.45 145.56 26.08 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.0 mt -114.68 144.66 43.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -113.91 139.09 49.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.99 161.54 35.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -134.07 147.52 50.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.673 1.589 . . . . 0.0 108.292 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -75.8 125.91 29.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.04 -0.16 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 111.389 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.69 -25.87 71.84 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.054 0.835 . . . . 0.0 113.26 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.944 1.297 . . . . 0.0 110.532 179.094 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -61.16 152.82 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.0 109.584 175.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -136.48 141.16 41.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.354 1.061 . . . . 0.0 108.232 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -141.63 163.38 33.09 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -124.64 144.25 35.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -150.46 170.98 17.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.414 1.086 . . . . 0.0 109.272 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -65.35 148.69 51.27 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 m -72.73 152.48 41.62 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.049 0.94 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -98.24 164.09 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 107.919 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -66.99 -39.4 87.14 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.158 -0.339 . . . . 0.0 111.048 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.99 -26.78 66.08 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.72 -0.32 56.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.212 0.46 . . . . 0.0 112.073 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.45 27.67 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.014 0.816 . . . . 0.0 113.455 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.35 -27.18 67.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.261 1.031 . . . . 0.0 112.119 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -68.04 -33.08 73.9 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.394 -0.816 . . . . 0.0 109.572 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.56 -38.54 62.68 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.03 -46.6 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.78 98.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.374 0.67 . . . . 0.0 112.076 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.6 mt -65.41 -49.7 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.285 1.034 . . . . 0.0 109.574 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -52.02 -48.45 64.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.96 0.504 . . . . 0.0 110.004 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 t -61.18 -50.83 71.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.036 0.534 . . . . 0.0 110.16 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -67.63 -28.78 68.02 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.956 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -68.39 -35.87 78.31 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.511 1.05 . . . . 0.0 110.689 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.88 -43.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.28 -26.88 63.07 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 113.345 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.28 16.56 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.984 0.914 . . . . 0.0 111.931 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -133.42 -7.14 2.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -169.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.3 30.26 5.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.225 1.375 . . . . 0.0 109.512 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.51 -18.16 50.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -51.22 -27.37 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.306 1.842 . . . . 0.0 112.303 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 102.89 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.087 1.755 . . . . 0.0 108.912 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -57.02 149.08 19.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.078 1.751 . . . . 0.0 112.546 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.54 70.69 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.61 -45.76 85.5 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.915 -0.491 . . . . 0.0 109.83 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.81 -32.95 62.12 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.944 -0.472 . . . . 0.0 110.241 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -53.94 -43.0 69.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.144 0.977 . . . . 0.0 110.235 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.6 m -62.31 -50.68 70.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.504 1.121 . . . . 0.0 110.153 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -65.03 -39.31 93.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.445 0.298 . . . . 0.0 110.373 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.27 -53.13 59.56 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.462 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -57.08 -39.99 76.05 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.683 1.129 . . . . 0.0 110.484 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.34 -48.92 73.73 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.124 0.569 . . . . 0.0 112.012 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -36.76 75.11 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.076 0.398 . . . . 0.0 110.296 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -58.64 -48.63 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 126.29 1.836 . . . . 0.0 109.023 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.54 -11.59 60.95 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.978 -1.076 . . . . 0.0 112.679 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -97.17 5.64 49.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.742 0.817 . . . . 0.0 110.652 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.4 -54.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.86 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.61 -38.65 69.8 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 120.674 1.579 . . . . 0.0 112.938 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.23 -13.34 31.66 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.407 2.072 . . . . 0.0 115.02 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -125.82 -20.71 4.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.946 1.703 . . . . 0.0 112.393 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.19 148.72 97.72 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.516 1.127 . . . . 0.0 110.69 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.17 45.51 1.99 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.727 3.618 . . . . 0.0 112.091 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.81 171.05 4.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.457 1.503 . . . . 0.0 112.187 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -119.44 148.52 43.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.541 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.67 137.69 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.351 1.06 . . . . 0.0 110.122 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.41 133.99 35.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.63 145.4 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -88.03 -171.67 3.49 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.479 169.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.73 -23.57 29.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.926 1.29 . . . . 0.0 113.47 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -82.93 5.33 22.28 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.679 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 53.9 30.47 11.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.934 1.693 . . . . 0.0 111.112 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.49 128.06 27.73 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 126.927 2.091 . . . . 0.0 106.22 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.62 136.19 35.44 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.727 1.618 . . . . 0.0 109.52 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.15 -14.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.354 1.062 . . . . 0.0 111.185 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.72 170.81 42.99 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.14 160.28 40.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.741 0.816 . . . . 0.0 111.257 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -139.83 132.23 28.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.574 2.35 . . . . 0.0 105.967 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.0 tp -112.19 124.2 51.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.74 133.02 23.17 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 m -142.23 150.7 41.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.08 -113.64 4.24 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.4 29.75 4.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.781 1.232 . . . . 0.0 110.596 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -126.82 111.87 14.69 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.591 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.2 ttp -82.74 88.81 6.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.06 -29.52 69.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.68 145.43 32.44 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.851 0.46 . . . . 0.0 110.667 -172.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.72 115.55 3.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.11 139.4 28.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.8 mt -150.02 144.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -170.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.29 123.61 76.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 108.826 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.8 -19.08 66.44 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.005 2.47 . . . . 0.0 113.832 -171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.5 -21.06 63.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.801 1.182 . . . . 0.0 112.299 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.68 3.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.807 0.843 . . . . 0.0 112.841 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.24 -29.86 58.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.122 -0.986 . . . . 0.0 111.756 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.85 -21.0 50.62 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.316 0.96 . . . . 0.0 113.823 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 66.8 m -73.74 -3.77 30.44 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.023 1.412 . . . . 0.0 112.266 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.01 12.96 75.76 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.276 0.941 . . . . 0.0 112.869 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.85 -33.03 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.485 1.143 . . . . 0.0 111.579 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.53 -50.52 47.96 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -38.7 88.65 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.295 1.047 . . . . 0.0 109.87 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -58.43 -49.59 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.624 1.102 . . . . 0.0 109.916 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.1 mt -67.76 -39.35 84.18 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.849 -0.532 . . . . 0.0 110.707 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.93 -39.74 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.933 -0.556 . . . . 0.0 109.8 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.67 -35.66 81.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.789 1.177 . . . . 0.0 110.388 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -61.23 -45.72 93.37 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.195 0.452 . . . . 0.0 110.3 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.17 74.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.846 0.858 . . . . 0.0 110.744 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.3 -33.29 69.29 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.77 1.228 . . . . 0.0 111.697 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.39 -31.9 72.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.361 0.528 . . . . 0.0 111.637 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 mtm -90.39 -25.51 20.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.157 0.583 . . . . 0.0 112.091 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.97 91.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 125.276 1.43 . . . . 0.0 108.863 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.09 -23.25 53.59 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.362 1.375 . . . . 0.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.48 29.46 4.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.595 1.558 . . . . 0.0 110.444 -174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.37 145.37 8.49 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.03 2.132 . . . . 0.0 113.327 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.9 p -128.03 164.77 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.545 1.538 . . . . 0.0 108.937 170.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.1 t -154.99 -174.15 4.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 110.354 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -146.96 161.97 39.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 109.799 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.4 p -156.13 146.22 12.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.59 133.93 47.16 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.0 -36.17 83.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 112.514 -172.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -35.5 77.42 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.196 0.907 . . . . 0.0 110.914 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.49 70.51 7.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.617 0.722 . . . . 0.0 111.037 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.43 -23.04 35.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.756 0.822 . . . . 0.0 112.074 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -63.61 -45.66 89.31 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.794 0.724 . . . . 0.0 109.593 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.11 -34.58 75.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.878 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.26 -46.06 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.374 0.988 . . . . 0.0 108.895 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.4 -48.16 84.26 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.649 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -54.18 -51.94 62.77 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.128 0.971 . . . . 0.0 110.144 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -64.94 -36.67 85.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -64.36 -40.82 96.6 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.063 -1.023 . . . . 0.0 112.718 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.75 -42.87 89.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.742 1.155 . . . . 0.0 110.255 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.31 -35.19 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.67 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.89 7.82 1.31 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.701 1.143 . . . . 0.0 114.904 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -77.1 164.78 25.38 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.132 1.966 . . . . 0.0 111.72 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -147.59 139.58 24.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.414 1.885 . . . . 0.0 106.218 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.0 t -72.88 132.98 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.23 -10.05 7.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.728 2.011 . . . . 0.0 111.417 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.87 178.99 42.5 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.786 0.721 . . . . 0.0 111.44 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -155.82 -178.02 6.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.129 0.971 . . . . 0.0 109.214 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -139.68 146.65 39.92 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.144 1.378 . . . . 0.0 108.892 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.45 -11.46 60.47 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.874 0.869 . . . . 0.0 112.226 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -137.89 178.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.678 1.991 . . . . 0.0 106.963 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -80.96 -65.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -161.07 -37.43 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.733 0.813 . . . . 0.0 113.024 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.01 28.81 4.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.732 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.35 44.2 97.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.741 0.686 . . . . 0.0 111.737 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -126.97 121.54 22.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 107.983 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -60.43 71.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 1 C-N-CA 125.471 4.114 . . . . 0.0 116.419 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -134.54 63.56 60.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -36.22 143.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.492 4.128 . . . . 0.0 118.223 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.56 144.49 36.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.1 151.55 27.09 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -119.63 139.52 52.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.23 160.78 38.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.852 0.861 . . . . 0.0 108.733 -172.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.7 149.95 51.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.555 1.542 . . . . 0.0 108.575 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.44 133.89 39.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.92 -25.69 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.97 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.27 -178.78 38.84 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.299 1.84 . . . . 0.0 107.725 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.17 143.1 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -135.96 146.4 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.899 1.28 . . . . 0.0 107.603 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -142.92 165.03 28.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 mm -121.67 142.46 37.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -150.19 172.8 14.73 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.876 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -65.5 147.77 52.85 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -73.89 146.74 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.004 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -84.8 160.21 20.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -66.87 -45.48 77.96 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.232 -0.293 . . . . 0.0 110.283 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.34 -28.54 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -83.07 0.93 42.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.915 0.486 . . . . 0.0 111.387 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.07 -45.19 33.37 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.298 0.951 . . . . 0.0 113.617 -176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.69 -21.83 63.47 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.499 1.15 . . . . 0.0 112.565 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -66.29 -33.33 75.5 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.757 1.162 . . . . 0.0 109.564 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.87 -39.49 56.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.45 -45.52 85.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.54 -44.71 95.67 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.142 0.577 . . . . 0.0 111.336 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.86 -52.56 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.47 1.108 . . . . 0.0 108.607 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -53.03 -48.79 67.33 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.589 0.756 . . . . 0.0 110.149 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.8 t -60.16 -50.17 74.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.283 0.633 . . . . 0.0 110.434 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -72.85 -31.39 64.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.154 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -61.19 -43.75 98.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.458 1.026 . . . . 0.0 110.372 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.39 -48.48 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.901 0.88 . . . . 0.0 109.053 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.02 -32.94 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 112.269 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.99 58.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.29 1.036 . . . . 0.0 113.341 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -134.81 -25.55 1.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -169.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.444 ' CD2' HD21 ' A' ' 110' ' ' ASN . 38.5 m-70 -104.09 35.84 2.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.846 1.258 . . . . 0.0 108.476 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.4 -26.81 63.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.805 -1.184 . . . . 0.0 112.428 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -56.49 -24.14 44.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.288 2.235 . . . . 0.0 113.515 173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.79 109.4 1.72 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.012 1.325 . . . . 0.0 107.934 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -58.1 141.84 48.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 111.173 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.72 65.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.932 0.893 . . . . 0.0 113.006 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.57 -45.0 96.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.389 0.676 . . . . 0.0 109.907 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CD1' ' HE3' ' A' ' 135' ' ' LYS . 8.7 t80 -77.9 -29.09 50.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.531 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -56.74 -42.9 80.08 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.491 1.496 . . . . 0.0 110.318 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -63.93 -49.61 71.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.859 0.864 . . . . 0.0 109.862 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -67.33 -36.11 80.78 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.017 -0.427 . . . . 0.0 110.986 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.0 mt -63.52 -49.63 72.75 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.446 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.91 -42.24 75.73 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 119.957 1.253 . . . . 0.0 109.769 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.85 -48.34 82.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.584 1.084 . . . . 0.0 112.446 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.52 74.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.81 -44.43 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.185 1.794 . . . . 0.0 110.117 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -62.94 -24.02 67.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.602 1.161 . . . . 0.0 111.134 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -97.93 7.79 45.79 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.549 1.14 . . . . 0.0 110.662 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -138.12 -59.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.547 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.6 -36.52 46.47 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 121.228 1.831 . . . . 0.0 113.113 -175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 -15.03 34.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 121.942 1.762 . . . . 0.0 115.419 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.61 -11.79 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.938 1.699 . . . . 0.0 113.455 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.8 154.85 88.02 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.408 1.483 . . . . 0.0 111.988 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.86 60.67 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.961 3.774 . . . . 0.0 111.733 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -87.24 172.99 9.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.434 1.893 . . . . 0.0 112.213 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -135.2 145.83 48.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.14 140.21 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.825 0.85 . . . . 0.0 110.41 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.88 134.42 35.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.31 144.09 38.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -83.77 -172.95 4.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -55.2 -24.36 26.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.033 1.333 . . . . 0.0 113.311 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -84.2 0.8 47.34 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.479 1.111 . . . . 0.0 111.831 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t0 52.24 53.87 11.7 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.013 1.387 . . . . 0.0 109.524 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.05 125.28 22.75 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.71 134.25 37.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.545 2.163 . . . . 0.0 110.881 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.39 -11.46 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.192 0.997 . . . . 0.0 111.981 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.65 169.25 41.94 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -139.79 160.92 38.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.709 0.754 . . . . 0.0 111.603 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -139.85 131.34 27.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.593 2.357 . . . . 0.0 105.949 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.84 116.46 28.04 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -144.04 132.97 22.68 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.4 m -141.97 152.97 43.96 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.8 -118.62 11.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -129.28 30.94 4.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.159 0.984 . . . . 0.0 111.022 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -122.87 112.74 18.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.253 0.621 . . . . 0.0 110.153 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -85.1 90.75 7.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.68 -26.42 67.78 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.32 144.99 30.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.043 0.537 . . . . 0.0 110.734 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -153.54 119.4 5.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -145.09 143.23 30.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -143.96 143.66 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -54.31 120.95 28.7 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.088 1.755 . . . . 0.0 109.407 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.03 -24.89 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.215 3.277 . . . . 0.0 114.919 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.11 -26.97 68.03 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.57 9.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.429 . . . . 0.0 112.54 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.88 -34.83 63.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.667 -1.271 . . . . 0.0 112.392 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.17 -13.59 81.73 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.165 -0.797 . . . . 0.0 113.244 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.14 173.68 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 0.0 110.08 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.51 -11.09 39.78 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.959 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -51.47 -34.42 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.601 1.701 . . . . 0.0 112.01 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.42 -54.64 19.59 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -65.54 -40.37 92.81 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.455 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.66 -48.39 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 121.186 1.812 . . . . 0.0 109.977 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -68.05 -40.99 82.68 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.973 -0.455 . . . . 0.0 110.701 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.296 0.498 . . . . 0.0 110.205 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.52 -34.07 75.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.325 0.966 . . . . 0.0 110.1 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.6 -46.33 90.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.338 0.517 . . . . 0.0 110.198 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.94 72.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.377 0.671 . . . . 0.0 110.822 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -58.77 -33.34 70.19 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.359 1.064 . . . . 0.0 111.734 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.1 m -62.95 -35.45 80.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.585 0.63 . . . . 0.0 111.503 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.41 -26.46 26.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.26 0.482 . . . . 0.0 111.86 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 89.91 12.08 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 125.101 1.36 . . . . 0.0 109.294 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.47 -22.78 58.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.468 1.446 . . . . 0.0 113.059 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.02 31.49 4.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.441 1.496 . . . . 0.0 110.095 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -50.3 143.99 7.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.232 2.213 . . . . 0.0 112.9 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.7 p -129.62 163.25 26.45 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.404 1.482 . . . . 0.0 108.778 171.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -154.78 -174.46 4.99 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.166 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.57 161.45 41.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 110.018 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.7 p -157.17 145.44 10.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.0 129.29 39.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -58.39 -30.88 67.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.18 1.392 . . . . 0.0 111.941 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.51 -35.28 78.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.203 0.456 . . . . 0.0 111.224 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.444 HD21 ' CD2' ' A' ' 28' ' ' HIS . 61.6 t-20 -78.6 63.8 3.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.039 1.336 . . . . 0.0 109.882 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.74 -26.8 47.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 111.394 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -45.25 94.3 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.94 73.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.88 -45.96 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.396 0.998 . . . . 0.0 108.828 171.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.8 83.07 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.58 -51.59 64.8 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.022 0.911 . . . . 0.0 110.379 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.53 -35.02 79.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -64.91 -38.95 92.66 Favored 'General case' 0 C--N 1.341 0.205 0 O-C-N 120.916 -1.115 . . . . 0.0 112.632 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.28 -41.37 88.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.956 1.253 . . . . 0.0 110.329 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.78 -39.36 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.794 . . . . 0.0 110.309 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.41 5.18 0.98 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.542 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.99 162.92 28.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.355 1.577 . . . . 0.0 111.169 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.77 140.01 25.53 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.11 129.31 36.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.984 0.914 . . . . 0.0 109.16 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 p -119.54 -9.88 9.74 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.599 1.959 . . . . 0.0 111.397 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -170.87 -179.29 42.01 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 171.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.31 179.08 8.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.679 0.792 . . . . 0.0 109.271 170.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m -138.71 138.2 37.49 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 0.0 106.893 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.12 -5.77 34.14 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.213 0.605 . . . . 0.0 112.389 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.1 m -138.5 174.42 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.305 1.842 . . . . 0.0 107.836 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.1 -63.58 1.32 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 119.486 -0.292 . . . . 0.0 110.93 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.17 -49.26 0.07 Allowed 'General case' 0 C--N 1.341 0.232 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.18 32.6 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.353 1.061 . . . . 0.0 110.032 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.17 14.32 73.81 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.044 0.83 . . . . 0.0 113.268 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.444 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 43.2 mmtt -67.57 132.68 92.8 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 117.053 -1.451 . . . . 0.0 108.363 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.09 46.09 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.677 2.918 . . . . 0.0 112.195 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -131.71 71.97 80.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.564 1.545 . . . . 0.0 107.682 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -34.26 147.2 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.613 1 C-N-CA 125.922 4.414 . . . . 0.0 119.09 -169.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.0 tp -102.18 147.62 26.42 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.9 mt -110.85 150.49 29.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -116.88 139.08 51.04 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.94 160.57 38.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.3 150.56 52.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.431 1.492 . . . . 0.0 108.195 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -75.12 128.26 35.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -129.85 -9.25 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.664 1.186 . . . . 0.0 109.925 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.0 37.52 92.13 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 C-N-CA 124.834 1.254 . . . . 0.0 111.011 179.487 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttp . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.924 0.392 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.36 156.88 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 mm -132.96 144.34 36.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.621 0.768 . . . . 0.0 109.348 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -141.6 164.49 30.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 mm -124.33 143.77 36.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -151.91 172.39 16.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.68 1.192 . . . . 0.0 109.162 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -66.68 149.82 49.96 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -71.34 154.11 41.83 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.482 1.113 . . . . 0.0 111.721 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -97.66 163.68 12.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.816 1.646 . . . . 0.0 108.258 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -69.17 -48.31 62.6 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.282 -0.261 . . . . 0.0 110.742 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.52 -28.62 67.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.79 -1.91 40.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.86 -38.19 37.04 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.25 0.929 . . . . 0.0 113.503 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.76 -28.44 67.62 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.58 1.19 . . . . 0.0 111.919 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.4 -30.73 69.71 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.89 -39.36 61.54 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -56.88 -45.64 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.34 98.01 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.884 0.474 . . . . 0.0 111.884 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mt -62.41 -48.45 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.345 0.658 . . . . 0.0 109.678 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -54.49 -48.42 71.88 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -59.29 -42.08 90.46 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.866 -0.521 . . . . 0.0 110.596 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -62.63 -39.79 94.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.47 1.108 . . . . 0.0 111.718 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -65.78 -36.52 83.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.572 0.749 . . . . 0.0 109.969 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.59 -45.81 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.254 -0.903 . . . . 0.0 109.127 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.26 -33.8 65.8 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.948 1.299 . . . . 0.0 113.004 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.11 -29.48 12.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -139.28 0.6 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -168.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -135.17 25.79 3.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.429 1.468 . . . . 0.0 110.963 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.58 -12.8 17.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.874 -1.141 . . . . 0.0 113.196 -174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -56.21 -20.34 17.74 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.325 1.85 . . . . 0.0 112.904 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.94 101.84 0.42 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.08 1.352 . . . . 0.0 108.8 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -56.69 157.71 5.18 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.342 1.457 . . . . 0.0 110.729 170.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 -37.9 63.59 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.88 -49.75 64.66 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.905 0.775 . . . . 0.0 109.701 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -63.72 -40.19 96.13 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.233 1.013 . . . . 0.0 109.956 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -55.58 -50.23 70.64 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.838 1.255 . . . . 0.0 109.614 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.1 m -64.1 -48.33 76.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.303 1.041 . . . . 0.0 110.274 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.46 -41.31 93.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.188 0.449 . . . . 0.0 110.723 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.99 -50.53 65.95 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.595 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.36 -41.94 76.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.061 0.846 . . . . 0.0 110.684 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.34 -44.51 83.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.452 0.701 . . . . 0.0 112.225 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.32 -38.24 74.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -56.8 -49.41 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.493 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -58.39 -24.27 59.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.646 1.178 . . . . 0.0 111.674 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -101.46 6.49 42.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.179 0.992 . . . . 0.0 110.959 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -136.89 -52.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.306 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -58.36 -37.89 59.78 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.265 1.393 . . . . 0.0 113.001 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -63.42 -14.01 39.68 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.129 1.886 . . . . 0.0 115.426 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -127.98 -19.01 4.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.042 1.746 . . . . 0.0 112.463 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.38 148.43 96.17 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.256 1.022 . . . . 0.0 110.416 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.43 43.74 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.748 3.632 . . . . 0.0 112.102 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.83 169.96 7.27 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.52 1.528 . . . . 0.0 112.07 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -113.27 149.54 33.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 138.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 110.238 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.93 132.35 35.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.64 141.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.59 -179.51 7.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.342 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -51.26 -25.67 6.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.594 1.558 . . . . 0.0 114.22 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -79.39 0.14 30.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.171 0.989 . . . . 0.0 111.773 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t0 52.01 56.97 7.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 123.34 1.543 . . . . 0.0 109.216 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -136.95 126.75 15.72 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.8 137.3 38.0 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.904 2.403 . . . . 0.0 111.695 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.6 m -113.82 -21.36 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.115 0.966 . . . . 0.0 111.68 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.84 170.61 39.2 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -141.44 157.43 45.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.855 0.862 . . . . 0.0 110.686 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -141.38 134.29 28.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.788 2.035 . . . . 0.0 106.668 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 tp -115.91 118.2 32.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 173.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.8 tp -142.07 133.49 26.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.215 1.006 . . . . 0.0 108.298 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -143.45 153.87 43.09 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.25 -119.48 13.58 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.52 37.12 4.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.194 0.998 . . . . 0.0 110.478 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -127.27 109.1 11.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.824 0.85 . . . . 0.0 110.066 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -85.45 97.41 10.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.47 -31.73 67.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.9 23.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.689 0.796 . . . . 0.0 110.282 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 tp -148.08 122.85 9.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 173.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.38 142.63 30.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 mt -148.55 144.37 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -61.07 115.33 13.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.19 -15.03 26.59 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.785 2.323 . . . . 0.0 114.364 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.83 -24.37 67.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.821 0.737 . . . . 0.0 112.554 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.32 -9.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 112.928 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -47.24 -46.43 24.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.581 1.152 . . . . 0.0 111.237 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.26 -14.52 71.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.884 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 72.0 m -68.91 -14.39 63.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.246 1.523 . . . . 0.0 112.062 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.52 -7.76 7.9 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.309 0.956 . . . . 0.0 112.589 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.73 -31.52 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.744 1.272 . . . . 0.0 111.059 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.74 -50.45 37.2 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.573 0.606 . . . . 0.0 111.895 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.22 -46.83 79.07 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.842 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.71 -49.28 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.646 1.112 . . . . 0.0 110.288 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.24 -36.81 74.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.118 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.98 -40.56 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.03 0.832 . . . . 0.0 109.789 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.67 -36.11 83.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.409 1.004 . . . . 0.0 110.02 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -61.5 -48.24 81.97 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.871 0.469 . . . . 0.0 110.3 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.59 76.03 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.511 0.724 . . . . 0.0 110.87 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.67 -33.37 70.04 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.697 1.199 . . . . 0.0 111.696 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -62.84 -35.03 78.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.583 0.629 . . . . 0.0 111.465 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.8 mtm -86.13 -24.39 26.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.381 0.537 . . . . 0.0 112.013 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.77 91.05 9.42 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.866 1.266 . . . . 0.0 109.899 -171.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.65 -23.86 48.74 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.341 1.361 . . . . 0.0 113.273 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -103.39 30.92 4.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.428 1.491 . . . . 0.0 110.292 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.3 tp -50.86 146.57 5.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.559 2.343 . . . . 0.0 113.673 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.7 p -128.32 162.23 27.55 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 108.92 169.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -155.31 -179.29 7.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.788 0.435 . . . . 0.0 111.108 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -137.19 155.14 49.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.3 p -155.41 148.61 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -74.54 134.09 42.22 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.88 -35.31 68.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.682 1.193 . . . . 0.0 112.069 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -64.11 -29.69 70.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.415 0.552 . . . . 0.0 111.873 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -79.78 65.81 5.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.69 -25.68 60.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.746 0.818 . . . . 0.0 111.342 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.58 -47.71 82.63 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.006 0.522 . . . . 0.0 109.897 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.85 80.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.592 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.0 -46.28 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 119.179 0.9 . . . . 0.0 108.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.18 -49.88 67.64 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -55.25 -49.76 71.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.932 0.893 . . . . 0.0 110.524 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.45 -36.1 81.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.56 -39.23 93.37 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.83 -1.169 . . . . 0.0 112.526 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.32 -42.94 92.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.863 1.21 . . . . 0.0 110.218 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.68 -34.32 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.847 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.53 7.53 1.88 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.394 0.997 . . . . 0.0 114.361 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -73.39 166.39 23.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.779 1.79 . . . . 0.0 111.518 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -143.42 140.57 30.48 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.142 2.177 . . . . 0.0 105.969 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.3 t -72.44 129.54 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.6 p -130.85 -6.64 4.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.054 1.742 . . . . 0.0 111.338 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.34 178.57 38.08 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -157.78 -172.33 3.9 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.733 0.813 . . . . 0.0 109.918 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.1 m -138.35 166.76 23.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.315 1.846 . . . . 0.0 108.94 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.16 -9.07 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.786 0.834 . . . . 0.0 111.507 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.74 178.36 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.916 2.486 . . . . 0.0 106.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.47 -66.18 0.87 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.185 0.448 . . . . 0.0 110.223 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -161.73 -45.61 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.508 0.723 . . . . 0.0 112.335 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.89 29.62 0.8 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.774 1.23 . . . . 0.0 110.093 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.0 14.65 73.62 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.484 1.04 . . . . 0.0 113.422 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -68.23 129.21 93.03 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 117.126 -1.416 . . . . 0.0 107.934 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.04 45.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.777 2.985 . . . . 0.0 112.227 -172.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.18 79.96 24.71 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -42.31 146.92 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.698 3.599 . . . . 0.0 118.829 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -97.45 149.42 22.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.0 mt -116.64 152.92 33.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -120.99 139.78 52.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.704 1.202 . . . . 0.0 107.874 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.35 157.71 46.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -170.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.34 150.87 52.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.988 1.315 . . . . 0.0 108.41 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.13 130.69 37.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -129.6 -10.98 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.486 1.515 . . . . 0.0 109.823 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.72 -27.38 70.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.216 0.912 . . . . 0.0 113.76 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 124.675 1.19 . . . . 0.0 110.527 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 ttp . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.17 159.88 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 110.504 169.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -138.63 144.98 28.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.636 1.174 . . . . 0.0 107.848 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -141.68 165.03 28.6 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 mm -127.06 144.06 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -154.24 169.99 22.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.13 1.372 . . . . 0.0 109.037 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -68.35 156.8 37.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -83.48 151.78 25.27 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.531 1.532 . . . . 0.0 112.103 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -84.72 161.11 20.16 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 168.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -70.61 -43.44 69.31 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.995 -0.441 . . . . 0.0 110.739 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.87 -28.31 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.07 -0.98 42.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.872 0.469 . . . . 0.0 111.621 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.84 52.58 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.02 0.827 . . . . 0.0 112.678 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -60.51 -34.04 73.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.418 1.109 . . . . 0.0 111.547 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -71.61 -32.68 68.26 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.261 0.624 . . . . 0.0 109.982 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.41 -39.88 67.59 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.768 -0.582 . . . . 0.0 109.437 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.62 -43.99 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.407 1.083 . . . . 0.0 109.231 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.54 89.47 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.048 0.539 . . . . 0.0 111.298 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.9 mt -58.46 -50.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.485 1.114 . . . . 0.0 109.167 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -53.35 -47.26 69.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.307 0.643 . . . . 0.0 110.299 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.8 t -60.05 -50.81 72.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.534 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -69.75 -29.75 67.18 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.44 -0.788 . . . . 0.0 112.281 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -63.23 -34.95 78.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.636 0.653 . . . . 0.0 110.909 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.99 -44.21 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.67 -35.36 72.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.766 0.712 . . . . 0.0 112.326 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -44.88 17.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.787 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 p -131.79 -2.12 3.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -168.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -129.5 26.45 5.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.57 1.077 . . . . 0.0 110.502 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.89 -15.76 34.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.969 0.908 . . . . 0.0 113.246 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -55.51 -18.7 7.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.895 2.078 . . . . 0.0 112.955 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.09 99.54 0.67 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -53.53 152.6 4.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.331 1.852 . . . . 0.0 111.162 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.38 68.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.26 -49.0 68.65 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.698 -0.626 . . . . 0.0 109.513 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.446 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 15.3 t80 -66.74 -36.53 82.66 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.126 -0.359 . . . . 0.0 110.574 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.55 -47.31 73.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.82 1.248 . . . . 0.0 109.839 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.4 m -65.03 -49.4 70.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.221 1.008 . . . . 0.0 110.053 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -65.12 -39.85 93.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.508 0.323 . . . . 0.0 110.631 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 mt -63.03 -52.0 64.58 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.308 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.91 -40.53 73.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.569 1.077 . . . . 0.0 110.592 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.59 -49.32 73.81 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.094 0.558 . . . . 0.0 111.954 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -37.44 76.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.998 0.363 . . . . 0.0 110.065 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.64 -48.85 84.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.412 1.885 . . . . 0.0 109.161 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -69.58 -11.67 61.02 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.241 -0.912 . . . . 0.0 112.304 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -99.03 6.09 46.78 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.098 0.959 . . . . 0.0 110.818 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.98 -53.98 0.71 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.744 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.36 -38.03 63.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.73 1.605 . . . . 0.0 112.948 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.67 -14.25 34.8 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.378 2.052 . . . . 0.0 115.223 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.55 -20.01 5.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.591 1.541 . . . . 0.0 112.03 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.19 146.49 97.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.437 1.095 . . . . 0.0 110.107 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.17 46.27 2.19 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.325 3.35 . . . . 0.0 111.421 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.67 157.28 30.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.948 -1.095 . . . . 0.0 110.154 -172.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -101.06 144.35 30.08 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.84 136.7 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.684 0.794 . . . . 0.0 110.166 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 168.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.46 141.51 45.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.437 ' ND2' HH21 ' A' ' 59' ' ' ARG . 20.1 p30 -82.22 -178.12 6.91 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.135 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -54.85 -23.78 20.06 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.441 1.497 . . . . 0.0 113.712 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.437 HH21 ' ND2' ' A' ' 57' ' ' ASN . 84.4 mtm180 -78.14 -1.83 34.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.345 1.058 . . . . 0.0 111.685 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 t0 52.19 58.31 5.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.577 1.656 . . . . 0.0 108.967 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -139.13 127.95 13.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 140.85 47.94 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.956 2.437 . . . . 0.0 112.527 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.424 ' CG1' HD21 ' A' ' 57' ' ' ASN . 27.2 m -118.94 -15.79 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.373 1.069 . . . . 0.0 112.294 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.71 168.81 40.38 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -141.7 156.33 45.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.347 0.659 . . . . 0.0 110.749 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.39 141.21 39.62 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.356 1.062 . . . . 0.0 108.522 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.56 117.98 31.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -148.88 134.99 19.18 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.125 0.875 . . . . 0.0 109.798 171.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.5 m -152.66 151.5 30.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 167.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.56 -122.9 26.0 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -129.67 22.16 5.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.517 1.127 . . . . 0.0 111.482 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -123.35 104.8 9.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.679 0.792 . . . . 0.0 109.548 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -83.21 82.0 8.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.18 -32.6 62.3 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.98 157.06 42.41 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 tp -154.94 126.44 7.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.916 2.086 . . . . 0.0 106.508 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.73 144.44 29.42 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.062 1.345 . . . . 0.0 107.959 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -149.9 146.01 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -53.48 116.51 9.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.702 1.201 . . . . 0.0 108.84 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.54 -18.65 60.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.317 2.678 . . . . 0.0 113.352 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.92 -20.86 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.222 0.919 . . . . 0.0 112.423 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.46 4.16 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.56 -45.31 66.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.065 -1.022 . . . . 0.0 110.469 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.49 -19.13 68.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.225 0.917 . . . . 0.0 113.632 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.81 -16.51 63.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.052 1.426 . . . . 0.0 111.749 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.99 -15.05 5.91 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.263 0.935 . . . . 0.0 112.637 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.15 -31.96 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.997 1.399 . . . . 0.0 111.656 -171.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.87 36.16 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.614 1.102 . . . . 0.0 113.693 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.72 -42.88 8.52 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 116.933 -1.508 . . . . 0.0 110.08 169.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.73 -45.13 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.58 1.537 . . . . 0.0 111.215 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.77 -38.53 83.54 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.94 0.791 . . . . 0.0 111.517 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.55 -42.94 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -64.39 -34.62 78.6 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.794 -0.566 . . . . 0.0 109.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -60.38 -49.03 79.2 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.09 0.404 . . . . 0.0 110.042 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.24 86.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.09 -34.67 75.29 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.918 0.887 . . . . 0.0 111.404 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -63.44 -37.35 86.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.271 0.487 . . . . 0.0 111.331 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.3 mtm -85.65 -24.1 27.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.101 0.56 . . . . 0.0 112.272 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.99 96.55 5.46 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.482 1.513 . . . . 0.0 108.342 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.77 -23.9 47.8 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.149 1.233 . . . . 0.0 112.225 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.77 28.49 4.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.77 1.628 . . . . 0.0 110.602 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 tp -52.2 145.86 10.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.155 2.182 . . . . 0.0 113.438 -169.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -128.11 158.0 39.21 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.069 1.348 . . . . 0.0 107.842 169.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -153.28 -173.72 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.773 0.429 . . . . 0.0 109.905 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.75 162.18 36.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.686 1.194 . . . . 0.0 109.552 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.3 p -154.55 143.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.69 125.58 27.23 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.37 -36.36 73.36 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.853 0.461 . . . . 0.0 111.957 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.47 -32.34 71.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.809 0.444 . . . . 0.0 110.851 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -77.3 65.98 2.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.646 1.179 . . . . 0.0 109.189 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.22 -26.49 60.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.332 1.053 . . . . 0.0 111.113 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -45.92 92.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.253 0.621 . . . . 0.0 109.791 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.79 -34.21 73.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.936 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.69 -46.72 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.464 1.029 . . . . 0.0 108.791 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.04 -49.96 70.1 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -54.99 -50.57 68.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.667 0.787 . . . . 0.0 110.873 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.9 -34.92 78.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -65.84 -38.61 89.33 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 120.99 -1.068 . . . . 0.0 112.296 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.85 -42.84 90.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.909 1.231 . . . . 0.0 110.191 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.93 -34.27 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.299 1.04 . . . . 0.0 110.787 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.87 0.89 2.16 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.323 0.963 . . . . 0.0 114.853 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -72.93 161.76 30.31 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.466 1.633 . . . . 0.0 111.688 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 141.81 27.19 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.82 1.648 . . . . 0.0 106.609 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.9 t -72.02 132.47 33.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.327 1.051 . . . . 0.0 109.863 -172.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.4 p -127.58 -8.81 5.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.754 2.022 . . . . 0.0 111.707 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.62 40.78 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -161.13 -174.84 4.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.919 0.86 . . . . 0.0 111.008 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.1 m -140.02 169.32 17.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.398 2.279 . . . . 0.0 107.121 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.36 -1.65 10.73 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.17 175.33 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.608 2.363 . . . . 0.0 105.772 171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.57 -63.65 1.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -163.48 -39.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.585 1.154 . . . . 0.0 112.081 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.6 -15.6 57.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.071 0.548 . . . . 0.0 111.785 -173.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.06 -16.67 9.3 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.254 1.407 . . . . 0.0 112.023 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.446 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 11.3 ptmt -61.51 121.96 67.48 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.524 1.13 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.97 63.17 0.3 Allowed 'Trans proline' 0 CA--C 1.549 1.244 1 C-N-CA 125.685 4.257 . . . . 0.0 116.497 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -131.76 66.46 78.02 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.771 -1.206 . . . . 0.0 109.174 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.7 166.76 21.18 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.965 2.443 . . . . 0.0 115.71 -169.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.75 148.21 44.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.228 2.211 . . . . 0.0 106.268 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.8 mt -111.82 150.97 29.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -118.4 140.07 50.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.86 160.47 39.21 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.748 1.219 . . . . 0.0 108.399 -169.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.43 151.88 51.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.268 1.427 . . . . 0.0 108.781 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -80.54 72.61 7.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.832 0.825 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.47 -21.33 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.681 0.792 . . . . 0.0 110.582 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.6 42.99 7.53 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.728 1.211 . . . . 0.0 110.715 177.588 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.498 0.189 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.85 141.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 mm -133.36 144.71 35.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -141.34 165.04 28.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 mm -124.98 142.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -154.01 170.98 19.8 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.044 0.938 . . . . 0.0 109.779 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -62.24 148.68 44.02 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 p -61.29 168.18 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.461 1.904 . . . . 0.0 113.166 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -118.93 157.89 26.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.356 1.862 . . . . 0.0 106.792 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.16 -43.33 74.49 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.915 -0.491 . . . . 0.0 110.842 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.11 -25.73 64.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -85.2 0.34 52.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.264 0.625 . . . . 0.0 111.533 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.81 -41.12 57.84 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.931 0.787 . . . . 0.0 113.41 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.29 -24.79 64.9 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.674 1.237 . . . . 0.0 111.771 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.3 -30.96 65.29 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.6 -38.97 67.66 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.58 -46.34 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.29 95.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.731 0.696 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.25 -50.98 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.628 0.771 . . . . 0.0 109.398 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -60.09 -46.93 87.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.715 0.406 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.38 -43.13 83.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.326 1.05 . . . . 0.0 111.148 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -66.29 -41.5 89.73 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.761 0.824 . . . . 0.0 111.083 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -41.53 88.48 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 110.328 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.56 -46.15 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.702 0.801 . . . . 0.0 109.397 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.5 -37.49 81.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.753 0.706 . . . . 0.0 112.17 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.29 -35.24 20.05 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.554 0.742 . . . . 0.0 112.843 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.9 p -137.43 2.98 2.53 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -128.75 31.56 4.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.626 1.103 . . . . 0.0 109.239 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.44 -24.03 42.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 0.0 113.314 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -24.32 58.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.973 2.109 . . . . 0.0 113.019 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.44 127.15 30.09 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.528 1.531 . . . . 0.0 111.386 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 m -55.83 141.59 38.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.767 1.227 . . . . 0.0 110.373 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -32.38 70.2 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.588 0.355 . . . . 0.0 111.891 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.61 -47.56 75.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.77 -40.94 88.42 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.575 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.03 -54.5 29.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.493 1.117 . . . . 0.0 109.373 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.2 m -64.95 -47.98 75.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.541 1.136 . . . . 0.0 111.409 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.19 -36.13 74.4 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.219 0.463 . . . . 0.0 110.654 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.0 mt -63.23 -50.78 68.88 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.887 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -40.52 69.74 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.498 1.044 . . . . 0.0 110.64 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.56 -44.72 81.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -35.79 68.02 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.084 -0.385 . . . . 0.0 110.437 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 t -59.65 -47.51 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 126.08 1.752 . . . . 0.0 109.128 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -70.01 -10.41 58.55 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.738 -1.226 . . . . 0.0 112.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -95.7 5.7 50.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.476 0.71 . . . . 0.0 110.777 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.39 -55.86 0.75 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.697 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.21 -39.1 75.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 120.635 1.561 . . . . 0.0 112.732 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -63.35 -11.57 26.27 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.423 2.082 . . . . 0.0 115.068 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.44 -20.55 5.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.704 1.593 . . . . 0.0 112.104 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 140.24 97.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.171 0.989 . . . . 0.0 110.068 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.26 50.05 3.41 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.635 3.557 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.86 164.07 4.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.364 1.466 . . . . 0.0 110.578 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -107.87 109.36 20.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.42 139.46 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 118.478 0.581 . . . . 0.0 109.946 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.98 133.28 35.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 103.714 -2.699 . . . . 0.0 103.714 167.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.54 141.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -80.56 -177.05 6.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.393 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -55.2 -23.62 22.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.299 1.439 . . . . 0.0 113.497 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.59 -0.43 42.27 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.394 1.078 . . . . 0.0 111.657 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t0 52.09 56.87 7.13 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.837 1.78 . . . . 0.0 109.522 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -137.09 126.15 15.2 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -171.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.36 142.53 55.01 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.592 2.195 . . . . 0.0 111.724 -169.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.51 -11.06 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 112.522 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.61 172.56 37.84 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.04 156.75 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.8 0.8 . . . . 0.0 110.369 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.43 162.1 36.12 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 108.758 169.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.38 130.38 52.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -146.26 135.07 22.38 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.2 m -161.64 156.18 22.79 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.025 2.53 . . . . 0.0 105.298 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.28 33.6 61.77 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.425 -0.797 . . . . 0.0 113.902 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 56.0 24.56 7.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.167 1.787 . . . . 0.0 114.148 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -124.02 110.74 15.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.102 0.961 . . . . 0.0 109.707 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.7 ttp -85.86 89.44 7.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.58 -27.14 68.98 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.633 1.173 . . . . 0.0 113.525 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.83 150.35 31.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.362 1.065 . . . . 0.0 109.443 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.2 tp -157.86 120.52 3.84 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.481 1.912 . . . . 0.0 106.432 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -145.88 145.88 30.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 108.107 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -149.98 143.6 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.81 134.01 95.1 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.498 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 -28.85 31.89 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.162 2.575 . . . . 0.0 114.849 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.62 -26.46 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.094 0.861 . . . . 0.0 112.851 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.1 m -111.93 -2.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.88 -39.71 82.22 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.252 -0.905 . . . . 0.0 110.09 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.37 -28.42 73.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.605 0.621 . . . . 0.0 112.838 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -74.01 -8.42 56.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.334 1.067 . . . . 0.0 112.293 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.49 9.38 61.63 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.523 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.63 -29.46 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.455 1.627 . . . . 0.0 110.68 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.97 -39.33 25.66 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.892 1.234 . . . . 0.0 113.455 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.42 -47.27 17.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.372 1.586 . . . . 0.0 109.869 169.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -52.87 -45.34 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.168 1.349 . . . . 0.0 111.428 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -68.03 -38.37 82.45 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.008 0.822 . . . . 0.0 111.422 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -41.47 90.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-N 118.446 0.566 . . . . 0.0 109.633 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.21 -36.27 83.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.62 -0.675 . . . . 0.0 109.718 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -60.51 -47.75 84.77 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.775 0.43 . . . . 0.0 110.203 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.76 74.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 122.823 0.449 . . . . 0.0 111.159 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.26 -34.25 72.01 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.385 1.074 . . . . 0.0 111.338 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.7 m -62.44 -37.51 86.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.331 0.514 . . . . 0.0 111.434 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.1 mtm -86.57 -21.06 27.08 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.306 0.503 . . . . 0.0 112.263 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.52 93.22 5.37 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.833 1.253 . . . . 0.0 109.872 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -22.84 53.97 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.345 1.363 . . . . 0.0 113.108 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -104.39 31.01 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.403 1.481 . . . . 0.0 110.335 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.7 tp -51.68 146.11 8.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.655 2.382 . . . . 0.0 113.126 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 p -129.97 160.49 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.293 1.437 . . . . 0.0 108.63 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -155.03 -176.75 6.1 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 172.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.0 156.04 41.0 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.132 0.973 . . . . 0.0 109.588 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.9 p -150.25 149.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.75 123.99 23.23 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.71 -32.28 67.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.639 1.175 . . . . 0.0 112.638 -170.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -57.68 -34.08 69.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.234 0.614 . . . . 0.0 110.963 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -77.43 65.62 3.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.682 1.193 . . . . 0.0 110.465 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.86 -26.09 61.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.582 0.753 . . . . 0.0 111.448 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.48 -47.46 85.57 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.815 0.446 . . . . 0.0 110.109 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.92 -37.3 84.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.354 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.56 -46.29 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.9 0.773 . . . . 0.0 109.168 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.35 -50.08 68.2 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -56.28 -49.54 73.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.796 0.838 . . . . 0.0 110.662 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.71 -34.81 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -66.28 -38.08 86.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.931 -1.106 . . . . 0.0 112.532 172.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.66 -42.47 88.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.95 1.25 . . . . 0.0 110.142 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.97 -35.44 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.253 1.021 . . . . 0.0 110.741 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.22 4.52 1.98 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.499 -1.167 . . . . 0.0 115.067 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.68 161.3 31.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.584 1.692 . . . . 0.0 111.392 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 139.93 25.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.74 131.23 35.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.137 0.975 . . . . 0.0 109.502 -173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.7 p -119.99 -11.41 9.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.638 1.975 . . . . 0.0 111.419 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.32 173.24 41.79 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -155.3 176.59 12.38 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 122.009 -0.7 . . . . 0.0 109.82 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.2 m -146.92 134.33 20.77 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.523 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.39 -23.33 67.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.997 . . . . 0.0 112.336 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.79 176.23 5.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.599 1.56 . . . . 0.0 107.589 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -107.3 -47.83 3.58 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -159.54 -52.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.49 -0.07 40.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.423 0.689 . . . . 0.0 112.044 -172.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.58 89.98 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -168.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -54.68 145.17 41.75 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.604 1.562 . . . . 0.0 109.633 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.51 68.8 5.26 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.241 2.627 . . . . 0.0 110.11 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -126.48 81.9 67.26 Favored Pre-proline 0 N--CA 1.457 -0.114 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.29 155.72 68.55 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 CA-C-N 119.908 1.003 . . . . 0.0 110.435 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.86 144.34 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.08 148.23 33.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -119.67 140.38 50.74 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.56 160.22 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.579 1.152 . . . . 0.0 108.703 -169.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.49 151.47 50.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.386 1.475 . . . . 0.0 108.208 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -76.45 127.64 33.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.58 -9.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.572 1.149 . . . . 0.0 109.959 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.72 37.91 92.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 124.819 1.248 . . . . 0.0 111.078 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.36 140.41 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -137.27 147.77 26.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -141.82 165.41 27.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.0 mm -123.14 142.43 39.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -151.48 174.72 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.907 0.883 . . . . 0.0 109.868 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -69.07 147.53 51.35 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 m -73.51 146.53 44.78 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.787 0.835 . . . . 0.0 111.91 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -81.73 158.73 24.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -67.77 -47.72 68.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.13 -27.43 67.31 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.03 1.8 34.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.846 0.458 . . . . 0.0 111.651 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.27 -38.71 33.96 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.962 0.792 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.73 -33.51 75.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.404 1.102 . . . . 0.0 111.516 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.94 -33.77 76.31 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 118.664 0.666 . . . . 0.0 109.583 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.47 -40.12 57.77 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.46 -47.35 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.76 90.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.122 0.569 . . . . 0.0 111.86 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.7 mt -59.59 -51.19 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 124.745 1.218 . . . . 0.0 108.776 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -53.07 -49.59 66.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.603 0.761 . . . . 0.0 110.079 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.4 t -59.42 -49.94 75.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.716 0.406 . . . . 0.0 110.196 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -75.17 -28.16 59.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.46 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.9 m -60.78 -40.26 91.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.224 0.92 . . . . 0.0 110.779 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -70.11 -45.9 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.3 -24.42 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.25 -47.08 10.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.237 1.015 . . . . 0.0 112.255 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -129.37 1.54 5.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -129.54 23.17 5.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.499 1.12 . . . . 0.0 109.508 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.2 -21.51 47.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.03 -25.8 13.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.183 1.793 . . . . 0.0 112.254 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.85 103.16 0.41 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 108.763 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 m -59.72 150.68 27.12 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.799 1.64 . . . . 0.0 112.444 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.81 -33.31 70.22 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.45 -48.17 76.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -74.45 -29.94 61.67 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.902 -0.499 . . . . 0.0 110.517 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -54.91 -44.75 74.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.318 0.963 . . . . 0.0 110.119 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.0 m -64.26 -48.79 74.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.304 1.042 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.14 -34.84 77.09 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.054 -0.404 . . . . 0.0 111.023 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.83 -48.29 77.42 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 117.532 -1.223 . . . . 0.0 109.462 172.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.57 -40.63 75.53 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.964 1.257 . . . . 0.0 109.813 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.82 -47.85 84.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.415 1.007 . . . . 0.0 112.37 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -37.92 75.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.848 1.659 . . . . 0.0 109.877 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -61.08 -24.79 66.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.866 1.266 . . . . 0.0 111.455 175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -98.21 7.37 46.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.39 1.076 . . . . 0.0 110.631 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -137.96 -59.21 0.65 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.6 -169.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.71 -36.42 45.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 121.01 1.732 . . . . 0.0 113.192 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -60.36 -18.49 53.33 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.899 1.733 . . . . 0.0 115.266 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -127.29 -13.78 5.49 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.313 1.415 . . . . 0.0 113.032 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.09 90.1 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.017 1.327 . . . . 0.0 111.516 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.37 58.93 6.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 112.064 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 mt -88.83 167.68 13.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.898 1.679 . . . . 0.0 112.921 -170.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -126.94 144.72 50.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.28 140.36 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.245 1.018 . . . . 0.0 110.524 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.25 134.19 35.28 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 167.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.72 142.74 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.64 179.24 7.41 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.43 -25.89 4.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.751 1.62 . . . . 0.0 114.039 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -77.0 -2.3 33.18 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.516 1.527 . . . . 0.0 112.014 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.3 57.24 6.83 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 124.294 1.997 . . . . 0.0 109.855 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -132.31 122.57 18.18 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.24 141.55 82.74 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.84 1.693 . . . . 0.0 109.906 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.2 -11.32 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.042 1.337 . . . . 0.0 112.042 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.25 168.76 41.09 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -142.71 159.16 42.78 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.489 0.716 . . . . 0.0 110.99 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.77 152.47 47.95 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.173 0.989 . . . . 0.0 109.726 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.59 119.53 34.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tt -143.13 137.41 29.09 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.7 m -150.74 155.55 39.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.87 -108.04 1.56 Allowed Glycine 0 CA--C 1.53 0.981 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -131.48 6.52 4.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.608 1.163 . . . . 0.0 111.988 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -105.42 124.97 50.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.558 1.072 . . . . 0.0 109.766 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.2 ttp -93.16 86.11 5.26 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.53 -26.61 68.78 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.41 147.51 34.73 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.53 0.732 . . . . 0.0 110.165 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.2 tp -155.59 122.29 5.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.868 2.067 . . . . 0.0 105.501 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.82 142.43 29.95 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.38 144.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -57.24 114.77 8.81 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 126.142 1.777 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.57 -29.88 11.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.087 3.192 . . . . 0.0 114.492 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.38 -21.84 66.76 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.37 10.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.143 0.977 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.03 -35.28 64.28 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.703 -1.248 . . . . 0.0 111.085 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.94 57.09 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.256 0.931 . . . . 0.0 113.613 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -72.69 -5.0 34.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.949 1.375 . . . . 0.0 112.456 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.69 69.41 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 119.08 0.854 . . . . 0.0 113.053 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.5 t -55.54 -31.07 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.357 1.079 . . . . 0.0 111.169 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.8 -53.04 14.56 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.048 0.832 . . . . 0.0 111.676 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.93 -42.29 97.4 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.381 -1.295 . . . . 0.0 110.206 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -58.6 -46.28 90.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.251 1.387 . . . . 0.0 110.052 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.23 -40.27 78.04 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.872 -0.518 . . . . 0.0 110.826 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.2 -40.44 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.632 0.651 . . . . 0.0 110.307 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.3 -33.3 72.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.037 -1.039 . . . . 0.0 109.989 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -62.3 -45.75 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.39 0.541 . . . . 0.0 110.383 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.04 83.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.286 0.634 . . . . 0.0 111.064 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.1 -34.27 73.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.114 0.966 . . . . 0.0 111.151 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -63.49 -37.88 88.99 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.219 0.463 . . . . 0.0 111.357 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 mtm -82.53 -28.54 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.371 0.532 . . . . 0.0 112.058 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 93.51 10.13 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.293 1.437 . . . . 0.0 108.613 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.85 -22.36 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 121.417 1.411 . . . . 0.0 112.202 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.68 31.53 4.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.741 . . . . 0.0 110.05 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.7 tp -48.4 141.74 6.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.073 2.149 . . . . 0.0 112.887 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -128.13 158.69 37.34 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 108.163 169.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -151.96 176.82 11.09 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.872 -0.518 . . . . 0.0 110.463 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -134.86 152.11 51.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.407 1.483 . . . . 0.0 108.823 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.0 p -152.95 144.47 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.69 130.09 38.15 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -61.56 -32.59 72.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -33.94 69.91 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.139 0.881 . . . . 0.0 111.321 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -77.72 68.22 3.75 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.168 0.987 . . . . 0.0 110.557 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.79 -24.75 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -62.55 -46.35 88.77 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.84 -0.537 . . . . 0.0 109.878 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.74 79.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.705 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.44 -49.16 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.297 0.953 . . . . 0.0 108.544 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.69 -46.94 93.47 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.83 -51.54 67.13 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 123.884 0.874 . . . . 0.0 110.097 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.62 -33.42 74.95 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.7 -47.92 82.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.174 0.897 . . . . 0.0 110.802 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.41 -42.58 87.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.065 0.848 . . . . 0.0 110.552 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.56 -34.3 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.182 0.993 . . . . 0.0 110.92 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.26 10.48 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.432 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -78.2 155.62 30.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.645 1.723 . . . . 0.0 111.53 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -141.06 138.95 33.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.362 1.865 . . . . 0.0 106.702 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.7 135.97 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.935 0.894 . . . . 0.0 110.057 -170.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.6 p -129.03 -8.72 4.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.468 1.907 . . . . 0.0 111.52 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.48 177.17 44.47 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.782 0.719 . . . . 0.0 111.55 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -157.46 178.0 10.79 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.066 0.946 . . . . 0.0 109.338 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m -145.76 126.16 14.02 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.938 2.095 . . . . 0.0 105.726 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.76 1.13 18.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.238 0.615 . . . . 0.0 112.542 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.7 175.78 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.98 1.712 . . . . 0.0 107.244 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -91.28 -65.41 1.01 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.292 -170.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -157.15 -43.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.64 28.24 3.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.67 1.188 . . . . 0.0 110.31 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.25 12.78 81.73 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.899 0.762 . . . . 0.0 113.019 -173.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -74.84 140.53 74.44 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 117.719 -1.134 . . . . 0.0 108.909 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.96 55.76 5.73 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.621 2.88 . . . . 0.0 111.699 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -130.07 67.69 79.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.165 0.986 . . . . 0.0 108.803 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.82 147.87 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 125.105 3.87 . . . . 0.0 117.461 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp -113.18 145.1 41.54 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 mt -116.85 152.05 35.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -125.65 137.84 53.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.852 1.261 . . . . 0.0 108.201 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.12 161.24 36.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.589 1.156 . . . . 0.0 108.162 -171.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.67 149.28 52.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.667 1.587 . . . . 0.0 108.562 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -75.44 129.93 38.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.3 t -127.45 -20.81 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.617 1.167 . . . . 0.0 109.913 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.54 31.26 78.16 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.517 -0.739 . . . . 0.0 112.318 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 C-N-CA 126.211 1.804 . . . . 0.0 107.923 178.247 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.476 0.179 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.82 143.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 mm -132.1 144.94 35.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -140.59 165.14 28.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.4 mm -128.07 143.22 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -156.45 173.8 16.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.865 0.866 . . . . 0.0 110.537 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -64.54 147.01 53.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -73.53 145.55 45.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.607 1.163 . . . . 0.0 111.928 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -82.25 131.33 35.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -57.51 -39.72 77.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.441 1.019 . . . . 0.0 111.071 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -70.12 -20.67 63.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.955 0.902 . . . . 0.0 113.202 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -84.11 -4.96 59.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.372 0.987 . . . . 0.0 111.042 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.9 -33.25 35.64 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 124.445 1.022 . . . . 0.0 113.355 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.59 -33.33 75.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.536 1.168 . . . . 0.0 111.836 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -65.97 -30.95 71.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.982 -0.449 . . . . 0.0 109.884 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.57 -37.57 56.33 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.05 0.54 . . . . 0.0 109.67 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.92 -46.06 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -44.11 97.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 111.917 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.2 mt -61.88 -50.27 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.34 1.056 . . . . 0.0 109.134 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.7 t90 -51.31 -47.54 62.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.356 0.662 . . . . 0.0 110.127 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.8 t -61.5 -50.44 72.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.105 0.411 . . . . 0.0 110.52 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -68.78 -32.13 71.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.042 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 m -62.15 -47.61 83.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.063 0.847 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.28 -44.45 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.622 0.769 . . . . 0.0 109.519 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.2 -28.56 69.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 0.0 112.064 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.69 -24.55 28.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.653 1.181 . . . . 0.0 113.939 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.8 p -137.34 -21.15 1.19 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.571 ' CE1' HD21 ' A' ' 110' ' ' ASN . 72.8 m80 -124.29 29.84 6.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.671 1.588 . . . . 0.0 109.28 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.28 -18.27 25.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.408 1.083 . . . . 0.0 113.589 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -51.13 -23.84 3.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.116 2.167 . . . . 0.0 113.162 170.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.01 97.84 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.941 1.296 . . . . 0.0 108.003 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.1 m -55.29 153.69 6.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.458 1.503 . . . . 0.0 110.991 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -35.86 63.07 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.07 -49.11 66.15 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.941 0.792 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -65.65 -39.04 90.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.001 0.521 . . . . 0.0 109.998 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -54.48 -46.49 73.4 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.833 1.253 . . . . 0.0 110.018 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.7 m -65.73 -48.04 73.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 110.367 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.77 -36.93 81.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.911 -0.493 . . . . 0.0 110.762 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 -51.51 67.37 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -56.85 -40.69 76.57 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.766 0.712 . . . . 0.0 110.528 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.28 -41.63 89.57 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.806 0.73 . . . . 0.0 112.597 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.45 -38.31 68.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.573 -0.705 . . . . 0.0 109.553 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.91 -47.38 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.814 1.645 . . . . 0.0 109.147 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -57.39 -23.95 52.4 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.36 1.464 . . . . 0.0 111.754 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -102.69 7.7 39.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.426 1.09 . . . . 0.0 111.187 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -136.29 -52.7 0.72 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.905 -169.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.15 -37.14 54.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 120.534 1.515 . . . . 0.0 113.251 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.4 -16.21 33.96 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.433 2.089 . . . . 0.0 115.607 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -126.27 -14.37 5.95 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.32 1.418 . . . . 0.0 112.527 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.75 151.54 92.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.761 1.224 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.38 63.57 7.85 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.693 3.595 . . . . 0.0 110.704 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.5 177.97 7.24 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.785 1.234 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -136.47 141.58 43.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 127.547 2.339 . . . . 0.0 105.244 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.42 141.9 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 119.164 0.893 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.16 134.14 34.58 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 167.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.51 142.31 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -79.33 -178.85 6.44 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.563 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.13 -25.03 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.557 1.543 . . . . 0.0 113.788 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -84.26 3.45 35.41 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.834 1.254 . . . . 0.0 111.999 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.6 t0 52.66 58.25 5.56 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 123.384 1.564 . . . . 0.0 109.79 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.06 124.12 17.29 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 -170.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.49 137.13 45.55 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.975 2.45 . . . . 0.0 111.497 -171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 m -124.17 -13.63 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.282 1.033 . . . . 0.0 112.082 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.9 42.9 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -147.49 160.9 42.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.159 0.584 . . . . 0.0 110.925 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.56 154.07 49.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 108.226 169.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 tp -110.12 118.9 37.63 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.49 132.26 18.98 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.6 m -145.61 153.32 40.92 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 168.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.32 -123.11 32.12 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -129.21 29.05 5.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.214 1.006 . . . . 0.0 111.26 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -122.94 108.59 13.13 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.655 -0.653 . . . . 0.0 110.218 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 ttp -85.59 87.36 7.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.06 -27.82 69.37 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.26 152.79 40.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.716 0.689 . . . . 0.0 110.963 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.9 tp -158.29 119.71 3.51 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.692 1.997 . . . . 0.0 106.38 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -147.04 141.43 26.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.561 1.144 . . . . 0.0 107.949 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.1 mt -150.95 145.71 16.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.29 126.18 77.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.379 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.63 -17.1 52.42 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.587 2.191 . . . . 0.0 113.834 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.18 -21.46 60.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.685 1.13 . . . . 0.0 112.018 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.49 -11.29 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -52.45 -39.71 61.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.892 1.224 . . . . 0.0 112.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.42 84.45 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.359 -176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.59 -18.64 65.07 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.175 1.488 . . . . 0.0 111.561 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.37 -23.16 1.22 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.07 0.843 . . . . 0.0 112.198 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.7 -32.82 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.602 1.201 . . . . 0.0 111.812 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.61 -31.45 37.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.128 0.871 . . . . 0.0 113.37 173.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -87.67 -45.94 9.95 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.01 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t -53.75 -43.85 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 120.364 1.438 . . . . 0.0 111.248 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -66.63 -37.02 83.96 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.872 0.76 . . . . 0.0 111.43 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.27 -42.07 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 118.44 0.563 . . . . 0.0 109.524 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.35 -35.1 79.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.554 0.615 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -61.43 -48.43 81.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.808 0.443 . . . . 0.0 110.382 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.31 82.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.891 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.34 -35.54 75.9 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.224 1.009 . . . . 0.0 111.458 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.82 -36.72 84.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.305 0.502 . . . . 0.0 111.408 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.3 mtm -86.16 -23.42 26.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.993 0.517 . . . . 0.0 112.218 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.15 91.45 7.05 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.267 1.427 . . . . 0.0 108.931 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -22.93 56.92 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.413 1.408 . . . . 0.0 112.788 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -103.81 30.74 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.347 1.459 . . . . 0.0 110.258 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.1 tp -49.61 144.55 5.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.179 2.192 . . . . 0.0 112.961 -171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.9 p -129.08 161.31 30.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.02 1.328 . . . . 0.0 108.796 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -153.09 -173.8 4.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -149.16 161.78 41.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.992 0.917 . . . . 0.0 110.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.25 145.24 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -74.26 128.83 36.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -57.43 -32.37 66.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.862 0.865 . . . . 0.0 113.088 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.47 -34.08 72.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.308 0.503 . . . . 0.0 111.195 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.571 HD21 ' CE1' ' A' ' 28' ' ' HIS . 64.2 t-20 -79.07 65.14 4.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.856 1.262 . . . . 0.0 109.611 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.3 -26.06 60.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.151 0.98 . . . . 0.0 111.1 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.12 84.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.959 0.503 . . . . 0.0 109.861 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.54 77.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.756 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.84 -49.31 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.402 1.001 . . . . 0.0 108.482 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.78 93.76 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -56.14 -50.63 70.59 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.763 0.825 . . . . 0.0 110.194 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -67.24 -33.96 76.43 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -59.46 -46.17 89.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.191 0.905 . . . . 0.0 110.977 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.92 -43.26 91.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.129 0.877 . . . . 0.0 110.384 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.4 t -63.13 -39.63 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.758 0.823 . . . . 0.0 110.365 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.26 11.58 0.89 Allowed Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.4 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.43 155.43 29.93 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.652 1.726 . . . . 0.0 111.479 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.01 139.22 34.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.103 1.761 . . . . 0.0 106.618 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.66 133.81 31.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.978 0.911 . . . . 0.0 109.8 -171.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.75 -9.66 7.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 111.459 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.09 178.31 43.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 118.849 0.75 . . . . 0.0 111.491 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -151.26 174.83 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.49 0.716 . . . . 0.0 109.572 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.1 m -147.45 139.32 24.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.267 2.227 . . . . 0.0 106.289 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.63 0.09 44.68 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.389 0.541 . . . . 0.0 111.832 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 m -137.92 173.1 13.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 126.83 2.052 . . . . 0.0 106.682 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.25 -47.69 4.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.305 -175.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -163.65 -45.91 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 78.5 mt -84.3 -1.38 55.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 112.147 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.25 79.93 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.185 0.898 . . . . 0.0 111.709 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -51.01 123.3 18.88 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.829 1.652 . . . . 0.0 109.473 169.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.74 60.41 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 124.982 3.788 . . . . 0.0 115.596 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -124.02 100.42 36.65 Favored Pre-proline 0 C--O 1.226 -0.157 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.69 160.8 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.544 2.162 . . . . 0.0 114.421 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.1 tp -131.69 144.04 50.72 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.2 mt -113.86 141.27 47.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -113.29 138.78 49.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 160.07 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.64 151.37 51.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.639 1.576 . . . . 0.0 108.575 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -75.8 126.37 30.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.57 -2.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 125.272 1.429 . . . . 0.0 109.89 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.82 -23.76 65.84 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.898 -1.126 . . . . 0.0 113.856 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.275 1.43 . . . . 0.0 110.932 178.806 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.326 0.108 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.1 163.15 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.354 0.597 . . . . 0.0 110.945 170.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -137.62 144.66 30.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 107.615 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -140.37 163.57 32.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -123.78 143.06 38.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.11 170.93 18.73 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.747 1.219 . . . . 0.0 108.956 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -66.35 148.65 51.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -73.27 148.43 43.62 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.282 1.033 . . . . 0.0 112.237 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -79.76 155.88 27.73 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -68.63 -40.59 80.27 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.909 -0.494 . . . . 0.0 110.269 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.7 -25.82 63.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.82 0.6 46.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.095 0.558 . . . . 0.0 111.394 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.4 -42.91 43.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.536 1.065 . . . . 0.0 113.64 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -72.52 -18.75 61.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.732 1.266 . . . . 0.0 112.066 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.67 -31.29 68.15 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.051 -1.031 . . . . 0.0 109.33 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -73.95 -38.35 64.26 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.57 -45.47 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.46 98.76 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.977 -0.452 . . . . 0.0 111.505 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.52 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.816 0.846 . . . . 0.0 109.466 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -54.26 -47.29 72.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.266 0.627 . . . . 0.0 110.298 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.48 -44.63 95.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.674 -0.642 . . . . 0.0 110.327 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -63.58 -37.04 85.82 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.677 -0.639 . . . . 0.0 110.993 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.2 m -67.87 -35.56 78.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.485 0.714 . . . . 0.0 110.819 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -70.9 -47.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.31 -33.54 69.59 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.559 0.744 . . . . 0.0 112.708 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.35 -35.63 15.11 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 118.344 -0.836 . . . . 0.0 113.17 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -138.63 2.0 2.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -136.44 26.61 3.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.91 -13.77 28.04 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.997 -1.064 . . . . 0.0 113.565 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -52.95 -22.93 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.741 2.017 . . . . 0.0 112.905 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -64.21 97.21 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.36 1.464 . . . . 0.0 108.679 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -56.26 158.81 3.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.57 1.548 . . . . 0.0 111.317 174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.41 65.03 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.37 -46.82 72.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.966 0.803 . . . . 0.0 109.98 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -64.91 -40.25 94.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.488 0.715 . . . . 0.0 109.748 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -55.57 -47.43 76.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.953 1.301 . . . . 0.0 110.097 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -64.94 -49.74 69.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.187 0.995 . . . . 0.0 110.019 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.26 -38.85 91.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.405 . . . . 0.0 110.785 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.86 -50.74 65.42 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.61 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.87 -38.83 79.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.734 1.152 . . . . 0.0 110.093 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.74 -48.22 82.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.98 0.809 . . . . 0.0 112.099 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -37.05 76.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.97 -46.37 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.801 1.641 . . . . 0.0 109.942 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -63.31 -20.57 65.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.515 1.052 . . . . 0.0 111.398 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -97.78 7.15 46.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 110.808 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -137.4 -56.13 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.215 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.99 -37.23 51.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 120.467 1.485 . . . . 0.0 112.708 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -63.94 -11.17 25.8 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.002 1.802 . . . . 0.0 115.706 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -128.06 -19.63 3.94 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.866 1.666 . . . . 0.0 112.746 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.74 149.67 97.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.408 1.083 . . . . 0.0 110.902 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.46 47.9 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.648 3.566 . . . . 0.0 112.305 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.36 165.49 16.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.038 1.735 . . . . 0.0 112.463 -171.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -115.77 147.4 40.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.37 138.58 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.935 . . . . 0.0 110.382 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.54 129.23 34.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 168.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.4 m -124.15 142.02 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -82.85 -179.7 7.52 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.05 -25.45 8.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 0.0 113.97 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -79.24 0.57 28.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.955 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 t0 51.63 55.96 8.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 124.207 1.956 . . . . 0.0 109.661 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.41 119.09 21.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 128.103 2.561 . . . . 0.0 104.333 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.64 138.74 65.98 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.693 1.596 . . . . 0.0 109.924 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.34 -9.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 0.0 112.468 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.46 168.67 40.16 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 171.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -142.46 156.34 45.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.813 0.806 . . . . 0.0 111.249 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -141.75 138.0 32.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.362 2.265 . . . . 0.0 106.037 -173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -124.15 119.57 29.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.7 tp -141.97 134.5 28.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.0 m -159.4 155.87 27.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.131 2.172 . . . . 0.0 105.422 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.14 35.46 59.9 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.564 -0.71 . . . . 0.0 113.774 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 58.14 22.24 8.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 113.697 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -125.47 114.36 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.6 ttp -80.89 87.32 5.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.96 -28.09 69.84 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.768 . . . . 0.0 112.837 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.97 144.63 29.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.755 0.822 . . . . 0.0 110.407 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.1 tp -156.19 117.58 3.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.955 1.702 . . . . 0.0 106.464 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -145.31 143.14 30.01 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -149.62 144.18 17.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.08 125.33 86.63 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.52 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.73 -30.21 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.882 3.055 . . . . 0.0 114.947 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -63.72 -25.18 68.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.94 -3.11 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.641 0.655 . . . . 0.0 112.497 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -59.62 -37.24 78.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.823 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.7 -26.62 68.75 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.859 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.0 m -78.29 -3.55 43.48 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.392 1.096 . . . . 0.0 112.212 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.11 13.15 64.57 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.486 172.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.0 t -57.21 -31.03 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.294 1.547 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.5 -49.85 44.12 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.634 0.635 . . . . 0.0 112.176 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -63.87 -46.85 83.08 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.716 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -54.03 -49.55 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 119.397 0.999 . . . . 0.0 110.152 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.95 -37.52 75.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.039 -174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.58 -39.75 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 119.088 0.858 . . . . 0.0 109.801 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.97 -36.11 82.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.74 1.154 . . . . 0.0 110.066 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.03 -48.33 80.78 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.872 0.469 . . . . 0.0 110.491 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.18 78.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.643 0.777 . . . . 0.0 110.753 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.49 -33.66 71.62 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.702 1.201 . . . . 0.0 111.646 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -62.66 -34.11 76.41 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.5 0.591 . . . . 0.0 111.548 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -87.19 -25.38 24.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 112.091 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.08 94.96 7.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.096 1.359 . . . . 0.0 109.175 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.91 -23.42 47.3 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 121.237 1.291 . . . . 0.0 112.318 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.12 28.87 4.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.789 1.635 . . . . 0.0 110.482 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.3 tp -53.0 146.49 10.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.281 2.232 . . . . 0.0 112.819 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.8 p -131.31 161.68 31.78 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 108.802 170.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 t -155.86 -178.37 7.24 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 122.636 0.374 . . . . 0.0 110.631 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -135.68 156.57 48.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.785 1.634 . . . . 0.0 108.695 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 p -154.39 145.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.53 132.48 42.91 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.17 -30.82 66.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.566 0.747 . . . . 0.0 112.213 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.53 -26.73 68.02 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.367 0.53 . . . . 0.0 112.193 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -79.95 67.84 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.748 0.785 . . . . 0.0 109.806 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.41 -27.7 49.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.446 1.099 . . . . 0.0 111.422 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.25 -50.59 65.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.006 0.523 . . . . 0.0 110.149 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.54 82.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.41 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.5 t -56.45 -49.14 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.92 -48.68 85.07 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.79 -50.88 70.99 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.392 0.677 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -66.94 -35.32 79.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.19 -47.37 85.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.983 0.81 . . . . 0.0 110.876 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -58.87 -42.03 88.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.021 0.828 . . . . 0.0 110.603 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.85 -40.28 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.701 0.8 . . . . 0.0 110.345 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.52 8.13 0.73 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.775 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.53 153.17 40.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.643 1.722 . . . . 0.0 111.142 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -140.5 139.49 35.11 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.126 1.77 . . . . 0.0 106.523 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.9 t -72.08 134.68 29.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.85 -171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 p -126.0 -8.6 6.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.789 2.036 . . . . 0.0 111.379 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.26 43.95 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 118.779 0.718 . . . . 0.0 111.467 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -154.44 176.91 11.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.83 0.852 . . . . 0.0 109.437 171.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -145.93 132.81 20.13 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.876 2.071 . . . . 0.0 105.831 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -77.37 2.04 17.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.17 170.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.748 1.619 . . . . 0.0 106.901 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.13 -60.77 2.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.562 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -159.08 -47.94 0.06 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 170.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.66 33.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.564 1.146 . . . . 0.0 109.931 -173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.58 15.15 70.52 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.061 0.838 . . . . 0.0 113.221 -171.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -66.46 125.75 90.97 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 116.82 -1.562 . . . . 0.0 107.926 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -78.35 46.25 2.06 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.753 2.969 . . . . 0.0 112.465 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -134.62 87.31 31.84 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -44.56 148.14 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.091 3.194 . . . . 0.0 117.687 -169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.8 tp -103.92 148.09 26.57 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.79 151.61 36.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -122.67 138.51 54.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.878 1.271 . . . . 0.0 107.849 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.03 159.79 41.08 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.435 1.094 . . . . 0.0 108.467 -170.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.18 149.66 51.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.413 1.485 . . . . 0.0 108.417 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -73.9 125.45 28.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.6 t -129.04 -7.98 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.63 1.172 . . . . 0.0 110.008 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.0 37.38 92.06 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -169.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.932 1.293 . . . . 0.0 111.127 178.833 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.87 141.52 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -136.72 146.74 28.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -140.9 164.02 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 168.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.8 mm -124.5 143.59 37.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -152.3 171.3 18.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.73 1.212 . . . . 0.0 109.136 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -65.85 147.47 53.32 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -76.35 148.85 37.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.623 1.169 . . . . 0.0 111.912 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -77.33 162.07 27.57 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -70.16 -46.67 64.21 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.93 -27.61 65.91 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.72 -1.48 47.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.789 0.436 . . . . 0.0 111.334 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.12 -35.96 55.66 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 124.14 0.876 . . . . 0.0 113.461 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.53 -28.14 69.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.979 1.39 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -68.09 -31.73 71.56 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.364 -0.835 . . . . 0.0 109.762 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -76.13 -37.36 58.13 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.11 -46.96 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.119 0.568 . . . . 0.0 112.042 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.18 -50.6 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.24 1.016 . . . . 0.0 109.569 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -51.36 -47.51 62.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.282 0.633 . . . . 0.0 110.005 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -61.51 -49.59 76.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.901 0.48 . . . . 0.0 110.233 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.21 -30.32 68.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.179 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -62.54 -46.15 89.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.628 1.104 . . . . 0.0 109.462 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -66.57 -44.02 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 123.877 0.871 . . . . 0.0 109.305 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.46 -28.62 68.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.361 0.982 . . . . 0.0 112.326 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.71 -33.3 27.61 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.984 0.914 . . . . 0.0 113.301 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.7 p -135.17 -12.17 2.17 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.415 ' CD2' HD21 ' A' ' 110' ' ' ASN . 28.5 m-70 -118.68 24.5 10.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.347 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.19 -19.76 35.96 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -53.41 -28.88 32.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.804 1.641 . . . . 0.0 111.927 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.21 104.98 1.96 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.961 2.104 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -59.87 157.83 11.71 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.557 1.943 . . . . 0.0 113.181 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.04 68.77 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -64.83 -50.18 67.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.631 0.65 . . . . 0.0 109.545 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -64.09 -38.58 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.138 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.18 -46.66 79.28 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.549 0.74 . . . . 0.0 109.917 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -64.81 -51.1 64.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.554 1.142 . . . . 0.0 110.105 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.37 -36.33 76.71 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.998 -0.439 . . . . 0.0 110.835 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.15 -50.97 68.3 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.834 -1.079 . . . . 0.0 109.276 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.822 1.192 . . . . 0.0 110.501 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.9 -44.66 72.75 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.86 -36.02 70.0 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.123 -0.361 . . . . 0.0 110.421 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.35 -47.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 125.992 1.717 . . . . 0.0 108.949 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -69.45 -12.1 61.37 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 120.847 -1.158 . . . . 0.0 112.819 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -95.53 6.05 49.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.715 0.806 . . . . 0.0 110.679 172.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -136.79 -55.32 0.73 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.58 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.09 -40.14 82.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 120.66 1.573 . . . . 0.0 112.632 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.49 -12.26 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.253 1.969 . . . . 0.0 114.853 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.85 -21.36 6.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.79 1.632 . . . . 0.0 111.937 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.55 148.65 97.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 110.778 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.65 48.85 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.653 3.569 . . . . 0.0 111.721 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.09 169.48 5.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.171 1.388 . . . . 0.0 112.272 -172.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -121.66 144.37 48.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.61 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.12 138.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.219 1.008 . . . . 0.0 110.659 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.72 129.48 34.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 103.617 -2.734 . . . . 0.0 103.617 167.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 m -126.86 144.63 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -80.47 -174.56 4.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.807 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.69 -22.43 46.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.476 1.11 . . . . 0.0 113.249 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.88 6.1 29.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.997 1.319 . . . . 0.0 111.682 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 53.01 41.94 32.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.964 1.364 . . . . 0.0 110.467 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 120.33 45.57 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -173.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.86 130.71 28.51 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.281 1.987 . . . . 0.0 110.286 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.32 -16.01 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.144 0.978 . . . . 0.0 111.637 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.97 172.72 42.16 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -147.35 161.73 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.372 0.669 . . . . 0.0 110.881 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.47 158.9 43.3 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.448 1.099 . . . . 0.0 109.717 169.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.5 tp -118.06 128.07 54.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.07 132.16 23.07 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 m -142.95 153.71 43.32 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.5 -118.44 10.54 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -129.07 30.76 5.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.181 0.992 . . . . 0.0 110.826 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -122.58 109.73 14.67 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.398 0.679 . . . . 0.0 110.452 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 ttp -85.78 87.85 7.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.37 -29.06 70.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.38 36.11 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.629 0.771 . . . . 0.0 109.815 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.7 tp -158.73 116.16 2.83 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.548 1.939 . . . . 0.0 105.958 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.97 143.21 29.34 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -149.91 145.44 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -171.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -60.41 121.58 61.19 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.99 -16.28 51.91 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.311 2.007 . . . . 0.0 113.704 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.02 -23.29 64.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.06 -9.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.438 1.095 . . . . 0.0 112.309 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -50.54 -44.18 56.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.341 1.056 . . . . 0.0 110.436 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.67 -18.77 66.42 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.165 0.888 . . . . 0.0 113.842 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.49 -9.11 57.68 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.108 1.454 . . . . 0.0 112.239 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.12 7.96 34.58 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.04 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -55.33 -31.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.053 1.426 . . . . 0.0 110.682 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.6 -51.7 27.0 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 119.377 -0.68 . . . . 0.0 111.706 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -62.24 -42.45 99.33 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.583 -1.198 . . . . 0.0 110.431 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.3 t -58.76 -46.54 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.98 1.264 . . . . 0.0 109.957 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.43 -41.19 80.67 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.949 -0.469 . . . . 0.0 110.806 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.51 -41.75 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.445 0.566 . . . . 0.0 109.943 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.3 -34.88 79.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.125 0.875 . . . . 0.0 110.14 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.38 -45.22 95.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.4 0.545 . . . . 0.0 110.424 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.31 -49.45 73.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.835 0.454 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.35 -33.67 69.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.113 0.965 . . . . 0.0 111.512 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.66 -35.97 81.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.297 0.499 . . . . 0.0 111.558 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.6 mtm -88.63 -23.0 23.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.267 0.485 . . . . 0.0 112.161 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.04 90.05 9.5 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 125.137 1.375 . . . . 0.0 108.914 -170.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -22.05 61.0 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.476 1.45 . . . . 0.0 112.919 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.45 31.93 4.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.535 1.534 . . . . 0.0 109.951 -175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 42.0 tp -49.2 144.81 4.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.238 2.215 . . . . 0.0 113.015 -171.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -129.23 162.25 28.3 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.186 1.395 . . . . 0.0 108.657 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -153.64 -173.72 4.68 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -148.92 161.78 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.481 0.713 . . . . 0.0 110.372 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.3 p -155.2 149.73 11.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -78.11 136.31 37.85 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.13 -26.2 60.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.224 1.41 . . . . 0.0 112.352 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -48.81 -47.45 42.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.056 0.844 . . . . 0.0 111.05 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.415 HD21 ' CD2' ' A' ' 28' ' ' HIS . 59.5 t-20 -85.82 65.3 9.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.327 1.451 . . . . 0.0 110.244 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.22 -29.36 46.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 111.441 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -43.89 97.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.409 0.684 . . . . 0.0 109.966 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.36 -33.99 72.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.148 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.25 -45.34 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 119.505 1.048 . . . . 0.0 108.678 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.39 -50.78 63.15 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -53.29 -50.54 64.68 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.869 0.868 . . . . 0.0 110.797 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -65.25 -38.51 90.57 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.91 -32.95 74.34 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.523 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -60.42 -40.88 92.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.353 1.433 . . . . 0.0 110.766 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.09 -39.13 80.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.05 9.32 0.82 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.841 171.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -69.01 159.58 32.57 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 1.537 . . . . 0.0 111.117 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.82 140.59 25.89 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 t -71.94 129.91 35.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.981 0.912 . . . . 0.0 109.324 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 p -124.93 -7.64 7.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.258 1.823 . . . . 0.0 111.796 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.91 173.06 42.2 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 118.82 0.737 . . . . 0.0 112.218 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -141.98 159.92 41.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.543 1.537 . . . . 0.0 111.061 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.3 m -136.69 127.7 27.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -69.88 -7.74 42.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.45 0.7 . . . . 0.0 112.827 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.41 173.06 13.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.452 1.901 . . . . 0.0 106.804 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.04 -55.93 3.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.05 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -165.05 -45.54 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.404 1.082 . . . . 0.0 112.65 176.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.51 -4.64 56.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.848 0.859 . . . . 0.0 112.195 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.38 -8.39 62.37 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.393 0.997 . . . . 0.0 111.817 -169.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.58 132.78 82.18 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 118.129 0.965 . . . . 0.0 109.444 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.38 55.73 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.177 3.251 . . . . 0.0 111.857 -169.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -122.38 87.83 48.77 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.7 148.41 21.68 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.929 1.753 . . . . 0.0 115.738 -170.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.0 tp -96.74 143.79 27.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.8 mt -114.73 134.72 54.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -102.98 139.73 38.16 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.19 159.94 39.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.24 51.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.538 1.535 . . . . 0.0 107.987 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -75.8 125.7 29.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.5 t -128.73 -8.87 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.552 1.141 . . . . 0.0 110.051 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.38 37.58 90.53 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -170.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 C-N-CA 124.681 1.192 . . . . 0.0 111.046 178.444 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttp . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.57 143.54 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 mm -134.66 144.38 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -142.39 166.12 25.54 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.52 142.65 40.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.69 171.17 19.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 109.507 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -64.57 147.73 52.27 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.929 0.786 . . . . 0.0 109.106 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.12 148.28 45.85 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -80.49 158.57 25.82 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -66.57 -48.99 67.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.73 -26.71 65.39 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -169.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.26 -1.97 43.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.161 0.437 . . . . 0.0 111.635 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.53 -39.14 36.7 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 124.185 0.898 . . . . 0.0 113.385 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.77 -26.78 67.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.686 1.243 . . . . 0.0 112.078 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.21 -31.77 71.53 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.15 -40.09 59.91 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.26 -46.01 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.603 0.761 . . . . 0.0 109.289 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -46.92 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.6 mt -57.35 -52.19 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.717 1.207 . . . . 0.0 108.934 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -52.94 -49.91 65.08 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.774 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 t -59.51 -50.49 73.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.109 0.564 . . . . 0.0 110.655 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -68.33 -33.05 73.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.145 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 m -63.34 -46.96 84.19 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.199 0.909 . . . . 0.0 109.688 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.63 -44.14 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.794 0.838 . . . . 0.0 108.912 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.99 -33.58 76.4 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.998 1.272 . . . . 0.0 112.052 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.24 60.9 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.428 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.8 p -135.07 -5.66 2.37 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -121.72 44.39 2.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.633 1.573 . . . . 0.0 108.486 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 -32.29 57.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.048 -1.033 . . . . 0.0 113.051 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.65 -21.72 66.59 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.745 1.218 . . . . 0.0 113.117 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.36 114.23 8.29 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.367 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -61.06 148.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 112.091 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.85 73.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.105 0.562 . . . . 0.0 112.464 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.82 -48.67 73.53 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -68.55 -35.5 77.5 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.137 -0.352 . . . . 0.0 110.381 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -54.87 -45.57 74.63 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.397 1.079 . . . . 0.0 110.313 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.4 m -65.23 -49.8 68.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.339 1.056 . . . . 0.0 110.235 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.01 -35.95 81.06 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.971 -0.456 . . . . 0.0 110.723 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.44 -52.84 62.9 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.345 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.75 -38.01 71.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.475 1.034 . . . . 0.0 110.74 -174.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.99 -48.82 72.6 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.089 0.556 . . . . 0.0 112.094 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.68 -36.03 73.11 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.974 -0.454 . . . . 0.0 110.471 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.49 -47.74 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.231 1.812 . . . . 0.0 109.098 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -69.85 -11.17 60.66 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.924 -1.11 . . . . 0.0 112.676 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m -95.87 5.47 51.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.691 0.796 . . . . 0.0 110.749 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.38 -56.43 0.75 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 117.892 -1.052 . . . . 0.0 112.628 -169.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -56.2 -38.37 67.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.558 . . . . 0.0 112.827 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.07 -14.86 35.72 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.8 1.666 . . . . 0.0 115.209 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.71 -13.57 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.741 1.61 . . . . 0.0 112.772 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.23 152.34 91.94 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.957 1.303 . . . . 0.0 111.321 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.82 56.18 5.86 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.831 3.688 . . . . 0.0 111.932 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.34 159.2 23.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.369 1.468 . . . . 0.0 112.009 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -116.24 142.45 46.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 141.22 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.259 1.024 . . . . 0.0 110.072 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.09 134.83 35.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 168.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -128.71 144.3 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -84.21 -171.77 3.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 110.763 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -62.33 11.04 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.501 2.32 . . . . 0.0 114.182 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -127.97 8.99 6.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.354 1.862 . . . . 0.0 111.314 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.0 t0 50.25 47.26 24.0 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.187 1.47 . . . . 0.0 110.259 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.41 122.99 26.59 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 -172.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.7 135.5 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.24 1.96 . . . . 0.0 110.994 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.93 -13.92 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.179 0.992 . . . . 0.0 112.136 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 170.86 42.61 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.41 159.88 41.23 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.295 1.038 . . . . 0.0 111.962 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -140.0 127.48 21.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.926 2.49 . . . . 0.0 105.999 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.97 116.8 31.17 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tt -146.56 129.29 16.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.348 0.522 . . . . 0.0 109.875 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.7 m -146.04 154.68 42.13 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.58 41.98 65.78 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 118.953 0.797 . . . . 0.0 113.996 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 59.53 21.97 10.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.811 1.644 . . . . 0.0 113.842 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -130.18 108.12 9.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.074 0.95 . . . . 0.0 108.97 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.2 ttp -85.9 86.14 7.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.13 -31.48 71.19 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.85 142.35 31.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.607 0.763 . . . . 0.0 110.296 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 tp -150.85 117.46 5.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -140.93 140.08 34.4 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.68 146.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.97 118.25 9.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.08 -18.6 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.636 2.224 . . . . 0.0 112.638 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.95 -23.52 66.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.1 0.864 . . . . 0.0 112.554 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.55 -2.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.939 1.295 . . . . 0.0 112.487 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -59.89 -27.64 66.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.678 -1.264 . . . . 0.0 111.698 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.97 -16.19 75.48 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.981 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.19 -175.09 2.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.713 1.256 . . . . 0.0 109.293 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.45 -31.58 36.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.632 -1.093 . . . . 0.0 113.612 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.34 -36.66 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.712 1.756 . . . . 0.0 112.733 -170.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.84 -23.04 43.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.873 0.749 . . . . 0.0 113.441 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -41.85 7.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.065 170.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.11 -45.98 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 121.605 2.002 . . . . 0.0 110.662 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.8 mt -68.9 -37.09 78.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.997 0.817 . . . . 0.0 111.641 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.15 -39.58 83.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 118.53 0.604 . . . . 0.0 109.674 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.49 -35.08 79.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.534 -0.729 . . . . 0.0 109.197 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.87 -48.36 79.35 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.574 0.75 . . . . 0.0 110.427 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.89 81.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.584 0.753 . . . . 0.0 110.888 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.11 -33.12 74.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 111.414 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -64.33 -39.06 93.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.491 0.587 . . . . 0.0 111.035 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.9 mtm -77.3 -29.83 53.88 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.438 0.563 . . . . 0.0 111.728 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 96.15 6.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.695 1.198 . . . . 0.0 110.13 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.01 -22.83 62.01 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.33 1.353 . . . . 0.0 112.409 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.55 29.19 4.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.509 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 tp -51.94 144.03 12.48 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.002 2.121 . . . . 0.0 113.589 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.4 p -129.87 161.3 31.13 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.47 1.508 . . . . 0.0 108.612 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -154.51 -179.33 7.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.918 0.487 . . . . 0.0 110.232 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.2 1.4 . . . . 0.0 109.018 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.5 p -153.86 145.3 14.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -75.78 137.71 40.72 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -63.89 -25.52 68.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.281 0.632 . . . . 0.0 111.944 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -71.74 31.57 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 112.415 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -149.7 67.04 1.0 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.946 1.698 . . . . 0.0 107.685 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.56 -26.42 61.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.52 -49.38 75.56 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.854 0.461 . . . . 0.0 110.085 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.27 76.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.673 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.42 -49.74 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.52 -46.32 94.56 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.294 0.497 . . . . 0.0 111.914 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -54.22 -53.17 57.25 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 125.146 1.379 . . . . 0.0 109.852 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -68.32 -33.38 74.21 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.855 -0.528 . . . . 0.0 109.852 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.26 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.418 1.008 . . . . 0.0 110.879 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.64 -43.27 89.69 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.841 0.746 . . . . 0.0 110.438 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.29 -37.61 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 110.607 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.59 10.07 0.83 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.618 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -81.78 155.93 25.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.635 1.717 . . . . 0.0 111.439 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.1 138.24 33.38 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.126 1.77 . . . . 0.0 106.558 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.85 133.67 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.03 0.932 . . . . 0.0 109.692 -172.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.4 p -125.59 -9.69 6.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.588 1.955 . . . . 0.0 111.414 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.61 -176.87 41.6 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.837 0.744 . . . . 0.0 111.758 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -151.54 -174.82 4.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.92 0.888 . . . . 0.0 109.338 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.3 m -133.02 150.22 52.16 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.382 1.873 . . . . 0.0 106.583 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.64 -9.84 59.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.827 -0.546 . . . . 0.0 112.023 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.45 178.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 127.43 2.292 . . . . 0.0 107.378 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -79.19 -64.79 1.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -159.8 -39.54 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -105.81 34.42 3.31 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.793 1.237 . . . . 0.0 110.212 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.15 9.52 86.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.737 0.684 . . . . 0.0 113.336 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.42 134.37 88.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.227 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.19 48.47 2.54 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.652 2.901 . . . . 0.0 111.634 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.17 71.26 79.93 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.275 1.83 . . . . 0.0 106.483 -172.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -42.71 142.67 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.402 2.734 . . . . 0.0 118.25 -169.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.22 145.96 24.67 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.36 152.86 33.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -124.61 138.67 54.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 108.206 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 161.19 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.678 1.191 . . . . 0.0 108.456 -170.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.26 150.27 52.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.67 1.588 . . . . 0.0 108.465 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.69 124.76 27.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.36 -17.09 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 30.91 1.98 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.999 1.285 . . . . 0.0 114.059 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 C-N-CA 124.399 1.08 . . . . 0.0 109.957 174.229 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.529 0.204 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.57 162.5 2.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.668 0.747 . . . . 0.0 112.018 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 mm -133.25 145.83 33.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -137.35 164.45 28.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -124.99 141.8 43.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.19 170.5 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.075 0.95 . . . . 0.0 109.771 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -61.67 148.97 40.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 p -62.59 167.0 4.74 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.19 1.796 . . . . 0.0 112.858 176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -118.69 135.48 54.46 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -55.72 -39.4 71.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.94 0.791 . . . . 0.0 111.73 -173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.64 -22.46 61.68 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -85.77 -4.18 59.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.829 0.74 . . . . 0.0 110.87 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.54 59.58 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.917 0.77 . . . . 0.0 113.107 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.65 -31.48 72.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.389 1.094 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.56 -30.82 69.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 109.631 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.2 mt -73.51 -39.47 64.8 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.7 -45.93 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 170.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.81 92.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.748 0.419 . . . . 0.0 111.129 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.66 -48.46 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.186 0.994 . . . . 0.0 109.927 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -53.24 -46.91 69.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 t -60.17 -43.93 95.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 110.525 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -63.95 -41.63 97.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.521 -0.737 . . . . 0.0 111.618 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -59.12 -39.78 83.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.553 0.741 . . . . 0.0 109.722 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.54 -45.86 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 123.56 0.744 . . . . 0.0 109.567 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.5 -35.07 73.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.918 0.781 . . . . 0.0 112.11 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.31 -46.41 27.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.76 0.824 . . . . 0.0 112.076 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 p -137.18 3.0 2.59 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -168.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.66 23.05 5.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.656 1.116 . . . . 0.0 110.63 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.99 -14.5 35.81 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.055 -1.028 . . . . 0.0 113.42 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.21 -21.83 15.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.242 1.817 . . . . 0.0 112.787 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.56 97.98 0.16 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.524 1.53 . . . . 0.0 108.27 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -58.84 156.85 10.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.133 0.973 . . . . 0.0 110.796 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.3 57.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -65.21 -51.68 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.495 0.589 . . . . 0.0 109.533 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.408 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 14.9 t80 -70.23 -33.7 71.97 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.864 -0.523 . . . . 0.0 110.553 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -55.14 -46.31 75.66 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.896 0.878 . . . . 0.0 109.566 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 m -64.76 -48.13 75.65 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.158 0.983 . . . . 0.0 110.187 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -62.55 -42.39 99.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.466 0.575 . . . . 0.0 110.775 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.11 -50.24 64.75 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.398 -0.81 . . . . 0.0 109.412 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.03 -39.27 74.49 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.263 0.938 . . . . 0.0 110.271 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.99 -49.89 74.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.723 0.692 . . . . 0.0 111.953 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -38.82 81.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.61 -48.15 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.009 1.723 . . . . 0.0 109.818 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -62.49 -22.08 65.98 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.913 0.885 . . . . 0.0 111.112 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -99.0 6.75 46.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.192 0.997 . . . . 0.0 110.941 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -136.84 -53.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.772 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.8 mt -59.05 -37.01 48.45 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 120.369 1.441 . . . . 0.0 112.73 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.64 -12.62 29.26 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 0.0 115.924 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.98 -21.19 5.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.602 1.546 . . . . 0.0 111.799 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.05 138.24 96.14 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 110.063 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -80.13 51.41 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.669 3.579 . . . . 0.0 110.761 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.47 164.93 3.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.374 1.47 . . . . 0.0 110.513 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -108.11 109.13 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 m -92.34 141.22 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 118.296 0.498 . . . . 0.0 110.015 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.33 133.28 34.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 167.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.89 143.07 42.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.23 -178.56 6.52 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.89 -23.87 8.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.715 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -75.32 -5.19 43.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.361 1.464 . . . . 0.0 111.982 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 t0 50.22 57.45 6.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 123.939 1.828 . . . . 0.0 109.64 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -139.59 128.13 13.48 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.57 139.85 41.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.618 2.212 . . . . 0.0 111.576 -169.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.79 -9.45 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.078 0.951 . . . . 0.0 111.968 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 175.5 42.16 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.63 42.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.628 0.714 . . . . 0.0 111.177 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.51 162.89 33.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 108.777 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 tp -122.99 129.09 51.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 tp -141.17 132.74 27.04 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 p -158.23 155.85 29.7 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.758 2.023 . . . . 0.0 105.837 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.11 36.18 56.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 121.445 -0.785 . . . . 0.0 113.896 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 58.33 21.97 8.87 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.957 1.703 . . . . 0.0 113.687 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -125.3 113.1 17.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.026 0.93 . . . . 0.0 110.296 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.6 ttp -85.5 90.46 7.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.65 -26.98 66.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -173.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.93 147.19 36.64 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.539 0.736 . . . . 0.0 109.67 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.8 tp -159.24 113.24 2.35 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.363 1.865 . . . . 0.0 106.137 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.21 140.74 29.46 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -150.52 148.38 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -62.59 125.94 87.22 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.45 -27.67 19.27 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 124.018 3.145 . . . . 0.0 115.39 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.14 -22.76 67.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.316 0.962 . . . . 0.0 112.57 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.05 -1.79 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.481 0.712 . . . . 0.0 112.753 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -57.11 -43.42 82.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.276 0.943 . . . . 0.0 109.655 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.17 74.63 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.5 0.571 . . . . 0.0 112.777 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -73.44 -8.36 55.59 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.234 1.017 . . . . 0.0 112.542 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.49 19.41 52.34 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.339 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.72 -30.21 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.315 1.557 . . . . 0.0 110.591 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.79 -50.42 20.24 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.95 0.785 . . . . 0.0 112.101 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.21 -44.17 97.18 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 118.658 1.229 . . . . 0.0 110.075 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.02 -45.8 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.924 1.238 . . . . 0.0 109.918 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -67.81 -41.46 83.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.913 -0.492 . . . . 0.0 110.687 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.42 -41.85 94.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.701 0.682 . . . . 0.0 110.234 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.07 -35.96 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.473 -0.767 . . . . 0.0 109.456 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.11 -45.39 94.89 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.719 0.408 . . . . 0.0 110.54 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.8 -48.89 75.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.713 0.405 . . . . 0.0 110.761 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.5 mt -59.98 -32.72 71.09 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.148 0.979 . . . . 0.0 111.437 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.12 -37.31 86.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.373 0.533 . . . . 0.0 111.565 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.2 mtm -86.84 -24.2 25.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.38 0.537 . . . . 0.0 112.288 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.36 94.73 7.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 125.389 1.476 . . . . 0.0 108.493 -172.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.34 -23.8 51.09 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.203 1.269 . . . . 0.0 112.243 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -99.42 28.65 4.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.718 1.607 . . . . 0.0 110.537 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.04 145.33 10.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.956 2.103 . . . . 0.0 113.547 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.7 p -129.25 163.14 26.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.479 1.511 . . . . 0.0 108.44 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.9 t -153.81 -173.5 4.6 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -147.52 161.88 40.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.179 0.992 . . . . 0.0 110.05 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.2 p -155.03 143.37 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.09 129.64 39.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.96 -37.38 74.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.512 0.725 . . . . 0.0 112.607 -170.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.23 -28.65 70.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.025 0.375 . . . . 0.0 111.476 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -78.12 66.47 3.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.72 0.772 . . . . 0.0 109.935 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.67 -24.87 62.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.21 -47.5 84.16 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.959 0.504 . . . . 0.0 109.841 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.22 79.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.595 176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.9 t -56.79 -46.2 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.172 0.896 . . . . 0.0 108.972 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.59 62.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.95 -49.66 70.81 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 124.036 0.934 . . . . 0.0 110.612 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -66.81 -35.34 79.83 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -66.18 -37.92 86.79 Favored 'General case' 0 C--N 1.34 0.167 0 O-C-N 120.837 -1.164 . . . . 0.0 112.508 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.19 -43.29 92.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.932 1.242 . . . . 0.0 110.177 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.41 -34.7 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.317 1.047 . . . . 0.0 110.793 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.48 8.8 1.92 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.397 0.998 . . . . 0.0 114.518 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -76.16 162.42 28.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.61 1.705 . . . . 0.0 111.407 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -147.42 140.67 25.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.221 1.808 . . . . 0.0 106.362 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.1 t -72.65 132.5 33.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.061 0.945 . . . . 0.0 109.78 -173.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 p -127.44 -9.3 5.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.741 2.016 . . . . 0.0 111.691 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.13 177.18 41.26 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -158.46 -174.08 4.62 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.05 -0.677 . . . . 0.0 110.576 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m -138.91 170.68 15.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.276 2.23 . . . . 0.0 107.495 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -116.91 -3.8 11.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.749 0.82 . . . . 0.0 111.407 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.13 178.8 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.887 2.475 . . . . 0.0 106.401 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -85.26 -70.22 0.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 122.551 0.34 . . . . 0.0 110.478 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -160.56 -41.1 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.451 0.7 . . . . 0.0 112.506 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.33 16.01 2.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.529 1.132 . . . . 0.0 111.114 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.97 8.53 83.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.355 0.979 . . . . 0.0 112.935 -170.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 7.9 ptmt -86.53 141.36 34.22 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.486 1.143 . . . . 0.0 110.473 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.26 73.89 5.81 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.672 2.915 . . . . 0.0 111.718 -172.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -131.94 65.26 75.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -57.35 161.0 12.3 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.067 2.511 . . . . 0.0 116.16 -168.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.0 tp -116.59 147.52 41.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 107.106 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.1 mt -116.01 147.74 40.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -118.75 139.26 51.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.96 160.25 39.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.111 0.964 . . . . 0.0 108.446 -170.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.37 151.78 51.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.63 1.572 . . . . 0.0 108.384 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.51 129.62 36.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 78.7 t -130.68 -10.41 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.18 1.392 . . . . 0.0 110.127 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.99 55.93 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.904 1.24 . . . . 0.0 113.91 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.849 2.059 . . . . 0.0 107.557 171.871 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.68 142.7 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -133.04 141.34 45.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -140.81 164.99 28.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -123.7 143.33 37.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -149.77 173.14 14.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 123.413 0.685 . . . . 0.0 110.376 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -65.26 147.66 53.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -71.99 179.36 3.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.863 1.265 . . . . 0.0 111.44 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -130.22 161.03 32.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.641 1.576 . . . . 0.0 107.131 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -69.15 -39.75 78.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.369 -0.207 . . . . 0.0 110.643 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.1 -37.2 75.31 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.679 0.392 . . . . 0.0 111.729 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.11 -2.95 26.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.172 0.589 . . . . 0.0 112.039 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.68 -39.5 31.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.267 0.937 . . . . 0.0 113.125 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.11 -28.51 68.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 111.969 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.07 -32.0 72.88 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 109.536 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -75.65 -39.22 58.02 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -56.83 -46.87 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.487 0.715 . . . . 0.0 109.203 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.29 95.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.95 0.5 . . . . 0.0 111.043 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.85 -54.08 36.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -51.76 -44.82 63.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.543 0.737 . . . . 0.0 110.255 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t -59.75 -42.28 92.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.635 0.374 . . . . 0.0 110.57 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -66.5 -43.23 85.9 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.611 -0.681 . . . . 0.0 111.006 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -58.92 -39.15 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.543 0.611 . . . . 0.0 110.305 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.61 -46.01 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.871 0.868 . . . . 0.0 109.765 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.16 -34.12 73.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.766 0.712 . . . . 0.0 111.968 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.36 -47.14 24.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.557 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.1 p -137.2 5.23 2.75 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -168.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -129.56 23.65 5.46 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.275 0.943 . . . . 0.0 110.175 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.4 -16.31 34.52 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.432 1.093 . . . . 0.0 113.624 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.77 -23.11 4.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.034 2.133 . . . . 0.0 113.221 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.1 94.37 0.34 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 m -53.9 156.55 2.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.253 1.421 . . . . 0.0 111.163 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.59 62.39 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.68 -48.01 73.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 109.973 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -67.39 -38.52 84.83 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.1 -47.94 71.24 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.628 1.171 . . . . 0.0 109.976 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.06 -49.89 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.113 0.965 . . . . 0.0 110.193 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.43 -37.09 82.5 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.081 -0.387 . . . . 0.0 110.739 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.95 -51.56 63.84 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.354 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -57.68 -37.58 73.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.467 1.03 . . . . 0.0 110.732 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.75 -48.37 74.83 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.139 0.575 . . . . 0.0 111.991 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -36.43 72.8 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -59.34 -47.35 90.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.076 1.75 . . . . 0.0 109.123 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -70.36 -11.06 60.66 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.852 -1.155 . . . . 0.0 112.707 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.2 4.85 52.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.621 0.768 . . . . 0.0 110.724 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -135.26 -54.49 0.8 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.887 -169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.0 -39.23 74.48 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.764 1.62 . . . . 0.0 112.703 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.33 -9.91 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.421 2.081 . . . . 0.0 114.883 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.63 -22.92 4.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.562 1.528 . . . . 0.0 112.332 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.83 152.06 96.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.62 65.91 8.07 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.887 3.724 . . . . 0.0 110.835 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.38 175.44 7.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.143 1.377 . . . . 0.0 112.023 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -133.71 151.0 51.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.6 2.36 . . . . 0.0 105.329 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.49 138.99 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.083 0.953 . . . . 0.0 110.886 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.03 132.65 35.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.72 142.81 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -83.4 -171.25 3.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.586 1.554 . . . . 0.0 110.656 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.39 8.31 0.05 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.215 2.206 . . . . 0.0 113.957 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -122.31 10.2 9.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 119.917 -1.739 . . . . 0.0 111.212 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 53.37 32.08 13.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.832 1.301 . . . . 0.0 111.127 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -116.68 132.4 23.4 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -169.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.59 138.0 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 112.367 -169.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.92 -10.0 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.431 1.093 . . . . 0.0 112.091 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.35 169.76 39.99 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -142.08 159.73 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.613 0.765 . . . . 0.0 111.239 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -139.74 136.0 33.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.569 2.347 . . . . 0.0 105.862 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -117.99 122.42 43.16 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -146.28 131.34 18.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.9 m -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.24 -114.06 4.31 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -129.11 14.82 6.25 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.791 0.836 . . . . 0.0 112.208 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.85 113.62 26.72 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.755 1.161 . . . . 0.0 110.735 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.8 ttp -83.23 85.41 7.21 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.07 -23.64 64.97 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.94 148.08 31.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.486 0.585 . . . . 0.0 110.606 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.3 tp -156.57 114.58 3.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -143.59 141.6 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.54 150.32 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.14 122.33 69.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.97 -27.49 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 124.334 3.356 . . . . 0.0 114.985 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.92 -23.45 65.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 112.856 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.15 -1.27 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.699 0.8 . . . . 0.0 112.782 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -57.12 -39.96 76.15 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.888 -1.133 . . . . 0.0 110.328 169.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.26 -27.96 71.49 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.473 0.559 . . . . 0.0 112.917 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.7 m -76.22 -6.52 51.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 112.34 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.25 60.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.245 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -54.8 -31.81 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.137 1.469 . . . . 0.0 110.74 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.42 -48.11 34.69 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.972 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -65.7 -40.56 92.42 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.483 1.141 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.9 t -58.86 -46.34 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.681 0.673 . . . . 0.0 109.597 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.86 -38.72 79.94 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.786 -0.571 . . . . 0.0 111.032 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.1 -40.13 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.804 0.729 . . . . 0.0 109.783 174.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.96 -37.31 86.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.058 1.299 . . . . 0.0 110.497 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -61.52 -46.97 87.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.113 0.482 . . . . 0.0 110.557 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.67 78.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.685 0.794 . . . . 0.0 110.92 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 mt -58.12 -34.44 70.22 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.053 1.341 . . . . 0.0 111.44 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.4 m -62.4 -32.48 73.31 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.277 0.489 . . . . 0.0 111.68 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.1 mtm -89.93 -25.26 21.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.464 0.574 . . . . 0.0 112.092 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.01 89.94 12.35 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.092 1.357 . . . . 0.0 109.263 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.55 -22.26 58.72 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.502 1.468 . . . . 0.0 113.192 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.38 31.55 5.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.492 1.517 . . . . 0.0 110.008 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.9 tp -48.16 142.68 5.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.507 2.323 . . . . 0.0 112.749 -171.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -126.15 161.05 28.56 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.334 1.453 . . . . 0.0 108.613 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -153.03 -176.23 5.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.723 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -147.17 160.76 42.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.585 1.154 . . . . 0.0 110.422 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.4 144.36 7.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.8 130.24 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.88 -31.61 62.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.585 0.63 . . . . 0.0 111.943 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -60.34 -32.36 71.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.654 0.782 . . . . 0.0 111.857 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -80.76 67.36 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.789 0.804 . . . . 0.0 109.535 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.8 -25.22 60.28 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.78 0.832 . . . . 0.0 111.405 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.64 -49.26 73.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.035 0.534 . . . . 0.0 110.017 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.41 -35.25 77.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.681 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.4 t -57.03 -49.2 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.94 -47.69 90.02 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -55.85 -51.3 68.01 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.578 0.751 . . . . 0.0 109.651 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.59 -34.77 78.62 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.791 -0.568 . . . . 0.0 109.787 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.98 -45.88 91.24 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.062 -1.024 . . . . 0.0 111.167 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -59.06 -39.71 82.89 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.256 0.934 . . . . 0.0 110.881 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.08 -39.07 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.514 0.726 . . . . 0.0 110.407 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.15 13.21 0.69 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.501 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -80.93 156.06 26.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.803 1.801 . . . . 0.0 111.652 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -144.43 140.76 29.18 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.444 1.897 . . . . 0.0 107.261 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 t -71.12 137.94 22.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.06 0.944 . . . . 0.0 110.318 -169.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.2 p -131.12 -9.73 3.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.809 2.044 . . . . 0.0 111.59 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.23 173.27 42.41 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.84 -173.63 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.873 0.836 . . . . 0.0 111.259 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -137.11 174.22 10.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.488 1.915 . . . . 0.0 108.542 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -122.74 -7.92 8.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.936 0.894 . . . . 0.0 111.599 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.94 172.68 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.708 2.003 . . . . 0.0 106.542 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -78.5 -64.7 1.11 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -161.22 -43.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.346 1.058 . . . . 0.0 112.126 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.99 -5.17 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.528 0.731 . . . . 0.0 112.083 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.1 -14.47 21.32 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.036 1.303 . . . . 0.0 112.502 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -60.63 138.59 92.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.055 0.928 . . . . 0.0 110.422 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.13 52.56 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.224 3.282 . . . . 0.0 112.413 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -121.88 66.74 21.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.52 1.128 . . . . 0.0 108.571 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.55 156.81 54.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.773 2.315 . . . . 0.0 114.699 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.15 142.98 33.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.39 149.62 29.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -123.01 137.9 54.83 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.65 161.84 35.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -169.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.47 146.54 51.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.662 1.585 . . . . 0.0 108.897 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.04 127.03 31.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.47 -12.75 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 111.943 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.87 29.07 3.09 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.558 1.075 . . . . 0.0 113.902 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 124.396 1.078 . . . . 0.0 110.054 176.302 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.06 179.92 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 107.011 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 mm -137.36 145.24 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -144.15 166.01 26.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -125.66 141.85 44.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.78 170.31 21.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 109.998 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -59.07 146.94 36.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 109.818 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 p -62.51 157.91 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.961 1.704 . . . . 0.0 112.595 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -106.55 155.18 19.89 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -67.92 -42.09 81.59 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.711 -0.618 . . . . 0.0 110.648 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.45 -25.66 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.07 -0.06 53.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.059 0.544 . . . . 0.0 111.4 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.21 -41.77 47.71 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 118.998 0.817 . . . . 0.0 113.281 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.78 -26.05 65.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.645 1.223 . . . . 0.0 111.901 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.54 -30.73 67.55 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.281 -0.887 . . . . 0.0 109.621 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 mt -73.01 -39.9 65.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.18 -45.02 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 109.456 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.94 98.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.831 0.452 . . . . 0.0 111.635 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.96 -49.56 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.589 0.756 . . . . 0.0 109.401 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -55.01 -47.79 74.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.688 0.395 . . . . 0.0 110.232 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -59.97 -44.52 94.41 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -64.4 -33.37 75.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.614 0.766 . . . . 0.0 111.813 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -68.4 -39.93 81.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.8 t -66.29 -47.25 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.07 -32.36 66.17 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.754 0.821 . . . . 0.0 112.65 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 -43.04 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.024 0.929 . . . . 0.0 112.482 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.7 p -138.76 -1.41 1.82 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -168.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -135.24 17.84 3.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.381 1.446 . . . . 0.0 112.326 -172.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.48 1.34 0.82 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.766 2.027 . . . . 0.0 114.368 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -59.41 -24.24 63.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.322 1.849 . . . . 0.0 112.523 172.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.08 112.21 2.53 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 m -56.91 154.37 9.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.971 1.308 . . . . 0.0 110.766 172.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.28 -36.75 71.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.2 -47.08 71.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.749 0.704 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -64.72 -40.24 95.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.282 0.633 . . . . 0.0 109.821 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -55.36 -48.56 74.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.611 1.164 . . . . 0.0 110.139 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.8 m -65.08 -49.18 71.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.177 0.991 . . . . 0.0 110.041 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -65.95 -38.45 88.65 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.223 -0.298 . . . . 0.0 110.641 -176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.78 -53.58 52.12 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.386 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.78 -38.22 75.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.244 0.929 . . . . 0.0 110.789 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.99 -48.81 72.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 111.857 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -36.54 75.34 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.177 0.444 . . . . 0.0 110.192 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.87 -48.95 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 126.071 1.748 . . . . 0.0 109.091 172.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -70.3 -10.56 59.31 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.001 -1.062 . . . . 0.0 112.742 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.46 4.2 53.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.625 0.77 . . . . 0.0 110.608 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -135.14 -56.58 0.81 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.805 -1.093 . . . . 0.0 112.336 -169.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.89 -38.65 70.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.644 1.565 . . . . 0.0 113.211 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 -14.8 36.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.422 2.081 . . . . 0.0 115.052 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.72 -13.82 5.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.484 1.493 . . . . 0.0 112.73 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.75 150.55 96.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.844 1.257 . . . . 0.0 111.166 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.78 55.94 5.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.663 3.575 . . . . 0.0 111.94 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.98 155.04 26.61 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.349 1.06 . . . . 0.0 111.146 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -111.32 109.7 19.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.66 138.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.44 133.88 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -126.47 141.5 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -83.71 178.74 7.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.05 -23.93 0.95 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.869 2.068 . . . . 0.0 114.661 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -79.27 -3.34 45.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.669 1.588 . . . . 0.0 112.274 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t0 50.76 57.69 6.36 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.929 1.823 . . . . 0.0 109.69 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -140.63 126.35 11.43 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 141.95 54.02 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.468 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.05 -8.67 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.372 1.069 . . . . 0.0 112.304 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.75 171.55 39.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.42 153.06 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.81 0.805 . . . . 0.0 110.667 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -136.91 132.02 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.539 2.336 . . . . 0.0 105.667 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.75 117.37 31.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.78 133.47 25.27 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 m -143.04 152.74 42.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.76 -114.89 5.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -130.68 27.66 4.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 110.679 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -125.58 111.47 15.05 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.53 -0.731 . . . . 0.0 110.458 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -79.39 89.02 4.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.23 -29.26 70.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.924 0.89 . . . . 0.0 112.979 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.95 148.81 29.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.826 0.851 . . . . 0.0 110.488 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 tp -155.36 119.37 4.58 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.0 1.72 . . . . 0.0 106.463 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.12 144.31 30.85 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -151.43 142.93 16.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.9 133.81 95.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.547 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.67 -24.31 70.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.755 2.303 . . . . 0.0 113.729 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.59 -24.2 67.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.416 1.007 . . . . 0.0 112.902 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.42 -1.22 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -59.91 -38.49 82.49 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.978 -1.076 . . . . 0.0 110.223 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.02 72.09 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.563 0.601 . . . . 0.0 112.776 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.1 m -75.03 -6.5 49.75 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.229 1.014 . . . . 0.0 112.214 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.39 13.73 65.1 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.377 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.64 -31.2 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 119.255 1.527 . . . . 0.0 111.088 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.27 -54.38 10.23 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.947 0.784 . . . . 0.0 111.95 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -64.32 -43.76 93.66 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.031 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 t -56.78 -46.66 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 120.453 1.479 . . . . 0.0 110.179 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.15 -40.33 78.29 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.349 0.522 . . . . 0.0 111.147 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.55 -40.94 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.713 0.688 . . . . 0.0 109.883 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.71 -34.45 77.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.21 0.914 . . . . 0.0 109.87 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -61.2 -46.79 88.99 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.404 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.73 80.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.268 0.627 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.97 -33.18 71.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 111.459 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -63.18 -36.61 84.19 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.486 0.584 . . . . 0.0 111.392 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.4 mtm -85.17 -23.95 28.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.32 0.509 . . . . 0.0 112.117 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.42 95.19 6.63 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 125.123 1.369 . . . . 0.0 109.184 -173.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.16 -25.99 50.19 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 121.29 1.326 . . . . 0.0 112.554 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.03 31.52 3.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.822 1.649 . . . . 0.0 110.369 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.9 tp -49.63 146.37 4.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.662 2.385 . . . . 0.0 113.118 -172.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.9 p -129.94 162.91 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.558 1.543 . . . . 0.0 108.969 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 t -155.76 -178.05 7.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.736 0.414 . . . . 0.0 110.548 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.13 155.39 50.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.621 1.569 . . . . 0.0 108.782 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.63 146.44 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -77.52 138.9 39.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -63.13 -24.19 67.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.637 0.375 . . . . 0.0 111.932 -176.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.97 -40.46 70.04 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.398 0.679 . . . . 0.0 111.538 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -86.15 63.81 8.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.551 1.141 . . . . 0.0 109.331 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.73 -28.27 47.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.207 1.003 . . . . 0.0 111.316 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -47.04 83.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.718 0.807 . . . . 0.0 109.802 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.17 78.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.907 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.14 -49.46 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 119.57 1.077 . . . . 0.0 108.476 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.84 93.59 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -56.2 -50.6 70.78 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.536 0.735 . . . . 0.0 110.147 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -67.13 -33.88 76.39 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.88 -0.513 . . . . 0.0 109.822 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -59.29 -47.09 86.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.144 0.884 . . . . 0.0 110.901 170.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -58.81 -42.68 89.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.986 0.812 . . . . 0.0 110.429 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.03 -36.61 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.932 0.893 . . . . 0.0 110.737 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 136.02 9.86 1.42 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.8 -1.0 . . . . 0.0 114.638 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.38 155.49 30.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.87 1.835 . . . . 0.0 111.252 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.49 138.99 33.21 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.147 1.779 . . . . 0.0 106.574 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.9 t -71.73 135.03 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.17 0.988 . . . . 0.0 109.995 -171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 p -126.77 -8.69 6.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.951 2.1 . . . . 0.0 111.481 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.3 43.94 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.901 0.773 . . . . 0.0 111.735 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -154.66 176.1 12.85 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.653 0.781 . . . . 0.0 110.185 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.2 m -147.11 136.95 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.679 2.392 . . . . 0.0 106.089 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.51 0.41 38.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.477 0.581 . . . . 0.0 112.371 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.27 172.32 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.948 1.699 . . . . 0.0 107.245 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.98 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.22 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -158.3 -48.45 0.06 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 27.06 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.352 1.061 . . . . 0.0 110.194 -177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.99 71.26 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.318 0.961 . . . . 0.0 113.127 -170.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -65.53 133.65 95.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -78.59 45.21 1.81 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.883 3.056 . . . . 0.0 112.438 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.57 112.82 15.29 Favored Pre-proline 0 N--CA 1.455 -0.189 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.0 162.93 8.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.09 1.86 . . . . 0.0 115.547 -173.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.42 145.64 50.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.2 mt -116.69 150.1 38.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -120.16 138.87 53.35 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.89 160.83 38.25 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.398 1.079 . . . . 0.0 108.591 -170.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.9 150.97 52.11 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.706 1.602 . . . . 0.0 108.569 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -76.46 124.84 28.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 99.6 t -130.53 -18.62 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.407 1.083 . . . . 0.0 110.434 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.99 29.52 2.42 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.787 1.184 . . . . 0.0 114.106 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.403 1.081 . . . . 0.0 110.004 175.019 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.94 158.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.458 0.647 . . . . 0.0 111.464 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 mm -138.14 144.77 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -140.78 165.35 27.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 168.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mm -127.12 143.18 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -155.02 170.63 21.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.041 0.937 . . . . 0.0 109.822 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -59.02 147.8 33.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.489 0.586 . . . . 0.0 109.905 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p -63.4 154.41 32.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.584 1.553 . . . . 0.0 112.6 174.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -100.16 155.28 17.83 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -65.48 -48.51 72.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.852 -0.53 . . . . 0.0 110.278 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.24 -27.33 64.37 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -169.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.5 -5.76 51.18 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.141 0.428 . . . . 0.0 111.497 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.37 -35.64 36.01 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 124.184 0.897 . . . . 0.0 113.355 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -66.72 -31.51 72.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.293 1.047 . . . . 0.0 111.281 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.96 -31.32 70.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.402 0.681 . . . . 0.0 109.587 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.38 -39.74 64.88 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.792 -0.567 . . . . 0.0 109.774 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -57.89 -46.11 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 171.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.13 99.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 111.688 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.3 mt -62.11 -50.27 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 109.432 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -51.98 -47.88 64.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.534 . . . . 0.0 110.269 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 t -58.62 -50.39 74.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.153 0.433 . . . . 0.0 110.747 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -70.74 -28.18 64.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.504 -0.748 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -63.16 -44.92 94.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.081 0.855 . . . . 0.0 109.435 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.89 -42.54 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.772 0.829 . . . . 0.0 109.425 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.37 -35.05 73.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.021 0.828 . . . . 0.0 111.888 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.47 -36.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.111 -0.947 . . . . 0.0 113.1 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -136.58 -13.41 1.74 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -169.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.76 29.64 4.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.129 0.971 . . . . 0.0 110.572 -169.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -12.76 11.4 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.289 1.436 . . . . 0.0 113.495 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -51.61 -23.0 3.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.333 1.853 . . . . 0.0 113.203 169.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.34 97.78 0.43 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.667 1.187 . . . . 0.0 108.741 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -54.35 157.82 2.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.999 1.319 . . . . 0.0 110.712 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.42 64.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -46.81 72.37 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.901 0.773 . . . . 0.0 110.246 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.16 -40.89 97.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.632 0.773 . . . . 0.0 109.715 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -56.65 -47.28 80.09 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 124.256 1.022 . . . . 0.0 109.992 175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 m -65.78 -47.03 76.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.242 1.017 . . . . 0.0 110.393 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.0 -36.97 83.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.228 0.467 . . . . 0.0 110.712 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.91 -49.92 66.3 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.68 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.09 -39.45 72.14 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.126 0.875 . . . . 0.0 110.27 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.92 -48.33 80.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.809 0.731 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.69 -38.9 77.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -58.88 -47.55 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.979 1.711 . . . . 0.0 109.781 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -60.82 -24.22 65.68 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.367 1.067 . . . . 0.0 111.121 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -99.66 7.13 45.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.316 1.046 . . . . 0.0 110.969 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -136.96 -54.08 0.71 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.81 -169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.26 -37.76 60.75 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.642 1.565 . . . . 0.0 113.048 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -61.84 -14.15 34.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.337 2.025 . . . . 0.0 115.479 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.32 -14.6 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.645 1.566 . . . . 0.0 112.48 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 150.15 93.28 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.835 1.254 . . . . 0.0 110.834 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.28 50.83 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.56 3.506 . . . . 0.0 111.675 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.36 162.05 29.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.461 1.104 . . . . 0.0 110.993 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.06 117.03 28.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -99.06 140.08 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.24 0.616 . . . . 0.0 109.992 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.88 137.83 34.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.92 144.52 37.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -85.43 -175.62 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.586 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.79 -25.3 40.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.335 1.454 . . . . 0.0 113.415 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -79.75 -1.66 39.6 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.04 0.936 . . . . 0.0 111.498 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.4 t0 51.98 57.43 6.5 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.558 1.647 . . . . 0.0 109.238 -169.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -136.35 127.59 16.85 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.26 141.34 47.01 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.498 2.132 . . . . 0.0 111.681 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.17 -11.74 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 112.103 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.25 172.69 41.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.5 160.96 40.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.545 0.688 . . . . 0.0 111.494 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -140.29 137.1 33.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.068 2.547 . . . . 0.0 106.1 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.2 tp -115.48 127.52 55.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -144.36 140.87 29.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -154.21 155.81 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.19 -114.24 4.85 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -169.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -133.98 36.81 3.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.641 1.177 . . . . 0.0 110.043 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -134.05 115.38 14.24 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 121.212 -0.93 . . . . 0.0 111.34 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 56.1 ttp -86.2 90.41 8.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.95 -29.31 67.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.75 144.69 35.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.218 0.607 . . . . 0.0 110.799 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.0 tp -157.12 115.47 3.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.451 1.901 . . . . 0.0 106.14 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.69 141.35 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -151.4 146.21 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -59.24 122.13 61.19 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.27 -24.47 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.815 3.01 . . . . 0.0 115.36 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.43 -25.14 67.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.244 0.929 . . . . 0.0 112.75 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.45 -8.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -46.99 -41.61 16.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.005 1.322 . . . . 0.0 111.799 171.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.43 -12.22 65.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.866 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.9 -22.18 62.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.317 1.558 . . . . 0.0 112.109 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 137.18 -9.17 3.83 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.031 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.66 -32.17 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 119.161 1.48 . . . . 0.0 111.278 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.92 -53.92 16.31 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 123.538 0.589 . . . . 0.0 111.656 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -63.57 -42.4 98.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.262 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.72 -46.46 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.593 1.542 . . . . 0.0 109.932 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.4 mt -68.28 -41.81 80.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.982 -0.448 . . . . 0.0 110.77 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.74 -42.87 96.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.535 0.607 . . . . 0.0 110.181 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.52 -36.22 82.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.561 0.745 . . . . 0.0 109.59 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.82 -44.97 93.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.884 0.474 . . . . 0.0 110.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.34 63.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.158 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.72 -31.13 67.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.393 1.077 . . . . 0.0 111.782 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.82 -31.79 72.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.759 0.709 . . . . 0.0 111.969 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.0 mtm -91.77 -20.79 21.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.286 0.635 . . . . 0.0 112.208 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 94.88 6.1 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.532 1.533 . . . . 0.0 108.175 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.99 -21.83 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 CA-C-N 120.738 1.299 . . . . 0.0 112.887 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -104.52 30.28 5.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.721 1.608 . . . . 0.0 110.182 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.93 149.16 12.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.477 2.311 . . . . 0.0 113.56 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p -128.04 162.1 27.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.188 1.395 . . . . 0.0 109.811 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 t -152.72 -174.12 4.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 109.75 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -147.85 162.59 38.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.231 1.012 . . . . 0.0 109.994 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -157.0 143.49 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -71.04 133.74 46.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.88 -31.73 70.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 0.0 111.782 -172.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.17 -32.2 73.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.848 0.459 . . . . 0.0 111.465 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -80.58 61.56 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.865 1.266 . . . . 0.0 109.143 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.92 -26.37 47.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.479 1.112 . . . . 0.0 111.381 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -47.65 81.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.6 75.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.83 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.0 t -57.02 -48.53 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 119.578 1.081 . . . . 0.0 108.484 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.76 93.9 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.92 -51.11 67.09 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 123.633 0.773 . . . . 0.0 110.02 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.76 -34.53 78.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.027 -0.42 . . . . 0.0 109.956 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.28 -47.91 82.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.246 0.93 . . . . 0.0 110.778 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -58.85 -41.6 87.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.051 0.841 . . . . 0.0 110.757 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.77 -36.07 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.091 0.957 . . . . 0.0 110.478 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.91 9.51 1.7 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.338 0.97 . . . . 0.0 114.272 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.92 154.84 35.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.222 1.511 . . . . 0.0 111.449 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -139.62 138.66 36.33 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.637 1.575 . . . . 0.0 106.759 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.6 t -72.64 135.28 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.214 1.006 . . . . 0.0 109.86 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 p -125.12 -9.75 7.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.714 2.006 . . . . 0.0 111.327 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.17 179.77 43.57 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 118.755 0.707 . . . . 0.0 111.43 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -154.8 179.0 9.51 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 109.246 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -145.44 141.64 28.56 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 107.96 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.48 -3.58 25.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.736 0.814 . . . . 0.0 112.693 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 m -134.67 171.51 17.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.559 1.544 . . . . 0.0 107.602 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.98 -57.31 3.35 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -163.48 -41.22 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.811 0.845 . . . . 0.0 112.745 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.0 mt -89.04 9.67 24.42 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.072 0.949 . . . . 0.0 111.691 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.53 -9.21 77.71 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.512 1.054 . . . . 0.0 112.742 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -63.17 132.41 95.08 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.184 0.993 . . . . 0.0 110.44 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.75 62.64 8.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.236 3.291 . . . . 0.0 112.131 -170.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.84 74.68 80.71 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -36.82 147.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 125.074 3.849 . . . . 0.0 118.902 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.22 148.27 32.18 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.661 1.584 . . . . 0.0 107.255 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.9 mt -113.77 148.33 36.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -119.09 138.27 53.0 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.756 1.223 . . . . 0.0 107.753 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.14 162.47 33.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 108.525 -171.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.02 51.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.792 1.637 . . . . 0.0 108.134 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -72.48 127.2 31.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.2 -9.98 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.191 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.72 38.14 89.54 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 124.907 1.283 . . . . 0.0 111.033 178.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.401 0.143 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.5 t -60.05 151.22 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.54 0.736 . . . . 0.0 109.499 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -128.46 146.22 34.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.61 167.14 22.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 168.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.5 mm -126.22 142.87 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -154.53 171.56 19.23 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.881 0.872 . . . . 0.0 109.955 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -61.31 150.31 35.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.544 0.611 . . . . 0.0 109.781 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 p -60.11 162.56 5.66 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.037 1.335 . . . . 0.0 112.046 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -120.82 139.18 53.5 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.489 1.916 . . . . 0.0 106.131 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -57.44 -41.45 80.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.474 0.579 . . . . 0.0 111.563 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.53 -19.3 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -88.56 -2.59 58.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.863 0.756 . . . . 0.0 111.33 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.52 -39.17 44.53 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 118.92 0.782 . . . . 0.0 113.467 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.88 -28.94 70.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.195 0.998 . . . . 0.0 112.13 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.33 -35.6 81.48 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 118.868 0.758 . . . . 0.0 109.647 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.3 -39.31 59.75 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.6 t -58.46 -45.58 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.284 0.634 . . . . 0.0 109.411 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.59 91.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.339 0.656 . . . . 0.0 112.176 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.36 -49.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.695 1.198 . . . . 0.0 109.258 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -55.87 -45.72 78.46 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.864 -0.523 . . . . 0.0 110.319 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.3 t -59.91 -49.74 76.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.739 0.816 . . . . 0.0 110.903 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.52 -25.72 64.17 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.018 -1.051 . . . . 0.0 111.976 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 m -68.6 -34.32 75.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.049 0.841 . . . . 0.0 110.595 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.1 -46.48 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.5 -40.67 92.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.38 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.448 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 p -137.9 3.14 2.44 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -168.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.44 ' CE1' HD21 ' A' ' 110' ' ' ASN . 15.9 m80 -126.99 37.53 4.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.324 1.42 . . . . 0.0 109.305 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.25 -27.47 55.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.353 1.061 . . . . 0.0 113.784 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.09 -17.19 64.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.534 0.734 . . . . 0.0 112.957 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.9 127.14 30.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.531 1.132 . . . . 0.0 110.783 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -56.48 138.08 52.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.096 1.358 . . . . 0.0 110.055 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.57 80.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.078 0.399 . . . . 0.0 112.024 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -66.17 -42.86 88.34 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.783 -0.573 . . . . 0.0 109.696 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.66 -38.89 84.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.37 -52.93 57.69 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.887 0.875 . . . . 0.0 109.329 172.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.9 m -59.39 -49.07 79.23 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 110.321 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.12 -35.37 71.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.29 -0.256 . . . . 0.0 111.18 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.81 -49.7 73.9 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.14 -36.59 77.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.052 0.842 . . . . 0.0 110.441 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.08 -47.89 80.97 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.014 0.525 . . . . 0.0 111.907 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -36.56 71.16 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.122 -0.361 . . . . 0.0 110.104 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.46 -46.99 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.111 1.765 . . . . 0.0 109.229 172.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -70.25 -9.05 54.77 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.797 -1.19 . . . . 0.0 112.555 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -101.28 6.68 42.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.174 0.99 . . . . 0.0 110.891 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.99 -55.1 0.72 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.653 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.45 -38.4 68.03 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 120.57 1.532 . . . . 0.0 112.932 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -61.46 -14.18 33.51 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.323 2.015 . . . . 0.0 114.94 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.63 -17.45 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.596 1.544 . . . . 0.0 112.38 -174.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.34 148.37 98.03 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.585 1.154 . . . . 0.0 110.826 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.39 51.48 3.89 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.942 3.762 . . . . 0.0 111.373 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.34 165.48 20.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.595 1.158 . . . . 0.0 110.691 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -118.38 109.77 16.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.04 138.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.191 0.596 . . . . 0.0 109.663 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.9 134.27 35.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 167.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.35 143.86 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -77.04 -177.32 4.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.172 0.987 . . . . 0.0 110.12 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.0 -17.86 20.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.446 1.898 . . . . 0.0 113.552 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.71 4.56 53.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.383 1.473 . . . . 0.0 112.046 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.6 t0 53.27 46.25 26.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.716 1.246 . . . . 0.0 110.235 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 129.19 24.21 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.86 138.96 71.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.85 1.7 . . . . 0.0 110.282 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.7 -8.89 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.714 1.205 . . . . 0.0 112.233 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.83 174.2 40.78 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -148.16 159.49 43.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.804 0.802 . . . . 0.0 111.517 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -136.97 141.25 42.59 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.329 2.652 . . . . 0.0 105.826 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -122.9 127.34 48.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 tp -145.37 139.85 27.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.7 m -153.25 156.3 38.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.2 -116.12 7.0 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -169.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.0 25.78 4.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.874 0.87 . . . . 0.0 111.51 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -110.9 112.36 24.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.306 1.042 . . . . 0.0 110.685 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.6 ttp -80.04 87.27 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 169.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.1 -23.02 65.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.12 146.55 30.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.447 0.567 . . . . 0.0 110.263 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.9 tp -156.08 116.05 3.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.74 141.4 30.45 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -148.11 146.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -59.64 122.76 67.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.06 -29.59 6.46 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.049 3.166 . . . . 0.0 114.638 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.38 -24.53 67.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.187 0.995 . . . . 0.0 113.563 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.77 -1.51 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -58.16 -37.4 74.61 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.905 -1.122 . . . . 0.0 110.67 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.27 -21.58 68.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.824 0.726 . . . . 0.0 113.394 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.7 m -79.36 -3.35 45.84 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.635 1.217 . . . . 0.0 111.846 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.97 68.44 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.359 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.7 -31.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.196 1.498 . . . . 0.0 110.994 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.9 -53.52 13.9 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 123.831 0.729 . . . . 0.0 111.722 170.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -63.25 -43.24 98.57 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.213 -1.375 . . . . 0.0 110.19 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -57.83 -46.27 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 120.356 1.435 . . . . 0.0 110.076 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.36 -40.59 77.39 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.803 -0.561 . . . . 0.0 111.144 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.2 t -62.69 -41.24 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.646 0.657 . . . . 0.0 109.991 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.91 -34.13 76.04 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.124 0.875 . . . . 0.0 109.876 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -60.1 -47.04 87.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.231 0.469 . . . . 0.0 110.261 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.64 75.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.419 0.688 . . . . 0.0 110.785 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.17 -34.07 69.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.532 1.133 . . . . 0.0 111.458 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.72 -34.11 76.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.447 0.567 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 43.5 mtm -90.2 -21.88 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.363 0.529 . . . . 0.0 112.124 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.12 90.63 9.18 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 -172.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -21.99 59.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.513 1.475 . . . . 0.0 113.134 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -107.34 33.02 4.23 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.606 1.562 . . . . 0.0 109.808 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.5 tp -48.58 144.86 3.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.412 2.285 . . . . 0.0 112.951 -171.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.7 p -129.9 161.57 30.56 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.761 1.625 . . . . 0.0 108.102 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 t -153.09 -179.55 7.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.42 0.628 . . . . 0.0 110.555 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -143.07 159.32 42.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.275 1.03 . . . . 0.0 109.758 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.7 p -155.14 142.85 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -71.26 131.54 43.62 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 110' ' ' ASN . 30.8 tt0 -60.62 -22.46 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.563 0.745 . . . . 0.0 112.001 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.61 21.13 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.99 1.716 . . . . 0.0 113.098 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.44 HD21 ' CE1' ' A' ' 28' ' ' HIS . 64.9 t-20 -148.51 66.24 1.07 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.975 1.71 . . . . 0.0 108.143 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.71 -24.77 58.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.513 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -62.71 -48.94 77.07 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.889 0.476 . . . . 0.0 110.105 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.62 82.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.442 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.29 -49.65 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.71 -46.2 94.69 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -56.59 -50.67 71.27 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -67.38 -33.62 75.59 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.907 -0.496 . . . . 0.0 109.665 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.53 -48.39 81.0 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.11 0.868 . . . . 0.0 110.853 170.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.38 -42.67 87.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.905 0.775 . . . . 0.0 110.499 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.53 -34.42 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.206 1.003 . . . . 0.0 111.069 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.64 9.86 1.94 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.297 169.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -77.19 155.22 32.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.737 1.769 . . . . 0.0 111.039 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.63 139.76 33.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.14 1.776 . . . . 0.0 106.58 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 t -71.73 135.42 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 123.888 0.875 . . . . 0.0 109.93 -170.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 p -124.2 -10.77 7.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.507 1.923 . . . . 0.0 111.244 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 179.16 45.02 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 118.823 0.738 . . . . 0.0 111.844 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.91 175.74 11.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.217 1.007 . . . . 0.0 108.4 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m -145.65 135.89 23.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -79.92 1.64 26.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.059 0.39 . . . . 0.0 111.629 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.61 170.71 19.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 126.208 1.803 . . . . 0.0 107.781 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -100.85 -58.3 1.92 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.337 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -161.68 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.47 10.62 5.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.595 1.158 . . . . 0.0 111.218 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.82 1.7 62.96 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.833 1.206 . . . . 0.0 112.472 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -70.5 138.2 86.22 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.768 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.55 62.95 7.86 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.21 3.273 . . . . 0.0 112.194 -171.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -123.79 101.48 36.2 Favored Pre-proline 0 C--O 1.224 -0.28 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.36 165.06 6.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.37 2.047 . . . . 0.0 116.557 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.1 tp -136.28 146.34 46.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.424 1.89 . . . . 0.0 106.368 169.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.86 149.18 39.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -126.71 137.28 53.24 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.676 1.19 . . . . 0.0 108.549 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.9 161.99 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.316 1.046 . . . . 0.0 108.583 -169.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.91 150.45 52.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 108.631 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -76.61 126.54 31.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.92 -14.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.939 1.296 . . . . 0.0 110.431 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -54.08 143.47 29.67 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.511 1.053 . . . . 0.0 112.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.722 2.009 . . . . 0.0 107.86 175.195 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.29 169.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 mm -127.74 144.16 38.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -142.13 165.38 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mm -124.1 142.71 39.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -151.84 174.24 13.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.814 0.846 . . . . 0.0 110.046 174.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -63.82 152.61 39.07 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -63.52 174.61 1.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.122 1.769 . . . . 0.0 112.326 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -132.06 142.44 49.54 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.168 1.787 . . . . 0.0 106.493 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -57.73 -40.26 79.22 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.205 0.457 . . . . 0.0 110.897 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.07 -13.43 61.58 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.74 -0.84 41.93 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.865 0.757 . . . . 0.0 110.957 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.2 -40.72 60.31 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.587 0.613 . . . . 0.0 113.182 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.82 -28.2 68.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.348 1.074 . . . . 0.0 111.685 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.485 -0.759 . . . . 0.0 109.908 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.15 -38.96 69.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.39 -47.79 83.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.82 89.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.056 0.542 . . . . 0.0 111.699 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.45 -51.25 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.825 1.25 . . . . 0.0 109.782 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -54.55 -50.17 68.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.933 0.493 . . . . 0.0 109.676 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.46 -48.63 68.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.394 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.74 -33.86 64.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.87 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -27.1 63.67 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 120.531 1.514 . . . . 0.0 111.313 172.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.26 -45.74 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 O-C-N 121.269 -0.894 . . . . 0.0 109.068 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.73 -38.01 83.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.004 0.82 . . . . 0.0 111.904 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.83 -36.59 56.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.249 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.0 p -138.94 -4.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CE1' HD21 ' A' ' 110' ' ' ASN . 20.4 m80 -126.96 25.23 6.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.9 1.227 . . . . 0.0 110.458 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.49 -15.9 31.58 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -53.03 -22.64 6.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.812 2.045 . . . . 0.0 113.155 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.94 97.54 0.36 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.876 1.27 . . . . 0.0 108.163 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -54.82 155.69 4.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 111.181 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.28 64.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.19 -48.13 68.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.85 0.75 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.44 -40.0 94.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.192 0.597 . . . . 0.0 109.872 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -55.2 -47.28 75.48 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.781 1.232 . . . . 0.0 110.195 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.5 m -64.97 -49.72 69.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.019 0.928 . . . . 0.0 110.011 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.01 -38.05 87.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.962 0.346 . . . . 0.0 110.725 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 mt -62.39 -53.67 51.6 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.519 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.16 -39.58 75.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.18 0.9 . . . . 0.0 110.54 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.42 -48.58 77.2 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.958 0.503 . . . . 0.0 111.882 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.072 0.396 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.43 -48.09 88.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 109.279 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -69.94 -10.56 58.99 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.013 -1.054 . . . . 0.0 112.498 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -98.21 5.62 48.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 110.702 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.15 -56.97 0.76 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 117.739 -1.124 . . . . 0.0 112.507 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.49 -38.95 73.55 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 120.793 1.633 . . . . 0.0 113.125 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.39 -14.38 34.39 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.266 1.977 . . . . 0.0 114.818 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -129.01 -14.03 4.47 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.862 1.665 . . . . 0.0 113.144 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.11 91.23 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.048 1.339 . . . . 0.0 111.514 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.46 60.25 7.01 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.844 3.696 . . . . 0.0 110.872 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -83.06 179.69 7.68 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.818 1.294 . . . . 0.0 110.831 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -135.38 140.66 45.17 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.58 2.752 . . . . 0.0 103.921 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.77 139.77 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 119.264 0.938 . . . . 0.0 110.063 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.8 132.66 35.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.43 141.78 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -81.74 -179.82 7.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.358 171.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.55 -25.87 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.769 2.028 . . . . 0.0 114.33 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -85.17 3.35 39.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.288 1.435 . . . . 0.0 112.175 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 51.33 59.31 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 123.761 1.743 . . . . 0.0 109.182 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -131.84 119.27 16.93 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.89 139.78 76.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.019 1.813 . . . . 0.0 109.393 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.66 -10.54 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.681 1.193 . . . . 0.0 111.977 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.12 173.03 41.63 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.86 160.94 41.08 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.615 0.722 . . . . 0.0 111.407 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -141.56 129.78 22.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.836 2.454 . . . . 0.0 105.506 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.7 tp -109.06 124.89 51.48 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 169.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.7 tp -145.86 134.75 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m -159.72 155.61 26.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.081 2.152 . . . . 0.0 105.281 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.67 57.53 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.862 0.756 . . . . 0.0 113.881 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 58.43 21.77 8.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.992 1.717 . . . . 0.0 113.731 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -124.46 112.87 17.41 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.946 0.899 . . . . 0.0 110.079 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -85.22 85.79 7.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.76 -28.31 69.79 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.26 144.19 31.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.015 0.526 . . . . 0.0 110.094 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.8 tp -153.7 112.07 3.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -142.58 140.88 31.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.07 154.63 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -171.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -65.0 124.17 85.94 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.65 -27.59 8.1 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.147 3.231 . . . . 0.0 114.759 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.59 -24.15 66.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.978 0.911 . . . . 0.0 112.935 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.49 -2.76 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.759 0.824 . . . . 0.0 112.86 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -55.18 -42.91 73.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.553 1.07 . . . . 0.0 109.786 169.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.81 -26.73 72.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.496 -0.613 . . . . 0.0 113.132 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.9 m -74.57 -8.07 55.14 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.497 1.149 . . . . 0.0 112.419 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.02 13.93 56.98 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.399 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -56.01 -30.22 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.403 1.602 . . . . 0.0 110.293 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -46.89 -52.38 11.8 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.221 0.915 . . . . 0.0 111.883 169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.35 -44.58 96.14 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.079 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.45 -46.96 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.835 1.198 . . . . 0.0 109.963 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.0 mt -69.3 -39.72 78.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.281 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.13 -40.27 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.817 0.735 . . . . 0.0 109.939 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.91 -34.68 78.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.375 0.989 . . . . 0.0 109.762 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -60.74 -48.51 81.49 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 122.908 0.483 . . . . 0.0 110.318 173.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.3 77.19 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.612 0.765 . . . . 0.0 110.93 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.46 -33.46 71.32 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.591 1.156 . . . . 0.0 111.546 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 m -62.92 -35.56 80.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.578 0.626 . . . . 0.0 111.547 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -85.73 -25.39 26.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.364 0.529 . . . . 0.0 112.082 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.05 94.29 7.9 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.176 1.391 . . . . 0.0 109.16 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.99 -23.31 46.88 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.24 1.293 . . . . 0.0 112.405 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.77 29.08 4.32 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.753 1.621 . . . . 0.0 110.489 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.7 tp -52.49 144.79 12.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.238 2.215 . . . . 0.0 113.248 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.9 p -129.28 164.57 23.21 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.82 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -154.86 -174.47 5.0 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.236 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -148.28 162.03 40.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 110.001 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.1 p -157.71 148.69 9.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -70.0 130.33 41.88 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.54 -33.23 65.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.038 1.335 . . . . 0.0 111.805 -172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.39 -27.77 68.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 0.0 111.779 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.451 HD21 ' CE1' ' A' ' 28' ' ' HIS . 57.5 t-20 -79.72 64.97 4.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.434 0.694 . . . . 0.0 109.52 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.27 -25.54 59.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.75 0.82 . . . . 0.0 111.388 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.79 -48.28 79.81 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 109.954 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.61 78.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.65 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.21 -45.35 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 119.319 0.963 . . . . 0.0 109.001 173.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.66 -49.59 71.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -54.74 -50.49 68.24 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.912 0.885 . . . . 0.0 110.44 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.02 -35.72 81.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.51 -39.75 94.36 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 120.875 -1.141 . . . . 0.0 112.552 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.18 -41.73 89.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.997 1.271 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.26 -34.18 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.307 1.043 . . . . 0.0 110.634 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.27 4.86 2.47 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.5 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -71.64 165.64 23.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.331 1.565 . . . . 0.0 111.197 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.52 140.78 33.54 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.755 2.022 . . . . 0.0 106.036 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.33 129.52 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.1 p -128.82 -7.2 5.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.012 1.725 . . . . 0.0 111.249 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.46 176.92 39.55 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 169.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -157.04 -178.81 7.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.728 0.811 . . . . 0.0 109.533 171.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.6 m -143.61 143.99 31.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.565 1.546 . . . . 0.0 108.073 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.23 -8.17 51.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.648 0.779 . . . . 0.0 112.494 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.66 174.76 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.138 1.775 . . . . 0.0 107.481 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.5 -61.91 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -160.82 -46.86 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 112.684 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.36 27.7 1.39 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.372 1.069 . . . . 0.0 110.387 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.29 14.8 79.02 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 123.898 0.761 . . . . 0.0 113.21 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -67.6 129.1 93.59 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.596 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.41 47.15 2.32 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.828 3.019 . . . . 0.0 112.388 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -137.45 78.28 38.65 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 125.533 1.533 . . . . 0.0 107.152 -171.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_exo -37.49 146.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.607 1 C-N-CA 125.467 4.111 . . . . 0.0 118.74 -169.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.4 147.77 27.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 106.886 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.76 148.82 32.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -115.11 139.2 50.1 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.07 157.97 45.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -172.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.94 150.85 52.04 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.053 1.341 . . . . 0.0 108.206 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -76.31 130.87 38.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t -130.25 -11.04 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.77 1.228 . . . . 0.0 109.895 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.51 91.75 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.843 1.257 . . . . 0.0 111.061 -179.777 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.04 168.15 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 mm -130.95 145.67 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -140.54 162.49 35.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.2 mm -117.76 141.7 35.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.54 177.77 10.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 109.872 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -73.63 150.3 41.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 m -72.69 -177.26 2.23 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.403 1.081 . . . . 0.0 111.154 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.87 161.45 32.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -67.34 -40.11 85.84 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.925 0.33 . . . . 0.0 110.116 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.73 -26.38 64.29 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.7 1.79 52.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.634 0.774 . . . . 0.0 111.301 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.53 -41.67 49.67 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.281 0.946 . . . . 0.0 112.837 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.03 -26.86 68.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.057 0.929 . . . . 0.0 112.228 -178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.88 -34.59 78.12 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.966 0.803 . . . . 0.0 109.598 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.46 -38.16 49.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.43 -45.45 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -45.71 91.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.074 0.55 . . . . 0.0 111.448 178.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.3 mt -59.56 -48.52 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 109.702 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.37 -51.04 66.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.619 0.767 . . . . 0.0 110.204 173.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.05 -40.83 90.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.897 -0.502 . . . . 0.0 110.367 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -66.23 -42.99 87.86 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.327 0.651 . . . . 0.0 111.216 177.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -59.05 -37.06 76.11 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.917 0.487 . . . . 0.0 111.052 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -72.2 -44.32 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.269 0.628 . . . . 0.0 109.319 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -60.27 -37.81 81.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.012 0.824 . . . . 0.0 111.721 174.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.36 61.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.855 -174.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.1 p -139.27 -3.1 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -169.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CE1' HD21 ' A' ' 110' ' ' ASN . 16.3 m80 -126.72 26.28 6.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.686 1.13 . . . . 0.0 110.456 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -13.92 28.99 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.847 -1.158 . . . . 0.0 113.053 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -57.25 -21.1 31.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.063 1.745 . . . . 0.0 112.995 170.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.05 109.69 1.9 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 m -58.05 147.53 29.25 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.533 1.533 . . . . 0.0 110.238 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.34 67.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.88 -52.48 56.35 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.475 ' CD1' ' HE3' ' A' ' 135' ' ' LYS . 4.3 t80 -70.79 -31.84 68.74 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.891 -0.506 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 tpp85 -54.67 -46.38 74.03 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.956 0.902 . . . . 0.0 109.922 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -64.94 -50.04 67.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 109.843 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -63.4 -39.31 94.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.784 0.266 . . . . 0.0 110.545 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -62.34 -54.5 39.62 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.467 175.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -58.61 -37.81 76.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.419 1.009 . . . . 0.0 110.505 -173.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.13 -48.96 71.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.2 0.6 . . . . 0.0 111.919 175.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.47 74.92 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.282 0.492 . . . . 0.0 110.49 -176.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.71 -48.71 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.195 1.798 . . . . 0.0 108.945 171.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttp85 -70.66 -8.4 51.61 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.001 -1.062 . . . . 0.0 112.764 176.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -99.63 5.55 45.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.066 0.947 . . . . 0.0 110.801 172.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -135.45 -55.37 0.79 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.957 -169.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.72 -37.91 61.4 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.411 1.459 . . . . 0.0 112.732 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.4 -9.03 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.235 1.957 . . . . 0.0 115.437 172.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.02 -16.08 3.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.207 1.821 . . . . 0.0 113.466 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.86 152.39 96.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.794 1.238 . . . . 0.0 112.348 -172.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.24 62.38 7.54 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 125.176 3.917 . . . . 0.0 111.616 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.1 mt -83.89 172.77 11.81 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.233 1.813 . . . . 0.0 112.404 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -134.26 145.86 49.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.58 139.63 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.523 1.129 . . . . 0.0 110.262 -176.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.12 130.81 35.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -123.31 142.16 40.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.1 p30 -84.21 -173.48 4.74 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.453 174.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.64 -22.34 22.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.434 1.494 . . . . 0.0 113.657 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -81.79 -2.36 50.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 111.659 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 53.26 56.31 7.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.286 1.517 . . . . 0.0 109.142 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.61 129.19 16.31 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 127.461 2.304 . . . . 0.0 105.465 -169.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.73 136.8 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.027 1.818 . . . . 0.0 110.217 -171.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 -16.08 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.722 1.209 . . . . 0.0 111.842 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.19 173.02 39.31 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.76 161.28 42.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.707 0.753 . . . . 0.0 110.592 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 154.13 47.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.129 0.971 . . . . 0.0 108.937 168.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.78 119.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 176.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 tp -146.28 134.6 21.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.275 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -159.47 156.32 28.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.358 2.263 . . . . 0.0 105.484 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.63 32.94 61.95 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.419 -0.8 . . . . 0.0 113.889 175.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 57.01 22.54 7.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.218 1.807 . . . . 0.0 114.121 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -122.69 111.02 16.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.579 0.751 . . . . 0.0 109.787 175.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 ttp -85.83 88.78 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.77 -23.95 67.4 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.14 144.88 32.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.378 0.671 . . . . 0.0 110.552 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.8 tp -156.87 117.22 3.57 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.69 1.996 . . . . 0.0 106.112 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -147.17 144.92 29.32 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.33 142.73 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -173.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.49 137.68 95.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.281 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.62 -24.53 23.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.803 3.002 . . . . 0.0 115.852 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.34 -21.1 61.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.541 1.064 . . . . 0.0 112.278 175.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.15 24.89 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.529 1.532 . . . . 0.0 110.493 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.91 132.84 54.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.778 -1.201 . . . . 0.0 108.826 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.95 2.65 53.1 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.995 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 98.7 m -70.78 169.23 15.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.654 1.727 . . . . 0.0 109.18 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.05 -28.22 16.95 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.545 1.069 . . . . 0.0 113.863 -177.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.55 -34.81 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 118.989 1.395 . . . . 0.0 112.203 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.15 -29.94 53.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.08 0.848 . . . . 0.0 112.807 175.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -91.95 -42.52 9.97 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 116.498 -1.715 . . . . 0.0 110.248 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.32 -45.56 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 121.56 1.982 . . . . 0.0 110.826 -172.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.2 -39.81 89.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.791 0.723 . . . . 0.0 111.065 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.53 -40.75 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.478 0.711 . . . . 0.0 109.798 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.54 -36.95 85.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.594 0.758 . . . . 0.0 109.544 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.52 -47.03 87.44 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.057 0.543 . . . . 0.0 110.276 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.77 76.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.06 0.544 . . . . 0.0 110.84 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -60.27 -33.72 72.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.191 0.996 . . . . 0.0 111.578 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -37.65 88.11 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.358 0.526 . . . . 0.0 111.414 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -83.92 -26.45 29.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.253 0.479 . . . . 0.0 112.117 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 91.32 10.39 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.143 1.377 . . . . 0.0 109.282 -169.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.96 -22.16 63.06 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.425 1.417 . . . . 0.0 112.822 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.86 30.92 5.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.286 1.434 . . . . 0.0 110.274 -174.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 tp -50.91 143.37 10.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.898 2.079 . . . . 0.0 112.826 -170.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 65.2 p -130.0 162.85 27.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.746 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 t -153.58 -173.58 4.63 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.014 0.526 . . . . 0.0 109.724 175.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -148.68 161.41 41.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.833 0.853 . . . . 0.0 110.631 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -156.07 147.34 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -72.56 132.16 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -58.34 -30.87 67.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.726 0.811 . . . . 0.0 112.33 -173.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.79 -33.16 72.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.506 0.594 . . . . 0.0 111.236 -177.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.451 HD21 ' CE1' ' A' ' 28' ' ' HIS . 54.5 t-20 -80.02 65.8 5.3 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.028 0.931 . . . . 0.0 110.523 176.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.11 -26.11 59.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 111.632 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -62.87 -46.97 85.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.102 0.561 . . . . 0.0 109.752 176.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.72 77.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.606 -0.711 . . . . 0.0 111.786 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.41 -46.21 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.236 0.925 . . . . 0.0 108.963 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.01 -49.59 73.79 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -55.45 -50.88 68.71 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.582 0.753 . . . . 0.0 110.755 -178.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -66.1 -34.41 78.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -174.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.15 -37.88 86.75 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.82 -1.175 . . . . 0.0 112.72 172.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.07 -42.81 91.26 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.877 1.217 . . . . 0.0 110.169 173.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.57 -35.65 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 110.788 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.72 9.08 1.82 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.418 1.008 . . . . 0.0 114.454 169.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.4 162.2 29.08 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.608 1.704 . . . . 0.0 111.107 171.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.92 140.39 25.6 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.9 t -72.26 129.75 35.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.907 0.883 . . . . 0.0 109.336 -174.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.6 p -123.77 -9.15 7.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.421 1.888 . . . . 0.0 111.681 -174.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.55 -179.92 41.12 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -156.36 177.87 10.96 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.804 0.841 . . . . 0.0 109.254 172.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.0 m -145.69 129.98 17.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.4 2.66 12.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.3 m -132.26 169.79 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.177 1.391 . . . . 0.0 107.513 169.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.44 -59.63 2.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.394 -177.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.24 -43.35 0.07 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.18 31.97 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.435 1.094 . . . . 0.0 110.28 -173.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.44 84.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.554 0.597 . . . . 0.0 112.966 -173.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.475 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 39.1 mmtt -68.39 129.26 92.87 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 116.953 -1.499 . . . . 0.0 108.129 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.63 47.7 2.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.762 2.975 . . . . 0.0 112.425 -171.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -130.68 79.46 71.92 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -41.12 145.73 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.168 3.246 . . . . 0.0 118.449 -169.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.67 146.15 26.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.7 mt -117.26 145.23 44.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -115.71 138.61 50.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.0 158.78 43.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -171.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.56 152.48 51.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.277 1.431 . . . . 0.0 108.348 176.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.5 127.36 32.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.8 t -130.24 -9.48 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.136 1.374 . . . . 0.0 110.146 -176.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.06 -27.01 69.77 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.108 -0.995 . . . . 0.0 113.75 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 C-N-CA 124.746 1.218 . . . . 0.0 110.629 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.267 4.3 t . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -135.2 141.84 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.88 1.672 . . . . 0.0 106.676 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -136.32 166.17 24.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mm -123.08 142.16 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -150.52 172.02 16.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.784 0.834 . . . . 0.0 109.76 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.47 HH12 ' HB2' ' A' ' 51' ' ' PRO . 24.6 mmt180 -61.67 148.39 42.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.492 -0.755 . . . . 0.0 110.488 166.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -70.84 160.76 32.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.735 1.214 . . . . 0.0 110.26 176.228 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -103.11 161.72 13.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.146 163.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -62.82 -51.76 65.79 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -24.9 62.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.754 -162.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.35 -0.61 46.61 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.404 -0.185 . . . . 0.0 111.1 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 -39.43 53.22 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.137 -0.977 . . . . 0.0 112.752 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -65.56 -28.56 69.25 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.616 1.208 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.19 -32.78 73.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.209 0.528 . . . . 0.0 109.644 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.88 -38.82 64.29 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 120.901 -1.125 . . . . 0.0 109.63 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.28 -46.46 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -47.15 87.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.06 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.84 -50.36 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.996 1.319 . . . . 0.0 109.52 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -53.76 -47.15 70.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.0 t -59.13 -47.32 85.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.279 0.632 . . . . 0.0 110.683 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.306 -0.871 . . . . 0.0 112.811 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.1 m -60.17 -38.06 82.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.342 0.974 . . . . 0.0 109.516 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -70.44 -42.74 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.077 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.41 -34.99 78.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.392 0.542 . . . . 0.0 111.094 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.78 -33.91 30.62 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.283 -0.886 . . . . 0.0 112.309 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.591 HG21 HH12 ' A' ' 83' ' ' ARG . 19.9 p -139.1 -5.12 1.47 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -167.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.404 ' CE1' HD22 ' A' ' 110' ' ' ASN . 57.4 m80 -126.61 30.06 5.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.697 1.59 . . . . 0.0 110.454 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -60.8 -18.94 58.36 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.962 0.887 . . . . 0.0 112.849 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.11 -23.52 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.212 1.405 . . . . 0.0 112.517 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -60.88 106.02 0.53 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.418 1.087 . . . . 0.0 111.591 172.062 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 m -56.25 151.09 13.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.056 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.06 -34.41 68.24 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 123.077 0.551 . . . . 0.0 112.351 -172.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -68.07 -47.91 67.01 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.714 1.245 . . . . 0.0 109.358 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -68.66 -34.98 76.63 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.574 -1.193 . . . . 0.0 112.02 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -53.86 -49.35 68.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.754 0.822 . . . . 0.0 110.773 170.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 m -62.91 -47.08 84.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 124.349 1.031 . . . . 0.0 109.16 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.37 -36.54 74.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.457 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.54 -50.77 70.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.414 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.69 -39.06 79.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.081 0.855 . . . . 0.0 111.237 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -51.07 69.46 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.06 0.544 . . . . 0.0 110.326 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -37.21 79.01 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.478 -0.764 . . . . 0.0 110.134 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.8 t -58.5 -46.99 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.51 1.524 . . . . 0.0 109.026 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -67.74 -18.04 64.76 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.913 -1.117 . . . . 0.0 113.034 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.3 m -95.02 10.61 35.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -140.09 -56.29 0.55 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 119.473 1.033 . . . . 0.0 111.796 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -55.81 -40.24 83.22 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 116.888 -1.53 . . . . 0.0 112.659 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.73 -11.63 18.36 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.315 2.01 . . . . 0.0 116.209 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.99 -15.35 3.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.14 1.336 . . . . 0.0 112.461 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.02 148.24 98.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 123.784 0.833 . . . . 0.0 110.124 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HB2' HH12 ' A' ' 7' ' ' ARG . 47.1 Cg_endo -77.84 65.23 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.347 3.365 . . . . 0.0 108.844 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.426 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 64.1 mt -83.9 170.89 13.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.033 0.933 . . . . 0.0 110.651 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -122.75 138.88 54.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 166.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.54 135.57 56.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.615 1.166 . . . . 0.0 108.811 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.28 133.0 41.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 160.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.4 140.65 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -79.22 -174.58 4.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.078 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.48 -19.53 9.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.537 1.535 . . . . 0.0 114.885 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.36 4.93 44.4 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.769 -1.207 . . . . 0.0 113.203 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.3 t0 52.24 52.45 14.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.27 1.509 . . . . 0.0 110.897 -169.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -131.7 124.57 19.96 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.23 137.83 45.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.113 1.875 . . . . 0.0 111.743 -169.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.86 -11.06 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.397 1.079 . . . . 0.0 111.38 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.93 171.49 41.07 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 169.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.66 161.96 39.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 111.704 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.422 ' HB3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -147.31 138.92 24.05 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.674 1.59 . . . . 0.0 106.942 -175.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 73' ' ' MET . 1.1 tp -112.6 121.34 44.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 174.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.5 tp -141.56 133.25 27.13 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.573 1.171 . . . . 0.0 108.424 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.5 m -147.27 160.2 42.76 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.761 2.024 . . . . 0.0 106.979 164.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.0 -115.01 6.68 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -170.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -135.46 32.71 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.567 1.183 . . . . 0.0 109.637 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -128.2 103.13 7.02 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.113 0.965 . . . . 0.0 109.216 -165.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 67.1 ttp -81.08 87.14 6.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -60.26 -36.32 77.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.932 0.893 . . . . 0.0 111.181 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.81 146.46 41.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.546 -1.346 . . . . 0.0 110.685 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.97 118.25 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.37 143.14 30.8 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -150.74 141.23 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -53.46 122.93 34.32 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 125.374 1.671 . . . . 0.0 108.929 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -51.84 -27.17 26.43 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.186 1.924 . . . . 0.0 114.39 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.3 -28.28 69.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.112 1.324 . . . . 0.0 111.89 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.66 2.04 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.867 -1.145 . . . . 0.0 112.262 -171.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.591 HH12 HG21 ' A' ' 27' ' ' THR . 46.2 mtt180 -53.36 -44.82 68.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.095 -1.003 . . . . 0.0 111.958 170.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.31 -22.95 67.85 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.369 1.043 . . . . 0.0 111.596 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.0 -7.41 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.696 1.248 . . . . 0.0 113.084 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.21 1.25 51.08 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-O 118.699 -1.056 . . . . 0.0 112.606 172.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.6 t -55.68 -31.35 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 118.725 1.263 . . . . 0.0 110.019 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.86 -49.8 34.14 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.003 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -64.62 -47.01 80.15 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.734 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.86 -43.41 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.558 1.072 . . . . 0.0 110.085 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 66' ' ' MET . 29.2 mt -69.34 -42.15 75.69 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.628 -0.67 . . . . 0.0 111.017 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.51 -41.25 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.813 0.733 . . . . 0.0 110.432 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.38 -38.69 90.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -59.32 -46.07 89.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.381 0.537 . . . . 0.0 110.605 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.93 91.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.989 0.516 . . . . 0.0 110.609 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.808 HD21 ' HD2' ' A' ' 144' ' ' TYR . 32.6 mt -62.59 -34.58 77.29 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.9 m -62.71 -33.97 76.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.536 0.523 . . . . 0.0 110.695 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.8 mtm -87.59 -22.52 24.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.626 0.648 . . . . 0.0 112.061 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.78 93.16 6.25 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.775 1.23 . . . . 0.0 108.237 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 -23.65 57.24 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.738 1.625 . . . . 0.0 113.266 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.32 31.18 4.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.379 1.471 . . . . 0.0 109.368 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.8 tp -49.86 144.64 6.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.529 1.932 . . . . 0.0 113.04 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -127.48 162.0 27.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.778 1.631 . . . . 0.0 108.751 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -153.35 -179.68 7.96 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -141.56 165.51 27.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.063 0.945 . . . . 0.0 109.856 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.72 145.63 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -71.29 131.85 44.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -58.35 -33.09 69.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.519 1.128 . . . . 0.0 111.534 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.167 0.587 . . . . 0.0 111.523 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.404 HD22 ' CE1' ' A' ' 28' ' ' HIS . 63.4 t-20 -85.81 68.62 10.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.291 0.567 . . . . 0.0 109.886 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.35 -26.07 62.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 111.018 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -61.47 -49.16 77.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.67 -0.644 . . . . 0.0 109.61 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.65 76.57 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.411 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.04 -48.32 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.058 . . . . 0.0 108.46 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.83 -47.15 92.67 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.525 0.602 . . . . 0.0 111.793 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.26 -51.04 70.96 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.91 0.884 . . . . 0.0 109.116 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.66 -35.39 80.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -42.69 99.12 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.738 1.154 . . . . 0.0 112.584 171.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -59.57 -41.01 89.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.052 0.842 . . . . 0.0 111.306 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.05 -37.82 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 123.998 0.812 . . . . 0.0 109.648 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.38 5.35 0.97 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-O 122.182 0.879 . . . . 0.0 115.003 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -73.9 159.09 33.31 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 118.294 -2.886 . . . . 0.0 111.475 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -142.59 139.36 31.32 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.5 t -71.69 136.28 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -130.28 -8.63 4.25 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.26 1.824 . . . . 0.0 110.922 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.36 178.1 42.65 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -157.32 178.69 10.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.122 -0.634 . . . . 0.0 109.62 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.671 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 N--CA 1.451 -1.022 0 N-CA-C 115.809 1.427 . . . . 0.0 115.809 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.7 tp -104.39 146.77 28.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.8 mt -114.57 145.93 41.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.68 138.08 51.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.654 1.182 . . . . 0.0 107.986 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.87 157.85 45.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -169.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.24 50.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.808 ' HD2' HD21 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -73.21 116.7 14.06 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 74.7 t . . . . . 0 N--CA 1.411 -2.403 1 CA-C-O 100.815 -9.183 . . . . 0.0 110.44 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.5 t . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 mm -126.76 144.45 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.7 m -141.65 167.59 21.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.45 142.83 36.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -148.72 173.51 13.16 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.539 0.736 . . . . 0.0 110.214 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -66.03 147.87 52.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.573 0.701 . . . . 0.0 109.11 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -77.71 147.17 35.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.854 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -85.99 175.85 8.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.803 0.841 . . . . 0.0 108.746 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -82.35 -49.06 10.44 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.43 -26.54 61.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.81 0.732 . . . . 0.0 112.203 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -72.77 -5.2 36.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.031 -0.418 . . . . 0.0 111.841 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.66 -38.64 29.43 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.487 1.041 . . . . 0.0 113.178 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.78 -28.61 69.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.926 1.363 . . . . 0.0 111.795 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.71 -31.28 70.26 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.401 -0.812 . . . . 0.0 109.578 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -75.49 -39.67 58.23 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -56.29 -44.82 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.497 0.719 . . . . 0.0 109.084 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.45 96.18 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.883 -0.51 . . . . 0.0 111.436 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.0 mt -59.8 -48.89 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.512 0.725 . . . . 0.0 109.705 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -54.19 -45.7 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.269 0.628 . . . . 0.0 110.111 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 t -60.54 -44.24 96.32 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.607 -0.683 . . . . 0.0 110.518 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -63.11 -42.69 99.6 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.658 -0.651 . . . . 0.0 110.833 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.7 m -59.6 -38.09 80.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.514 0.726 . . . . 0.0 110.876 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.44 -45.52 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.273 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.02 -37.39 76.83 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.153 0.888 . . . . 0.0 111.83 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.6 26.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.147 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.5 p -135.44 -5.78 2.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CE1' HD22 ' A' ' 110' ' ' ASN . 12.7 m80 -128.52 26.89 5.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.009 1.277 . . . . 0.0 110.632 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.5 -14.41 28.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.323 -0.861 . . . . 0.0 113.293 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -53.38 -22.79 8.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.737 2.015 . . . . 0.0 112.988 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.01 100.29 0.41 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.057 1.343 . . . . 0.0 108.529 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -56.32 157.33 5.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.527 1.531 . . . . 0.0 111.109 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.32 -36.98 66.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -67.14 -48.56 67.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.888 0.767 . . . . 0.0 109.783 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.52 -40.27 96.61 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.663 0.785 . . . . 0.0 109.796 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 -55.54 -48.45 74.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.932 1.293 . . . . 0.0 110.168 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -65.42 -49.53 68.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.0 0.92 . . . . 0.0 110.05 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.83 -38.13 88.08 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.861 0.3 . . . . 0.0 110.66 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 mt -62.79 -53.74 49.72 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.565 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.53 -38.22 74.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.442 1.019 . . . . 0.0 110.701 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.9 -49.09 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.221 0.609 . . . . 0.0 111.854 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -36.45 74.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.201 0.455 . . . . 0.0 110.296 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.02 -48.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 126.211 1.805 . . . . 0.0 109.038 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -70.41 -10.76 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.987 -1.071 . . . . 0.0 112.679 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.7 m -96.05 4.7 52.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 110.681 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.24 -56.45 0.8 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.158 -169.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.81 -38.47 68.4 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 120.466 1.485 . . . . 0.0 112.91 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.19 -13.01 29.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.945 1.764 . . . . 0.0 115.362 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -128.95 -14.7 4.41 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.63 1.559 . . . . 0.0 113.196 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 152.19 95.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.792 1.237 . . . . 0.0 111.999 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.19 62.71 7.61 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.98 3.787 . . . . 0.0 111.65 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.8 173.73 8.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.185 1.794 . . . . 0.0 112.374 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -133.07 146.15 51.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.45 137.87 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 110.487 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.87 35.74 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.01 140.89 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -76.67 -174.83 3.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.609 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.08 -15.56 34.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.821 1.648 . . . . 0.0 113.118 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -87.74 3.73 46.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.037 1.335 . . . . 0.0 111.713 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.14 33.28 21.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.675 1.59 . . . . 0.0 111.412 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -117.79 133.49 23.33 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.26 138.18 46.04 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.703 2.268 . . . . 0.0 112.4 -169.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.76 -9.64 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.601 1.16 . . . . 0.0 112.348 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.96 170.43 37.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.08 158.56 43.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.882 0.841 . . . . 0.0 110.7 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.92 153.34 48.24 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.948 0.899 . . . . 0.0 109.54 169.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.35 120.62 38.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.1 tp -145.45 140.26 27.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 m -154.4 155.97 35.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.985 2.114 . . . . 0.0 105.334 169.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.39 -114.56 5.63 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -130.96 13.99 5.25 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.785 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -114.74 106.21 13.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.491 1.041 . . . . 0.0 110.407 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.7 ttp -79.16 82.56 5.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.5 -19.52 62.16 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.01 148.54 30.83 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.247 0.93 . . . . 0.0 110.573 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.9 tp -156.63 119.88 4.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.525 1.93 . . . . 0.0 105.932 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -146.03 145.08 30.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mt -151.34 142.07 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -55.55 120.03 28.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.03 -30.76 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 114.471 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.98 -24.16 67.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.9 0.33 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 118.701 0.682 . . . . 0.0 112.408 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -60.59 -38.27 84.06 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.293 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.22 -27.73 71.08 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.589 0.614 . . . . 0.0 112.742 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.35 -6.2 48.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.236 1.018 . . . . 0.0 112.14 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.61 16.1 64.59 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.292 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.38 -31.74 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.134 1.467 . . . . 0.0 111.094 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.86 -52.82 15.32 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.388 -0.674 . . . . 0.0 111.921 170.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.49 -42.92 98.53 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 117.327 -1.321 . . . . 0.0 110.291 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.6 t -58.1 -45.62 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.297 1.408 . . . . 0.0 110.011 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.3 mt -68.59 -42.23 78.53 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.855 -0.528 . . . . 0.0 110.81 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.65 -41.56 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.041 0.536 . . . . 0.0 110.024 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.2 -33.19 73.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.317 -0.864 . . . . 0.0 110.121 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.93 -46.55 88.85 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.317 0.508 . . . . 0.0 110.382 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.89 82.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.083 0.553 . . . . 0.0 111.019 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 mt -58.98 -34.82 72.26 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.102 0.961 . . . . 0.0 111.303 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.81 -32.81 74.07 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.13 0.423 . . . . 0.0 111.784 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mtm -91.45 -23.21 20.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.237 0.615 . . . . 0.0 112.148 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.53 92.47 8.12 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.548 1.539 . . . . 0.0 108.339 -172.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.49 -22.75 65.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.474 1.449 . . . . 0.0 112.35 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.22 31.69 4.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.862 1.665 . . . . 0.0 110.039 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -48.33 143.3 4.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.254 2.222 . . . . 0.0 112.843 -171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -130.49 159.18 37.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.56 1.544 . . . . 0.0 108.01 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 t -154.17 -175.41 5.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.157 0.503 . . . . 0.0 109.792 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -148.48 160.38 43.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.135 0.974 . . . . 0.0 110.609 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -157.11 147.94 10.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -72.51 132.57 44.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.98 -35.13 63.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.963 1.305 . . . . 0.0 111.939 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.11 -30.84 71.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.419 0.554 . . . . 0.0 111.771 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.442 HD22 ' CE1' ' A' ' 28' ' ' HIS . 58.9 t-20 -80.47 63.37 4.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.953 0.901 . . . . 0.0 109.374 176.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.27 -26.62 52.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.3 1.04 . . . . 0.0 111.151 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -47.44 83.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.688 0.795 . . . . 0.0 109.833 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.53 -35.01 75.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.856 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.45 -47.93 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.47 1.032 . . . . 0.0 108.444 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.07 -46.44 94.55 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.544 0.592 . . . . 0.0 111.817 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -55.14 -51.33 66.82 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 117.762 0.781 . . . . 0.0 110.008 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.23 -33.7 75.91 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.926 -0.484 . . . . 0.0 109.917 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -58.48 -47.48 83.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.433 1.015 . . . . 0.0 110.852 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.44 -42.88 88.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.951 0.796 . . . . 0.0 110.463 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.76 -37.76 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.945 0.898 . . . . 0.0 110.776 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.85 1.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.28 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -79.71 154.94 28.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.596 1.698 . . . . 0.0 111.248 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -140.79 138.51 34.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.267 1.827 . . . . 0.0 106.39 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 142' ' ' LEU . 22.0 t -71.41 134.39 30.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.935 0.894 . . . . 0.0 109.75 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 p -125.34 -9.99 6.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.453 1.901 . . . . 0.0 111.364 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.88 42.12 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 118.822 0.737 . . . . 0.0 111.565 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -152.65 -176.43 5.72 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.124 0.969 . . . . 0.0 108.839 169.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 125.329 1.452 . . . . 0.0 108.59 174.463 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 118.344 2.401 . . . . 0.0 118.344 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.7 148.44 23.33 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 168.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.16 148.16 41.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -120.65 138.64 53.82 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.609 1.164 . . . . 0.0 108.131 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.88 160.75 38.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.343 1.057 . . . . 0.0 108.288 -169.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.26 150.1 52.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.567 1.547 . . . . 0.0 108.536 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -75.67 124.01 26.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 124.468 1.107 . . . . 0.0 110.336 -177.338 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.234 0.266 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mm -132.69 140.79 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -135.58 164.16 28.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 55' ' ' ALA . 15.5 mm -127.16 143.21 41.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -154.99 171.94 18.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.798 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -60.59 148.98 36.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.884 0.765 . . . . 0.0 109.082 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 p -62.84 161.62 12.41 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.764 1.626 . . . . 0.0 112.27 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -112.24 160.47 17.59 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.691 1.596 . . . . 0.0 107.251 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -69.84 -45.46 67.75 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.094 -0.378 . . . . 0.0 111.031 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.47 -27.21 65.03 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -82.82 -2.36 54.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.021 0.528 . . . . 0.0 111.483 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.34 -40.19 60.46 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.201 0.909 . . . . 0.0 112.766 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.34 -28.54 69.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.551 1.175 . . . . 0.0 111.766 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.65 -32.52 69.84 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.346 -0.846 . . . . 0.0 109.711 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.6 mt -72.81 -39.44 66.65 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.728 -0.607 . . . . 0.0 109.592 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.74 -44.78 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.205 170.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.21 93.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.363 0.665 . . . . 0.0 112.258 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.22 -48.94 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.398 1.079 . . . . 0.0 109.505 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 60.3 t90 -54.7 -44.92 73.84 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.885 -0.509 . . . . 0.0 110.396 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.84 -50.28 74.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.991 0.814 . . . . 0.0 110.832 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -68.98 -25.19 64.4 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.273 -0.892 . . . . 0.0 111.94 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.6 m -69.58 -31.89 70.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.94 0.791 . . . . 0.0 111.085 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.87 -47.16 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -58.92 -39.33 81.23 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.15 -34.23 20.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.706 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.0 p -138.41 -0.43 1.99 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -133.57 33.45 3.52 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.324 1.42 . . . . 0.0 110.812 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.06 -14.19 9.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 113.534 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.02 -27.81 63.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.222 1.809 . . . . 0.0 112.709 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.21 129.52 42.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.499 1.12 . . . . 0.0 108.917 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 p -61.85 161.97 9.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.375 0.67 . . . . 0.0 110.41 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.49 78.11 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.9 -0.5 . . . . 0.0 110.647 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.32 -50.76 68.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.398 0.679 . . . . 0.0 109.97 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -67.89 -36.93 81.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.145 -0.347 . . . . 0.0 110.103 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -55.25 -42.3 73.31 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.707 1.203 . . . . 0.0 110.732 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -72.55 -50.83 22.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 118.587 0.631 . . . . 0.0 109.658 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -69.34 -35.14 75.6 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.125 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.38 -51.47 67.43 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.121 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.48 -37.94 76.58 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.554 1.07 . . . . 0.0 110.843 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.49 -48.07 81.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.653 0.66 . . . . 0.0 111.807 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -38.11 72.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.47 -46.37 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 126.236 1.814 . . . . 0.0 109.291 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.6 ttp85 -72.34 -10.29 59.6 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 120.753 -1.217 . . . . 0.0 112.23 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -98.0 5.71 48.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 110.696 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -136.09 -56.77 0.76 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.617 -1.183 . . . . 0.0 112.724 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.39 -38.83 69.82 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 121.019 1.736 . . . . 0.0 113.246 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -61.09 -13.55 28.48 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.409 2.072 . . . . 0.0 114.845 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.38 -12.61 3.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.772 1.624 . . . . 0.0 113.272 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 153.21 91.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.227 1.411 . . . . 0.0 111.626 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 66.29 7.33 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 110.136 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.3 mt -87.58 179.08 6.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.336 1.065 . . . . 0.0 109.907 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -137.37 127.67 26.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.63 141.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.026 0.83 . . . . 0.0 110.237 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -85.05 134.77 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.94 142.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.525 HD22 ' CG1' ' A' ' 63' ' ' VAL . 16.4 p30 -85.08 -178.31 6.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.251 169.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.6 -26.38 8.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.805 1.642 . . . . 0.0 114.18 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -76.64 -3.07 35.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.31 1.044 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t0 51.48 57.98 5.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.729 1.728 . . . . 0.0 109.358 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -138.58 127.15 14.09 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.64 142.64 49.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.634 2.222 . . . . 0.0 112.396 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' CG1' HD22 ' A' ' 57' ' ' ASN . 32.3 m -124.96 -11.92 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.111 0.964 . . . . 0.0 112.596 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.22 172.13 41.46 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -148.51 159.58 43.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.331 0.566 . . . . 0.0 110.479 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.18 140.47 45.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.539 1.136 . . . . 0.0 108.125 169.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.85 113.92 25.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 tp -149.9 138.57 20.82 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.571 0.7 . . . . 0.0 109.531 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.9 m -158.5 153.7 25.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.83 23.31 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -128.93 20.53 5.93 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.49 1.116 . . . . 0.0 111.382 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -123.46 103.64 8.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.535 0.734 . . . . 0.0 109.565 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.1 ttp -85.39 80.84 8.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.95 -32.51 63.9 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -172.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.53 157.09 43.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.241 0.616 . . . . 0.0 111.037 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -155.13 123.47 5.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.064 2.146 . . . . 0.0 105.418 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -145.46 141.82 28.7 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -149.37 146.69 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -60.06 122.15 64.1 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.45 -29.8 7.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.069 3.18 . . . . 0.0 114.665 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.06 -23.86 67.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.998 0.919 . . . . 0.0 113.392 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 m -117.86 -0.27 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 118.716 0.689 . . . . 0.0 112.669 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.35 -37.03 76.83 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.918 -1.114 . . . . 0.0 110.539 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.92 68.73 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.719 0.676 . . . . 0.0 113.004 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.3 m -74.96 -6.71 50.78 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.486 1.143 . . . . 0.0 112.119 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.85 14.18 63.4 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.841 -0.977 . . . . 0.0 113.345 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.21 -31.58 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.185 1.492 . . . . 0.0 110.996 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.12 -53.44 14.98 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.881 0.753 . . . . 0.0 111.838 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.47 -41.25 96.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.138 -1.41 . . . . 0.0 110.365 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.43 -46.52 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 120.693 1.588 . . . . 0.0 110.011 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.5 -41.91 83.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.963 -0.461 . . . . 0.0 110.602 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.63 -43.24 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 118.489 0.586 . . . . 0.0 110.407 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.58 -32.51 73.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.796 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -59.59 -49.07 79.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.131 0.423 . . . . 0.0 109.991 171.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.21 81.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.878 0.471 . . . . 0.0 111.265 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.67 -35.03 75.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.802 0.841 . . . . 0.0 111.356 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.28 -35.21 79.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.29 0.495 . . . . 0.0 111.523 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtm -87.78 -24.07 23.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.421 0.688 . . . . 0.0 112.062 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.43 96.18 5.32 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.55 1.54 . . . . 0.0 108.305 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -23.72 53.11 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.198 1.265 . . . . 0.0 112.084 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.68 28.35 4.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.754 1.622 . . . . 0.0 110.654 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.3 tp -51.84 144.24 11.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 112.906 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.2 p -129.17 159.4 36.17 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 108.811 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -153.42 -179.68 7.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.865 0.466 . . . . 0.0 110.271 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -138.26 160.0 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.088 1.355 . . . . 0.0 109.185 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.446 HG12 HD21 ' A' ' 142' ' ' LEU . 7.3 p -155.84 145.89 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -70.66 131.51 44.02 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.49 -32.74 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.96 0.904 . . . . 0.0 111.583 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -66.88 -30.27 70.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.015 0.526 . . . . 0.0 111.691 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -79.65 64.19 4.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 108.795 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.83 -25.97 44.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.565 1.146 . . . . 0.0 111.151 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -49.46 75.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.465 0.706 . . . . 0.0 109.864 176.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.81 76.14 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.775 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.02 -49.09 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.415 1.007 . . . . 0.0 108.471 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.81 -47.44 91.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -54.13 -52.08 62.2 Favored 'General case' 0 C--N 1.338 0.065 0 C-N-CA 123.976 0.911 . . . . 0.0 110.124 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.65 -34.39 76.85 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.775 -0.578 . . . . 0.0 109.975 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -60.03 -46.51 89.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.52 1.055 . . . . 0.0 110.806 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.1 -43.05 86.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.093 0.86 . . . . 0.0 110.427 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.41 -34.4 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.15 0.98 . . . . 0.0 110.963 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.41 10.04 1.73 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.282 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.17 158.04 26.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.726 1.763 . . . . 0.0 111.28 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -143.04 136.22 28.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.868 1.667 . . . . 0.0 106.606 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.523 HG22 HD22 ' A' ' 142' ' ' LEU . 23.3 t -68.63 134.94 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.909 0.883 . . . . 0.0 110.353 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -128.17 -9.45 5.32 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.927 2.091 . . . . 0.0 111.578 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.86 174.52 42.83 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 170.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -159.68 -173.66 4.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.722 0.761 . . . . 0.0 110.884 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 126.911 2.084 . . . . 0.0 108.315 172.931 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 N-CA-C 115.684 1.378 . . . . 0.0 115.684 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 tp -110.04 151.02 27.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.528 1.931 . . . . 0.0 107.141 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.35 151.63 32.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 142' ' ' LEU . 14.7 t-20 -119.86 139.62 52.1 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.756 1.222 . . . . 0.0 107.844 172.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.75 161.56 36.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.706 1.203 . . . . 0.0 108.529 -171.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.92 149.32 52.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 108.396 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -73.76 132.38 42.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.6 t . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 125.317 1.447 . . . . 0.0 109.912 176.384 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.26 144.52 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -141.92 165.78 26.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.56 142.99 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -151.21 173.52 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.636 0.774 . . . . 0.0 110.167 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -65.73 148.75 51.25 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -73.94 146.45 43.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.242 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.16 131.88 35.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -33.32 70.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.399 0.545 . . . . 0.0 112.198 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.88 -16.66 60.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.513 0.725 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -86.85 -2.57 58.68 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.379 0.99 . . . . 0.0 111.217 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.59 -38.28 28.23 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.79 1.185 . . . . 0.0 114.186 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.91 -28.5 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.769 1.285 . . . . 0.0 111.818 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -69.11 -31.53 70.29 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.465 -0.772 . . . . 0.0 109.702 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.7 -38.86 64.73 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.8 -47.16 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.42 83.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.556 0.616 . . . . 0.0 111.721 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.2 mt -65.16 -50.87 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.406 1.082 . . . . 0.0 109.449 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -57.13 -46.89 82.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.702 0.683 . . . . 0.0 110.49 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.3 m -55.32 -52.76 62.43 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.745 1.218 . . . . 0.0 111.005 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -69.97 -29.17 66.22 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.473 -0.767 . . . . 0.0 112.041 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -63.07 -42.46 99.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.962 0.801 . . . . 0.0 110.117 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.9 t -70.27 -42.93 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -34.49 73.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.902 0.773 . . . . 0.0 112.306 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.74 -34.47 21.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.992 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -137.13 -0.14 2.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -130.67 22.57 5.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.403 1.456 . . . . 0.0 110.63 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.67 -10.89 14.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -169.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -29.8 65.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.942 1.297 . . . . 0.0 111.618 169.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.5 tp -53.22 125.35 17.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.125 2.17 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -53.09 140.0 26.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.01 1.324 . . . . 0.0 110.704 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.17 76.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.92 -49.87 64.18 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.48 -35.31 77.35 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 122.081 -0.387 . . . . 0.0 110.404 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -57.19 -44.65 83.8 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.5 m -64.69 -48.64 73.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.711 0.687 . . . . 0.0 110.145 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.17 -37.3 83.51 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.009 -0.432 . . . . 0.0 110.819 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.41 -51.27 69.46 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.258 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.59 -41.07 76.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.688 1.131 . . . . 0.0 110.659 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.74 -47.45 81.0 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.775 0.43 . . . . 0.0 111.824 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -36.59 72.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.949 0.34 . . . . 0.0 110.323 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 t -58.26 -48.69 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.257 1.823 . . . . 0.0 109.064 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -69.76 -10.33 57.95 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.095 -1.003 . . . . 0.0 112.639 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -99.5 5.94 46.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.79 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -136.06 -56.28 0.77 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.451 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.73 -39.34 75.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 120.643 1.565 . . . . 0.0 112.844 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -61.63 -15.51 42.29 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.065 1.844 . . . . 0.0 115.073 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -127.6 -14.24 5.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.45 1.477 . . . . 0.0 112.852 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.85 153.39 88.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.128 1.371 . . . . 0.0 111.475 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -77.54 62.51 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.743 3.629 . . . . 0.0 110.972 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.18 176.74 7.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.098 1.359 . . . . 0.0 111.462 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.02 150.84 50.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.124 2.57 . . . . 0.0 104.868 168.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.69 140.48 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 123.942 0.897 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.36 132.7 35.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.88 142.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -82.87 -177.26 6.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.442 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -49.74 -24.27 2.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.488 1.915 . . . . 0.0 114.488 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -84.41 2.19 41.84 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t0 50.46 58.21 5.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 123.512 1.625 . . . . 0.0 108.77 -169.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.08 124.52 15.35 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.48 138.63 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.65 2.233 . . . . 0.0 109.727 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.36 -12.11 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.27 1.028 . . . . 0.0 112.289 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.03 170.15 40.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.83 159.01 43.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.027 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -140.8 126.78 19.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.302 2.241 . . . . 0.0 105.717 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 74' ' ' ASP . 25.7 tp -105.27 124.65 49.9 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -145.95 139.67 26.36 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -153.44 154.57 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.79 5.87 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -132.27 29.07 4.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.609 1.164 . . . . 0.0 110.455 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -125.5 112.03 15.75 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.425 -0.797 . . . . 0.0 110.601 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.5 ttp -85.09 86.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.536 ' HB3' HD23 ' A' ' 67' ' ' LEU . 31.2 t70 -63.48 -28.91 70.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.45 144.58 31.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.008 0.523 . . . . 0.0 110.217 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 tp -153.66 114.58 4.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -142.36 141.05 32.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.5 mt -148.43 145.43 18.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -58.23 122.24 57.6 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.154 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.2 -29.81 7.05 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.192 3.262 . . . . 0.0 114.723 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.74 -23.41 67.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.122 0.969 . . . . 0.0 113.537 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.45 2.73 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.788 0.722 . . . . 0.0 112.827 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -58.99 -37.6 77.21 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.897 -1.127 . . . . 0.0 110.506 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.99 -25.59 69.51 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.71 0.671 . . . . 0.0 113.039 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.9 m -74.79 -7.34 53.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.515 1.158 . . . . 0.0 112.03 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.91 13.97 63.62 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.335 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.72 -31.69 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.288 1.544 . . . . 0.0 110.925 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.47 -52.85 18.13 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 123.819 0.723 . . . . 0.0 111.754 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -62.94 -42.38 99.79 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.356 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 t -58.55 -46.29 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.055 1.298 . . . . 0.0 109.82 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.9 mt -70.4 -39.33 74.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.215 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.15 -40.69 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.83 0.741 . . . . 0.0 109.925 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.04 -37.7 88.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.195 0.907 . . . . 0.0 109.71 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.05 -47.94 84.05 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.819 0.448 . . . . 0.0 110.439 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.93 -49.07 77.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.583 0.753 . . . . 0.0 110.739 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -60.09 -33.06 71.57 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.401 1.08 . . . . 0.0 111.734 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.5 -32.71 73.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.475 0.58 . . . . 0.0 111.625 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -90.06 -24.82 21.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.435 0.561 . . . . 0.0 112.074 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.06 93.35 9.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.287 1.435 . . . . 0.0 108.713 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.46 -23.39 50.68 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.342 1.361 . . . . 0.0 112.654 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.61 30.39 4.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.67 1.588 . . . . 0.0 110.219 -174.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.3 tp -51.42 145.76 8.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.195 2.198 . . . . 0.0 113.185 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -128.53 163.9 23.97 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.511 1.524 . . . . 0.0 108.912 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -153.75 -175.15 5.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 110.149 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -146.75 161.12 41.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.158 0.983 . . . . 0.0 109.824 172.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.431 HG12 HD21 ' A' ' 142' ' ' LEU . 10.0 p -156.21 149.06 11.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -80.04 129.72 34.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.2 -27.01 53.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.806 2.043 . . . . 0.0 111.974 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . 0.251 1.2 pt20 -51.48 -33.36 31.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.113 0.965 . . . . 0.0 112.651 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -105.71 69.51 0.83 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.132 1.373 . . . . 0.0 109.621 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.76 -23.99 32.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.894 0.877 . . . . 0.0 111.987 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -63.43 -43.93 96.04 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.454 0.702 . . . . 0.0 109.662 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.669 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.03 -45.81 84.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 119.206 0.912 . . . . 0.0 108.945 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.25 59.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.05 -50.73 66.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 117.811 0.805 . . . . 0.0 110.601 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.22 -39.07 93.58 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.84 -33.94 76.29 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.631 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.85 -40.24 94.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.022 1.283 . . . . 0.0 110.919 174.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.8 -39.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.9 11.81 0.69 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-O 118.825 -0.986 . . . . 0.0 114.112 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -72.97 160.83 31.49 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.635 1.718 . . . . 0.0 111.189 172.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -149.72 141.18 23.34 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.884 1.674 . . . . 0.0 106.884 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.576 HG22 HD22 ' A' ' 142' ' ' LEU . 30.9 t -71.43 133.05 32.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.972 0.909 . . . . 0.0 109.436 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 p -127.11 -8.1 5.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.671 1.989 . . . . 0.0 111.492 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.82 170.71 40.73 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 111.761 171.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -142.62 164.53 29.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.815 1.246 . . . . 0.0 111.279 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.141 169.197 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.458 -0.602 0 N-CA-C 115.625 1.356 . . . . 0.0 115.625 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.45 145.56 26.08 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.0 mt -114.68 144.66 43.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.8 t-20 -113.91 139.09 49.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.99 161.54 35.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -134.07 147.52 50.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.673 1.589 . . . . 0.0 108.292 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -75.8 125.91 29.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 111.389 -178.418 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -136.48 141.16 41.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.354 1.061 . . . . 0.0 108.232 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -141.63 163.38 33.09 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -124.64 144.25 35.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -150.46 170.98 17.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.414 1.086 . . . . 0.0 109.272 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -65.35 148.69 51.27 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 m -72.73 152.48 41.62 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.049 0.94 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -98.24 164.09 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 107.919 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -66.99 -39.4 87.14 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.158 -0.339 . . . . 0.0 111.048 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.99 -26.78 66.08 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.72 -0.32 56.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.212 0.46 . . . . 0.0 112.073 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.45 27.67 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.014 0.816 . . . . 0.0 113.455 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.35 -27.18 67.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.261 1.031 . . . . 0.0 112.119 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -68.04 -33.08 73.9 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.394 -0.816 . . . . 0.0 109.572 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.56 -38.54 62.68 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.03 -46.6 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.78 98.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.374 0.67 . . . . 0.0 112.076 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.6 mt -65.41 -49.7 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.285 1.034 . . . . 0.0 109.574 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -52.02 -48.45 64.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.96 0.504 . . . . 0.0 110.004 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 t -61.18 -50.83 71.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.036 0.534 . . . . 0.0 110.16 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -67.63 -28.78 68.02 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.956 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -68.39 -35.87 78.31 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.511 1.05 . . . . 0.0 110.689 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.88 -43.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.28 -26.88 63.07 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 113.345 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.28 16.56 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.984 0.914 . . . . 0.0 111.931 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -133.42 -7.14 2.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -169.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.3 30.26 5.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.225 1.375 . . . . 0.0 109.512 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.51 -18.16 50.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -51.22 -27.37 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.306 1.842 . . . . 0.0 112.303 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 102.89 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.087 1.755 . . . . 0.0 108.912 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -57.02 149.08 19.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.078 1.751 . . . . 0.0 112.546 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.54 70.69 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.61 -45.76 85.5 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.915 -0.491 . . . . 0.0 109.83 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.81 -32.95 62.12 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.944 -0.472 . . . . 0.0 110.241 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -53.94 -43.0 69.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.144 0.977 . . . . 0.0 110.235 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.6 m -62.31 -50.68 70.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.504 1.121 . . . . 0.0 110.153 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -65.03 -39.31 93.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.445 0.298 . . . . 0.0 110.373 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.27 -53.13 59.56 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.462 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -57.08 -39.99 76.05 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.683 1.129 . . . . 0.0 110.484 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.34 -48.92 73.73 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.124 0.569 . . . . 0.0 112.012 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -36.76 75.11 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.076 0.398 . . . . 0.0 110.296 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -58.64 -48.63 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 126.29 1.836 . . . . 0.0 109.023 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.54 -11.59 60.95 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.978 -1.076 . . . . 0.0 112.679 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -97.17 5.64 49.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.742 0.817 . . . . 0.0 110.652 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.4 -54.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.86 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.61 -38.65 69.8 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 120.674 1.579 . . . . 0.0 112.938 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.23 -13.34 31.66 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.407 2.072 . . . . 0.0 115.02 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -125.82 -20.71 4.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.946 1.703 . . . . 0.0 112.393 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.19 148.72 97.72 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.516 1.127 . . . . 0.0 110.69 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.17 45.51 1.99 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.727 3.618 . . . . 0.0 112.091 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.81 171.05 4.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.457 1.503 . . . . 0.0 112.187 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -119.44 148.52 43.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.541 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.67 137.69 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.351 1.06 . . . . 0.0 110.122 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.41 133.99 35.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.63 145.4 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -88.03 -171.67 3.49 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.479 169.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.73 -23.57 29.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.926 1.29 . . . . 0.0 113.47 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -82.93 5.33 22.28 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.679 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 53.9 30.47 11.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.934 1.693 . . . . 0.0 111.112 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.49 128.06 27.73 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 126.927 2.091 . . . . 0.0 106.22 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.62 136.19 35.44 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.727 1.618 . . . . 0.0 109.52 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.15 -14.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.354 1.062 . . . . 0.0 111.185 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.72 170.81 42.99 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.14 160.28 40.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.741 0.816 . . . . 0.0 111.257 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -139.83 132.23 28.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.574 2.35 . . . . 0.0 105.967 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 74' ' ' ASP . 27.0 tp -112.19 124.2 51.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 169.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.74 133.02 23.17 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 m -142.23 150.7 41.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.08 -113.64 4.24 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.4 29.75 4.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.781 1.232 . . . . 0.0 110.596 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -126.82 111.87 14.69 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.591 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.2 ttp -82.74 88.81 6.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' HB3' HD23 ' A' ' 67' ' ' LEU . 31.7 t70 -66.06 -29.52 69.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.68 145.43 32.44 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.851 0.46 . . . . 0.0 110.667 -172.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.72 115.55 3.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.11 139.4 28.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.8 mt -150.02 144.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -170.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.29 123.61 76.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 108.826 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.8 -19.08 66.44 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.005 2.47 . . . . 0.0 113.832 -171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.5 -21.06 63.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.801 1.182 . . . . 0.0 112.299 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.68 3.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.807 0.843 . . . . 0.0 112.841 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.24 -29.86 58.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.122 -0.986 . . . . 0.0 111.756 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.85 -21.0 50.62 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.316 0.96 . . . . 0.0 113.823 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 66.8 m -73.74 -3.77 30.44 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.023 1.412 . . . . 0.0 112.266 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.01 12.96 75.76 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.276 0.941 . . . . 0.0 112.869 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.85 -33.03 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.485 1.143 . . . . 0.0 111.579 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.53 -50.52 47.96 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -38.7 88.65 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.295 1.047 . . . . 0.0 109.87 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -58.43 -49.59 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.624 1.102 . . . . 0.0 109.916 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.1 mt -67.76 -39.35 84.18 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.849 -0.532 . . . . 0.0 110.707 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.93 -39.74 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.933 -0.556 . . . . 0.0 109.8 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.67 -35.66 81.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.789 1.177 . . . . 0.0 110.388 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -61.23 -45.72 93.37 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.195 0.452 . . . . 0.0 110.3 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.17 74.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.846 0.858 . . . . 0.0 110.744 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.3 -33.29 69.29 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.77 1.228 . . . . 0.0 111.697 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.39 -31.9 72.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.361 0.528 . . . . 0.0 111.637 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 mtm -90.39 -25.51 20.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.157 0.583 . . . . 0.0 112.091 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.97 91.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 125.276 1.43 . . . . 0.0 108.863 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.09 -23.25 53.59 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.362 1.375 . . . . 0.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.48 29.46 4.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.595 1.558 . . . . 0.0 110.444 -174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.37 145.37 8.49 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.03 2.132 . . . . 0.0 113.327 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.9 p -128.03 164.77 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.545 1.538 . . . . 0.0 108.937 170.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.1 t -154.99 -174.15 4.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 110.354 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -146.96 161.97 39.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 109.799 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.497 HG12 HD21 ' A' ' 142' ' ' LEU . 8.4 p -156.13 146.22 12.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.59 133.93 47.16 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.0 -36.17 83.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 112.514 -172.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -35.5 77.42 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.196 0.907 . . . . 0.0 110.914 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.49 70.51 7.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.617 0.722 . . . . 0.0 111.037 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.43 -23.04 35.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.756 0.822 . . . . 0.0 112.074 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -63.61 -45.66 89.31 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.794 0.724 . . . . 0.0 109.593 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.11 -34.58 75.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.878 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.26 -46.06 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.374 0.988 . . . . 0.0 108.895 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.4 -48.16 84.26 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.649 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -54.18 -51.94 62.77 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.128 0.971 . . . . 0.0 110.144 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -64.94 -36.67 85.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -64.36 -40.82 96.6 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.063 -1.023 . . . . 0.0 112.718 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.75 -42.87 89.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.742 1.155 . . . . 0.0 110.255 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.31 -35.19 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.67 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.89 7.82 1.31 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.701 1.143 . . . . 0.0 114.904 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -77.1 164.78 25.38 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.132 1.966 . . . . 0.0 111.72 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -147.59 139.58 24.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.414 1.885 . . . . 0.0 106.218 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 142' ' ' LEU . 32.0 t -72.88 132.98 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -172.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.23 -10.05 7.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.728 2.011 . . . . 0.0 111.417 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.87 178.99 42.5 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.786 0.721 . . . . 0.0 111.44 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -155.82 -178.02 6.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.129 0.971 . . . . 0.0 109.214 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.325 -0.479 0 C-N-CA 125.144 1.378 . . . . 0.0 108.892 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 N--CA 1.46 -0.486 0 N-CA-C 118.223 2.355 . . . . 0.0 118.223 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.56 144.49 36.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.1 151.55 27.09 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.562 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.4 t-20 -119.63 139.52 52.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.608 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.23 160.78 38.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.852 0.861 . . . . 0.0 108.733 -172.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.7 149.95 51.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.555 1.542 . . . . 0.0 108.575 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.44 133.89 39.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.97 178.963 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -135.96 146.4 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.899 1.28 . . . . 0.0 107.603 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -142.92 165.03 28.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 mm -121.67 142.46 37.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -150.19 172.8 14.73 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.876 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -65.5 147.77 52.85 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -73.89 146.74 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.004 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -84.8 160.21 20.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -66.87 -45.48 77.96 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.232 -0.293 . . . . 0.0 110.283 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.34 -28.54 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -83.07 0.93 42.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.915 0.486 . . . . 0.0 111.387 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.07 -45.19 33.37 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.298 0.951 . . . . 0.0 113.617 -176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.69 -21.83 63.47 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.499 1.15 . . . . 0.0 112.565 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -66.29 -33.33 75.5 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.757 1.162 . . . . 0.0 109.564 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.87 -39.49 56.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.45 -45.52 85.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.54 -44.71 95.67 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.142 0.577 . . . . 0.0 111.336 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.86 -52.56 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.47 1.108 . . . . 0.0 108.607 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -53.03 -48.79 67.33 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.589 0.756 . . . . 0.0 110.149 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.8 t -60.16 -50.17 74.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.283 0.633 . . . . 0.0 110.434 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -72.85 -31.39 64.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.154 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -61.19 -43.75 98.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.458 1.026 . . . . 0.0 110.372 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.39 -48.48 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.901 0.88 . . . . 0.0 109.053 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.02 -32.94 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 112.269 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.99 58.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.29 1.036 . . . . 0.0 113.341 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -134.81 -25.55 1.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -169.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.449 ' CD2' HD22 ' A' ' 110' ' ' ASN . 38.5 m-70 -104.09 35.84 2.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.846 1.258 . . . . 0.0 108.476 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.4 -26.81 63.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.805 -1.184 . . . . 0.0 112.428 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -56.49 -24.14 44.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.288 2.235 . . . . 0.0 113.515 173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.79 109.4 1.72 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.012 1.325 . . . . 0.0 107.934 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -58.1 141.84 48.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 111.173 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.72 65.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.932 0.893 . . . . 0.0 113.006 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.57 -45.0 96.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.389 0.676 . . . . 0.0 109.907 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -77.9 -29.09 50.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.531 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -56.74 -42.9 80.08 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.491 1.496 . . . . 0.0 110.318 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -63.93 -49.61 71.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.859 0.864 . . . . 0.0 109.862 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -67.33 -36.11 80.78 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.017 -0.427 . . . . 0.0 110.986 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.0 mt -63.52 -49.63 72.75 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.446 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.91 -42.24 75.73 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 119.957 1.253 . . . . 0.0 109.769 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.85 -48.34 82.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.584 1.084 . . . . 0.0 112.446 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.52 74.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.81 -44.43 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.185 1.794 . . . . 0.0 110.117 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -62.94 -24.02 67.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.602 1.161 . . . . 0.0 111.134 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -97.93 7.79 45.79 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.549 1.14 . . . . 0.0 110.662 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -138.12 -59.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.547 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.6 -36.52 46.47 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 121.228 1.831 . . . . 0.0 113.113 -175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 -15.03 34.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 121.942 1.762 . . . . 0.0 115.419 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.61 -11.79 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.938 1.699 . . . . 0.0 113.455 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.8 154.85 88.02 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.408 1.483 . . . . 0.0 111.988 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.86 60.67 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.961 3.774 . . . . 0.0 111.733 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -87.24 172.99 9.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.434 1.893 . . . . 0.0 112.213 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -135.2 145.83 48.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.14 140.21 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.825 0.85 . . . . 0.0 110.41 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.88 134.42 35.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.31 144.09 38.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -83.77 -172.95 4.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -55.2 -24.36 26.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.033 1.333 . . . . 0.0 113.311 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -84.2 0.8 47.34 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.479 1.111 . . . . 0.0 111.831 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t0 52.24 53.87 11.7 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.013 1.387 . . . . 0.0 109.524 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.05 125.28 22.75 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.71 134.25 37.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.545 2.163 . . . . 0.0 110.881 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.39 -11.46 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.192 0.997 . . . . 0.0 111.981 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.65 169.25 41.94 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -139.79 160.92 38.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.709 0.754 . . . . 0.0 111.603 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -139.85 131.34 27.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.593 2.357 . . . . 0.0 105.949 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.84 116.46 28.04 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -144.04 132.97 22.68 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.4 m -141.97 152.97 43.96 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.8 -118.62 11.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -129.28 30.94 4.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.159 0.984 . . . . 0.0 111.022 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -122.87 112.74 18.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.253 0.621 . . . . 0.0 110.153 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -85.1 90.75 7.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.68 -26.42 67.78 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.32 144.99 30.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.043 0.537 . . . . 0.0 110.734 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -153.54 119.4 5.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -145.09 143.23 30.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -143.96 143.66 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -54.31 120.95 28.7 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.088 1.755 . . . . 0.0 109.407 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.03 -24.89 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.215 3.277 . . . . 0.0 114.919 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.11 -26.97 68.03 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.57 9.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.429 . . . . 0.0 112.54 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.88 -34.83 63.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.667 -1.271 . . . . 0.0 112.392 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.17 -13.59 81.73 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.165 -0.797 . . . . 0.0 113.244 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.14 173.68 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 0.0 110.08 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.51 -11.09 39.78 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.959 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -51.47 -34.42 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.601 1.701 . . . . 0.0 112.01 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.42 -54.64 19.59 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -65.54 -40.37 92.81 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.455 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.66 -48.39 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 121.186 1.812 . . . . 0.0 109.977 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -68.05 -40.99 82.68 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.973 -0.455 . . . . 0.0 110.701 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.296 0.498 . . . . 0.0 110.205 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.52 -34.07 75.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.325 0.966 . . . . 0.0 110.1 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -60.6 -46.33 90.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.338 0.517 . . . . 0.0 110.198 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.94 72.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.377 0.671 . . . . 0.0 110.822 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -58.77 -33.34 70.19 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.359 1.064 . . . . 0.0 111.734 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.1 m -62.95 -35.45 80.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.585 0.63 . . . . 0.0 111.503 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.41 -26.46 26.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.26 0.482 . . . . 0.0 111.86 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 89.91 12.08 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 125.101 1.36 . . . . 0.0 109.294 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.47 -22.78 58.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.468 1.446 . . . . 0.0 113.059 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.02 31.49 4.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.441 1.496 . . . . 0.0 110.095 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -50.3 143.99 7.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.232 2.213 . . . . 0.0 112.9 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.7 p -129.62 163.25 26.45 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.404 1.482 . . . . 0.0 108.778 171.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -154.78 -174.46 4.99 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.166 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.57 161.45 41.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 110.018 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG12 HD21 ' A' ' 142' ' ' LEU . 9.7 p -157.17 145.44 10.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.0 129.29 39.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -58.39 -30.88 67.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.18 1.392 . . . . 0.0 111.941 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.51 -35.28 78.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.203 0.456 . . . . 0.0 111.224 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.449 HD22 ' CD2' ' A' ' 28' ' ' HIS . 61.6 t-20 -78.6 63.8 3.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.039 1.336 . . . . 0.0 109.882 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.74 -26.8 47.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 111.394 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -45.25 94.3 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.94 73.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.88 -45.96 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.396 0.998 . . . . 0.0 108.828 171.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.8 83.07 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.58 -51.59 64.8 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.022 0.911 . . . . 0.0 110.379 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.53 -35.02 79.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -64.91 -38.95 92.66 Favored 'General case' 0 C--N 1.341 0.205 0 O-C-N 120.916 -1.115 . . . . 0.0 112.632 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.28 -41.37 88.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.956 1.253 . . . . 0.0 110.329 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.78 -39.36 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.794 . . . . 0.0 110.309 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.41 5.18 0.98 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.542 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.99 162.92 28.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.355 1.577 . . . . 0.0 111.169 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.77 140.01 25.53 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 142' ' ' LEU . 41.3 t -73.11 129.31 36.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.984 0.914 . . . . 0.0 109.16 -173.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 p -119.54 -9.88 9.74 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.599 1.959 . . . . 0.0 111.397 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -170.87 -179.29 42.01 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 171.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.31 179.08 8.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.679 0.792 . . . . 0.0 109.271 170.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 0.0 106.893 -179.883 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 CA--C 1.536 0.613 0 N-CA-C 119.09 2.689 . . . . 0.0 119.09 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.0 tp -102.18 147.62 26.42 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.9 mt -110.85 150.49 29.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.537 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.5 t-20 -116.88 139.08 51.04 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.94 160.57 38.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.3 150.56 52.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.431 1.492 . . . . 0.0 108.195 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -75.12 128.26 35.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 124.664 1.186 . . . . 0.0 109.925 -178.145 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 mm -132.96 144.34 36.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.621 0.768 . . . . 0.0 109.348 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -141.6 164.49 30.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 mm -124.33 143.77 36.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -151.91 172.39 16.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.68 1.192 . . . . 0.0 109.162 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -66.68 149.82 49.96 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -71.34 154.11 41.83 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.482 1.113 . . . . 0.0 111.721 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -97.66 163.68 12.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.816 1.646 . . . . 0.0 108.258 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -69.17 -48.31 62.6 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.282 -0.261 . . . . 0.0 110.742 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.52 -28.62 67.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.79 -1.91 40.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.86 -38.19 37.04 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.25 0.929 . . . . 0.0 113.503 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.76 -28.44 67.62 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.58 1.19 . . . . 0.0 111.919 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.4 -30.73 69.71 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.89 -39.36 61.54 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -56.88 -45.64 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.34 98.01 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.884 0.474 . . . . 0.0 111.884 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mt -62.41 -48.45 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.345 0.658 . . . . 0.0 109.678 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -54.49 -48.42 71.88 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -59.29 -42.08 90.46 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.866 -0.521 . . . . 0.0 110.596 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -62.63 -39.79 94.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.47 1.108 . . . . 0.0 111.718 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -65.78 -36.52 83.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.572 0.749 . . . . 0.0 109.969 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.59 -45.81 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.254 -0.903 . . . . 0.0 109.127 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.26 -33.8 65.8 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.948 1.299 . . . . 0.0 113.004 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.11 -29.48 12.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -139.28 0.6 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -168.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -135.17 25.79 3.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.429 1.468 . . . . 0.0 110.963 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.58 -12.8 17.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.874 -1.141 . . . . 0.0 113.196 -174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -56.21 -20.34 17.74 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.325 1.85 . . . . 0.0 112.904 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.94 101.84 0.42 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.08 1.352 . . . . 0.0 108.8 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -56.69 157.71 5.18 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.342 1.457 . . . . 0.0 110.729 170.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 -37.9 63.59 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.88 -49.75 64.66 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.905 0.775 . . . . 0.0 109.701 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -63.72 -40.19 96.13 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.233 1.013 . . . . 0.0 109.956 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -55.58 -50.23 70.64 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.838 1.255 . . . . 0.0 109.614 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.1 m -64.1 -48.33 76.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.303 1.041 . . . . 0.0 110.274 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.46 -41.31 93.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.188 0.449 . . . . 0.0 110.723 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.99 -50.53 65.95 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.595 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.36 -41.94 76.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.061 0.846 . . . . 0.0 110.684 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.34 -44.51 83.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.452 0.701 . . . . 0.0 112.225 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.32 -38.24 74.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -56.8 -49.41 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.493 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -58.39 -24.27 59.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.646 1.178 . . . . 0.0 111.674 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -101.46 6.49 42.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.179 0.992 . . . . 0.0 110.959 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -136.89 -52.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.306 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -58.36 -37.89 59.78 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.265 1.393 . . . . 0.0 113.001 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -63.42 -14.01 39.68 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.129 1.886 . . . . 0.0 115.426 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -127.98 -19.01 4.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.042 1.746 . . . . 0.0 112.463 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.38 148.43 96.17 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.256 1.022 . . . . 0.0 110.416 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.43 43.74 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.748 3.632 . . . . 0.0 112.102 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.83 169.96 7.27 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.52 1.528 . . . . 0.0 112.07 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -113.27 149.54 33.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 138.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 110.238 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.93 132.35 35.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.64 141.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.59 -179.51 7.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.342 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -51.26 -25.67 6.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.594 1.558 . . . . 0.0 114.22 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -79.39 0.14 30.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.171 0.989 . . . . 0.0 111.773 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t0 52.01 56.97 7.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 123.34 1.543 . . . . 0.0 109.216 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -136.95 126.75 15.72 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.8 137.3 38.0 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.904 2.403 . . . . 0.0 111.695 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.6 m -113.82 -21.36 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.115 0.966 . . . . 0.0 111.68 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.84 170.61 39.2 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -141.44 157.43 45.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.855 0.862 . . . . 0.0 110.686 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -141.38 134.29 28.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.788 2.035 . . . . 0.0 106.668 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 74' ' ' ASP . 24.0 tp -115.91 118.2 32.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.8 tp -142.07 133.49 26.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.215 1.006 . . . . 0.0 108.298 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -143.45 153.87 43.09 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.25 -119.48 13.58 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.52 37.12 4.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.194 0.998 . . . . 0.0 110.478 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -127.27 109.1 11.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.824 0.85 . . . . 0.0 110.066 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -85.45 97.41 10.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.437 ' HB3' HD23 ' A' ' 67' ' ' LEU . 32.3 t70 -71.47 -31.73 67.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.9 23.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.689 0.796 . . . . 0.0 110.282 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 tp -148.08 122.85 9.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 173.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.38 142.63 30.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 mt -148.55 144.37 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -61.07 115.33 13.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.19 -15.03 26.59 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.785 2.323 . . . . 0.0 114.364 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.83 -24.37 67.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.821 0.737 . . . . 0.0 112.554 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.32 -9.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 112.928 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -47.24 -46.43 24.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.581 1.152 . . . . 0.0 111.237 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.26 -14.52 71.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.884 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 72.0 m -68.91 -14.39 63.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.246 1.523 . . . . 0.0 112.062 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.52 -7.76 7.9 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.309 0.956 . . . . 0.0 112.589 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.73 -31.52 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.744 1.272 . . . . 0.0 111.059 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.74 -50.45 37.2 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.573 0.606 . . . . 0.0 111.895 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.22 -46.83 79.07 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.842 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.71 -49.28 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.646 1.112 . . . . 0.0 110.288 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.24 -36.81 74.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.118 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.98 -40.56 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.03 0.832 . . . . 0.0 109.789 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.67 -36.11 83.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.409 1.004 . . . . 0.0 110.02 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -61.5 -48.24 81.97 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.871 0.469 . . . . 0.0 110.3 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.59 76.03 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.511 0.724 . . . . 0.0 110.87 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.67 -33.37 70.04 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.697 1.199 . . . . 0.0 111.696 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -62.84 -35.03 78.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.583 0.629 . . . . 0.0 111.465 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.8 mtm -86.13 -24.39 26.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.381 0.537 . . . . 0.0 112.013 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.77 91.05 9.42 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.866 1.266 . . . . 0.0 109.899 -171.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.65 -23.86 48.74 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.341 1.361 . . . . 0.0 113.273 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -103.39 30.92 4.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.428 1.491 . . . . 0.0 110.292 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.3 tp -50.86 146.57 5.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.559 2.343 . . . . 0.0 113.673 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.7 p -128.32 162.23 27.55 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 108.92 169.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -155.31 -179.29 7.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.788 0.435 . . . . 0.0 111.108 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -137.19 155.14 49.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 142' ' ' LEU . 10.3 p -155.41 148.61 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -74.54 134.09 42.22 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.88 -35.31 68.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.682 1.193 . . . . 0.0 112.069 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -64.11 -29.69 70.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.415 0.552 . . . . 0.0 111.873 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -79.78 65.81 5.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.69 -25.68 60.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.746 0.818 . . . . 0.0 111.342 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.58 -47.71 82.63 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.006 0.522 . . . . 0.0 109.897 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.85 80.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.592 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.0 -46.28 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 119.179 0.9 . . . . 0.0 108.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.18 -49.88 67.64 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -55.25 -49.76 71.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.932 0.893 . . . . 0.0 110.524 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.45 -36.1 81.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.56 -39.23 93.37 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.83 -1.169 . . . . 0.0 112.526 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.32 -42.94 92.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.863 1.21 . . . . 0.0 110.218 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.68 -34.32 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.847 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.53 7.53 1.88 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.394 0.997 . . . . 0.0 114.361 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -73.39 166.39 23.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.779 1.79 . . . . 0.0 111.518 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -143.42 140.57 30.48 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.142 2.177 . . . . 0.0 105.969 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.617 HG22 HD22 ' A' ' 142' ' ' LEU . 40.3 t -72.44 129.54 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.6 p -130.85 -6.64 4.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.054 1.742 . . . . 0.0 111.338 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.34 178.57 38.08 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -157.78 -172.33 3.9 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.733 0.813 . . . . 0.0 109.918 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.315 1.846 . . . . 0.0 108.94 176.046 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo . . . . . 0 N--CA 1.458 -0.562 0 N-CA-C 118.829 2.588 . . . . 0.0 118.829 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -97.45 149.42 22.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.0 mt -116.64 152.92 33.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.555 ' C ' HD23 ' A' ' 142' ' ' LEU . 17.4 t-20 -120.99 139.78 52.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.704 1.202 . . . . 0.0 107.874 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.35 157.71 46.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -170.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.34 150.87 52.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.988 1.315 . . . . 0.0 108.41 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.13 130.69 37.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.486 1.515 . . . . 0.0 109.823 -176.578 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -138.63 144.98 28.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.636 1.174 . . . . 0.0 107.848 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -141.68 165.03 28.6 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 55' ' ' ALA . 12.5 mm -127.06 144.06 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -154.24 169.99 22.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.13 1.372 . . . . 0.0 109.037 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -68.35 156.8 37.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -83.48 151.78 25.27 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.531 1.532 . . . . 0.0 112.103 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -84.72 161.11 20.16 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 168.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -70.61 -43.44 69.31 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.995 -0.441 . . . . 0.0 110.739 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.87 -28.31 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.07 -0.98 42.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.872 0.469 . . . . 0.0 111.621 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.84 52.58 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.02 0.827 . . . . 0.0 112.678 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -60.51 -34.04 73.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.418 1.109 . . . . 0.0 111.547 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -71.61 -32.68 68.26 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.261 0.624 . . . . 0.0 109.982 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.41 -39.88 67.59 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.768 -0.582 . . . . 0.0 109.437 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.62 -43.99 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.407 1.083 . . . . 0.0 109.231 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.54 89.47 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.048 0.539 . . . . 0.0 111.298 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.9 mt -58.46 -50.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.485 1.114 . . . . 0.0 109.167 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -53.35 -47.26 69.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.307 0.643 . . . . 0.0 110.299 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.8 t -60.05 -50.81 72.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.534 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -69.75 -29.75 67.18 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.44 -0.788 . . . . 0.0 112.281 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -63.23 -34.95 78.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.636 0.653 . . . . 0.0 110.909 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.99 -44.21 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.67 -35.36 72.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.766 0.712 . . . . 0.0 112.326 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -44.88 17.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.787 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 p -131.79 -2.12 3.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -168.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -129.5 26.45 5.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.57 1.077 . . . . 0.0 110.502 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.89 -15.76 34.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.969 0.908 . . . . 0.0 113.246 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -55.51 -18.7 7.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.895 2.078 . . . . 0.0 112.955 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.09 99.54 0.67 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -53.53 152.6 4.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.331 1.852 . . . . 0.0 111.162 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.38 68.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.26 -49.0 68.65 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.698 -0.626 . . . . 0.0 109.513 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -66.74 -36.53 82.66 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.126 -0.359 . . . . 0.0 110.574 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.55 -47.31 73.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.82 1.248 . . . . 0.0 109.839 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.4 m -65.03 -49.4 70.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.221 1.008 . . . . 0.0 110.053 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -65.12 -39.85 93.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.508 0.323 . . . . 0.0 110.631 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 mt -63.03 -52.0 64.58 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.308 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.91 -40.53 73.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.569 1.077 . . . . 0.0 110.592 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.59 -49.32 73.81 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.094 0.558 . . . . 0.0 111.954 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -37.44 76.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.998 0.363 . . . . 0.0 110.065 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.64 -48.85 84.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.412 1.885 . . . . 0.0 109.161 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -69.58 -11.67 61.02 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.241 -0.912 . . . . 0.0 112.304 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -99.03 6.09 46.78 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.098 0.959 . . . . 0.0 110.818 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.98 -53.98 0.71 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.744 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.36 -38.03 63.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.73 1.605 . . . . 0.0 112.948 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.67 -14.25 34.8 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.378 2.052 . . . . 0.0 115.223 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.55 -20.01 5.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.591 1.541 . . . . 0.0 112.03 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.19 146.49 97.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.437 1.095 . . . . 0.0 110.107 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.17 46.27 2.19 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.325 3.35 . . . . 0.0 111.421 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.67 157.28 30.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.948 -1.095 . . . . 0.0 110.154 -172.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -101.06 144.35 30.08 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.84 136.7 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.684 0.794 . . . . 0.0 110.166 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.478 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 168.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.46 141.51 45.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.436 ' ND2' HH21 ' A' ' 59' ' ' ARG . 20.1 p30 -82.22 -178.12 6.91 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.135 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -54.85 -23.78 20.06 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.441 1.497 . . . . 0.0 113.712 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.436 HH21 ' ND2' ' A' ' 57' ' ' ASN . 84.4 mtm180 -78.14 -1.83 34.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.345 1.058 . . . . 0.0 111.685 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 t0 52.19 58.31 5.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.577 1.656 . . . . 0.0 108.967 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -139.13 127.95 13.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 140.85 47.94 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.956 2.437 . . . . 0.0 112.527 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 57' ' ' ASN . 27.2 m -118.94 -15.79 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.373 1.069 . . . . 0.0 112.294 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.71 168.81 40.38 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -141.7 156.33 45.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.347 0.659 . . . . 0.0 110.749 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.39 141.21 39.62 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.356 1.062 . . . . 0.0 108.522 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.56 117.98 31.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -148.88 134.99 19.18 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.125 0.875 . . . . 0.0 109.798 171.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.5 m -152.66 151.5 30.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 167.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.56 -122.9 26.0 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -129.67 22.16 5.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.517 1.127 . . . . 0.0 111.482 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -123.35 104.8 9.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.679 0.792 . . . . 0.0 109.548 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -83.21 82.0 8.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.18 -32.6 62.3 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.98 157.06 42.41 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 tp -154.94 126.44 7.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.916 2.086 . . . . 0.0 106.508 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.73 144.44 29.42 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.062 1.345 . . . . 0.0 107.959 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -149.9 146.01 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -53.48 116.51 9.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.702 1.201 . . . . 0.0 108.84 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.54 -18.65 60.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.317 2.678 . . . . 0.0 113.352 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.92 -20.86 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.222 0.919 . . . . 0.0 112.423 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.46 4.16 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.56 -45.31 66.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.065 -1.022 . . . . 0.0 110.469 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.49 -19.13 68.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.225 0.917 . . . . 0.0 113.632 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.81 -16.51 63.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.052 1.426 . . . . 0.0 111.749 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.99 -15.05 5.91 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.263 0.935 . . . . 0.0 112.637 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.15 -31.96 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.997 1.399 . . . . 0.0 111.656 -171.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.87 36.16 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.614 1.102 . . . . 0.0 113.693 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.72 -42.88 8.52 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 116.933 -1.508 . . . . 0.0 110.08 169.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.73 -45.13 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.58 1.537 . . . . 0.0 111.215 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.77 -38.53 83.54 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.94 0.791 . . . . 0.0 111.517 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.55 -42.94 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -64.39 -34.62 78.6 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.794 -0.566 . . . . 0.0 109.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -60.38 -49.03 79.2 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.09 0.404 . . . . 0.0 110.042 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.24 86.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.09 -34.67 75.29 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.918 0.887 . . . . 0.0 111.404 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -63.44 -37.35 86.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.271 0.487 . . . . 0.0 111.331 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.3 mtm -85.65 -24.1 27.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.101 0.56 . . . . 0.0 112.272 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.99 96.55 5.46 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.482 1.513 . . . . 0.0 108.342 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.77 -23.9 47.8 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.149 1.233 . . . . 0.0 112.225 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.77 28.49 4.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.77 1.628 . . . . 0.0 110.602 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 tp -52.2 145.86 10.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.155 2.182 . . . . 0.0 113.438 -169.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -128.11 158.0 39.21 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.069 1.348 . . . . 0.0 107.842 169.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -153.28 -173.72 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.773 0.429 . . . . 0.0 109.905 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.75 162.18 36.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.686 1.194 . . . . 0.0 109.552 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.527 HG12 HD21 ' A' ' 142' ' ' LEU . 10.3 p -154.55 143.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.69 125.58 27.23 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.37 -36.36 73.36 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.853 0.461 . . . . 0.0 111.957 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.47 -32.34 71.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.809 0.444 . . . . 0.0 110.851 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -77.3 65.98 2.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.646 1.179 . . . . 0.0 109.189 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.22 -26.49 60.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.332 1.053 . . . . 0.0 111.113 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -45.92 92.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.253 0.621 . . . . 0.0 109.791 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.79 -34.21 73.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.936 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.69 -46.72 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.464 1.029 . . . . 0.0 108.791 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.04 -49.96 70.1 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -54.99 -50.57 68.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.667 0.787 . . . . 0.0 110.873 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.9 -34.92 78.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -65.84 -38.61 89.33 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 120.99 -1.068 . . . . 0.0 112.296 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.85 -42.84 90.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.909 1.231 . . . . 0.0 110.191 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.93 -34.27 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.299 1.04 . . . . 0.0 110.787 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.87 0.89 2.16 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.323 0.963 . . . . 0.0 114.853 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -72.93 161.76 30.31 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.466 1.633 . . . . 0.0 111.688 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 141.81 27.19 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.82 1.648 . . . . 0.0 106.609 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 142' ' ' LEU . 32.9 t -72.02 132.47 33.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.327 1.051 . . . . 0.0 109.863 -172.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.4 p -127.58 -8.81 5.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.754 2.022 . . . . 0.0 111.707 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.62 40.78 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -161.13 -174.84 4.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.919 0.86 . . . . 0.0 111.008 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 127.398 2.279 . . . . 0.0 107.121 169.767 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 115.71 1.388 . . . . 0.0 115.71 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.75 148.21 44.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.228 2.211 . . . . 0.0 106.268 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.8 mt -111.82 150.97 29.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.49 ' C ' HD23 ' A' ' 142' ' ' LEU . 15.0 t-20 -118.4 140.07 50.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.86 160.47 39.21 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.748 1.219 . . . . 0.0 108.399 -169.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.43 151.88 51.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.268 1.427 . . . . 0.0 108.781 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -80.54 72.61 7.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.832 0.825 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 123.681 0.792 . . . . 0.0 110.582 179.891 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 mm -133.36 144.71 35.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -141.34 165.04 28.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.0 mm -124.98 142.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -154.01 170.98 19.8 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.044 0.938 . . . . 0.0 109.779 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -62.24 148.68 44.02 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 p -61.29 168.18 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.461 1.904 . . . . 0.0 113.166 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -118.93 157.89 26.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.356 1.862 . . . . 0.0 106.792 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.16 -43.33 74.49 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.915 -0.491 . . . . 0.0 110.842 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.11 -25.73 64.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -85.2 0.34 52.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.264 0.625 . . . . 0.0 111.533 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.81 -41.12 57.84 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.931 0.787 . . . . 0.0 113.41 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.29 -24.79 64.9 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.674 1.237 . . . . 0.0 111.771 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.3 -30.96 65.29 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.6 -38.97 67.66 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.58 -46.34 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.29 95.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.731 0.696 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.25 -50.98 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.628 0.771 . . . . 0.0 109.398 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -60.09 -46.93 87.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.715 0.406 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.38 -43.13 83.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.326 1.05 . . . . 0.0 111.148 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -66.29 -41.5 89.73 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.761 0.824 . . . . 0.0 111.083 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -41.53 88.48 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 110.328 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.56 -46.15 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.702 0.801 . . . . 0.0 109.397 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.5 -37.49 81.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.753 0.706 . . . . 0.0 112.17 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.29 -35.24 20.05 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.554 0.742 . . . . 0.0 112.843 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.9 p -137.43 2.98 2.53 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -128.75 31.56 4.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.626 1.103 . . . . 0.0 109.239 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.44 -24.03 42.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 0.0 113.314 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -24.32 58.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.973 2.109 . . . . 0.0 113.019 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.44 127.15 30.09 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.528 1.531 . . . . 0.0 111.386 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 m -55.83 141.59 38.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.767 1.227 . . . . 0.0 110.373 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -32.38 70.2 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.588 0.355 . . . . 0.0 111.891 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.61 -47.56 75.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.77 -40.94 88.42 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.575 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.03 -54.5 29.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.493 1.117 . . . . 0.0 109.373 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.2 m -64.95 -47.98 75.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.541 1.136 . . . . 0.0 111.409 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.19 -36.13 74.4 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.219 0.463 . . . . 0.0 110.654 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.0 mt -63.23 -50.78 68.88 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.887 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -40.52 69.74 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.498 1.044 . . . . 0.0 110.64 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.56 -44.72 81.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -35.79 68.02 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.084 -0.385 . . . . 0.0 110.437 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 t -59.65 -47.51 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 126.08 1.752 . . . . 0.0 109.128 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -70.01 -10.41 58.55 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.738 -1.226 . . . . 0.0 112.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -95.7 5.7 50.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.476 0.71 . . . . 0.0 110.777 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.39 -55.86 0.75 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.697 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.21 -39.1 75.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 120.635 1.561 . . . . 0.0 112.732 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -63.35 -11.57 26.27 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.423 2.082 . . . . 0.0 115.068 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.44 -20.55 5.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.704 1.593 . . . . 0.0 112.104 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 140.24 97.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.171 0.989 . . . . 0.0 110.068 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.26 50.05 3.41 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.635 3.557 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.86 164.07 4.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.364 1.466 . . . . 0.0 110.578 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -107.87 109.36 20.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.42 139.46 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 118.478 0.581 . . . . 0.0 109.946 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.98 133.28 35.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 103.714 -2.699 . . . . 0.0 103.714 167.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.54 141.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -80.56 -177.05 6.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.393 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -55.2 -23.62 22.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.299 1.439 . . . . 0.0 113.497 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.59 -0.43 42.27 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.394 1.078 . . . . 0.0 111.657 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t0 52.09 56.87 7.13 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.837 1.78 . . . . 0.0 109.522 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -137.09 126.15 15.2 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -171.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.36 142.53 55.01 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.592 2.195 . . . . 0.0 111.724 -169.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.51 -11.06 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 112.522 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.61 172.56 37.84 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.04 156.75 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.8 0.8 . . . . 0.0 110.369 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.43 162.1 36.12 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 108.758 169.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.38 130.38 52.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -146.26 135.07 22.38 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.2 m -161.64 156.18 22.79 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.025 2.53 . . . . 0.0 105.298 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.28 33.6 61.77 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.425 -0.797 . . . . 0.0 113.902 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 56.0 24.56 7.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.167 1.787 . . . . 0.0 114.148 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -124.02 110.74 15.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.102 0.961 . . . . 0.0 109.707 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.7 ttp -85.86 89.44 7.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.58 -27.14 68.98 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.633 1.173 . . . . 0.0 113.525 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.83 150.35 31.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.362 1.065 . . . . 0.0 109.443 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.2 tp -157.86 120.52 3.84 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.481 1.912 . . . . 0.0 106.432 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -145.88 145.88 30.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 108.107 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -149.98 143.6 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.81 134.01 95.1 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.498 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 -28.85 31.89 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.162 2.575 . . . . 0.0 114.849 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.62 -26.46 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.094 0.861 . . . . 0.0 112.851 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.1 m -111.93 -2.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.88 -39.71 82.22 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.252 -0.905 . . . . 0.0 110.09 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.37 -28.42 73.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.605 0.621 . . . . 0.0 112.838 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -74.01 -8.42 56.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.334 1.067 . . . . 0.0 112.293 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.49 9.38 61.63 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.523 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.63 -29.46 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.455 1.627 . . . . 0.0 110.68 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.97 -39.33 25.66 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.892 1.234 . . . . 0.0 113.455 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.42 -47.27 17.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.372 1.586 . . . . 0.0 109.869 169.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -52.87 -45.34 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.168 1.349 . . . . 0.0 111.428 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -68.03 -38.37 82.45 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.008 0.822 . . . . 0.0 111.422 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -41.47 90.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-N 118.446 0.566 . . . . 0.0 109.633 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.21 -36.27 83.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.62 -0.675 . . . . 0.0 109.718 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -60.51 -47.75 84.77 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.775 0.43 . . . . 0.0 110.203 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.76 74.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 122.823 0.449 . . . . 0.0 111.159 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.26 -34.25 72.01 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.385 1.074 . . . . 0.0 111.338 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.7 m -62.44 -37.51 86.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.331 0.514 . . . . 0.0 111.434 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.1 mtm -86.57 -21.06 27.08 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.306 0.503 . . . . 0.0 112.263 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.52 93.22 5.37 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.833 1.253 . . . . 0.0 109.872 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -22.84 53.97 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.345 1.363 . . . . 0.0 113.108 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -104.39 31.01 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.403 1.481 . . . . 0.0 110.335 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.7 tp -51.68 146.11 8.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.655 2.382 . . . . 0.0 113.126 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 p -129.97 160.49 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.293 1.437 . . . . 0.0 108.63 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -155.03 -176.75 6.1 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 172.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.0 156.04 41.0 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.132 0.973 . . . . 0.0 109.588 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.9 p -150.25 149.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.75 123.99 23.23 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.71 -32.28 67.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.639 1.175 . . . . 0.0 112.638 -170.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -57.68 -34.08 69.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.234 0.614 . . . . 0.0 110.963 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -77.43 65.62 3.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.682 1.193 . . . . 0.0 110.465 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.86 -26.09 61.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.582 0.753 . . . . 0.0 111.448 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.48 -47.46 85.57 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.815 0.446 . . . . 0.0 110.109 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.92 -37.3 84.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.354 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.56 -46.29 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.9 0.773 . . . . 0.0 109.168 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.35 -50.08 68.2 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -56.28 -49.54 73.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.796 0.838 . . . . 0.0 110.662 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.71 -34.81 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -66.28 -38.08 86.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.931 -1.106 . . . . 0.0 112.532 172.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.66 -42.47 88.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.95 1.25 . . . . 0.0 110.142 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.97 -35.44 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.253 1.021 . . . . 0.0 110.741 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.22 4.52 1.98 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.499 -1.167 . . . . 0.0 115.067 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.68 161.3 31.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.584 1.692 . . . . 0.0 111.392 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 139.93 25.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 HD22 ' A' ' 142' ' ' LEU . 41.2 t -72.74 131.23 35.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.137 0.975 . . . . 0.0 109.502 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.7 p -119.99 -11.41 9.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.638 1.975 . . . . 0.0 111.419 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.32 173.24 41.79 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -155.3 176.59 12.38 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 122.009 -0.7 . . . . 0.0 109.82 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.523 -179.649 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.451 -1.004 0 N-CA-C 110.435 -0.64 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.86 144.34 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.08 148.23 33.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.45 ' C ' HD23 ' A' ' 142' ' ' LEU . 17.1 t-20 -119.67 140.38 50.74 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.56 160.22 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.579 1.152 . . . . 0.0 108.703 -169.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.49 151.47 50.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.386 1.475 . . . . 0.0 108.208 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -76.45 127.64 33.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.572 1.149 . . . . 0.0 109.959 -177.235 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -137.27 147.77 26.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -141.82 165.41 27.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.0 mm -123.14 142.43 39.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -151.48 174.72 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.907 0.883 . . . . 0.0 109.868 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -69.07 147.53 51.35 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 m -73.51 146.53 44.78 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.787 0.835 . . . . 0.0 111.91 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -81.73 158.73 24.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -67.77 -47.72 68.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.13 -27.43 67.31 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.03 1.8 34.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.846 0.458 . . . . 0.0 111.651 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.27 -38.71 33.96 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.962 0.792 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.73 -33.51 75.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.404 1.102 . . . . 0.0 111.516 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.94 -33.77 76.31 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 118.664 0.666 . . . . 0.0 109.583 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.47 -40.12 57.77 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.413 HG21 ' HD2' ' A' ' 44' ' ' ARG . 72.5 t -55.46 -47.35 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.76 90.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.122 0.569 . . . . 0.0 111.86 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.7 mt -59.59 -51.19 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 124.745 1.218 . . . . 0.0 108.776 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -53.07 -49.59 66.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.603 0.761 . . . . 0.0 110.079 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.4 t -59.42 -49.94 75.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.716 0.406 . . . . 0.0 110.196 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -75.17 -28.16 59.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.46 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.9 m -60.78 -40.26 91.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.224 0.92 . . . . 0.0 110.779 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -70.11 -45.9 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.3 -24.42 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.25 -47.08 10.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.237 1.015 . . . . 0.0 112.255 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -129.37 1.54 5.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -129.54 23.17 5.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.499 1.12 . . . . 0.0 109.508 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.2 -21.51 47.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.03 -25.8 13.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.183 1.793 . . . . 0.0 112.254 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.85 103.16 0.41 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 108.763 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 m -59.72 150.68 27.12 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.799 1.64 . . . . 0.0 112.444 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.81 -33.31 70.22 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.45 -48.17 76.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -74.45 -29.94 61.67 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.902 -0.499 . . . . 0.0 110.517 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -54.91 -44.75 74.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.318 0.963 . . . . 0.0 110.119 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.0 m -64.26 -48.79 74.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.304 1.042 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.14 -34.84 77.09 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.054 -0.404 . . . . 0.0 111.023 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.83 -48.29 77.42 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 117.532 -1.223 . . . . 0.0 109.462 172.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.57 -40.63 75.53 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.964 1.257 . . . . 0.0 109.813 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.82 -47.85 84.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.415 1.007 . . . . 0.0 112.37 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -37.92 75.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.848 1.659 . . . . 0.0 109.877 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HD2' HG21 ' A' ' 17' ' ' VAL . 3.0 tpt180 -61.08 -24.79 66.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.866 1.266 . . . . 0.0 111.455 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -98.21 7.37 46.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.39 1.076 . . . . 0.0 110.631 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -137.96 -59.21 0.65 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.6 -169.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.71 -36.42 45.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 121.01 1.732 . . . . 0.0 113.192 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -60.36 -18.49 53.33 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.899 1.733 . . . . 0.0 115.266 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -127.29 -13.78 5.49 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.313 1.415 . . . . 0.0 113.032 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.09 90.1 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.017 1.327 . . . . 0.0 111.516 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.37 58.93 6.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 112.064 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 mt -88.83 167.68 13.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.898 1.679 . . . . 0.0 112.921 -170.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -126.94 144.72 50.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.28 140.36 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.245 1.018 . . . . 0.0 110.524 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.25 134.19 35.28 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.72 142.74 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.64 179.24 7.41 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.43 -25.89 4.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.751 1.62 . . . . 0.0 114.039 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -77.0 -2.3 33.18 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.516 1.527 . . . . 0.0 112.014 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.3 57.24 6.83 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 124.294 1.997 . . . . 0.0 109.855 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -132.31 122.57 18.18 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.24 141.55 82.74 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.84 1.693 . . . . 0.0 109.906 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.2 -11.32 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.042 1.337 . . . . 0.0 112.042 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.25 168.76 41.09 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -142.71 159.16 42.78 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.489 0.716 . . . . 0.0 110.99 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.77 152.47 47.95 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.173 0.989 . . . . 0.0 109.726 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.59 119.53 34.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 69' ' ' SER . 4.2 tt -143.13 137.41 29.09 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.487 ' N ' HD23 ' A' ' 68' ' ' LEU . 68.7 m -150.74 155.55 39.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.87 -108.04 1.56 Allowed Glycine 0 CA--C 1.53 0.981 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -131.48 6.52 4.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.608 1.163 . . . . 0.0 111.988 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -105.42 124.97 50.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.558 1.072 . . . . 0.0 109.766 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.2 ttp -93.16 86.11 5.26 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.53 -26.61 68.78 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.41 147.51 34.73 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.53 0.732 . . . . 0.0 110.165 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.2 tp -155.59 122.29 5.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.868 2.067 . . . . 0.0 105.501 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.82 142.43 29.95 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.38 144.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -57.24 114.77 8.81 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 126.142 1.777 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.57 -29.88 11.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.087 3.192 . . . . 0.0 114.492 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.38 -21.84 66.76 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.37 10.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.143 0.977 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.03 -35.28 64.28 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.703 -1.248 . . . . 0.0 111.085 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.94 57.09 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.256 0.931 . . . . 0.0 113.613 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -72.69 -5.0 34.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.949 1.375 . . . . 0.0 112.456 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.69 69.41 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 119.08 0.854 . . . . 0.0 113.053 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.5 t -55.54 -31.07 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.357 1.079 . . . . 0.0 111.169 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.8 -53.04 14.56 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.048 0.832 . . . . 0.0 111.676 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.93 -42.29 97.4 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.381 -1.295 . . . . 0.0 110.206 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -58.6 -46.28 90.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.251 1.387 . . . . 0.0 110.052 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.23 -40.27 78.04 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.872 -0.518 . . . . 0.0 110.826 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.2 -40.44 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.632 0.651 . . . . 0.0 110.307 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.3 -33.3 72.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.037 -1.039 . . . . 0.0 109.989 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -62.3 -45.75 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.39 0.541 . . . . 0.0 110.383 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.04 83.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.286 0.634 . . . . 0.0 111.064 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.1 -34.27 73.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.114 0.966 . . . . 0.0 111.151 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -63.49 -37.88 88.99 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.219 0.463 . . . . 0.0 111.357 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 mtm -82.53 -28.54 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.371 0.532 . . . . 0.0 112.058 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 93.51 10.13 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.293 1.437 . . . . 0.0 108.613 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.85 -22.36 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 121.417 1.411 . . . . 0.0 112.202 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.68 31.53 4.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.741 . . . . 0.0 110.05 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.7 tp -48.4 141.74 6.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.073 2.149 . . . . 0.0 112.887 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -128.13 158.69 37.34 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 108.163 169.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -151.96 176.82 11.09 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.872 -0.518 . . . . 0.0 110.463 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -134.86 152.11 51.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.407 1.483 . . . . 0.0 108.823 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.0 p -152.95 144.47 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.69 130.09 38.15 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -61.56 -32.59 72.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -33.94 69.91 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.139 0.881 . . . . 0.0 111.321 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -77.72 68.22 3.75 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.168 0.987 . . . . 0.0 110.557 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.79 -24.75 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -62.55 -46.35 88.77 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.84 -0.537 . . . . 0.0 109.878 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.74 79.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.705 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.44 -49.16 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.297 0.953 . . . . 0.0 108.544 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.69 -46.94 93.47 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.83 -51.54 67.13 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 123.884 0.874 . . . . 0.0 110.097 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.62 -33.42 74.95 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.7 -47.92 82.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.174 0.897 . . . . 0.0 110.802 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.41 -42.58 87.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.065 0.848 . . . . 0.0 110.552 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.56 -34.3 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.182 0.993 . . . . 0.0 110.92 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.26 10.48 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.432 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -78.2 155.62 30.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.645 1.723 . . . . 0.0 111.53 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -141.06 138.95 33.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.362 1.865 . . . . 0.0 106.702 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.472 HG22 HD22 ' A' ' 142' ' ' LEU . 21.5 t -71.7 135.97 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.935 0.894 . . . . 0.0 110.057 -170.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.6 p -129.03 -8.72 4.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.468 1.907 . . . . 0.0 111.52 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.48 177.17 44.47 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.782 0.719 . . . . 0.0 111.55 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -157.46 178.0 10.79 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.066 0.946 . . . . 0.0 109.338 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.323 -0.549 0 C-N-CA 126.938 2.095 . . . . 0.0 105.726 178.352 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--O 1.237 0.463 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp -113.18 145.1 41.54 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 mt -116.85 152.05 35.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -125.65 137.84 53.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.852 1.261 . . . . 0.0 108.201 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.472 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.12 161.24 36.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.589 1.156 . . . . 0.0 108.162 -171.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.67 149.28 52.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.667 1.587 . . . . 0.0 108.562 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -75.44 129.93 38.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.617 1.167 . . . . 0.0 109.913 177.93 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 mm -132.1 144.94 35.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -140.59 165.14 28.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 55' ' ' ALA . 13.4 mm -128.07 143.22 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -156.45 173.8 16.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.865 0.866 . . . . 0.0 110.537 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -64.54 147.01 53.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -73.53 145.55 45.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.607 1.163 . . . . 0.0 111.928 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -82.25 131.33 35.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -57.51 -39.72 77.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.441 1.019 . . . . 0.0 111.071 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -70.12 -20.67 63.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.955 0.902 . . . . 0.0 113.202 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -84.11 -4.96 59.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.372 0.987 . . . . 0.0 111.042 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.9 -33.25 35.64 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 124.445 1.022 . . . . 0.0 113.355 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.59 -33.33 75.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.536 1.168 . . . . 0.0 111.836 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -65.97 -30.95 71.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.982 -0.449 . . . . 0.0 109.884 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.57 -37.57 56.33 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.05 0.54 . . . . 0.0 109.67 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.92 -46.06 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -44.11 97.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 111.917 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.2 mt -61.88 -50.27 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.34 1.056 . . . . 0.0 109.134 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.7 t90 -51.31 -47.54 62.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.356 0.662 . . . . 0.0 110.127 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.8 t -61.5 -50.44 72.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.105 0.411 . . . . 0.0 110.52 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -68.78 -32.13 71.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.042 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 m -62.15 -47.61 83.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.063 0.847 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.28 -44.45 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.622 0.769 . . . . 0.0 109.519 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.2 -28.56 69.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 0.0 112.064 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.69 -24.55 28.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.653 1.181 . . . . 0.0 113.939 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.8 p -137.34 -21.15 1.19 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.571 ' CE1' HD22 ' A' ' 110' ' ' ASN . 72.8 m80 -124.29 29.84 6.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.671 1.588 . . . . 0.0 109.28 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.28 -18.27 25.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.408 1.083 . . . . 0.0 113.589 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -51.13 -23.84 3.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.116 2.167 . . . . 0.0 113.162 170.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.01 97.84 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.941 1.296 . . . . 0.0 108.003 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.1 m -55.29 153.69 6.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.458 1.503 . . . . 0.0 110.991 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -35.86 63.07 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.07 -49.11 66.15 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.941 0.792 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -65.65 -39.04 90.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.001 0.521 . . . . 0.0 109.998 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -54.48 -46.49 73.4 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.833 1.253 . . . . 0.0 110.018 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.7 m -65.73 -48.04 73.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 110.367 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.77 -36.93 81.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.911 -0.493 . . . . 0.0 110.762 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 -51.51 67.37 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -56.85 -40.69 76.57 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.766 0.712 . . . . 0.0 110.528 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.28 -41.63 89.57 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.806 0.73 . . . . 0.0 112.597 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.45 -38.31 68.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.573 -0.705 . . . . 0.0 109.553 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.91 -47.38 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.814 1.645 . . . . 0.0 109.147 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -57.39 -23.95 52.4 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.36 1.464 . . . . 0.0 111.754 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -102.69 7.7 39.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.426 1.09 . . . . 0.0 111.187 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -136.29 -52.7 0.72 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.905 -169.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.15 -37.14 54.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 120.534 1.515 . . . . 0.0 113.251 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.4 -16.21 33.96 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.433 2.089 . . . . 0.0 115.607 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -126.27 -14.37 5.95 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.32 1.418 . . . . 0.0 112.527 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.75 151.54 92.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.761 1.224 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.38 63.57 7.85 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.693 3.595 . . . . 0.0 110.704 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.5 177.97 7.24 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.785 1.234 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -136.47 141.58 43.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 127.547 2.339 . . . . 0.0 105.244 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.42 141.9 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 119.164 0.893 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -84.16 134.14 34.58 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 167.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.51 142.31 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -79.33 -178.85 6.44 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.563 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.13 -25.03 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.557 1.543 . . . . 0.0 113.788 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -84.26 3.45 35.41 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.834 1.254 . . . . 0.0 111.999 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.6 t0 52.66 58.25 5.56 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 123.384 1.564 . . . . 0.0 109.79 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.06 124.12 17.29 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 -170.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.49 137.13 45.55 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.975 2.45 . . . . 0.0 111.497 -171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 m -124.17 -13.63 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.282 1.033 . . . . 0.0 112.082 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.9 42.9 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -147.49 160.9 42.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.159 0.584 . . . . 0.0 110.925 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.56 154.07 49.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 108.226 169.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 74' ' ' ASP . 13.8 tp -110.12 118.9 37.63 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.49 132.26 18.98 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.6 m -145.61 153.32 40.92 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 168.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.32 -123.11 32.12 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -129.21 29.05 5.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.214 1.006 . . . . 0.0 111.26 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -122.94 108.59 13.13 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.655 -0.653 . . . . 0.0 110.218 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 ttp -85.59 87.36 7.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' HB3' HD23 ' A' ' 67' ' ' LEU . 30.3 t70 -64.06 -27.82 69.37 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.26 152.79 40.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.716 0.689 . . . . 0.0 110.963 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.9 tp -158.29 119.71 3.51 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.692 1.997 . . . . 0.0 106.38 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -147.04 141.43 26.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.561 1.144 . . . . 0.0 107.949 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.1 mt -150.95 145.71 16.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.29 126.18 77.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.379 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.63 -17.1 52.42 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.587 2.191 . . . . 0.0 113.834 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.18 -21.46 60.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.685 1.13 . . . . 0.0 112.018 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.49 -11.29 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -52.45 -39.71 61.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.892 1.224 . . . . 0.0 112.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.42 84.45 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.359 -176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.59 -18.64 65.07 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.175 1.488 . . . . 0.0 111.561 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.37 -23.16 1.22 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.07 0.843 . . . . 0.0 112.198 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.7 -32.82 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.602 1.201 . . . . 0.0 111.812 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.61 -31.45 37.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.128 0.871 . . . . 0.0 113.37 173.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -87.67 -45.94 9.95 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.01 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t -53.75 -43.85 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 120.364 1.438 . . . . 0.0 111.248 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -66.63 -37.02 83.96 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.872 0.76 . . . . 0.0 111.43 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.27 -42.07 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 118.44 0.563 . . . . 0.0 109.524 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.35 -35.1 79.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.554 0.615 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -61.43 -48.43 81.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.808 0.443 . . . . 0.0 110.382 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.31 82.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.891 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.34 -35.54 75.9 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.224 1.009 . . . . 0.0 111.458 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.82 -36.72 84.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.305 0.502 . . . . 0.0 111.408 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.3 mtm -86.16 -23.42 26.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.993 0.517 . . . . 0.0 112.218 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.15 91.45 7.05 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.267 1.427 . . . . 0.0 108.931 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -22.93 56.92 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.413 1.408 . . . . 0.0 112.788 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -103.81 30.74 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.347 1.459 . . . . 0.0 110.258 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.1 tp -49.61 144.55 5.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.179 2.192 . . . . 0.0 112.961 -171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.9 p -129.08 161.31 30.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.02 1.328 . . . . 0.0 108.796 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -153.09 -173.8 4.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -149.16 161.78 41.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.992 0.917 . . . . 0.0 110.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.25 145.24 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -74.26 128.83 36.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -57.43 -32.37 66.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.862 0.865 . . . . 0.0 113.088 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.47 -34.08 72.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.308 0.503 . . . . 0.0 111.195 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.571 HD22 ' CE1' ' A' ' 28' ' ' HIS . 64.2 t-20 -79.07 65.14 4.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.856 1.262 . . . . 0.0 109.611 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.3 -26.06 60.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.151 0.98 . . . . 0.0 111.1 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.12 84.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.959 0.503 . . . . 0.0 109.861 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.54 77.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.756 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.84 -49.31 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.402 1.001 . . . . 0.0 108.482 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.78 93.76 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -56.14 -50.63 70.59 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.763 0.825 . . . . 0.0 110.194 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -67.24 -33.96 76.43 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -59.46 -46.17 89.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.191 0.905 . . . . 0.0 110.977 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.92 -43.26 91.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.129 0.877 . . . . 0.0 110.384 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.4 t -63.13 -39.63 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.758 0.823 . . . . 0.0 110.365 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.26 11.58 0.89 Allowed Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.4 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.43 155.43 29.93 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.652 1.726 . . . . 0.0 111.479 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.01 139.22 34.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.103 1.761 . . . . 0.0 106.618 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.504 HG22 HD22 ' A' ' 142' ' ' LEU . 21.9 t -71.66 133.81 31.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.978 0.911 . . . . 0.0 109.8 -171.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.75 -9.66 7.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 111.459 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.09 178.31 43.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 118.849 0.75 . . . . 0.0 111.491 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -151.26 174.83 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.49 0.716 . . . . 0.0 109.572 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--N 1.323 -0.574 0 C-N-CA 127.267 2.227 . . . . 0.0 106.289 176.303 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 N-CA-C 114.421 0.893 . . . . 0.0 114.421 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.1 tp -131.69 144.04 50.72 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.2 mt -113.86 141.27 47.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -113.29 138.78 49.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.504 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.07 160.07 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.39 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.64 151.37 51.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.639 1.576 . . . . 0.0 108.575 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -75.8 126.37 30.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 68.2 t . . . . . 0 CA--C 1.548 0.891 0 C-N-CA 125.272 1.429 . . . . 0.0 109.89 -178.903 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 CA-C-O 121.354 0.597 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -137.62 144.66 30.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 107.615 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -140.37 163.57 32.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -123.78 143.06 38.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.11 170.93 18.73 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.747 1.219 . . . . 0.0 108.956 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -66.35 148.65 51.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -73.27 148.43 43.62 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.282 1.033 . . . . 0.0 112.237 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -79.76 155.88 27.73 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -68.63 -40.59 80.27 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.909 -0.494 . . . . 0.0 110.269 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.7 -25.82 63.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.82 0.6 46.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.095 0.558 . . . . 0.0 111.394 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.4 -42.91 43.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.536 1.065 . . . . 0.0 113.64 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -72.52 -18.75 61.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.732 1.266 . . . . 0.0 112.066 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.67 -31.29 68.15 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.051 -1.031 . . . . 0.0 109.33 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -73.95 -38.35 64.26 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.57 -45.47 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.46 98.76 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.977 -0.452 . . . . 0.0 111.505 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.52 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.816 0.846 . . . . 0.0 109.466 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -54.26 -47.29 72.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.266 0.627 . . . . 0.0 110.298 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.48 -44.63 95.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.674 -0.642 . . . . 0.0 110.327 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -63.58 -37.04 85.82 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.677 -0.639 . . . . 0.0 110.993 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.2 m -67.87 -35.56 78.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.485 0.714 . . . . 0.0 110.819 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -70.9 -47.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.31 -33.54 69.59 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.559 0.744 . . . . 0.0 112.708 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.35 -35.63 15.11 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 118.344 -0.836 . . . . 0.0 113.17 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -138.63 2.0 2.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -136.44 26.61 3.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.91 -13.77 28.04 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.997 -1.064 . . . . 0.0 113.565 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -52.95 -22.93 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.741 2.017 . . . . 0.0 112.905 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -64.21 97.21 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.36 1.464 . . . . 0.0 108.679 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -56.26 158.81 3.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.57 1.548 . . . . 0.0 111.317 174.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.41 65.03 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.37 -46.82 72.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.966 0.803 . . . . 0.0 109.98 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -64.91 -40.25 94.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.488 0.715 . . . . 0.0 109.748 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -55.57 -47.43 76.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.953 1.301 . . . . 0.0 110.097 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -64.94 -49.74 69.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.187 0.995 . . . . 0.0 110.019 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.26 -38.85 91.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.405 . . . . 0.0 110.785 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.86 -50.74 65.42 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.61 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.87 -38.83 79.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.734 1.152 . . . . 0.0 110.093 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.74 -48.22 82.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.98 0.809 . . . . 0.0 112.099 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -37.05 76.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.97 -46.37 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.801 1.641 . . . . 0.0 109.942 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -63.31 -20.57 65.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.515 1.052 . . . . 0.0 111.398 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -97.78 7.15 46.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 110.808 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -137.4 -56.13 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.215 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.99 -37.23 51.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 120.467 1.485 . . . . 0.0 112.708 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -63.94 -11.17 25.8 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.002 1.802 . . . . 0.0 115.706 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -128.06 -19.63 3.94 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.866 1.666 . . . . 0.0 112.746 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.74 149.67 97.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.408 1.083 . . . . 0.0 110.902 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.46 47.9 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.648 3.566 . . . . 0.0 112.305 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.36 165.49 16.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.038 1.735 . . . . 0.0 112.463 -171.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -115.77 147.4 40.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.37 138.58 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.935 . . . . 0.0 110.382 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.54 129.23 34.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 168.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.4 m -124.15 142.02 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -82.85 -179.7 7.52 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.05 -25.45 8.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 0.0 113.97 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -79.24 0.57 28.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.955 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 t0 51.63 55.96 8.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 124.207 1.956 . . . . 0.0 109.661 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.41 119.09 21.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 128.103 2.561 . . . . 0.0 104.333 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.64 138.74 65.98 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.693 1.596 . . . . 0.0 109.924 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.34 -9.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 0.0 112.468 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.46 168.67 40.16 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 171.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -142.46 156.34 45.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.813 0.806 . . . . 0.0 111.249 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -141.75 138.0 32.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.362 2.265 . . . . 0.0 106.037 -173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -124.15 119.57 29.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.7 tp -141.97 134.5 28.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.0 m -159.4 155.87 27.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.131 2.172 . . . . 0.0 105.422 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.14 35.46 59.9 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.564 -0.71 . . . . 0.0 113.774 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 58.14 22.24 8.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 113.697 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -125.47 114.36 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.6 ttp -80.89 87.32 5.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.96 -28.09 69.84 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.768 . . . . 0.0 112.837 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.97 144.63 29.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.755 0.822 . . . . 0.0 110.407 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.1 tp -156.19 117.58 3.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.955 1.702 . . . . 0.0 106.464 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -145.31 143.14 30.01 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -149.62 144.18 17.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.08 125.33 86.63 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.52 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.73 -30.21 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.882 3.055 . . . . 0.0 114.947 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -63.72 -25.18 68.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.94 -3.11 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.641 0.655 . . . . 0.0 112.497 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -59.62 -37.24 78.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.823 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.7 -26.62 68.75 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.859 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.0 m -78.29 -3.55 43.48 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.392 1.096 . . . . 0.0 112.212 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.11 13.15 64.57 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.486 172.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.0 t -57.21 -31.03 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.294 1.547 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.5 -49.85 44.12 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.634 0.635 . . . . 0.0 112.176 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -63.87 -46.85 83.08 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.716 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -54.03 -49.55 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 119.397 0.999 . . . . 0.0 110.152 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.95 -37.52 75.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.039 -174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.58 -39.75 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 119.088 0.858 . . . . 0.0 109.801 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.97 -36.11 82.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.74 1.154 . . . . 0.0 110.066 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.03 -48.33 80.78 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.872 0.469 . . . . 0.0 110.491 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.18 78.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.643 0.777 . . . . 0.0 110.753 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.49 -33.66 71.62 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.702 1.201 . . . . 0.0 111.646 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -62.66 -34.11 76.41 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.5 0.591 . . . . 0.0 111.548 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -87.19 -25.38 24.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 112.091 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.08 94.96 7.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.096 1.359 . . . . 0.0 109.175 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.91 -23.42 47.3 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 121.237 1.291 . . . . 0.0 112.318 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.12 28.87 4.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.789 1.635 . . . . 0.0 110.482 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.3 tp -53.0 146.49 10.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.281 2.232 . . . . 0.0 112.819 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.8 p -131.31 161.68 31.78 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 108.802 170.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 t -155.86 -178.37 7.24 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 122.636 0.374 . . . . 0.0 110.631 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -135.68 156.57 48.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.785 1.634 . . . . 0.0 108.695 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 p -154.39 145.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.53 132.48 42.91 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.17 -30.82 66.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.566 0.747 . . . . 0.0 112.213 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.53 -26.73 68.02 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.367 0.53 . . . . 0.0 112.193 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -79.95 67.84 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.748 0.785 . . . . 0.0 109.806 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.41 -27.7 49.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.446 1.099 . . . . 0.0 111.422 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.25 -50.59 65.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.006 0.523 . . . . 0.0 110.149 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.54 82.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.41 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.5 t -56.45 -49.14 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.92 -48.68 85.07 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.79 -50.88 70.99 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.392 0.677 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -66.94 -35.32 79.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.19 -47.37 85.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.983 0.81 . . . . 0.0 110.876 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -58.87 -42.03 88.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.021 0.828 . . . . 0.0 110.603 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.85 -40.28 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.701 0.8 . . . . 0.0 110.345 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.52 8.13 0.73 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.775 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.53 153.17 40.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.643 1.722 . . . . 0.0 111.142 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -140.5 139.49 35.11 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.126 1.77 . . . . 0.0 106.523 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.491 HG22 HD22 ' A' ' 142' ' ' LEU . 23.9 t -72.08 134.68 29.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.85 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 p -126.0 -8.6 6.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.789 2.036 . . . . 0.0 111.379 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.26 43.95 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 118.779 0.718 . . . . 0.0 111.467 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -154.44 176.91 11.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.83 0.852 . . . . 0.0 109.437 171.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.323 -0.56 0 C-N-CA 126.876 2.071 . . . . 0.0 105.831 176.671 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 N--CA 1.459 -0.513 0 N-CA-C 117.687 2.149 . . . . 0.0 117.687 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.8 tp -103.92 148.09 26.57 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.79 151.61 36.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -122.67 138.51 54.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.878 1.271 . . . . 0.0 107.849 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.491 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.03 159.79 41.08 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.435 1.094 . . . . 0.0 108.467 -170.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.18 149.66 51.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.413 1.485 . . . . 0.0 108.417 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -73.9 125.45 28.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 124.63 1.172 . . . . 0.0 110.008 -178.479 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -136.72 146.74 28.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -140.9 164.02 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 168.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 55' ' ' ALA . 13.8 mm -124.5 143.59 37.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -152.3 171.3 18.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.73 1.212 . . . . 0.0 109.136 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -65.85 147.47 53.32 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -76.35 148.85 37.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.623 1.169 . . . . 0.0 111.912 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -77.33 162.07 27.57 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -70.16 -46.67 64.21 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.93 -27.61 65.91 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.72 -1.48 47.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.789 0.436 . . . . 0.0 111.334 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.12 -35.96 55.66 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 124.14 0.876 . . . . 0.0 113.461 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.53 -28.14 69.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.979 1.39 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -68.09 -31.73 71.56 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.364 -0.835 . . . . 0.0 109.762 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -76.13 -37.36 58.13 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.11 -46.96 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.119 0.568 . . . . 0.0 112.042 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.18 -50.6 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.24 1.016 . . . . 0.0 109.569 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -51.36 -47.51 62.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.282 0.633 . . . . 0.0 110.005 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -61.51 -49.59 76.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.901 0.48 . . . . 0.0 110.233 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.21 -30.32 68.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.179 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -62.54 -46.15 89.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.628 1.104 . . . . 0.0 109.462 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -66.57 -44.02 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 123.877 0.871 . . . . 0.0 109.305 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.46 -28.62 68.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.361 0.982 . . . . 0.0 112.326 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.71 -33.3 27.61 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.984 0.914 . . . . 0.0 113.301 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.7 p -135.17 -12.17 2.17 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.408 ' CD2' HD22 ' A' ' 110' ' ' ASN . 28.5 m-70 -118.68 24.5 10.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.347 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.19 -19.76 35.96 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -53.41 -28.88 32.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.804 1.641 . . . . 0.0 111.927 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.21 104.98 1.96 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.961 2.104 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -59.87 157.83 11.71 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.557 1.943 . . . . 0.0 113.181 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.04 68.77 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -64.83 -50.18 67.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.631 0.65 . . . . 0.0 109.545 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -64.09 -38.58 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.138 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.18 -46.66 79.28 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.549 0.74 . . . . 0.0 109.917 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -64.81 -51.1 64.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.554 1.142 . . . . 0.0 110.105 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.37 -36.33 76.71 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.998 -0.439 . . . . 0.0 110.835 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.15 -50.97 68.3 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.834 -1.079 . . . . 0.0 109.276 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.822 1.192 . . . . 0.0 110.501 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.9 -44.66 72.75 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.86 -36.02 70.0 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.123 -0.361 . . . . 0.0 110.421 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.35 -47.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 125.992 1.717 . . . . 0.0 108.949 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -69.45 -12.1 61.37 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 120.847 -1.158 . . . . 0.0 112.819 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -95.53 6.05 49.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.715 0.806 . . . . 0.0 110.679 172.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -136.79 -55.32 0.73 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.58 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.09 -40.14 82.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 120.66 1.573 . . . . 0.0 112.632 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.49 -12.26 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.253 1.969 . . . . 0.0 114.853 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.85 -21.36 6.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.79 1.632 . . . . 0.0 111.937 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.55 148.65 97.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 110.778 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.65 48.85 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.653 3.569 . . . . 0.0 111.721 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.09 169.48 5.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.171 1.388 . . . . 0.0 112.272 -172.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -121.66 144.37 48.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.61 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.12 138.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.219 1.008 . . . . 0.0 110.659 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.72 129.48 34.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 103.617 -2.734 . . . . 0.0 103.617 167.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 m -126.86 144.63 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -80.47 -174.56 4.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.807 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.69 -22.43 46.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.476 1.11 . . . . 0.0 113.249 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.88 6.1 29.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.997 1.319 . . . . 0.0 111.682 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 53.01 41.94 32.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.964 1.364 . . . . 0.0 110.467 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 120.33 45.57 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -173.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.86 130.71 28.51 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.281 1.987 . . . . 0.0 110.286 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.32 -16.01 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.144 0.978 . . . . 0.0 111.637 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.97 172.72 42.16 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -147.35 161.73 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.372 0.669 . . . . 0.0 110.881 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.47 158.9 43.3 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.448 1.099 . . . . 0.0 109.717 169.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.5 tp -118.06 128.07 54.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.07 132.16 23.07 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 m -142.95 153.71 43.32 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.5 -118.44 10.54 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -129.07 30.76 5.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.181 0.992 . . . . 0.0 110.826 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -122.58 109.73 14.67 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.398 0.679 . . . . 0.0 110.452 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 ttp -85.78 87.85 7.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.37 -29.06 70.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.38 36.11 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.629 0.771 . . . . 0.0 109.815 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.7 tp -158.73 116.16 2.83 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.548 1.939 . . . . 0.0 105.958 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.97 143.21 29.34 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -149.91 145.44 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -171.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -60.41 121.58 61.19 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.99 -16.28 51.91 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.311 2.007 . . . . 0.0 113.704 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.02 -23.29 64.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.06 -9.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.438 1.095 . . . . 0.0 112.309 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -50.54 -44.18 56.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.341 1.056 . . . . 0.0 110.436 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.67 -18.77 66.42 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.165 0.888 . . . . 0.0 113.842 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.49 -9.11 57.68 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.108 1.454 . . . . 0.0 112.239 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.12 7.96 34.58 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.04 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -55.33 -31.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.053 1.426 . . . . 0.0 110.682 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.6 -51.7 27.0 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 119.377 -0.68 . . . . 0.0 111.706 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -62.24 -42.45 99.33 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.583 -1.198 . . . . 0.0 110.431 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.3 t -58.76 -46.54 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.98 1.264 . . . . 0.0 109.957 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.43 -41.19 80.67 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.949 -0.469 . . . . 0.0 110.806 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.51 -41.75 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.445 0.566 . . . . 0.0 109.943 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.3 -34.88 79.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.125 0.875 . . . . 0.0 110.14 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.38 -45.22 95.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.4 0.545 . . . . 0.0 110.424 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.31 -49.45 73.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.835 0.454 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.35 -33.67 69.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.113 0.965 . . . . 0.0 111.512 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.66 -35.97 81.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.297 0.499 . . . . 0.0 111.558 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.6 mtm -88.63 -23.0 23.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.267 0.485 . . . . 0.0 112.161 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.04 90.05 9.5 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 125.137 1.375 . . . . 0.0 108.914 -170.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -22.05 61.0 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.476 1.45 . . . . 0.0 112.919 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.45 31.93 4.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.535 1.534 . . . . 0.0 109.951 -175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 42.0 tp -49.2 144.81 4.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.238 2.215 . . . . 0.0 113.015 -171.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -129.23 162.25 28.3 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.186 1.395 . . . . 0.0 108.657 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -153.64 -173.72 4.68 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -148.92 161.78 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.481 0.713 . . . . 0.0 110.372 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.3 p -155.2 149.73 11.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -78.11 136.31 37.85 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.13 -26.2 60.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.224 1.41 . . . . 0.0 112.352 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -48.81 -47.45 42.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.056 0.844 . . . . 0.0 111.05 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.408 HD22 ' CD2' ' A' ' 28' ' ' HIS . 59.5 t-20 -85.82 65.3 9.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.327 1.451 . . . . 0.0 110.244 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.22 -29.36 46.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 111.441 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -43.89 97.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.409 0.684 . . . . 0.0 109.966 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.36 -33.99 72.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.148 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.25 -45.34 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 119.505 1.048 . . . . 0.0 108.678 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.39 -50.78 63.15 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -53.29 -50.54 64.68 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.869 0.868 . . . . 0.0 110.797 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -65.25 -38.51 90.57 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.91 -32.95 74.34 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.523 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -60.42 -40.88 92.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.353 1.433 . . . . 0.0 110.766 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.09 -39.13 80.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.05 9.32 0.82 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.841 171.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -69.01 159.58 32.57 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 1.537 . . . . 0.0 111.117 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.82 140.59 25.89 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 HD22 ' A' ' 142' ' ' LEU . 28.2 t -71.94 129.91 35.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.981 0.912 . . . . 0.0 109.324 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 p -124.93 -7.64 7.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.258 1.823 . . . . 0.0 111.796 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.91 173.06 42.2 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 118.82 0.737 . . . . 0.0 112.218 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -141.98 159.92 41.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.543 1.537 . . . . 0.0 111.061 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.646 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 115.738 1.399 . . . . 0.0 115.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.0 tp -96.74 143.79 27.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.8 mt -114.73 134.72 54.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.41 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.3 t-20 -102.98 139.73 38.16 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.554 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -134.19 159.94 39.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.24 51.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.538 1.535 . . . . 0.0 107.987 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -75.8 125.7 29.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 124.552 1.141 . . . . 0.0 110.051 -177.259 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 mm -134.66 144.38 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -142.39 166.12 25.54 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.52 142.65 40.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.69 171.17 19.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 109.507 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -64.57 147.73 52.27 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.929 0.786 . . . . 0.0 109.106 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.12 148.28 45.85 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -80.49 158.57 25.82 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -66.57 -48.99 67.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.73 -26.71 65.39 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -169.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.26 -1.97 43.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.161 0.437 . . . . 0.0 111.635 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.53 -39.14 36.7 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 124.185 0.898 . . . . 0.0 113.385 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.77 -26.78 67.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.686 1.243 . . . . 0.0 112.078 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.21 -31.77 71.53 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.15 -40.09 59.91 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.26 -46.01 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.603 0.761 . . . . 0.0 109.289 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -46.92 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.6 mt -57.35 -52.19 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.717 1.207 . . . . 0.0 108.934 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -52.94 -49.91 65.08 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.774 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 t -59.51 -50.49 73.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.109 0.564 . . . . 0.0 110.655 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -68.33 -33.05 73.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.145 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 m -63.34 -46.96 84.19 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.199 0.909 . . . . 0.0 109.688 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.63 -44.14 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.794 0.838 . . . . 0.0 108.912 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.99 -33.58 76.4 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.998 1.272 . . . . 0.0 112.052 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.24 60.9 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.428 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.8 p -135.07 -5.66 2.37 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -121.72 44.39 2.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.633 1.573 . . . . 0.0 108.486 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 -32.29 57.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.048 -1.033 . . . . 0.0 113.051 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.65 -21.72 66.59 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.745 1.218 . . . . 0.0 113.117 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.36 114.23 8.29 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.367 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -61.06 148.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 112.091 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.85 73.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.105 0.562 . . . . 0.0 112.464 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.82 -48.67 73.53 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -68.55 -35.5 77.5 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.137 -0.352 . . . . 0.0 110.381 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -54.87 -45.57 74.63 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.397 1.079 . . . . 0.0 110.313 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.4 m -65.23 -49.8 68.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.339 1.056 . . . . 0.0 110.235 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.01 -35.95 81.06 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.971 -0.456 . . . . 0.0 110.723 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.44 -52.84 62.9 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.345 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.75 -38.01 71.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.475 1.034 . . . . 0.0 110.74 -174.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.99 -48.82 72.6 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.089 0.556 . . . . 0.0 112.094 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.68 -36.03 73.11 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.974 -0.454 . . . . 0.0 110.471 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.49 -47.74 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.231 1.812 . . . . 0.0 109.098 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -69.85 -11.17 60.66 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.924 -1.11 . . . . 0.0 112.676 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m -95.87 5.47 51.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.691 0.796 . . . . 0.0 110.749 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.38 -56.43 0.75 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 117.892 -1.052 . . . . 0.0 112.628 -169.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -56.2 -38.37 67.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.558 . . . . 0.0 112.827 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.07 -14.86 35.72 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.8 1.666 . . . . 0.0 115.209 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.71 -13.57 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.741 1.61 . . . . 0.0 112.772 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.23 152.34 91.94 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.957 1.303 . . . . 0.0 111.321 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.82 56.18 5.86 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.831 3.688 . . . . 0.0 111.932 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.34 159.2 23.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.369 1.468 . . . . 0.0 112.009 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -116.24 142.45 46.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 141.22 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.259 1.024 . . . . 0.0 110.072 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.09 134.83 35.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 168.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -128.71 144.3 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -84.21 -171.77 3.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 110.763 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -62.33 11.04 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.501 2.32 . . . . 0.0 114.182 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -127.97 8.99 6.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.354 1.862 . . . . 0.0 111.314 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.0 t0 50.25 47.26 24.0 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.187 1.47 . . . . 0.0 110.259 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.41 122.99 26.59 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 -172.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.7 135.5 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.24 1.96 . . . . 0.0 110.994 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.93 -13.92 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.179 0.992 . . . . 0.0 112.136 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 170.86 42.61 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.41 159.88 41.23 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.295 1.038 . . . . 0.0 111.962 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -140.0 127.48 21.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.926 2.49 . . . . 0.0 105.999 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.97 116.8 31.17 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 69' ' ' SER . 2.9 tt -146.56 129.29 16.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.348 0.522 . . . . 0.0 109.875 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.461 ' N ' HD23 ' A' ' 68' ' ' LEU . 36.7 m -146.04 154.68 42.13 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.58 41.98 65.78 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 118.953 0.797 . . . . 0.0 113.996 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 59.53 21.97 10.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.811 1.644 . . . . 0.0 113.842 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -130.18 108.12 9.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.074 0.95 . . . . 0.0 108.97 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.2 ttp -85.9 86.14 7.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.13 -31.48 71.19 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.85 142.35 31.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.607 0.763 . . . . 0.0 110.296 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 tp -150.85 117.46 5.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -140.93 140.08 34.4 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.68 146.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.97 118.25 9.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.08 -18.6 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.636 2.224 . . . . 0.0 112.638 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.95 -23.52 66.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.1 0.864 . . . . 0.0 112.554 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.55 -2.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.939 1.295 . . . . 0.0 112.487 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -59.89 -27.64 66.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.678 -1.264 . . . . 0.0 111.698 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.97 -16.19 75.48 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.981 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.19 -175.09 2.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.713 1.256 . . . . 0.0 109.293 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.45 -31.58 36.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.632 -1.093 . . . . 0.0 113.612 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.34 -36.66 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.712 1.756 . . . . 0.0 112.733 -170.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.84 -23.04 43.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.873 0.749 . . . . 0.0 113.441 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -41.85 7.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.065 170.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.11 -45.98 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 121.605 2.002 . . . . 0.0 110.662 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.8 mt -68.9 -37.09 78.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.997 0.817 . . . . 0.0 111.641 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.15 -39.58 83.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 118.53 0.604 . . . . 0.0 109.674 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.49 -35.08 79.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.534 -0.729 . . . . 0.0 109.197 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -62.87 -48.36 79.35 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.574 0.75 . . . . 0.0 110.427 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -58.02 -47.89 81.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.584 0.753 . . . . 0.0 110.888 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.11 -33.12 74.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 111.414 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -64.33 -39.06 93.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.491 0.587 . . . . 0.0 111.035 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.9 mtm -77.3 -29.83 53.88 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.438 0.563 . . . . 0.0 111.728 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 96.15 6.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.695 1.198 . . . . 0.0 110.13 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.01 -22.83 62.01 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.33 1.353 . . . . 0.0 112.409 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.55 29.19 4.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.509 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 tp -51.94 144.03 12.48 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.002 2.121 . . . . 0.0 113.589 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.4 p -129.87 161.3 31.13 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.47 1.508 . . . . 0.0 108.612 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -154.51 -179.33 7.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.918 0.487 . . . . 0.0 110.232 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.2 1.4 . . . . 0.0 109.018 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.416 HG12 HD21 ' A' ' 142' ' ' LEU . 10.5 p -153.86 145.3 14.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -75.78 137.71 40.72 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -63.89 -25.52 68.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.281 0.632 . . . . 0.0 111.944 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -71.74 31.57 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 112.415 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -149.7 67.04 1.0 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.946 1.698 . . . . 0.0 107.685 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.56 -26.42 61.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.52 -49.38 75.56 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.854 0.461 . . . . 0.0 110.085 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.27 76.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.673 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.42 -49.74 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.52 -46.32 94.56 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.294 0.497 . . . . 0.0 111.914 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -54.22 -53.17 57.25 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 125.146 1.379 . . . . 0.0 109.852 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -68.32 -33.38 74.21 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.855 -0.528 . . . . 0.0 109.852 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.26 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.418 1.008 . . . . 0.0 110.879 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.64 -43.27 89.69 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.841 0.746 . . . . 0.0 110.438 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.29 -37.61 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 110.607 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.59 10.07 0.83 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.618 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -81.78 155.93 25.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.635 1.717 . . . . 0.0 111.439 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.1 138.24 33.38 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.126 1.77 . . . . 0.0 106.558 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.523 HG22 HD22 ' A' ' 142' ' ' LEU . 25.2 t -70.85 133.67 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.03 0.932 . . . . 0.0 109.692 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.4 p -125.59 -9.69 6.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.588 1.955 . . . . 0.0 111.414 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.61 -176.87 41.6 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.837 0.744 . . . . 0.0 111.758 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -151.54 -174.82 4.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.92 0.888 . . . . 0.0 109.338 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.323 -0.561 0 C-N-CA 126.382 1.873 . . . . 0.0 106.583 169.88 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 N-CA-C 118.25 2.365 . . . . 0.0 118.25 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.22 145.96 24.67 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.36 152.86 33.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.461 ' C ' HD23 ' A' ' 142' ' ' LEU . 16.8 t-20 -124.61 138.67 54.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 108.206 176.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.58 161.19 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.678 1.191 . . . . 0.0 108.456 -170.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.26 150.27 52.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.67 1.588 . . . . 0.0 108.465 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.69 124.76 27.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 -177.35 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.668 0.747 . . . . 0.0 112.018 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 mm -133.25 145.83 33.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -137.35 164.45 28.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.6 mm -124.99 141.8 43.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.19 170.5 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.075 0.95 . . . . 0.0 109.771 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -61.67 148.97 40.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 p -62.59 167.0 4.74 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.19 1.796 . . . . 0.0 112.858 176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -118.69 135.48 54.46 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -55.72 -39.4 71.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.94 0.791 . . . . 0.0 111.73 -173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.64 -22.46 61.68 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -85.77 -4.18 59.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.829 0.74 . . . . 0.0 110.87 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.54 59.58 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.917 0.77 . . . . 0.0 113.107 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.65 -31.48 72.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.389 1.094 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.56 -30.82 69.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 109.631 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.2 mt -73.51 -39.47 64.8 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.7 -45.93 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 170.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.81 92.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.748 0.419 . . . . 0.0 111.129 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.66 -48.46 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.186 0.994 . . . . 0.0 109.927 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -53.24 -46.91 69.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 t -60.17 -43.93 95.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 110.525 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -63.95 -41.63 97.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.521 -0.737 . . . . 0.0 111.618 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -59.12 -39.78 83.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.553 0.741 . . . . 0.0 109.722 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.54 -45.86 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 123.56 0.744 . . . . 0.0 109.567 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.5 -35.07 73.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.918 0.781 . . . . 0.0 112.11 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.31 -46.41 27.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.76 0.824 . . . . 0.0 112.076 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 p -137.18 3.0 2.59 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -168.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.66 23.05 5.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.656 1.116 . . . . 0.0 110.63 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.99 -14.5 35.81 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.055 -1.028 . . . . 0.0 113.42 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.21 -21.83 15.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.242 1.817 . . . . 0.0 112.787 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.56 97.98 0.16 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.524 1.53 . . . . 0.0 108.27 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -58.84 156.85 10.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.133 0.973 . . . . 0.0 110.796 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.3 57.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -65.21 -51.68 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.495 0.589 . . . . 0.0 109.533 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -70.23 -33.7 71.97 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.864 -0.523 . . . . 0.0 110.553 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -55.14 -46.31 75.66 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.896 0.878 . . . . 0.0 109.566 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 m -64.76 -48.13 75.65 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.158 0.983 . . . . 0.0 110.187 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -62.55 -42.39 99.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.466 0.575 . . . . 0.0 110.775 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.11 -50.24 64.75 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.398 -0.81 . . . . 0.0 109.412 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.03 -39.27 74.49 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.263 0.938 . . . . 0.0 110.271 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.99 -49.89 74.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.723 0.692 . . . . 0.0 111.953 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -38.82 81.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.61 -48.15 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.009 1.723 . . . . 0.0 109.818 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -62.49 -22.08 65.98 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.913 0.885 . . . . 0.0 111.112 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -99.0 6.75 46.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.192 0.997 . . . . 0.0 110.941 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -136.84 -53.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.772 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.8 mt -59.05 -37.01 48.45 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 120.369 1.441 . . . . 0.0 112.73 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.64 -12.62 29.26 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 0.0 115.924 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.98 -21.19 5.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.602 1.546 . . . . 0.0 111.799 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.05 138.24 96.14 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 110.063 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -80.13 51.41 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.669 3.579 . . . . 0.0 110.761 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.47 164.93 3.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.374 1.47 . . . . 0.0 110.513 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -108.11 109.13 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 m -92.34 141.22 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 118.296 0.498 . . . . 0.0 110.015 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -85.33 133.28 34.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.89 143.07 42.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.23 -178.56 6.52 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.89 -23.87 8.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.715 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -75.32 -5.19 43.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.361 1.464 . . . . 0.0 111.982 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 t0 50.22 57.45 6.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 123.939 1.828 . . . . 0.0 109.64 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -139.59 128.13 13.48 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.57 139.85 41.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.618 2.212 . . . . 0.0 111.576 -169.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.79 -9.45 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.078 0.951 . . . . 0.0 111.968 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 175.5 42.16 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.63 42.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.628 0.714 . . . . 0.0 111.177 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.51 162.89 33.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 108.777 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 tp -122.99 129.09 51.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 tp -141.17 132.74 27.04 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 p -158.23 155.85 29.7 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.758 2.023 . . . . 0.0 105.837 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.11 36.18 56.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 121.445 -0.785 . . . . 0.0 113.896 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 58.33 21.97 8.87 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.957 1.703 . . . . 0.0 113.687 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -125.3 113.1 17.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.026 0.93 . . . . 0.0 110.296 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.6 ttp -85.5 90.46 7.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.65 -26.98 66.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -173.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.93 147.19 36.64 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.539 0.736 . . . . 0.0 109.67 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.8 tp -159.24 113.24 2.35 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.363 1.865 . . . . 0.0 106.137 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.21 140.74 29.46 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -150.52 148.38 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -62.59 125.94 87.22 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.45 -27.67 19.27 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 124.018 3.145 . . . . 0.0 115.39 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.14 -22.76 67.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.316 0.962 . . . . 0.0 112.57 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.05 -1.79 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.481 0.712 . . . . 0.0 112.753 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -57.11 -43.42 82.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.276 0.943 . . . . 0.0 109.655 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.17 74.63 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.5 0.571 . . . . 0.0 112.777 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -73.44 -8.36 55.59 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.234 1.017 . . . . 0.0 112.542 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.49 19.41 52.34 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.339 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.72 -30.21 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.315 1.557 . . . . 0.0 110.591 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.79 -50.42 20.24 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.95 0.785 . . . . 0.0 112.101 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.21 -44.17 97.18 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 118.658 1.229 . . . . 0.0 110.075 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.02 -45.8 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.924 1.238 . . . . 0.0 109.918 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -67.81 -41.46 83.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.913 -0.492 . . . . 0.0 110.687 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.42 -41.85 94.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.701 0.682 . . . . 0.0 110.234 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.07 -35.96 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.473 -0.767 . . . . 0.0 109.456 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.11 -45.39 94.89 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.719 0.408 . . . . 0.0 110.54 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.8 -48.89 75.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.713 0.405 . . . . 0.0 110.761 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.5 mt -59.98 -32.72 71.09 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.148 0.979 . . . . 0.0 111.437 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.12 -37.31 86.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.373 0.533 . . . . 0.0 111.565 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.2 mtm -86.84 -24.2 25.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.38 0.537 . . . . 0.0 112.288 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.36 94.73 7.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 125.389 1.476 . . . . 0.0 108.493 -172.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.34 -23.8 51.09 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.203 1.269 . . . . 0.0 112.243 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -99.42 28.65 4.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.718 1.607 . . . . 0.0 110.537 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.04 145.33 10.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.956 2.103 . . . . 0.0 113.547 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.7 p -129.25 163.14 26.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.479 1.511 . . . . 0.0 108.44 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.9 t -153.81 -173.5 4.6 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -147.52 161.88 40.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.179 0.992 . . . . 0.0 110.05 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.517 HG12 HD21 ' A' ' 142' ' ' LEU . 9.2 p -155.03 143.37 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.09 129.64 39.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.96 -37.38 74.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.512 0.725 . . . . 0.0 112.607 -170.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.23 -28.65 70.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.025 0.375 . . . . 0.0 111.476 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -78.12 66.47 3.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.72 0.772 . . . . 0.0 109.935 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.67 -24.87 62.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.21 -47.5 84.16 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.959 0.504 . . . . 0.0 109.841 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.22 79.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.595 176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.9 t -56.79 -46.2 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.172 0.896 . . . . 0.0 108.972 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.59 62.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.95 -49.66 70.81 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 124.036 0.934 . . . . 0.0 110.612 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -66.81 -35.34 79.83 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -66.18 -37.92 86.79 Favored 'General case' 0 C--N 1.34 0.167 0 O-C-N 120.837 -1.164 . . . . 0.0 112.508 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.19 -43.29 92.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.932 1.242 . . . . 0.0 110.177 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.41 -34.7 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.317 1.047 . . . . 0.0 110.793 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.48 8.8 1.92 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.397 0.998 . . . . 0.0 114.518 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -76.16 162.42 28.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.61 1.705 . . . . 0.0 111.407 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -147.42 140.67 25.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.221 1.808 . . . . 0.0 106.362 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.578 HG22 HD22 ' A' ' 142' ' ' LEU . 26.1 t -72.65 132.5 33.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.061 0.945 . . . . 0.0 109.78 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 p -127.44 -9.3 5.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.741 2.016 . . . . 0.0 111.691 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.13 177.18 41.26 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -158.46 -174.08 4.62 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.05 -0.677 . . . . 0.0 110.576 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.326 -0.423 0 C-N-CA 127.276 2.23 . . . . 0.0 107.495 171.63 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 N--CA 1.457 -0.618 0 N-CA-C 116.16 1.561 . . . . 0.0 116.16 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.0 tp -116.59 147.52 41.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 107.106 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.1 mt -116.01 147.74 40.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.506 ' C ' HD23 ' A' ' 142' ' ' LEU . 9.0 t-20 -118.75 139.26 51.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.578 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.96 160.25 39.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.111 0.964 . . . . 0.0 108.446 -170.239 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.37 151.78 51.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.63 1.572 . . . . 0.0 108.384 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.51 129.62 36.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 125.18 1.392 . . . . 0.0 110.127 -178.366 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -133.04 141.34 45.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -140.81 164.99 28.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -123.7 143.33 37.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -149.77 173.14 14.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 123.413 0.685 . . . . 0.0 110.376 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -65.26 147.66 53.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -71.99 179.36 3.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.863 1.265 . . . . 0.0 111.44 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -130.22 161.03 32.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.641 1.576 . . . . 0.0 107.131 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -69.15 -39.75 78.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.369 -0.207 . . . . 0.0 110.643 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.1 -37.2 75.31 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.679 0.392 . . . . 0.0 111.729 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.11 -2.95 26.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.172 0.589 . . . . 0.0 112.039 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.68 -39.5 31.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.267 0.937 . . . . 0.0 113.125 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.11 -28.51 68.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 111.969 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.07 -32.0 72.88 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 109.536 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -75.65 -39.22 58.02 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -56.83 -46.87 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.487 0.715 . . . . 0.0 109.203 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.29 95.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.95 0.5 . . . . 0.0 111.043 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.85 -54.08 36.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -51.76 -44.82 63.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.543 0.737 . . . . 0.0 110.255 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t -59.75 -42.28 92.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.635 0.374 . . . . 0.0 110.57 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -66.5 -43.23 85.9 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.611 -0.681 . . . . 0.0 111.006 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -58.92 -39.15 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.543 0.611 . . . . 0.0 110.305 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.61 -46.01 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.871 0.868 . . . . 0.0 109.765 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.16 -34.12 73.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.766 0.712 . . . . 0.0 111.968 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.36 -47.14 24.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.557 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.1 p -137.2 5.23 2.75 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -168.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -129.56 23.65 5.46 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.275 0.943 . . . . 0.0 110.175 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.4 -16.31 34.52 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.432 1.093 . . . . 0.0 113.624 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.77 -23.11 4.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.034 2.133 . . . . 0.0 113.221 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.1 94.37 0.34 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 m -53.9 156.55 2.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.253 1.421 . . . . 0.0 111.163 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.59 62.39 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.68 -48.01 73.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 109.973 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -67.39 -38.52 84.83 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.1 -47.94 71.24 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.628 1.171 . . . . 0.0 109.976 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.06 -49.89 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.113 0.965 . . . . 0.0 110.193 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.43 -37.09 82.5 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.081 -0.387 . . . . 0.0 110.739 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.95 -51.56 63.84 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.354 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -57.68 -37.58 73.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.467 1.03 . . . . 0.0 110.732 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.75 -48.37 74.83 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.139 0.575 . . . . 0.0 111.991 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -36.43 72.8 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -59.34 -47.35 90.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.076 1.75 . . . . 0.0 109.123 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -70.36 -11.06 60.66 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.852 -1.155 . . . . 0.0 112.707 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.2 4.85 52.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.621 0.768 . . . . 0.0 110.724 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -135.26 -54.49 0.8 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.887 -169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.0 -39.23 74.48 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.764 1.62 . . . . 0.0 112.703 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.33 -9.91 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.421 2.081 . . . . 0.0 114.883 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.63 -22.92 4.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.562 1.528 . . . . 0.0 112.332 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.83 152.06 96.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.62 65.91 8.07 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.887 3.724 . . . . 0.0 110.835 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.38 175.44 7.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.143 1.377 . . . . 0.0 112.023 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -133.71 151.0 51.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.6 2.36 . . . . 0.0 105.329 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.49 138.99 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.083 0.953 . . . . 0.0 110.886 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.03 132.65 35.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.72 142.81 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -83.4 -171.25 3.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.586 1.554 . . . . 0.0 110.656 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.39 8.31 0.05 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.215 2.206 . . . . 0.0 113.957 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -122.31 10.2 9.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 119.917 -1.739 . . . . 0.0 111.212 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 53.37 32.08 13.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.832 1.301 . . . . 0.0 111.127 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -116.68 132.4 23.4 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -169.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.59 138.0 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 112.367 -169.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.92 -10.0 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.431 1.093 . . . . 0.0 112.091 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.35 169.76 39.99 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -142.08 159.73 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.613 0.765 . . . . 0.0 111.239 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -139.74 136.0 33.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.569 2.347 . . . . 0.0 105.862 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -117.99 122.42 43.16 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -146.28 131.34 18.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.9 m -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.24 -114.06 4.31 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -129.11 14.82 6.25 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.791 0.836 . . . . 0.0 112.208 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.85 113.62 26.72 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.755 1.161 . . . . 0.0 110.735 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.621 ' HB2' HD11 ' A' ' 102' ' ' LEU . 64.8 ttp -83.23 85.41 7.21 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.07 -23.64 64.97 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.94 148.08 31.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.486 0.585 . . . . 0.0 110.606 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.3 tp -156.57 114.58 3.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -143.59 141.6 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.54 150.32 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.14 122.33 69.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.97 -27.49 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 124.334 3.356 . . . . 0.0 114.985 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.92 -23.45 65.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 112.856 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.15 -1.27 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.699 0.8 . . . . 0.0 112.782 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -57.12 -39.96 76.15 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.888 -1.133 . . . . 0.0 110.328 169.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.26 -27.96 71.49 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.473 0.559 . . . . 0.0 112.917 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.7 m -76.22 -6.52 51.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 112.34 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.25 60.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.245 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -54.8 -31.81 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.137 1.469 . . . . 0.0 110.74 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.42 -48.11 34.69 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.972 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -65.7 -40.56 92.42 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.483 1.141 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.9 t -58.86 -46.34 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.681 0.673 . . . . 0.0 109.597 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.86 -38.72 79.94 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.786 -0.571 . . . . 0.0 111.032 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.1 -40.13 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.804 0.729 . . . . 0.0 109.783 174.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.96 -37.31 86.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.058 1.299 . . . . 0.0 110.497 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.52 -46.97 87.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.113 0.482 . . . . 0.0 110.557 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.67 78.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.685 0.794 . . . . 0.0 110.92 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 mt -58.12 -34.44 70.22 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.053 1.341 . . . . 0.0 111.44 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.4 m -62.4 -32.48 73.31 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.277 0.489 . . . . 0.0 111.68 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.1 mtm -89.93 -25.26 21.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.464 0.574 . . . . 0.0 112.092 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.01 89.94 12.35 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.092 1.357 . . . . 0.0 109.263 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.55 -22.26 58.72 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.502 1.468 . . . . 0.0 113.192 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.38 31.55 5.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.492 1.517 . . . . 0.0 110.008 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 73' ' ' MET . 31.9 tp -48.16 142.68 5.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.507 2.323 . . . . 0.0 112.749 -171.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -126.15 161.05 28.56 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.334 1.453 . . . . 0.0 108.613 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -153.03 -176.23 5.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.723 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -147.17 160.76 42.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.585 1.154 . . . . 0.0 110.422 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.4 144.36 7.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.8 130.24 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.88 -31.61 62.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.585 0.63 . . . . 0.0 111.943 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -60.34 -32.36 71.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.654 0.782 . . . . 0.0 111.857 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -80.76 67.36 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.789 0.804 . . . . 0.0 109.535 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.8 -25.22 60.28 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.78 0.832 . . . . 0.0 111.405 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.64 -49.26 73.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.035 0.534 . . . . 0.0 110.017 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.41 -35.25 77.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.681 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.4 t -57.03 -49.2 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.94 -47.69 90.02 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -55.85 -51.3 68.01 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.578 0.751 . . . . 0.0 109.651 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.59 -34.77 78.62 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.791 -0.568 . . . . 0.0 109.787 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.98 -45.88 91.24 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.062 -1.024 . . . . 0.0 111.167 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -59.06 -39.71 82.89 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.256 0.934 . . . . 0.0 110.881 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.08 -39.07 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.514 0.726 . . . . 0.0 110.407 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.15 13.21 0.69 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.501 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -80.93 156.06 26.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.803 1.801 . . . . 0.0 111.652 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -144.43 140.76 29.18 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.444 1.897 . . . . 0.0 107.261 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.506 HG22 HD22 ' A' ' 142' ' ' LEU . 21.6 t -71.12 137.94 22.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.06 0.944 . . . . 0.0 110.318 -169.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.2 p -131.12 -9.73 3.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.809 2.044 . . . . 0.0 111.59 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.23 173.27 42.41 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.84 -173.63 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.873 0.836 . . . . 0.0 111.259 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 126.488 1.915 . . . . 0.0 108.542 177.618 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.457 -0.651 0 N-CA-C 114.699 1.0 . . . . 0.0 114.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.15 142.98 33.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.39 149.62 29.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -123.01 137.9 54.83 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.506 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.65 161.84 35.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.47 146.54 51.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.662 1.585 . . . . 0.0 108.897 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.04 127.03 31.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 111.943 179.646 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.236 0.391 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 mm -137.36 145.24 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -144.15 166.01 26.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -125.66 141.85 44.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.78 170.31 21.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 109.998 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -59.07 146.94 36.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 109.818 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 p -62.51 157.91 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.961 1.704 . . . . 0.0 112.595 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -106.55 155.18 19.89 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -67.92 -42.09 81.59 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.711 -0.618 . . . . 0.0 110.648 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.45 -25.66 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.07 -0.06 53.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.059 0.544 . . . . 0.0 111.4 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.21 -41.77 47.71 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 118.998 0.817 . . . . 0.0 113.281 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.78 -26.05 65.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.645 1.223 . . . . 0.0 111.901 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.54 -30.73 67.55 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.281 -0.887 . . . . 0.0 109.621 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 mt -73.01 -39.9 65.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.18 -45.02 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 109.456 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.94 98.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.831 0.452 . . . . 0.0 111.635 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.96 -49.56 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.589 0.756 . . . . 0.0 109.401 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -55.01 -47.79 74.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.688 0.395 . . . . 0.0 110.232 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -59.97 -44.52 94.41 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -64.4 -33.37 75.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.614 0.766 . . . . 0.0 111.813 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -68.4 -39.93 81.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.8 t -66.29 -47.25 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.07 -32.36 66.17 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.754 0.821 . . . . 0.0 112.65 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 -43.04 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.024 0.929 . . . . 0.0 112.482 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.7 p -138.76 -1.41 1.82 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -168.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -135.24 17.84 3.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.381 1.446 . . . . 0.0 112.326 -172.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.48 1.34 0.82 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.766 2.027 . . . . 0.0 114.368 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -59.41 -24.24 63.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.322 1.849 . . . . 0.0 112.523 172.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.08 112.21 2.53 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 m -56.91 154.37 9.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.971 1.308 . . . . 0.0 110.766 172.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.28 -36.75 71.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.2 -47.08 71.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.749 0.704 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -64.72 -40.24 95.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.282 0.633 . . . . 0.0 109.821 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -55.36 -48.56 74.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.611 1.164 . . . . 0.0 110.139 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.8 m -65.08 -49.18 71.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.177 0.991 . . . . 0.0 110.041 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -65.95 -38.45 88.65 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.223 -0.298 . . . . 0.0 110.641 -176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.78 -53.58 52.12 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.386 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.78 -38.22 75.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.244 0.929 . . . . 0.0 110.789 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.99 -48.81 72.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 111.857 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -36.54 75.34 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.177 0.444 . . . . 0.0 110.192 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.87 -48.95 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 126.071 1.748 . . . . 0.0 109.091 172.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -70.3 -10.56 59.31 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.001 -1.062 . . . . 0.0 112.742 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.46 4.2 53.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.625 0.77 . . . . 0.0 110.608 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -135.14 -56.58 0.81 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.805 -1.093 . . . . 0.0 112.336 -169.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.89 -38.65 70.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.644 1.565 . . . . 0.0 113.211 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 -14.8 36.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.422 2.081 . . . . 0.0 115.052 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.72 -13.82 5.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.484 1.493 . . . . 0.0 112.73 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.75 150.55 96.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.844 1.257 . . . . 0.0 111.166 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.78 55.94 5.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.663 3.575 . . . . 0.0 111.94 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.98 155.04 26.61 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.349 1.06 . . . . 0.0 111.146 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -111.32 109.7 19.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.66 138.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.44 133.88 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -126.47 141.5 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -83.71 178.74 7.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.05 -23.93 0.95 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.869 2.068 . . . . 0.0 114.661 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -79.27 -3.34 45.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.669 1.588 . . . . 0.0 112.274 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t0 50.76 57.69 6.36 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.929 1.823 . . . . 0.0 109.69 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -140.63 126.35 11.43 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 141.95 54.02 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.468 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.05 -8.67 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.372 1.069 . . . . 0.0 112.304 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.75 171.55 39.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.42 153.06 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.81 0.805 . . . . 0.0 110.667 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -136.91 132.02 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.539 2.336 . . . . 0.0 105.667 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.75 117.37 31.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.78 133.47 25.27 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 m -143.04 152.74 42.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.76 -114.89 5.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -130.68 27.66 4.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 110.679 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -125.58 111.47 15.05 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.53 -0.731 . . . . 0.0 110.458 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -79.39 89.02 4.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.23 -29.26 70.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.924 0.89 . . . . 0.0 112.979 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.95 148.81 29.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.826 0.851 . . . . 0.0 110.488 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 tp -155.36 119.37 4.58 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.0 1.72 . . . . 0.0 106.463 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.12 144.31 30.85 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -151.43 142.93 16.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.9 133.81 95.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.547 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.67 -24.31 70.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.755 2.303 . . . . 0.0 113.729 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.59 -24.2 67.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.416 1.007 . . . . 0.0 112.902 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.42 -1.22 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -59.91 -38.49 82.49 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.978 -1.076 . . . . 0.0 110.223 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.02 72.09 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.563 0.601 . . . . 0.0 112.776 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.1 m -75.03 -6.5 49.75 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.229 1.014 . . . . 0.0 112.214 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.39 13.73 65.1 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.377 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.64 -31.2 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 119.255 1.527 . . . . 0.0 111.088 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.27 -54.38 10.23 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.947 0.784 . . . . 0.0 111.95 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -64.32 -43.76 93.66 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.031 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 t -56.78 -46.66 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 120.453 1.479 . . . . 0.0 110.179 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.15 -40.33 78.29 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.349 0.522 . . . . 0.0 111.147 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.55 -40.94 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.713 0.688 . . . . 0.0 109.883 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.71 -34.45 77.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.21 0.914 . . . . 0.0 109.87 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -61.2 -46.79 88.99 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.404 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.73 80.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.268 0.627 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.97 -33.18 71.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 111.459 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -63.18 -36.61 84.19 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.486 0.584 . . . . 0.0 111.392 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.4 mtm -85.17 -23.95 28.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.32 0.509 . . . . 0.0 112.117 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.42 95.19 6.63 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 125.123 1.369 . . . . 0.0 109.184 -173.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.16 -25.99 50.19 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 121.29 1.326 . . . . 0.0 112.554 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.03 31.52 3.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.822 1.649 . . . . 0.0 110.369 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.9 tp -49.63 146.37 4.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.662 2.385 . . . . 0.0 113.118 -172.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.9 p -129.94 162.91 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.558 1.543 . . . . 0.0 108.969 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 t -155.76 -178.05 7.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.736 0.414 . . . . 0.0 110.548 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.13 155.39 50.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.621 1.569 . . . . 0.0 108.782 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.63 146.44 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -77.52 138.9 39.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -63.13 -24.19 67.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.637 0.375 . . . . 0.0 111.932 -176.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.97 -40.46 70.04 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.398 0.679 . . . . 0.0 111.538 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -86.15 63.81 8.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.551 1.141 . . . . 0.0 109.331 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.73 -28.27 47.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.207 1.003 . . . . 0.0 111.316 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -47.04 83.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.718 0.807 . . . . 0.0 109.802 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.17 78.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.907 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.14 -49.46 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 119.57 1.077 . . . . 0.0 108.476 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.84 93.59 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -56.2 -50.6 70.78 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.536 0.735 . . . . 0.0 110.147 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -67.13 -33.88 76.39 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.88 -0.513 . . . . 0.0 109.822 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -59.29 -47.09 86.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.144 0.884 . . . . 0.0 110.901 170.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -58.81 -42.68 89.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.986 0.812 . . . . 0.0 110.429 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.03 -36.61 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.932 0.893 . . . . 0.0 110.737 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 136.02 9.86 1.42 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.8 -1.0 . . . . 0.0 114.638 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.38 155.49 30.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.87 1.835 . . . . 0.0 111.252 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.49 138.99 33.21 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.147 1.779 . . . . 0.0 106.574 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.492 HG22 HD22 ' A' ' 142' ' ' LEU . 25.9 t -71.73 135.03 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.17 0.988 . . . . 0.0 109.995 -171.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 p -126.77 -8.69 6.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.951 2.1 . . . . 0.0 111.481 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.3 43.94 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.901 0.773 . . . . 0.0 111.735 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -154.66 176.1 12.85 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.653 0.781 . . . . 0.0 110.185 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 127.679 2.392 . . . . 0.0 106.089 176.29 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 115.547 1.326 . . . . 0.0 115.547 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.42 145.64 50.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.2 mt -116.69 150.1 38.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.429 ' C ' HD23 ' A' ' 142' ' ' LEU . 16.6 t-20 -120.16 138.87 53.35 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.492 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.89 160.83 38.25 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.398 1.079 . . . . 0.0 108.591 -170.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.9 150.97 52.11 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.706 1.602 . . . . 0.0 108.569 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -76.46 124.84 28.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.407 1.083 . . . . 0.0 110.434 -177.306 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 121.458 0.647 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 mm -138.14 144.77 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -140.78 165.35 27.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 168.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mm -127.12 143.18 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -155.02 170.63 21.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.041 0.937 . . . . 0.0 109.822 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -59.02 147.8 33.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.489 0.586 . . . . 0.0 109.905 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p -63.4 154.41 32.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.584 1.553 . . . . 0.0 112.6 174.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -100.16 155.28 17.83 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -65.48 -48.51 72.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.852 -0.53 . . . . 0.0 110.278 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.24 -27.33 64.37 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -169.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.5 -5.76 51.18 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.141 0.428 . . . . 0.0 111.497 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.37 -35.64 36.01 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 124.184 0.897 . . . . 0.0 113.355 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -66.72 -31.51 72.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.293 1.047 . . . . 0.0 111.281 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.96 -31.32 70.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.402 0.681 . . . . 0.0 109.587 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.38 -39.74 64.88 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.792 -0.567 . . . . 0.0 109.774 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -57.89 -46.11 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 171.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.13 99.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 111.688 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.3 mt -62.11 -50.27 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 109.432 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -51.98 -47.88 64.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.534 . . . . 0.0 110.269 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 t -58.62 -50.39 74.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.153 0.433 . . . . 0.0 110.747 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -70.74 -28.18 64.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.504 -0.748 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -63.16 -44.92 94.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.081 0.855 . . . . 0.0 109.435 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.89 -42.54 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.772 0.829 . . . . 0.0 109.425 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.37 -35.05 73.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.021 0.828 . . . . 0.0 111.888 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.47 -36.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.111 -0.947 . . . . 0.0 113.1 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -136.58 -13.41 1.74 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.76 29.64 4.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.129 0.971 . . . . 0.0 110.572 -169.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -12.76 11.4 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.289 1.436 . . . . 0.0 113.495 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -51.61 -23.0 3.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.333 1.853 . . . . 0.0 113.203 169.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.34 97.78 0.43 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.667 1.187 . . . . 0.0 108.741 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -54.35 157.82 2.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.999 1.319 . . . . 0.0 110.712 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.42 64.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -46.81 72.37 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.901 0.773 . . . . 0.0 110.246 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.16 -40.89 97.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.632 0.773 . . . . 0.0 109.715 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -56.65 -47.28 80.09 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 124.256 1.022 . . . . 0.0 109.992 175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 m -65.78 -47.03 76.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.242 1.017 . . . . 0.0 110.393 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.0 -36.97 83.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.228 0.467 . . . . 0.0 110.712 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.91 -49.92 66.3 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.68 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.09 -39.45 72.14 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.126 0.875 . . . . 0.0 110.27 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.92 -48.33 80.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.809 0.731 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.69 -38.9 77.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -58.88 -47.55 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.979 1.711 . . . . 0.0 109.781 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -60.82 -24.22 65.68 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.367 1.067 . . . . 0.0 111.121 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -99.66 7.13 45.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.316 1.046 . . . . 0.0 110.969 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -136.96 -54.08 0.71 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.81 -169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.26 -37.76 60.75 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.642 1.565 . . . . 0.0 113.048 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -61.84 -14.15 34.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.337 2.025 . . . . 0.0 115.479 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.32 -14.6 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.645 1.566 . . . . 0.0 112.48 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 150.15 93.28 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.835 1.254 . . . . 0.0 110.834 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.28 50.83 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.56 3.506 . . . . 0.0 111.675 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.36 162.05 29.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.461 1.104 . . . . 0.0 110.993 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.06 117.03 28.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -99.06 140.08 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.24 0.616 . . . . 0.0 109.992 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.88 137.83 34.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.92 144.52 37.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -85.43 -175.62 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.586 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.79 -25.3 40.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.335 1.454 . . . . 0.0 113.415 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -79.75 -1.66 39.6 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.04 0.936 . . . . 0.0 111.498 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.4 t0 51.98 57.43 6.5 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.558 1.647 . . . . 0.0 109.238 -169.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -136.35 127.59 16.85 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.26 141.34 47.01 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.498 2.132 . . . . 0.0 111.681 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.17 -11.74 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 112.103 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.25 172.69 41.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.5 160.96 40.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.545 0.688 . . . . 0.0 111.494 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -140.29 137.1 33.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.068 2.547 . . . . 0.0 106.1 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.2 tp -115.48 127.52 55.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -144.36 140.87 29.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -154.21 155.81 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.19 -114.24 4.85 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -169.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -133.98 36.81 3.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.641 1.177 . . . . 0.0 110.043 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -134.05 115.38 14.24 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 121.212 -0.93 . . . . 0.0 111.34 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 56.1 ttp -86.2 90.41 8.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.95 -29.31 67.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.75 144.69 35.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.218 0.607 . . . . 0.0 110.799 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.0 tp -157.12 115.47 3.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.451 1.901 . . . . 0.0 106.14 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.69 141.35 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -151.4 146.21 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -59.24 122.13 61.19 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.27 -24.47 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.815 3.01 . . . . 0.0 115.36 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.43 -25.14 67.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.244 0.929 . . . . 0.0 112.75 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.45 -8.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -46.99 -41.61 16.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.005 1.322 . . . . 0.0 111.799 171.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.43 -12.22 65.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.866 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.9 -22.18 62.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.317 1.558 . . . . 0.0 112.109 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 137.18 -9.17 3.83 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.031 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.66 -32.17 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 119.161 1.48 . . . . 0.0 111.278 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.92 -53.92 16.31 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 123.538 0.589 . . . . 0.0 111.656 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -63.57 -42.4 98.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.262 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.72 -46.46 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.593 1.542 . . . . 0.0 109.932 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.4 mt -68.28 -41.81 80.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.982 -0.448 . . . . 0.0 110.77 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.74 -42.87 96.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.535 0.607 . . . . 0.0 110.181 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.52 -36.22 82.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.561 0.745 . . . . 0.0 109.59 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.82 -44.97 93.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.884 0.474 . . . . 0.0 110.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.34 63.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.158 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.72 -31.13 67.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.393 1.077 . . . . 0.0 111.782 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.82 -31.79 72.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.759 0.709 . . . . 0.0 111.969 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.0 mtm -91.77 -20.79 21.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.286 0.635 . . . . 0.0 112.208 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 94.88 6.1 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.532 1.533 . . . . 0.0 108.175 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.99 -21.83 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 CA-C-N 120.738 1.299 . . . . 0.0 112.887 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -104.52 30.28 5.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.721 1.608 . . . . 0.0 110.182 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.93 149.16 12.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.477 2.311 . . . . 0.0 113.56 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p -128.04 162.1 27.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.188 1.395 . . . . 0.0 109.811 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 t -152.72 -174.12 4.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 109.75 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -147.85 162.59 38.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.231 1.012 . . . . 0.0 109.994 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -157.0 143.49 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -71.04 133.74 46.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.88 -31.73 70.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 0.0 111.782 -172.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.17 -32.2 73.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.848 0.459 . . . . 0.0 111.465 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -80.58 61.56 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.865 1.266 . . . . 0.0 109.143 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.92 -26.37 47.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.479 1.112 . . . . 0.0 111.381 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -47.65 81.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.6 75.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.83 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.0 t -57.02 -48.53 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 119.578 1.081 . . . . 0.0 108.484 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.76 93.9 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.92 -51.11 67.09 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 123.633 0.773 . . . . 0.0 110.02 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.76 -34.53 78.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.027 -0.42 . . . . 0.0 109.956 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.28 -47.91 82.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.246 0.93 . . . . 0.0 110.778 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -58.85 -41.6 87.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.051 0.841 . . . . 0.0 110.757 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.77 -36.07 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.091 0.957 . . . . 0.0 110.478 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.91 9.51 1.7 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.338 0.97 . . . . 0.0 114.272 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.92 154.84 35.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.222 1.511 . . . . 0.0 111.449 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -139.62 138.66 36.33 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.637 1.575 . . . . 0.0 106.759 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 142' ' ' LEU . 25.6 t -72.64 135.28 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.214 1.006 . . . . 0.0 109.86 -171.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 p -125.12 -9.75 7.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.714 2.006 . . . . 0.0 111.327 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.17 179.77 43.57 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 118.755 0.707 . . . . 0.0 111.43 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -154.8 179.0 9.51 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 109.246 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 107.96 -178.477 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 CA--C 1.537 0.646 0 N-CA-C 118.902 2.616 . . . . 0.0 118.902 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.22 148.27 32.18 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.661 1.584 . . . . 0.0 107.255 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.9 mt -113.77 148.33 36.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.443 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.2 t-20 -119.09 138.27 53.0 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.756 1.223 . . . . 0.0 107.753 175.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.517 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.14 162.47 33.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 108.525 -171.122 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.02 51.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.792 1.637 . . . . 0.0 108.134 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -72.48 127.2 31.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.191 -179.086 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.5 t . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -128.46 146.22 34.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.61 167.14 22.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 168.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.411 HD12 ' CD2' ' A' ' 91' ' ' LEU . 13.5 mm -126.22 142.87 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -154.53 171.56 19.23 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.881 0.872 . . . . 0.0 109.955 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -61.31 150.31 35.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.544 0.611 . . . . 0.0 109.781 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 p -60.11 162.56 5.66 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.037 1.335 . . . . 0.0 112.046 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -120.82 139.18 53.5 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.489 1.916 . . . . 0.0 106.131 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -57.44 -41.45 80.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.474 0.579 . . . . 0.0 111.563 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.53 -19.3 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -88.56 -2.59 58.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.863 0.756 . . . . 0.0 111.33 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.52 -39.17 44.53 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 118.92 0.782 . . . . 0.0 113.467 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.88 -28.94 70.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.195 0.998 . . . . 0.0 112.13 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.33 -35.6 81.48 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 118.868 0.758 . . . . 0.0 109.647 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.3 -39.31 59.75 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.6 t -58.46 -45.58 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.284 0.634 . . . . 0.0 109.411 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.59 91.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.339 0.656 . . . . 0.0 112.176 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.36 -49.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.695 1.198 . . . . 0.0 109.258 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -55.87 -45.72 78.46 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.864 -0.523 . . . . 0.0 110.319 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.3 t -59.91 -49.74 76.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.739 0.816 . . . . 0.0 110.903 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.52 -25.72 64.17 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.018 -1.051 . . . . 0.0 111.976 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 m -68.6 -34.32 75.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.049 0.841 . . . . 0.0 110.595 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.1 -46.48 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.5 -40.67 92.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.38 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.448 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 p -137.9 3.14 2.44 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -168.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' CE1' HD22 ' A' ' 110' ' ' ASN . 15.9 m80 -126.99 37.53 4.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.324 1.42 . . . . 0.0 109.305 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.25 -27.47 55.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.353 1.061 . . . . 0.0 113.784 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.09 -17.19 64.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.534 0.734 . . . . 0.0 112.957 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.9 127.14 30.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.531 1.132 . . . . 0.0 110.783 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -56.48 138.08 52.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.096 1.358 . . . . 0.0 110.055 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.57 80.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.078 0.399 . . . . 0.0 112.024 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -66.17 -42.86 88.34 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.783 -0.573 . . . . 0.0 109.696 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.66 -38.89 84.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.37 -52.93 57.69 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.887 0.875 . . . . 0.0 109.329 172.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.9 m -59.39 -49.07 79.23 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 110.321 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.12 -35.37 71.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.29 -0.256 . . . . 0.0 111.18 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.81 -49.7 73.9 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.14 -36.59 77.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.052 0.842 . . . . 0.0 110.441 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.08 -47.89 80.97 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.014 0.525 . . . . 0.0 111.907 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -36.56 71.16 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.122 -0.361 . . . . 0.0 110.104 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.46 -46.99 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.111 1.765 . . . . 0.0 109.229 172.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -70.25 -9.05 54.77 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.797 -1.19 . . . . 0.0 112.555 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -101.28 6.68 42.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.174 0.99 . . . . 0.0 110.891 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.99 -55.1 0.72 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.653 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.45 -38.4 68.03 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 120.57 1.532 . . . . 0.0 112.932 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -61.46 -14.18 33.51 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.323 2.015 . . . . 0.0 114.94 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.63 -17.45 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.596 1.544 . . . . 0.0 112.38 -174.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.34 148.37 98.03 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.585 1.154 . . . . 0.0 110.826 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.39 51.48 3.89 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.942 3.762 . . . . 0.0 111.373 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.34 165.48 20.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.595 1.158 . . . . 0.0 110.691 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -118.38 109.77 16.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.04 138.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.191 0.596 . . . . 0.0 109.663 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.9 134.27 35.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 167.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.35 143.86 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -77.04 -177.32 4.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.172 0.987 . . . . 0.0 110.12 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.0 -17.86 20.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.446 1.898 . . . . 0.0 113.552 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.71 4.56 53.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.383 1.473 . . . . 0.0 112.046 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.6 t0 53.27 46.25 26.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.716 1.246 . . . . 0.0 110.235 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 129.19 24.21 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.86 138.96 71.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.85 1.7 . . . . 0.0 110.282 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.7 -8.89 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.714 1.205 . . . . 0.0 112.233 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.83 174.2 40.78 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -148.16 159.49 43.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.804 0.802 . . . . 0.0 111.517 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -136.97 141.25 42.59 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.329 2.652 . . . . 0.0 105.826 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -122.9 127.34 48.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 tp -145.37 139.85 27.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.7 m -153.25 156.3 38.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.2 -116.12 7.0 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -169.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.0 25.78 4.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.874 0.87 . . . . 0.0 111.51 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -110.9 112.36 24.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.306 1.042 . . . . 0.0 110.685 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.6 ttp -80.04 87.27 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 169.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.1 -23.02 65.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.12 146.55 30.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.447 0.567 . . . . 0.0 110.263 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.9 tp -156.08 116.05 3.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.74 141.4 30.45 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -148.11 146.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -59.64 122.76 67.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.06 -29.59 6.46 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.049 3.166 . . . . 0.0 114.638 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.38 -24.53 67.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.187 0.995 . . . . 0.0 113.563 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.77 -1.51 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -58.16 -37.4 74.61 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.905 -1.122 . . . . 0.0 110.67 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.27 -21.58 68.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.824 0.726 . . . . 0.0 113.394 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.7 m -79.36 -3.35 45.84 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.635 1.217 . . . . 0.0 111.846 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.97 68.44 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.359 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.7 -31.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.196 1.498 . . . . 0.0 110.994 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.9 -53.52 13.9 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 123.831 0.729 . . . . 0.0 111.722 170.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -63.25 -43.24 98.57 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.213 -1.375 . . . . 0.0 110.19 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -57.83 -46.27 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 120.356 1.435 . . . . 0.0 110.076 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.411 ' CD2' HD12 ' A' ' 5' ' ' ILE . 24.7 mt -69.36 -40.59 77.39 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.803 -0.561 . . . . 0.0 111.144 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.2 t -62.69 -41.24 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.646 0.657 . . . . 0.0 109.991 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.91 -34.13 76.04 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.124 0.875 . . . . 0.0 109.876 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.1 -47.04 87.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.231 0.469 . . . . 0.0 110.261 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.64 75.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.419 0.688 . . . . 0.0 110.785 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.17 -34.07 69.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.532 1.133 . . . . 0.0 111.458 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.72 -34.11 76.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.447 0.567 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 43.5 mtm -90.2 -21.88 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.363 0.529 . . . . 0.0 112.124 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.12 90.63 9.18 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 -172.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -21.99 59.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.513 1.475 . . . . 0.0 113.134 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -107.34 33.02 4.23 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.606 1.562 . . . . 0.0 109.808 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.5 tp -48.58 144.86 3.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.412 2.285 . . . . 0.0 112.951 -171.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.7 p -129.9 161.57 30.56 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.761 1.625 . . . . 0.0 108.102 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 t -153.09 -179.55 7.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.42 0.628 . . . . 0.0 110.555 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -143.07 159.32 42.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.275 1.03 . . . . 0.0 109.758 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.7 p -155.14 142.85 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -71.26 131.54 43.62 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.62 -22.46 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.563 0.745 . . . . 0.0 112.001 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.61 21.13 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.99 1.716 . . . . 0.0 113.098 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.407 HD22 ' CE1' ' A' ' 28' ' ' HIS . 64.9 t-20 -148.51 66.24 1.07 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.975 1.71 . . . . 0.0 108.143 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.71 -24.77 58.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.513 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -62.71 -48.94 77.07 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.889 0.476 . . . . 0.0 110.105 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.62 82.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.442 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.29 -49.65 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.71 -46.2 94.69 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -56.59 -50.67 71.27 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -67.38 -33.62 75.59 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.907 -0.496 . . . . 0.0 109.665 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.53 -48.39 81.0 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.11 0.868 . . . . 0.0 110.853 170.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.38 -42.67 87.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.905 0.775 . . . . 0.0 110.499 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.53 -34.42 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.206 1.003 . . . . 0.0 111.069 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.64 9.86 1.94 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.297 169.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -77.19 155.22 32.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.737 1.769 . . . . 0.0 111.039 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.63 139.76 33.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.14 1.776 . . . . 0.0 106.58 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.487 HG22 HD22 ' A' ' 142' ' ' LEU . 21.8 t -71.73 135.42 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 123.888 0.875 . . . . 0.0 109.93 -170.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 p -124.2 -10.77 7.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.507 1.923 . . . . 0.0 111.244 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 179.16 45.02 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 118.823 0.738 . . . . 0.0 111.844 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.91 175.74 11.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.217 1.007 . . . . 0.0 108.4 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.532 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 CA--C 1.536 0.601 0 N-CA-C 116.557 1.714 . . . . 0.0 116.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.1 tp -136.28 146.34 46.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.424 1.89 . . . . 0.0 106.368 169.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.86 149.18 39.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -126.71 137.28 53.24 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.676 1.19 . . . . 0.0 108.549 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.9 161.99 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.316 1.046 . . . . 0.0 108.583 -169.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.91 150.45 52.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 108.631 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -76.61 126.54 31.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 124.939 1.296 . . . . 0.0 110.431 -177.284 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 mm -127.74 144.16 38.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -142.13 165.38 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mm -124.1 142.71 39.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -151.84 174.24 13.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.814 0.846 . . . . 0.0 110.046 174.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -63.82 152.61 39.07 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -63.52 174.61 1.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.122 1.769 . . . . 0.0 112.326 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -132.06 142.44 49.54 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.168 1.787 . . . . 0.0 106.493 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -57.73 -40.26 79.22 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.205 0.457 . . . . 0.0 110.897 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.07 -13.43 61.58 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.74 -0.84 41.93 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.865 0.757 . . . . 0.0 110.957 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.2 -40.72 60.31 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.587 0.613 . . . . 0.0 113.182 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.82 -28.2 68.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.348 1.074 . . . . 0.0 111.685 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.485 -0.759 . . . . 0.0 109.908 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.15 -38.96 69.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.39 -47.79 83.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.82 89.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.056 0.542 . . . . 0.0 111.699 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.45 -51.25 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.825 1.25 . . . . 0.0 109.782 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -54.55 -50.17 68.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.933 0.493 . . . . 0.0 109.676 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.46 -48.63 68.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.394 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.74 -33.86 64.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.87 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -27.1 63.67 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 120.531 1.514 . . . . 0.0 111.313 172.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.26 -45.74 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 O-C-N 121.269 -0.894 . . . . 0.0 109.068 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.73 -38.01 83.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.004 0.82 . . . . 0.0 111.904 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.83 -36.59 56.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.249 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.0 p -138.94 -4.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CE1' HD22 ' A' ' 110' ' ' ASN . 20.4 m80 -126.96 25.23 6.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.9 1.227 . . . . 0.0 110.458 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.49 -15.9 31.58 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -53.03 -22.64 6.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.812 2.045 . . . . 0.0 113.155 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.94 97.54 0.36 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.876 1.27 . . . . 0.0 108.163 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -54.82 155.69 4.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 111.181 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.28 64.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.19 -48.13 68.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.85 0.75 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.44 -40.0 94.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.192 0.597 . . . . 0.0 109.872 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -55.2 -47.28 75.48 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.781 1.232 . . . . 0.0 110.195 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.5 m -64.97 -49.72 69.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.019 0.928 . . . . 0.0 110.011 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.01 -38.05 87.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.962 0.346 . . . . 0.0 110.725 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 mt -62.39 -53.67 51.6 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.519 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.16 -39.58 75.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.18 0.9 . . . . 0.0 110.54 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.42 -48.58 77.2 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.958 0.503 . . . . 0.0 111.882 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.072 0.396 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.43 -48.09 88.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 109.279 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -69.94 -10.56 58.99 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.013 -1.054 . . . . 0.0 112.498 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -98.21 5.62 48.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 110.702 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.15 -56.97 0.76 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 117.739 -1.124 . . . . 0.0 112.507 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.49 -38.95 73.55 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 120.793 1.633 . . . . 0.0 113.125 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.39 -14.38 34.39 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.266 1.977 . . . . 0.0 114.818 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -129.01 -14.03 4.47 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.862 1.665 . . . . 0.0 113.144 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.11 91.23 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.048 1.339 . . . . 0.0 111.514 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.46 60.25 7.01 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.844 3.696 . . . . 0.0 110.872 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -83.06 179.69 7.68 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.818 1.294 . . . . 0.0 110.831 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -135.38 140.66 45.17 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.58 2.752 . . . . 0.0 103.921 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.77 139.77 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 119.264 0.938 . . . . 0.0 110.063 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.8 132.66 35.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.43 141.78 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -81.74 -179.82 7.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.358 171.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.55 -25.87 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.769 2.028 . . . . 0.0 114.33 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -85.17 3.35 39.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.288 1.435 . . . . 0.0 112.175 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 51.33 59.31 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 123.761 1.743 . . . . 0.0 109.182 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -131.84 119.27 16.93 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.89 139.78 76.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.019 1.813 . . . . 0.0 109.393 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.66 -10.54 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.681 1.193 . . . . 0.0 111.977 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.12 173.03 41.63 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.86 160.94 41.08 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.615 0.722 . . . . 0.0 111.407 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -141.56 129.78 22.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.836 2.454 . . . . 0.0 105.506 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 74' ' ' ASP . 24.7 tp -109.06 124.89 51.48 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 169.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.7 tp -145.86 134.75 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m -159.72 155.61 26.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.081 2.152 . . . . 0.0 105.281 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.67 57.53 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.862 0.756 . . . . 0.0 113.881 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 58.43 21.77 8.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.992 1.717 . . . . 0.0 113.731 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -124.46 112.87 17.41 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.946 0.899 . . . . 0.0 110.079 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -85.22 85.79 7.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.535 ' HB3' HD23 ' A' ' 67' ' ' LEU . 33.0 t70 -63.76 -28.31 69.79 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.26 144.19 31.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.015 0.526 . . . . 0.0 110.094 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.8 tp -153.7 112.07 3.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -142.58 140.88 31.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.07 154.63 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -171.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -65.0 124.17 85.94 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.65 -27.59 8.1 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.147 3.231 . . . . 0.0 114.759 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.59 -24.15 66.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.978 0.911 . . . . 0.0 112.935 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.49 -2.76 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.759 0.824 . . . . 0.0 112.86 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -55.18 -42.91 73.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.553 1.07 . . . . 0.0 109.786 169.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.81 -26.73 72.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.496 -0.613 . . . . 0.0 113.132 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.9 m -74.57 -8.07 55.14 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.497 1.149 . . . . 0.0 112.419 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.02 13.93 56.98 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.399 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -56.01 -30.22 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.403 1.602 . . . . 0.0 110.293 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -46.89 -52.38 11.8 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.221 0.915 . . . . 0.0 111.883 169.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.35 -44.58 96.14 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.079 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.45 -46.96 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.835 1.198 . . . . 0.0 109.963 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.0 mt -69.3 -39.72 78.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.281 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.13 -40.27 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.817 0.735 . . . . 0.0 109.939 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.91 -34.68 78.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.375 0.989 . . . . 0.0 109.762 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -60.74 -48.51 81.49 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 122.908 0.483 . . . . 0.0 110.318 173.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.3 77.19 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.612 0.765 . . . . 0.0 110.93 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.46 -33.46 71.32 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.591 1.156 . . . . 0.0 111.546 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 m -62.92 -35.56 80.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.578 0.626 . . . . 0.0 111.547 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -85.73 -25.39 26.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.364 0.529 . . . . 0.0 112.082 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.05 94.29 7.9 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.176 1.391 . . . . 0.0 109.16 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.99 -23.31 46.88 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.24 1.293 . . . . 0.0 112.405 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.77 29.08 4.32 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.753 1.621 . . . . 0.0 110.489 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.7 tp -52.49 144.79 12.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.238 2.215 . . . . 0.0 113.248 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.9 p -129.28 164.57 23.21 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.82 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -154.86 -174.47 5.0 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.236 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -148.28 162.03 40.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 110.001 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.5 HG12 HD21 ' A' ' 142' ' ' LEU . 13.1 p -157.71 148.69 9.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -70.0 130.33 41.88 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.54 -33.23 65.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.038 1.335 . . . . 0.0 111.805 -172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.39 -27.77 68.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 0.0 111.779 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.442 HD22 ' CE1' ' A' ' 28' ' ' HIS . 57.5 t-20 -79.72 64.97 4.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.434 0.694 . . . . 0.0 109.52 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.27 -25.54 59.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.75 0.82 . . . . 0.0 111.388 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.79 -48.28 79.81 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 109.954 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.61 78.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.65 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.21 -45.35 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 119.319 0.963 . . . . 0.0 109.001 173.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.66 -49.59 71.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -54.74 -50.49 68.24 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.912 0.885 . . . . 0.0 110.44 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.02 -35.72 81.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.51 -39.75 94.36 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 120.875 -1.141 . . . . 0.0 112.552 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.18 -41.73 89.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.997 1.271 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.26 -34.18 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.307 1.043 . . . . 0.0 110.634 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.27 4.86 2.47 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.5 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -71.64 165.64 23.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.331 1.565 . . . . 0.0 111.197 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.52 140.78 33.54 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.755 2.022 . . . . 0.0 106.036 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.622 HG22 HD22 ' A' ' 142' ' ' LEU . 43.4 t -72.33 129.52 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.1 p -128.82 -7.2 5.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.012 1.725 . . . . 0.0 111.249 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.46 176.92 39.55 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 169.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -157.04 -178.81 7.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.728 0.811 . . . . 0.0 109.533 171.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 125.565 1.546 . . . . 0.0 108.073 -178.789 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_exo . . . . . 0 CA--C 1.536 0.607 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.4 147.77 27.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 106.886 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.76 148.82 32.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.546 ' C ' HD23 ' A' ' 142' ' ' LEU . 9.9 t-20 -115.11 139.2 50.1 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.622 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.07 157.97 45.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -172.51 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.94 150.85 52.04 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.053 1.341 . . . . 0.0 108.206 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -76.31 130.87 38.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 124.77 1.228 . . . . 0.0 109.895 -177.418 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 mm -130.95 145.67 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -140.54 162.49 35.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 55' ' ' ALA . 23.2 mm -117.76 141.7 35.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.54 177.77 10.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 109.872 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -73.63 150.3 41.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 m -72.69 -177.26 2.23 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.403 1.081 . . . . 0.0 111.154 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.87 161.45 32.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -67.34 -40.11 85.84 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.925 0.33 . . . . 0.0 110.116 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.73 -26.38 64.29 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.7 1.79 52.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.634 0.774 . . . . 0.0 111.301 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.53 -41.67 49.67 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.281 0.946 . . . . 0.0 112.837 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.03 -26.86 68.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.057 0.929 . . . . 0.0 112.228 -178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.88 -34.59 78.12 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.966 0.803 . . . . 0.0 109.598 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.46 -38.16 49.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.43 -45.45 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -45.71 91.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.074 0.55 . . . . 0.0 111.448 178.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.3 mt -59.56 -48.52 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 109.702 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.37 -51.04 66.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.619 0.767 . . . . 0.0 110.204 173.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.05 -40.83 90.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.897 -0.502 . . . . 0.0 110.367 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -66.23 -42.99 87.86 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.327 0.651 . . . . 0.0 111.216 177.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -59.05 -37.06 76.11 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.917 0.487 . . . . 0.0 111.052 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -72.2 -44.32 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.269 0.628 . . . . 0.0 109.319 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -60.27 -37.81 81.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.012 0.824 . . . . 0.0 111.721 174.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.36 61.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.855 -174.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.1 p -139.27 -3.1 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -169.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CE1' HD22 ' A' ' 110' ' ' ASN . 16.3 m80 -126.72 26.28 6.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.686 1.13 . . . . 0.0 110.456 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -13.92 28.99 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.847 -1.158 . . . . 0.0 113.053 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -57.25 -21.1 31.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.063 1.745 . . . . 0.0 112.995 170.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.05 109.69 1.9 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 m -58.05 147.53 29.25 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.533 1.533 . . . . 0.0 110.238 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.34 67.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.88 -52.48 56.35 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -70.79 -31.84 68.74 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.891 -0.506 . . . . 0.0 110.596 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 tpp85 -54.67 -46.38 74.03 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.956 0.902 . . . . 0.0 109.922 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -64.94 -50.04 67.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 109.843 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -63.4 -39.31 94.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.784 0.266 . . . . 0.0 110.545 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -62.34 -54.5 39.62 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.467 175.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -58.61 -37.81 76.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.419 1.009 . . . . 0.0 110.505 -173.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.13 -48.96 71.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.2 0.6 . . . . 0.0 111.919 175.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.47 74.92 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.282 0.492 . . . . 0.0 110.49 -176.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.71 -48.71 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.195 1.798 . . . . 0.0 108.945 171.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttp85 -70.66 -8.4 51.61 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.001 -1.062 . . . . 0.0 112.764 176.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -99.63 5.55 45.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.066 0.947 . . . . 0.0 110.801 172.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -135.45 -55.37 0.79 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.957 -169.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.72 -37.91 61.4 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.411 1.459 . . . . 0.0 112.732 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.4 -9.03 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.235 1.957 . . . . 0.0 115.437 172.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.02 -16.08 3.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.207 1.821 . . . . 0.0 113.466 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.86 152.39 96.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.794 1.238 . . . . 0.0 112.348 -172.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.24 62.38 7.54 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 125.176 3.917 . . . . 0.0 111.616 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.1 mt -83.89 172.77 11.81 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.233 1.813 . . . . 0.0 112.404 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -134.26 145.86 49.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.58 139.63 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.523 1.129 . . . . 0.0 110.262 -176.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.12 130.81 35.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.018 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -123.31 142.16 40.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.1 p30 -84.21 -173.48 4.74 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.453 174.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.64 -22.34 22.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.434 1.494 . . . . 0.0 113.657 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -81.79 -2.36 50.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 111.659 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 53.26 56.31 7.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.286 1.517 . . . . 0.0 109.142 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.61 129.19 16.31 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 127.461 2.304 . . . . 0.0 105.465 -169.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.73 136.8 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.027 1.818 . . . . 0.0 110.217 -171.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 -16.08 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.722 1.209 . . . . 0.0 111.842 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.19 173.02 39.31 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.76 161.28 42.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.707 0.753 . . . . 0.0 110.592 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 154.13 47.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.129 0.971 . . . . 0.0 108.937 168.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.78 119.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 176.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 95' ' ' ALA . 25.2 tp -146.28 134.6 21.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.275 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -159.47 156.32 28.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.358 2.263 . . . . 0.0 105.484 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.63 32.94 61.95 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.419 -0.8 . . . . 0.0 113.889 175.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 57.01 22.54 7.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.218 1.807 . . . . 0.0 114.121 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -122.69 111.02 16.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.579 0.751 . . . . 0.0 109.787 175.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 ttp -85.83 88.78 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.77 -23.95 67.4 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.14 144.88 32.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.378 0.671 . . . . 0.0 110.552 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.8 tp -156.87 117.22 3.57 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.69 1.996 . . . . 0.0 106.112 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -147.17 144.92 29.32 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.33 142.73 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -173.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.49 137.68 95.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.281 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.62 -24.53 23.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.803 3.002 . . . . 0.0 115.852 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.34 -21.1 61.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.541 1.064 . . . . 0.0 112.278 175.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.15 24.89 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.529 1.532 . . . . 0.0 110.493 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.91 132.84 54.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.778 -1.201 . . . . 0.0 108.826 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.95 2.65 53.1 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.995 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 98.7 m -70.78 169.23 15.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.654 1.727 . . . . 0.0 109.18 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.05 -28.22 16.95 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.545 1.069 . . . . 0.0 113.863 -177.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.55 -34.81 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 118.989 1.395 . . . . 0.0 112.203 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.15 -29.94 53.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.08 0.848 . . . . 0.0 112.807 175.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -91.95 -42.52 9.97 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 116.498 -1.715 . . . . 0.0 110.248 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.32 -45.56 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 121.56 1.982 . . . . 0.0 110.826 -172.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.2 -39.81 89.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.791 0.723 . . . . 0.0 111.065 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.53 -40.75 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.478 0.711 . . . . 0.0 109.798 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.54 -36.95 85.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.594 0.758 . . . . 0.0 109.544 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.52 -47.03 87.44 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.057 0.543 . . . . 0.0 110.276 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 68' ' ' LEU . . . -60.13 -49.77 76.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.06 0.544 . . . . 0.0 110.84 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -60.27 -33.72 72.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.191 0.996 . . . . 0.0 111.578 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -37.65 88.11 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.358 0.526 . . . . 0.0 111.414 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -83.92 -26.45 29.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.253 0.479 . . . . 0.0 112.117 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 91.32 10.39 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.143 1.377 . . . . 0.0 109.282 -169.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.96 -22.16 63.06 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.425 1.417 . . . . 0.0 112.822 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.86 30.92 5.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.286 1.434 . . . . 0.0 110.274 -174.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 tp -50.91 143.37 10.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.898 2.079 . . . . 0.0 112.826 -170.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 65.2 p -130.0 162.85 27.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.746 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 t -153.58 -173.58 4.63 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.014 0.526 . . . . 0.0 109.724 175.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -148.68 161.41 41.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.833 0.853 . . . . 0.0 110.631 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -156.07 147.34 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -72.56 132.16 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -58.34 -30.87 67.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.726 0.811 . . . . 0.0 112.33 -173.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.79 -33.16 72.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.506 0.594 . . . . 0.0 111.236 -177.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.445 HD22 ' CE1' ' A' ' 28' ' ' HIS . 54.5 t-20 -80.02 65.8 5.3 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.028 0.931 . . . . 0.0 110.523 176.227 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.11 -26.11 59.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 111.632 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.4 ' H ' ' NE2' ' A' ' 112' ' ' GLN . 2.7 mp0 -62.87 -46.97 85.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.102 0.561 . . . . 0.0 109.752 176.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.72 77.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.606 -0.711 . . . . 0.0 111.786 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.41 -46.21 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.236 0.925 . . . . 0.0 108.963 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.01 -49.59 73.79 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -55.45 -50.88 68.71 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.582 0.753 . . . . 0.0 110.755 -178.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -66.1 -34.41 78.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -174.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.15 -37.88 86.75 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.82 -1.175 . . . . 0.0 112.72 172.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.07 -42.81 91.26 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.877 1.217 . . . . 0.0 110.169 173.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.57 -35.65 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 110.788 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.72 9.08 1.82 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.418 1.008 . . . . 0.0 114.454 169.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.4 162.2 29.08 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.608 1.704 . . . . 0.0 111.107 171.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.92 140.39 25.6 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.559 HG22 HD22 ' A' ' 142' ' ' LEU . 29.9 t -72.26 129.75 35.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.907 0.883 . . . . 0.0 109.336 -174.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.6 p -123.77 -9.15 7.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.421 1.888 . . . . 0.0 111.681 -174.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.55 -179.92 41.12 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -156.36 177.87 10.96 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.804 0.841 . . . . 0.0 109.254 172.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--N 1.322 -0.609 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.53 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 N-CA-C 118.449 2.442 . . . . 0.0 118.449 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.67 146.15 26.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.7 mt -117.26 145.23 44.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.451 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.1 t-20 -115.71 138.61 50.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.559 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.0 158.78 43.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -171.242 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.56 152.48 51.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.277 1.431 . . . . 0.0 108.348 176.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.5 127.36 32.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.8 t . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 125.136 1.374 . . . . 0.0 110.146 -176.644 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.267 4.3 t -74.74 155.95 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 127.702 2.401 . . . . 0.0 107.874 177.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -135.2 141.84 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.88 1.672 . . . . 0.0 106.676 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -136.32 166.17 24.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mm -123.08 142.16 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -150.52 172.02 16.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.784 0.834 . . . . 0.0 109.76 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.47 HH12 ' HB2' ' A' ' 51' ' ' PRO . 24.6 mmt180 -61.67 148.39 42.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.492 -0.755 . . . . 0.0 110.488 166.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -70.84 160.76 32.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.735 1.214 . . . . 0.0 110.26 176.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -103.11 161.72 13.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.146 163.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -62.82 -51.76 65.79 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -24.9 62.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.754 -162.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.35 -0.61 46.61 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.404 -0.185 . . . . 0.0 111.1 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 -39.43 53.22 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.137 -0.977 . . . . 0.0 112.752 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -65.56 -28.56 69.25 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.616 1.208 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.19 -32.78 73.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.209 0.528 . . . . 0.0 109.644 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.88 -38.82 64.29 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 120.901 -1.125 . . . . 0.0 109.63 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.28 -46.46 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -47.15 87.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.06 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.84 -50.36 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.996 1.319 . . . . 0.0 109.52 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -53.76 -47.15 70.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.0 t -59.13 -47.32 85.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.279 0.632 . . . . 0.0 110.683 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.306 -0.871 . . . . 0.0 112.811 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.1 m -60.17 -38.06 82.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.342 0.974 . . . . 0.0 109.516 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -70.44 -42.74 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.077 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.41 -34.99 78.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.392 0.542 . . . . 0.0 111.094 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.78 -33.91 30.62 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.283 -0.886 . . . . 0.0 112.309 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.591 HG21 HH12 ' A' ' 83' ' ' ARG . 19.9 p -139.1 -5.12 1.47 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -167.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.404 ' CE1' HD22 ' A' ' 110' ' ' ASN . 57.4 m80 -126.61 30.06 5.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.697 1.59 . . . . 0.0 110.454 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -60.8 -18.94 58.36 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.962 0.887 . . . . 0.0 112.849 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.11 -23.52 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.212 1.405 . . . . 0.0 112.517 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -60.88 106.02 0.53 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.418 1.087 . . . . 0.0 111.591 172.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 m -56.25 151.09 13.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.056 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.06 -34.41 68.24 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 123.077 0.551 . . . . 0.0 112.351 -172.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -68.07 -47.91 67.01 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.714 1.245 . . . . 0.0 109.358 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.812 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 5.9 t80 -68.66 -34.98 76.63 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.574 -1.193 . . . . 0.0 112.02 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -53.86 -49.35 68.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.754 0.822 . . . . 0.0 110.773 170.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 m -62.91 -47.08 84.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 124.349 1.031 . . . . 0.0 109.16 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.37 -36.54 74.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.457 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.54 -50.77 70.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.414 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.69 -39.06 79.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.081 0.855 . . . . 0.0 111.237 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -51.07 69.46 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.06 0.544 . . . . 0.0 110.326 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -37.21 79.01 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.478 -0.764 . . . . 0.0 110.134 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.8 t -58.5 -46.99 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.51 1.524 . . . . 0.0 109.026 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -67.74 -18.04 64.76 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.913 -1.117 . . . . 0.0 113.034 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.3 m -95.02 10.61 35.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -140.09 -56.29 0.55 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 119.473 1.033 . . . . 0.0 111.796 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -55.81 -40.24 83.22 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 116.888 -1.53 . . . . 0.0 112.659 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.73 -11.63 18.36 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.315 2.01 . . . . 0.0 116.209 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.99 -15.35 3.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.14 1.336 . . . . 0.0 112.461 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.02 148.24 98.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 123.784 0.833 . . . . 0.0 110.124 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HB2' HH12 ' A' ' 7' ' ' ARG . 47.1 Cg_endo -77.84 65.23 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.347 3.365 . . . . 0.0 108.844 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.426 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 64.1 mt -83.9 170.89 13.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.033 0.933 . . . . 0.0 110.651 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -122.75 138.88 54.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 166.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.54 135.57 56.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.615 1.166 . . . . 0.0 108.811 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.28 133.0 41.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 160.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.4 140.65 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -79.22 -174.58 4.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.078 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.48 -19.53 9.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.537 1.535 . . . . 0.0 114.885 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.36 4.93 44.4 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.769 -1.207 . . . . 0.0 113.203 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.3 t0 52.24 52.45 14.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.27 1.509 . . . . 0.0 110.897 -169.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -131.7 124.57 19.96 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.23 137.83 45.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.113 1.875 . . . . 0.0 111.743 -169.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.86 -11.06 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.397 1.079 . . . . 0.0 111.38 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.93 171.49 41.07 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 169.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.66 161.96 39.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 111.704 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.422 ' HB3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -147.31 138.92 24.05 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.674 1.59 . . . . 0.0 106.942 -175.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 73' ' ' MET . 1.1 tp -112.6 121.34 44.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 174.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.5 tp -141.56 133.25 27.13 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.573 1.171 . . . . 0.0 108.424 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.5 m -147.27 160.2 42.76 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.761 2.024 . . . . 0.0 106.979 164.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.0 -115.01 6.68 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -170.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -135.46 32.71 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.567 1.183 . . . . 0.0 109.637 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -128.2 103.13 7.02 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.113 0.965 . . . . 0.0 109.216 -165.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 67.1 ttp -81.08 87.14 6.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -60.26 -36.32 77.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.932 0.893 . . . . 0.0 111.181 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.81 146.46 41.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.546 -1.346 . . . . 0.0 110.685 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.97 118.25 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.37 143.14 30.8 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -150.74 141.23 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -53.46 122.93 34.32 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 125.374 1.671 . . . . 0.0 108.929 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -51.84 -27.17 26.43 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.186 1.924 . . . . 0.0 114.39 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.3 -28.28 69.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.112 1.324 . . . . 0.0 111.89 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.66 2.04 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.867 -1.145 . . . . 0.0 112.262 -171.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.591 HH12 HG21 ' A' ' 27' ' ' THR . 46.2 mtt180 -53.36 -44.82 68.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.095 -1.003 . . . . 0.0 111.958 170.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.31 -22.95 67.85 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.369 1.043 . . . . 0.0 111.596 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.0 -7.41 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.696 1.248 . . . . 0.0 113.084 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.21 1.25 51.08 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-O 118.699 -1.056 . . . . 0.0 112.606 172.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.6 t -55.68 -31.35 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 118.725 1.263 . . . . 0.0 110.019 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.86 -49.8 34.14 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.003 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -64.62 -47.01 80.15 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.734 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.86 -43.41 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.558 1.072 . . . . 0.0 110.085 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 66' ' ' MET . 29.2 mt -69.34 -42.15 75.69 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.628 -0.67 . . . . 0.0 111.017 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.51 -41.25 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.813 0.733 . . . . 0.0 110.432 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.38 -38.69 90.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -59.32 -46.07 89.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.381 0.537 . . . . 0.0 110.605 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.93 91.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.989 0.516 . . . . 0.0 110.609 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.808 HD21 ' HD2' ' A' ' 144' ' ' TYR . 32.6 mt -62.59 -34.58 77.29 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.9 m -62.71 -33.97 76.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.536 0.523 . . . . 0.0 110.695 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.8 mtm -87.59 -22.52 24.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.626 0.648 . . . . 0.0 112.061 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.78 93.16 6.25 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.775 1.23 . . . . 0.0 108.237 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 -23.65 57.24 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.738 1.625 . . . . 0.0 113.266 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.32 31.18 4.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.379 1.471 . . . . 0.0 109.368 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.8 tp -49.86 144.64 6.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.529 1.932 . . . . 0.0 113.04 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -127.48 162.0 27.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.778 1.631 . . . . 0.0 108.751 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -153.35 -179.68 7.96 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -141.56 165.51 27.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.063 0.945 . . . . 0.0 109.856 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.72 145.63 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -71.29 131.85 44.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -58.35 -33.09 69.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.519 1.128 . . . . 0.0 111.534 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.444 ' NE2' ' CD1' ' A' ' 137' ' ' TYR . 95.2 mt-30 -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.167 0.587 . . . . 0.0 111.523 -176.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.404 HD22 ' CE1' ' A' ' 28' ' ' HIS . 63.4 t-20 -85.81 68.62 10.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.291 0.567 . . . . 0.0 109.886 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.35 -26.07 62.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 111.018 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -61.47 -49.16 77.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.67 -0.644 . . . . 0.0 109.61 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.65 76.57 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.411 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.04 -48.32 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.058 . . . . 0.0 108.46 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.83 -47.15 92.67 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.525 0.602 . . . . 0.0 111.793 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.26 -51.04 70.96 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.91 0.884 . . . . 0.0 109.116 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.66 -35.39 80.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -42.69 99.12 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.738 1.154 . . . . 0.0 112.584 171.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -59.57 -41.01 89.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.052 0.842 . . . . 0.0 111.306 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.05 -37.82 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 123.998 0.812 . . . . 0.0 109.648 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.689 ' HA3' ' HA3' ' A' ' 146' ' ' GLY . . . 141.38 5.35 0.97 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-O 122.182 0.879 . . . . 0.0 115.003 168.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -73.9 159.09 33.31 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 118.294 -2.886 . . . . 0.0 111.475 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -142.59 139.36 31.32 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.5 t -71.69 136.28 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -130.28 -8.63 4.25 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.26 1.824 . . . . 0.0 110.922 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.36 178.1 42.65 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -157.32 178.69 10.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.122 -0.634 . . . . 0.0 109.62 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -138.09 155.06 49.15 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -91.34 -7.29 51.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.312 1.053 . . . . 0.0 112.093 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -136.18 173.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.9 -62.45 1.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.942 0.776 . . . . 0.0 109.25 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -161.16 -47.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 135' ' ' LYS . 80.5 mt -90.23 23.67 2.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.821 -1.174 . . . . 0.0 110.463 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 4.57 89.28 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.127 -0.983 . . . . 0.0 112.476 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.812 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -67.27 137.73 94.1 Favored Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 117.253 -1.356 . . . . 0.0 109.629 175.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.36 52.24 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.86 3.04 . . . . 0.0 112.404 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.444 ' CD1' ' NE2' ' A' ' 109' ' ' GLN . 21.9 m-85 -126.82 76.93 74.95 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.424 1.49 . . . . 0.0 108.813 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -47.84 148.14 6.6 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.705 2.27 . . . . 0.0 115.809 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.7 tp -104.39 146.77 28.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.8 mt -114.57 145.93 41.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.68 138.08 51.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.654 1.182 . . . . 0.0 107.986 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.87 157.85 45.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -169.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.24 50.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.808 ' HD2' HD21 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -73.21 116.7 14.06 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.596 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 74.7 t -109.36 -30.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 1 CA-C-O 100.815 -9.183 . . . . 0.0 110.44 171.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.802 ' HA3' ' HE1' ' A' ' 144' ' ' TYR . . . -35.19 -16.14 0.0 OUTLIER Glycine 2 N--CA 1.567 7.373 3 C-N-CA 151.441 13.877 . . . . 0.0 132.066 -151.649 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 145' ' ' VAL 0.265 . . . . . . . 0 C--N 1.275 -2.664 1 CA-C-N 100.476 -7.862 . . . . 0.0 117.36 125.994 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.95 149.82 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.685 0.794 . . . . 0.0 109.73 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 mm -126.76 144.45 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.7 m -141.65 167.59 21.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.45 142.83 36.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -148.72 173.51 13.16 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.539 0.736 . . . . 0.0 110.214 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -66.03 147.87 52.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.573 0.701 . . . . 0.0 109.11 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -77.71 147.17 35.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.854 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -85.99 175.85 8.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.803 0.841 . . . . 0.0 108.746 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -82.35 -49.06 10.44 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.43 -26.54 61.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.81 0.732 . . . . 0.0 112.203 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -72.77 -5.2 36.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.031 -0.418 . . . . 0.0 111.841 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.66 -38.64 29.43 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.487 1.041 . . . . 0.0 113.178 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.78 -28.61 69.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.926 1.363 . . . . 0.0 111.795 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.71 -31.28 70.26 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.401 -0.812 . . . . 0.0 109.578 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -75.49 -39.67 58.23 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -56.29 -44.82 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.497 0.719 . . . . 0.0 109.084 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.45 96.18 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.883 -0.51 . . . . 0.0 111.436 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.0 mt -59.8 -48.89 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.512 0.725 . . . . 0.0 109.705 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -54.19 -45.7 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.269 0.628 . . . . 0.0 110.111 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 t -60.54 -44.24 96.32 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.607 -0.683 . . . . 0.0 110.518 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -63.11 -42.69 99.6 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.658 -0.651 . . . . 0.0 110.833 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.7 m -59.6 -38.09 80.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.514 0.726 . . . . 0.0 110.876 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.44 -45.52 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.273 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.02 -37.39 76.83 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.153 0.888 . . . . 0.0 111.83 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.6 26.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.147 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.5 p -135.44 -5.78 2.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CE1' HD22 ' A' ' 110' ' ' ASN . 12.7 m80 -128.52 26.89 5.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.009 1.277 . . . . 0.0 110.632 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.5 -14.41 28.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.323 -0.861 . . . . 0.0 113.293 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -53.38 -22.79 8.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.737 2.015 . . . . 0.0 112.988 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.01 100.29 0.41 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.057 1.343 . . . . 0.0 108.529 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -56.32 157.33 5.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.527 1.531 . . . . 0.0 111.109 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.32 -36.98 66.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -67.14 -48.56 67.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.888 0.767 . . . . 0.0 109.783 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.52 -40.27 96.61 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.663 0.785 . . . . 0.0 109.796 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 -55.54 -48.45 74.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.932 1.293 . . . . 0.0 110.168 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -65.42 -49.53 68.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.0 0.92 . . . . 0.0 110.05 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.83 -38.13 88.08 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.861 0.3 . . . . 0.0 110.66 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 mt -62.79 -53.74 49.72 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.565 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.53 -38.22 74.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.442 1.019 . . . . 0.0 110.701 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.9 -49.09 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.221 0.609 . . . . 0.0 111.854 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -36.45 74.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.201 0.455 . . . . 0.0 110.296 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.02 -48.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 126.211 1.805 . . . . 0.0 109.038 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -70.41 -10.76 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.987 -1.071 . . . . 0.0 112.679 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.7 m -96.05 4.7 52.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 110.681 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.24 -56.45 0.8 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.158 -169.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.81 -38.47 68.4 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 120.466 1.485 . . . . 0.0 112.91 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.19 -13.01 29.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.945 1.764 . . . . 0.0 115.362 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -128.95 -14.7 4.41 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.63 1.559 . . . . 0.0 113.196 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 152.19 95.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.792 1.237 . . . . 0.0 111.999 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.19 62.71 7.61 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.98 3.787 . . . . 0.0 111.65 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.8 173.73 8.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.185 1.794 . . . . 0.0 112.374 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -133.07 146.15 51.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.45 137.87 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 110.487 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.87 35.74 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.01 140.89 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -76.67 -174.83 3.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.609 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.08 -15.56 34.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.821 1.648 . . . . 0.0 113.118 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -87.74 3.73 46.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.037 1.335 . . . . 0.0 111.713 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.14 33.28 21.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.675 1.59 . . . . 0.0 111.412 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -117.79 133.49 23.33 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.26 138.18 46.04 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.703 2.268 . . . . 0.0 112.4 -169.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.76 -9.64 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.601 1.16 . . . . 0.0 112.348 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.96 170.43 37.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.08 158.56 43.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.882 0.841 . . . . 0.0 110.7 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.92 153.34 48.24 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.948 0.899 . . . . 0.0 109.54 169.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.35 120.62 38.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.1 tp -145.45 140.26 27.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 m -154.4 155.97 35.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.985 2.114 . . . . 0.0 105.334 169.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.39 -114.56 5.63 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -130.96 13.99 5.25 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.785 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -114.74 106.21 13.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.491 1.041 . . . . 0.0 110.407 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.7 ttp -79.16 82.56 5.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.5 -19.52 62.16 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.01 148.54 30.83 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.247 0.93 . . . . 0.0 110.573 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.9 tp -156.63 119.88 4.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.525 1.93 . . . . 0.0 105.932 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -146.03 145.08 30.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mt -151.34 142.07 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -55.55 120.03 28.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.03 -30.76 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 114.471 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.98 -24.16 67.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.9 0.33 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 118.701 0.682 . . . . 0.0 112.408 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -60.59 -38.27 84.06 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.293 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.22 -27.73 71.08 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.589 0.614 . . . . 0.0 112.742 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.35 -6.2 48.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.236 1.018 . . . . 0.0 112.14 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.61 16.1 64.59 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.292 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.38 -31.74 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.134 1.467 . . . . 0.0 111.094 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.86 -52.82 15.32 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.388 -0.674 . . . . 0.0 111.921 170.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.49 -42.92 98.53 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 117.327 -1.321 . . . . 0.0 110.291 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.6 t -58.1 -45.62 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.297 1.408 . . . . 0.0 110.011 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.3 mt -68.59 -42.23 78.53 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.855 -0.528 . . . . 0.0 110.81 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.65 -41.56 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.041 0.536 . . . . 0.0 110.024 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.2 -33.19 73.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.317 -0.864 . . . . 0.0 110.121 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.93 -46.55 88.85 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.317 0.508 . . . . 0.0 110.382 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.89 82.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.083 0.553 . . . . 0.0 111.019 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 mt -58.98 -34.82 72.26 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.102 0.961 . . . . 0.0 111.303 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.81 -32.81 74.07 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.13 0.423 . . . . 0.0 111.784 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mtm -91.45 -23.21 20.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.237 0.615 . . . . 0.0 112.148 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.53 92.47 8.12 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.548 1.539 . . . . 0.0 108.339 -172.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.49 -22.75 65.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.474 1.449 . . . . 0.0 112.35 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.22 31.69 4.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.862 1.665 . . . . 0.0 110.039 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -48.33 143.3 4.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.254 2.222 . . . . 0.0 112.843 -171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -130.49 159.18 37.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.56 1.544 . . . . 0.0 108.01 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 t -154.17 -175.41 5.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.157 0.503 . . . . 0.0 109.792 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -148.48 160.38 43.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.135 0.974 . . . . 0.0 110.609 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -157.11 147.94 10.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -72.51 132.57 44.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.98 -35.13 63.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.963 1.305 . . . . 0.0 111.939 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.11 -30.84 71.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.419 0.554 . . . . 0.0 111.771 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.442 HD22 ' CE1' ' A' ' 28' ' ' HIS . 58.9 t-20 -80.47 63.37 4.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.953 0.901 . . . . 0.0 109.374 176.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.27 -26.62 52.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.3 1.04 . . . . 0.0 111.151 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -47.44 83.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.688 0.795 . . . . 0.0 109.833 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.53 -35.01 75.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.856 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.45 -47.93 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.47 1.032 . . . . 0.0 108.444 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.07 -46.44 94.55 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.544 0.592 . . . . 0.0 111.817 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -55.14 -51.33 66.82 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 117.762 0.781 . . . . 0.0 110.008 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.23 -33.7 75.91 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.926 -0.484 . . . . 0.0 109.917 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -58.48 -47.48 83.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.433 1.015 . . . . 0.0 110.852 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.44 -42.88 88.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.951 0.796 . . . . 0.0 110.463 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.76 -37.76 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.945 0.898 . . . . 0.0 110.776 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.85 1.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.28 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -79.71 154.94 28.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.596 1.698 . . . . 0.0 111.248 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -140.79 138.51 34.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.267 1.827 . . . . 0.0 106.39 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 142' ' ' LEU . 22.0 t -71.41 134.39 30.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.935 0.894 . . . . 0.0 109.75 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 p -125.34 -9.99 6.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.453 1.901 . . . . 0.0 111.364 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.88 42.12 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 118.822 0.737 . . . . 0.0 111.565 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -152.65 -176.43 5.72 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.124 0.969 . . . . 0.0 108.839 169.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 m -131.05 162.91 28.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.329 1.452 . . . . 0.0 108.59 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -80.44 -12.41 59.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.695 0.798 . . . . 0.0 111.622 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.14 178.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.286 2.235 . . . . 0.0 106.942 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.47 -61.7 1.92 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.977 0.353 . . . . 0.0 110.175 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -161.81 -46.52 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.587 0.755 . . . . 0.0 112.482 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.72 28.77 1.26 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.661 1.184 . . . . 0.0 110.327 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.12 13.65 81.0 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.786 0.707 . . . . 0.0 113.369 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -67.07 129.79 93.9 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.665 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.11 43.94 1.49 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.817 3.011 . . . . 0.0 112.564 -170.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -138.01 82.31 25.45 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -170.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -43.4 147.58 0.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.112 3.208 . . . . 0.0 118.344 -169.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.7 148.44 23.33 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 168.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.16 148.16 41.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -120.65 138.64 53.82 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.609 1.164 . . . . 0.0 108.131 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.88 160.75 38.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.343 1.057 . . . . 0.0 108.288 -169.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.26 150.1 52.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.567 1.547 . . . . 0.0 108.536 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -75.67 124.01 26.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -130.05 -17.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.468 1.107 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.04 31.56 2.02 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.0 1.286 . . . . 0.0 113.999 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.324 1.05 . . . . 0.0 109.909 174.023 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.96 153.42 8.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 169.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mm -132.69 140.79 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -135.58 164.16 28.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 55' ' ' ALA . 15.5 mm -127.16 143.21 41.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -154.99 171.94 18.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.798 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -60.59 148.98 36.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.884 0.765 . . . . 0.0 109.082 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 p -62.84 161.62 12.41 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.764 1.626 . . . . 0.0 112.27 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -112.24 160.47 17.59 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.691 1.596 . . . . 0.0 107.251 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -69.84 -45.46 67.75 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.094 -0.378 . . . . 0.0 111.031 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.47 -27.21 65.03 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -82.82 -2.36 54.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.021 0.528 . . . . 0.0 111.483 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.34 -40.19 60.46 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.201 0.909 . . . . 0.0 112.766 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.34 -28.54 69.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.551 1.175 . . . . 0.0 111.766 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.65 -32.52 69.84 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.346 -0.846 . . . . 0.0 109.711 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.6 mt -72.81 -39.44 66.65 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.728 -0.607 . . . . 0.0 109.592 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.74 -44.78 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.205 170.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.21 93.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.363 0.665 . . . . 0.0 112.258 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.22 -48.94 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.398 1.079 . . . . 0.0 109.505 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 60.3 t90 -54.7 -44.92 73.84 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.885 -0.509 . . . . 0.0 110.396 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.84 -50.28 74.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.991 0.814 . . . . 0.0 110.832 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -68.98 -25.19 64.4 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.273 -0.892 . . . . 0.0 111.94 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.6 m -69.58 -31.89 70.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.94 0.791 . . . . 0.0 111.085 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.87 -47.16 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -58.92 -39.33 81.23 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.15 -34.23 20.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.706 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.0 p -138.41 -0.43 1.99 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -133.57 33.45 3.52 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.324 1.42 . . . . 0.0 110.812 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.06 -14.19 9.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 113.534 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.02 -27.81 63.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.222 1.809 . . . . 0.0 112.709 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.21 129.52 42.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.499 1.12 . . . . 0.0 108.917 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 p -61.85 161.97 9.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.375 0.67 . . . . 0.0 110.41 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.49 78.11 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.9 -0.5 . . . . 0.0 110.647 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.32 -50.76 68.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.398 0.679 . . . . 0.0 109.97 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.433 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 6.1 t80 -67.89 -36.93 81.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.145 -0.347 . . . . 0.0 110.103 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -55.25 -42.3 73.31 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.707 1.203 . . . . 0.0 110.732 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -72.55 -50.83 22.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 118.587 0.631 . . . . 0.0 109.658 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -69.34 -35.14 75.6 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.125 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.38 -51.47 67.43 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.121 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.48 -37.94 76.58 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.554 1.07 . . . . 0.0 110.843 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.49 -48.07 81.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.653 0.66 . . . . 0.0 111.807 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -38.11 72.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.47 -46.37 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 126.236 1.814 . . . . 0.0 109.291 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.6 ttp85 -72.34 -10.29 59.6 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 120.753 -1.217 . . . . 0.0 112.23 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -98.0 5.71 48.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 110.696 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -136.09 -56.77 0.76 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.617 -1.183 . . . . 0.0 112.724 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.39 -38.83 69.82 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 121.019 1.736 . . . . 0.0 113.246 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -61.09 -13.55 28.48 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.409 2.072 . . . . 0.0 114.845 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.38 -12.61 3.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.772 1.624 . . . . 0.0 113.272 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 153.21 91.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.227 1.411 . . . . 0.0 111.626 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 66.29 7.33 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 110.136 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.3 mt -87.58 179.08 6.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.336 1.065 . . . . 0.0 109.907 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -137.37 127.67 26.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.63 141.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.026 0.83 . . . . 0.0 110.237 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -85.05 134.77 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.94 142.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.525 HD22 ' CG1' ' A' ' 63' ' ' VAL . 16.4 p30 -85.08 -178.31 6.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.251 169.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.6 -26.38 8.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.805 1.642 . . . . 0.0 114.18 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -76.64 -3.07 35.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.31 1.044 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t0 51.48 57.98 5.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.729 1.728 . . . . 0.0 109.358 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -138.58 127.15 14.09 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.64 142.64 49.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.634 2.222 . . . . 0.0 112.396 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' CG1' HD22 ' A' ' 57' ' ' ASN . 32.3 m -124.96 -11.92 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.111 0.964 . . . . 0.0 112.596 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.22 172.13 41.46 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -148.51 159.58 43.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.331 0.566 . . . . 0.0 110.479 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.18 140.47 45.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.539 1.136 . . . . 0.0 108.125 169.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.85 113.92 25.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 tp -149.9 138.57 20.82 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.571 0.7 . . . . 0.0 109.531 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.9 m -158.5 153.7 25.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.83 23.31 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -128.93 20.53 5.93 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.49 1.116 . . . . 0.0 111.382 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -123.46 103.64 8.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.535 0.734 . . . . 0.0 109.565 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.1 ttp -85.39 80.84 8.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.95 -32.51 63.9 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -172.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.53 157.09 43.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.241 0.616 . . . . 0.0 111.037 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -155.13 123.47 5.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.064 2.146 . . . . 0.0 105.418 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -145.46 141.82 28.7 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -149.37 146.69 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -60.06 122.15 64.1 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.45 -29.8 7.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.069 3.18 . . . . 0.0 114.665 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.06 -23.86 67.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.998 0.919 . . . . 0.0 113.392 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 m -117.86 -0.27 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 118.716 0.689 . . . . 0.0 112.669 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.35 -37.03 76.83 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.918 -1.114 . . . . 0.0 110.539 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.92 68.73 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.719 0.676 . . . . 0.0 113.004 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.3 m -74.96 -6.71 50.78 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.486 1.143 . . . . 0.0 112.119 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.85 14.18 63.4 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.841 -0.977 . . . . 0.0 113.345 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.21 -31.58 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.185 1.492 . . . . 0.0 110.996 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.12 -53.44 14.98 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.881 0.753 . . . . 0.0 111.838 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.47 -41.25 96.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.138 -1.41 . . . . 0.0 110.365 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.43 -46.52 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 120.693 1.588 . . . . 0.0 110.011 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.5 -41.91 83.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.963 -0.461 . . . . 0.0 110.602 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.63 -43.24 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 118.489 0.586 . . . . 0.0 110.407 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.58 -32.51 73.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.796 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -59.59 -49.07 79.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.131 0.423 . . . . 0.0 109.991 171.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.21 81.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.878 0.471 . . . . 0.0 111.265 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.67 -35.03 75.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.802 0.841 . . . . 0.0 111.356 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.28 -35.21 79.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.29 0.495 . . . . 0.0 111.523 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtm -87.78 -24.07 23.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.421 0.688 . . . . 0.0 112.062 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.43 96.18 5.32 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.55 1.54 . . . . 0.0 108.305 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -23.72 53.11 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.198 1.265 . . . . 0.0 112.084 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.68 28.35 4.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.754 1.622 . . . . 0.0 110.654 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.3 tp -51.84 144.24 11.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 112.906 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.2 p -129.17 159.4 36.17 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 108.811 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -153.42 -179.68 7.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.865 0.466 . . . . 0.0 110.271 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -138.26 160.0 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.088 1.355 . . . . 0.0 109.185 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.446 HG12 HD21 ' A' ' 142' ' ' LEU . 7.3 p -155.84 145.89 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -70.66 131.51 44.02 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.49 -32.74 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.96 0.904 . . . . 0.0 111.583 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -66.88 -30.27 70.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.015 0.526 . . . . 0.0 111.691 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -79.65 64.19 4.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 108.795 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.83 -25.97 44.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.565 1.146 . . . . 0.0 111.151 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -49.46 75.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.465 0.706 . . . . 0.0 109.864 176.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.81 76.14 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.775 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.02 -49.09 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.415 1.007 . . . . 0.0 108.471 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.81 -47.44 91.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -54.13 -52.08 62.2 Favored 'General case' 0 C--N 1.338 0.065 0 C-N-CA 123.976 0.911 . . . . 0.0 110.124 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.65 -34.39 76.85 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.775 -0.578 . . . . 0.0 109.975 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -60.03 -46.51 89.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.52 1.055 . . . . 0.0 110.806 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.1 -43.05 86.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.093 0.86 . . . . 0.0 110.427 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.41 -34.4 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.15 0.98 . . . . 0.0 110.963 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.41 10.04 1.73 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.282 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.17 158.04 26.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.726 1.763 . . . . 0.0 111.28 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -143.04 136.22 28.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.868 1.667 . . . . 0.0 106.606 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.523 HG22 HD22 ' A' ' 142' ' ' LEU . 23.3 t -68.63 134.94 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.909 0.883 . . . . 0.0 110.353 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -128.17 -9.45 5.32 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.927 2.091 . . . . 0.0 111.578 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.86 174.52 42.83 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 170.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -159.68 -173.66 4.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.722 0.761 . . . . 0.0 110.884 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -138.15 171.78 13.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.911 2.084 . . . . 0.0 108.315 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.77 -8.02 11.43 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.998 0.919 . . . . 0.0 111.502 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 m -143.88 178.08 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.314 2.246 . . . . 0.0 106.763 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.45 -73.39 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -165.04 -40.82 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.83 1.252 . . . . 0.0 111.273 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.69 22.7 1.06 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.978 1.311 . . . . 0.0 110.65 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.46 11.03 82.69 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.55 1.072 . . . . 0.0 113.507 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.433 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 12.4 mtpp -67.92 131.06 92.54 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-O 116.427 -1.749 . . . . 0.0 108.458 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -64.73 42.38 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.986 3.79 . . . . 0.0 115.795 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.04 56.26 20.31 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.599 1.56 . . . . 0.0 110.353 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.83 161.68 24.56 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.251 2.634 . . . . 0.0 115.684 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 tp -110.04 151.02 27.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.528 1.931 . . . . 0.0 107.141 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.35 151.63 32.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 142' ' ' LEU . 14.7 t-20 -119.86 139.62 52.1 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.756 1.222 . . . . 0.0 107.844 172.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.75 161.56 36.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.706 1.203 . . . . 0.0 108.529 -171.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.92 149.32 52.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 108.396 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -73.76 132.38 42.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.52 -23.95 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.317 1.447 . . . . 0.0 109.912 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.21 -172.92 55.09 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 C-N-CA 123.942 0.897 . . . . 0.0 110.013 176.701 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.94 -179.48 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.906 1.682 . . . . 0.0 107.092 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.26 144.52 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -141.92 165.78 26.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.56 142.99 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -151.21 173.52 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.636 0.774 . . . . 0.0 110.167 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -65.73 148.75 51.25 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -73.94 146.45 43.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.242 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.16 131.88 35.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -33.32 70.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.399 0.545 . . . . 0.0 112.198 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.88 -16.66 60.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.513 0.725 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -86.85 -2.57 58.68 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.379 0.99 . . . . 0.0 111.217 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.59 -38.28 28.23 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.79 1.185 . . . . 0.0 114.186 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.91 -28.5 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.769 1.285 . . . . 0.0 111.818 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -69.11 -31.53 70.29 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.465 -0.772 . . . . 0.0 109.702 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.7 -38.86 64.73 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.8 -47.16 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.42 83.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.556 0.616 . . . . 0.0 111.721 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.2 mt -65.16 -50.87 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.406 1.082 . . . . 0.0 109.449 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -57.13 -46.89 82.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.702 0.683 . . . . 0.0 110.49 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.3 m -55.32 -52.76 62.43 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.745 1.218 . . . . 0.0 111.005 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -69.97 -29.17 66.22 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.473 -0.767 . . . . 0.0 112.041 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -63.07 -42.46 99.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.962 0.801 . . . . 0.0 110.117 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.9 t -70.27 -42.93 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -34.49 73.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.902 0.773 . . . . 0.0 112.306 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.74 -34.47 21.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.992 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -137.13 -0.14 2.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -130.67 22.57 5.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.403 1.456 . . . . 0.0 110.63 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.67 -10.89 14.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -169.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -29.8 65.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.942 1.297 . . . . 0.0 111.618 169.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.5 tp -53.22 125.35 17.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.125 2.17 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -53.09 140.0 26.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.01 1.324 . . . . 0.0 110.704 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.17 76.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.92 -49.87 64.18 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.48 -35.31 77.35 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 122.081 -0.387 . . . . 0.0 110.404 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -57.19 -44.65 83.8 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.5 m -64.69 -48.64 73.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.711 0.687 . . . . 0.0 110.145 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.17 -37.3 83.51 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.009 -0.432 . . . . 0.0 110.819 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.41 -51.27 69.46 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.258 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.59 -41.07 76.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.688 1.131 . . . . 0.0 110.659 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.74 -47.45 81.0 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.775 0.43 . . . . 0.0 111.824 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -36.59 72.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.949 0.34 . . . . 0.0 110.323 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 t -58.26 -48.69 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.257 1.823 . . . . 0.0 109.064 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -69.76 -10.33 57.95 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.095 -1.003 . . . . 0.0 112.639 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -99.5 5.94 46.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.79 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -136.06 -56.28 0.77 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.451 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.73 -39.34 75.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 120.643 1.565 . . . . 0.0 112.844 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -61.63 -15.51 42.29 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.065 1.844 . . . . 0.0 115.073 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -127.6 -14.24 5.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.45 1.477 . . . . 0.0 112.852 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.85 153.39 88.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.128 1.371 . . . . 0.0 111.475 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -77.54 62.51 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.743 3.629 . . . . 0.0 110.972 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.18 176.74 7.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.098 1.359 . . . . 0.0 111.462 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.02 150.84 50.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.124 2.57 . . . . 0.0 104.868 168.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.69 140.48 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 123.942 0.897 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.36 132.7 35.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.88 142.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -82.87 -177.26 6.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.442 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -49.74 -24.27 2.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.488 1.915 . . . . 0.0 114.488 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -84.41 2.19 41.84 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t0 50.46 58.21 5.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 123.512 1.625 . . . . 0.0 108.77 -169.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.08 124.52 15.35 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.48 138.63 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.65 2.233 . . . . 0.0 109.727 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.36 -12.11 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.27 1.028 . . . . 0.0 112.289 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.03 170.15 40.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.83 159.01 43.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.027 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -140.8 126.78 19.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.302 2.241 . . . . 0.0 105.717 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 74' ' ' ASP . 25.7 tp -105.27 124.65 49.9 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -145.95 139.67 26.36 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -153.44 154.57 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.79 5.87 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -132.27 29.07 4.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.609 1.164 . . . . 0.0 110.455 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -125.5 112.03 15.75 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.425 -0.797 . . . . 0.0 110.601 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.5 ttp -85.09 86.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' HB3' HD23 ' A' ' 67' ' ' LEU . 31.2 t70 -63.48 -28.91 70.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.45 144.58 31.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.008 0.523 . . . . 0.0 110.217 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 tp -153.66 114.58 4.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -142.36 141.05 32.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.5 mt -148.43 145.43 18.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -58.23 122.24 57.6 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.154 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.2 -29.81 7.05 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.192 3.262 . . . . 0.0 114.723 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.74 -23.41 67.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.122 0.969 . . . . 0.0 113.537 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.45 2.73 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.788 0.722 . . . . 0.0 112.827 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -58.99 -37.6 77.21 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.897 -1.127 . . . . 0.0 110.506 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.99 -25.59 69.51 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.71 0.671 . . . . 0.0 113.039 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.9 m -74.79 -7.34 53.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.515 1.158 . . . . 0.0 112.03 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.91 13.97 63.62 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.335 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.72 -31.69 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.288 1.544 . . . . 0.0 110.925 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.47 -52.85 18.13 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 123.819 0.723 . . . . 0.0 111.754 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -62.94 -42.38 99.79 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.356 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 t -58.55 -46.29 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.055 1.298 . . . . 0.0 109.82 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.9 mt -70.4 -39.33 74.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.215 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.15 -40.69 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.83 0.741 . . . . 0.0 109.925 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.04 -37.7 88.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.195 0.907 . . . . 0.0 109.71 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.05 -47.94 84.05 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.819 0.448 . . . . 0.0 110.439 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.93 -49.07 77.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.583 0.753 . . . . 0.0 110.739 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -60.09 -33.06 71.57 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.401 1.08 . . . . 0.0 111.734 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.5 -32.71 73.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.475 0.58 . . . . 0.0 111.625 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -90.06 -24.82 21.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.435 0.561 . . . . 0.0 112.074 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.06 93.35 9.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.287 1.435 . . . . 0.0 108.713 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.46 -23.39 50.68 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.342 1.361 . . . . 0.0 112.654 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.61 30.39 4.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.67 1.588 . . . . 0.0 110.219 -174.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.3 tp -51.42 145.76 8.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.195 2.198 . . . . 0.0 113.185 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -128.53 163.9 23.97 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.511 1.524 . . . . 0.0 108.912 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -153.75 -175.15 5.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 110.149 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -146.75 161.12 41.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.158 0.983 . . . . 0.0 109.824 172.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.431 HG12 HD21 ' A' ' 142' ' ' LEU . 10.0 p -156.21 149.06 11.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -80.04 129.72 34.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.2 -27.01 53.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.806 2.043 . . . . 0.0 111.974 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . 0.251 1.2 pt20 -51.48 -33.36 31.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.113 0.965 . . . . 0.0 112.651 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -105.71 69.51 0.83 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.132 1.373 . . . . 0.0 109.621 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.76 -23.99 32.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.894 0.877 . . . . 0.0 111.987 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -63.43 -43.93 96.04 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.454 0.702 . . . . 0.0 109.662 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.669 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.03 -45.81 84.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 119.206 0.912 . . . . 0.0 108.945 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.25 59.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.05 -50.73 66.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 117.811 0.805 . . . . 0.0 110.601 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.22 -39.07 93.58 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.84 -33.94 76.29 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.631 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.85 -40.24 94.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.022 1.283 . . . . 0.0 110.919 174.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.8 -39.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.9 11.81 0.69 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-O 118.825 -0.986 . . . . 0.0 114.112 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -72.97 160.83 31.49 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.635 1.718 . . . . 0.0 111.189 172.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -149.72 141.18 23.34 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.884 1.674 . . . . 0.0 106.884 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.576 HG22 HD22 ' A' ' 142' ' ' LEU . 30.9 t -71.43 133.05 32.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.972 0.909 . . . . 0.0 109.436 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 p -127.11 -8.1 5.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.671 1.989 . . . . 0.0 111.492 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.82 170.71 40.73 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 111.761 171.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -142.62 164.53 29.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.815 1.246 . . . . 0.0 111.279 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -124.15 167.92 13.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.141 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.64 -10.93 24.2 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.754 -0.591 . . . . 0.0 111.296 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.6 m -149.91 177.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 127.794 2.438 . . . . 0.0 106.918 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.94 -60.6 2.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.876 -0.106 . . . . 0.0 110.938 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -160.4 -38.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 98.0 mt -109.37 32.97 4.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.851 1.26 . . . . 0.0 110.501 -172.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.85 11.74 84.9 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.511 0.577 . . . . 0.0 113.096 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -75.37 134.25 73.66 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-O 117.563 -1.208 . . . . 0.0 108.366 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.71 50.12 3.33 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.87 3.047 . . . . 0.0 112.342 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.49 83.04 26.59 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.58 154.96 18.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.793 1.662 . . . . 0.0 115.625 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.45 145.56 26.08 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.0 mt -114.68 144.66 43.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.8 t-20 -113.91 139.09 49.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.99 161.54 35.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -134.07 147.52 50.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.673 1.589 . . . . 0.0 108.292 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -75.8 125.91 29.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.04 -0.16 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 111.389 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.69 -25.87 71.84 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.054 0.835 . . . . 0.0 113.26 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.944 1.297 . . . . 0.0 110.532 179.094 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -61.16 152.82 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.0 109.584 175.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -136.48 141.16 41.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.354 1.061 . . . . 0.0 108.232 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -141.63 163.38 33.09 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -124.64 144.25 35.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -150.46 170.98 17.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.414 1.086 . . . . 0.0 109.272 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -65.35 148.69 51.27 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 m -72.73 152.48 41.62 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.049 0.94 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -98.24 164.09 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 107.919 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -66.99 -39.4 87.14 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.158 -0.339 . . . . 0.0 111.048 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.99 -26.78 66.08 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.72 -0.32 56.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.212 0.46 . . . . 0.0 112.073 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.45 27.67 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.014 0.816 . . . . 0.0 113.455 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.35 -27.18 67.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.261 1.031 . . . . 0.0 112.119 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -68.04 -33.08 73.9 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.394 -0.816 . . . . 0.0 109.572 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.56 -38.54 62.68 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.03 -46.6 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.78 98.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.374 0.67 . . . . 0.0 112.076 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.6 mt -65.41 -49.7 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.285 1.034 . . . . 0.0 109.574 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -52.02 -48.45 64.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.96 0.504 . . . . 0.0 110.004 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 t -61.18 -50.83 71.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.036 0.534 . . . . 0.0 110.16 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -67.63 -28.78 68.02 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.956 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -68.39 -35.87 78.31 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.511 1.05 . . . . 0.0 110.689 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.88 -43.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.28 -26.88 63.07 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 113.345 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.28 16.56 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.984 0.914 . . . . 0.0 111.931 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -133.42 -7.14 2.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -169.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.3 30.26 5.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.225 1.375 . . . . 0.0 109.512 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.51 -18.16 50.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -51.22 -27.37 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.306 1.842 . . . . 0.0 112.303 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 102.89 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.087 1.755 . . . . 0.0 108.912 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -57.02 149.08 19.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.078 1.751 . . . . 0.0 112.546 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.54 70.69 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.61 -45.76 85.5 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.915 -0.491 . . . . 0.0 109.83 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.81 -32.95 62.12 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.944 -0.472 . . . . 0.0 110.241 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -53.94 -43.0 69.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.144 0.977 . . . . 0.0 110.235 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.6 m -62.31 -50.68 70.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.504 1.121 . . . . 0.0 110.153 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -65.03 -39.31 93.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.445 0.298 . . . . 0.0 110.373 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.27 -53.13 59.56 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.462 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -57.08 -39.99 76.05 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.683 1.129 . . . . 0.0 110.484 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.34 -48.92 73.73 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.124 0.569 . . . . 0.0 112.012 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -36.76 75.11 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.076 0.398 . . . . 0.0 110.296 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -58.64 -48.63 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 126.29 1.836 . . . . 0.0 109.023 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.54 -11.59 60.95 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.978 -1.076 . . . . 0.0 112.679 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -97.17 5.64 49.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.742 0.817 . . . . 0.0 110.652 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.4 -54.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.86 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.61 -38.65 69.8 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 120.674 1.579 . . . . 0.0 112.938 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.23 -13.34 31.66 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.407 2.072 . . . . 0.0 115.02 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -125.82 -20.71 4.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.946 1.703 . . . . 0.0 112.393 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.19 148.72 97.72 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.516 1.127 . . . . 0.0 110.69 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.17 45.51 1.99 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.727 3.618 . . . . 0.0 112.091 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.81 171.05 4.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.457 1.503 . . . . 0.0 112.187 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -119.44 148.52 43.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.541 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.67 137.69 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.351 1.06 . . . . 0.0 110.122 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.41 133.99 35.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.63 145.4 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -88.03 -171.67 3.49 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.479 169.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.73 -23.57 29.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.926 1.29 . . . . 0.0 113.47 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -82.93 5.33 22.28 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.679 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 53.9 30.47 11.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.934 1.693 . . . . 0.0 111.112 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.49 128.06 27.73 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 126.927 2.091 . . . . 0.0 106.22 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.62 136.19 35.44 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.727 1.618 . . . . 0.0 109.52 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.15 -14.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.354 1.062 . . . . 0.0 111.185 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.72 170.81 42.99 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.14 160.28 40.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.741 0.816 . . . . 0.0 111.257 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -139.83 132.23 28.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.574 2.35 . . . . 0.0 105.967 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 74' ' ' ASP . 27.0 tp -112.19 124.2 51.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 169.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.74 133.02 23.17 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 m -142.23 150.7 41.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.08 -113.64 4.24 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.4 29.75 4.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.781 1.232 . . . . 0.0 110.596 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -126.82 111.87 14.69 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.591 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.2 ttp -82.74 88.81 6.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' HB3' HD23 ' A' ' 67' ' ' LEU . 31.7 t70 -66.06 -29.52 69.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.68 145.43 32.44 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.851 0.46 . . . . 0.0 110.667 -172.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.72 115.55 3.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.11 139.4 28.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.8 mt -150.02 144.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -170.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.29 123.61 76.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 108.826 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.8 -19.08 66.44 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.005 2.47 . . . . 0.0 113.832 -171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.5 -21.06 63.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.801 1.182 . . . . 0.0 112.299 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.68 3.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.807 0.843 . . . . 0.0 112.841 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.24 -29.86 58.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.122 -0.986 . . . . 0.0 111.756 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.85 -21.0 50.62 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.316 0.96 . . . . 0.0 113.823 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 66.8 m -73.74 -3.77 30.44 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.023 1.412 . . . . 0.0 112.266 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.01 12.96 75.76 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.276 0.941 . . . . 0.0 112.869 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.85 -33.03 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.485 1.143 . . . . 0.0 111.579 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.53 -50.52 47.96 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -38.7 88.65 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.295 1.047 . . . . 0.0 109.87 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -58.43 -49.59 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.624 1.102 . . . . 0.0 109.916 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.1 mt -67.76 -39.35 84.18 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.849 -0.532 . . . . 0.0 110.707 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.93 -39.74 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.933 -0.556 . . . . 0.0 109.8 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.67 -35.66 81.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.789 1.177 . . . . 0.0 110.388 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -61.23 -45.72 93.37 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.195 0.452 . . . . 0.0 110.3 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.17 74.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.846 0.858 . . . . 0.0 110.744 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.3 -33.29 69.29 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.77 1.228 . . . . 0.0 111.697 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.39 -31.9 72.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.361 0.528 . . . . 0.0 111.637 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 mtm -90.39 -25.51 20.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.157 0.583 . . . . 0.0 112.091 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.97 91.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 125.276 1.43 . . . . 0.0 108.863 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.09 -23.25 53.59 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.362 1.375 . . . . 0.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.48 29.46 4.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.595 1.558 . . . . 0.0 110.444 -174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.37 145.37 8.49 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.03 2.132 . . . . 0.0 113.327 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.9 p -128.03 164.77 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.545 1.538 . . . . 0.0 108.937 170.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.1 t -154.99 -174.15 4.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 110.354 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -146.96 161.97 39.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 109.799 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.497 HG12 HD21 ' A' ' 142' ' ' LEU . 8.4 p -156.13 146.22 12.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.59 133.93 47.16 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.0 -36.17 83.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 112.514 -172.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -35.5 77.42 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.196 0.907 . . . . 0.0 110.914 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.49 70.51 7.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.617 0.722 . . . . 0.0 111.037 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.43 -23.04 35.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.756 0.822 . . . . 0.0 112.074 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -63.61 -45.66 89.31 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.794 0.724 . . . . 0.0 109.593 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.11 -34.58 75.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.878 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.26 -46.06 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.374 0.988 . . . . 0.0 108.895 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.4 -48.16 84.26 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.649 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -54.18 -51.94 62.77 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.128 0.971 . . . . 0.0 110.144 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -64.94 -36.67 85.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -64.36 -40.82 96.6 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.063 -1.023 . . . . 0.0 112.718 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.75 -42.87 89.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.742 1.155 . . . . 0.0 110.255 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.31 -35.19 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.67 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.89 7.82 1.31 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.701 1.143 . . . . 0.0 114.904 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -77.1 164.78 25.38 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.132 1.966 . . . . 0.0 111.72 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -147.59 139.58 24.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.414 1.885 . . . . 0.0 106.218 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 142' ' ' LEU . 32.0 t -72.88 132.98 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -172.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.23 -10.05 7.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.728 2.011 . . . . 0.0 111.417 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.87 178.99 42.5 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.786 0.721 . . . . 0.0 111.44 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -155.82 -178.02 6.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.129 0.971 . . . . 0.0 109.214 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -139.68 146.65 39.92 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.144 1.378 . . . . 0.0 108.892 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.45 -11.46 60.47 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.874 0.869 . . . . 0.0 112.226 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -137.89 178.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.678 1.991 . . . . 0.0 106.963 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -80.96 -65.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -161.07 -37.43 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.733 0.813 . . . . 0.0 113.024 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.01 28.81 4.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.732 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.35 44.2 97.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.741 0.686 . . . . 0.0 111.737 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -126.97 121.54 22.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 107.983 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -60.43 71.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 1 C-N-CA 125.471 4.114 . . . . 0.0 116.419 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -134.54 63.56 60.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -36.22 143.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.492 4.128 . . . . 0.0 118.223 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.56 144.49 36.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.1 151.55 27.09 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.562 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.4 t-20 -119.63 139.52 52.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.608 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.23 160.78 38.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.852 0.861 . . . . 0.0 108.733 -172.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.7 149.95 51.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.555 1.542 . . . . 0.0 108.575 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.44 133.89 39.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.92 -25.69 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.97 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.27 -178.78 38.84 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.299 1.84 . . . . 0.0 107.725 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.17 143.1 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -135.96 146.4 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.899 1.28 . . . . 0.0 107.603 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -142.92 165.03 28.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 mm -121.67 142.46 37.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -150.19 172.8 14.73 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.876 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -65.5 147.77 52.85 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -73.89 146.74 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.004 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -84.8 160.21 20.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -66.87 -45.48 77.96 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.232 -0.293 . . . . 0.0 110.283 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.34 -28.54 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -83.07 0.93 42.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.915 0.486 . . . . 0.0 111.387 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.07 -45.19 33.37 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.298 0.951 . . . . 0.0 113.617 -176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.69 -21.83 63.47 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.499 1.15 . . . . 0.0 112.565 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -66.29 -33.33 75.5 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.757 1.162 . . . . 0.0 109.564 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.87 -39.49 56.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.45 -45.52 85.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.54 -44.71 95.67 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.142 0.577 . . . . 0.0 111.336 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.86 -52.56 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.47 1.108 . . . . 0.0 108.607 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -53.03 -48.79 67.33 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.589 0.756 . . . . 0.0 110.149 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.8 t -60.16 -50.17 74.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.283 0.633 . . . . 0.0 110.434 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -72.85 -31.39 64.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.154 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -61.19 -43.75 98.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.458 1.026 . . . . 0.0 110.372 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.39 -48.48 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.901 0.88 . . . . 0.0 109.053 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.02 -32.94 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 112.269 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.99 58.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.29 1.036 . . . . 0.0 113.341 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -134.81 -25.55 1.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -169.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.449 ' CD2' HD22 ' A' ' 110' ' ' ASN . 38.5 m-70 -104.09 35.84 2.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.846 1.258 . . . . 0.0 108.476 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.4 -26.81 63.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.805 -1.184 . . . . 0.0 112.428 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -56.49 -24.14 44.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.288 2.235 . . . . 0.0 113.515 173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.79 109.4 1.72 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.012 1.325 . . . . 0.0 107.934 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -58.1 141.84 48.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 111.173 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.72 65.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.932 0.893 . . . . 0.0 113.006 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.57 -45.0 96.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.389 0.676 . . . . 0.0 109.907 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CD1' ' HE3' ' A' ' 135' ' ' LYS . 8.7 t80 -77.9 -29.09 50.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.531 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -56.74 -42.9 80.08 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.491 1.496 . . . . 0.0 110.318 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -63.93 -49.61 71.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.859 0.864 . . . . 0.0 109.862 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -67.33 -36.11 80.78 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.017 -0.427 . . . . 0.0 110.986 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.0 mt -63.52 -49.63 72.75 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.446 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.91 -42.24 75.73 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 119.957 1.253 . . . . 0.0 109.769 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.85 -48.34 82.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.584 1.084 . . . . 0.0 112.446 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.52 74.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.81 -44.43 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.185 1.794 . . . . 0.0 110.117 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -62.94 -24.02 67.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.602 1.161 . . . . 0.0 111.134 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -97.93 7.79 45.79 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.549 1.14 . . . . 0.0 110.662 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -138.12 -59.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.547 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.6 -36.52 46.47 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 121.228 1.831 . . . . 0.0 113.113 -175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 -15.03 34.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 121.942 1.762 . . . . 0.0 115.419 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.61 -11.79 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.938 1.699 . . . . 0.0 113.455 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.8 154.85 88.02 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.408 1.483 . . . . 0.0 111.988 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.86 60.67 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.961 3.774 . . . . 0.0 111.733 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -87.24 172.99 9.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.434 1.893 . . . . 0.0 112.213 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -135.2 145.83 48.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.14 140.21 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.825 0.85 . . . . 0.0 110.41 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.88 134.42 35.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.31 144.09 38.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -83.77 -172.95 4.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -55.2 -24.36 26.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.033 1.333 . . . . 0.0 113.311 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -84.2 0.8 47.34 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.479 1.111 . . . . 0.0 111.831 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t0 52.24 53.87 11.7 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.013 1.387 . . . . 0.0 109.524 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.05 125.28 22.75 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.71 134.25 37.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.545 2.163 . . . . 0.0 110.881 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.39 -11.46 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.192 0.997 . . . . 0.0 111.981 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.65 169.25 41.94 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -139.79 160.92 38.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.709 0.754 . . . . 0.0 111.603 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -139.85 131.34 27.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.593 2.357 . . . . 0.0 105.949 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.84 116.46 28.04 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -144.04 132.97 22.68 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.4 m -141.97 152.97 43.96 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.8 -118.62 11.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -129.28 30.94 4.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.159 0.984 . . . . 0.0 111.022 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -122.87 112.74 18.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.253 0.621 . . . . 0.0 110.153 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -85.1 90.75 7.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.68 -26.42 67.78 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.32 144.99 30.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.043 0.537 . . . . 0.0 110.734 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -153.54 119.4 5.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -145.09 143.23 30.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -143.96 143.66 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -54.31 120.95 28.7 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.088 1.755 . . . . 0.0 109.407 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.03 -24.89 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.215 3.277 . . . . 0.0 114.919 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.11 -26.97 68.03 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.57 9.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.429 . . . . 0.0 112.54 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.88 -34.83 63.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.667 -1.271 . . . . 0.0 112.392 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.17 -13.59 81.73 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.165 -0.797 . . . . 0.0 113.244 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.14 173.68 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 0.0 110.08 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.51 -11.09 39.78 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.959 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -51.47 -34.42 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.601 1.701 . . . . 0.0 112.01 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.42 -54.64 19.59 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -65.54 -40.37 92.81 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.455 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.66 -48.39 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 121.186 1.812 . . . . 0.0 109.977 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -68.05 -40.99 82.68 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.973 -0.455 . . . . 0.0 110.701 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.296 0.498 . . . . 0.0 110.205 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.52 -34.07 75.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.325 0.966 . . . . 0.0 110.1 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -60.6 -46.33 90.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.338 0.517 . . . . 0.0 110.198 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.94 72.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.377 0.671 . . . . 0.0 110.822 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -58.77 -33.34 70.19 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.359 1.064 . . . . 0.0 111.734 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.1 m -62.95 -35.45 80.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.585 0.63 . . . . 0.0 111.503 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.41 -26.46 26.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.26 0.482 . . . . 0.0 111.86 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 89.91 12.08 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 125.101 1.36 . . . . 0.0 109.294 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.47 -22.78 58.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.468 1.446 . . . . 0.0 113.059 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.02 31.49 4.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.441 1.496 . . . . 0.0 110.095 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -50.3 143.99 7.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.232 2.213 . . . . 0.0 112.9 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.7 p -129.62 163.25 26.45 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.404 1.482 . . . . 0.0 108.778 171.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -154.78 -174.46 4.99 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.166 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.57 161.45 41.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 110.018 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG12 HD21 ' A' ' 142' ' ' LEU . 9.7 p -157.17 145.44 10.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.0 129.29 39.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -58.39 -30.88 67.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.18 1.392 . . . . 0.0 111.941 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.51 -35.28 78.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.203 0.456 . . . . 0.0 111.224 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.449 HD22 ' CD2' ' A' ' 28' ' ' HIS . 61.6 t-20 -78.6 63.8 3.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.039 1.336 . . . . 0.0 109.882 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.74 -26.8 47.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 111.394 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -45.25 94.3 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.94 73.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.88 -45.96 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.396 0.998 . . . . 0.0 108.828 171.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.8 83.07 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.58 -51.59 64.8 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.022 0.911 . . . . 0.0 110.379 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.53 -35.02 79.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -64.91 -38.95 92.66 Favored 'General case' 0 C--N 1.341 0.205 0 O-C-N 120.916 -1.115 . . . . 0.0 112.632 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.28 -41.37 88.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.956 1.253 . . . . 0.0 110.329 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.78 -39.36 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.794 . . . . 0.0 110.309 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.41 5.18 0.98 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.542 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.99 162.92 28.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.355 1.577 . . . . 0.0 111.169 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.77 140.01 25.53 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 142' ' ' LEU . 41.3 t -73.11 129.31 36.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.984 0.914 . . . . 0.0 109.16 -173.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 p -119.54 -9.88 9.74 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.599 1.959 . . . . 0.0 111.397 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -170.87 -179.29 42.01 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 171.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.31 179.08 8.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.679 0.792 . . . . 0.0 109.271 170.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m -138.71 138.2 37.49 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 0.0 106.893 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.12 -5.77 34.14 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.213 0.605 . . . . 0.0 112.389 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.1 m -138.5 174.42 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.305 1.842 . . . . 0.0 107.836 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.1 -63.58 1.32 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 119.486 -0.292 . . . . 0.0 110.93 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.17 -49.26 0.07 Allowed 'General case' 0 C--N 1.341 0.232 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.18 32.6 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.353 1.061 . . . . 0.0 110.032 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.17 14.32 73.81 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.044 0.83 . . . . 0.0 113.268 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 43.2 mmtt -67.57 132.68 92.8 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 117.053 -1.451 . . . . 0.0 108.363 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.09 46.09 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.677 2.918 . . . . 0.0 112.195 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -131.71 71.97 80.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.564 1.545 . . . . 0.0 107.682 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -34.26 147.2 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.613 1 C-N-CA 125.922 4.414 . . . . 0.0 119.09 -169.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.0 tp -102.18 147.62 26.42 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.9 mt -110.85 150.49 29.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.537 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.5 t-20 -116.88 139.08 51.04 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.94 160.57 38.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.3 150.56 52.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.431 1.492 . . . . 0.0 108.195 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -75.12 128.26 35.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -129.85 -9.25 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.664 1.186 . . . . 0.0 109.925 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.0 37.52 92.13 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 C-N-CA 124.834 1.254 . . . . 0.0 111.011 179.487 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttp . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.924 0.392 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.36 156.88 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 mm -132.96 144.34 36.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.621 0.768 . . . . 0.0 109.348 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -141.6 164.49 30.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 mm -124.33 143.77 36.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -151.91 172.39 16.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.68 1.192 . . . . 0.0 109.162 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -66.68 149.82 49.96 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -71.34 154.11 41.83 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.482 1.113 . . . . 0.0 111.721 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -97.66 163.68 12.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.816 1.646 . . . . 0.0 108.258 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -69.17 -48.31 62.6 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.282 -0.261 . . . . 0.0 110.742 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.52 -28.62 67.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.79 -1.91 40.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.86 -38.19 37.04 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.25 0.929 . . . . 0.0 113.503 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.76 -28.44 67.62 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.58 1.19 . . . . 0.0 111.919 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.4 -30.73 69.71 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.89 -39.36 61.54 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -56.88 -45.64 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.34 98.01 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.884 0.474 . . . . 0.0 111.884 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mt -62.41 -48.45 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.345 0.658 . . . . 0.0 109.678 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -54.49 -48.42 71.88 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -59.29 -42.08 90.46 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.866 -0.521 . . . . 0.0 110.596 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -62.63 -39.79 94.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.47 1.108 . . . . 0.0 111.718 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -65.78 -36.52 83.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.572 0.749 . . . . 0.0 109.969 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.59 -45.81 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.254 -0.903 . . . . 0.0 109.127 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.26 -33.8 65.8 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.948 1.299 . . . . 0.0 113.004 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.11 -29.48 12.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -139.28 0.6 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -168.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -135.17 25.79 3.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.429 1.468 . . . . 0.0 110.963 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.58 -12.8 17.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.874 -1.141 . . . . 0.0 113.196 -174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -56.21 -20.34 17.74 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.325 1.85 . . . . 0.0 112.904 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.94 101.84 0.42 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.08 1.352 . . . . 0.0 108.8 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -56.69 157.71 5.18 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.342 1.457 . . . . 0.0 110.729 170.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 -37.9 63.59 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.88 -49.75 64.66 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.905 0.775 . . . . 0.0 109.701 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -63.72 -40.19 96.13 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.233 1.013 . . . . 0.0 109.956 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -55.58 -50.23 70.64 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.838 1.255 . . . . 0.0 109.614 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.1 m -64.1 -48.33 76.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.303 1.041 . . . . 0.0 110.274 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.46 -41.31 93.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.188 0.449 . . . . 0.0 110.723 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.99 -50.53 65.95 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.595 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.36 -41.94 76.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.061 0.846 . . . . 0.0 110.684 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.34 -44.51 83.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.452 0.701 . . . . 0.0 112.225 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.32 -38.24 74.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -56.8 -49.41 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.493 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -58.39 -24.27 59.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.646 1.178 . . . . 0.0 111.674 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -101.46 6.49 42.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.179 0.992 . . . . 0.0 110.959 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -136.89 -52.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.306 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -58.36 -37.89 59.78 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.265 1.393 . . . . 0.0 113.001 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -63.42 -14.01 39.68 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.129 1.886 . . . . 0.0 115.426 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -127.98 -19.01 4.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.042 1.746 . . . . 0.0 112.463 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.38 148.43 96.17 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.256 1.022 . . . . 0.0 110.416 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.43 43.74 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.748 3.632 . . . . 0.0 112.102 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.83 169.96 7.27 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.52 1.528 . . . . 0.0 112.07 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -113.27 149.54 33.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 138.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 110.238 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.93 132.35 35.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.64 141.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.59 -179.51 7.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.342 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -51.26 -25.67 6.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.594 1.558 . . . . 0.0 114.22 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -79.39 0.14 30.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.171 0.989 . . . . 0.0 111.773 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t0 52.01 56.97 7.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 123.34 1.543 . . . . 0.0 109.216 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -136.95 126.75 15.72 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.8 137.3 38.0 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.904 2.403 . . . . 0.0 111.695 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.6 m -113.82 -21.36 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.115 0.966 . . . . 0.0 111.68 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.84 170.61 39.2 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -141.44 157.43 45.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.855 0.862 . . . . 0.0 110.686 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -141.38 134.29 28.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.788 2.035 . . . . 0.0 106.668 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 74' ' ' ASP . 24.0 tp -115.91 118.2 32.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.8 tp -142.07 133.49 26.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.215 1.006 . . . . 0.0 108.298 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -143.45 153.87 43.09 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.25 -119.48 13.58 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.52 37.12 4.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.194 0.998 . . . . 0.0 110.478 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -127.27 109.1 11.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.824 0.85 . . . . 0.0 110.066 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -85.45 97.41 10.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.437 ' HB3' HD23 ' A' ' 67' ' ' LEU . 32.3 t70 -71.47 -31.73 67.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.9 23.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.689 0.796 . . . . 0.0 110.282 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 tp -148.08 122.85 9.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 173.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.38 142.63 30.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 mt -148.55 144.37 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -61.07 115.33 13.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.19 -15.03 26.59 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.785 2.323 . . . . 0.0 114.364 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.83 -24.37 67.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.821 0.737 . . . . 0.0 112.554 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.32 -9.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 112.928 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -47.24 -46.43 24.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.581 1.152 . . . . 0.0 111.237 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.26 -14.52 71.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.884 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 72.0 m -68.91 -14.39 63.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.246 1.523 . . . . 0.0 112.062 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.52 -7.76 7.9 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.309 0.956 . . . . 0.0 112.589 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.73 -31.52 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.744 1.272 . . . . 0.0 111.059 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.74 -50.45 37.2 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.573 0.606 . . . . 0.0 111.895 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.22 -46.83 79.07 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.842 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.71 -49.28 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.646 1.112 . . . . 0.0 110.288 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.24 -36.81 74.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.118 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.98 -40.56 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.03 0.832 . . . . 0.0 109.789 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.67 -36.11 83.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.409 1.004 . . . . 0.0 110.02 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -61.5 -48.24 81.97 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.871 0.469 . . . . 0.0 110.3 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.59 76.03 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.511 0.724 . . . . 0.0 110.87 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.67 -33.37 70.04 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.697 1.199 . . . . 0.0 111.696 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -62.84 -35.03 78.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.583 0.629 . . . . 0.0 111.465 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.8 mtm -86.13 -24.39 26.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.381 0.537 . . . . 0.0 112.013 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.77 91.05 9.42 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.866 1.266 . . . . 0.0 109.899 -171.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.65 -23.86 48.74 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.341 1.361 . . . . 0.0 113.273 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -103.39 30.92 4.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.428 1.491 . . . . 0.0 110.292 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.3 tp -50.86 146.57 5.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.559 2.343 . . . . 0.0 113.673 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.7 p -128.32 162.23 27.55 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 108.92 169.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -155.31 -179.29 7.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.788 0.435 . . . . 0.0 111.108 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -137.19 155.14 49.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 142' ' ' LEU . 10.3 p -155.41 148.61 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -74.54 134.09 42.22 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.88 -35.31 68.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.682 1.193 . . . . 0.0 112.069 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -64.11 -29.69 70.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.415 0.552 . . . . 0.0 111.873 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -79.78 65.81 5.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.69 -25.68 60.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.746 0.818 . . . . 0.0 111.342 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.58 -47.71 82.63 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.006 0.522 . . . . 0.0 109.897 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.85 80.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.592 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.0 -46.28 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 119.179 0.9 . . . . 0.0 108.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.18 -49.88 67.64 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -55.25 -49.76 71.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.932 0.893 . . . . 0.0 110.524 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.45 -36.1 81.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.56 -39.23 93.37 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.83 -1.169 . . . . 0.0 112.526 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.32 -42.94 92.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.863 1.21 . . . . 0.0 110.218 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.68 -34.32 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.847 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.53 7.53 1.88 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.394 0.997 . . . . 0.0 114.361 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -73.39 166.39 23.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.779 1.79 . . . . 0.0 111.518 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -143.42 140.57 30.48 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.142 2.177 . . . . 0.0 105.969 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.617 HG22 HD22 ' A' ' 142' ' ' LEU . 40.3 t -72.44 129.54 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.6 p -130.85 -6.64 4.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.054 1.742 . . . . 0.0 111.338 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.34 178.57 38.08 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -157.78 -172.33 3.9 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.733 0.813 . . . . 0.0 109.918 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.1 m -138.35 166.76 23.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.315 1.846 . . . . 0.0 108.94 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.16 -9.07 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.786 0.834 . . . . 0.0 111.507 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.74 178.36 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.916 2.486 . . . . 0.0 106.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.47 -66.18 0.87 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.185 0.448 . . . . 0.0 110.223 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -161.73 -45.61 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.508 0.723 . . . . 0.0 112.335 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.89 29.62 0.8 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.774 1.23 . . . . 0.0 110.093 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.0 14.65 73.62 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.484 1.04 . . . . 0.0 113.422 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -68.23 129.21 93.03 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 117.126 -1.416 . . . . 0.0 107.934 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.04 45.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.777 2.985 . . . . 0.0 112.227 -172.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.18 79.96 24.71 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -42.31 146.92 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.698 3.599 . . . . 0.0 118.829 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -97.45 149.42 22.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.0 mt -116.64 152.92 33.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.555 ' C ' HD23 ' A' ' 142' ' ' LEU . 17.4 t-20 -120.99 139.78 52.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.704 1.202 . . . . 0.0 107.874 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.35 157.71 46.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -170.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.34 150.87 52.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.988 1.315 . . . . 0.0 108.41 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.13 130.69 37.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -129.6 -10.98 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.486 1.515 . . . . 0.0 109.823 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.72 -27.38 70.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.216 0.912 . . . . 0.0 113.76 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 124.675 1.19 . . . . 0.0 110.527 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 ttp . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.17 159.88 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 110.504 169.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -138.63 144.98 28.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.636 1.174 . . . . 0.0 107.848 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -141.68 165.03 28.6 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 55' ' ' ALA . 12.5 mm -127.06 144.06 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -154.24 169.99 22.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.13 1.372 . . . . 0.0 109.037 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -68.35 156.8 37.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -83.48 151.78 25.27 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.531 1.532 . . . . 0.0 112.103 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -84.72 161.11 20.16 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 168.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -70.61 -43.44 69.31 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.995 -0.441 . . . . 0.0 110.739 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.87 -28.31 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.07 -0.98 42.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.872 0.469 . . . . 0.0 111.621 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.84 52.58 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.02 0.827 . . . . 0.0 112.678 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -60.51 -34.04 73.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.418 1.109 . . . . 0.0 111.547 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -71.61 -32.68 68.26 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.261 0.624 . . . . 0.0 109.982 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.41 -39.88 67.59 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.768 -0.582 . . . . 0.0 109.437 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.62 -43.99 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.407 1.083 . . . . 0.0 109.231 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.54 89.47 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.048 0.539 . . . . 0.0 111.298 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.9 mt -58.46 -50.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.485 1.114 . . . . 0.0 109.167 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -53.35 -47.26 69.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.307 0.643 . . . . 0.0 110.299 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.8 t -60.05 -50.81 72.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.534 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -69.75 -29.75 67.18 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.44 -0.788 . . . . 0.0 112.281 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -63.23 -34.95 78.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.636 0.653 . . . . 0.0 110.909 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.99 -44.21 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.67 -35.36 72.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.766 0.712 . . . . 0.0 112.326 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -44.88 17.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.787 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 p -131.79 -2.12 3.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -168.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -129.5 26.45 5.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.57 1.077 . . . . 0.0 110.502 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.89 -15.76 34.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.969 0.908 . . . . 0.0 113.246 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -55.51 -18.7 7.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.895 2.078 . . . . 0.0 112.955 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.09 99.54 0.67 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -53.53 152.6 4.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.331 1.852 . . . . 0.0 111.162 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.38 68.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.26 -49.0 68.65 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.698 -0.626 . . . . 0.0 109.513 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.449 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 15.3 t80 -66.74 -36.53 82.66 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.126 -0.359 . . . . 0.0 110.574 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.55 -47.31 73.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.82 1.248 . . . . 0.0 109.839 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.4 m -65.03 -49.4 70.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.221 1.008 . . . . 0.0 110.053 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -65.12 -39.85 93.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.508 0.323 . . . . 0.0 110.631 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 mt -63.03 -52.0 64.58 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.308 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.91 -40.53 73.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.569 1.077 . . . . 0.0 110.592 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.59 -49.32 73.81 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.094 0.558 . . . . 0.0 111.954 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -37.44 76.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.998 0.363 . . . . 0.0 110.065 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.64 -48.85 84.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.412 1.885 . . . . 0.0 109.161 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -69.58 -11.67 61.02 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.241 -0.912 . . . . 0.0 112.304 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -99.03 6.09 46.78 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.098 0.959 . . . . 0.0 110.818 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.98 -53.98 0.71 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.744 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.36 -38.03 63.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.73 1.605 . . . . 0.0 112.948 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.67 -14.25 34.8 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.378 2.052 . . . . 0.0 115.223 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.55 -20.01 5.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.591 1.541 . . . . 0.0 112.03 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.19 146.49 97.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.437 1.095 . . . . 0.0 110.107 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.17 46.27 2.19 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.325 3.35 . . . . 0.0 111.421 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.67 157.28 30.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.948 -1.095 . . . . 0.0 110.154 -172.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -101.06 144.35 30.08 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.84 136.7 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.684 0.794 . . . . 0.0 110.166 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.478 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 168.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.46 141.51 45.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.436 ' ND2' HH21 ' A' ' 59' ' ' ARG . 20.1 p30 -82.22 -178.12 6.91 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.135 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -54.85 -23.78 20.06 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.441 1.497 . . . . 0.0 113.712 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.436 HH21 ' ND2' ' A' ' 57' ' ' ASN . 84.4 mtm180 -78.14 -1.83 34.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.345 1.058 . . . . 0.0 111.685 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 t0 52.19 58.31 5.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.577 1.656 . . . . 0.0 108.967 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -139.13 127.95 13.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 140.85 47.94 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.956 2.437 . . . . 0.0 112.527 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 57' ' ' ASN . 27.2 m -118.94 -15.79 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.373 1.069 . . . . 0.0 112.294 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.71 168.81 40.38 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -141.7 156.33 45.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.347 0.659 . . . . 0.0 110.749 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.39 141.21 39.62 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.356 1.062 . . . . 0.0 108.522 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.56 117.98 31.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -148.88 134.99 19.18 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.125 0.875 . . . . 0.0 109.798 171.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.5 m -152.66 151.5 30.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 167.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.56 -122.9 26.0 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -129.67 22.16 5.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.517 1.127 . . . . 0.0 111.482 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -123.35 104.8 9.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.679 0.792 . . . . 0.0 109.548 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -83.21 82.0 8.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.18 -32.6 62.3 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.98 157.06 42.41 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 tp -154.94 126.44 7.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.916 2.086 . . . . 0.0 106.508 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.73 144.44 29.42 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.062 1.345 . . . . 0.0 107.959 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -149.9 146.01 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -53.48 116.51 9.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.702 1.201 . . . . 0.0 108.84 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.54 -18.65 60.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.317 2.678 . . . . 0.0 113.352 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.92 -20.86 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.222 0.919 . . . . 0.0 112.423 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.46 4.16 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.56 -45.31 66.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.065 -1.022 . . . . 0.0 110.469 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.49 -19.13 68.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.225 0.917 . . . . 0.0 113.632 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.81 -16.51 63.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.052 1.426 . . . . 0.0 111.749 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.99 -15.05 5.91 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.263 0.935 . . . . 0.0 112.637 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.15 -31.96 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.997 1.399 . . . . 0.0 111.656 -171.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.87 36.16 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.614 1.102 . . . . 0.0 113.693 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.72 -42.88 8.52 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 116.933 -1.508 . . . . 0.0 110.08 169.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.73 -45.13 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.58 1.537 . . . . 0.0 111.215 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.77 -38.53 83.54 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.94 0.791 . . . . 0.0 111.517 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.55 -42.94 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -64.39 -34.62 78.6 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.794 -0.566 . . . . 0.0 109.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -60.38 -49.03 79.2 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.09 0.404 . . . . 0.0 110.042 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.24 86.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.09 -34.67 75.29 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.918 0.887 . . . . 0.0 111.404 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -63.44 -37.35 86.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.271 0.487 . . . . 0.0 111.331 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.3 mtm -85.65 -24.1 27.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.101 0.56 . . . . 0.0 112.272 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.99 96.55 5.46 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.482 1.513 . . . . 0.0 108.342 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.77 -23.9 47.8 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.149 1.233 . . . . 0.0 112.225 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.77 28.49 4.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.77 1.628 . . . . 0.0 110.602 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 tp -52.2 145.86 10.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.155 2.182 . . . . 0.0 113.438 -169.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -128.11 158.0 39.21 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.069 1.348 . . . . 0.0 107.842 169.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -153.28 -173.72 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.773 0.429 . . . . 0.0 109.905 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.75 162.18 36.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.686 1.194 . . . . 0.0 109.552 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.527 HG12 HD21 ' A' ' 142' ' ' LEU . 10.3 p -154.55 143.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.69 125.58 27.23 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.37 -36.36 73.36 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.853 0.461 . . . . 0.0 111.957 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.47 -32.34 71.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.809 0.444 . . . . 0.0 110.851 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -77.3 65.98 2.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.646 1.179 . . . . 0.0 109.189 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.22 -26.49 60.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.332 1.053 . . . . 0.0 111.113 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -45.92 92.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.253 0.621 . . . . 0.0 109.791 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.79 -34.21 73.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.936 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.69 -46.72 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.464 1.029 . . . . 0.0 108.791 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.04 -49.96 70.1 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -54.99 -50.57 68.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.667 0.787 . . . . 0.0 110.873 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.9 -34.92 78.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -65.84 -38.61 89.33 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 120.99 -1.068 . . . . 0.0 112.296 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.85 -42.84 90.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.909 1.231 . . . . 0.0 110.191 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.93 -34.27 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.299 1.04 . . . . 0.0 110.787 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.87 0.89 2.16 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.323 0.963 . . . . 0.0 114.853 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -72.93 161.76 30.31 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.466 1.633 . . . . 0.0 111.688 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 141.81 27.19 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.82 1.648 . . . . 0.0 106.609 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 142' ' ' LEU . 32.9 t -72.02 132.47 33.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.327 1.051 . . . . 0.0 109.863 -172.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.4 p -127.58 -8.81 5.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.754 2.022 . . . . 0.0 111.707 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.62 40.78 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -161.13 -174.84 4.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.919 0.86 . . . . 0.0 111.008 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.1 m -140.02 169.32 17.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.398 2.279 . . . . 0.0 107.121 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.36 -1.65 10.73 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.17 175.33 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.608 2.363 . . . . 0.0 105.772 171.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.57 -63.65 1.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -163.48 -39.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.585 1.154 . . . . 0.0 112.081 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.6 -15.6 57.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.071 0.548 . . . . 0.0 111.785 -173.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.06 -16.67 9.3 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.254 1.407 . . . . 0.0 112.023 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.449 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 11.3 ptmt -61.51 121.96 67.48 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.524 1.13 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.97 63.17 0.3 Allowed 'Trans proline' 0 CA--C 1.549 1.244 1 C-N-CA 125.685 4.257 . . . . 0.0 116.497 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -131.76 66.46 78.02 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.771 -1.206 . . . . 0.0 109.174 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.7 166.76 21.18 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.965 2.443 . . . . 0.0 115.71 -169.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.75 148.21 44.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.228 2.211 . . . . 0.0 106.268 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.8 mt -111.82 150.97 29.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.49 ' C ' HD23 ' A' ' 142' ' ' LEU . 15.0 t-20 -118.4 140.07 50.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.86 160.47 39.21 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.748 1.219 . . . . 0.0 108.399 -169.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.43 151.88 51.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.268 1.427 . . . . 0.0 108.781 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -80.54 72.61 7.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.832 0.825 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.47 -21.33 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.681 0.792 . . . . 0.0 110.582 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.6 42.99 7.53 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.728 1.211 . . . . 0.0 110.715 177.588 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.498 0.189 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.85 141.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 mm -133.36 144.71 35.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -141.34 165.04 28.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.0 mm -124.98 142.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -154.01 170.98 19.8 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.044 0.938 . . . . 0.0 109.779 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -62.24 148.68 44.02 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 p -61.29 168.18 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.461 1.904 . . . . 0.0 113.166 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -118.93 157.89 26.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.356 1.862 . . . . 0.0 106.792 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.16 -43.33 74.49 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.915 -0.491 . . . . 0.0 110.842 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.11 -25.73 64.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -85.2 0.34 52.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.264 0.625 . . . . 0.0 111.533 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.81 -41.12 57.84 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.931 0.787 . . . . 0.0 113.41 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.29 -24.79 64.9 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.674 1.237 . . . . 0.0 111.771 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.3 -30.96 65.29 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.6 -38.97 67.66 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.58 -46.34 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.29 95.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.731 0.696 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.25 -50.98 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.628 0.771 . . . . 0.0 109.398 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -60.09 -46.93 87.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.715 0.406 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.38 -43.13 83.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.326 1.05 . . . . 0.0 111.148 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -66.29 -41.5 89.73 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.761 0.824 . . . . 0.0 111.083 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -41.53 88.48 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 110.328 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.56 -46.15 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.702 0.801 . . . . 0.0 109.397 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.5 -37.49 81.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.753 0.706 . . . . 0.0 112.17 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.29 -35.24 20.05 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.554 0.742 . . . . 0.0 112.843 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.9 p -137.43 2.98 2.53 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -128.75 31.56 4.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.626 1.103 . . . . 0.0 109.239 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.44 -24.03 42.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 0.0 113.314 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -24.32 58.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.973 2.109 . . . . 0.0 113.019 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.44 127.15 30.09 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.528 1.531 . . . . 0.0 111.386 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 m -55.83 141.59 38.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.767 1.227 . . . . 0.0 110.373 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -32.38 70.2 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.588 0.355 . . . . 0.0 111.891 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.61 -47.56 75.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.77 -40.94 88.42 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.575 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.03 -54.5 29.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.493 1.117 . . . . 0.0 109.373 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.2 m -64.95 -47.98 75.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.541 1.136 . . . . 0.0 111.409 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.19 -36.13 74.4 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.219 0.463 . . . . 0.0 110.654 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.0 mt -63.23 -50.78 68.88 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.887 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -40.52 69.74 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.498 1.044 . . . . 0.0 110.64 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.56 -44.72 81.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -35.79 68.02 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.084 -0.385 . . . . 0.0 110.437 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 t -59.65 -47.51 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 126.08 1.752 . . . . 0.0 109.128 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -70.01 -10.41 58.55 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.738 -1.226 . . . . 0.0 112.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -95.7 5.7 50.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.476 0.71 . . . . 0.0 110.777 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.39 -55.86 0.75 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.697 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.21 -39.1 75.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 120.635 1.561 . . . . 0.0 112.732 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -63.35 -11.57 26.27 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.423 2.082 . . . . 0.0 115.068 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.44 -20.55 5.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.704 1.593 . . . . 0.0 112.104 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 140.24 97.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.171 0.989 . . . . 0.0 110.068 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.26 50.05 3.41 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.635 3.557 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.86 164.07 4.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.364 1.466 . . . . 0.0 110.578 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -107.87 109.36 20.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.42 139.46 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 118.478 0.581 . . . . 0.0 109.946 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.98 133.28 35.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 103.714 -2.699 . . . . 0.0 103.714 167.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.54 141.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -80.56 -177.05 6.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.393 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -55.2 -23.62 22.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.299 1.439 . . . . 0.0 113.497 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.59 -0.43 42.27 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.394 1.078 . . . . 0.0 111.657 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t0 52.09 56.87 7.13 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.837 1.78 . . . . 0.0 109.522 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -137.09 126.15 15.2 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -171.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.36 142.53 55.01 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.592 2.195 . . . . 0.0 111.724 -169.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.51 -11.06 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 112.522 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.61 172.56 37.84 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.04 156.75 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.8 0.8 . . . . 0.0 110.369 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.43 162.1 36.12 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 108.758 169.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.38 130.38 52.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -146.26 135.07 22.38 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.2 m -161.64 156.18 22.79 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.025 2.53 . . . . 0.0 105.298 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.28 33.6 61.77 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.425 -0.797 . . . . 0.0 113.902 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 56.0 24.56 7.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.167 1.787 . . . . 0.0 114.148 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -124.02 110.74 15.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.102 0.961 . . . . 0.0 109.707 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.7 ttp -85.86 89.44 7.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.58 -27.14 68.98 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.633 1.173 . . . . 0.0 113.525 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.83 150.35 31.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.362 1.065 . . . . 0.0 109.443 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.2 tp -157.86 120.52 3.84 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.481 1.912 . . . . 0.0 106.432 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -145.88 145.88 30.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 108.107 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -149.98 143.6 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.81 134.01 95.1 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.498 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 -28.85 31.89 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.162 2.575 . . . . 0.0 114.849 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.62 -26.46 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.094 0.861 . . . . 0.0 112.851 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.1 m -111.93 -2.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.88 -39.71 82.22 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.252 -0.905 . . . . 0.0 110.09 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.37 -28.42 73.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.605 0.621 . . . . 0.0 112.838 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -74.01 -8.42 56.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.334 1.067 . . . . 0.0 112.293 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.49 9.38 61.63 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.523 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.63 -29.46 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.455 1.627 . . . . 0.0 110.68 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.97 -39.33 25.66 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.892 1.234 . . . . 0.0 113.455 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.42 -47.27 17.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.372 1.586 . . . . 0.0 109.869 169.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -52.87 -45.34 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.168 1.349 . . . . 0.0 111.428 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -68.03 -38.37 82.45 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.008 0.822 . . . . 0.0 111.422 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -41.47 90.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-N 118.446 0.566 . . . . 0.0 109.633 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.21 -36.27 83.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.62 -0.675 . . . . 0.0 109.718 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -60.51 -47.75 84.77 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.775 0.43 . . . . 0.0 110.203 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.76 74.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 122.823 0.449 . . . . 0.0 111.159 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.26 -34.25 72.01 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.385 1.074 . . . . 0.0 111.338 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.7 m -62.44 -37.51 86.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.331 0.514 . . . . 0.0 111.434 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.1 mtm -86.57 -21.06 27.08 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.306 0.503 . . . . 0.0 112.263 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.52 93.22 5.37 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.833 1.253 . . . . 0.0 109.872 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -22.84 53.97 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.345 1.363 . . . . 0.0 113.108 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -104.39 31.01 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.403 1.481 . . . . 0.0 110.335 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.7 tp -51.68 146.11 8.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.655 2.382 . . . . 0.0 113.126 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 p -129.97 160.49 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.293 1.437 . . . . 0.0 108.63 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -155.03 -176.75 6.1 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 172.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.0 156.04 41.0 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.132 0.973 . . . . 0.0 109.588 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.9 p -150.25 149.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.75 123.99 23.23 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.71 -32.28 67.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.639 1.175 . . . . 0.0 112.638 -170.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -57.68 -34.08 69.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.234 0.614 . . . . 0.0 110.963 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -77.43 65.62 3.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.682 1.193 . . . . 0.0 110.465 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.86 -26.09 61.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.582 0.753 . . . . 0.0 111.448 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.48 -47.46 85.57 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.815 0.446 . . . . 0.0 110.109 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.92 -37.3 84.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.354 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.56 -46.29 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.9 0.773 . . . . 0.0 109.168 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.35 -50.08 68.2 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -56.28 -49.54 73.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.796 0.838 . . . . 0.0 110.662 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.71 -34.81 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -66.28 -38.08 86.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.931 -1.106 . . . . 0.0 112.532 172.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.66 -42.47 88.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.95 1.25 . . . . 0.0 110.142 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.97 -35.44 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.253 1.021 . . . . 0.0 110.741 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.22 4.52 1.98 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.499 -1.167 . . . . 0.0 115.067 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.68 161.3 31.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.584 1.692 . . . . 0.0 111.392 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 139.93 25.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 HD22 ' A' ' 142' ' ' LEU . 41.2 t -72.74 131.23 35.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.137 0.975 . . . . 0.0 109.502 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.7 p -119.99 -11.41 9.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.638 1.975 . . . . 0.0 111.419 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.32 173.24 41.79 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -155.3 176.59 12.38 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 122.009 -0.7 . . . . 0.0 109.82 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.2 m -146.92 134.33 20.77 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.523 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.39 -23.33 67.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.997 . . . . 0.0 112.336 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.79 176.23 5.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.599 1.56 . . . . 0.0 107.589 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -107.3 -47.83 3.58 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -159.54 -52.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.49 -0.07 40.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.423 0.689 . . . . 0.0 112.044 -172.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.58 89.98 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -168.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -54.68 145.17 41.75 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.604 1.562 . . . . 0.0 109.633 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.51 68.8 5.26 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.241 2.627 . . . . 0.0 110.11 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -126.48 81.9 67.26 Favored Pre-proline 0 N--CA 1.457 -0.114 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.29 155.72 68.55 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 CA-C-N 119.908 1.003 . . . . 0.0 110.435 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.86 144.34 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.08 148.23 33.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.45 ' C ' HD23 ' A' ' 142' ' ' LEU . 17.1 t-20 -119.67 140.38 50.74 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.56 160.22 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.579 1.152 . . . . 0.0 108.703 -169.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.49 151.47 50.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.386 1.475 . . . . 0.0 108.208 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -76.45 127.64 33.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.58 -9.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.572 1.149 . . . . 0.0 109.959 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.72 37.91 92.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 124.819 1.248 . . . . 0.0 111.078 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.36 140.41 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -137.27 147.77 26.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -141.82 165.41 27.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.0 mm -123.14 142.43 39.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -151.48 174.72 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.907 0.883 . . . . 0.0 109.868 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -69.07 147.53 51.35 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 m -73.51 146.53 44.78 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.787 0.835 . . . . 0.0 111.91 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -81.73 158.73 24.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -67.77 -47.72 68.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.13 -27.43 67.31 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.03 1.8 34.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.846 0.458 . . . . 0.0 111.651 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.27 -38.71 33.96 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.962 0.792 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.73 -33.51 75.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.404 1.102 . . . . 0.0 111.516 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.94 -33.77 76.31 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 118.664 0.666 . . . . 0.0 109.583 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.47 -40.12 57.77 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.413 HG21 ' HD2' ' A' ' 44' ' ' ARG . 72.5 t -55.46 -47.35 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.76 90.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.122 0.569 . . . . 0.0 111.86 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.7 mt -59.59 -51.19 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 124.745 1.218 . . . . 0.0 108.776 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -53.07 -49.59 66.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.603 0.761 . . . . 0.0 110.079 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.4 t -59.42 -49.94 75.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.716 0.406 . . . . 0.0 110.196 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -75.17 -28.16 59.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.46 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.9 m -60.78 -40.26 91.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.224 0.92 . . . . 0.0 110.779 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -70.11 -45.9 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.3 -24.42 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.25 -47.08 10.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.237 1.015 . . . . 0.0 112.255 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -129.37 1.54 5.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -129.54 23.17 5.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.499 1.12 . . . . 0.0 109.508 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.2 -21.51 47.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.03 -25.8 13.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.183 1.793 . . . . 0.0 112.254 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.85 103.16 0.41 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 108.763 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 m -59.72 150.68 27.12 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.799 1.64 . . . . 0.0 112.444 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.81 -33.31 70.22 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.45 -48.17 76.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -74.45 -29.94 61.67 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.902 -0.499 . . . . 0.0 110.517 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -54.91 -44.75 74.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.318 0.963 . . . . 0.0 110.119 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.0 m -64.26 -48.79 74.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.304 1.042 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.14 -34.84 77.09 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.054 -0.404 . . . . 0.0 111.023 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.83 -48.29 77.42 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 117.532 -1.223 . . . . 0.0 109.462 172.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.57 -40.63 75.53 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.964 1.257 . . . . 0.0 109.813 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.82 -47.85 84.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.415 1.007 . . . . 0.0 112.37 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -37.92 75.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.848 1.659 . . . . 0.0 109.877 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HD2' HG21 ' A' ' 17' ' ' VAL . 3.0 tpt180 -61.08 -24.79 66.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.866 1.266 . . . . 0.0 111.455 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -98.21 7.37 46.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.39 1.076 . . . . 0.0 110.631 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -137.96 -59.21 0.65 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.6 -169.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.71 -36.42 45.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 121.01 1.732 . . . . 0.0 113.192 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -60.36 -18.49 53.33 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.899 1.733 . . . . 0.0 115.266 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -127.29 -13.78 5.49 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.313 1.415 . . . . 0.0 113.032 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.09 90.1 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.017 1.327 . . . . 0.0 111.516 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.37 58.93 6.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 112.064 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 mt -88.83 167.68 13.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.898 1.679 . . . . 0.0 112.921 -170.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -126.94 144.72 50.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.28 140.36 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.245 1.018 . . . . 0.0 110.524 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.25 134.19 35.28 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.72 142.74 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.64 179.24 7.41 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.43 -25.89 4.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.751 1.62 . . . . 0.0 114.039 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -77.0 -2.3 33.18 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.516 1.527 . . . . 0.0 112.014 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.3 57.24 6.83 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 124.294 1.997 . . . . 0.0 109.855 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -132.31 122.57 18.18 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.24 141.55 82.74 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.84 1.693 . . . . 0.0 109.906 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.2 -11.32 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.042 1.337 . . . . 0.0 112.042 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.25 168.76 41.09 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -142.71 159.16 42.78 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.489 0.716 . . . . 0.0 110.99 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.77 152.47 47.95 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.173 0.989 . . . . 0.0 109.726 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.59 119.53 34.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 69' ' ' SER . 4.2 tt -143.13 137.41 29.09 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.487 ' N ' HD23 ' A' ' 68' ' ' LEU . 68.7 m -150.74 155.55 39.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.87 -108.04 1.56 Allowed Glycine 0 CA--C 1.53 0.981 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -131.48 6.52 4.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.608 1.163 . . . . 0.0 111.988 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -105.42 124.97 50.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.558 1.072 . . . . 0.0 109.766 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.2 ttp -93.16 86.11 5.26 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.53 -26.61 68.78 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.41 147.51 34.73 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.53 0.732 . . . . 0.0 110.165 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.2 tp -155.59 122.29 5.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.868 2.067 . . . . 0.0 105.501 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.82 142.43 29.95 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.38 144.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -57.24 114.77 8.81 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 126.142 1.777 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.57 -29.88 11.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.087 3.192 . . . . 0.0 114.492 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.38 -21.84 66.76 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.37 10.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.143 0.977 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.03 -35.28 64.28 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.703 -1.248 . . . . 0.0 111.085 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.94 57.09 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.256 0.931 . . . . 0.0 113.613 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -72.69 -5.0 34.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.949 1.375 . . . . 0.0 112.456 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.69 69.41 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 119.08 0.854 . . . . 0.0 113.053 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.5 t -55.54 -31.07 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.357 1.079 . . . . 0.0 111.169 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.8 -53.04 14.56 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.048 0.832 . . . . 0.0 111.676 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.93 -42.29 97.4 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.381 -1.295 . . . . 0.0 110.206 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -58.6 -46.28 90.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.251 1.387 . . . . 0.0 110.052 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.23 -40.27 78.04 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.872 -0.518 . . . . 0.0 110.826 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.2 -40.44 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.632 0.651 . . . . 0.0 110.307 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.3 -33.3 72.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.037 -1.039 . . . . 0.0 109.989 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -62.3 -45.75 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.39 0.541 . . . . 0.0 110.383 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.04 83.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.286 0.634 . . . . 0.0 111.064 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.1 -34.27 73.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.114 0.966 . . . . 0.0 111.151 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -63.49 -37.88 88.99 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.219 0.463 . . . . 0.0 111.357 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 mtm -82.53 -28.54 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.371 0.532 . . . . 0.0 112.058 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 93.51 10.13 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.293 1.437 . . . . 0.0 108.613 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.85 -22.36 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 121.417 1.411 . . . . 0.0 112.202 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.68 31.53 4.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.741 . . . . 0.0 110.05 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.7 tp -48.4 141.74 6.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.073 2.149 . . . . 0.0 112.887 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -128.13 158.69 37.34 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 108.163 169.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -151.96 176.82 11.09 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.872 -0.518 . . . . 0.0 110.463 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -134.86 152.11 51.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.407 1.483 . . . . 0.0 108.823 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.0 p -152.95 144.47 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.69 130.09 38.15 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -61.56 -32.59 72.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -33.94 69.91 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.139 0.881 . . . . 0.0 111.321 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -77.72 68.22 3.75 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.168 0.987 . . . . 0.0 110.557 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.79 -24.75 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -62.55 -46.35 88.77 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.84 -0.537 . . . . 0.0 109.878 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.74 79.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.705 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.44 -49.16 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.297 0.953 . . . . 0.0 108.544 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.69 -46.94 93.47 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.83 -51.54 67.13 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 123.884 0.874 . . . . 0.0 110.097 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.62 -33.42 74.95 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.7 -47.92 82.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.174 0.897 . . . . 0.0 110.802 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.41 -42.58 87.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.065 0.848 . . . . 0.0 110.552 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.56 -34.3 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.182 0.993 . . . . 0.0 110.92 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.26 10.48 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.432 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -78.2 155.62 30.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.645 1.723 . . . . 0.0 111.53 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -141.06 138.95 33.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.362 1.865 . . . . 0.0 106.702 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.472 HG22 HD22 ' A' ' 142' ' ' LEU . 21.5 t -71.7 135.97 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.935 0.894 . . . . 0.0 110.057 -170.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.6 p -129.03 -8.72 4.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.468 1.907 . . . . 0.0 111.52 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.48 177.17 44.47 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.782 0.719 . . . . 0.0 111.55 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -157.46 178.0 10.79 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.066 0.946 . . . . 0.0 109.338 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m -145.76 126.16 14.02 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.938 2.095 . . . . 0.0 105.726 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.76 1.13 18.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.238 0.615 . . . . 0.0 112.542 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.7 175.78 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.98 1.712 . . . . 0.0 107.244 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -91.28 -65.41 1.01 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.292 -170.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -157.15 -43.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.64 28.24 3.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.67 1.188 . . . . 0.0 110.31 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.25 12.78 81.73 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.899 0.762 . . . . 0.0 113.019 -173.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -74.84 140.53 74.44 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 117.719 -1.134 . . . . 0.0 108.909 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.96 55.76 5.73 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.621 2.88 . . . . 0.0 111.699 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -130.07 67.69 79.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.165 0.986 . . . . 0.0 108.803 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.82 147.87 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 125.105 3.87 . . . . 0.0 117.461 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp -113.18 145.1 41.54 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 mt -116.85 152.05 35.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -125.65 137.84 53.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.852 1.261 . . . . 0.0 108.201 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.472 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.12 161.24 36.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.589 1.156 . . . . 0.0 108.162 -171.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.67 149.28 52.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.667 1.587 . . . . 0.0 108.562 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -75.44 129.93 38.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.3 t -127.45 -20.81 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.617 1.167 . . . . 0.0 109.913 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.54 31.26 78.16 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.517 -0.739 . . . . 0.0 112.318 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 C-N-CA 126.211 1.804 . . . . 0.0 107.923 178.247 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.476 0.179 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.82 143.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 mm -132.1 144.94 35.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -140.59 165.14 28.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 55' ' ' ALA . 13.4 mm -128.07 143.22 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -156.45 173.8 16.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.865 0.866 . . . . 0.0 110.537 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -64.54 147.01 53.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -73.53 145.55 45.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.607 1.163 . . . . 0.0 111.928 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -82.25 131.33 35.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -57.51 -39.72 77.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.441 1.019 . . . . 0.0 111.071 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -70.12 -20.67 63.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.955 0.902 . . . . 0.0 113.202 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -84.11 -4.96 59.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.372 0.987 . . . . 0.0 111.042 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.9 -33.25 35.64 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 124.445 1.022 . . . . 0.0 113.355 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.59 -33.33 75.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.536 1.168 . . . . 0.0 111.836 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -65.97 -30.95 71.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.982 -0.449 . . . . 0.0 109.884 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.57 -37.57 56.33 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.05 0.54 . . . . 0.0 109.67 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.92 -46.06 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -44.11 97.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 111.917 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.2 mt -61.88 -50.27 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.34 1.056 . . . . 0.0 109.134 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.7 t90 -51.31 -47.54 62.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.356 0.662 . . . . 0.0 110.127 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.8 t -61.5 -50.44 72.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.105 0.411 . . . . 0.0 110.52 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -68.78 -32.13 71.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.042 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 m -62.15 -47.61 83.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.063 0.847 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.28 -44.45 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.622 0.769 . . . . 0.0 109.519 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.2 -28.56 69.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 0.0 112.064 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.69 -24.55 28.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.653 1.181 . . . . 0.0 113.939 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.8 p -137.34 -21.15 1.19 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.571 ' CE1' HD22 ' A' ' 110' ' ' ASN . 72.8 m80 -124.29 29.84 6.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.671 1.588 . . . . 0.0 109.28 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.28 -18.27 25.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.408 1.083 . . . . 0.0 113.589 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -51.13 -23.84 3.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.116 2.167 . . . . 0.0 113.162 170.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.01 97.84 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.941 1.296 . . . . 0.0 108.003 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.1 m -55.29 153.69 6.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.458 1.503 . . . . 0.0 110.991 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -35.86 63.07 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.07 -49.11 66.15 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.941 0.792 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -65.65 -39.04 90.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.001 0.521 . . . . 0.0 109.998 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -54.48 -46.49 73.4 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.833 1.253 . . . . 0.0 110.018 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.7 m -65.73 -48.04 73.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 110.367 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.77 -36.93 81.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.911 -0.493 . . . . 0.0 110.762 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 -51.51 67.37 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -56.85 -40.69 76.57 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.766 0.712 . . . . 0.0 110.528 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.28 -41.63 89.57 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.806 0.73 . . . . 0.0 112.597 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.45 -38.31 68.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.573 -0.705 . . . . 0.0 109.553 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.91 -47.38 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.814 1.645 . . . . 0.0 109.147 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -57.39 -23.95 52.4 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.36 1.464 . . . . 0.0 111.754 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -102.69 7.7 39.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.426 1.09 . . . . 0.0 111.187 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -136.29 -52.7 0.72 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.905 -169.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.15 -37.14 54.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 120.534 1.515 . . . . 0.0 113.251 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.4 -16.21 33.96 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.433 2.089 . . . . 0.0 115.607 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -126.27 -14.37 5.95 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.32 1.418 . . . . 0.0 112.527 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.75 151.54 92.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.761 1.224 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.38 63.57 7.85 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.693 3.595 . . . . 0.0 110.704 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.5 177.97 7.24 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.785 1.234 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -136.47 141.58 43.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 127.547 2.339 . . . . 0.0 105.244 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.42 141.9 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 119.164 0.893 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -84.16 134.14 34.58 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 167.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.51 142.31 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -79.33 -178.85 6.44 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.563 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.13 -25.03 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.557 1.543 . . . . 0.0 113.788 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -84.26 3.45 35.41 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.834 1.254 . . . . 0.0 111.999 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.6 t0 52.66 58.25 5.56 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 123.384 1.564 . . . . 0.0 109.79 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.06 124.12 17.29 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 -170.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.49 137.13 45.55 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.975 2.45 . . . . 0.0 111.497 -171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 m -124.17 -13.63 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.282 1.033 . . . . 0.0 112.082 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.9 42.9 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -147.49 160.9 42.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.159 0.584 . . . . 0.0 110.925 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.56 154.07 49.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 108.226 169.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 74' ' ' ASP . 13.8 tp -110.12 118.9 37.63 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.49 132.26 18.98 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.6 m -145.61 153.32 40.92 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 168.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.32 -123.11 32.12 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -129.21 29.05 5.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.214 1.006 . . . . 0.0 111.26 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -122.94 108.59 13.13 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.655 -0.653 . . . . 0.0 110.218 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 ttp -85.59 87.36 7.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' HB3' HD23 ' A' ' 67' ' ' LEU . 30.3 t70 -64.06 -27.82 69.37 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.26 152.79 40.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.716 0.689 . . . . 0.0 110.963 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.9 tp -158.29 119.71 3.51 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.692 1.997 . . . . 0.0 106.38 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -147.04 141.43 26.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.561 1.144 . . . . 0.0 107.949 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.1 mt -150.95 145.71 16.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.29 126.18 77.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.379 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.63 -17.1 52.42 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.587 2.191 . . . . 0.0 113.834 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.18 -21.46 60.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.685 1.13 . . . . 0.0 112.018 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.49 -11.29 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -52.45 -39.71 61.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.892 1.224 . . . . 0.0 112.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.42 84.45 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.359 -176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.59 -18.64 65.07 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.175 1.488 . . . . 0.0 111.561 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.37 -23.16 1.22 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.07 0.843 . . . . 0.0 112.198 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.7 -32.82 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.602 1.201 . . . . 0.0 111.812 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.61 -31.45 37.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.128 0.871 . . . . 0.0 113.37 173.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -87.67 -45.94 9.95 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.01 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t -53.75 -43.85 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 120.364 1.438 . . . . 0.0 111.248 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -66.63 -37.02 83.96 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.872 0.76 . . . . 0.0 111.43 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.27 -42.07 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 118.44 0.563 . . . . 0.0 109.524 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.35 -35.1 79.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.554 0.615 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -61.43 -48.43 81.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.808 0.443 . . . . 0.0 110.382 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.31 82.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.891 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.34 -35.54 75.9 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.224 1.009 . . . . 0.0 111.458 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.82 -36.72 84.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.305 0.502 . . . . 0.0 111.408 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.3 mtm -86.16 -23.42 26.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.993 0.517 . . . . 0.0 112.218 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.15 91.45 7.05 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.267 1.427 . . . . 0.0 108.931 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -22.93 56.92 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.413 1.408 . . . . 0.0 112.788 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -103.81 30.74 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.347 1.459 . . . . 0.0 110.258 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.1 tp -49.61 144.55 5.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.179 2.192 . . . . 0.0 112.961 -171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.9 p -129.08 161.31 30.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.02 1.328 . . . . 0.0 108.796 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -153.09 -173.8 4.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -149.16 161.78 41.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.992 0.917 . . . . 0.0 110.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.25 145.24 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -74.26 128.83 36.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -57.43 -32.37 66.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.862 0.865 . . . . 0.0 113.088 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.47 -34.08 72.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.308 0.503 . . . . 0.0 111.195 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.571 HD22 ' CE1' ' A' ' 28' ' ' HIS . 64.2 t-20 -79.07 65.14 4.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.856 1.262 . . . . 0.0 109.611 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.3 -26.06 60.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.151 0.98 . . . . 0.0 111.1 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.12 84.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.959 0.503 . . . . 0.0 109.861 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.54 77.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.756 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.84 -49.31 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.402 1.001 . . . . 0.0 108.482 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.78 93.76 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -56.14 -50.63 70.59 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.763 0.825 . . . . 0.0 110.194 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -67.24 -33.96 76.43 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -59.46 -46.17 89.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.191 0.905 . . . . 0.0 110.977 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.92 -43.26 91.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.129 0.877 . . . . 0.0 110.384 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.4 t -63.13 -39.63 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.758 0.823 . . . . 0.0 110.365 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.26 11.58 0.89 Allowed Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.4 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.43 155.43 29.93 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.652 1.726 . . . . 0.0 111.479 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.01 139.22 34.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.103 1.761 . . . . 0.0 106.618 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.504 HG22 HD22 ' A' ' 142' ' ' LEU . 21.9 t -71.66 133.81 31.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.978 0.911 . . . . 0.0 109.8 -171.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.75 -9.66 7.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 111.459 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.09 178.31 43.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 118.849 0.75 . . . . 0.0 111.491 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -151.26 174.83 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.49 0.716 . . . . 0.0 109.572 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.1 m -147.45 139.32 24.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.267 2.227 . . . . 0.0 106.289 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.63 0.09 44.68 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.389 0.541 . . . . 0.0 111.832 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 m -137.92 173.1 13.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 126.83 2.052 . . . . 0.0 106.682 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.25 -47.69 4.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.305 -175.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -163.65 -45.91 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 78.5 mt -84.3 -1.38 55.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 112.147 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.25 79.93 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.185 0.898 . . . . 0.0 111.709 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -51.01 123.3 18.88 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.829 1.652 . . . . 0.0 109.473 169.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.74 60.41 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 124.982 3.788 . . . . 0.0 115.596 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -124.02 100.42 36.65 Favored Pre-proline 0 C--O 1.226 -0.157 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.69 160.8 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.544 2.162 . . . . 0.0 114.421 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.1 tp -131.69 144.04 50.72 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.2 mt -113.86 141.27 47.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -113.29 138.78 49.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.504 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.07 160.07 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.39 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.64 151.37 51.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.639 1.576 . . . . 0.0 108.575 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -75.8 126.37 30.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.57 -2.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 125.272 1.429 . . . . 0.0 109.89 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.82 -23.76 65.84 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.898 -1.126 . . . . 0.0 113.856 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.275 1.43 . . . . 0.0 110.932 178.806 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.326 0.108 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.1 163.15 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.354 0.597 . . . . 0.0 110.945 170.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -137.62 144.66 30.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 107.615 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -140.37 163.57 32.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -123.78 143.06 38.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.11 170.93 18.73 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.747 1.219 . . . . 0.0 108.956 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -66.35 148.65 51.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -73.27 148.43 43.62 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.282 1.033 . . . . 0.0 112.237 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -79.76 155.88 27.73 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -68.63 -40.59 80.27 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.909 -0.494 . . . . 0.0 110.269 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.7 -25.82 63.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.82 0.6 46.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.095 0.558 . . . . 0.0 111.394 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.4 -42.91 43.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.536 1.065 . . . . 0.0 113.64 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -72.52 -18.75 61.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.732 1.266 . . . . 0.0 112.066 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.67 -31.29 68.15 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.051 -1.031 . . . . 0.0 109.33 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -73.95 -38.35 64.26 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.57 -45.47 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.46 98.76 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.977 -0.452 . . . . 0.0 111.505 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.52 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.816 0.846 . . . . 0.0 109.466 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -54.26 -47.29 72.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.266 0.627 . . . . 0.0 110.298 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.48 -44.63 95.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.674 -0.642 . . . . 0.0 110.327 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -63.58 -37.04 85.82 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.677 -0.639 . . . . 0.0 110.993 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.2 m -67.87 -35.56 78.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.485 0.714 . . . . 0.0 110.819 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -70.9 -47.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.31 -33.54 69.59 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.559 0.744 . . . . 0.0 112.708 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.35 -35.63 15.11 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 118.344 -0.836 . . . . 0.0 113.17 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -138.63 2.0 2.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -136.44 26.61 3.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.91 -13.77 28.04 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.997 -1.064 . . . . 0.0 113.565 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -52.95 -22.93 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.741 2.017 . . . . 0.0 112.905 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -64.21 97.21 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.36 1.464 . . . . 0.0 108.679 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -56.26 158.81 3.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.57 1.548 . . . . 0.0 111.317 174.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.41 65.03 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.37 -46.82 72.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.966 0.803 . . . . 0.0 109.98 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -64.91 -40.25 94.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.488 0.715 . . . . 0.0 109.748 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -55.57 -47.43 76.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.953 1.301 . . . . 0.0 110.097 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -64.94 -49.74 69.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.187 0.995 . . . . 0.0 110.019 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.26 -38.85 91.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.405 . . . . 0.0 110.785 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.86 -50.74 65.42 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.61 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.87 -38.83 79.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.734 1.152 . . . . 0.0 110.093 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.74 -48.22 82.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.98 0.809 . . . . 0.0 112.099 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -37.05 76.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.97 -46.37 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.801 1.641 . . . . 0.0 109.942 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -63.31 -20.57 65.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.515 1.052 . . . . 0.0 111.398 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -97.78 7.15 46.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 110.808 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -137.4 -56.13 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.215 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.99 -37.23 51.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 120.467 1.485 . . . . 0.0 112.708 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -63.94 -11.17 25.8 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.002 1.802 . . . . 0.0 115.706 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -128.06 -19.63 3.94 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.866 1.666 . . . . 0.0 112.746 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.74 149.67 97.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.408 1.083 . . . . 0.0 110.902 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.46 47.9 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.648 3.566 . . . . 0.0 112.305 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.36 165.49 16.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.038 1.735 . . . . 0.0 112.463 -171.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -115.77 147.4 40.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.37 138.58 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.935 . . . . 0.0 110.382 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.54 129.23 34.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 168.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.4 m -124.15 142.02 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -82.85 -179.7 7.52 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.05 -25.45 8.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 0.0 113.97 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -79.24 0.57 28.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.955 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 t0 51.63 55.96 8.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 124.207 1.956 . . . . 0.0 109.661 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.41 119.09 21.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 128.103 2.561 . . . . 0.0 104.333 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.64 138.74 65.98 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.693 1.596 . . . . 0.0 109.924 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.34 -9.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 0.0 112.468 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.46 168.67 40.16 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 171.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -142.46 156.34 45.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.813 0.806 . . . . 0.0 111.249 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -141.75 138.0 32.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.362 2.265 . . . . 0.0 106.037 -173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -124.15 119.57 29.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.7 tp -141.97 134.5 28.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.0 m -159.4 155.87 27.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.131 2.172 . . . . 0.0 105.422 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.14 35.46 59.9 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.564 -0.71 . . . . 0.0 113.774 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 58.14 22.24 8.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 113.697 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -125.47 114.36 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.6 ttp -80.89 87.32 5.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.96 -28.09 69.84 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.768 . . . . 0.0 112.837 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.97 144.63 29.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.755 0.822 . . . . 0.0 110.407 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.1 tp -156.19 117.58 3.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.955 1.702 . . . . 0.0 106.464 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -145.31 143.14 30.01 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -149.62 144.18 17.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.08 125.33 86.63 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.52 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.73 -30.21 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.882 3.055 . . . . 0.0 114.947 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -63.72 -25.18 68.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.94 -3.11 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.641 0.655 . . . . 0.0 112.497 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -59.62 -37.24 78.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.823 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.7 -26.62 68.75 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.859 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.0 m -78.29 -3.55 43.48 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.392 1.096 . . . . 0.0 112.212 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.11 13.15 64.57 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.486 172.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.0 t -57.21 -31.03 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.294 1.547 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.5 -49.85 44.12 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.634 0.635 . . . . 0.0 112.176 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -63.87 -46.85 83.08 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.716 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -54.03 -49.55 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 119.397 0.999 . . . . 0.0 110.152 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.95 -37.52 75.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.039 -174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.58 -39.75 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 119.088 0.858 . . . . 0.0 109.801 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.97 -36.11 82.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.74 1.154 . . . . 0.0 110.066 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.03 -48.33 80.78 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.872 0.469 . . . . 0.0 110.491 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.18 78.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.643 0.777 . . . . 0.0 110.753 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.49 -33.66 71.62 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.702 1.201 . . . . 0.0 111.646 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -62.66 -34.11 76.41 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.5 0.591 . . . . 0.0 111.548 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -87.19 -25.38 24.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 112.091 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.08 94.96 7.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.096 1.359 . . . . 0.0 109.175 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.91 -23.42 47.3 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 121.237 1.291 . . . . 0.0 112.318 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.12 28.87 4.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.789 1.635 . . . . 0.0 110.482 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.3 tp -53.0 146.49 10.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.281 2.232 . . . . 0.0 112.819 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.8 p -131.31 161.68 31.78 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 108.802 170.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 t -155.86 -178.37 7.24 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 122.636 0.374 . . . . 0.0 110.631 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -135.68 156.57 48.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.785 1.634 . . . . 0.0 108.695 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 p -154.39 145.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.53 132.48 42.91 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.17 -30.82 66.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.566 0.747 . . . . 0.0 112.213 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.53 -26.73 68.02 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.367 0.53 . . . . 0.0 112.193 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -79.95 67.84 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.748 0.785 . . . . 0.0 109.806 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.41 -27.7 49.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.446 1.099 . . . . 0.0 111.422 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.25 -50.59 65.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.006 0.523 . . . . 0.0 110.149 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.54 82.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.41 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.5 t -56.45 -49.14 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.92 -48.68 85.07 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.79 -50.88 70.99 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.392 0.677 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -66.94 -35.32 79.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.19 -47.37 85.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.983 0.81 . . . . 0.0 110.876 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -58.87 -42.03 88.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.021 0.828 . . . . 0.0 110.603 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.85 -40.28 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.701 0.8 . . . . 0.0 110.345 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.52 8.13 0.73 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.775 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.53 153.17 40.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.643 1.722 . . . . 0.0 111.142 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -140.5 139.49 35.11 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.126 1.77 . . . . 0.0 106.523 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.491 HG22 HD22 ' A' ' 142' ' ' LEU . 23.9 t -72.08 134.68 29.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.85 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 p -126.0 -8.6 6.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.789 2.036 . . . . 0.0 111.379 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.26 43.95 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 118.779 0.718 . . . . 0.0 111.467 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -154.44 176.91 11.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.83 0.852 . . . . 0.0 109.437 171.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -145.93 132.81 20.13 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.876 2.071 . . . . 0.0 105.831 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -77.37 2.04 17.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.17 170.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.748 1.619 . . . . 0.0 106.901 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.13 -60.77 2.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.562 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -159.08 -47.94 0.06 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 170.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.66 33.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.564 1.146 . . . . 0.0 109.931 -173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.58 15.15 70.52 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.061 0.838 . . . . 0.0 113.221 -171.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -66.46 125.75 90.97 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 116.82 -1.562 . . . . 0.0 107.926 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -78.35 46.25 2.06 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.753 2.969 . . . . 0.0 112.465 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -134.62 87.31 31.84 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -44.56 148.14 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.091 3.194 . . . . 0.0 117.687 -169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.8 tp -103.92 148.09 26.57 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.79 151.61 36.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -122.67 138.51 54.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.878 1.271 . . . . 0.0 107.849 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.491 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.03 159.79 41.08 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.435 1.094 . . . . 0.0 108.467 -170.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.18 149.66 51.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.413 1.485 . . . . 0.0 108.417 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -73.9 125.45 28.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.6 t -129.04 -7.98 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.63 1.172 . . . . 0.0 110.008 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.0 37.38 92.06 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -169.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.932 1.293 . . . . 0.0 111.127 178.833 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.87 141.52 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -136.72 146.74 28.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -140.9 164.02 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 168.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 55' ' ' ALA . 13.8 mm -124.5 143.59 37.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -152.3 171.3 18.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.73 1.212 . . . . 0.0 109.136 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -65.85 147.47 53.32 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -76.35 148.85 37.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.623 1.169 . . . . 0.0 111.912 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -77.33 162.07 27.57 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -70.16 -46.67 64.21 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.93 -27.61 65.91 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.72 -1.48 47.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.789 0.436 . . . . 0.0 111.334 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.12 -35.96 55.66 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 124.14 0.876 . . . . 0.0 113.461 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.53 -28.14 69.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.979 1.39 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -68.09 -31.73 71.56 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.364 -0.835 . . . . 0.0 109.762 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -76.13 -37.36 58.13 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.11 -46.96 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.119 0.568 . . . . 0.0 112.042 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.18 -50.6 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.24 1.016 . . . . 0.0 109.569 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -51.36 -47.51 62.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.282 0.633 . . . . 0.0 110.005 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -61.51 -49.59 76.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.901 0.48 . . . . 0.0 110.233 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.21 -30.32 68.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.179 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -62.54 -46.15 89.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.628 1.104 . . . . 0.0 109.462 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -66.57 -44.02 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 123.877 0.871 . . . . 0.0 109.305 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.46 -28.62 68.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.361 0.982 . . . . 0.0 112.326 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.71 -33.3 27.61 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.984 0.914 . . . . 0.0 113.301 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.7 p -135.17 -12.17 2.17 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.408 ' CD2' HD22 ' A' ' 110' ' ' ASN . 28.5 m-70 -118.68 24.5 10.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.347 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.19 -19.76 35.96 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -53.41 -28.88 32.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.804 1.641 . . . . 0.0 111.927 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.21 104.98 1.96 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.961 2.104 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -59.87 157.83 11.71 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.557 1.943 . . . . 0.0 113.181 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.04 68.77 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -64.83 -50.18 67.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.631 0.65 . . . . 0.0 109.545 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -64.09 -38.58 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.138 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.18 -46.66 79.28 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.549 0.74 . . . . 0.0 109.917 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -64.81 -51.1 64.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.554 1.142 . . . . 0.0 110.105 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.37 -36.33 76.71 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.998 -0.439 . . . . 0.0 110.835 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.15 -50.97 68.3 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.834 -1.079 . . . . 0.0 109.276 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.822 1.192 . . . . 0.0 110.501 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.9 -44.66 72.75 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.86 -36.02 70.0 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.123 -0.361 . . . . 0.0 110.421 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.35 -47.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 125.992 1.717 . . . . 0.0 108.949 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -69.45 -12.1 61.37 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 120.847 -1.158 . . . . 0.0 112.819 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -95.53 6.05 49.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.715 0.806 . . . . 0.0 110.679 172.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -136.79 -55.32 0.73 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.58 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.09 -40.14 82.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 120.66 1.573 . . . . 0.0 112.632 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.49 -12.26 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.253 1.969 . . . . 0.0 114.853 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.85 -21.36 6.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.79 1.632 . . . . 0.0 111.937 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.55 148.65 97.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 110.778 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.65 48.85 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.653 3.569 . . . . 0.0 111.721 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.09 169.48 5.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.171 1.388 . . . . 0.0 112.272 -172.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -121.66 144.37 48.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.61 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.12 138.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.219 1.008 . . . . 0.0 110.659 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.72 129.48 34.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 103.617 -2.734 . . . . 0.0 103.617 167.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 m -126.86 144.63 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -80.47 -174.56 4.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.807 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.69 -22.43 46.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.476 1.11 . . . . 0.0 113.249 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.88 6.1 29.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.997 1.319 . . . . 0.0 111.682 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 53.01 41.94 32.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.964 1.364 . . . . 0.0 110.467 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 120.33 45.57 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -173.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.86 130.71 28.51 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.281 1.987 . . . . 0.0 110.286 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.32 -16.01 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.144 0.978 . . . . 0.0 111.637 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.97 172.72 42.16 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -147.35 161.73 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.372 0.669 . . . . 0.0 110.881 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.47 158.9 43.3 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.448 1.099 . . . . 0.0 109.717 169.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.5 tp -118.06 128.07 54.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.07 132.16 23.07 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 m -142.95 153.71 43.32 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.5 -118.44 10.54 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -129.07 30.76 5.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.181 0.992 . . . . 0.0 110.826 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -122.58 109.73 14.67 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.398 0.679 . . . . 0.0 110.452 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 ttp -85.78 87.85 7.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.37 -29.06 70.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.38 36.11 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.629 0.771 . . . . 0.0 109.815 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.7 tp -158.73 116.16 2.83 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.548 1.939 . . . . 0.0 105.958 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.97 143.21 29.34 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -149.91 145.44 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -171.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -60.41 121.58 61.19 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.99 -16.28 51.91 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.311 2.007 . . . . 0.0 113.704 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.02 -23.29 64.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.06 -9.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.438 1.095 . . . . 0.0 112.309 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -50.54 -44.18 56.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.341 1.056 . . . . 0.0 110.436 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.67 -18.77 66.42 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.165 0.888 . . . . 0.0 113.842 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.49 -9.11 57.68 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.108 1.454 . . . . 0.0 112.239 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.12 7.96 34.58 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.04 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -55.33 -31.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.053 1.426 . . . . 0.0 110.682 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.6 -51.7 27.0 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 119.377 -0.68 . . . . 0.0 111.706 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -62.24 -42.45 99.33 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.583 -1.198 . . . . 0.0 110.431 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.3 t -58.76 -46.54 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.98 1.264 . . . . 0.0 109.957 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.43 -41.19 80.67 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.949 -0.469 . . . . 0.0 110.806 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.51 -41.75 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.445 0.566 . . . . 0.0 109.943 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.3 -34.88 79.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.125 0.875 . . . . 0.0 110.14 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.38 -45.22 95.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.4 0.545 . . . . 0.0 110.424 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.31 -49.45 73.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.835 0.454 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.35 -33.67 69.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.113 0.965 . . . . 0.0 111.512 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.66 -35.97 81.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.297 0.499 . . . . 0.0 111.558 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.6 mtm -88.63 -23.0 23.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.267 0.485 . . . . 0.0 112.161 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.04 90.05 9.5 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 125.137 1.375 . . . . 0.0 108.914 -170.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -22.05 61.0 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.476 1.45 . . . . 0.0 112.919 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.45 31.93 4.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.535 1.534 . . . . 0.0 109.951 -175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 42.0 tp -49.2 144.81 4.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.238 2.215 . . . . 0.0 113.015 -171.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -129.23 162.25 28.3 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.186 1.395 . . . . 0.0 108.657 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -153.64 -173.72 4.68 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -148.92 161.78 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.481 0.713 . . . . 0.0 110.372 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.3 p -155.2 149.73 11.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -78.11 136.31 37.85 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.13 -26.2 60.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.224 1.41 . . . . 0.0 112.352 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -48.81 -47.45 42.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.056 0.844 . . . . 0.0 111.05 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.408 HD22 ' CD2' ' A' ' 28' ' ' HIS . 59.5 t-20 -85.82 65.3 9.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.327 1.451 . . . . 0.0 110.244 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.22 -29.36 46.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 111.441 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -43.89 97.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.409 0.684 . . . . 0.0 109.966 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.36 -33.99 72.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.148 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.25 -45.34 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 119.505 1.048 . . . . 0.0 108.678 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.39 -50.78 63.15 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -53.29 -50.54 64.68 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.869 0.868 . . . . 0.0 110.797 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -65.25 -38.51 90.57 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.91 -32.95 74.34 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.523 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -60.42 -40.88 92.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.353 1.433 . . . . 0.0 110.766 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.09 -39.13 80.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.05 9.32 0.82 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.841 171.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -69.01 159.58 32.57 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 1.537 . . . . 0.0 111.117 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.82 140.59 25.89 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 HD22 ' A' ' 142' ' ' LEU . 28.2 t -71.94 129.91 35.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.981 0.912 . . . . 0.0 109.324 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 p -124.93 -7.64 7.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.258 1.823 . . . . 0.0 111.796 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.91 173.06 42.2 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 118.82 0.737 . . . . 0.0 112.218 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -141.98 159.92 41.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.543 1.537 . . . . 0.0 111.061 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.3 m -136.69 127.7 27.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -69.88 -7.74 42.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.45 0.7 . . . . 0.0 112.827 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.41 173.06 13.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.452 1.901 . . . . 0.0 106.804 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.04 -55.93 3.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.05 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -165.05 -45.54 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.404 1.082 . . . . 0.0 112.65 176.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.51 -4.64 56.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.848 0.859 . . . . 0.0 112.195 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.38 -8.39 62.37 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.393 0.997 . . . . 0.0 111.817 -169.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.58 132.78 82.18 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 118.129 0.965 . . . . 0.0 109.444 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.38 55.73 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.177 3.251 . . . . 0.0 111.857 -169.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -122.38 87.83 48.77 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.7 148.41 21.68 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.929 1.753 . . . . 0.0 115.738 -170.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.0 tp -96.74 143.79 27.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.8 mt -114.73 134.72 54.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.41 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.3 t-20 -102.98 139.73 38.16 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.554 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -134.19 159.94 39.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.24 51.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.538 1.535 . . . . 0.0 107.987 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -75.8 125.7 29.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.5 t -128.73 -8.87 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.552 1.141 . . . . 0.0 110.051 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.38 37.58 90.53 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -170.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 C-N-CA 124.681 1.192 . . . . 0.0 111.046 178.444 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttp . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.57 143.54 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 mm -134.66 144.38 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -142.39 166.12 25.54 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.52 142.65 40.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.69 171.17 19.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 109.507 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -64.57 147.73 52.27 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.929 0.786 . . . . 0.0 109.106 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.12 148.28 45.85 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -80.49 158.57 25.82 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -66.57 -48.99 67.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.73 -26.71 65.39 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -169.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.26 -1.97 43.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.161 0.437 . . . . 0.0 111.635 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.53 -39.14 36.7 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 124.185 0.898 . . . . 0.0 113.385 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.77 -26.78 67.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.686 1.243 . . . . 0.0 112.078 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.21 -31.77 71.53 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.15 -40.09 59.91 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.26 -46.01 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.603 0.761 . . . . 0.0 109.289 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -46.92 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.6 mt -57.35 -52.19 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.717 1.207 . . . . 0.0 108.934 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -52.94 -49.91 65.08 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.774 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 t -59.51 -50.49 73.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.109 0.564 . . . . 0.0 110.655 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -68.33 -33.05 73.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.145 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 m -63.34 -46.96 84.19 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.199 0.909 . . . . 0.0 109.688 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.63 -44.14 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.794 0.838 . . . . 0.0 108.912 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.99 -33.58 76.4 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.998 1.272 . . . . 0.0 112.052 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.24 60.9 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.428 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.8 p -135.07 -5.66 2.37 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -121.72 44.39 2.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.633 1.573 . . . . 0.0 108.486 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 -32.29 57.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.048 -1.033 . . . . 0.0 113.051 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.65 -21.72 66.59 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.745 1.218 . . . . 0.0 113.117 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.36 114.23 8.29 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.367 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -61.06 148.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 112.091 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.85 73.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.105 0.562 . . . . 0.0 112.464 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.82 -48.67 73.53 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -68.55 -35.5 77.5 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.137 -0.352 . . . . 0.0 110.381 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -54.87 -45.57 74.63 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.397 1.079 . . . . 0.0 110.313 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.4 m -65.23 -49.8 68.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.339 1.056 . . . . 0.0 110.235 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.01 -35.95 81.06 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.971 -0.456 . . . . 0.0 110.723 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.44 -52.84 62.9 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.345 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.75 -38.01 71.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.475 1.034 . . . . 0.0 110.74 -174.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.99 -48.82 72.6 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.089 0.556 . . . . 0.0 112.094 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.68 -36.03 73.11 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.974 -0.454 . . . . 0.0 110.471 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.49 -47.74 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.231 1.812 . . . . 0.0 109.098 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -69.85 -11.17 60.66 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.924 -1.11 . . . . 0.0 112.676 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m -95.87 5.47 51.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.691 0.796 . . . . 0.0 110.749 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.38 -56.43 0.75 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 117.892 -1.052 . . . . 0.0 112.628 -169.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -56.2 -38.37 67.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.558 . . . . 0.0 112.827 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.07 -14.86 35.72 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.8 1.666 . . . . 0.0 115.209 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.71 -13.57 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.741 1.61 . . . . 0.0 112.772 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.23 152.34 91.94 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.957 1.303 . . . . 0.0 111.321 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.82 56.18 5.86 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.831 3.688 . . . . 0.0 111.932 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.34 159.2 23.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.369 1.468 . . . . 0.0 112.009 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -116.24 142.45 46.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 141.22 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.259 1.024 . . . . 0.0 110.072 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.09 134.83 35.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 168.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -128.71 144.3 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -84.21 -171.77 3.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 110.763 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -62.33 11.04 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.501 2.32 . . . . 0.0 114.182 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -127.97 8.99 6.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.354 1.862 . . . . 0.0 111.314 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.0 t0 50.25 47.26 24.0 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.187 1.47 . . . . 0.0 110.259 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.41 122.99 26.59 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 -172.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.7 135.5 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.24 1.96 . . . . 0.0 110.994 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.93 -13.92 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.179 0.992 . . . . 0.0 112.136 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 170.86 42.61 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.41 159.88 41.23 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.295 1.038 . . . . 0.0 111.962 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -140.0 127.48 21.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.926 2.49 . . . . 0.0 105.999 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.97 116.8 31.17 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 69' ' ' SER . 2.9 tt -146.56 129.29 16.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.348 0.522 . . . . 0.0 109.875 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.461 ' N ' HD23 ' A' ' 68' ' ' LEU . 36.7 m -146.04 154.68 42.13 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.58 41.98 65.78 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 118.953 0.797 . . . . 0.0 113.996 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 59.53 21.97 10.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.811 1.644 . . . . 0.0 113.842 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -130.18 108.12 9.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.074 0.95 . . . . 0.0 108.97 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.2 ttp -85.9 86.14 7.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.13 -31.48 71.19 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.85 142.35 31.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.607 0.763 . . . . 0.0 110.296 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 tp -150.85 117.46 5.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -140.93 140.08 34.4 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.68 146.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.97 118.25 9.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.08 -18.6 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.636 2.224 . . . . 0.0 112.638 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.95 -23.52 66.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.1 0.864 . . . . 0.0 112.554 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.55 -2.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.939 1.295 . . . . 0.0 112.487 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -59.89 -27.64 66.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.678 -1.264 . . . . 0.0 111.698 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.97 -16.19 75.48 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.981 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.19 -175.09 2.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.713 1.256 . . . . 0.0 109.293 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.45 -31.58 36.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.632 -1.093 . . . . 0.0 113.612 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.34 -36.66 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.712 1.756 . . . . 0.0 112.733 -170.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.84 -23.04 43.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.873 0.749 . . . . 0.0 113.441 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -41.85 7.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.065 170.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.11 -45.98 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 121.605 2.002 . . . . 0.0 110.662 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.8 mt -68.9 -37.09 78.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.997 0.817 . . . . 0.0 111.641 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.15 -39.58 83.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 118.53 0.604 . . . . 0.0 109.674 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.49 -35.08 79.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.534 -0.729 . . . . 0.0 109.197 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -62.87 -48.36 79.35 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.574 0.75 . . . . 0.0 110.427 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -58.02 -47.89 81.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.584 0.753 . . . . 0.0 110.888 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.11 -33.12 74.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 111.414 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -64.33 -39.06 93.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.491 0.587 . . . . 0.0 111.035 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.9 mtm -77.3 -29.83 53.88 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.438 0.563 . . . . 0.0 111.728 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 96.15 6.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.695 1.198 . . . . 0.0 110.13 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.01 -22.83 62.01 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.33 1.353 . . . . 0.0 112.409 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.55 29.19 4.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.509 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 tp -51.94 144.03 12.48 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.002 2.121 . . . . 0.0 113.589 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.4 p -129.87 161.3 31.13 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.47 1.508 . . . . 0.0 108.612 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -154.51 -179.33 7.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.918 0.487 . . . . 0.0 110.232 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.2 1.4 . . . . 0.0 109.018 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.416 HG12 HD21 ' A' ' 142' ' ' LEU . 10.5 p -153.86 145.3 14.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -75.78 137.71 40.72 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -63.89 -25.52 68.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.281 0.632 . . . . 0.0 111.944 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -71.74 31.57 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 112.415 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -149.7 67.04 1.0 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.946 1.698 . . . . 0.0 107.685 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.56 -26.42 61.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.52 -49.38 75.56 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.854 0.461 . . . . 0.0 110.085 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.27 76.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.673 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.42 -49.74 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.52 -46.32 94.56 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.294 0.497 . . . . 0.0 111.914 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -54.22 -53.17 57.25 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 125.146 1.379 . . . . 0.0 109.852 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -68.32 -33.38 74.21 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.855 -0.528 . . . . 0.0 109.852 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.26 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.418 1.008 . . . . 0.0 110.879 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.64 -43.27 89.69 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.841 0.746 . . . . 0.0 110.438 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.29 -37.61 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 110.607 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.59 10.07 0.83 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.618 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -81.78 155.93 25.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.635 1.717 . . . . 0.0 111.439 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.1 138.24 33.38 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.126 1.77 . . . . 0.0 106.558 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.523 HG22 HD22 ' A' ' 142' ' ' LEU . 25.2 t -70.85 133.67 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.03 0.932 . . . . 0.0 109.692 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.4 p -125.59 -9.69 6.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.588 1.955 . . . . 0.0 111.414 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.61 -176.87 41.6 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.837 0.744 . . . . 0.0 111.758 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -151.54 -174.82 4.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.92 0.888 . . . . 0.0 109.338 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.3 m -133.02 150.22 52.16 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.382 1.873 . . . . 0.0 106.583 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.64 -9.84 59.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.827 -0.546 . . . . 0.0 112.023 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.45 178.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 127.43 2.292 . . . . 0.0 107.378 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -79.19 -64.79 1.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -159.8 -39.54 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -105.81 34.42 3.31 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.793 1.237 . . . . 0.0 110.212 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.15 9.52 86.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.737 0.684 . . . . 0.0 113.336 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.42 134.37 88.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.227 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.19 48.47 2.54 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.652 2.901 . . . . 0.0 111.634 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.17 71.26 79.93 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.275 1.83 . . . . 0.0 106.483 -172.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -42.71 142.67 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.402 2.734 . . . . 0.0 118.25 -169.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.22 145.96 24.67 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.36 152.86 33.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.461 ' C ' HD23 ' A' ' 142' ' ' LEU . 16.8 t-20 -124.61 138.67 54.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 108.206 176.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.58 161.19 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.678 1.191 . . . . 0.0 108.456 -170.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.26 150.27 52.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.67 1.588 . . . . 0.0 108.465 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.69 124.76 27.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.36 -17.09 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 30.91 1.98 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.999 1.285 . . . . 0.0 114.059 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 C-N-CA 124.399 1.08 . . . . 0.0 109.957 174.229 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.529 0.204 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.57 162.5 2.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.668 0.747 . . . . 0.0 112.018 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 mm -133.25 145.83 33.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -137.35 164.45 28.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.6 mm -124.99 141.8 43.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.19 170.5 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.075 0.95 . . . . 0.0 109.771 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -61.67 148.97 40.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 p -62.59 167.0 4.74 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.19 1.796 . . . . 0.0 112.858 176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -118.69 135.48 54.46 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -55.72 -39.4 71.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.94 0.791 . . . . 0.0 111.73 -173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.64 -22.46 61.68 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -85.77 -4.18 59.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.829 0.74 . . . . 0.0 110.87 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.54 59.58 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.917 0.77 . . . . 0.0 113.107 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.65 -31.48 72.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.389 1.094 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.56 -30.82 69.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 109.631 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.2 mt -73.51 -39.47 64.8 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.7 -45.93 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 170.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.81 92.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.748 0.419 . . . . 0.0 111.129 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.66 -48.46 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.186 0.994 . . . . 0.0 109.927 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -53.24 -46.91 69.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 t -60.17 -43.93 95.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 110.525 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -63.95 -41.63 97.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.521 -0.737 . . . . 0.0 111.618 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -59.12 -39.78 83.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.553 0.741 . . . . 0.0 109.722 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.54 -45.86 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 123.56 0.744 . . . . 0.0 109.567 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.5 -35.07 73.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.918 0.781 . . . . 0.0 112.11 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.31 -46.41 27.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.76 0.824 . . . . 0.0 112.076 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 p -137.18 3.0 2.59 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -168.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.66 23.05 5.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.656 1.116 . . . . 0.0 110.63 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.99 -14.5 35.81 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.055 -1.028 . . . . 0.0 113.42 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.21 -21.83 15.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.242 1.817 . . . . 0.0 112.787 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.56 97.98 0.16 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.524 1.53 . . . . 0.0 108.27 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -58.84 156.85 10.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.133 0.973 . . . . 0.0 110.796 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.3 57.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -65.21 -51.68 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.495 0.589 . . . . 0.0 109.533 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 14.9 t80 -70.23 -33.7 71.97 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.864 -0.523 . . . . 0.0 110.553 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -55.14 -46.31 75.66 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.896 0.878 . . . . 0.0 109.566 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 m -64.76 -48.13 75.65 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.158 0.983 . . . . 0.0 110.187 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -62.55 -42.39 99.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.466 0.575 . . . . 0.0 110.775 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.11 -50.24 64.75 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.398 -0.81 . . . . 0.0 109.412 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.03 -39.27 74.49 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.263 0.938 . . . . 0.0 110.271 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.99 -49.89 74.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.723 0.692 . . . . 0.0 111.953 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -38.82 81.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.61 -48.15 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.009 1.723 . . . . 0.0 109.818 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -62.49 -22.08 65.98 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.913 0.885 . . . . 0.0 111.112 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -99.0 6.75 46.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.192 0.997 . . . . 0.0 110.941 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -136.84 -53.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.772 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.8 mt -59.05 -37.01 48.45 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 120.369 1.441 . . . . 0.0 112.73 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.64 -12.62 29.26 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 0.0 115.924 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.98 -21.19 5.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.602 1.546 . . . . 0.0 111.799 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.05 138.24 96.14 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 110.063 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -80.13 51.41 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.669 3.579 . . . . 0.0 110.761 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.47 164.93 3.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.374 1.47 . . . . 0.0 110.513 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -108.11 109.13 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 m -92.34 141.22 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 118.296 0.498 . . . . 0.0 110.015 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -85.33 133.28 34.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.89 143.07 42.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.23 -178.56 6.52 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.89 -23.87 8.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.715 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -75.32 -5.19 43.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.361 1.464 . . . . 0.0 111.982 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 t0 50.22 57.45 6.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 123.939 1.828 . . . . 0.0 109.64 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -139.59 128.13 13.48 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.57 139.85 41.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.618 2.212 . . . . 0.0 111.576 -169.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.79 -9.45 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.078 0.951 . . . . 0.0 111.968 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 175.5 42.16 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.63 42.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.628 0.714 . . . . 0.0 111.177 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.51 162.89 33.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 108.777 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 tp -122.99 129.09 51.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 tp -141.17 132.74 27.04 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 p -158.23 155.85 29.7 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.758 2.023 . . . . 0.0 105.837 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.11 36.18 56.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 121.445 -0.785 . . . . 0.0 113.896 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 58.33 21.97 8.87 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.957 1.703 . . . . 0.0 113.687 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -125.3 113.1 17.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.026 0.93 . . . . 0.0 110.296 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.6 ttp -85.5 90.46 7.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.65 -26.98 66.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -173.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.93 147.19 36.64 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.539 0.736 . . . . 0.0 109.67 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.8 tp -159.24 113.24 2.35 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.363 1.865 . . . . 0.0 106.137 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.21 140.74 29.46 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -150.52 148.38 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -62.59 125.94 87.22 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.45 -27.67 19.27 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 124.018 3.145 . . . . 0.0 115.39 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.14 -22.76 67.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.316 0.962 . . . . 0.0 112.57 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.05 -1.79 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.481 0.712 . . . . 0.0 112.753 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -57.11 -43.42 82.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.276 0.943 . . . . 0.0 109.655 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.17 74.63 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.5 0.571 . . . . 0.0 112.777 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -73.44 -8.36 55.59 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.234 1.017 . . . . 0.0 112.542 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.49 19.41 52.34 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.339 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.72 -30.21 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.315 1.557 . . . . 0.0 110.591 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.79 -50.42 20.24 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.95 0.785 . . . . 0.0 112.101 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.21 -44.17 97.18 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 118.658 1.229 . . . . 0.0 110.075 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.02 -45.8 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.924 1.238 . . . . 0.0 109.918 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -67.81 -41.46 83.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.913 -0.492 . . . . 0.0 110.687 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.42 -41.85 94.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.701 0.682 . . . . 0.0 110.234 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.07 -35.96 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.473 -0.767 . . . . 0.0 109.456 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.11 -45.39 94.89 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.719 0.408 . . . . 0.0 110.54 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.8 -48.89 75.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.713 0.405 . . . . 0.0 110.761 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.5 mt -59.98 -32.72 71.09 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.148 0.979 . . . . 0.0 111.437 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.12 -37.31 86.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.373 0.533 . . . . 0.0 111.565 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.2 mtm -86.84 -24.2 25.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.38 0.537 . . . . 0.0 112.288 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.36 94.73 7.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 125.389 1.476 . . . . 0.0 108.493 -172.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.34 -23.8 51.09 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.203 1.269 . . . . 0.0 112.243 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -99.42 28.65 4.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.718 1.607 . . . . 0.0 110.537 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.04 145.33 10.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.956 2.103 . . . . 0.0 113.547 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.7 p -129.25 163.14 26.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.479 1.511 . . . . 0.0 108.44 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.9 t -153.81 -173.5 4.6 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -147.52 161.88 40.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.179 0.992 . . . . 0.0 110.05 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.517 HG12 HD21 ' A' ' 142' ' ' LEU . 9.2 p -155.03 143.37 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.09 129.64 39.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.96 -37.38 74.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.512 0.725 . . . . 0.0 112.607 -170.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.23 -28.65 70.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.025 0.375 . . . . 0.0 111.476 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -78.12 66.47 3.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.72 0.772 . . . . 0.0 109.935 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.67 -24.87 62.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.21 -47.5 84.16 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.959 0.504 . . . . 0.0 109.841 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.22 79.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.595 176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.9 t -56.79 -46.2 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.172 0.896 . . . . 0.0 108.972 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.59 62.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.95 -49.66 70.81 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 124.036 0.934 . . . . 0.0 110.612 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -66.81 -35.34 79.83 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -66.18 -37.92 86.79 Favored 'General case' 0 C--N 1.34 0.167 0 O-C-N 120.837 -1.164 . . . . 0.0 112.508 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.19 -43.29 92.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.932 1.242 . . . . 0.0 110.177 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.41 -34.7 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.317 1.047 . . . . 0.0 110.793 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.48 8.8 1.92 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.397 0.998 . . . . 0.0 114.518 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -76.16 162.42 28.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.61 1.705 . . . . 0.0 111.407 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -147.42 140.67 25.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.221 1.808 . . . . 0.0 106.362 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.578 HG22 HD22 ' A' ' 142' ' ' LEU . 26.1 t -72.65 132.5 33.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.061 0.945 . . . . 0.0 109.78 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 p -127.44 -9.3 5.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.741 2.016 . . . . 0.0 111.691 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.13 177.18 41.26 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -158.46 -174.08 4.62 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.05 -0.677 . . . . 0.0 110.576 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m -138.91 170.68 15.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.276 2.23 . . . . 0.0 107.495 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -116.91 -3.8 11.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.749 0.82 . . . . 0.0 111.407 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.13 178.8 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.887 2.475 . . . . 0.0 106.401 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -85.26 -70.22 0.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 122.551 0.34 . . . . 0.0 110.478 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -160.56 -41.1 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.451 0.7 . . . . 0.0 112.506 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.33 16.01 2.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.529 1.132 . . . . 0.0 111.114 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.97 8.53 83.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.355 0.979 . . . . 0.0 112.935 -170.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 7.9 ptmt -86.53 141.36 34.22 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.486 1.143 . . . . 0.0 110.473 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.26 73.89 5.81 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.672 2.915 . . . . 0.0 111.718 -172.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -131.94 65.26 75.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -57.35 161.0 12.3 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.067 2.511 . . . . 0.0 116.16 -168.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.0 tp -116.59 147.52 41.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 107.106 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.1 mt -116.01 147.74 40.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.506 ' C ' HD23 ' A' ' 142' ' ' LEU . 9.0 t-20 -118.75 139.26 51.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.96 160.25 39.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.111 0.964 . . . . 0.0 108.446 -170.239 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.37 151.78 51.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.63 1.572 . . . . 0.0 108.384 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.51 129.62 36.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 78.7 t -130.68 -10.41 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.18 1.392 . . . . 0.0 110.127 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.99 55.93 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.904 1.24 . . . . 0.0 113.91 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.849 2.059 . . . . 0.0 107.557 171.871 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.68 142.7 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -133.04 141.34 45.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -140.81 164.99 28.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -123.7 143.33 37.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -149.77 173.14 14.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 123.413 0.685 . . . . 0.0 110.376 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -65.26 147.66 53.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -71.99 179.36 3.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.863 1.265 . . . . 0.0 111.44 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -130.22 161.03 32.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.641 1.576 . . . . 0.0 107.131 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -69.15 -39.75 78.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.369 -0.207 . . . . 0.0 110.643 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.1 -37.2 75.31 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.679 0.392 . . . . 0.0 111.729 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.11 -2.95 26.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.172 0.589 . . . . 0.0 112.039 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.68 -39.5 31.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.267 0.937 . . . . 0.0 113.125 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.11 -28.51 68.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 111.969 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.07 -32.0 72.88 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 109.536 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -75.65 -39.22 58.02 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -56.83 -46.87 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.487 0.715 . . . . 0.0 109.203 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.29 95.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.95 0.5 . . . . 0.0 111.043 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.85 -54.08 36.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -51.76 -44.82 63.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.543 0.737 . . . . 0.0 110.255 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t -59.75 -42.28 92.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.635 0.374 . . . . 0.0 110.57 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -66.5 -43.23 85.9 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.611 -0.681 . . . . 0.0 111.006 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -58.92 -39.15 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.543 0.611 . . . . 0.0 110.305 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.61 -46.01 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.871 0.868 . . . . 0.0 109.765 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.16 -34.12 73.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.766 0.712 . . . . 0.0 111.968 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.36 -47.14 24.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.557 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.1 p -137.2 5.23 2.75 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -168.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -129.56 23.65 5.46 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.275 0.943 . . . . 0.0 110.175 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.4 -16.31 34.52 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.432 1.093 . . . . 0.0 113.624 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.77 -23.11 4.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.034 2.133 . . . . 0.0 113.221 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.1 94.37 0.34 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 m -53.9 156.55 2.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.253 1.421 . . . . 0.0 111.163 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.59 62.39 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.68 -48.01 73.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 109.973 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -67.39 -38.52 84.83 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.1 -47.94 71.24 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.628 1.171 . . . . 0.0 109.976 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.06 -49.89 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.113 0.965 . . . . 0.0 110.193 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.43 -37.09 82.5 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.081 -0.387 . . . . 0.0 110.739 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.95 -51.56 63.84 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.354 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -57.68 -37.58 73.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.467 1.03 . . . . 0.0 110.732 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.75 -48.37 74.83 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.139 0.575 . . . . 0.0 111.991 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -36.43 72.8 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -59.34 -47.35 90.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.076 1.75 . . . . 0.0 109.123 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -70.36 -11.06 60.66 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.852 -1.155 . . . . 0.0 112.707 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.2 4.85 52.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.621 0.768 . . . . 0.0 110.724 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -135.26 -54.49 0.8 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.887 -169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.0 -39.23 74.48 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.764 1.62 . . . . 0.0 112.703 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.33 -9.91 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.421 2.081 . . . . 0.0 114.883 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.63 -22.92 4.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.562 1.528 . . . . 0.0 112.332 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.83 152.06 96.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.62 65.91 8.07 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.887 3.724 . . . . 0.0 110.835 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.38 175.44 7.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.143 1.377 . . . . 0.0 112.023 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -133.71 151.0 51.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.6 2.36 . . . . 0.0 105.329 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.49 138.99 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.083 0.953 . . . . 0.0 110.886 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.03 132.65 35.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.72 142.81 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -83.4 -171.25 3.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.586 1.554 . . . . 0.0 110.656 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.39 8.31 0.05 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.215 2.206 . . . . 0.0 113.957 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -122.31 10.2 9.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 119.917 -1.739 . . . . 0.0 111.212 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 53.37 32.08 13.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.832 1.301 . . . . 0.0 111.127 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -116.68 132.4 23.4 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -169.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.59 138.0 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 112.367 -169.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.92 -10.0 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.431 1.093 . . . . 0.0 112.091 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.35 169.76 39.99 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -142.08 159.73 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.613 0.765 . . . . 0.0 111.239 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -139.74 136.0 33.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.569 2.347 . . . . 0.0 105.862 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -117.99 122.42 43.16 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -146.28 131.34 18.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.9 m -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.24 -114.06 4.31 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -129.11 14.82 6.25 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.791 0.836 . . . . 0.0 112.208 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.85 113.62 26.72 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.755 1.161 . . . . 0.0 110.735 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.621 ' HB2' HD11 ' A' ' 102' ' ' LEU . 64.8 ttp -83.23 85.41 7.21 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.07 -23.64 64.97 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.94 148.08 31.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.486 0.585 . . . . 0.0 110.606 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.3 tp -156.57 114.58 3.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -143.59 141.6 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.54 150.32 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.14 122.33 69.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.97 -27.49 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 124.334 3.356 . . . . 0.0 114.985 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.92 -23.45 65.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 112.856 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.15 -1.27 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.699 0.8 . . . . 0.0 112.782 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -57.12 -39.96 76.15 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.888 -1.133 . . . . 0.0 110.328 169.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.26 -27.96 71.49 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.473 0.559 . . . . 0.0 112.917 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.7 m -76.22 -6.52 51.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 112.34 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.25 60.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.245 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -54.8 -31.81 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.137 1.469 . . . . 0.0 110.74 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.42 -48.11 34.69 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.972 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -65.7 -40.56 92.42 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.483 1.141 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.9 t -58.86 -46.34 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.681 0.673 . . . . 0.0 109.597 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.86 -38.72 79.94 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.786 -0.571 . . . . 0.0 111.032 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.1 -40.13 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.804 0.729 . . . . 0.0 109.783 174.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.96 -37.31 86.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.058 1.299 . . . . 0.0 110.497 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.52 -46.97 87.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.113 0.482 . . . . 0.0 110.557 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.67 78.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.685 0.794 . . . . 0.0 110.92 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 mt -58.12 -34.44 70.22 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.053 1.341 . . . . 0.0 111.44 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.4 m -62.4 -32.48 73.31 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.277 0.489 . . . . 0.0 111.68 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.1 mtm -89.93 -25.26 21.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.464 0.574 . . . . 0.0 112.092 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.01 89.94 12.35 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.092 1.357 . . . . 0.0 109.263 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.55 -22.26 58.72 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.502 1.468 . . . . 0.0 113.192 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.38 31.55 5.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.492 1.517 . . . . 0.0 110.008 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 73' ' ' MET . 31.9 tp -48.16 142.68 5.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.507 2.323 . . . . 0.0 112.749 -171.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -126.15 161.05 28.56 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.334 1.453 . . . . 0.0 108.613 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -153.03 -176.23 5.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.723 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -147.17 160.76 42.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.585 1.154 . . . . 0.0 110.422 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.4 144.36 7.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.8 130.24 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.88 -31.61 62.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.585 0.63 . . . . 0.0 111.943 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -60.34 -32.36 71.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.654 0.782 . . . . 0.0 111.857 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -80.76 67.36 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.789 0.804 . . . . 0.0 109.535 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.8 -25.22 60.28 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.78 0.832 . . . . 0.0 111.405 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.64 -49.26 73.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.035 0.534 . . . . 0.0 110.017 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.41 -35.25 77.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.681 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.4 t -57.03 -49.2 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.94 -47.69 90.02 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -55.85 -51.3 68.01 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.578 0.751 . . . . 0.0 109.651 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.59 -34.77 78.62 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.791 -0.568 . . . . 0.0 109.787 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.98 -45.88 91.24 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.062 -1.024 . . . . 0.0 111.167 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -59.06 -39.71 82.89 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.256 0.934 . . . . 0.0 110.881 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.08 -39.07 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.514 0.726 . . . . 0.0 110.407 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.15 13.21 0.69 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.501 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -80.93 156.06 26.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.803 1.801 . . . . 0.0 111.652 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -144.43 140.76 29.18 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.444 1.897 . . . . 0.0 107.261 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.506 HG22 HD22 ' A' ' 142' ' ' LEU . 21.6 t -71.12 137.94 22.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.06 0.944 . . . . 0.0 110.318 -169.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.2 p -131.12 -9.73 3.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.809 2.044 . . . . 0.0 111.59 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.23 173.27 42.41 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.84 -173.63 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.873 0.836 . . . . 0.0 111.259 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -137.11 174.22 10.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.488 1.915 . . . . 0.0 108.542 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -122.74 -7.92 8.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.936 0.894 . . . . 0.0 111.599 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.94 172.68 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.708 2.003 . . . . 0.0 106.542 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -78.5 -64.7 1.11 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -161.22 -43.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.346 1.058 . . . . 0.0 112.126 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.99 -5.17 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.528 0.731 . . . . 0.0 112.083 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.1 -14.47 21.32 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.036 1.303 . . . . 0.0 112.502 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -60.63 138.59 92.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.055 0.928 . . . . 0.0 110.422 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.13 52.56 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.224 3.282 . . . . 0.0 112.413 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -121.88 66.74 21.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.52 1.128 . . . . 0.0 108.571 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.55 156.81 54.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.773 2.315 . . . . 0.0 114.699 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.15 142.98 33.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.39 149.62 29.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -123.01 137.9 54.83 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.506 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.65 161.84 35.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.47 146.54 51.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.662 1.585 . . . . 0.0 108.897 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.04 127.03 31.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.47 -12.75 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 111.943 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.87 29.07 3.09 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.558 1.075 . . . . 0.0 113.902 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 124.396 1.078 . . . . 0.0 110.054 176.302 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.06 179.92 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 107.011 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 mm -137.36 145.24 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -144.15 166.01 26.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -125.66 141.85 44.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.78 170.31 21.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 109.998 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -59.07 146.94 36.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 109.818 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 p -62.51 157.91 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.961 1.704 . . . . 0.0 112.595 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -106.55 155.18 19.89 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -67.92 -42.09 81.59 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.711 -0.618 . . . . 0.0 110.648 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.45 -25.66 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.07 -0.06 53.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.059 0.544 . . . . 0.0 111.4 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.21 -41.77 47.71 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 118.998 0.817 . . . . 0.0 113.281 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.78 -26.05 65.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.645 1.223 . . . . 0.0 111.901 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.54 -30.73 67.55 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.281 -0.887 . . . . 0.0 109.621 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 mt -73.01 -39.9 65.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.18 -45.02 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 109.456 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.94 98.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.831 0.452 . . . . 0.0 111.635 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.96 -49.56 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.589 0.756 . . . . 0.0 109.401 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -55.01 -47.79 74.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.688 0.395 . . . . 0.0 110.232 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -59.97 -44.52 94.41 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -64.4 -33.37 75.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.614 0.766 . . . . 0.0 111.813 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -68.4 -39.93 81.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.8 t -66.29 -47.25 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.07 -32.36 66.17 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.754 0.821 . . . . 0.0 112.65 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 -43.04 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.024 0.929 . . . . 0.0 112.482 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.7 p -138.76 -1.41 1.82 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -168.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -135.24 17.84 3.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.381 1.446 . . . . 0.0 112.326 -172.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.48 1.34 0.82 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.766 2.027 . . . . 0.0 114.368 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -59.41 -24.24 63.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.322 1.849 . . . . 0.0 112.523 172.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.08 112.21 2.53 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 m -56.91 154.37 9.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.971 1.308 . . . . 0.0 110.766 172.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.28 -36.75 71.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.2 -47.08 71.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.749 0.704 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -64.72 -40.24 95.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.282 0.633 . . . . 0.0 109.821 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -55.36 -48.56 74.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.611 1.164 . . . . 0.0 110.139 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.8 m -65.08 -49.18 71.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.177 0.991 . . . . 0.0 110.041 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -65.95 -38.45 88.65 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.223 -0.298 . . . . 0.0 110.641 -176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.78 -53.58 52.12 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.386 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.78 -38.22 75.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.244 0.929 . . . . 0.0 110.789 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.99 -48.81 72.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 111.857 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -36.54 75.34 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.177 0.444 . . . . 0.0 110.192 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.87 -48.95 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 126.071 1.748 . . . . 0.0 109.091 172.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -70.3 -10.56 59.31 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.001 -1.062 . . . . 0.0 112.742 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.46 4.2 53.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.625 0.77 . . . . 0.0 110.608 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -135.14 -56.58 0.81 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.805 -1.093 . . . . 0.0 112.336 -169.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.89 -38.65 70.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.644 1.565 . . . . 0.0 113.211 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 -14.8 36.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.422 2.081 . . . . 0.0 115.052 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.72 -13.82 5.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.484 1.493 . . . . 0.0 112.73 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.75 150.55 96.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.844 1.257 . . . . 0.0 111.166 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.78 55.94 5.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.663 3.575 . . . . 0.0 111.94 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.98 155.04 26.61 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.349 1.06 . . . . 0.0 111.146 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -111.32 109.7 19.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.66 138.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.44 133.88 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -126.47 141.5 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -83.71 178.74 7.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.05 -23.93 0.95 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.869 2.068 . . . . 0.0 114.661 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -79.27 -3.34 45.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.669 1.588 . . . . 0.0 112.274 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t0 50.76 57.69 6.36 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.929 1.823 . . . . 0.0 109.69 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -140.63 126.35 11.43 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 141.95 54.02 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.468 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.05 -8.67 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.372 1.069 . . . . 0.0 112.304 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.75 171.55 39.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.42 153.06 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.81 0.805 . . . . 0.0 110.667 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -136.91 132.02 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.539 2.336 . . . . 0.0 105.667 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.75 117.37 31.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.78 133.47 25.27 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 m -143.04 152.74 42.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.76 -114.89 5.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -130.68 27.66 4.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 110.679 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -125.58 111.47 15.05 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.53 -0.731 . . . . 0.0 110.458 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -79.39 89.02 4.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.23 -29.26 70.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.924 0.89 . . . . 0.0 112.979 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.95 148.81 29.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.826 0.851 . . . . 0.0 110.488 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 tp -155.36 119.37 4.58 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.0 1.72 . . . . 0.0 106.463 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.12 144.31 30.85 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -151.43 142.93 16.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.9 133.81 95.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.547 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.67 -24.31 70.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.755 2.303 . . . . 0.0 113.729 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.59 -24.2 67.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.416 1.007 . . . . 0.0 112.902 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.42 -1.22 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -59.91 -38.49 82.49 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.978 -1.076 . . . . 0.0 110.223 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.02 72.09 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.563 0.601 . . . . 0.0 112.776 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.1 m -75.03 -6.5 49.75 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.229 1.014 . . . . 0.0 112.214 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.39 13.73 65.1 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.377 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.64 -31.2 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 119.255 1.527 . . . . 0.0 111.088 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.27 -54.38 10.23 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.947 0.784 . . . . 0.0 111.95 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -64.32 -43.76 93.66 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.031 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 t -56.78 -46.66 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 120.453 1.479 . . . . 0.0 110.179 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.15 -40.33 78.29 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.349 0.522 . . . . 0.0 111.147 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.55 -40.94 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.713 0.688 . . . . 0.0 109.883 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.71 -34.45 77.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.21 0.914 . . . . 0.0 109.87 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -61.2 -46.79 88.99 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.404 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.73 80.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.268 0.627 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.97 -33.18 71.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 111.459 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -63.18 -36.61 84.19 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.486 0.584 . . . . 0.0 111.392 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.4 mtm -85.17 -23.95 28.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.32 0.509 . . . . 0.0 112.117 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.42 95.19 6.63 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 125.123 1.369 . . . . 0.0 109.184 -173.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.16 -25.99 50.19 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 121.29 1.326 . . . . 0.0 112.554 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.03 31.52 3.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.822 1.649 . . . . 0.0 110.369 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.9 tp -49.63 146.37 4.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.662 2.385 . . . . 0.0 113.118 -172.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.9 p -129.94 162.91 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.558 1.543 . . . . 0.0 108.969 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 t -155.76 -178.05 7.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.736 0.414 . . . . 0.0 110.548 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.13 155.39 50.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.621 1.569 . . . . 0.0 108.782 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.63 146.44 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -77.52 138.9 39.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -63.13 -24.19 67.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.637 0.375 . . . . 0.0 111.932 -176.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.97 -40.46 70.04 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.398 0.679 . . . . 0.0 111.538 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -86.15 63.81 8.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.551 1.141 . . . . 0.0 109.331 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.73 -28.27 47.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.207 1.003 . . . . 0.0 111.316 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -47.04 83.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.718 0.807 . . . . 0.0 109.802 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.17 78.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.907 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.14 -49.46 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 119.57 1.077 . . . . 0.0 108.476 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.84 93.59 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -56.2 -50.6 70.78 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.536 0.735 . . . . 0.0 110.147 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -67.13 -33.88 76.39 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.88 -0.513 . . . . 0.0 109.822 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -59.29 -47.09 86.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.144 0.884 . . . . 0.0 110.901 170.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -58.81 -42.68 89.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.986 0.812 . . . . 0.0 110.429 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.03 -36.61 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.932 0.893 . . . . 0.0 110.737 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 136.02 9.86 1.42 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.8 -1.0 . . . . 0.0 114.638 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.38 155.49 30.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.87 1.835 . . . . 0.0 111.252 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.49 138.99 33.21 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.147 1.779 . . . . 0.0 106.574 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.492 HG22 HD22 ' A' ' 142' ' ' LEU . 25.9 t -71.73 135.03 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.17 0.988 . . . . 0.0 109.995 -171.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 p -126.77 -8.69 6.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.951 2.1 . . . . 0.0 111.481 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.3 43.94 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.901 0.773 . . . . 0.0 111.735 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -154.66 176.1 12.85 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.653 0.781 . . . . 0.0 110.185 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.2 m -147.11 136.95 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.679 2.392 . . . . 0.0 106.089 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.51 0.41 38.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.477 0.581 . . . . 0.0 112.371 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.27 172.32 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.948 1.699 . . . . 0.0 107.245 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.98 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.22 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -158.3 -48.45 0.06 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 27.06 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.352 1.061 . . . . 0.0 110.194 -177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.99 71.26 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.318 0.961 . . . . 0.0 113.127 -170.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -65.53 133.65 95.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -78.59 45.21 1.81 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.883 3.056 . . . . 0.0 112.438 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.57 112.82 15.29 Favored Pre-proline 0 N--CA 1.455 -0.189 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.0 162.93 8.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.09 1.86 . . . . 0.0 115.547 -173.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.42 145.64 50.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.2 mt -116.69 150.1 38.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.429 ' C ' HD23 ' A' ' 142' ' ' LEU . 16.6 t-20 -120.16 138.87 53.35 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.492 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.89 160.83 38.25 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.398 1.079 . . . . 0.0 108.591 -170.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.9 150.97 52.11 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.706 1.602 . . . . 0.0 108.569 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -76.46 124.84 28.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 99.6 t -130.53 -18.62 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.407 1.083 . . . . 0.0 110.434 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.99 29.52 2.42 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.787 1.184 . . . . 0.0 114.106 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.403 1.081 . . . . 0.0 110.004 175.019 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.94 158.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.458 0.647 . . . . 0.0 111.464 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 mm -138.14 144.77 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -140.78 165.35 27.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 168.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mm -127.12 143.18 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -155.02 170.63 21.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.041 0.937 . . . . 0.0 109.822 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -59.02 147.8 33.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.489 0.586 . . . . 0.0 109.905 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p -63.4 154.41 32.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.584 1.553 . . . . 0.0 112.6 174.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -100.16 155.28 17.83 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -65.48 -48.51 72.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.852 -0.53 . . . . 0.0 110.278 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.24 -27.33 64.37 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -169.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.5 -5.76 51.18 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.141 0.428 . . . . 0.0 111.497 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.37 -35.64 36.01 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 124.184 0.897 . . . . 0.0 113.355 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -66.72 -31.51 72.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.293 1.047 . . . . 0.0 111.281 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.96 -31.32 70.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.402 0.681 . . . . 0.0 109.587 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.38 -39.74 64.88 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.792 -0.567 . . . . 0.0 109.774 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -57.89 -46.11 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 171.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.13 99.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 111.688 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.3 mt -62.11 -50.27 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 109.432 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -51.98 -47.88 64.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.534 . . . . 0.0 110.269 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 t -58.62 -50.39 74.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.153 0.433 . . . . 0.0 110.747 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -70.74 -28.18 64.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.504 -0.748 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -63.16 -44.92 94.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.081 0.855 . . . . 0.0 109.435 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.89 -42.54 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.772 0.829 . . . . 0.0 109.425 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.37 -35.05 73.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.021 0.828 . . . . 0.0 111.888 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.47 -36.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.111 -0.947 . . . . 0.0 113.1 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -136.58 -13.41 1.74 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.76 29.64 4.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.129 0.971 . . . . 0.0 110.572 -169.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -12.76 11.4 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.289 1.436 . . . . 0.0 113.495 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -51.61 -23.0 3.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.333 1.853 . . . . 0.0 113.203 169.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.34 97.78 0.43 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.667 1.187 . . . . 0.0 108.741 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -54.35 157.82 2.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.999 1.319 . . . . 0.0 110.712 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.42 64.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -46.81 72.37 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.901 0.773 . . . . 0.0 110.246 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.16 -40.89 97.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.632 0.773 . . . . 0.0 109.715 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -56.65 -47.28 80.09 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 124.256 1.022 . . . . 0.0 109.992 175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 m -65.78 -47.03 76.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.242 1.017 . . . . 0.0 110.393 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.0 -36.97 83.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.228 0.467 . . . . 0.0 110.712 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.91 -49.92 66.3 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.68 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.09 -39.45 72.14 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.126 0.875 . . . . 0.0 110.27 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.92 -48.33 80.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.809 0.731 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.69 -38.9 77.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -58.88 -47.55 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.979 1.711 . . . . 0.0 109.781 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -60.82 -24.22 65.68 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.367 1.067 . . . . 0.0 111.121 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -99.66 7.13 45.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.316 1.046 . . . . 0.0 110.969 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -136.96 -54.08 0.71 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.81 -169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.26 -37.76 60.75 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.642 1.565 . . . . 0.0 113.048 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -61.84 -14.15 34.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.337 2.025 . . . . 0.0 115.479 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.32 -14.6 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.645 1.566 . . . . 0.0 112.48 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 150.15 93.28 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.835 1.254 . . . . 0.0 110.834 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.28 50.83 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.56 3.506 . . . . 0.0 111.675 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.36 162.05 29.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.461 1.104 . . . . 0.0 110.993 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.06 117.03 28.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -99.06 140.08 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.24 0.616 . . . . 0.0 109.992 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.88 137.83 34.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.92 144.52 37.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -85.43 -175.62 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.586 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.79 -25.3 40.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.335 1.454 . . . . 0.0 113.415 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -79.75 -1.66 39.6 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.04 0.936 . . . . 0.0 111.498 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.4 t0 51.98 57.43 6.5 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.558 1.647 . . . . 0.0 109.238 -169.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -136.35 127.59 16.85 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.26 141.34 47.01 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.498 2.132 . . . . 0.0 111.681 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.17 -11.74 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 112.103 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.25 172.69 41.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.5 160.96 40.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.545 0.688 . . . . 0.0 111.494 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -140.29 137.1 33.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.068 2.547 . . . . 0.0 106.1 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.2 tp -115.48 127.52 55.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -144.36 140.87 29.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -154.21 155.81 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.19 -114.24 4.85 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -169.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -133.98 36.81 3.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.641 1.177 . . . . 0.0 110.043 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -134.05 115.38 14.24 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 121.212 -0.93 . . . . 0.0 111.34 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 56.1 ttp -86.2 90.41 8.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.95 -29.31 67.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.75 144.69 35.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.218 0.607 . . . . 0.0 110.799 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.0 tp -157.12 115.47 3.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.451 1.901 . . . . 0.0 106.14 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.69 141.35 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -151.4 146.21 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -59.24 122.13 61.19 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.27 -24.47 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.815 3.01 . . . . 0.0 115.36 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.43 -25.14 67.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.244 0.929 . . . . 0.0 112.75 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.45 -8.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -46.99 -41.61 16.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.005 1.322 . . . . 0.0 111.799 171.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.43 -12.22 65.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.866 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.9 -22.18 62.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.317 1.558 . . . . 0.0 112.109 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 137.18 -9.17 3.83 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.031 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.66 -32.17 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 119.161 1.48 . . . . 0.0 111.278 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.92 -53.92 16.31 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 123.538 0.589 . . . . 0.0 111.656 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -63.57 -42.4 98.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.262 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.72 -46.46 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.593 1.542 . . . . 0.0 109.932 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.4 mt -68.28 -41.81 80.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.982 -0.448 . . . . 0.0 110.77 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.74 -42.87 96.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.535 0.607 . . . . 0.0 110.181 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.52 -36.22 82.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.561 0.745 . . . . 0.0 109.59 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.82 -44.97 93.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.884 0.474 . . . . 0.0 110.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.34 63.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.158 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.72 -31.13 67.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.393 1.077 . . . . 0.0 111.782 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.82 -31.79 72.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.759 0.709 . . . . 0.0 111.969 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.0 mtm -91.77 -20.79 21.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.286 0.635 . . . . 0.0 112.208 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 94.88 6.1 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.532 1.533 . . . . 0.0 108.175 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.99 -21.83 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 CA-C-N 120.738 1.299 . . . . 0.0 112.887 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -104.52 30.28 5.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.721 1.608 . . . . 0.0 110.182 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.93 149.16 12.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.477 2.311 . . . . 0.0 113.56 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p -128.04 162.1 27.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.188 1.395 . . . . 0.0 109.811 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 t -152.72 -174.12 4.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 109.75 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -147.85 162.59 38.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.231 1.012 . . . . 0.0 109.994 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -157.0 143.49 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -71.04 133.74 46.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.88 -31.73 70.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 0.0 111.782 -172.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.17 -32.2 73.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.848 0.459 . . . . 0.0 111.465 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -80.58 61.56 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.865 1.266 . . . . 0.0 109.143 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.92 -26.37 47.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.479 1.112 . . . . 0.0 111.381 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -47.65 81.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.6 75.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.83 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.0 t -57.02 -48.53 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 119.578 1.081 . . . . 0.0 108.484 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.76 93.9 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.92 -51.11 67.09 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 123.633 0.773 . . . . 0.0 110.02 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.76 -34.53 78.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.027 -0.42 . . . . 0.0 109.956 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.28 -47.91 82.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.246 0.93 . . . . 0.0 110.778 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -58.85 -41.6 87.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.051 0.841 . . . . 0.0 110.757 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.77 -36.07 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.091 0.957 . . . . 0.0 110.478 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.91 9.51 1.7 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.338 0.97 . . . . 0.0 114.272 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.92 154.84 35.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.222 1.511 . . . . 0.0 111.449 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -139.62 138.66 36.33 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.637 1.575 . . . . 0.0 106.759 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 142' ' ' LEU . 25.6 t -72.64 135.28 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.214 1.006 . . . . 0.0 109.86 -171.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 p -125.12 -9.75 7.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.714 2.006 . . . . 0.0 111.327 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.17 179.77 43.57 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 118.755 0.707 . . . . 0.0 111.43 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -154.8 179.0 9.51 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 109.246 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -145.44 141.64 28.56 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 107.96 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.48 -3.58 25.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.736 0.814 . . . . 0.0 112.693 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 m -134.67 171.51 17.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.559 1.544 . . . . 0.0 107.602 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.98 -57.31 3.35 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -163.48 -41.22 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.811 0.845 . . . . 0.0 112.745 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.0 mt -89.04 9.67 24.42 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.072 0.949 . . . . 0.0 111.691 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.53 -9.21 77.71 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.512 1.054 . . . . 0.0 112.742 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -63.17 132.41 95.08 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.184 0.993 . . . . 0.0 110.44 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.75 62.64 8.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.236 3.291 . . . . 0.0 112.131 -170.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.84 74.68 80.71 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -36.82 147.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 125.074 3.849 . . . . 0.0 118.902 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.22 148.27 32.18 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.661 1.584 . . . . 0.0 107.255 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.9 mt -113.77 148.33 36.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.443 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.2 t-20 -119.09 138.27 53.0 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.756 1.223 . . . . 0.0 107.753 175.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.517 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.14 162.47 33.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 108.525 -171.122 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.02 51.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.792 1.637 . . . . 0.0 108.134 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -72.48 127.2 31.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.2 -9.98 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.191 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.72 38.14 89.54 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 124.907 1.283 . . . . 0.0 111.033 178.925 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.401 0.143 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.5 t -60.05 151.22 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.54 0.736 . . . . 0.0 109.499 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -128.46 146.22 34.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.61 167.14 22.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 168.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 HD12 ' CD2' ' A' ' 91' ' ' LEU . 13.5 mm -126.22 142.87 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -154.53 171.56 19.23 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.881 0.872 . . . . 0.0 109.955 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -61.31 150.31 35.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.544 0.611 . . . . 0.0 109.781 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 p -60.11 162.56 5.66 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.037 1.335 . . . . 0.0 112.046 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -120.82 139.18 53.5 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.489 1.916 . . . . 0.0 106.131 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -57.44 -41.45 80.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.474 0.579 . . . . 0.0 111.563 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.53 -19.3 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -88.56 -2.59 58.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.863 0.756 . . . . 0.0 111.33 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.52 -39.17 44.53 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 118.92 0.782 . . . . 0.0 113.467 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.88 -28.94 70.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.195 0.998 . . . . 0.0 112.13 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.33 -35.6 81.48 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 118.868 0.758 . . . . 0.0 109.647 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.3 -39.31 59.75 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.6 t -58.46 -45.58 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.284 0.634 . . . . 0.0 109.411 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.59 91.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.339 0.656 . . . . 0.0 112.176 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.36 -49.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.695 1.198 . . . . 0.0 109.258 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -55.87 -45.72 78.46 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.864 -0.523 . . . . 0.0 110.319 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.3 t -59.91 -49.74 76.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.739 0.816 . . . . 0.0 110.903 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.52 -25.72 64.17 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.018 -1.051 . . . . 0.0 111.976 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 m -68.6 -34.32 75.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.049 0.841 . . . . 0.0 110.595 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.1 -46.48 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.5 -40.67 92.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.38 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.448 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 p -137.9 3.14 2.44 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -168.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' CE1' HD22 ' A' ' 110' ' ' ASN . 15.9 m80 -126.99 37.53 4.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.324 1.42 . . . . 0.0 109.305 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.25 -27.47 55.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.353 1.061 . . . . 0.0 113.784 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.09 -17.19 64.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.534 0.734 . . . . 0.0 112.957 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.9 127.14 30.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.531 1.132 . . . . 0.0 110.783 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -56.48 138.08 52.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.096 1.358 . . . . 0.0 110.055 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.57 80.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.078 0.399 . . . . 0.0 112.024 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -66.17 -42.86 88.34 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.783 -0.573 . . . . 0.0 109.696 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.66 -38.89 84.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.37 -52.93 57.69 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.887 0.875 . . . . 0.0 109.329 172.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.9 m -59.39 -49.07 79.23 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 110.321 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.12 -35.37 71.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.29 -0.256 . . . . 0.0 111.18 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.81 -49.7 73.9 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.14 -36.59 77.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.052 0.842 . . . . 0.0 110.441 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.08 -47.89 80.97 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.014 0.525 . . . . 0.0 111.907 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -36.56 71.16 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.122 -0.361 . . . . 0.0 110.104 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.46 -46.99 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.111 1.765 . . . . 0.0 109.229 172.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -70.25 -9.05 54.77 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.797 -1.19 . . . . 0.0 112.555 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -101.28 6.68 42.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.174 0.99 . . . . 0.0 110.891 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.99 -55.1 0.72 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.653 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.45 -38.4 68.03 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 120.57 1.532 . . . . 0.0 112.932 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -61.46 -14.18 33.51 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.323 2.015 . . . . 0.0 114.94 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.63 -17.45 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.596 1.544 . . . . 0.0 112.38 -174.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.34 148.37 98.03 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.585 1.154 . . . . 0.0 110.826 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.39 51.48 3.89 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.942 3.762 . . . . 0.0 111.373 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.34 165.48 20.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.595 1.158 . . . . 0.0 110.691 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -118.38 109.77 16.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.04 138.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.191 0.596 . . . . 0.0 109.663 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.9 134.27 35.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 167.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.35 143.86 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -77.04 -177.32 4.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.172 0.987 . . . . 0.0 110.12 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.0 -17.86 20.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.446 1.898 . . . . 0.0 113.552 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.71 4.56 53.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.383 1.473 . . . . 0.0 112.046 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.6 t0 53.27 46.25 26.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.716 1.246 . . . . 0.0 110.235 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 129.19 24.21 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.86 138.96 71.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.85 1.7 . . . . 0.0 110.282 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.7 -8.89 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.714 1.205 . . . . 0.0 112.233 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.83 174.2 40.78 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -148.16 159.49 43.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.804 0.802 . . . . 0.0 111.517 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -136.97 141.25 42.59 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.329 2.652 . . . . 0.0 105.826 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -122.9 127.34 48.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 tp -145.37 139.85 27.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.7 m -153.25 156.3 38.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.2 -116.12 7.0 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -169.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.0 25.78 4.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.874 0.87 . . . . 0.0 111.51 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -110.9 112.36 24.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.306 1.042 . . . . 0.0 110.685 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.6 ttp -80.04 87.27 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 169.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.1 -23.02 65.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.12 146.55 30.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.447 0.567 . . . . 0.0 110.263 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.9 tp -156.08 116.05 3.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.74 141.4 30.45 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -148.11 146.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -59.64 122.76 67.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.06 -29.59 6.46 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.049 3.166 . . . . 0.0 114.638 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.38 -24.53 67.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.187 0.995 . . . . 0.0 113.563 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.77 -1.51 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -58.16 -37.4 74.61 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.905 -1.122 . . . . 0.0 110.67 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.27 -21.58 68.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.824 0.726 . . . . 0.0 113.394 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.7 m -79.36 -3.35 45.84 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.635 1.217 . . . . 0.0 111.846 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.97 68.44 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.359 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.7 -31.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.196 1.498 . . . . 0.0 110.994 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.9 -53.52 13.9 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 123.831 0.729 . . . . 0.0 111.722 170.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -63.25 -43.24 98.57 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.213 -1.375 . . . . 0.0 110.19 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -57.83 -46.27 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 120.356 1.435 . . . . 0.0 110.076 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.411 ' CD2' HD12 ' A' ' 5' ' ' ILE . 24.7 mt -69.36 -40.59 77.39 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.803 -0.561 . . . . 0.0 111.144 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.2 t -62.69 -41.24 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.646 0.657 . . . . 0.0 109.991 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.91 -34.13 76.04 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.124 0.875 . . . . 0.0 109.876 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.1 -47.04 87.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.231 0.469 . . . . 0.0 110.261 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.64 75.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.419 0.688 . . . . 0.0 110.785 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.17 -34.07 69.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.532 1.133 . . . . 0.0 111.458 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.72 -34.11 76.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.447 0.567 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 43.5 mtm -90.2 -21.88 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.363 0.529 . . . . 0.0 112.124 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.12 90.63 9.18 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 -172.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -21.99 59.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.513 1.475 . . . . 0.0 113.134 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -107.34 33.02 4.23 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.606 1.562 . . . . 0.0 109.808 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.5 tp -48.58 144.86 3.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.412 2.285 . . . . 0.0 112.951 -171.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.7 p -129.9 161.57 30.56 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.761 1.625 . . . . 0.0 108.102 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 t -153.09 -179.55 7.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.42 0.628 . . . . 0.0 110.555 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -143.07 159.32 42.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.275 1.03 . . . . 0.0 109.758 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.7 p -155.14 142.85 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -71.26 131.54 43.62 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.62 -22.46 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.563 0.745 . . . . 0.0 112.001 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.61 21.13 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.99 1.716 . . . . 0.0 113.098 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.407 HD22 ' CE1' ' A' ' 28' ' ' HIS . 64.9 t-20 -148.51 66.24 1.07 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.975 1.71 . . . . 0.0 108.143 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.71 -24.77 58.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.513 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -62.71 -48.94 77.07 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.889 0.476 . . . . 0.0 110.105 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.62 82.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.442 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.29 -49.65 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.71 -46.2 94.69 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -56.59 -50.67 71.27 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -67.38 -33.62 75.59 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.907 -0.496 . . . . 0.0 109.665 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.53 -48.39 81.0 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.11 0.868 . . . . 0.0 110.853 170.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.38 -42.67 87.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.905 0.775 . . . . 0.0 110.499 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.53 -34.42 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.206 1.003 . . . . 0.0 111.069 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.64 9.86 1.94 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.297 169.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -77.19 155.22 32.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.737 1.769 . . . . 0.0 111.039 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.63 139.76 33.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.14 1.776 . . . . 0.0 106.58 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.487 HG22 HD22 ' A' ' 142' ' ' LEU . 21.8 t -71.73 135.42 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 123.888 0.875 . . . . 0.0 109.93 -170.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 p -124.2 -10.77 7.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.507 1.923 . . . . 0.0 111.244 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 179.16 45.02 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 118.823 0.738 . . . . 0.0 111.844 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.91 175.74 11.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.217 1.007 . . . . 0.0 108.4 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m -145.65 135.89 23.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -79.92 1.64 26.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.059 0.39 . . . . 0.0 111.629 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.61 170.71 19.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 126.208 1.803 . . . . 0.0 107.781 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -100.85 -58.3 1.92 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.337 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -161.68 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.47 10.62 5.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.595 1.158 . . . . 0.0 111.218 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.82 1.7 62.96 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.833 1.206 . . . . 0.0 112.472 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -70.5 138.2 86.22 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.768 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.55 62.95 7.86 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.21 3.273 . . . . 0.0 112.194 -171.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -123.79 101.48 36.2 Favored Pre-proline 0 C--O 1.224 -0.28 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.36 165.06 6.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.37 2.047 . . . . 0.0 116.557 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.1 tp -136.28 146.34 46.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.424 1.89 . . . . 0.0 106.368 169.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.86 149.18 39.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -126.71 137.28 53.24 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.676 1.19 . . . . 0.0 108.549 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.9 161.99 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.316 1.046 . . . . 0.0 108.583 -169.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.91 150.45 52.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 108.631 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -76.61 126.54 31.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.92 -14.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.939 1.296 . . . . 0.0 110.431 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -54.08 143.47 29.67 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.511 1.053 . . . . 0.0 112.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.722 2.009 . . . . 0.0 107.86 175.195 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.29 169.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 mm -127.74 144.16 38.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -142.13 165.38 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mm -124.1 142.71 39.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -151.84 174.24 13.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.814 0.846 . . . . 0.0 110.046 174.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -63.82 152.61 39.07 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -63.52 174.61 1.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.122 1.769 . . . . 0.0 112.326 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -132.06 142.44 49.54 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.168 1.787 . . . . 0.0 106.493 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -57.73 -40.26 79.22 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.205 0.457 . . . . 0.0 110.897 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.07 -13.43 61.58 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.74 -0.84 41.93 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.865 0.757 . . . . 0.0 110.957 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.2 -40.72 60.31 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.587 0.613 . . . . 0.0 113.182 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.82 -28.2 68.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.348 1.074 . . . . 0.0 111.685 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.485 -0.759 . . . . 0.0 109.908 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.15 -38.96 69.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.39 -47.79 83.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.82 89.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.056 0.542 . . . . 0.0 111.699 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.45 -51.25 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.825 1.25 . . . . 0.0 109.782 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -54.55 -50.17 68.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.933 0.493 . . . . 0.0 109.676 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.46 -48.63 68.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.394 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.74 -33.86 64.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.87 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -27.1 63.67 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 120.531 1.514 . . . . 0.0 111.313 172.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.26 -45.74 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 O-C-N 121.269 -0.894 . . . . 0.0 109.068 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.73 -38.01 83.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.004 0.82 . . . . 0.0 111.904 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.83 -36.59 56.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.249 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.0 p -138.94 -4.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CE1' HD22 ' A' ' 110' ' ' ASN . 20.4 m80 -126.96 25.23 6.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.9 1.227 . . . . 0.0 110.458 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.49 -15.9 31.58 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -53.03 -22.64 6.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.812 2.045 . . . . 0.0 113.155 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.94 97.54 0.36 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.876 1.27 . . . . 0.0 108.163 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -54.82 155.69 4.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 111.181 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.28 64.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.19 -48.13 68.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.85 0.75 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.44 -40.0 94.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.192 0.597 . . . . 0.0 109.872 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -55.2 -47.28 75.48 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.781 1.232 . . . . 0.0 110.195 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.5 m -64.97 -49.72 69.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.019 0.928 . . . . 0.0 110.011 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.01 -38.05 87.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.962 0.346 . . . . 0.0 110.725 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 mt -62.39 -53.67 51.6 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.519 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.16 -39.58 75.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.18 0.9 . . . . 0.0 110.54 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.42 -48.58 77.2 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.958 0.503 . . . . 0.0 111.882 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.072 0.396 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.43 -48.09 88.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 109.279 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -69.94 -10.56 58.99 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.013 -1.054 . . . . 0.0 112.498 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -98.21 5.62 48.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 110.702 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.15 -56.97 0.76 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 117.739 -1.124 . . . . 0.0 112.507 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.49 -38.95 73.55 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 120.793 1.633 . . . . 0.0 113.125 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.39 -14.38 34.39 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.266 1.977 . . . . 0.0 114.818 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -129.01 -14.03 4.47 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.862 1.665 . . . . 0.0 113.144 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.11 91.23 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.048 1.339 . . . . 0.0 111.514 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.46 60.25 7.01 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.844 3.696 . . . . 0.0 110.872 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -83.06 179.69 7.68 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.818 1.294 . . . . 0.0 110.831 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -135.38 140.66 45.17 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.58 2.752 . . . . 0.0 103.921 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.77 139.77 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 119.264 0.938 . . . . 0.0 110.063 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.8 132.66 35.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.43 141.78 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -81.74 -179.82 7.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.358 171.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.55 -25.87 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.769 2.028 . . . . 0.0 114.33 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -85.17 3.35 39.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.288 1.435 . . . . 0.0 112.175 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 51.33 59.31 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 123.761 1.743 . . . . 0.0 109.182 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -131.84 119.27 16.93 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.89 139.78 76.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.019 1.813 . . . . 0.0 109.393 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.66 -10.54 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.681 1.193 . . . . 0.0 111.977 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.12 173.03 41.63 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.86 160.94 41.08 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.615 0.722 . . . . 0.0 111.407 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -141.56 129.78 22.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.836 2.454 . . . . 0.0 105.506 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 74' ' ' ASP . 24.7 tp -109.06 124.89 51.48 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 169.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.7 tp -145.86 134.75 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m -159.72 155.61 26.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.081 2.152 . . . . 0.0 105.281 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.67 57.53 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.862 0.756 . . . . 0.0 113.881 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 58.43 21.77 8.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.992 1.717 . . . . 0.0 113.731 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -124.46 112.87 17.41 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.946 0.899 . . . . 0.0 110.079 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -85.22 85.79 7.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.535 ' HB3' HD23 ' A' ' 67' ' ' LEU . 33.0 t70 -63.76 -28.31 69.79 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.26 144.19 31.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.015 0.526 . . . . 0.0 110.094 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.8 tp -153.7 112.07 3.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -142.58 140.88 31.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.07 154.63 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -171.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -65.0 124.17 85.94 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.65 -27.59 8.1 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.147 3.231 . . . . 0.0 114.759 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.59 -24.15 66.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.978 0.911 . . . . 0.0 112.935 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.49 -2.76 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.759 0.824 . . . . 0.0 112.86 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -55.18 -42.91 73.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.553 1.07 . . . . 0.0 109.786 169.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.81 -26.73 72.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.496 -0.613 . . . . 0.0 113.132 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.9 m -74.57 -8.07 55.14 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.497 1.149 . . . . 0.0 112.419 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.02 13.93 56.98 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.399 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -56.01 -30.22 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.403 1.602 . . . . 0.0 110.293 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -46.89 -52.38 11.8 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.221 0.915 . . . . 0.0 111.883 169.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.35 -44.58 96.14 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.079 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.45 -46.96 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.835 1.198 . . . . 0.0 109.963 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.0 mt -69.3 -39.72 78.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.281 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.13 -40.27 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.817 0.735 . . . . 0.0 109.939 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.91 -34.68 78.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.375 0.989 . . . . 0.0 109.762 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -60.74 -48.51 81.49 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 122.908 0.483 . . . . 0.0 110.318 173.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.3 77.19 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.612 0.765 . . . . 0.0 110.93 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.46 -33.46 71.32 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.591 1.156 . . . . 0.0 111.546 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 m -62.92 -35.56 80.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.578 0.626 . . . . 0.0 111.547 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -85.73 -25.39 26.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.364 0.529 . . . . 0.0 112.082 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.05 94.29 7.9 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.176 1.391 . . . . 0.0 109.16 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.99 -23.31 46.88 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.24 1.293 . . . . 0.0 112.405 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.77 29.08 4.32 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.753 1.621 . . . . 0.0 110.489 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.7 tp -52.49 144.79 12.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.238 2.215 . . . . 0.0 113.248 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.9 p -129.28 164.57 23.21 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.82 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -154.86 -174.47 5.0 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.236 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -148.28 162.03 40.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 110.001 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.5 HG12 HD21 ' A' ' 142' ' ' LEU . 13.1 p -157.71 148.69 9.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -70.0 130.33 41.88 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.54 -33.23 65.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.038 1.335 . . . . 0.0 111.805 -172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.39 -27.77 68.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 0.0 111.779 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.442 HD22 ' CE1' ' A' ' 28' ' ' HIS . 57.5 t-20 -79.72 64.97 4.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.434 0.694 . . . . 0.0 109.52 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.27 -25.54 59.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.75 0.82 . . . . 0.0 111.388 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.79 -48.28 79.81 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 109.954 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.61 78.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.65 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.21 -45.35 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 119.319 0.963 . . . . 0.0 109.001 173.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.66 -49.59 71.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -54.74 -50.49 68.24 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.912 0.885 . . . . 0.0 110.44 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.02 -35.72 81.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.51 -39.75 94.36 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 120.875 -1.141 . . . . 0.0 112.552 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.18 -41.73 89.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.997 1.271 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.26 -34.18 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.307 1.043 . . . . 0.0 110.634 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.27 4.86 2.47 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.5 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -71.64 165.64 23.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.331 1.565 . . . . 0.0 111.197 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.52 140.78 33.54 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.755 2.022 . . . . 0.0 106.036 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.622 HG22 HD22 ' A' ' 142' ' ' LEU . 43.4 t -72.33 129.52 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.1 p -128.82 -7.2 5.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.012 1.725 . . . . 0.0 111.249 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.46 176.92 39.55 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 169.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -157.04 -178.81 7.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.728 0.811 . . . . 0.0 109.533 171.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.6 m -143.61 143.99 31.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.565 1.546 . . . . 0.0 108.073 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.23 -8.17 51.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.648 0.779 . . . . 0.0 112.494 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.66 174.76 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.138 1.775 . . . . 0.0 107.481 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.5 -61.91 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -160.82 -46.86 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 112.684 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.36 27.7 1.39 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.372 1.069 . . . . 0.0 110.387 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.29 14.8 79.02 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 123.898 0.761 . . . . 0.0 113.21 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -67.6 129.1 93.59 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.596 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.41 47.15 2.32 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.828 3.019 . . . . 0.0 112.388 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -137.45 78.28 38.65 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 125.533 1.533 . . . . 0.0 107.152 -171.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_exo -37.49 146.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.607 1 C-N-CA 125.467 4.111 . . . . 0.0 118.74 -169.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.4 147.77 27.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 106.886 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.76 148.82 32.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.546 ' C ' HD23 ' A' ' 142' ' ' LEU . 9.9 t-20 -115.11 139.2 50.1 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.622 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.07 157.97 45.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -172.51 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.94 150.85 52.04 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.053 1.341 . . . . 0.0 108.206 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -76.31 130.87 38.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t -130.25 -11.04 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.77 1.228 . . . . 0.0 109.895 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.51 91.75 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.843 1.257 . . . . 0.0 111.061 -179.777 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.04 168.15 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 mm -130.95 145.67 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -140.54 162.49 35.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 55' ' ' ALA . 23.2 mm -117.76 141.7 35.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.54 177.77 10.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 109.872 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -73.63 150.3 41.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 m -72.69 -177.26 2.23 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.403 1.081 . . . . 0.0 111.154 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.87 161.45 32.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -67.34 -40.11 85.84 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.925 0.33 . . . . 0.0 110.116 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.73 -26.38 64.29 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.7 1.79 52.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.634 0.774 . . . . 0.0 111.301 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.53 -41.67 49.67 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.281 0.946 . . . . 0.0 112.837 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.03 -26.86 68.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.057 0.929 . . . . 0.0 112.228 -178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.88 -34.59 78.12 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.966 0.803 . . . . 0.0 109.598 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.46 -38.16 49.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.43 -45.45 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -45.71 91.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.074 0.55 . . . . 0.0 111.448 178.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.3 mt -59.56 -48.52 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 109.702 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.37 -51.04 66.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.619 0.767 . . . . 0.0 110.204 173.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.05 -40.83 90.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.897 -0.502 . . . . 0.0 110.367 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -66.23 -42.99 87.86 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.327 0.651 . . . . 0.0 111.216 177.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -59.05 -37.06 76.11 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.917 0.487 . . . . 0.0 111.052 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -72.2 -44.32 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.269 0.628 . . . . 0.0 109.319 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -60.27 -37.81 81.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.012 0.824 . . . . 0.0 111.721 174.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.36 61.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.855 -174.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.1 p -139.27 -3.1 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -169.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CE1' HD22 ' A' ' 110' ' ' ASN . 16.3 m80 -126.72 26.28 6.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.686 1.13 . . . . 0.0 110.456 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -13.92 28.99 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.847 -1.158 . . . . 0.0 113.053 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -57.25 -21.1 31.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.063 1.745 . . . . 0.0 112.995 170.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.05 109.69 1.9 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 m -58.05 147.53 29.25 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.533 1.533 . . . . 0.0 110.238 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.34 67.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.88 -52.48 56.35 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.503 ' CD1' ' HE3' ' A' ' 135' ' ' LYS . 4.3 t80 -70.79 -31.84 68.74 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.891 -0.506 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 tpp85 -54.67 -46.38 74.03 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.956 0.902 . . . . 0.0 109.922 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -64.94 -50.04 67.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 109.843 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -63.4 -39.31 94.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.784 0.266 . . . . 0.0 110.545 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -62.34 -54.5 39.62 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.467 175.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -58.61 -37.81 76.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.419 1.009 . . . . 0.0 110.505 -173.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.13 -48.96 71.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.2 0.6 . . . . 0.0 111.919 175.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.47 74.92 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.282 0.492 . . . . 0.0 110.49 -176.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.71 -48.71 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.195 1.798 . . . . 0.0 108.945 171.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttp85 -70.66 -8.4 51.61 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.001 -1.062 . . . . 0.0 112.764 176.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -99.63 5.55 45.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.066 0.947 . . . . 0.0 110.801 172.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -135.45 -55.37 0.79 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.957 -169.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.72 -37.91 61.4 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.411 1.459 . . . . 0.0 112.732 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.4 -9.03 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.235 1.957 . . . . 0.0 115.437 172.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.02 -16.08 3.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.207 1.821 . . . . 0.0 113.466 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.86 152.39 96.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.794 1.238 . . . . 0.0 112.348 -172.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.24 62.38 7.54 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 125.176 3.917 . . . . 0.0 111.616 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.1 mt -83.89 172.77 11.81 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.233 1.813 . . . . 0.0 112.404 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -134.26 145.86 49.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.58 139.63 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.523 1.129 . . . . 0.0 110.262 -176.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.12 130.81 35.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -123.31 142.16 40.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.1 p30 -84.21 -173.48 4.74 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.453 174.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.64 -22.34 22.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.434 1.494 . . . . 0.0 113.657 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -81.79 -2.36 50.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 111.659 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 53.26 56.31 7.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.286 1.517 . . . . 0.0 109.142 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.61 129.19 16.31 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 127.461 2.304 . . . . 0.0 105.465 -169.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.73 136.8 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.027 1.818 . . . . 0.0 110.217 -171.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 -16.08 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.722 1.209 . . . . 0.0 111.842 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.19 173.02 39.31 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.76 161.28 42.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.707 0.753 . . . . 0.0 110.592 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 154.13 47.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.129 0.971 . . . . 0.0 108.937 168.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.78 119.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 176.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 95' ' ' ALA . 25.2 tp -146.28 134.6 21.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.275 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -159.47 156.32 28.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.358 2.263 . . . . 0.0 105.484 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.63 32.94 61.95 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.419 -0.8 . . . . 0.0 113.889 175.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 57.01 22.54 7.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.218 1.807 . . . . 0.0 114.121 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -122.69 111.02 16.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.579 0.751 . . . . 0.0 109.787 175.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 ttp -85.83 88.78 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.77 -23.95 67.4 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.14 144.88 32.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.378 0.671 . . . . 0.0 110.552 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.8 tp -156.87 117.22 3.57 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.69 1.996 . . . . 0.0 106.112 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -147.17 144.92 29.32 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.33 142.73 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -173.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.49 137.68 95.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.281 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.62 -24.53 23.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.803 3.002 . . . . 0.0 115.852 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.34 -21.1 61.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.541 1.064 . . . . 0.0 112.278 175.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.15 24.89 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.529 1.532 . . . . 0.0 110.493 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.91 132.84 54.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.778 -1.201 . . . . 0.0 108.826 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.95 2.65 53.1 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.995 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 98.7 m -70.78 169.23 15.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.654 1.727 . . . . 0.0 109.18 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.05 -28.22 16.95 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.545 1.069 . . . . 0.0 113.863 -177.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.55 -34.81 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 118.989 1.395 . . . . 0.0 112.203 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.15 -29.94 53.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.08 0.848 . . . . 0.0 112.807 175.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -91.95 -42.52 9.97 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 116.498 -1.715 . . . . 0.0 110.248 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.32 -45.56 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 121.56 1.982 . . . . 0.0 110.826 -172.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.2 -39.81 89.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.791 0.723 . . . . 0.0 111.065 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.53 -40.75 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.478 0.711 . . . . 0.0 109.798 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.54 -36.95 85.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.594 0.758 . . . . 0.0 109.544 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.52 -47.03 87.44 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.057 0.543 . . . . 0.0 110.276 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 68' ' ' LEU . . . -60.13 -49.77 76.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.06 0.544 . . . . 0.0 110.84 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -60.27 -33.72 72.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.191 0.996 . . . . 0.0 111.578 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -37.65 88.11 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.358 0.526 . . . . 0.0 111.414 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -83.92 -26.45 29.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.253 0.479 . . . . 0.0 112.117 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 91.32 10.39 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.143 1.377 . . . . 0.0 109.282 -169.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.96 -22.16 63.06 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.425 1.417 . . . . 0.0 112.822 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.86 30.92 5.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.286 1.434 . . . . 0.0 110.274 -174.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 tp -50.91 143.37 10.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.898 2.079 . . . . 0.0 112.826 -170.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 65.2 p -130.0 162.85 27.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.746 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 t -153.58 -173.58 4.63 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.014 0.526 . . . . 0.0 109.724 175.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -148.68 161.41 41.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.833 0.853 . . . . 0.0 110.631 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -156.07 147.34 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -72.56 132.16 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -58.34 -30.87 67.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.726 0.811 . . . . 0.0 112.33 -173.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.79 -33.16 72.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.506 0.594 . . . . 0.0 111.236 -177.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.445 HD22 ' CE1' ' A' ' 28' ' ' HIS . 54.5 t-20 -80.02 65.8 5.3 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.028 0.931 . . . . 0.0 110.523 176.227 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.11 -26.11 59.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 111.632 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.4 ' H ' ' NE2' ' A' ' 112' ' ' GLN . 2.7 mp0 -62.87 -46.97 85.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.102 0.561 . . . . 0.0 109.752 176.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.72 77.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.606 -0.711 . . . . 0.0 111.786 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.41 -46.21 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.236 0.925 . . . . 0.0 108.963 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.01 -49.59 73.79 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -55.45 -50.88 68.71 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.582 0.753 . . . . 0.0 110.755 -178.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -66.1 -34.41 78.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -174.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.15 -37.88 86.75 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.82 -1.175 . . . . 0.0 112.72 172.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.07 -42.81 91.26 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.877 1.217 . . . . 0.0 110.169 173.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.57 -35.65 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 110.788 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.72 9.08 1.82 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.418 1.008 . . . . 0.0 114.454 169.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.4 162.2 29.08 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.608 1.704 . . . . 0.0 111.107 171.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.92 140.39 25.6 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.559 HG22 HD22 ' A' ' 142' ' ' LEU . 29.9 t -72.26 129.75 35.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.907 0.883 . . . . 0.0 109.336 -174.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.6 p -123.77 -9.15 7.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.421 1.888 . . . . 0.0 111.681 -174.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.55 -179.92 41.12 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -156.36 177.87 10.96 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.804 0.841 . . . . 0.0 109.254 172.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.0 m -145.69 129.98 17.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.4 2.66 12.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.3 m -132.26 169.79 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.177 1.391 . . . . 0.0 107.513 169.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.44 -59.63 2.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.394 -177.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.24 -43.35 0.07 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.18 31.97 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.435 1.094 . . . . 0.0 110.28 -173.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.44 84.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.554 0.597 . . . . 0.0 112.966 -173.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.503 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 39.1 mmtt -68.39 129.26 92.87 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 116.953 -1.499 . . . . 0.0 108.129 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.63 47.7 2.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.762 2.975 . . . . 0.0 112.425 -171.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -130.68 79.46 71.92 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -41.12 145.73 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.168 3.246 . . . . 0.0 118.449 -169.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.67 146.15 26.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.7 mt -117.26 145.23 44.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.451 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.1 t-20 -115.71 138.61 50.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.559 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.0 158.78 43.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -171.242 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.56 152.48 51.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.277 1.431 . . . . 0.0 108.348 176.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.5 127.36 32.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.8 t -130.24 -9.48 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.136 1.374 . . . . 0.0 110.146 -176.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.06 -27.01 69.77 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.108 -0.995 . . . . 0.0 113.75 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 C-N-CA 124.746 1.218 . . . . 0.0 110.629 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.267 4.3 t . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -135.2 141.84 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.88 1.672 . . . . 0.0 106.676 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -136.32 166.17 24.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mm -123.08 142.16 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -150.52 172.02 16.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.784 0.834 . . . . 0.0 109.76 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.47 HH12 ' HB2' ' A' ' 51' ' ' PRO . 24.6 mmt180 -61.67 148.39 42.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.492 -0.755 . . . . 0.0 110.488 166.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -70.84 160.76 32.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.735 1.214 . . . . 0.0 110.26 176.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -103.11 161.72 13.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.146 163.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -62.82 -51.76 65.79 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -24.9 62.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.754 -162.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.35 -0.61 46.61 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.404 -0.185 . . . . 0.0 111.1 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 -39.43 53.22 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.137 -0.977 . . . . 0.0 112.752 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -65.56 -28.56 69.25 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.616 1.208 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.19 -32.78 73.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.209 0.528 . . . . 0.0 109.644 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.88 -38.82 64.29 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 120.901 -1.125 . . . . 0.0 109.63 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.28 -46.46 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -47.15 87.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.06 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.84 -50.36 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.996 1.319 . . . . 0.0 109.52 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -53.76 -47.15 70.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.0 t -59.13 -47.32 85.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.279 0.632 . . . . 0.0 110.683 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.306 -0.871 . . . . 0.0 112.811 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.1 m -60.17 -38.06 82.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.342 0.974 . . . . 0.0 109.516 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -70.44 -42.74 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.077 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.41 -34.99 78.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.392 0.542 . . . . 0.0 111.094 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.78 -33.91 30.62 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.283 -0.886 . . . . 0.0 112.309 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.591 HG21 HH12 ' A' ' 83' ' ' ARG . 19.9 p -139.1 -5.12 1.47 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -167.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.404 ' CE1' HD22 ' A' ' 110' ' ' ASN . 57.4 m80 -126.61 30.06 5.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.697 1.59 . . . . 0.0 110.454 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -60.8 -18.94 58.36 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.962 0.887 . . . . 0.0 112.849 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.11 -23.52 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.212 1.405 . . . . 0.0 112.517 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -60.88 106.02 0.53 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.418 1.087 . . . . 0.0 111.591 172.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 m -56.25 151.09 13.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.056 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.06 -34.41 68.24 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 123.077 0.551 . . . . 0.0 112.351 -172.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -68.07 -47.91 67.01 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.714 1.245 . . . . 0.0 109.358 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -68.66 -34.98 76.63 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.574 -1.193 . . . . 0.0 112.02 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -53.86 -49.35 68.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.754 0.822 . . . . 0.0 110.773 170.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 m -62.91 -47.08 84.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 124.349 1.031 . . . . 0.0 109.16 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.37 -36.54 74.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.457 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.54 -50.77 70.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.414 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.69 -39.06 79.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.081 0.855 . . . . 0.0 111.237 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -51.07 69.46 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.06 0.544 . . . . 0.0 110.326 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -37.21 79.01 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.478 -0.764 . . . . 0.0 110.134 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.8 t -58.5 -46.99 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.51 1.524 . . . . 0.0 109.026 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -67.74 -18.04 64.76 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.913 -1.117 . . . . 0.0 113.034 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.3 m -95.02 10.61 35.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -140.09 -56.29 0.55 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 119.473 1.033 . . . . 0.0 111.796 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -55.81 -40.24 83.22 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 116.888 -1.53 . . . . 0.0 112.659 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.73 -11.63 18.36 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.315 2.01 . . . . 0.0 116.209 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.99 -15.35 3.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.14 1.336 . . . . 0.0 112.461 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.02 148.24 98.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 123.784 0.833 . . . . 0.0 110.124 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HB2' HH12 ' A' ' 7' ' ' ARG . 47.1 Cg_endo -77.84 65.23 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.347 3.365 . . . . 0.0 108.844 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.426 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 64.1 mt -83.9 170.89 13.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.033 0.933 . . . . 0.0 110.651 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -122.75 138.88 54.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 166.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.54 135.57 56.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.615 1.166 . . . . 0.0 108.811 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.28 133.0 41.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 160.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.4 140.65 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -79.22 -174.58 4.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.078 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.48 -19.53 9.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.537 1.535 . . . . 0.0 114.885 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.36 4.93 44.4 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.769 -1.207 . . . . 0.0 113.203 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.3 t0 52.24 52.45 14.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.27 1.509 . . . . 0.0 110.897 -169.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -131.7 124.57 19.96 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.23 137.83 45.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.113 1.875 . . . . 0.0 111.743 -169.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.86 -11.06 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.397 1.079 . . . . 0.0 111.38 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.93 171.49 41.07 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 169.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.66 161.96 39.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 111.704 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.422 ' HB3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -147.31 138.92 24.05 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.674 1.59 . . . . 0.0 106.942 -175.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 73' ' ' MET . 1.1 tp -112.6 121.34 44.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 174.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.5 tp -141.56 133.25 27.13 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.573 1.171 . . . . 0.0 108.424 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.5 m -147.27 160.2 42.76 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.761 2.024 . . . . 0.0 106.979 164.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.0 -115.01 6.68 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -170.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -135.46 32.71 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.567 1.183 . . . . 0.0 109.637 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -128.2 103.13 7.02 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.113 0.965 . . . . 0.0 109.216 -165.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 67.1 ttp -81.08 87.14 6.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -60.26 -36.32 77.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.932 0.893 . . . . 0.0 111.181 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.81 146.46 41.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.546 -1.346 . . . . 0.0 110.685 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.97 118.25 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.37 143.14 30.8 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -150.74 141.23 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -53.46 122.93 34.32 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 125.374 1.671 . . . . 0.0 108.929 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -51.84 -27.17 26.43 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.186 1.924 . . . . 0.0 114.39 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.3 -28.28 69.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.112 1.324 . . . . 0.0 111.89 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.66 2.04 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.867 -1.145 . . . . 0.0 112.262 -171.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.591 HH12 HG21 ' A' ' 27' ' ' THR . 46.2 mtt180 -53.36 -44.82 68.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.095 -1.003 . . . . 0.0 111.958 170.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.31 -22.95 67.85 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.369 1.043 . . . . 0.0 111.596 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.0 -7.41 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.696 1.248 . . . . 0.0 113.084 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.21 1.25 51.08 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-O 118.699 -1.056 . . . . 0.0 112.606 172.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.6 t -55.68 -31.35 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 118.725 1.263 . . . . 0.0 110.019 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.86 -49.8 34.14 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.003 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -64.62 -47.01 80.15 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.734 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.86 -43.41 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.558 1.072 . . . . 0.0 110.085 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 66' ' ' MET . 29.2 mt -69.34 -42.15 75.69 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.628 -0.67 . . . . 0.0 111.017 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.51 -41.25 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.813 0.733 . . . . 0.0 110.432 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.38 -38.69 90.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -59.32 -46.07 89.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.381 0.537 . . . . 0.0 110.605 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.93 91.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.989 0.516 . . . . 0.0 110.609 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.808 HD21 ' HD2' ' A' ' 144' ' ' TYR . 32.6 mt -62.59 -34.58 77.29 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.9 m -62.71 -33.97 76.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.536 0.523 . . . . 0.0 110.695 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.8 mtm -87.59 -22.52 24.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.626 0.648 . . . . 0.0 112.061 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.78 93.16 6.25 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.775 1.23 . . . . 0.0 108.237 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 -23.65 57.24 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.738 1.625 . . . . 0.0 113.266 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.32 31.18 4.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.379 1.471 . . . . 0.0 109.368 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.8 tp -49.86 144.64 6.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.529 1.932 . . . . 0.0 113.04 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -127.48 162.0 27.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.778 1.631 . . . . 0.0 108.751 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -153.35 -179.68 7.96 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -141.56 165.51 27.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.063 0.945 . . . . 0.0 109.856 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.72 145.63 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -71.29 131.85 44.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -58.35 -33.09 69.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.519 1.128 . . . . 0.0 111.534 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.167 0.587 . . . . 0.0 111.523 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.404 HD22 ' CE1' ' A' ' 28' ' ' HIS . 63.4 t-20 -85.81 68.62 10.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.291 0.567 . . . . 0.0 109.886 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.35 -26.07 62.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 111.018 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -61.47 -49.16 77.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.67 -0.644 . . . . 0.0 109.61 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.65 76.57 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.411 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.04 -48.32 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.058 . . . . 0.0 108.46 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.83 -47.15 92.67 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.525 0.602 . . . . 0.0 111.793 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.26 -51.04 70.96 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.91 0.884 . . . . 0.0 109.116 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.66 -35.39 80.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -42.69 99.12 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.738 1.154 . . . . 0.0 112.584 171.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -59.57 -41.01 89.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.052 0.842 . . . . 0.0 111.306 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.05 -37.82 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 123.998 0.812 . . . . 0.0 109.648 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.38 5.35 0.97 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-O 122.182 0.879 . . . . 0.0 115.003 168.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -73.9 159.09 33.31 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 118.294 -2.886 . . . . 0.0 111.475 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -142.59 139.36 31.32 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.5 t -71.69 136.28 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -130.28 -8.63 4.25 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.26 1.824 . . . . 0.0 110.922 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.36 178.1 42.65 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -157.32 178.69 10.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.122 -0.634 . . . . 0.0 109.62 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.671 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 N--CA 1.451 -1.022 0 N-CA-C 115.809 1.427 . . . . 0.0 115.809 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.7 tp -104.39 146.77 28.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.8 mt -114.57 145.93 41.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.68 138.08 51.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.654 1.182 . . . . 0.0 107.986 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.87 157.85 45.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -169.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.24 50.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.808 ' HD2' HD21 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -73.21 116.7 14.06 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 74.7 t . . . . . 0 N--CA 1.411 -2.403 1 CA-C-O 100.815 -9.183 . . . . 0.0 110.44 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.5 t . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 mm -126.76 144.45 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.7 m -141.65 167.59 21.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.45 142.83 36.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -148.72 173.51 13.16 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.539 0.736 . . . . 0.0 110.214 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -66.03 147.87 52.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.573 0.701 . . . . 0.0 109.11 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -77.71 147.17 35.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.854 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -85.99 175.85 8.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.803 0.841 . . . . 0.0 108.746 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -82.35 -49.06 10.44 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.43 -26.54 61.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.81 0.732 . . . . 0.0 112.203 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -72.77 -5.2 36.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.031 -0.418 . . . . 0.0 111.841 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.66 -38.64 29.43 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.487 1.041 . . . . 0.0 113.178 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.78 -28.61 69.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.926 1.363 . . . . 0.0 111.795 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.71 -31.28 70.26 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.401 -0.812 . . . . 0.0 109.578 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -75.49 -39.67 58.23 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -56.29 -44.82 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.497 0.719 . . . . 0.0 109.084 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.45 96.18 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.883 -0.51 . . . . 0.0 111.436 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.0 mt -59.8 -48.89 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.512 0.725 . . . . 0.0 109.705 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -54.19 -45.7 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.269 0.628 . . . . 0.0 110.111 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 t -60.54 -44.24 96.32 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.607 -0.683 . . . . 0.0 110.518 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -63.11 -42.69 99.6 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.658 -0.651 . . . . 0.0 110.833 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.7 m -59.6 -38.09 80.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.514 0.726 . . . . 0.0 110.876 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.44 -45.52 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.273 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.02 -37.39 76.83 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.153 0.888 . . . . 0.0 111.83 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.6 26.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.147 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.5 p -135.44 -5.78 2.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CE1' HD22 ' A' ' 110' ' ' ASN . 12.7 m80 -128.52 26.89 5.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.009 1.277 . . . . 0.0 110.632 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.5 -14.41 28.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.323 -0.861 . . . . 0.0 113.293 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -53.38 -22.79 8.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.737 2.015 . . . . 0.0 112.988 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.01 100.29 0.41 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.057 1.343 . . . . 0.0 108.529 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -56.32 157.33 5.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.527 1.531 . . . . 0.0 111.109 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.32 -36.98 66.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -67.14 -48.56 67.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.888 0.767 . . . . 0.0 109.783 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.52 -40.27 96.61 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.663 0.785 . . . . 0.0 109.796 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 -55.54 -48.45 74.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.932 1.293 . . . . 0.0 110.168 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -65.42 -49.53 68.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.0 0.92 . . . . 0.0 110.05 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.83 -38.13 88.08 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.861 0.3 . . . . 0.0 110.66 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 mt -62.79 -53.74 49.72 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.565 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.53 -38.22 74.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.442 1.019 . . . . 0.0 110.701 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.9 -49.09 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.221 0.609 . . . . 0.0 111.854 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -36.45 74.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.201 0.455 . . . . 0.0 110.296 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.02 -48.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 126.211 1.805 . . . . 0.0 109.038 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -70.41 -10.76 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.987 -1.071 . . . . 0.0 112.679 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.7 m -96.05 4.7 52.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 110.681 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.24 -56.45 0.8 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.158 -169.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.81 -38.47 68.4 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 120.466 1.485 . . . . 0.0 112.91 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.19 -13.01 29.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.945 1.764 . . . . 0.0 115.362 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -128.95 -14.7 4.41 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.63 1.559 . . . . 0.0 113.196 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 152.19 95.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.792 1.237 . . . . 0.0 111.999 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.19 62.71 7.61 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.98 3.787 . . . . 0.0 111.65 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.8 173.73 8.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.185 1.794 . . . . 0.0 112.374 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -133.07 146.15 51.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.45 137.87 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 110.487 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.87 35.74 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.01 140.89 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -76.67 -174.83 3.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.609 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.08 -15.56 34.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.821 1.648 . . . . 0.0 113.118 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -87.74 3.73 46.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.037 1.335 . . . . 0.0 111.713 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.14 33.28 21.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.675 1.59 . . . . 0.0 111.412 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -117.79 133.49 23.33 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.26 138.18 46.04 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.703 2.268 . . . . 0.0 112.4 -169.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.76 -9.64 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.601 1.16 . . . . 0.0 112.348 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.96 170.43 37.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.08 158.56 43.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.882 0.841 . . . . 0.0 110.7 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.92 153.34 48.24 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.948 0.899 . . . . 0.0 109.54 169.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.35 120.62 38.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.1 tp -145.45 140.26 27.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 m -154.4 155.97 35.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.985 2.114 . . . . 0.0 105.334 169.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.39 -114.56 5.63 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -130.96 13.99 5.25 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.785 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -114.74 106.21 13.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.491 1.041 . . . . 0.0 110.407 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.7 ttp -79.16 82.56 5.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.5 -19.52 62.16 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.01 148.54 30.83 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.247 0.93 . . . . 0.0 110.573 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.9 tp -156.63 119.88 4.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.525 1.93 . . . . 0.0 105.932 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -146.03 145.08 30.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mt -151.34 142.07 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -55.55 120.03 28.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.03 -30.76 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 114.471 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.98 -24.16 67.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.9 0.33 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 118.701 0.682 . . . . 0.0 112.408 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -60.59 -38.27 84.06 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.293 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.22 -27.73 71.08 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.589 0.614 . . . . 0.0 112.742 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.35 -6.2 48.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.236 1.018 . . . . 0.0 112.14 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.61 16.1 64.59 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.292 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.38 -31.74 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.134 1.467 . . . . 0.0 111.094 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.86 -52.82 15.32 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.388 -0.674 . . . . 0.0 111.921 170.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.49 -42.92 98.53 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 117.327 -1.321 . . . . 0.0 110.291 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.6 t -58.1 -45.62 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.297 1.408 . . . . 0.0 110.011 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.3 mt -68.59 -42.23 78.53 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.855 -0.528 . . . . 0.0 110.81 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.65 -41.56 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.041 0.536 . . . . 0.0 110.024 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.2 -33.19 73.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.317 -0.864 . . . . 0.0 110.121 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.93 -46.55 88.85 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.317 0.508 . . . . 0.0 110.382 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.89 82.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.083 0.553 . . . . 0.0 111.019 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 mt -58.98 -34.82 72.26 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.102 0.961 . . . . 0.0 111.303 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.81 -32.81 74.07 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.13 0.423 . . . . 0.0 111.784 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mtm -91.45 -23.21 20.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.237 0.615 . . . . 0.0 112.148 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.53 92.47 8.12 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.548 1.539 . . . . 0.0 108.339 -172.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.49 -22.75 65.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.474 1.449 . . . . 0.0 112.35 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.22 31.69 4.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.862 1.665 . . . . 0.0 110.039 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -48.33 143.3 4.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.254 2.222 . . . . 0.0 112.843 -171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -130.49 159.18 37.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.56 1.544 . . . . 0.0 108.01 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 t -154.17 -175.41 5.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.157 0.503 . . . . 0.0 109.792 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -148.48 160.38 43.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.135 0.974 . . . . 0.0 110.609 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -157.11 147.94 10.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -72.51 132.57 44.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.98 -35.13 63.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.963 1.305 . . . . 0.0 111.939 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.11 -30.84 71.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.419 0.554 . . . . 0.0 111.771 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.442 HD22 ' CE1' ' A' ' 28' ' ' HIS . 58.9 t-20 -80.47 63.37 4.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.953 0.901 . . . . 0.0 109.374 176.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.27 -26.62 52.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.3 1.04 . . . . 0.0 111.151 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -47.44 83.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.688 0.795 . . . . 0.0 109.833 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.53 -35.01 75.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.856 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.45 -47.93 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.47 1.032 . . . . 0.0 108.444 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.07 -46.44 94.55 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.544 0.592 . . . . 0.0 111.817 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -55.14 -51.33 66.82 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 117.762 0.781 . . . . 0.0 110.008 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.23 -33.7 75.91 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.926 -0.484 . . . . 0.0 109.917 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -58.48 -47.48 83.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.433 1.015 . . . . 0.0 110.852 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.44 -42.88 88.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.951 0.796 . . . . 0.0 110.463 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.76 -37.76 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.945 0.898 . . . . 0.0 110.776 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.85 1.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.28 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -79.71 154.94 28.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.596 1.698 . . . . 0.0 111.248 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -140.79 138.51 34.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.267 1.827 . . . . 0.0 106.39 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 142' ' ' LEU . 22.0 t -71.41 134.39 30.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.935 0.894 . . . . 0.0 109.75 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 p -125.34 -9.99 6.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.453 1.901 . . . . 0.0 111.364 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.88 42.12 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 118.822 0.737 . . . . 0.0 111.565 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -152.65 -176.43 5.72 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.124 0.969 . . . . 0.0 108.839 169.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 125.329 1.452 . . . . 0.0 108.59 174.463 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 118.344 2.401 . . . . 0.0 118.344 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.7 148.44 23.33 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 168.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.16 148.16 41.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -120.65 138.64 53.82 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.609 1.164 . . . . 0.0 108.131 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.88 160.75 38.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.343 1.057 . . . . 0.0 108.288 -169.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.26 150.1 52.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.567 1.547 . . . . 0.0 108.536 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -75.67 124.01 26.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 124.468 1.107 . . . . 0.0 110.336 -177.338 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.234 0.266 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mm -132.69 140.79 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -135.58 164.16 28.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 55' ' ' ALA . 15.5 mm -127.16 143.21 41.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -154.99 171.94 18.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.798 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -60.59 148.98 36.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.884 0.765 . . . . 0.0 109.082 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 p -62.84 161.62 12.41 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.764 1.626 . . . . 0.0 112.27 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -112.24 160.47 17.59 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.691 1.596 . . . . 0.0 107.251 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -69.84 -45.46 67.75 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.094 -0.378 . . . . 0.0 111.031 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.47 -27.21 65.03 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -82.82 -2.36 54.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.021 0.528 . . . . 0.0 111.483 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.34 -40.19 60.46 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.201 0.909 . . . . 0.0 112.766 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.34 -28.54 69.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.551 1.175 . . . . 0.0 111.766 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.65 -32.52 69.84 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.346 -0.846 . . . . 0.0 109.711 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.6 mt -72.81 -39.44 66.65 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.728 -0.607 . . . . 0.0 109.592 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.74 -44.78 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.205 170.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.21 93.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.363 0.665 . . . . 0.0 112.258 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.22 -48.94 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.398 1.079 . . . . 0.0 109.505 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 60.3 t90 -54.7 -44.92 73.84 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.885 -0.509 . . . . 0.0 110.396 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.84 -50.28 74.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.991 0.814 . . . . 0.0 110.832 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -68.98 -25.19 64.4 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.273 -0.892 . . . . 0.0 111.94 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.6 m -69.58 -31.89 70.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.94 0.791 . . . . 0.0 111.085 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.87 -47.16 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -58.92 -39.33 81.23 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.15 -34.23 20.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.706 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.0 p -138.41 -0.43 1.99 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -133.57 33.45 3.52 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.324 1.42 . . . . 0.0 110.812 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.06 -14.19 9.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 113.534 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.02 -27.81 63.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.222 1.809 . . . . 0.0 112.709 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.21 129.52 42.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.499 1.12 . . . . 0.0 108.917 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 p -61.85 161.97 9.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.375 0.67 . . . . 0.0 110.41 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.49 78.11 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.9 -0.5 . . . . 0.0 110.647 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.32 -50.76 68.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.398 0.679 . . . . 0.0 109.97 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -67.89 -36.93 81.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.145 -0.347 . . . . 0.0 110.103 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -55.25 -42.3 73.31 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.707 1.203 . . . . 0.0 110.732 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -72.55 -50.83 22.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 118.587 0.631 . . . . 0.0 109.658 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -69.34 -35.14 75.6 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.125 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.38 -51.47 67.43 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.121 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.48 -37.94 76.58 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.554 1.07 . . . . 0.0 110.843 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.49 -48.07 81.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.653 0.66 . . . . 0.0 111.807 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -38.11 72.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.47 -46.37 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 126.236 1.814 . . . . 0.0 109.291 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.6 ttp85 -72.34 -10.29 59.6 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 120.753 -1.217 . . . . 0.0 112.23 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -98.0 5.71 48.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 110.696 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -136.09 -56.77 0.76 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.617 -1.183 . . . . 0.0 112.724 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.39 -38.83 69.82 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 121.019 1.736 . . . . 0.0 113.246 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -61.09 -13.55 28.48 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.409 2.072 . . . . 0.0 114.845 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.38 -12.61 3.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.772 1.624 . . . . 0.0 113.272 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 153.21 91.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.227 1.411 . . . . 0.0 111.626 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 66.29 7.33 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 110.136 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.3 mt -87.58 179.08 6.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.336 1.065 . . . . 0.0 109.907 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -137.37 127.67 26.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.63 141.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.026 0.83 . . . . 0.0 110.237 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -85.05 134.77 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.94 142.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.525 HD22 ' CG1' ' A' ' 63' ' ' VAL . 16.4 p30 -85.08 -178.31 6.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.251 169.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.6 -26.38 8.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.805 1.642 . . . . 0.0 114.18 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -76.64 -3.07 35.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.31 1.044 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t0 51.48 57.98 5.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.729 1.728 . . . . 0.0 109.358 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -138.58 127.15 14.09 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.64 142.64 49.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.634 2.222 . . . . 0.0 112.396 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' CG1' HD22 ' A' ' 57' ' ' ASN . 32.3 m -124.96 -11.92 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.111 0.964 . . . . 0.0 112.596 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.22 172.13 41.46 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -148.51 159.58 43.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.331 0.566 . . . . 0.0 110.479 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.18 140.47 45.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.539 1.136 . . . . 0.0 108.125 169.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.85 113.92 25.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 tp -149.9 138.57 20.82 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.571 0.7 . . . . 0.0 109.531 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.9 m -158.5 153.7 25.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.83 23.31 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -128.93 20.53 5.93 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.49 1.116 . . . . 0.0 111.382 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -123.46 103.64 8.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.535 0.734 . . . . 0.0 109.565 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.1 ttp -85.39 80.84 8.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.95 -32.51 63.9 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -172.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.53 157.09 43.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.241 0.616 . . . . 0.0 111.037 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -155.13 123.47 5.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.064 2.146 . . . . 0.0 105.418 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -145.46 141.82 28.7 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -149.37 146.69 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -60.06 122.15 64.1 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.45 -29.8 7.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.069 3.18 . . . . 0.0 114.665 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.06 -23.86 67.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.998 0.919 . . . . 0.0 113.392 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 m -117.86 -0.27 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 118.716 0.689 . . . . 0.0 112.669 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.35 -37.03 76.83 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.918 -1.114 . . . . 0.0 110.539 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.92 68.73 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.719 0.676 . . . . 0.0 113.004 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.3 m -74.96 -6.71 50.78 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.486 1.143 . . . . 0.0 112.119 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.85 14.18 63.4 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.841 -0.977 . . . . 0.0 113.345 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.21 -31.58 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.185 1.492 . . . . 0.0 110.996 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.12 -53.44 14.98 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.881 0.753 . . . . 0.0 111.838 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.47 -41.25 96.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.138 -1.41 . . . . 0.0 110.365 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.43 -46.52 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 120.693 1.588 . . . . 0.0 110.011 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.5 -41.91 83.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.963 -0.461 . . . . 0.0 110.602 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.63 -43.24 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 118.489 0.586 . . . . 0.0 110.407 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.58 -32.51 73.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.796 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -59.59 -49.07 79.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.131 0.423 . . . . 0.0 109.991 171.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.21 81.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.878 0.471 . . . . 0.0 111.265 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.67 -35.03 75.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.802 0.841 . . . . 0.0 111.356 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.28 -35.21 79.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.29 0.495 . . . . 0.0 111.523 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtm -87.78 -24.07 23.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.421 0.688 . . . . 0.0 112.062 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.43 96.18 5.32 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.55 1.54 . . . . 0.0 108.305 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -23.72 53.11 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.198 1.265 . . . . 0.0 112.084 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.68 28.35 4.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.754 1.622 . . . . 0.0 110.654 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.3 tp -51.84 144.24 11.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 112.906 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.2 p -129.17 159.4 36.17 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 108.811 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -153.42 -179.68 7.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.865 0.466 . . . . 0.0 110.271 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -138.26 160.0 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.088 1.355 . . . . 0.0 109.185 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.446 HG12 HD21 ' A' ' 142' ' ' LEU . 7.3 p -155.84 145.89 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -70.66 131.51 44.02 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.49 -32.74 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.96 0.904 . . . . 0.0 111.583 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -66.88 -30.27 70.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.015 0.526 . . . . 0.0 111.691 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -79.65 64.19 4.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 108.795 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.83 -25.97 44.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.565 1.146 . . . . 0.0 111.151 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -49.46 75.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.465 0.706 . . . . 0.0 109.864 176.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.81 76.14 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.775 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.02 -49.09 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.415 1.007 . . . . 0.0 108.471 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.81 -47.44 91.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -54.13 -52.08 62.2 Favored 'General case' 0 C--N 1.338 0.065 0 C-N-CA 123.976 0.911 . . . . 0.0 110.124 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.65 -34.39 76.85 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.775 -0.578 . . . . 0.0 109.975 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -60.03 -46.51 89.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.52 1.055 . . . . 0.0 110.806 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.1 -43.05 86.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.093 0.86 . . . . 0.0 110.427 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.41 -34.4 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.15 0.98 . . . . 0.0 110.963 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.41 10.04 1.73 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.282 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.17 158.04 26.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.726 1.763 . . . . 0.0 111.28 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -143.04 136.22 28.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.868 1.667 . . . . 0.0 106.606 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.523 HG22 HD22 ' A' ' 142' ' ' LEU . 23.3 t -68.63 134.94 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.909 0.883 . . . . 0.0 110.353 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -128.17 -9.45 5.32 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.927 2.091 . . . . 0.0 111.578 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.86 174.52 42.83 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 170.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -159.68 -173.66 4.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.722 0.761 . . . . 0.0 110.884 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 126.911 2.084 . . . . 0.0 108.315 172.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 N-CA-C 115.684 1.378 . . . . 0.0 115.684 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 tp -110.04 151.02 27.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.528 1.931 . . . . 0.0 107.141 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.35 151.63 32.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 142' ' ' LEU . 14.7 t-20 -119.86 139.62 52.1 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.756 1.222 . . . . 0.0 107.844 172.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.75 161.56 36.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.706 1.203 . . . . 0.0 108.529 -171.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.92 149.32 52.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 108.396 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -73.76 132.38 42.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.6 t . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 125.317 1.447 . . . . 0.0 109.912 176.384 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.26 144.52 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -141.92 165.78 26.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.56 142.99 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -151.21 173.52 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.636 0.774 . . . . 0.0 110.167 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -65.73 148.75 51.25 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -73.94 146.45 43.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.242 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.16 131.88 35.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -33.32 70.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.399 0.545 . . . . 0.0 112.198 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.88 -16.66 60.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.513 0.725 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -86.85 -2.57 58.68 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.379 0.99 . . . . 0.0 111.217 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.59 -38.28 28.23 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.79 1.185 . . . . 0.0 114.186 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.91 -28.5 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.769 1.285 . . . . 0.0 111.818 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -69.11 -31.53 70.29 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.465 -0.772 . . . . 0.0 109.702 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.7 -38.86 64.73 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.8 -47.16 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.42 83.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.556 0.616 . . . . 0.0 111.721 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.2 mt -65.16 -50.87 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.406 1.082 . . . . 0.0 109.449 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -57.13 -46.89 82.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.702 0.683 . . . . 0.0 110.49 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.3 m -55.32 -52.76 62.43 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.745 1.218 . . . . 0.0 111.005 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -69.97 -29.17 66.22 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.473 -0.767 . . . . 0.0 112.041 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -63.07 -42.46 99.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.962 0.801 . . . . 0.0 110.117 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.9 t -70.27 -42.93 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -34.49 73.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.902 0.773 . . . . 0.0 112.306 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.74 -34.47 21.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.992 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -137.13 -0.14 2.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -130.67 22.57 5.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.403 1.456 . . . . 0.0 110.63 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.67 -10.89 14.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -169.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -29.8 65.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.942 1.297 . . . . 0.0 111.618 169.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.5 tp -53.22 125.35 17.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.125 2.17 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -53.09 140.0 26.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.01 1.324 . . . . 0.0 110.704 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.17 76.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.92 -49.87 64.18 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.48 -35.31 77.35 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 122.081 -0.387 . . . . 0.0 110.404 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -57.19 -44.65 83.8 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.5 m -64.69 -48.64 73.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.711 0.687 . . . . 0.0 110.145 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.17 -37.3 83.51 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.009 -0.432 . . . . 0.0 110.819 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.41 -51.27 69.46 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.258 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.59 -41.07 76.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.688 1.131 . . . . 0.0 110.659 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.74 -47.45 81.0 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.775 0.43 . . . . 0.0 111.824 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -36.59 72.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.949 0.34 . . . . 0.0 110.323 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 t -58.26 -48.69 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.257 1.823 . . . . 0.0 109.064 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -69.76 -10.33 57.95 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.095 -1.003 . . . . 0.0 112.639 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -99.5 5.94 46.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.79 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -136.06 -56.28 0.77 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.451 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.73 -39.34 75.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 120.643 1.565 . . . . 0.0 112.844 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -61.63 -15.51 42.29 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.065 1.844 . . . . 0.0 115.073 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -127.6 -14.24 5.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.45 1.477 . . . . 0.0 112.852 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.85 153.39 88.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.128 1.371 . . . . 0.0 111.475 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -77.54 62.51 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.743 3.629 . . . . 0.0 110.972 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.18 176.74 7.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.098 1.359 . . . . 0.0 111.462 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.02 150.84 50.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.124 2.57 . . . . 0.0 104.868 168.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.69 140.48 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 123.942 0.897 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.36 132.7 35.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.88 142.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -82.87 -177.26 6.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.442 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -49.74 -24.27 2.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.488 1.915 . . . . 0.0 114.488 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -84.41 2.19 41.84 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t0 50.46 58.21 5.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 123.512 1.625 . . . . 0.0 108.77 -169.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.08 124.52 15.35 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.48 138.63 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.65 2.233 . . . . 0.0 109.727 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.36 -12.11 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.27 1.028 . . . . 0.0 112.289 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.03 170.15 40.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.83 159.01 43.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.027 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -140.8 126.78 19.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.302 2.241 . . . . 0.0 105.717 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 74' ' ' ASP . 25.7 tp -105.27 124.65 49.9 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -145.95 139.67 26.36 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -153.44 154.57 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.79 5.87 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -132.27 29.07 4.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.609 1.164 . . . . 0.0 110.455 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -125.5 112.03 15.75 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.425 -0.797 . . . . 0.0 110.601 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.5 ttp -85.09 86.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.536 ' HB3' HD23 ' A' ' 67' ' ' LEU . 31.2 t70 -63.48 -28.91 70.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.45 144.58 31.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.008 0.523 . . . . 0.0 110.217 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 tp -153.66 114.58 4.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -142.36 141.05 32.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.5 mt -148.43 145.43 18.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -58.23 122.24 57.6 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.154 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.2 -29.81 7.05 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.192 3.262 . . . . 0.0 114.723 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.74 -23.41 67.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.122 0.969 . . . . 0.0 113.537 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.45 2.73 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.788 0.722 . . . . 0.0 112.827 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -58.99 -37.6 77.21 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.897 -1.127 . . . . 0.0 110.506 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.99 -25.59 69.51 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.71 0.671 . . . . 0.0 113.039 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.9 m -74.79 -7.34 53.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.515 1.158 . . . . 0.0 112.03 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.91 13.97 63.62 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.335 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.72 -31.69 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.288 1.544 . . . . 0.0 110.925 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.47 -52.85 18.13 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 123.819 0.723 . . . . 0.0 111.754 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -62.94 -42.38 99.79 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.356 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 t -58.55 -46.29 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.055 1.298 . . . . 0.0 109.82 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.9 mt -70.4 -39.33 74.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.215 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.15 -40.69 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.83 0.741 . . . . 0.0 109.925 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.04 -37.7 88.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.195 0.907 . . . . 0.0 109.71 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -61.05 -47.94 84.05 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.819 0.448 . . . . 0.0 110.439 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.93 -49.07 77.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.583 0.753 . . . . 0.0 110.739 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -60.09 -33.06 71.57 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.401 1.08 . . . . 0.0 111.734 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.5 -32.71 73.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.475 0.58 . . . . 0.0 111.625 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -90.06 -24.82 21.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.435 0.561 . . . . 0.0 112.074 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.06 93.35 9.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.287 1.435 . . . . 0.0 108.713 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.46 -23.39 50.68 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.342 1.361 . . . . 0.0 112.654 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.61 30.39 4.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.67 1.588 . . . . 0.0 110.219 -174.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.3 tp -51.42 145.76 8.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.195 2.198 . . . . 0.0 113.185 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -128.53 163.9 23.97 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.511 1.524 . . . . 0.0 108.912 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -153.75 -175.15 5.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 110.149 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -146.75 161.12 41.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.158 0.983 . . . . 0.0 109.824 172.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.431 HG12 HD21 ' A' ' 142' ' ' LEU . 10.0 p -156.21 149.06 11.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -80.04 129.72 34.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.2 -27.01 53.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.806 2.043 . . . . 0.0 111.974 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . 0.251 1.2 pt20 -51.48 -33.36 31.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.113 0.965 . . . . 0.0 112.651 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -105.71 69.51 0.83 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.132 1.373 . . . . 0.0 109.621 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.76 -23.99 32.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.894 0.877 . . . . 0.0 111.987 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -63.43 -43.93 96.04 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.454 0.702 . . . . 0.0 109.662 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.669 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.03 -45.81 84.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 119.206 0.912 . . . . 0.0 108.945 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.25 59.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.05 -50.73 66.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 117.811 0.805 . . . . 0.0 110.601 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.22 -39.07 93.58 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.84 -33.94 76.29 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.631 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.85 -40.24 94.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.022 1.283 . . . . 0.0 110.919 174.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.8 -39.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.9 11.81 0.69 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-O 118.825 -0.986 . . . . 0.0 114.112 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -72.97 160.83 31.49 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.635 1.718 . . . . 0.0 111.189 172.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -149.72 141.18 23.34 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.884 1.674 . . . . 0.0 106.884 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.576 HG22 HD22 ' A' ' 142' ' ' LEU . 30.9 t -71.43 133.05 32.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.972 0.909 . . . . 0.0 109.436 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 p -127.11 -8.1 5.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.671 1.989 . . . . 0.0 111.492 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.82 170.71 40.73 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 111.761 171.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -142.62 164.53 29.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.815 1.246 . . . . 0.0 111.279 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.141 169.197 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.458 -0.602 0 N-CA-C 115.625 1.356 . . . . 0.0 115.625 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.45 145.56 26.08 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.0 mt -114.68 144.66 43.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.8 t-20 -113.91 139.09 49.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.99 161.54 35.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -134.07 147.52 50.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.673 1.589 . . . . 0.0 108.292 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -75.8 125.91 29.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 111.389 -178.418 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -136.48 141.16 41.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.354 1.061 . . . . 0.0 108.232 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -141.63 163.38 33.09 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -124.64 144.25 35.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -150.46 170.98 17.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.414 1.086 . . . . 0.0 109.272 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -65.35 148.69 51.27 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 m -72.73 152.48 41.62 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.049 0.94 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -98.24 164.09 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 107.919 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -66.99 -39.4 87.14 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.158 -0.339 . . . . 0.0 111.048 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.99 -26.78 66.08 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.72 -0.32 56.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.212 0.46 . . . . 0.0 112.073 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.45 27.67 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.014 0.816 . . . . 0.0 113.455 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.35 -27.18 67.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.261 1.031 . . . . 0.0 112.119 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -68.04 -33.08 73.9 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.394 -0.816 . . . . 0.0 109.572 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.56 -38.54 62.68 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.03 -46.6 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.78 98.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.374 0.67 . . . . 0.0 112.076 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.6 mt -65.41 -49.7 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.285 1.034 . . . . 0.0 109.574 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -52.02 -48.45 64.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.96 0.504 . . . . 0.0 110.004 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 t -61.18 -50.83 71.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.036 0.534 . . . . 0.0 110.16 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -67.63 -28.78 68.02 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.956 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -68.39 -35.87 78.31 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.511 1.05 . . . . 0.0 110.689 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.88 -43.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.28 -26.88 63.07 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 113.345 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.28 16.56 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.984 0.914 . . . . 0.0 111.931 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -133.42 -7.14 2.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -169.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.3 30.26 5.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.225 1.375 . . . . 0.0 109.512 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.51 -18.16 50.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -51.22 -27.37 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.306 1.842 . . . . 0.0 112.303 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 102.89 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.087 1.755 . . . . 0.0 108.912 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -57.02 149.08 19.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.078 1.751 . . . . 0.0 112.546 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.54 70.69 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.61 -45.76 85.5 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.915 -0.491 . . . . 0.0 109.83 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.81 -32.95 62.12 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.944 -0.472 . . . . 0.0 110.241 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -53.94 -43.0 69.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.144 0.977 . . . . 0.0 110.235 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.6 m -62.31 -50.68 70.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.504 1.121 . . . . 0.0 110.153 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -65.03 -39.31 93.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.445 0.298 . . . . 0.0 110.373 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.27 -53.13 59.56 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.462 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -57.08 -39.99 76.05 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.683 1.129 . . . . 0.0 110.484 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.34 -48.92 73.73 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.124 0.569 . . . . 0.0 112.012 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -36.76 75.11 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.076 0.398 . . . . 0.0 110.296 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -58.64 -48.63 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 126.29 1.836 . . . . 0.0 109.023 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.54 -11.59 60.95 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.978 -1.076 . . . . 0.0 112.679 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -97.17 5.64 49.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.742 0.817 . . . . 0.0 110.652 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.4 -54.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.86 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.61 -38.65 69.8 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 120.674 1.579 . . . . 0.0 112.938 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.23 -13.34 31.66 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.407 2.072 . . . . 0.0 115.02 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -125.82 -20.71 4.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.946 1.703 . . . . 0.0 112.393 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.19 148.72 97.72 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.516 1.127 . . . . 0.0 110.69 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.17 45.51 1.99 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.727 3.618 . . . . 0.0 112.091 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.81 171.05 4.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.457 1.503 . . . . 0.0 112.187 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -119.44 148.52 43.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.541 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.67 137.69 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.351 1.06 . . . . 0.0 110.122 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.41 133.99 35.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.63 145.4 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -88.03 -171.67 3.49 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.479 169.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.73 -23.57 29.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.926 1.29 . . . . 0.0 113.47 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -82.93 5.33 22.28 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.679 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 53.9 30.47 11.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.934 1.693 . . . . 0.0 111.112 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.49 128.06 27.73 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 126.927 2.091 . . . . 0.0 106.22 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.62 136.19 35.44 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.727 1.618 . . . . 0.0 109.52 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.15 -14.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.354 1.062 . . . . 0.0 111.185 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.72 170.81 42.99 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.14 160.28 40.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.741 0.816 . . . . 0.0 111.257 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -139.83 132.23 28.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.574 2.35 . . . . 0.0 105.967 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 74' ' ' ASP . 27.0 tp -112.19 124.2 51.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 169.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.74 133.02 23.17 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 m -142.23 150.7 41.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.08 -113.64 4.24 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.4 29.75 4.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.781 1.232 . . . . 0.0 110.596 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -126.82 111.87 14.69 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.591 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.2 ttp -82.74 88.81 6.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' HB3' HD23 ' A' ' 67' ' ' LEU . 31.7 t70 -66.06 -29.52 69.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.68 145.43 32.44 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.851 0.46 . . . . 0.0 110.667 -172.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.72 115.55 3.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.11 139.4 28.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.8 mt -150.02 144.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -170.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.29 123.61 76.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 108.826 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.8 -19.08 66.44 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.005 2.47 . . . . 0.0 113.832 -171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.5 -21.06 63.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.801 1.182 . . . . 0.0 112.299 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.68 3.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.807 0.843 . . . . 0.0 112.841 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.24 -29.86 58.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.122 -0.986 . . . . 0.0 111.756 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.85 -21.0 50.62 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.316 0.96 . . . . 0.0 113.823 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 66.8 m -73.74 -3.77 30.44 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.023 1.412 . . . . 0.0 112.266 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.01 12.96 75.76 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.276 0.941 . . . . 0.0 112.869 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.85 -33.03 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.485 1.143 . . . . 0.0 111.579 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.53 -50.52 47.96 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -38.7 88.65 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.295 1.047 . . . . 0.0 109.87 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -58.43 -49.59 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.624 1.102 . . . . 0.0 109.916 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.1 mt -67.76 -39.35 84.18 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.849 -0.532 . . . . 0.0 110.707 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.93 -39.74 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.933 -0.556 . . . . 0.0 109.8 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.67 -35.66 81.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.789 1.177 . . . . 0.0 110.388 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -61.23 -45.72 93.37 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.195 0.452 . . . . 0.0 110.3 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.17 74.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.846 0.858 . . . . 0.0 110.744 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.3 -33.29 69.29 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.77 1.228 . . . . 0.0 111.697 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.39 -31.9 72.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.361 0.528 . . . . 0.0 111.637 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 mtm -90.39 -25.51 20.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.157 0.583 . . . . 0.0 112.091 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.97 91.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 125.276 1.43 . . . . 0.0 108.863 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.09 -23.25 53.59 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.362 1.375 . . . . 0.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.48 29.46 4.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.595 1.558 . . . . 0.0 110.444 -174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.37 145.37 8.49 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.03 2.132 . . . . 0.0 113.327 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.9 p -128.03 164.77 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.545 1.538 . . . . 0.0 108.937 170.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.1 t -154.99 -174.15 4.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 110.354 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -146.96 161.97 39.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 109.799 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.497 HG12 HD21 ' A' ' 142' ' ' LEU . 8.4 p -156.13 146.22 12.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.59 133.93 47.16 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.0 -36.17 83.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 112.514 -172.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -35.5 77.42 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.196 0.907 . . . . 0.0 110.914 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.49 70.51 7.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.617 0.722 . . . . 0.0 111.037 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.43 -23.04 35.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.756 0.822 . . . . 0.0 112.074 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -63.61 -45.66 89.31 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.794 0.724 . . . . 0.0 109.593 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.11 -34.58 75.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.878 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.26 -46.06 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.374 0.988 . . . . 0.0 108.895 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.4 -48.16 84.26 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.649 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -54.18 -51.94 62.77 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.128 0.971 . . . . 0.0 110.144 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -64.94 -36.67 85.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -64.36 -40.82 96.6 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.063 -1.023 . . . . 0.0 112.718 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.75 -42.87 89.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.742 1.155 . . . . 0.0 110.255 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.31 -35.19 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.67 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.89 7.82 1.31 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.701 1.143 . . . . 0.0 114.904 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -77.1 164.78 25.38 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.132 1.966 . . . . 0.0 111.72 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -147.59 139.58 24.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.414 1.885 . . . . 0.0 106.218 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 142' ' ' LEU . 32.0 t -72.88 132.98 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -172.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.23 -10.05 7.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.728 2.011 . . . . 0.0 111.417 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.87 178.99 42.5 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.786 0.721 . . . . 0.0 111.44 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -155.82 -178.02 6.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.129 0.971 . . . . 0.0 109.214 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--N 1.325 -0.479 0 C-N-CA 125.144 1.378 . . . . 0.0 108.892 179.192 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 N--CA 1.46 -0.486 0 N-CA-C 118.223 2.355 . . . . 0.0 118.223 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.56 144.49 36.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.1 151.55 27.09 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.562 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.4 t-20 -119.63 139.52 52.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.608 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.23 160.78 38.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.852 0.861 . . . . 0.0 108.733 -172.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.7 149.95 51.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.555 1.542 . . . . 0.0 108.575 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.44 133.89 39.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.97 178.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -135.96 146.4 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.899 1.28 . . . . 0.0 107.603 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -142.92 165.03 28.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 mm -121.67 142.46 37.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -150.19 172.8 14.73 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.876 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -65.5 147.77 52.85 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -73.89 146.74 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.004 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -84.8 160.21 20.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -66.87 -45.48 77.96 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.232 -0.293 . . . . 0.0 110.283 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.34 -28.54 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -83.07 0.93 42.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.915 0.486 . . . . 0.0 111.387 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.07 -45.19 33.37 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.298 0.951 . . . . 0.0 113.617 -176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.69 -21.83 63.47 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.499 1.15 . . . . 0.0 112.565 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -66.29 -33.33 75.5 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.757 1.162 . . . . 0.0 109.564 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.87 -39.49 56.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.45 -45.52 85.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.54 -44.71 95.67 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.142 0.577 . . . . 0.0 111.336 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.86 -52.56 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.47 1.108 . . . . 0.0 108.607 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -53.03 -48.79 67.33 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.589 0.756 . . . . 0.0 110.149 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.8 t -60.16 -50.17 74.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.283 0.633 . . . . 0.0 110.434 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -72.85 -31.39 64.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.154 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -61.19 -43.75 98.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.458 1.026 . . . . 0.0 110.372 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.39 -48.48 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.901 0.88 . . . . 0.0 109.053 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.02 -32.94 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 112.269 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.99 58.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.29 1.036 . . . . 0.0 113.341 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -134.81 -25.55 1.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -169.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.449 ' CD2' HD22 ' A' ' 110' ' ' ASN . 38.5 m-70 -104.09 35.84 2.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.846 1.258 . . . . 0.0 108.476 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.4 -26.81 63.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.805 -1.184 . . . . 0.0 112.428 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -56.49 -24.14 44.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.288 2.235 . . . . 0.0 113.515 173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.79 109.4 1.72 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.012 1.325 . . . . 0.0 107.934 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -58.1 141.84 48.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 111.173 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.72 65.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.932 0.893 . . . . 0.0 113.006 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.57 -45.0 96.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.389 0.676 . . . . 0.0 109.907 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -77.9 -29.09 50.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.531 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -56.74 -42.9 80.08 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.491 1.496 . . . . 0.0 110.318 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -63.93 -49.61 71.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.859 0.864 . . . . 0.0 109.862 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -67.33 -36.11 80.78 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.017 -0.427 . . . . 0.0 110.986 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.0 mt -63.52 -49.63 72.75 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.446 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.91 -42.24 75.73 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 119.957 1.253 . . . . 0.0 109.769 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.85 -48.34 82.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.584 1.084 . . . . 0.0 112.446 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.52 74.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.81 -44.43 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.185 1.794 . . . . 0.0 110.117 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -62.94 -24.02 67.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.602 1.161 . . . . 0.0 111.134 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -97.93 7.79 45.79 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.549 1.14 . . . . 0.0 110.662 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -138.12 -59.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.547 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.6 -36.52 46.47 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 121.228 1.831 . . . . 0.0 113.113 -175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 -15.03 34.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 121.942 1.762 . . . . 0.0 115.419 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.61 -11.79 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.938 1.699 . . . . 0.0 113.455 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.8 154.85 88.02 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.408 1.483 . . . . 0.0 111.988 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.86 60.67 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.961 3.774 . . . . 0.0 111.733 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -87.24 172.99 9.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.434 1.893 . . . . 0.0 112.213 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -135.2 145.83 48.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.14 140.21 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.825 0.85 . . . . 0.0 110.41 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.88 134.42 35.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.31 144.09 38.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -83.77 -172.95 4.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -55.2 -24.36 26.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.033 1.333 . . . . 0.0 113.311 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -84.2 0.8 47.34 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.479 1.111 . . . . 0.0 111.831 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t0 52.24 53.87 11.7 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.013 1.387 . . . . 0.0 109.524 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.05 125.28 22.75 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.71 134.25 37.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.545 2.163 . . . . 0.0 110.881 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.39 -11.46 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.192 0.997 . . . . 0.0 111.981 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.65 169.25 41.94 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -139.79 160.92 38.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.709 0.754 . . . . 0.0 111.603 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -139.85 131.34 27.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.593 2.357 . . . . 0.0 105.949 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.84 116.46 28.04 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -144.04 132.97 22.68 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.4 m -141.97 152.97 43.96 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.8 -118.62 11.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -129.28 30.94 4.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.159 0.984 . . . . 0.0 111.022 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -122.87 112.74 18.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.253 0.621 . . . . 0.0 110.153 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -85.1 90.75 7.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.68 -26.42 67.78 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.32 144.99 30.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.043 0.537 . . . . 0.0 110.734 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -153.54 119.4 5.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -145.09 143.23 30.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -143.96 143.66 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -54.31 120.95 28.7 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.088 1.755 . . . . 0.0 109.407 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.03 -24.89 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.215 3.277 . . . . 0.0 114.919 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.11 -26.97 68.03 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.57 9.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.429 . . . . 0.0 112.54 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.88 -34.83 63.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.667 -1.271 . . . . 0.0 112.392 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.17 -13.59 81.73 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.165 -0.797 . . . . 0.0 113.244 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.14 173.68 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 0.0 110.08 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.51 -11.09 39.78 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.959 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -51.47 -34.42 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.601 1.701 . . . . 0.0 112.01 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.42 -54.64 19.59 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -65.54 -40.37 92.81 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.455 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.66 -48.39 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 121.186 1.812 . . . . 0.0 109.977 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -68.05 -40.99 82.68 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.973 -0.455 . . . . 0.0 110.701 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.296 0.498 . . . . 0.0 110.205 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.52 -34.07 75.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.325 0.966 . . . . 0.0 110.1 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.6 -46.33 90.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.338 0.517 . . . . 0.0 110.198 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.94 72.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.377 0.671 . . . . 0.0 110.822 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -58.77 -33.34 70.19 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.359 1.064 . . . . 0.0 111.734 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.1 m -62.95 -35.45 80.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.585 0.63 . . . . 0.0 111.503 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.41 -26.46 26.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.26 0.482 . . . . 0.0 111.86 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 89.91 12.08 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 125.101 1.36 . . . . 0.0 109.294 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.47 -22.78 58.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.468 1.446 . . . . 0.0 113.059 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.02 31.49 4.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.441 1.496 . . . . 0.0 110.095 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -50.3 143.99 7.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.232 2.213 . . . . 0.0 112.9 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.7 p -129.62 163.25 26.45 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.404 1.482 . . . . 0.0 108.778 171.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -154.78 -174.46 4.99 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.166 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.57 161.45 41.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 110.018 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG12 HD21 ' A' ' 142' ' ' LEU . 9.7 p -157.17 145.44 10.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.0 129.29 39.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -58.39 -30.88 67.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.18 1.392 . . . . 0.0 111.941 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.51 -35.28 78.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.203 0.456 . . . . 0.0 111.224 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.449 HD22 ' CD2' ' A' ' 28' ' ' HIS . 61.6 t-20 -78.6 63.8 3.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.039 1.336 . . . . 0.0 109.882 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.74 -26.8 47.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 111.394 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -45.25 94.3 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.94 73.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.88 -45.96 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.396 0.998 . . . . 0.0 108.828 171.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.8 83.07 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.58 -51.59 64.8 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.022 0.911 . . . . 0.0 110.379 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.53 -35.02 79.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -64.91 -38.95 92.66 Favored 'General case' 0 C--N 1.341 0.205 0 O-C-N 120.916 -1.115 . . . . 0.0 112.632 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.28 -41.37 88.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.956 1.253 . . . . 0.0 110.329 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.78 -39.36 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.794 . . . . 0.0 110.309 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.41 5.18 0.98 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.542 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.99 162.92 28.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.355 1.577 . . . . 0.0 111.169 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.77 140.01 25.53 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 142' ' ' LEU . 41.3 t -73.11 129.31 36.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.984 0.914 . . . . 0.0 109.16 -173.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 p -119.54 -9.88 9.74 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.599 1.959 . . . . 0.0 111.397 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -170.87 -179.29 42.01 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 171.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.31 179.08 8.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.679 0.792 . . . . 0.0 109.271 170.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 0.0 106.893 -179.883 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo . . . . . 0 CA--C 1.536 0.613 0 N-CA-C 119.09 2.689 . . . . 0.0 119.09 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.0 tp -102.18 147.62 26.42 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.9 mt -110.85 150.49 29.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.537 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.5 t-20 -116.88 139.08 51.04 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.94 160.57 38.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.3 150.56 52.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.431 1.492 . . . . 0.0 108.195 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -75.12 128.26 35.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 124.664 1.186 . . . . 0.0 109.925 -178.145 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 mm -132.96 144.34 36.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.621 0.768 . . . . 0.0 109.348 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -141.6 164.49 30.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 mm -124.33 143.77 36.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -151.91 172.39 16.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.68 1.192 . . . . 0.0 109.162 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -66.68 149.82 49.96 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -71.34 154.11 41.83 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.482 1.113 . . . . 0.0 111.721 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -97.66 163.68 12.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.816 1.646 . . . . 0.0 108.258 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -69.17 -48.31 62.6 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.282 -0.261 . . . . 0.0 110.742 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.52 -28.62 67.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.79 -1.91 40.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.86 -38.19 37.04 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.25 0.929 . . . . 0.0 113.503 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.76 -28.44 67.62 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.58 1.19 . . . . 0.0 111.919 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.4 -30.73 69.71 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.89 -39.36 61.54 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -56.88 -45.64 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.34 98.01 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.884 0.474 . . . . 0.0 111.884 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mt -62.41 -48.45 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.345 0.658 . . . . 0.0 109.678 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -54.49 -48.42 71.88 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -59.29 -42.08 90.46 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.866 -0.521 . . . . 0.0 110.596 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -62.63 -39.79 94.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.47 1.108 . . . . 0.0 111.718 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -65.78 -36.52 83.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.572 0.749 . . . . 0.0 109.969 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.59 -45.81 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.254 -0.903 . . . . 0.0 109.127 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.26 -33.8 65.8 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.948 1.299 . . . . 0.0 113.004 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.11 -29.48 12.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -139.28 0.6 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -168.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -135.17 25.79 3.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.429 1.468 . . . . 0.0 110.963 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.58 -12.8 17.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.874 -1.141 . . . . 0.0 113.196 -174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -56.21 -20.34 17.74 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.325 1.85 . . . . 0.0 112.904 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.94 101.84 0.42 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.08 1.352 . . . . 0.0 108.8 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -56.69 157.71 5.18 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.342 1.457 . . . . 0.0 110.729 170.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 -37.9 63.59 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.88 -49.75 64.66 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.905 0.775 . . . . 0.0 109.701 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -63.72 -40.19 96.13 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.233 1.013 . . . . 0.0 109.956 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -55.58 -50.23 70.64 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.838 1.255 . . . . 0.0 109.614 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.1 m -64.1 -48.33 76.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.303 1.041 . . . . 0.0 110.274 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.46 -41.31 93.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.188 0.449 . . . . 0.0 110.723 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.99 -50.53 65.95 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.595 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.36 -41.94 76.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.061 0.846 . . . . 0.0 110.684 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.34 -44.51 83.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.452 0.701 . . . . 0.0 112.225 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.32 -38.24 74.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -56.8 -49.41 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.493 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -58.39 -24.27 59.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.646 1.178 . . . . 0.0 111.674 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -101.46 6.49 42.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.179 0.992 . . . . 0.0 110.959 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -136.89 -52.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.306 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -58.36 -37.89 59.78 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.265 1.393 . . . . 0.0 113.001 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -63.42 -14.01 39.68 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.129 1.886 . . . . 0.0 115.426 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -127.98 -19.01 4.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.042 1.746 . . . . 0.0 112.463 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.38 148.43 96.17 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.256 1.022 . . . . 0.0 110.416 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.43 43.74 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.748 3.632 . . . . 0.0 112.102 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.83 169.96 7.27 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.52 1.528 . . . . 0.0 112.07 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -113.27 149.54 33.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 138.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 110.238 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.93 132.35 35.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.64 141.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.59 -179.51 7.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.342 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -51.26 -25.67 6.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.594 1.558 . . . . 0.0 114.22 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -79.39 0.14 30.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.171 0.989 . . . . 0.0 111.773 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t0 52.01 56.97 7.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 123.34 1.543 . . . . 0.0 109.216 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -136.95 126.75 15.72 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.8 137.3 38.0 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.904 2.403 . . . . 0.0 111.695 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.6 m -113.82 -21.36 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.115 0.966 . . . . 0.0 111.68 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.84 170.61 39.2 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -141.44 157.43 45.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.855 0.862 . . . . 0.0 110.686 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -141.38 134.29 28.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.788 2.035 . . . . 0.0 106.668 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 74' ' ' ASP . 24.0 tp -115.91 118.2 32.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.8 tp -142.07 133.49 26.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.215 1.006 . . . . 0.0 108.298 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -143.45 153.87 43.09 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.25 -119.48 13.58 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.52 37.12 4.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.194 0.998 . . . . 0.0 110.478 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -127.27 109.1 11.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.824 0.85 . . . . 0.0 110.066 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -85.45 97.41 10.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.437 ' HB3' HD23 ' A' ' 67' ' ' LEU . 32.3 t70 -71.47 -31.73 67.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.9 23.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.689 0.796 . . . . 0.0 110.282 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 tp -148.08 122.85 9.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 173.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.38 142.63 30.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 mt -148.55 144.37 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -61.07 115.33 13.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.19 -15.03 26.59 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.785 2.323 . . . . 0.0 114.364 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.83 -24.37 67.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.821 0.737 . . . . 0.0 112.554 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.32 -9.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 112.928 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -47.24 -46.43 24.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.581 1.152 . . . . 0.0 111.237 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.26 -14.52 71.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.884 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 72.0 m -68.91 -14.39 63.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.246 1.523 . . . . 0.0 112.062 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.52 -7.76 7.9 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.309 0.956 . . . . 0.0 112.589 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.73 -31.52 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.744 1.272 . . . . 0.0 111.059 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.74 -50.45 37.2 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.573 0.606 . . . . 0.0 111.895 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.22 -46.83 79.07 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.842 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.71 -49.28 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.646 1.112 . . . . 0.0 110.288 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.24 -36.81 74.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.118 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.98 -40.56 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.03 0.832 . . . . 0.0 109.789 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.67 -36.11 83.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.409 1.004 . . . . 0.0 110.02 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -61.5 -48.24 81.97 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.871 0.469 . . . . 0.0 110.3 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.59 76.03 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.511 0.724 . . . . 0.0 110.87 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.67 -33.37 70.04 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.697 1.199 . . . . 0.0 111.696 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -62.84 -35.03 78.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.583 0.629 . . . . 0.0 111.465 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.8 mtm -86.13 -24.39 26.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.381 0.537 . . . . 0.0 112.013 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.77 91.05 9.42 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.866 1.266 . . . . 0.0 109.899 -171.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.65 -23.86 48.74 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.341 1.361 . . . . 0.0 113.273 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -103.39 30.92 4.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.428 1.491 . . . . 0.0 110.292 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.3 tp -50.86 146.57 5.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.559 2.343 . . . . 0.0 113.673 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.7 p -128.32 162.23 27.55 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 108.92 169.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -155.31 -179.29 7.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.788 0.435 . . . . 0.0 111.108 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -137.19 155.14 49.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 142' ' ' LEU . 10.3 p -155.41 148.61 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -74.54 134.09 42.22 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.88 -35.31 68.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.682 1.193 . . . . 0.0 112.069 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -64.11 -29.69 70.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.415 0.552 . . . . 0.0 111.873 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -79.78 65.81 5.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.69 -25.68 60.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.746 0.818 . . . . 0.0 111.342 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.58 -47.71 82.63 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.006 0.522 . . . . 0.0 109.897 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.85 80.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.592 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.0 -46.28 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 119.179 0.9 . . . . 0.0 108.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.18 -49.88 67.64 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -55.25 -49.76 71.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.932 0.893 . . . . 0.0 110.524 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.45 -36.1 81.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.56 -39.23 93.37 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.83 -1.169 . . . . 0.0 112.526 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.32 -42.94 92.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.863 1.21 . . . . 0.0 110.218 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.68 -34.32 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.847 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.53 7.53 1.88 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.394 0.997 . . . . 0.0 114.361 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -73.39 166.39 23.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.779 1.79 . . . . 0.0 111.518 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -143.42 140.57 30.48 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.142 2.177 . . . . 0.0 105.969 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.617 HG22 HD22 ' A' ' 142' ' ' LEU . 40.3 t -72.44 129.54 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.6 p -130.85 -6.64 4.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.054 1.742 . . . . 0.0 111.338 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.34 178.57 38.08 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -157.78 -172.33 3.9 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.733 0.813 . . . . 0.0 109.918 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.315 1.846 . . . . 0.0 108.94 176.046 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo . . . . . 0 N--CA 1.458 -0.562 0 N-CA-C 118.829 2.588 . . . . 0.0 118.829 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -97.45 149.42 22.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.0 mt -116.64 152.92 33.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.555 ' C ' HD23 ' A' ' 142' ' ' LEU . 17.4 t-20 -120.99 139.78 52.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.704 1.202 . . . . 0.0 107.874 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.35 157.71 46.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -170.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.34 150.87 52.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.988 1.315 . . . . 0.0 108.41 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.13 130.69 37.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.486 1.515 . . . . 0.0 109.823 -176.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -138.63 144.98 28.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.636 1.174 . . . . 0.0 107.848 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -141.68 165.03 28.6 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 55' ' ' ALA . 12.5 mm -127.06 144.06 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -154.24 169.99 22.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.13 1.372 . . . . 0.0 109.037 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -68.35 156.8 37.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -83.48 151.78 25.27 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.531 1.532 . . . . 0.0 112.103 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -84.72 161.11 20.16 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 168.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -70.61 -43.44 69.31 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.995 -0.441 . . . . 0.0 110.739 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.87 -28.31 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.07 -0.98 42.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.872 0.469 . . . . 0.0 111.621 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.84 52.58 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.02 0.827 . . . . 0.0 112.678 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -60.51 -34.04 73.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.418 1.109 . . . . 0.0 111.547 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -71.61 -32.68 68.26 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.261 0.624 . . . . 0.0 109.982 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.41 -39.88 67.59 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.768 -0.582 . . . . 0.0 109.437 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.62 -43.99 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.407 1.083 . . . . 0.0 109.231 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.54 89.47 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.048 0.539 . . . . 0.0 111.298 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.9 mt -58.46 -50.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.485 1.114 . . . . 0.0 109.167 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -53.35 -47.26 69.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.307 0.643 . . . . 0.0 110.299 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.8 t -60.05 -50.81 72.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.534 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -69.75 -29.75 67.18 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.44 -0.788 . . . . 0.0 112.281 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -63.23 -34.95 78.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.636 0.653 . . . . 0.0 110.909 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.99 -44.21 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.67 -35.36 72.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.766 0.712 . . . . 0.0 112.326 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -44.88 17.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.787 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 p -131.79 -2.12 3.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -168.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -129.5 26.45 5.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.57 1.077 . . . . 0.0 110.502 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.89 -15.76 34.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.969 0.908 . . . . 0.0 113.246 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -55.51 -18.7 7.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.895 2.078 . . . . 0.0 112.955 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.09 99.54 0.67 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -53.53 152.6 4.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.331 1.852 . . . . 0.0 111.162 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.38 68.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.26 -49.0 68.65 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.698 -0.626 . . . . 0.0 109.513 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -66.74 -36.53 82.66 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.126 -0.359 . . . . 0.0 110.574 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.55 -47.31 73.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.82 1.248 . . . . 0.0 109.839 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.4 m -65.03 -49.4 70.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.221 1.008 . . . . 0.0 110.053 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -65.12 -39.85 93.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.508 0.323 . . . . 0.0 110.631 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 mt -63.03 -52.0 64.58 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.308 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.91 -40.53 73.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.569 1.077 . . . . 0.0 110.592 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.59 -49.32 73.81 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.094 0.558 . . . . 0.0 111.954 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -37.44 76.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.998 0.363 . . . . 0.0 110.065 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.64 -48.85 84.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.412 1.885 . . . . 0.0 109.161 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -69.58 -11.67 61.02 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.241 -0.912 . . . . 0.0 112.304 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -99.03 6.09 46.78 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.098 0.959 . . . . 0.0 110.818 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.98 -53.98 0.71 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.744 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.36 -38.03 63.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.73 1.605 . . . . 0.0 112.948 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.67 -14.25 34.8 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.378 2.052 . . . . 0.0 115.223 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.55 -20.01 5.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.591 1.541 . . . . 0.0 112.03 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.19 146.49 97.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.437 1.095 . . . . 0.0 110.107 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.17 46.27 2.19 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.325 3.35 . . . . 0.0 111.421 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.67 157.28 30.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.948 -1.095 . . . . 0.0 110.154 -172.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -101.06 144.35 30.08 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.84 136.7 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.684 0.794 . . . . 0.0 110.166 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.478 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 168.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.46 141.51 45.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.436 ' ND2' HH21 ' A' ' 59' ' ' ARG . 20.1 p30 -82.22 -178.12 6.91 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.135 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -54.85 -23.78 20.06 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.441 1.497 . . . . 0.0 113.712 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.436 HH21 ' ND2' ' A' ' 57' ' ' ASN . 84.4 mtm180 -78.14 -1.83 34.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.345 1.058 . . . . 0.0 111.685 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 t0 52.19 58.31 5.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.577 1.656 . . . . 0.0 108.967 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -139.13 127.95 13.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 140.85 47.94 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.956 2.437 . . . . 0.0 112.527 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 57' ' ' ASN . 27.2 m -118.94 -15.79 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.373 1.069 . . . . 0.0 112.294 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.71 168.81 40.38 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -141.7 156.33 45.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.347 0.659 . . . . 0.0 110.749 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.39 141.21 39.62 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.356 1.062 . . . . 0.0 108.522 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.56 117.98 31.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -148.88 134.99 19.18 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.125 0.875 . . . . 0.0 109.798 171.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.5 m -152.66 151.5 30.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 167.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.56 -122.9 26.0 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -129.67 22.16 5.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.517 1.127 . . . . 0.0 111.482 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -123.35 104.8 9.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.679 0.792 . . . . 0.0 109.548 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -83.21 82.0 8.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.18 -32.6 62.3 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.98 157.06 42.41 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 tp -154.94 126.44 7.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.916 2.086 . . . . 0.0 106.508 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.73 144.44 29.42 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.062 1.345 . . . . 0.0 107.959 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -149.9 146.01 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -53.48 116.51 9.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.702 1.201 . . . . 0.0 108.84 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.54 -18.65 60.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.317 2.678 . . . . 0.0 113.352 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.92 -20.86 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.222 0.919 . . . . 0.0 112.423 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.46 4.16 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.56 -45.31 66.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.065 -1.022 . . . . 0.0 110.469 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.49 -19.13 68.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.225 0.917 . . . . 0.0 113.632 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.81 -16.51 63.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.052 1.426 . . . . 0.0 111.749 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.99 -15.05 5.91 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.263 0.935 . . . . 0.0 112.637 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.15 -31.96 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.997 1.399 . . . . 0.0 111.656 -171.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.87 36.16 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.614 1.102 . . . . 0.0 113.693 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.72 -42.88 8.52 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 116.933 -1.508 . . . . 0.0 110.08 169.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.73 -45.13 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.58 1.537 . . . . 0.0 111.215 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.77 -38.53 83.54 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.94 0.791 . . . . 0.0 111.517 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.55 -42.94 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -64.39 -34.62 78.6 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.794 -0.566 . . . . 0.0 109.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -60.38 -49.03 79.2 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.09 0.404 . . . . 0.0 110.042 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.24 86.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.09 -34.67 75.29 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.918 0.887 . . . . 0.0 111.404 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -63.44 -37.35 86.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.271 0.487 . . . . 0.0 111.331 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.3 mtm -85.65 -24.1 27.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.101 0.56 . . . . 0.0 112.272 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.99 96.55 5.46 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.482 1.513 . . . . 0.0 108.342 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.77 -23.9 47.8 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.149 1.233 . . . . 0.0 112.225 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.77 28.49 4.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.77 1.628 . . . . 0.0 110.602 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 tp -52.2 145.86 10.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.155 2.182 . . . . 0.0 113.438 -169.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -128.11 158.0 39.21 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.069 1.348 . . . . 0.0 107.842 169.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -153.28 -173.72 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.773 0.429 . . . . 0.0 109.905 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.75 162.18 36.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.686 1.194 . . . . 0.0 109.552 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.527 HG12 HD21 ' A' ' 142' ' ' LEU . 10.3 p -154.55 143.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.69 125.58 27.23 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.37 -36.36 73.36 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.853 0.461 . . . . 0.0 111.957 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.47 -32.34 71.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.809 0.444 . . . . 0.0 110.851 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -77.3 65.98 2.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.646 1.179 . . . . 0.0 109.189 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.22 -26.49 60.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.332 1.053 . . . . 0.0 111.113 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -45.92 92.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.253 0.621 . . . . 0.0 109.791 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.79 -34.21 73.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.936 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.69 -46.72 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.464 1.029 . . . . 0.0 108.791 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.04 -49.96 70.1 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -54.99 -50.57 68.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.667 0.787 . . . . 0.0 110.873 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.9 -34.92 78.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -65.84 -38.61 89.33 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 120.99 -1.068 . . . . 0.0 112.296 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.85 -42.84 90.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.909 1.231 . . . . 0.0 110.191 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.93 -34.27 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.299 1.04 . . . . 0.0 110.787 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.87 0.89 2.16 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.323 0.963 . . . . 0.0 114.853 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -72.93 161.76 30.31 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.466 1.633 . . . . 0.0 111.688 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 141.81 27.19 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.82 1.648 . . . . 0.0 106.609 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 142' ' ' LEU . 32.9 t -72.02 132.47 33.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.327 1.051 . . . . 0.0 109.863 -172.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.4 p -127.58 -8.81 5.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.754 2.022 . . . . 0.0 111.707 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.62 40.78 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -161.13 -174.84 4.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.919 0.86 . . . . 0.0 111.008 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 127.398 2.279 . . . . 0.0 107.121 169.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 115.71 1.388 . . . . 0.0 115.71 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.75 148.21 44.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.228 2.211 . . . . 0.0 106.268 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.8 mt -111.82 150.97 29.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.49 ' C ' HD23 ' A' ' 142' ' ' LEU . 15.0 t-20 -118.4 140.07 50.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.86 160.47 39.21 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.748 1.219 . . . . 0.0 108.399 -169.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.43 151.88 51.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.268 1.427 . . . . 0.0 108.781 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -80.54 72.61 7.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.832 0.825 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 123.681 0.792 . . . . 0.0 110.582 179.891 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 mm -133.36 144.71 35.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -141.34 165.04 28.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.0 mm -124.98 142.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -154.01 170.98 19.8 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.044 0.938 . . . . 0.0 109.779 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -62.24 148.68 44.02 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 p -61.29 168.18 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.461 1.904 . . . . 0.0 113.166 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -118.93 157.89 26.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.356 1.862 . . . . 0.0 106.792 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.16 -43.33 74.49 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.915 -0.491 . . . . 0.0 110.842 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.11 -25.73 64.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -85.2 0.34 52.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.264 0.625 . . . . 0.0 111.533 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.81 -41.12 57.84 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.931 0.787 . . . . 0.0 113.41 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.29 -24.79 64.9 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.674 1.237 . . . . 0.0 111.771 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.3 -30.96 65.29 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.6 -38.97 67.66 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.58 -46.34 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.29 95.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.731 0.696 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.25 -50.98 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.628 0.771 . . . . 0.0 109.398 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -60.09 -46.93 87.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.715 0.406 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.38 -43.13 83.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.326 1.05 . . . . 0.0 111.148 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -66.29 -41.5 89.73 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.761 0.824 . . . . 0.0 111.083 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -41.53 88.48 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 110.328 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.56 -46.15 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.702 0.801 . . . . 0.0 109.397 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.5 -37.49 81.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.753 0.706 . . . . 0.0 112.17 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.29 -35.24 20.05 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.554 0.742 . . . . 0.0 112.843 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.9 p -137.43 2.98 2.53 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -128.75 31.56 4.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.626 1.103 . . . . 0.0 109.239 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.44 -24.03 42.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 0.0 113.314 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -24.32 58.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.973 2.109 . . . . 0.0 113.019 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.44 127.15 30.09 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.528 1.531 . . . . 0.0 111.386 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 m -55.83 141.59 38.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.767 1.227 . . . . 0.0 110.373 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -32.38 70.2 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.588 0.355 . . . . 0.0 111.891 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.61 -47.56 75.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.77 -40.94 88.42 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.575 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.03 -54.5 29.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.493 1.117 . . . . 0.0 109.373 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.2 m -64.95 -47.98 75.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.541 1.136 . . . . 0.0 111.409 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.19 -36.13 74.4 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.219 0.463 . . . . 0.0 110.654 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.0 mt -63.23 -50.78 68.88 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.887 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -40.52 69.74 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.498 1.044 . . . . 0.0 110.64 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.56 -44.72 81.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -35.79 68.02 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.084 -0.385 . . . . 0.0 110.437 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 t -59.65 -47.51 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 126.08 1.752 . . . . 0.0 109.128 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -70.01 -10.41 58.55 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.738 -1.226 . . . . 0.0 112.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -95.7 5.7 50.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.476 0.71 . . . . 0.0 110.777 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.39 -55.86 0.75 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.697 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.21 -39.1 75.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 120.635 1.561 . . . . 0.0 112.732 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -63.35 -11.57 26.27 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.423 2.082 . . . . 0.0 115.068 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.44 -20.55 5.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.704 1.593 . . . . 0.0 112.104 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 140.24 97.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.171 0.989 . . . . 0.0 110.068 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.26 50.05 3.41 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.635 3.557 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.86 164.07 4.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.364 1.466 . . . . 0.0 110.578 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -107.87 109.36 20.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.42 139.46 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 118.478 0.581 . . . . 0.0 109.946 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.98 133.28 35.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 103.714 -2.699 . . . . 0.0 103.714 167.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.54 141.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -80.56 -177.05 6.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.393 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -55.2 -23.62 22.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.299 1.439 . . . . 0.0 113.497 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.59 -0.43 42.27 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.394 1.078 . . . . 0.0 111.657 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t0 52.09 56.87 7.13 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.837 1.78 . . . . 0.0 109.522 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -137.09 126.15 15.2 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -171.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.36 142.53 55.01 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.592 2.195 . . . . 0.0 111.724 -169.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.51 -11.06 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 112.522 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.61 172.56 37.84 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.04 156.75 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.8 0.8 . . . . 0.0 110.369 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.43 162.1 36.12 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 108.758 169.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.38 130.38 52.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -146.26 135.07 22.38 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.2 m -161.64 156.18 22.79 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.025 2.53 . . . . 0.0 105.298 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.28 33.6 61.77 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.425 -0.797 . . . . 0.0 113.902 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 56.0 24.56 7.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.167 1.787 . . . . 0.0 114.148 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -124.02 110.74 15.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.102 0.961 . . . . 0.0 109.707 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.7 ttp -85.86 89.44 7.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.58 -27.14 68.98 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.633 1.173 . . . . 0.0 113.525 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.83 150.35 31.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.362 1.065 . . . . 0.0 109.443 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.2 tp -157.86 120.52 3.84 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.481 1.912 . . . . 0.0 106.432 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -145.88 145.88 30.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 108.107 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -149.98 143.6 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.81 134.01 95.1 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.498 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 -28.85 31.89 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.162 2.575 . . . . 0.0 114.849 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.62 -26.46 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.094 0.861 . . . . 0.0 112.851 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.1 m -111.93 -2.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.88 -39.71 82.22 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.252 -0.905 . . . . 0.0 110.09 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.37 -28.42 73.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.605 0.621 . . . . 0.0 112.838 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -74.01 -8.42 56.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.334 1.067 . . . . 0.0 112.293 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.49 9.38 61.63 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.523 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.63 -29.46 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.455 1.627 . . . . 0.0 110.68 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.97 -39.33 25.66 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.892 1.234 . . . . 0.0 113.455 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.42 -47.27 17.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.372 1.586 . . . . 0.0 109.869 169.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -52.87 -45.34 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.168 1.349 . . . . 0.0 111.428 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -68.03 -38.37 82.45 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.008 0.822 . . . . 0.0 111.422 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -41.47 90.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-N 118.446 0.566 . . . . 0.0 109.633 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.21 -36.27 83.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.62 -0.675 . . . . 0.0 109.718 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -60.51 -47.75 84.77 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.775 0.43 . . . . 0.0 110.203 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.76 74.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 122.823 0.449 . . . . 0.0 111.159 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.26 -34.25 72.01 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.385 1.074 . . . . 0.0 111.338 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.7 m -62.44 -37.51 86.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.331 0.514 . . . . 0.0 111.434 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.1 mtm -86.57 -21.06 27.08 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.306 0.503 . . . . 0.0 112.263 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.52 93.22 5.37 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.833 1.253 . . . . 0.0 109.872 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -22.84 53.97 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.345 1.363 . . . . 0.0 113.108 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -104.39 31.01 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.403 1.481 . . . . 0.0 110.335 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.7 tp -51.68 146.11 8.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.655 2.382 . . . . 0.0 113.126 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 p -129.97 160.49 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.293 1.437 . . . . 0.0 108.63 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -155.03 -176.75 6.1 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 172.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.0 156.04 41.0 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.132 0.973 . . . . 0.0 109.588 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.9 p -150.25 149.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.75 123.99 23.23 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.71 -32.28 67.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.639 1.175 . . . . 0.0 112.638 -170.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -57.68 -34.08 69.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.234 0.614 . . . . 0.0 110.963 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -77.43 65.62 3.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.682 1.193 . . . . 0.0 110.465 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.86 -26.09 61.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.582 0.753 . . . . 0.0 111.448 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.48 -47.46 85.57 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.815 0.446 . . . . 0.0 110.109 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.92 -37.3 84.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.354 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.56 -46.29 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.9 0.773 . . . . 0.0 109.168 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.35 -50.08 68.2 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -56.28 -49.54 73.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.796 0.838 . . . . 0.0 110.662 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.71 -34.81 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -66.28 -38.08 86.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.931 -1.106 . . . . 0.0 112.532 172.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.66 -42.47 88.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.95 1.25 . . . . 0.0 110.142 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.97 -35.44 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.253 1.021 . . . . 0.0 110.741 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.22 4.52 1.98 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.499 -1.167 . . . . 0.0 115.067 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.68 161.3 31.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.584 1.692 . . . . 0.0 111.392 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 139.93 25.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 HD22 ' A' ' 142' ' ' LEU . 41.2 t -72.74 131.23 35.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.137 0.975 . . . . 0.0 109.502 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.7 p -119.99 -11.41 9.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.638 1.975 . . . . 0.0 111.419 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.32 173.24 41.79 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -155.3 176.59 12.38 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 122.009 -0.7 . . . . 0.0 109.82 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.523 -179.649 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.451 -1.004 0 N-CA-C 110.435 -0.64 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.86 144.34 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.08 148.23 33.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.45 ' C ' HD23 ' A' ' 142' ' ' LEU . 17.1 t-20 -119.67 140.38 50.74 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.56 160.22 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.579 1.152 . . . . 0.0 108.703 -169.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.49 151.47 50.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.386 1.475 . . . . 0.0 108.208 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -76.45 127.64 33.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.572 1.149 . . . . 0.0 109.959 -177.235 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -137.27 147.77 26.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -141.82 165.41 27.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.0 mm -123.14 142.43 39.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -151.48 174.72 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.907 0.883 . . . . 0.0 109.868 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -69.07 147.53 51.35 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 m -73.51 146.53 44.78 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.787 0.835 . . . . 0.0 111.91 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -81.73 158.73 24.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -67.77 -47.72 68.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.13 -27.43 67.31 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.03 1.8 34.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.846 0.458 . . . . 0.0 111.651 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.27 -38.71 33.96 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.962 0.792 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.73 -33.51 75.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.404 1.102 . . . . 0.0 111.516 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.94 -33.77 76.31 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 118.664 0.666 . . . . 0.0 109.583 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.47 -40.12 57.77 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.413 HG21 ' HD2' ' A' ' 44' ' ' ARG . 72.5 t -55.46 -47.35 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.76 90.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.122 0.569 . . . . 0.0 111.86 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.7 mt -59.59 -51.19 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 124.745 1.218 . . . . 0.0 108.776 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -53.07 -49.59 66.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.603 0.761 . . . . 0.0 110.079 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.4 t -59.42 -49.94 75.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.716 0.406 . . . . 0.0 110.196 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -75.17 -28.16 59.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.46 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.9 m -60.78 -40.26 91.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.224 0.92 . . . . 0.0 110.779 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -70.11 -45.9 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.3 -24.42 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.25 -47.08 10.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.237 1.015 . . . . 0.0 112.255 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -129.37 1.54 5.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -129.54 23.17 5.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.499 1.12 . . . . 0.0 109.508 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.2 -21.51 47.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.03 -25.8 13.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.183 1.793 . . . . 0.0 112.254 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.85 103.16 0.41 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 108.763 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 m -59.72 150.68 27.12 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.799 1.64 . . . . 0.0 112.444 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.81 -33.31 70.22 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.45 -48.17 76.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -74.45 -29.94 61.67 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.902 -0.499 . . . . 0.0 110.517 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -54.91 -44.75 74.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.318 0.963 . . . . 0.0 110.119 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.0 m -64.26 -48.79 74.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.304 1.042 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.14 -34.84 77.09 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.054 -0.404 . . . . 0.0 111.023 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.83 -48.29 77.42 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 117.532 -1.223 . . . . 0.0 109.462 172.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.57 -40.63 75.53 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.964 1.257 . . . . 0.0 109.813 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.82 -47.85 84.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.415 1.007 . . . . 0.0 112.37 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -37.92 75.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.848 1.659 . . . . 0.0 109.877 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HD2' HG21 ' A' ' 17' ' ' VAL . 3.0 tpt180 -61.08 -24.79 66.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.866 1.266 . . . . 0.0 111.455 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -98.21 7.37 46.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.39 1.076 . . . . 0.0 110.631 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -137.96 -59.21 0.65 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.6 -169.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.71 -36.42 45.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 121.01 1.732 . . . . 0.0 113.192 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -60.36 -18.49 53.33 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.899 1.733 . . . . 0.0 115.266 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -127.29 -13.78 5.49 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.313 1.415 . . . . 0.0 113.032 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.09 90.1 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.017 1.327 . . . . 0.0 111.516 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.37 58.93 6.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 112.064 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 mt -88.83 167.68 13.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.898 1.679 . . . . 0.0 112.921 -170.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -126.94 144.72 50.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.28 140.36 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.245 1.018 . . . . 0.0 110.524 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.25 134.19 35.28 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.72 142.74 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.64 179.24 7.41 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.43 -25.89 4.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.751 1.62 . . . . 0.0 114.039 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -77.0 -2.3 33.18 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.516 1.527 . . . . 0.0 112.014 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.3 57.24 6.83 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 124.294 1.997 . . . . 0.0 109.855 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -132.31 122.57 18.18 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.24 141.55 82.74 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.84 1.693 . . . . 0.0 109.906 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.2 -11.32 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.042 1.337 . . . . 0.0 112.042 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.25 168.76 41.09 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -142.71 159.16 42.78 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.489 0.716 . . . . 0.0 110.99 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.77 152.47 47.95 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.173 0.989 . . . . 0.0 109.726 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.59 119.53 34.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 69' ' ' SER . 4.2 tt -143.13 137.41 29.09 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.487 ' N ' HD23 ' A' ' 68' ' ' LEU . 68.7 m -150.74 155.55 39.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.87 -108.04 1.56 Allowed Glycine 0 CA--C 1.53 0.981 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -131.48 6.52 4.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.608 1.163 . . . . 0.0 111.988 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -105.42 124.97 50.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.558 1.072 . . . . 0.0 109.766 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.2 ttp -93.16 86.11 5.26 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.53 -26.61 68.78 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.41 147.51 34.73 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.53 0.732 . . . . 0.0 110.165 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.2 tp -155.59 122.29 5.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.868 2.067 . . . . 0.0 105.501 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.82 142.43 29.95 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.38 144.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -57.24 114.77 8.81 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 126.142 1.777 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.57 -29.88 11.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.087 3.192 . . . . 0.0 114.492 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.38 -21.84 66.76 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.37 10.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.143 0.977 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.03 -35.28 64.28 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.703 -1.248 . . . . 0.0 111.085 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.94 57.09 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.256 0.931 . . . . 0.0 113.613 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -72.69 -5.0 34.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.949 1.375 . . . . 0.0 112.456 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.69 69.41 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 119.08 0.854 . . . . 0.0 113.053 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.5 t -55.54 -31.07 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.357 1.079 . . . . 0.0 111.169 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.8 -53.04 14.56 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.048 0.832 . . . . 0.0 111.676 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.93 -42.29 97.4 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.381 -1.295 . . . . 0.0 110.206 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -58.6 -46.28 90.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.251 1.387 . . . . 0.0 110.052 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.23 -40.27 78.04 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.872 -0.518 . . . . 0.0 110.826 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.2 -40.44 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.632 0.651 . . . . 0.0 110.307 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.3 -33.3 72.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.037 -1.039 . . . . 0.0 109.989 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -62.3 -45.75 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.39 0.541 . . . . 0.0 110.383 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.04 83.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.286 0.634 . . . . 0.0 111.064 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.1 -34.27 73.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.114 0.966 . . . . 0.0 111.151 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -63.49 -37.88 88.99 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.219 0.463 . . . . 0.0 111.357 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 mtm -82.53 -28.54 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.371 0.532 . . . . 0.0 112.058 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 93.51 10.13 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.293 1.437 . . . . 0.0 108.613 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.85 -22.36 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 121.417 1.411 . . . . 0.0 112.202 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.68 31.53 4.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.741 . . . . 0.0 110.05 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.7 tp -48.4 141.74 6.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.073 2.149 . . . . 0.0 112.887 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -128.13 158.69 37.34 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 108.163 169.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -151.96 176.82 11.09 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.872 -0.518 . . . . 0.0 110.463 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -134.86 152.11 51.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.407 1.483 . . . . 0.0 108.823 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.0 p -152.95 144.47 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.69 130.09 38.15 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -61.56 -32.59 72.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -33.94 69.91 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.139 0.881 . . . . 0.0 111.321 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -77.72 68.22 3.75 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.168 0.987 . . . . 0.0 110.557 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.79 -24.75 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -62.55 -46.35 88.77 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.84 -0.537 . . . . 0.0 109.878 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.74 79.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.705 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.44 -49.16 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.297 0.953 . . . . 0.0 108.544 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.69 -46.94 93.47 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.83 -51.54 67.13 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 123.884 0.874 . . . . 0.0 110.097 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.62 -33.42 74.95 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.7 -47.92 82.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.174 0.897 . . . . 0.0 110.802 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.41 -42.58 87.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.065 0.848 . . . . 0.0 110.552 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.56 -34.3 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.182 0.993 . . . . 0.0 110.92 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.26 10.48 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.432 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -78.2 155.62 30.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.645 1.723 . . . . 0.0 111.53 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -141.06 138.95 33.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.362 1.865 . . . . 0.0 106.702 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.472 HG22 HD22 ' A' ' 142' ' ' LEU . 21.5 t -71.7 135.97 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.935 0.894 . . . . 0.0 110.057 -170.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.6 p -129.03 -8.72 4.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.468 1.907 . . . . 0.0 111.52 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.48 177.17 44.47 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.782 0.719 . . . . 0.0 111.55 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -157.46 178.0 10.79 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.066 0.946 . . . . 0.0 109.338 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.323 -0.549 0 C-N-CA 126.938 2.095 . . . . 0.0 105.726 178.352 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 C--O 1.237 0.463 0 N-CA-C 117.461 2.062 . . . . 0.0 117.461 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp -113.18 145.1 41.54 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 mt -116.85 152.05 35.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -125.65 137.84 53.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.852 1.261 . . . . 0.0 108.201 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.472 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.12 161.24 36.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.589 1.156 . . . . 0.0 108.162 -171.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.67 149.28 52.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.667 1.587 . . . . 0.0 108.562 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -75.44 129.93 38.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.617 1.167 . . . . 0.0 109.913 177.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 mm -132.1 144.94 35.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -140.59 165.14 28.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 55' ' ' ALA . 13.4 mm -128.07 143.22 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -156.45 173.8 16.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.865 0.866 . . . . 0.0 110.537 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -64.54 147.01 53.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -73.53 145.55 45.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.607 1.163 . . . . 0.0 111.928 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -82.25 131.33 35.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -57.51 -39.72 77.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.441 1.019 . . . . 0.0 111.071 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -70.12 -20.67 63.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.955 0.902 . . . . 0.0 113.202 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -84.11 -4.96 59.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.372 0.987 . . . . 0.0 111.042 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.9 -33.25 35.64 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 124.445 1.022 . . . . 0.0 113.355 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.59 -33.33 75.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.536 1.168 . . . . 0.0 111.836 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -65.97 -30.95 71.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.982 -0.449 . . . . 0.0 109.884 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.57 -37.57 56.33 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.05 0.54 . . . . 0.0 109.67 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.92 -46.06 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -44.11 97.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 111.917 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.2 mt -61.88 -50.27 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.34 1.056 . . . . 0.0 109.134 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.7 t90 -51.31 -47.54 62.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.356 0.662 . . . . 0.0 110.127 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.8 t -61.5 -50.44 72.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.105 0.411 . . . . 0.0 110.52 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -68.78 -32.13 71.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.042 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 m -62.15 -47.61 83.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.063 0.847 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.28 -44.45 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.622 0.769 . . . . 0.0 109.519 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.2 -28.56 69.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 0.0 112.064 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.69 -24.55 28.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.653 1.181 . . . . 0.0 113.939 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.8 p -137.34 -21.15 1.19 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.571 ' CE1' HD22 ' A' ' 110' ' ' ASN . 72.8 m80 -124.29 29.84 6.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.671 1.588 . . . . 0.0 109.28 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.28 -18.27 25.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.408 1.083 . . . . 0.0 113.589 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -51.13 -23.84 3.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.116 2.167 . . . . 0.0 113.162 170.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.01 97.84 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.941 1.296 . . . . 0.0 108.003 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.1 m -55.29 153.69 6.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.458 1.503 . . . . 0.0 110.991 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -35.86 63.07 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.07 -49.11 66.15 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.941 0.792 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -65.65 -39.04 90.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.001 0.521 . . . . 0.0 109.998 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -54.48 -46.49 73.4 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.833 1.253 . . . . 0.0 110.018 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.7 m -65.73 -48.04 73.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 110.367 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.77 -36.93 81.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.911 -0.493 . . . . 0.0 110.762 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 -51.51 67.37 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -56.85 -40.69 76.57 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.766 0.712 . . . . 0.0 110.528 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.28 -41.63 89.57 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.806 0.73 . . . . 0.0 112.597 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.45 -38.31 68.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.573 -0.705 . . . . 0.0 109.553 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.91 -47.38 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.814 1.645 . . . . 0.0 109.147 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -57.39 -23.95 52.4 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.36 1.464 . . . . 0.0 111.754 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -102.69 7.7 39.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.426 1.09 . . . . 0.0 111.187 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -136.29 -52.7 0.72 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.905 -169.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.15 -37.14 54.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 120.534 1.515 . . . . 0.0 113.251 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.4 -16.21 33.96 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.433 2.089 . . . . 0.0 115.607 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -126.27 -14.37 5.95 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.32 1.418 . . . . 0.0 112.527 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.75 151.54 92.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.761 1.224 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.38 63.57 7.85 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.693 3.595 . . . . 0.0 110.704 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.5 177.97 7.24 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.785 1.234 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -136.47 141.58 43.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 127.547 2.339 . . . . 0.0 105.244 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.42 141.9 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 119.164 0.893 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -84.16 134.14 34.58 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 167.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.51 142.31 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -79.33 -178.85 6.44 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.563 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.13 -25.03 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.557 1.543 . . . . 0.0 113.788 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -84.26 3.45 35.41 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.834 1.254 . . . . 0.0 111.999 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.6 t0 52.66 58.25 5.56 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 123.384 1.564 . . . . 0.0 109.79 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.06 124.12 17.29 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 -170.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.49 137.13 45.55 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.975 2.45 . . . . 0.0 111.497 -171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 m -124.17 -13.63 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.282 1.033 . . . . 0.0 112.082 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.9 42.9 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -147.49 160.9 42.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.159 0.584 . . . . 0.0 110.925 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.56 154.07 49.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 108.226 169.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 74' ' ' ASP . 13.8 tp -110.12 118.9 37.63 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.49 132.26 18.98 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.6 m -145.61 153.32 40.92 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 168.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.32 -123.11 32.12 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -129.21 29.05 5.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.214 1.006 . . . . 0.0 111.26 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -122.94 108.59 13.13 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.655 -0.653 . . . . 0.0 110.218 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 ttp -85.59 87.36 7.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.429 ' HB3' HD23 ' A' ' 67' ' ' LEU . 30.3 t70 -64.06 -27.82 69.37 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.26 152.79 40.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.716 0.689 . . . . 0.0 110.963 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.9 tp -158.29 119.71 3.51 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.692 1.997 . . . . 0.0 106.38 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -147.04 141.43 26.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.561 1.144 . . . . 0.0 107.949 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.1 mt -150.95 145.71 16.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.29 126.18 77.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.379 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.63 -17.1 52.42 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.587 2.191 . . . . 0.0 113.834 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.18 -21.46 60.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.685 1.13 . . . . 0.0 112.018 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.49 -11.29 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -52.45 -39.71 61.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.892 1.224 . . . . 0.0 112.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.42 84.45 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.359 -176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.59 -18.64 65.07 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.175 1.488 . . . . 0.0 111.561 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.37 -23.16 1.22 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.07 0.843 . . . . 0.0 112.198 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.7 -32.82 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.602 1.201 . . . . 0.0 111.812 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.61 -31.45 37.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.128 0.871 . . . . 0.0 113.37 173.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -87.67 -45.94 9.95 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.01 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t -53.75 -43.85 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 120.364 1.438 . . . . 0.0 111.248 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -66.63 -37.02 83.96 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.872 0.76 . . . . 0.0 111.43 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.27 -42.07 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 118.44 0.563 . . . . 0.0 109.524 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.35 -35.1 79.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.554 0.615 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -61.43 -48.43 81.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.808 0.443 . . . . 0.0 110.382 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.31 82.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.891 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.34 -35.54 75.9 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.224 1.009 . . . . 0.0 111.458 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.82 -36.72 84.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.305 0.502 . . . . 0.0 111.408 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.3 mtm -86.16 -23.42 26.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.993 0.517 . . . . 0.0 112.218 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.15 91.45 7.05 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.267 1.427 . . . . 0.0 108.931 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -22.93 56.92 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.413 1.408 . . . . 0.0 112.788 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -103.81 30.74 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.347 1.459 . . . . 0.0 110.258 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.1 tp -49.61 144.55 5.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.179 2.192 . . . . 0.0 112.961 -171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.9 p -129.08 161.31 30.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.02 1.328 . . . . 0.0 108.796 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -153.09 -173.8 4.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -149.16 161.78 41.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.992 0.917 . . . . 0.0 110.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.25 145.24 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -74.26 128.83 36.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -57.43 -32.37 66.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.862 0.865 . . . . 0.0 113.088 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.47 -34.08 72.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.308 0.503 . . . . 0.0 111.195 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.571 HD22 ' CE1' ' A' ' 28' ' ' HIS . 64.2 t-20 -79.07 65.14 4.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.856 1.262 . . . . 0.0 109.611 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.3 -26.06 60.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.151 0.98 . . . . 0.0 111.1 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.12 84.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.959 0.503 . . . . 0.0 109.861 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.54 77.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.756 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.84 -49.31 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.402 1.001 . . . . 0.0 108.482 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.78 93.76 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -56.14 -50.63 70.59 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.763 0.825 . . . . 0.0 110.194 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -67.24 -33.96 76.43 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -59.46 -46.17 89.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.191 0.905 . . . . 0.0 110.977 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.92 -43.26 91.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.129 0.877 . . . . 0.0 110.384 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.4 t -63.13 -39.63 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.758 0.823 . . . . 0.0 110.365 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.26 11.58 0.89 Allowed Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.4 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.43 155.43 29.93 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.652 1.726 . . . . 0.0 111.479 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.01 139.22 34.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.103 1.761 . . . . 0.0 106.618 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.504 HG22 HD22 ' A' ' 142' ' ' LEU . 21.9 t -71.66 133.81 31.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.978 0.911 . . . . 0.0 109.8 -171.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.75 -9.66 7.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 111.459 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.09 178.31 43.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 118.849 0.75 . . . . 0.0 111.491 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -151.26 174.83 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.49 0.716 . . . . 0.0 109.572 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--N 1.323 -0.574 0 C-N-CA 127.267 2.227 . . . . 0.0 106.289 176.303 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 N-CA-C 114.421 0.893 . . . . 0.0 114.421 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.1 tp -131.69 144.04 50.72 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.2 mt -113.86 141.27 47.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -113.29 138.78 49.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.504 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.07 160.07 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.64 151.37 51.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.639 1.576 . . . . 0.0 108.575 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -75.8 126.37 30.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 68.2 t . . . . . 0 CA--C 1.548 0.891 0 C-N-CA 125.272 1.429 . . . . 0.0 109.89 -178.903 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.263 0 CA-C-O 121.354 0.597 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -137.62 144.66 30.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 107.615 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -140.37 163.57 32.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -123.78 143.06 38.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.11 170.93 18.73 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.747 1.219 . . . . 0.0 108.956 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -66.35 148.65 51.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -73.27 148.43 43.62 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.282 1.033 . . . . 0.0 112.237 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -79.76 155.88 27.73 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -68.63 -40.59 80.27 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.909 -0.494 . . . . 0.0 110.269 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.7 -25.82 63.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.82 0.6 46.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.095 0.558 . . . . 0.0 111.394 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.4 -42.91 43.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.536 1.065 . . . . 0.0 113.64 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -72.52 -18.75 61.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.732 1.266 . . . . 0.0 112.066 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.67 -31.29 68.15 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.051 -1.031 . . . . 0.0 109.33 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -73.95 -38.35 64.26 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.57 -45.47 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.46 98.76 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.977 -0.452 . . . . 0.0 111.505 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.52 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.816 0.846 . . . . 0.0 109.466 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -54.26 -47.29 72.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.266 0.627 . . . . 0.0 110.298 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.48 -44.63 95.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.674 -0.642 . . . . 0.0 110.327 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -63.58 -37.04 85.82 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.677 -0.639 . . . . 0.0 110.993 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.2 m -67.87 -35.56 78.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.485 0.714 . . . . 0.0 110.819 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -70.9 -47.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.31 -33.54 69.59 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.559 0.744 . . . . 0.0 112.708 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.35 -35.63 15.11 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 118.344 -0.836 . . . . 0.0 113.17 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -138.63 2.0 2.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -136.44 26.61 3.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.91 -13.77 28.04 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.997 -1.064 . . . . 0.0 113.565 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -52.95 -22.93 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.741 2.017 . . . . 0.0 112.905 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -64.21 97.21 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.36 1.464 . . . . 0.0 108.679 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -56.26 158.81 3.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.57 1.548 . . . . 0.0 111.317 174.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.41 65.03 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.37 -46.82 72.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.966 0.803 . . . . 0.0 109.98 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -64.91 -40.25 94.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.488 0.715 . . . . 0.0 109.748 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -55.57 -47.43 76.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.953 1.301 . . . . 0.0 110.097 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -64.94 -49.74 69.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.187 0.995 . . . . 0.0 110.019 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.26 -38.85 91.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.405 . . . . 0.0 110.785 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.86 -50.74 65.42 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.61 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.87 -38.83 79.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.734 1.152 . . . . 0.0 110.093 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.74 -48.22 82.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.98 0.809 . . . . 0.0 112.099 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -37.05 76.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.97 -46.37 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.801 1.641 . . . . 0.0 109.942 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -63.31 -20.57 65.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.515 1.052 . . . . 0.0 111.398 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -97.78 7.15 46.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 110.808 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -137.4 -56.13 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.215 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.99 -37.23 51.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 120.467 1.485 . . . . 0.0 112.708 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -63.94 -11.17 25.8 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.002 1.802 . . . . 0.0 115.706 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -128.06 -19.63 3.94 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.866 1.666 . . . . 0.0 112.746 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.74 149.67 97.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.408 1.083 . . . . 0.0 110.902 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.46 47.9 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.648 3.566 . . . . 0.0 112.305 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.36 165.49 16.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.038 1.735 . . . . 0.0 112.463 -171.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -115.77 147.4 40.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.37 138.58 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.935 . . . . 0.0 110.382 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.54 129.23 34.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 168.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.4 m -124.15 142.02 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -82.85 -179.7 7.52 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.05 -25.45 8.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 0.0 113.97 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -79.24 0.57 28.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.955 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 t0 51.63 55.96 8.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 124.207 1.956 . . . . 0.0 109.661 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.41 119.09 21.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 128.103 2.561 . . . . 0.0 104.333 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.64 138.74 65.98 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.693 1.596 . . . . 0.0 109.924 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.34 -9.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 0.0 112.468 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.46 168.67 40.16 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 171.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -142.46 156.34 45.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.813 0.806 . . . . 0.0 111.249 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -141.75 138.0 32.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.362 2.265 . . . . 0.0 106.037 -173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -124.15 119.57 29.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.7 tp -141.97 134.5 28.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.0 m -159.4 155.87 27.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.131 2.172 . . . . 0.0 105.422 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.14 35.46 59.9 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.564 -0.71 . . . . 0.0 113.774 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 58.14 22.24 8.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 113.697 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -125.47 114.36 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.6 ttp -80.89 87.32 5.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.96 -28.09 69.84 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.768 . . . . 0.0 112.837 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.97 144.63 29.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.755 0.822 . . . . 0.0 110.407 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.1 tp -156.19 117.58 3.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.955 1.702 . . . . 0.0 106.464 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -145.31 143.14 30.01 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -149.62 144.18 17.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.08 125.33 86.63 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.52 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.73 -30.21 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.882 3.055 . . . . 0.0 114.947 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -63.72 -25.18 68.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.94 -3.11 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.641 0.655 . . . . 0.0 112.497 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -59.62 -37.24 78.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.823 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.7 -26.62 68.75 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.859 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.0 m -78.29 -3.55 43.48 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.392 1.096 . . . . 0.0 112.212 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.11 13.15 64.57 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.486 172.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.0 t -57.21 -31.03 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.294 1.547 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.5 -49.85 44.12 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.634 0.635 . . . . 0.0 112.176 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -63.87 -46.85 83.08 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.716 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -54.03 -49.55 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 119.397 0.999 . . . . 0.0 110.152 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.95 -37.52 75.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.039 -174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.58 -39.75 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 119.088 0.858 . . . . 0.0 109.801 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.97 -36.11 82.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.74 1.154 . . . . 0.0 110.066 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.03 -48.33 80.78 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.872 0.469 . . . . 0.0 110.491 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.18 78.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.643 0.777 . . . . 0.0 110.753 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.49 -33.66 71.62 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.702 1.201 . . . . 0.0 111.646 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -62.66 -34.11 76.41 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.5 0.591 . . . . 0.0 111.548 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -87.19 -25.38 24.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 112.091 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.08 94.96 7.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.096 1.359 . . . . 0.0 109.175 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.91 -23.42 47.3 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 121.237 1.291 . . . . 0.0 112.318 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.12 28.87 4.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.789 1.635 . . . . 0.0 110.482 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.3 tp -53.0 146.49 10.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.281 2.232 . . . . 0.0 112.819 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.8 p -131.31 161.68 31.78 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 108.802 170.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 t -155.86 -178.37 7.24 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 122.636 0.374 . . . . 0.0 110.631 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -135.68 156.57 48.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.785 1.634 . . . . 0.0 108.695 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 p -154.39 145.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.53 132.48 42.91 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.17 -30.82 66.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.566 0.747 . . . . 0.0 112.213 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.53 -26.73 68.02 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.367 0.53 . . . . 0.0 112.193 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -79.95 67.84 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.748 0.785 . . . . 0.0 109.806 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.41 -27.7 49.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.446 1.099 . . . . 0.0 111.422 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.25 -50.59 65.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.006 0.523 . . . . 0.0 110.149 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.54 82.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.41 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.5 t -56.45 -49.14 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.92 -48.68 85.07 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.79 -50.88 70.99 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.392 0.677 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -66.94 -35.32 79.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.19 -47.37 85.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.983 0.81 . . . . 0.0 110.876 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -58.87 -42.03 88.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.021 0.828 . . . . 0.0 110.603 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.85 -40.28 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.701 0.8 . . . . 0.0 110.345 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.52 8.13 0.73 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.775 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.53 153.17 40.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.643 1.722 . . . . 0.0 111.142 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -140.5 139.49 35.11 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.126 1.77 . . . . 0.0 106.523 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.491 HG22 HD22 ' A' ' 142' ' ' LEU . 23.9 t -72.08 134.68 29.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.85 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 p -126.0 -8.6 6.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.789 2.036 . . . . 0.0 111.379 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.26 43.95 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 118.779 0.718 . . . . 0.0 111.467 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -154.44 176.91 11.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.83 0.852 . . . . 0.0 109.437 171.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.323 -0.56 0 C-N-CA 126.876 2.071 . . . . 0.0 105.831 176.671 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 N--CA 1.459 -0.513 0 N-CA-C 117.687 2.149 . . . . 0.0 117.687 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.8 tp -103.92 148.09 26.57 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.79 151.61 36.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -122.67 138.51 54.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.878 1.271 . . . . 0.0 107.849 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.491 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.03 159.79 41.08 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.435 1.094 . . . . 0.0 108.467 -170.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.18 149.66 51.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.413 1.485 . . . . 0.0 108.417 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -73.9 125.45 28.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 124.63 1.172 . . . . 0.0 110.008 -178.479 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -136.72 146.74 28.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -140.9 164.02 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 168.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 55' ' ' ALA . 13.8 mm -124.5 143.59 37.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -152.3 171.3 18.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.73 1.212 . . . . 0.0 109.136 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -65.85 147.47 53.32 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -76.35 148.85 37.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.623 1.169 . . . . 0.0 111.912 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -77.33 162.07 27.57 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -70.16 -46.67 64.21 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.93 -27.61 65.91 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.72 -1.48 47.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.789 0.436 . . . . 0.0 111.334 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.12 -35.96 55.66 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 124.14 0.876 . . . . 0.0 113.461 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.53 -28.14 69.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.979 1.39 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -68.09 -31.73 71.56 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.364 -0.835 . . . . 0.0 109.762 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -76.13 -37.36 58.13 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.11 -46.96 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.119 0.568 . . . . 0.0 112.042 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.18 -50.6 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.24 1.016 . . . . 0.0 109.569 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -51.36 -47.51 62.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.282 0.633 . . . . 0.0 110.005 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -61.51 -49.59 76.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.901 0.48 . . . . 0.0 110.233 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.21 -30.32 68.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.179 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -62.54 -46.15 89.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.628 1.104 . . . . 0.0 109.462 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -66.57 -44.02 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 123.877 0.871 . . . . 0.0 109.305 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.46 -28.62 68.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.361 0.982 . . . . 0.0 112.326 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.71 -33.3 27.61 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.984 0.914 . . . . 0.0 113.301 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.7 p -135.17 -12.17 2.17 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.408 ' CD2' HD22 ' A' ' 110' ' ' ASN . 28.5 m-70 -118.68 24.5 10.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.347 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.19 -19.76 35.96 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -53.41 -28.88 32.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.804 1.641 . . . . 0.0 111.927 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.21 104.98 1.96 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.961 2.104 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -59.87 157.83 11.71 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.557 1.943 . . . . 0.0 113.181 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.04 68.77 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -64.83 -50.18 67.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.631 0.65 . . . . 0.0 109.545 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -64.09 -38.58 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.138 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.18 -46.66 79.28 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.549 0.74 . . . . 0.0 109.917 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -64.81 -51.1 64.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.554 1.142 . . . . 0.0 110.105 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.37 -36.33 76.71 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.998 -0.439 . . . . 0.0 110.835 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.15 -50.97 68.3 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.834 -1.079 . . . . 0.0 109.276 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.822 1.192 . . . . 0.0 110.501 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.9 -44.66 72.75 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.86 -36.02 70.0 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.123 -0.361 . . . . 0.0 110.421 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.35 -47.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 125.992 1.717 . . . . 0.0 108.949 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -69.45 -12.1 61.37 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 120.847 -1.158 . . . . 0.0 112.819 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -95.53 6.05 49.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.715 0.806 . . . . 0.0 110.679 172.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -136.79 -55.32 0.73 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.58 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.09 -40.14 82.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 120.66 1.573 . . . . 0.0 112.632 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.49 -12.26 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.253 1.969 . . . . 0.0 114.853 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.85 -21.36 6.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.79 1.632 . . . . 0.0 111.937 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.55 148.65 97.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 110.778 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.65 48.85 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.653 3.569 . . . . 0.0 111.721 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.09 169.48 5.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.171 1.388 . . . . 0.0 112.272 -172.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -121.66 144.37 48.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.61 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.12 138.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.219 1.008 . . . . 0.0 110.659 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.72 129.48 34.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 103.617 -2.734 . . . . 0.0 103.617 167.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 m -126.86 144.63 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -80.47 -174.56 4.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.807 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.69 -22.43 46.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.476 1.11 . . . . 0.0 113.249 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.88 6.1 29.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.997 1.319 . . . . 0.0 111.682 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 53.01 41.94 32.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.964 1.364 . . . . 0.0 110.467 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 120.33 45.57 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -173.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.86 130.71 28.51 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.281 1.987 . . . . 0.0 110.286 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.32 -16.01 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.144 0.978 . . . . 0.0 111.637 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.97 172.72 42.16 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -147.35 161.73 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.372 0.669 . . . . 0.0 110.881 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.47 158.9 43.3 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.448 1.099 . . . . 0.0 109.717 169.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.5 tp -118.06 128.07 54.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.07 132.16 23.07 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 m -142.95 153.71 43.32 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.5 -118.44 10.54 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -129.07 30.76 5.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.181 0.992 . . . . 0.0 110.826 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -122.58 109.73 14.67 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.398 0.679 . . . . 0.0 110.452 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 ttp -85.78 87.85 7.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.37 -29.06 70.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.38 36.11 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.629 0.771 . . . . 0.0 109.815 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.7 tp -158.73 116.16 2.83 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.548 1.939 . . . . 0.0 105.958 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.97 143.21 29.34 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -149.91 145.44 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -171.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -60.41 121.58 61.19 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.99 -16.28 51.91 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.311 2.007 . . . . 0.0 113.704 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.02 -23.29 64.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.06 -9.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.438 1.095 . . . . 0.0 112.309 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -50.54 -44.18 56.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.341 1.056 . . . . 0.0 110.436 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.67 -18.77 66.42 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.165 0.888 . . . . 0.0 113.842 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.49 -9.11 57.68 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.108 1.454 . . . . 0.0 112.239 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.12 7.96 34.58 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.04 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -55.33 -31.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.053 1.426 . . . . 0.0 110.682 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.6 -51.7 27.0 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 119.377 -0.68 . . . . 0.0 111.706 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -62.24 -42.45 99.33 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.583 -1.198 . . . . 0.0 110.431 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.3 t -58.76 -46.54 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.98 1.264 . . . . 0.0 109.957 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.43 -41.19 80.67 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.949 -0.469 . . . . 0.0 110.806 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.51 -41.75 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.445 0.566 . . . . 0.0 109.943 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.3 -34.88 79.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.125 0.875 . . . . 0.0 110.14 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.38 -45.22 95.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.4 0.545 . . . . 0.0 110.424 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.31 -49.45 73.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.835 0.454 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.35 -33.67 69.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.113 0.965 . . . . 0.0 111.512 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.66 -35.97 81.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.297 0.499 . . . . 0.0 111.558 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.6 mtm -88.63 -23.0 23.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.267 0.485 . . . . 0.0 112.161 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.04 90.05 9.5 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 125.137 1.375 . . . . 0.0 108.914 -170.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -22.05 61.0 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.476 1.45 . . . . 0.0 112.919 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.45 31.93 4.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.535 1.534 . . . . 0.0 109.951 -175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 42.0 tp -49.2 144.81 4.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.238 2.215 . . . . 0.0 113.015 -171.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -129.23 162.25 28.3 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.186 1.395 . . . . 0.0 108.657 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -153.64 -173.72 4.68 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -148.92 161.78 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.481 0.713 . . . . 0.0 110.372 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.3 p -155.2 149.73 11.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -78.11 136.31 37.85 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.13 -26.2 60.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.224 1.41 . . . . 0.0 112.352 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -48.81 -47.45 42.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.056 0.844 . . . . 0.0 111.05 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.408 HD22 ' CD2' ' A' ' 28' ' ' HIS . 59.5 t-20 -85.82 65.3 9.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.327 1.451 . . . . 0.0 110.244 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.22 -29.36 46.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 111.441 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -43.89 97.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.409 0.684 . . . . 0.0 109.966 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.36 -33.99 72.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.148 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.25 -45.34 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 119.505 1.048 . . . . 0.0 108.678 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.39 -50.78 63.15 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -53.29 -50.54 64.68 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.869 0.868 . . . . 0.0 110.797 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -65.25 -38.51 90.57 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.91 -32.95 74.34 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.523 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -60.42 -40.88 92.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.353 1.433 . . . . 0.0 110.766 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.09 -39.13 80.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.05 9.32 0.82 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.841 171.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -69.01 159.58 32.57 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 1.537 . . . . 0.0 111.117 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.82 140.59 25.89 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 HD22 ' A' ' 142' ' ' LEU . 28.2 t -71.94 129.91 35.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.981 0.912 . . . . 0.0 109.324 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 p -124.93 -7.64 7.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.258 1.823 . . . . 0.0 111.796 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.91 173.06 42.2 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 118.82 0.737 . . . . 0.0 112.218 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -141.98 159.92 41.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.543 1.537 . . . . 0.0 111.061 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.646 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo . . . . . 0 N--CA 1.457 -0.644 0 N-CA-C 115.738 1.399 . . . . 0.0 115.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.0 tp -96.74 143.79 27.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.8 mt -114.73 134.72 54.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.41 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.3 t-20 -102.98 139.73 38.16 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.554 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -134.19 159.94 39.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.24 51.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.538 1.535 . . . . 0.0 107.987 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -75.8 125.7 29.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 124.552 1.141 . . . . 0.0 110.051 -177.259 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 mm -134.66 144.38 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -142.39 166.12 25.54 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.52 142.65 40.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.69 171.17 19.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 109.507 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -64.57 147.73 52.27 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.929 0.786 . . . . 0.0 109.106 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.12 148.28 45.85 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -80.49 158.57 25.82 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -66.57 -48.99 67.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.73 -26.71 65.39 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -169.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.26 -1.97 43.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.161 0.437 . . . . 0.0 111.635 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.53 -39.14 36.7 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 124.185 0.898 . . . . 0.0 113.385 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.77 -26.78 67.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.686 1.243 . . . . 0.0 112.078 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.21 -31.77 71.53 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.15 -40.09 59.91 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.26 -46.01 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.603 0.761 . . . . 0.0 109.289 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -46.92 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.6 mt -57.35 -52.19 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.717 1.207 . . . . 0.0 108.934 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -52.94 -49.91 65.08 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.774 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 t -59.51 -50.49 73.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.109 0.564 . . . . 0.0 110.655 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -68.33 -33.05 73.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.145 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 m -63.34 -46.96 84.19 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.199 0.909 . . . . 0.0 109.688 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.63 -44.14 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.794 0.838 . . . . 0.0 108.912 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.99 -33.58 76.4 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.998 1.272 . . . . 0.0 112.052 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.24 60.9 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.428 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.8 p -135.07 -5.66 2.37 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -121.72 44.39 2.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.633 1.573 . . . . 0.0 108.486 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 -32.29 57.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.048 -1.033 . . . . 0.0 113.051 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.65 -21.72 66.59 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.745 1.218 . . . . 0.0 113.117 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.36 114.23 8.29 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.367 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -61.06 148.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 112.091 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.85 73.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.105 0.562 . . . . 0.0 112.464 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.82 -48.67 73.53 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -68.55 -35.5 77.5 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.137 -0.352 . . . . 0.0 110.381 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -54.87 -45.57 74.63 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.397 1.079 . . . . 0.0 110.313 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.4 m -65.23 -49.8 68.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.339 1.056 . . . . 0.0 110.235 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.01 -35.95 81.06 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.971 -0.456 . . . . 0.0 110.723 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.44 -52.84 62.9 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.345 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.75 -38.01 71.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.475 1.034 . . . . 0.0 110.74 -174.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.99 -48.82 72.6 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.089 0.556 . . . . 0.0 112.094 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.68 -36.03 73.11 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.974 -0.454 . . . . 0.0 110.471 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.49 -47.74 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.231 1.812 . . . . 0.0 109.098 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -69.85 -11.17 60.66 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.924 -1.11 . . . . 0.0 112.676 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m -95.87 5.47 51.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.691 0.796 . . . . 0.0 110.749 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.38 -56.43 0.75 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 117.892 -1.052 . . . . 0.0 112.628 -169.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -56.2 -38.37 67.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.558 . . . . 0.0 112.827 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.07 -14.86 35.72 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.8 1.666 . . . . 0.0 115.209 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.71 -13.57 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.741 1.61 . . . . 0.0 112.772 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.23 152.34 91.94 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.957 1.303 . . . . 0.0 111.321 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.82 56.18 5.86 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.831 3.688 . . . . 0.0 111.932 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.34 159.2 23.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.369 1.468 . . . . 0.0 112.009 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -116.24 142.45 46.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 141.22 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.259 1.024 . . . . 0.0 110.072 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.09 134.83 35.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 168.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -128.71 144.3 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -84.21 -171.77 3.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 110.763 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -62.33 11.04 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.501 2.32 . . . . 0.0 114.182 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -127.97 8.99 6.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.354 1.862 . . . . 0.0 111.314 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.0 t0 50.25 47.26 24.0 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.187 1.47 . . . . 0.0 110.259 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.41 122.99 26.59 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 -172.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.7 135.5 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.24 1.96 . . . . 0.0 110.994 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.93 -13.92 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.179 0.992 . . . . 0.0 112.136 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 170.86 42.61 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.41 159.88 41.23 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.295 1.038 . . . . 0.0 111.962 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -140.0 127.48 21.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.926 2.49 . . . . 0.0 105.999 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.97 116.8 31.17 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 69' ' ' SER . 2.9 tt -146.56 129.29 16.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.348 0.522 . . . . 0.0 109.875 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.461 ' N ' HD23 ' A' ' 68' ' ' LEU . 36.7 m -146.04 154.68 42.13 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.58 41.98 65.78 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 118.953 0.797 . . . . 0.0 113.996 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 59.53 21.97 10.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.811 1.644 . . . . 0.0 113.842 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -130.18 108.12 9.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.074 0.95 . . . . 0.0 108.97 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.2 ttp -85.9 86.14 7.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.13 -31.48 71.19 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.85 142.35 31.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.607 0.763 . . . . 0.0 110.296 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 tp -150.85 117.46 5.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -140.93 140.08 34.4 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.68 146.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.97 118.25 9.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.08 -18.6 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.636 2.224 . . . . 0.0 112.638 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.95 -23.52 66.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.1 0.864 . . . . 0.0 112.554 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.55 -2.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.939 1.295 . . . . 0.0 112.487 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -59.89 -27.64 66.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.678 -1.264 . . . . 0.0 111.698 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.97 -16.19 75.48 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.981 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.19 -175.09 2.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.713 1.256 . . . . 0.0 109.293 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.45 -31.58 36.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.632 -1.093 . . . . 0.0 113.612 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.34 -36.66 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.712 1.756 . . . . 0.0 112.733 -170.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.84 -23.04 43.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.873 0.749 . . . . 0.0 113.441 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -41.85 7.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.065 170.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.11 -45.98 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 121.605 2.002 . . . . 0.0 110.662 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.8 mt -68.9 -37.09 78.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.997 0.817 . . . . 0.0 111.641 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.15 -39.58 83.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 118.53 0.604 . . . . 0.0 109.674 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.49 -35.08 79.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.534 -0.729 . . . . 0.0 109.197 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.87 -48.36 79.35 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.574 0.75 . . . . 0.0 110.427 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -58.02 -47.89 81.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.584 0.753 . . . . 0.0 110.888 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.11 -33.12 74.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 111.414 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -64.33 -39.06 93.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.491 0.587 . . . . 0.0 111.035 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.9 mtm -77.3 -29.83 53.88 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.438 0.563 . . . . 0.0 111.728 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 96.15 6.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.695 1.198 . . . . 0.0 110.13 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.01 -22.83 62.01 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.33 1.353 . . . . 0.0 112.409 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.55 29.19 4.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.509 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 tp -51.94 144.03 12.48 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.002 2.121 . . . . 0.0 113.589 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.4 p -129.87 161.3 31.13 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.47 1.508 . . . . 0.0 108.612 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -154.51 -179.33 7.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.918 0.487 . . . . 0.0 110.232 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.2 1.4 . . . . 0.0 109.018 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.416 HG12 HD21 ' A' ' 142' ' ' LEU . 10.5 p -153.86 145.3 14.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -75.78 137.71 40.72 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -63.89 -25.52 68.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.281 0.632 . . . . 0.0 111.944 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -71.74 31.57 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 112.415 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -149.7 67.04 1.0 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.946 1.698 . . . . 0.0 107.685 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.56 -26.42 61.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.52 -49.38 75.56 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.854 0.461 . . . . 0.0 110.085 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.27 76.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.673 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.42 -49.74 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.52 -46.32 94.56 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.294 0.497 . . . . 0.0 111.914 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -54.22 -53.17 57.25 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 125.146 1.379 . . . . 0.0 109.852 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -68.32 -33.38 74.21 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.855 -0.528 . . . . 0.0 109.852 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.26 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.418 1.008 . . . . 0.0 110.879 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.64 -43.27 89.69 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.841 0.746 . . . . 0.0 110.438 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.29 -37.61 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 110.607 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.59 10.07 0.83 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.618 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -81.78 155.93 25.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.635 1.717 . . . . 0.0 111.439 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.1 138.24 33.38 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.126 1.77 . . . . 0.0 106.558 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.523 HG22 HD22 ' A' ' 142' ' ' LEU . 25.2 t -70.85 133.67 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.03 0.932 . . . . 0.0 109.692 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.4 p -125.59 -9.69 6.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.588 1.955 . . . . 0.0 111.414 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.61 -176.87 41.6 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.837 0.744 . . . . 0.0 111.758 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -151.54 -174.82 4.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.92 0.888 . . . . 0.0 109.338 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.323 -0.561 0 C-N-CA 126.382 1.873 . . . . 0.0 106.583 169.88 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo . . . . . 0 N--CA 1.459 -0.552 0 N-CA-C 118.25 2.365 . . . . 0.0 118.25 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.22 145.96 24.67 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.36 152.86 33.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.461 ' C ' HD23 ' A' ' 142' ' ' LEU . 16.8 t-20 -124.61 138.67 54.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 108.206 176.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.58 161.19 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.678 1.191 . . . . 0.0 108.456 -170.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.26 150.27 52.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.67 1.588 . . . . 0.0 108.465 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.69 124.76 27.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 -177.35 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.668 0.747 . . . . 0.0 112.018 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 mm -133.25 145.83 33.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -137.35 164.45 28.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.6 mm -124.99 141.8 43.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.19 170.5 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.075 0.95 . . . . 0.0 109.771 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -61.67 148.97 40.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 p -62.59 167.0 4.74 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.19 1.796 . . . . 0.0 112.858 176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -118.69 135.48 54.46 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -55.72 -39.4 71.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.94 0.791 . . . . 0.0 111.73 -173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.64 -22.46 61.68 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -85.77 -4.18 59.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.829 0.74 . . . . 0.0 110.87 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.54 59.58 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.917 0.77 . . . . 0.0 113.107 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.65 -31.48 72.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.389 1.094 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.56 -30.82 69.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 109.631 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.2 mt -73.51 -39.47 64.8 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.7 -45.93 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 170.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.81 92.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.748 0.419 . . . . 0.0 111.129 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.66 -48.46 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.186 0.994 . . . . 0.0 109.927 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -53.24 -46.91 69.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 t -60.17 -43.93 95.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 110.525 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -63.95 -41.63 97.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.521 -0.737 . . . . 0.0 111.618 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -59.12 -39.78 83.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.553 0.741 . . . . 0.0 109.722 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.54 -45.86 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 123.56 0.744 . . . . 0.0 109.567 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.5 -35.07 73.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.918 0.781 . . . . 0.0 112.11 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.31 -46.41 27.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.76 0.824 . . . . 0.0 112.076 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 p -137.18 3.0 2.59 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -168.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.66 23.05 5.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.656 1.116 . . . . 0.0 110.63 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.99 -14.5 35.81 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.055 -1.028 . . . . 0.0 113.42 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.21 -21.83 15.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.242 1.817 . . . . 0.0 112.787 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.56 97.98 0.16 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.524 1.53 . . . . 0.0 108.27 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -58.84 156.85 10.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.133 0.973 . . . . 0.0 110.796 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.3 57.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -65.21 -51.68 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.495 0.589 . . . . 0.0 109.533 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -70.23 -33.7 71.97 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.864 -0.523 . . . . 0.0 110.553 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -55.14 -46.31 75.66 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.896 0.878 . . . . 0.0 109.566 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 m -64.76 -48.13 75.65 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.158 0.983 . . . . 0.0 110.187 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -62.55 -42.39 99.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.466 0.575 . . . . 0.0 110.775 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.11 -50.24 64.75 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.398 -0.81 . . . . 0.0 109.412 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.03 -39.27 74.49 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.263 0.938 . . . . 0.0 110.271 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.99 -49.89 74.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.723 0.692 . . . . 0.0 111.953 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -38.82 81.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.61 -48.15 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.009 1.723 . . . . 0.0 109.818 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -62.49 -22.08 65.98 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.913 0.885 . . . . 0.0 111.112 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -99.0 6.75 46.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.192 0.997 . . . . 0.0 110.941 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -136.84 -53.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.772 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.8 mt -59.05 -37.01 48.45 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 120.369 1.441 . . . . 0.0 112.73 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.64 -12.62 29.26 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 0.0 115.924 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.98 -21.19 5.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.602 1.546 . . . . 0.0 111.799 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.05 138.24 96.14 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 110.063 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -80.13 51.41 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.669 3.579 . . . . 0.0 110.761 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.47 164.93 3.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.374 1.47 . . . . 0.0 110.513 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -108.11 109.13 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 m -92.34 141.22 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 118.296 0.498 . . . . 0.0 110.015 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -85.33 133.28 34.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.89 143.07 42.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.23 -178.56 6.52 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.89 -23.87 8.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.715 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -75.32 -5.19 43.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.361 1.464 . . . . 0.0 111.982 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 t0 50.22 57.45 6.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 123.939 1.828 . . . . 0.0 109.64 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -139.59 128.13 13.48 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.57 139.85 41.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.618 2.212 . . . . 0.0 111.576 -169.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.79 -9.45 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.078 0.951 . . . . 0.0 111.968 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 175.5 42.16 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.63 42.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.628 0.714 . . . . 0.0 111.177 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.51 162.89 33.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 108.777 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 tp -122.99 129.09 51.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 tp -141.17 132.74 27.04 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 p -158.23 155.85 29.7 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.758 2.023 . . . . 0.0 105.837 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.11 36.18 56.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 121.445 -0.785 . . . . 0.0 113.896 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 58.33 21.97 8.87 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.957 1.703 . . . . 0.0 113.687 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -125.3 113.1 17.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.026 0.93 . . . . 0.0 110.296 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.6 ttp -85.5 90.46 7.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.65 -26.98 66.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -173.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.93 147.19 36.64 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.539 0.736 . . . . 0.0 109.67 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.8 tp -159.24 113.24 2.35 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.363 1.865 . . . . 0.0 106.137 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.21 140.74 29.46 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -150.52 148.38 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -62.59 125.94 87.22 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.45 -27.67 19.27 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 124.018 3.145 . . . . 0.0 115.39 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.14 -22.76 67.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.316 0.962 . . . . 0.0 112.57 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.05 -1.79 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.481 0.712 . . . . 0.0 112.753 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -57.11 -43.42 82.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.276 0.943 . . . . 0.0 109.655 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.17 74.63 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.5 0.571 . . . . 0.0 112.777 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -73.44 -8.36 55.59 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.234 1.017 . . . . 0.0 112.542 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.49 19.41 52.34 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.339 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.72 -30.21 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.315 1.557 . . . . 0.0 110.591 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.79 -50.42 20.24 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.95 0.785 . . . . 0.0 112.101 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.21 -44.17 97.18 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 118.658 1.229 . . . . 0.0 110.075 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.02 -45.8 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.924 1.238 . . . . 0.0 109.918 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -67.81 -41.46 83.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.913 -0.492 . . . . 0.0 110.687 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.42 -41.85 94.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.701 0.682 . . . . 0.0 110.234 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.07 -35.96 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.473 -0.767 . . . . 0.0 109.456 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.11 -45.39 94.89 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.719 0.408 . . . . 0.0 110.54 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.8 -48.89 75.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.713 0.405 . . . . 0.0 110.761 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.5 mt -59.98 -32.72 71.09 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.148 0.979 . . . . 0.0 111.437 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.12 -37.31 86.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.373 0.533 . . . . 0.0 111.565 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.2 mtm -86.84 -24.2 25.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.38 0.537 . . . . 0.0 112.288 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.36 94.73 7.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 125.389 1.476 . . . . 0.0 108.493 -172.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.34 -23.8 51.09 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.203 1.269 . . . . 0.0 112.243 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -99.42 28.65 4.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.718 1.607 . . . . 0.0 110.537 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.04 145.33 10.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.956 2.103 . . . . 0.0 113.547 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.7 p -129.25 163.14 26.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.479 1.511 . . . . 0.0 108.44 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.9 t -153.81 -173.5 4.6 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -147.52 161.88 40.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.179 0.992 . . . . 0.0 110.05 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.517 HG12 HD21 ' A' ' 142' ' ' LEU . 9.2 p -155.03 143.37 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.09 129.64 39.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.96 -37.38 74.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.512 0.725 . . . . 0.0 112.607 -170.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.23 -28.65 70.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.025 0.375 . . . . 0.0 111.476 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -78.12 66.47 3.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.72 0.772 . . . . 0.0 109.935 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.67 -24.87 62.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.21 -47.5 84.16 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.959 0.504 . . . . 0.0 109.841 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.22 79.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.595 176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.9 t -56.79 -46.2 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.172 0.896 . . . . 0.0 108.972 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.59 62.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.95 -49.66 70.81 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 124.036 0.934 . . . . 0.0 110.612 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -66.81 -35.34 79.83 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -66.18 -37.92 86.79 Favored 'General case' 0 C--N 1.34 0.167 0 O-C-N 120.837 -1.164 . . . . 0.0 112.508 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.19 -43.29 92.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.932 1.242 . . . . 0.0 110.177 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.41 -34.7 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.317 1.047 . . . . 0.0 110.793 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.48 8.8 1.92 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.397 0.998 . . . . 0.0 114.518 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -76.16 162.42 28.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.61 1.705 . . . . 0.0 111.407 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -147.42 140.67 25.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.221 1.808 . . . . 0.0 106.362 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.578 HG22 HD22 ' A' ' 142' ' ' LEU . 26.1 t -72.65 132.5 33.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.061 0.945 . . . . 0.0 109.78 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 p -127.44 -9.3 5.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.741 2.016 . . . . 0.0 111.691 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.13 177.18 41.26 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -158.46 -174.08 4.62 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.05 -0.677 . . . . 0.0 110.576 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.326 -0.423 0 C-N-CA 127.276 2.23 . . . . 0.0 107.495 171.63 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo . . . . . 0 N--CA 1.457 -0.618 0 N-CA-C 116.16 1.561 . . . . 0.0 116.16 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.0 tp -116.59 147.52 41.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 107.106 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.1 mt -116.01 147.74 40.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.506 ' C ' HD23 ' A' ' 142' ' ' LEU . 9.0 t-20 -118.75 139.26 51.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.578 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.96 160.25 39.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.111 0.964 . . . . 0.0 108.446 -170.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.37 151.78 51.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.63 1.572 . . . . 0.0 108.384 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.51 129.62 36.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 125.18 1.392 . . . . 0.0 110.127 -178.366 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -133.04 141.34 45.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -140.81 164.99 28.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -123.7 143.33 37.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -149.77 173.14 14.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 123.413 0.685 . . . . 0.0 110.376 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -65.26 147.66 53.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -71.99 179.36 3.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.863 1.265 . . . . 0.0 111.44 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -130.22 161.03 32.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.641 1.576 . . . . 0.0 107.131 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -69.15 -39.75 78.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.369 -0.207 . . . . 0.0 110.643 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.1 -37.2 75.31 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.679 0.392 . . . . 0.0 111.729 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.11 -2.95 26.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.172 0.589 . . . . 0.0 112.039 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.68 -39.5 31.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.267 0.937 . . . . 0.0 113.125 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.11 -28.51 68.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 111.969 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.07 -32.0 72.88 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 109.536 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -75.65 -39.22 58.02 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -56.83 -46.87 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.487 0.715 . . . . 0.0 109.203 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.29 95.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.95 0.5 . . . . 0.0 111.043 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.85 -54.08 36.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -51.76 -44.82 63.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.543 0.737 . . . . 0.0 110.255 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t -59.75 -42.28 92.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.635 0.374 . . . . 0.0 110.57 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -66.5 -43.23 85.9 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.611 -0.681 . . . . 0.0 111.006 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -58.92 -39.15 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.543 0.611 . . . . 0.0 110.305 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.61 -46.01 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.871 0.868 . . . . 0.0 109.765 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.16 -34.12 73.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.766 0.712 . . . . 0.0 111.968 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.36 -47.14 24.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.557 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.1 p -137.2 5.23 2.75 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -168.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -129.56 23.65 5.46 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.275 0.943 . . . . 0.0 110.175 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.4 -16.31 34.52 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.432 1.093 . . . . 0.0 113.624 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.77 -23.11 4.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.034 2.133 . . . . 0.0 113.221 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.1 94.37 0.34 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 m -53.9 156.55 2.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.253 1.421 . . . . 0.0 111.163 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.59 62.39 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.68 -48.01 73.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 109.973 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -67.39 -38.52 84.83 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.1 -47.94 71.24 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.628 1.171 . . . . 0.0 109.976 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.06 -49.89 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.113 0.965 . . . . 0.0 110.193 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.43 -37.09 82.5 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.081 -0.387 . . . . 0.0 110.739 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.95 -51.56 63.84 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.354 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -57.68 -37.58 73.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.467 1.03 . . . . 0.0 110.732 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.75 -48.37 74.83 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.139 0.575 . . . . 0.0 111.991 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -36.43 72.8 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -59.34 -47.35 90.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.076 1.75 . . . . 0.0 109.123 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -70.36 -11.06 60.66 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.852 -1.155 . . . . 0.0 112.707 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.2 4.85 52.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.621 0.768 . . . . 0.0 110.724 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -135.26 -54.49 0.8 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.887 -169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.0 -39.23 74.48 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.764 1.62 . . . . 0.0 112.703 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.33 -9.91 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.421 2.081 . . . . 0.0 114.883 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.63 -22.92 4.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.562 1.528 . . . . 0.0 112.332 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.83 152.06 96.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.62 65.91 8.07 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.887 3.724 . . . . 0.0 110.835 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.38 175.44 7.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.143 1.377 . . . . 0.0 112.023 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -133.71 151.0 51.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.6 2.36 . . . . 0.0 105.329 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.49 138.99 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.083 0.953 . . . . 0.0 110.886 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.03 132.65 35.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.72 142.81 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -83.4 -171.25 3.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.586 1.554 . . . . 0.0 110.656 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.39 8.31 0.05 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.215 2.206 . . . . 0.0 113.957 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -122.31 10.2 9.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 119.917 -1.739 . . . . 0.0 111.212 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 53.37 32.08 13.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.832 1.301 . . . . 0.0 111.127 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -116.68 132.4 23.4 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -169.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.59 138.0 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 112.367 -169.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.92 -10.0 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.431 1.093 . . . . 0.0 112.091 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.35 169.76 39.99 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -142.08 159.73 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.613 0.765 . . . . 0.0 111.239 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -139.74 136.0 33.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.569 2.347 . . . . 0.0 105.862 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -117.99 122.42 43.16 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -146.28 131.34 18.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.9 m -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.24 -114.06 4.31 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -129.11 14.82 6.25 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.791 0.836 . . . . 0.0 112.208 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.85 113.62 26.72 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.755 1.161 . . . . 0.0 110.735 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.621 ' HB2' HD11 ' A' ' 102' ' ' LEU . 64.8 ttp -83.23 85.41 7.21 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.07 -23.64 64.97 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.94 148.08 31.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.486 0.585 . . . . 0.0 110.606 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.3 tp -156.57 114.58 3.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -143.59 141.6 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.54 150.32 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.14 122.33 69.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.97 -27.49 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 124.334 3.356 . . . . 0.0 114.985 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.92 -23.45 65.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 112.856 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.15 -1.27 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.699 0.8 . . . . 0.0 112.782 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -57.12 -39.96 76.15 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.888 -1.133 . . . . 0.0 110.328 169.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.26 -27.96 71.49 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.473 0.559 . . . . 0.0 112.917 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.7 m -76.22 -6.52 51.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 112.34 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.25 60.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.245 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -54.8 -31.81 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.137 1.469 . . . . 0.0 110.74 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.42 -48.11 34.69 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.972 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -65.7 -40.56 92.42 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.483 1.141 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.9 t -58.86 -46.34 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.681 0.673 . . . . 0.0 109.597 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.86 -38.72 79.94 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.786 -0.571 . . . . 0.0 111.032 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.1 -40.13 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.804 0.729 . . . . 0.0 109.783 174.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.96 -37.31 86.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.058 1.299 . . . . 0.0 110.497 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -61.52 -46.97 87.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.113 0.482 . . . . 0.0 110.557 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.67 78.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.685 0.794 . . . . 0.0 110.92 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 mt -58.12 -34.44 70.22 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.053 1.341 . . . . 0.0 111.44 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.4 m -62.4 -32.48 73.31 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.277 0.489 . . . . 0.0 111.68 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.1 mtm -89.93 -25.26 21.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.464 0.574 . . . . 0.0 112.092 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.01 89.94 12.35 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.092 1.357 . . . . 0.0 109.263 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.55 -22.26 58.72 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.502 1.468 . . . . 0.0 113.192 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.38 31.55 5.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.492 1.517 . . . . 0.0 110.008 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 73' ' ' MET . 31.9 tp -48.16 142.68 5.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.507 2.323 . . . . 0.0 112.749 -171.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -126.15 161.05 28.56 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.334 1.453 . . . . 0.0 108.613 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -153.03 -176.23 5.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.723 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -147.17 160.76 42.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.585 1.154 . . . . 0.0 110.422 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.4 144.36 7.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.8 130.24 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.88 -31.61 62.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.585 0.63 . . . . 0.0 111.943 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -60.34 -32.36 71.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.654 0.782 . . . . 0.0 111.857 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -80.76 67.36 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.789 0.804 . . . . 0.0 109.535 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.8 -25.22 60.28 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.78 0.832 . . . . 0.0 111.405 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.64 -49.26 73.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.035 0.534 . . . . 0.0 110.017 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.41 -35.25 77.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.681 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.4 t -57.03 -49.2 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.94 -47.69 90.02 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -55.85 -51.3 68.01 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.578 0.751 . . . . 0.0 109.651 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.59 -34.77 78.62 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.791 -0.568 . . . . 0.0 109.787 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.98 -45.88 91.24 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.062 -1.024 . . . . 0.0 111.167 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -59.06 -39.71 82.89 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.256 0.934 . . . . 0.0 110.881 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.08 -39.07 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.514 0.726 . . . . 0.0 110.407 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.15 13.21 0.69 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.501 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -80.93 156.06 26.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.803 1.801 . . . . 0.0 111.652 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -144.43 140.76 29.18 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.444 1.897 . . . . 0.0 107.261 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.506 HG22 HD22 ' A' ' 142' ' ' LEU . 21.6 t -71.12 137.94 22.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.06 0.944 . . . . 0.0 110.318 -169.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.2 p -131.12 -9.73 3.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.809 2.044 . . . . 0.0 111.59 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.23 173.27 42.41 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.84 -173.63 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.873 0.836 . . . . 0.0 111.259 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 126.488 1.915 . . . . 0.0 108.542 177.618 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.457 -0.651 0 N-CA-C 114.699 1.0 . . . . 0.0 114.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.15 142.98 33.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.39 149.62 29.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -123.01 137.9 54.83 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.506 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.65 161.84 35.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.47 146.54 51.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.662 1.585 . . . . 0.0 108.897 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.04 127.03 31.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 111.943 179.646 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 C--O 1.236 0.391 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 mm -137.36 145.24 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -144.15 166.01 26.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -125.66 141.85 44.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.78 170.31 21.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 109.998 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -59.07 146.94 36.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 109.818 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 p -62.51 157.91 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.961 1.704 . . . . 0.0 112.595 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -106.55 155.18 19.89 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -67.92 -42.09 81.59 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.711 -0.618 . . . . 0.0 110.648 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.45 -25.66 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.07 -0.06 53.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.059 0.544 . . . . 0.0 111.4 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.21 -41.77 47.71 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 118.998 0.817 . . . . 0.0 113.281 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.78 -26.05 65.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.645 1.223 . . . . 0.0 111.901 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.54 -30.73 67.55 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.281 -0.887 . . . . 0.0 109.621 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 mt -73.01 -39.9 65.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.18 -45.02 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 109.456 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.94 98.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.831 0.452 . . . . 0.0 111.635 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.96 -49.56 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.589 0.756 . . . . 0.0 109.401 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -55.01 -47.79 74.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.688 0.395 . . . . 0.0 110.232 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -59.97 -44.52 94.41 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -64.4 -33.37 75.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.614 0.766 . . . . 0.0 111.813 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -68.4 -39.93 81.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.8 t -66.29 -47.25 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.07 -32.36 66.17 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.754 0.821 . . . . 0.0 112.65 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 -43.04 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.024 0.929 . . . . 0.0 112.482 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.7 p -138.76 -1.41 1.82 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -168.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -135.24 17.84 3.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.381 1.446 . . . . 0.0 112.326 -172.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.48 1.34 0.82 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.766 2.027 . . . . 0.0 114.368 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -59.41 -24.24 63.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.322 1.849 . . . . 0.0 112.523 172.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.08 112.21 2.53 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 m -56.91 154.37 9.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.971 1.308 . . . . 0.0 110.766 172.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.28 -36.75 71.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.2 -47.08 71.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.749 0.704 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -64.72 -40.24 95.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.282 0.633 . . . . 0.0 109.821 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -55.36 -48.56 74.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.611 1.164 . . . . 0.0 110.139 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.8 m -65.08 -49.18 71.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.177 0.991 . . . . 0.0 110.041 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -65.95 -38.45 88.65 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.223 -0.298 . . . . 0.0 110.641 -176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.78 -53.58 52.12 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.386 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.78 -38.22 75.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.244 0.929 . . . . 0.0 110.789 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.99 -48.81 72.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 111.857 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -36.54 75.34 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.177 0.444 . . . . 0.0 110.192 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.87 -48.95 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 126.071 1.748 . . . . 0.0 109.091 172.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -70.3 -10.56 59.31 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.001 -1.062 . . . . 0.0 112.742 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.46 4.2 53.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.625 0.77 . . . . 0.0 110.608 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -135.14 -56.58 0.81 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.805 -1.093 . . . . 0.0 112.336 -169.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.89 -38.65 70.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.644 1.565 . . . . 0.0 113.211 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 -14.8 36.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.422 2.081 . . . . 0.0 115.052 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.72 -13.82 5.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.484 1.493 . . . . 0.0 112.73 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.75 150.55 96.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.844 1.257 . . . . 0.0 111.166 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.78 55.94 5.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.663 3.575 . . . . 0.0 111.94 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.98 155.04 26.61 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.349 1.06 . . . . 0.0 111.146 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -111.32 109.7 19.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.66 138.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.44 133.88 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -126.47 141.5 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -83.71 178.74 7.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.05 -23.93 0.95 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.869 2.068 . . . . 0.0 114.661 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -79.27 -3.34 45.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.669 1.588 . . . . 0.0 112.274 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t0 50.76 57.69 6.36 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.929 1.823 . . . . 0.0 109.69 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -140.63 126.35 11.43 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 141.95 54.02 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.468 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.05 -8.67 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.372 1.069 . . . . 0.0 112.304 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.75 171.55 39.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.42 153.06 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.81 0.805 . . . . 0.0 110.667 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -136.91 132.02 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.539 2.336 . . . . 0.0 105.667 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.75 117.37 31.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.78 133.47 25.27 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 m -143.04 152.74 42.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.76 -114.89 5.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -130.68 27.66 4.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 110.679 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -125.58 111.47 15.05 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.53 -0.731 . . . . 0.0 110.458 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -79.39 89.02 4.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.23 -29.26 70.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.924 0.89 . . . . 0.0 112.979 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.95 148.81 29.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.826 0.851 . . . . 0.0 110.488 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 tp -155.36 119.37 4.58 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.0 1.72 . . . . 0.0 106.463 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.12 144.31 30.85 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -151.43 142.93 16.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.9 133.81 95.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.547 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.67 -24.31 70.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.755 2.303 . . . . 0.0 113.729 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.59 -24.2 67.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.416 1.007 . . . . 0.0 112.902 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.42 -1.22 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -59.91 -38.49 82.49 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.978 -1.076 . . . . 0.0 110.223 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.02 72.09 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.563 0.601 . . . . 0.0 112.776 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.1 m -75.03 -6.5 49.75 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.229 1.014 . . . . 0.0 112.214 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.39 13.73 65.1 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.377 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.64 -31.2 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 119.255 1.527 . . . . 0.0 111.088 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.27 -54.38 10.23 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.947 0.784 . . . . 0.0 111.95 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -64.32 -43.76 93.66 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.031 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 t -56.78 -46.66 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 120.453 1.479 . . . . 0.0 110.179 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.15 -40.33 78.29 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.349 0.522 . . . . 0.0 111.147 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.55 -40.94 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.713 0.688 . . . . 0.0 109.883 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.71 -34.45 77.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.21 0.914 . . . . 0.0 109.87 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -61.2 -46.79 88.99 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.404 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.73 80.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.268 0.627 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.97 -33.18 71.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 111.459 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -63.18 -36.61 84.19 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.486 0.584 . . . . 0.0 111.392 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.4 mtm -85.17 -23.95 28.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.32 0.509 . . . . 0.0 112.117 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.42 95.19 6.63 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 125.123 1.369 . . . . 0.0 109.184 -173.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.16 -25.99 50.19 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 121.29 1.326 . . . . 0.0 112.554 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.03 31.52 3.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.822 1.649 . . . . 0.0 110.369 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.9 tp -49.63 146.37 4.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.662 2.385 . . . . 0.0 113.118 -172.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.9 p -129.94 162.91 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.558 1.543 . . . . 0.0 108.969 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 t -155.76 -178.05 7.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.736 0.414 . . . . 0.0 110.548 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.13 155.39 50.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.621 1.569 . . . . 0.0 108.782 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.63 146.44 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -77.52 138.9 39.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -63.13 -24.19 67.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.637 0.375 . . . . 0.0 111.932 -176.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.97 -40.46 70.04 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.398 0.679 . . . . 0.0 111.538 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -86.15 63.81 8.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.551 1.141 . . . . 0.0 109.331 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.73 -28.27 47.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.207 1.003 . . . . 0.0 111.316 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -47.04 83.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.718 0.807 . . . . 0.0 109.802 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.17 78.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.907 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.14 -49.46 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 119.57 1.077 . . . . 0.0 108.476 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.84 93.59 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -56.2 -50.6 70.78 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.536 0.735 . . . . 0.0 110.147 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -67.13 -33.88 76.39 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.88 -0.513 . . . . 0.0 109.822 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -59.29 -47.09 86.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.144 0.884 . . . . 0.0 110.901 170.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -58.81 -42.68 89.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.986 0.812 . . . . 0.0 110.429 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.03 -36.61 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.932 0.893 . . . . 0.0 110.737 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 136.02 9.86 1.42 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.8 -1.0 . . . . 0.0 114.638 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.38 155.49 30.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.87 1.835 . . . . 0.0 111.252 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.49 138.99 33.21 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.147 1.779 . . . . 0.0 106.574 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.492 HG22 HD22 ' A' ' 142' ' ' LEU . 25.9 t -71.73 135.03 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.17 0.988 . . . . 0.0 109.995 -171.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 p -126.77 -8.69 6.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.951 2.1 . . . . 0.0 111.481 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.3 43.94 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.901 0.773 . . . . 0.0 111.735 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -154.66 176.1 12.85 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.653 0.781 . . . . 0.0 110.185 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 127.679 2.392 . . . . 0.0 106.089 176.29 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 115.547 1.326 . . . . 0.0 115.547 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.42 145.64 50.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.2 mt -116.69 150.1 38.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.429 ' C ' HD23 ' A' ' 142' ' ' LEU . 16.6 t-20 -120.16 138.87 53.35 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.492 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.89 160.83 38.25 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.398 1.079 . . . . 0.0 108.591 -170.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.9 150.97 52.11 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.706 1.602 . . . . 0.0 108.569 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -76.46 124.84 28.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.407 1.083 . . . . 0.0 110.434 -177.306 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 121.458 0.647 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 mm -138.14 144.77 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -140.78 165.35 27.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 168.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mm -127.12 143.18 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -155.02 170.63 21.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.041 0.937 . . . . 0.0 109.822 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -59.02 147.8 33.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.489 0.586 . . . . 0.0 109.905 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p -63.4 154.41 32.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.584 1.553 . . . . 0.0 112.6 174.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -100.16 155.28 17.83 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -65.48 -48.51 72.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.852 -0.53 . . . . 0.0 110.278 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.24 -27.33 64.37 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -169.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.5 -5.76 51.18 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.141 0.428 . . . . 0.0 111.497 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.37 -35.64 36.01 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 124.184 0.897 . . . . 0.0 113.355 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -66.72 -31.51 72.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.293 1.047 . . . . 0.0 111.281 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.96 -31.32 70.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.402 0.681 . . . . 0.0 109.587 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.38 -39.74 64.88 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.792 -0.567 . . . . 0.0 109.774 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -57.89 -46.11 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 171.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.13 99.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 111.688 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.3 mt -62.11 -50.27 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 109.432 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -51.98 -47.88 64.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.534 . . . . 0.0 110.269 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 t -58.62 -50.39 74.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.153 0.433 . . . . 0.0 110.747 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -70.74 -28.18 64.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.504 -0.748 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -63.16 -44.92 94.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.081 0.855 . . . . 0.0 109.435 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.89 -42.54 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.772 0.829 . . . . 0.0 109.425 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.37 -35.05 73.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.021 0.828 . . . . 0.0 111.888 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.47 -36.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.111 -0.947 . . . . 0.0 113.1 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -136.58 -13.41 1.74 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.76 29.64 4.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.129 0.971 . . . . 0.0 110.572 -169.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -12.76 11.4 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.289 1.436 . . . . 0.0 113.495 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -51.61 -23.0 3.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.333 1.853 . . . . 0.0 113.203 169.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.34 97.78 0.43 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.667 1.187 . . . . 0.0 108.741 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -54.35 157.82 2.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.999 1.319 . . . . 0.0 110.712 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.42 64.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -46.81 72.37 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.901 0.773 . . . . 0.0 110.246 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.16 -40.89 97.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.632 0.773 . . . . 0.0 109.715 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -56.65 -47.28 80.09 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 124.256 1.022 . . . . 0.0 109.992 175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 m -65.78 -47.03 76.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.242 1.017 . . . . 0.0 110.393 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.0 -36.97 83.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.228 0.467 . . . . 0.0 110.712 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.91 -49.92 66.3 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.68 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.09 -39.45 72.14 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.126 0.875 . . . . 0.0 110.27 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.92 -48.33 80.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.809 0.731 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.69 -38.9 77.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -58.88 -47.55 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.979 1.711 . . . . 0.0 109.781 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -60.82 -24.22 65.68 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.367 1.067 . . . . 0.0 111.121 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -99.66 7.13 45.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.316 1.046 . . . . 0.0 110.969 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -136.96 -54.08 0.71 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.81 -169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.26 -37.76 60.75 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.642 1.565 . . . . 0.0 113.048 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -61.84 -14.15 34.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.337 2.025 . . . . 0.0 115.479 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.32 -14.6 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.645 1.566 . . . . 0.0 112.48 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 150.15 93.28 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.835 1.254 . . . . 0.0 110.834 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.28 50.83 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.56 3.506 . . . . 0.0 111.675 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.36 162.05 29.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.461 1.104 . . . . 0.0 110.993 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.06 117.03 28.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -99.06 140.08 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.24 0.616 . . . . 0.0 109.992 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.88 137.83 34.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.92 144.52 37.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -85.43 -175.62 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.586 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.79 -25.3 40.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.335 1.454 . . . . 0.0 113.415 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -79.75 -1.66 39.6 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.04 0.936 . . . . 0.0 111.498 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.4 t0 51.98 57.43 6.5 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.558 1.647 . . . . 0.0 109.238 -169.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -136.35 127.59 16.85 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.26 141.34 47.01 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.498 2.132 . . . . 0.0 111.681 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.17 -11.74 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 112.103 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.25 172.69 41.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.5 160.96 40.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.545 0.688 . . . . 0.0 111.494 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -140.29 137.1 33.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.068 2.547 . . . . 0.0 106.1 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.2 tp -115.48 127.52 55.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -144.36 140.87 29.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -154.21 155.81 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.19 -114.24 4.85 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -169.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -133.98 36.81 3.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.641 1.177 . . . . 0.0 110.043 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -134.05 115.38 14.24 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 121.212 -0.93 . . . . 0.0 111.34 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 56.1 ttp -86.2 90.41 8.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.95 -29.31 67.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.75 144.69 35.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.218 0.607 . . . . 0.0 110.799 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.0 tp -157.12 115.47 3.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.451 1.901 . . . . 0.0 106.14 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.69 141.35 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -151.4 146.21 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -59.24 122.13 61.19 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.27 -24.47 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.815 3.01 . . . . 0.0 115.36 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.43 -25.14 67.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.244 0.929 . . . . 0.0 112.75 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.45 -8.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -46.99 -41.61 16.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.005 1.322 . . . . 0.0 111.799 171.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.43 -12.22 65.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.866 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.9 -22.18 62.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.317 1.558 . . . . 0.0 112.109 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 137.18 -9.17 3.83 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.031 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.66 -32.17 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 119.161 1.48 . . . . 0.0 111.278 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.92 -53.92 16.31 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 123.538 0.589 . . . . 0.0 111.656 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -63.57 -42.4 98.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.262 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.72 -46.46 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.593 1.542 . . . . 0.0 109.932 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.4 mt -68.28 -41.81 80.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.982 -0.448 . . . . 0.0 110.77 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.74 -42.87 96.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.535 0.607 . . . . 0.0 110.181 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.52 -36.22 82.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.561 0.745 . . . . 0.0 109.59 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.82 -44.97 93.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.884 0.474 . . . . 0.0 110.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.34 63.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.158 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.72 -31.13 67.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.393 1.077 . . . . 0.0 111.782 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.82 -31.79 72.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.759 0.709 . . . . 0.0 111.969 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.0 mtm -91.77 -20.79 21.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.286 0.635 . . . . 0.0 112.208 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 94.88 6.1 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.532 1.533 . . . . 0.0 108.175 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.99 -21.83 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 CA-C-N 120.738 1.299 . . . . 0.0 112.887 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -104.52 30.28 5.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.721 1.608 . . . . 0.0 110.182 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.93 149.16 12.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.477 2.311 . . . . 0.0 113.56 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p -128.04 162.1 27.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.188 1.395 . . . . 0.0 109.811 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 t -152.72 -174.12 4.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 109.75 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -147.85 162.59 38.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.231 1.012 . . . . 0.0 109.994 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -157.0 143.49 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -71.04 133.74 46.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.88 -31.73 70.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 0.0 111.782 -172.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.17 -32.2 73.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.848 0.459 . . . . 0.0 111.465 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -80.58 61.56 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.865 1.266 . . . . 0.0 109.143 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.92 -26.37 47.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.479 1.112 . . . . 0.0 111.381 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -47.65 81.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.6 75.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.83 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.0 t -57.02 -48.53 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 119.578 1.081 . . . . 0.0 108.484 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.76 93.9 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.92 -51.11 67.09 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 123.633 0.773 . . . . 0.0 110.02 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.76 -34.53 78.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.027 -0.42 . . . . 0.0 109.956 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.28 -47.91 82.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.246 0.93 . . . . 0.0 110.778 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -58.85 -41.6 87.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.051 0.841 . . . . 0.0 110.757 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.77 -36.07 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.091 0.957 . . . . 0.0 110.478 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.91 9.51 1.7 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.338 0.97 . . . . 0.0 114.272 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.92 154.84 35.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.222 1.511 . . . . 0.0 111.449 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -139.62 138.66 36.33 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.637 1.575 . . . . 0.0 106.759 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 142' ' ' LEU . 25.6 t -72.64 135.28 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.214 1.006 . . . . 0.0 109.86 -171.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 p -125.12 -9.75 7.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.714 2.006 . . . . 0.0 111.327 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.17 179.77 43.57 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 118.755 0.707 . . . . 0.0 111.43 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -154.8 179.0 9.51 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 109.246 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 107.96 -178.477 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 CA--C 1.537 0.646 0 N-CA-C 118.902 2.616 . . . . 0.0 118.902 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.22 148.27 32.18 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.661 1.584 . . . . 0.0 107.255 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.9 mt -113.77 148.33 36.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.443 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.2 t-20 -119.09 138.27 53.0 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.756 1.223 . . . . 0.0 107.753 175.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.517 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.14 162.47 33.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 108.525 -171.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.02 51.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.792 1.637 . . . . 0.0 108.134 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -72.48 127.2 31.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.191 -179.086 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.5 t . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -128.46 146.22 34.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.61 167.14 22.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 168.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.411 HD12 ' CD2' ' A' ' 91' ' ' LEU . 13.5 mm -126.22 142.87 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -154.53 171.56 19.23 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.881 0.872 . . . . 0.0 109.955 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -61.31 150.31 35.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.544 0.611 . . . . 0.0 109.781 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 p -60.11 162.56 5.66 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.037 1.335 . . . . 0.0 112.046 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -120.82 139.18 53.5 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.489 1.916 . . . . 0.0 106.131 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -57.44 -41.45 80.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.474 0.579 . . . . 0.0 111.563 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.53 -19.3 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -88.56 -2.59 58.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.863 0.756 . . . . 0.0 111.33 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.52 -39.17 44.53 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 118.92 0.782 . . . . 0.0 113.467 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.88 -28.94 70.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.195 0.998 . . . . 0.0 112.13 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.33 -35.6 81.48 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 118.868 0.758 . . . . 0.0 109.647 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.3 -39.31 59.75 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.6 t -58.46 -45.58 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.284 0.634 . . . . 0.0 109.411 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.59 91.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.339 0.656 . . . . 0.0 112.176 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.36 -49.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.695 1.198 . . . . 0.0 109.258 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -55.87 -45.72 78.46 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.864 -0.523 . . . . 0.0 110.319 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.3 t -59.91 -49.74 76.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.739 0.816 . . . . 0.0 110.903 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.52 -25.72 64.17 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.018 -1.051 . . . . 0.0 111.976 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 m -68.6 -34.32 75.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.049 0.841 . . . . 0.0 110.595 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.1 -46.48 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.5 -40.67 92.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.38 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.448 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 p -137.9 3.14 2.44 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -168.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' CE1' HD22 ' A' ' 110' ' ' ASN . 15.9 m80 -126.99 37.53 4.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.324 1.42 . . . . 0.0 109.305 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.25 -27.47 55.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.353 1.061 . . . . 0.0 113.784 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.09 -17.19 64.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.534 0.734 . . . . 0.0 112.957 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.9 127.14 30.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.531 1.132 . . . . 0.0 110.783 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -56.48 138.08 52.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.096 1.358 . . . . 0.0 110.055 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.57 80.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.078 0.399 . . . . 0.0 112.024 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -66.17 -42.86 88.34 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.783 -0.573 . . . . 0.0 109.696 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.66 -38.89 84.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.37 -52.93 57.69 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.887 0.875 . . . . 0.0 109.329 172.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.9 m -59.39 -49.07 79.23 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 110.321 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.12 -35.37 71.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.29 -0.256 . . . . 0.0 111.18 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.81 -49.7 73.9 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.14 -36.59 77.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.052 0.842 . . . . 0.0 110.441 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.08 -47.89 80.97 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.014 0.525 . . . . 0.0 111.907 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -36.56 71.16 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.122 -0.361 . . . . 0.0 110.104 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.46 -46.99 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.111 1.765 . . . . 0.0 109.229 172.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -70.25 -9.05 54.77 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.797 -1.19 . . . . 0.0 112.555 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -101.28 6.68 42.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.174 0.99 . . . . 0.0 110.891 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.99 -55.1 0.72 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.653 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.45 -38.4 68.03 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 120.57 1.532 . . . . 0.0 112.932 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -61.46 -14.18 33.51 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.323 2.015 . . . . 0.0 114.94 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.63 -17.45 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.596 1.544 . . . . 0.0 112.38 -174.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.34 148.37 98.03 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.585 1.154 . . . . 0.0 110.826 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.39 51.48 3.89 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.942 3.762 . . . . 0.0 111.373 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.34 165.48 20.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.595 1.158 . . . . 0.0 110.691 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -118.38 109.77 16.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.04 138.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.191 0.596 . . . . 0.0 109.663 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.9 134.27 35.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 167.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.35 143.86 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -77.04 -177.32 4.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.172 0.987 . . . . 0.0 110.12 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.0 -17.86 20.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.446 1.898 . . . . 0.0 113.552 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.71 4.56 53.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.383 1.473 . . . . 0.0 112.046 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.6 t0 53.27 46.25 26.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.716 1.246 . . . . 0.0 110.235 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 129.19 24.21 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.86 138.96 71.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.85 1.7 . . . . 0.0 110.282 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.7 -8.89 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.714 1.205 . . . . 0.0 112.233 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.83 174.2 40.78 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -148.16 159.49 43.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.804 0.802 . . . . 0.0 111.517 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -136.97 141.25 42.59 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.329 2.652 . . . . 0.0 105.826 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -122.9 127.34 48.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 tp -145.37 139.85 27.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.7 m -153.25 156.3 38.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.2 -116.12 7.0 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -169.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.0 25.78 4.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.874 0.87 . . . . 0.0 111.51 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -110.9 112.36 24.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.306 1.042 . . . . 0.0 110.685 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.6 ttp -80.04 87.27 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 169.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.1 -23.02 65.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.12 146.55 30.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.447 0.567 . . . . 0.0 110.263 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.9 tp -156.08 116.05 3.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.74 141.4 30.45 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -148.11 146.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -59.64 122.76 67.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.06 -29.59 6.46 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.049 3.166 . . . . 0.0 114.638 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.38 -24.53 67.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.187 0.995 . . . . 0.0 113.563 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.77 -1.51 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -58.16 -37.4 74.61 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.905 -1.122 . . . . 0.0 110.67 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.27 -21.58 68.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.824 0.726 . . . . 0.0 113.394 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.7 m -79.36 -3.35 45.84 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.635 1.217 . . . . 0.0 111.846 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.97 68.44 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.359 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.7 -31.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.196 1.498 . . . . 0.0 110.994 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.9 -53.52 13.9 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 123.831 0.729 . . . . 0.0 111.722 170.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -63.25 -43.24 98.57 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.213 -1.375 . . . . 0.0 110.19 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -57.83 -46.27 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 120.356 1.435 . . . . 0.0 110.076 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.411 ' CD2' HD12 ' A' ' 5' ' ' ILE . 24.7 mt -69.36 -40.59 77.39 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.803 -0.561 . . . . 0.0 111.144 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.2 t -62.69 -41.24 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.646 0.657 . . . . 0.0 109.991 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.91 -34.13 76.04 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.124 0.875 . . . . 0.0 109.876 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -60.1 -47.04 87.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.231 0.469 . . . . 0.0 110.261 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.64 75.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.419 0.688 . . . . 0.0 110.785 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.17 -34.07 69.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.532 1.133 . . . . 0.0 111.458 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.72 -34.11 76.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.447 0.567 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 43.5 mtm -90.2 -21.88 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.363 0.529 . . . . 0.0 112.124 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.12 90.63 9.18 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 -172.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -21.99 59.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.513 1.475 . . . . 0.0 113.134 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -107.34 33.02 4.23 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.606 1.562 . . . . 0.0 109.808 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.5 tp -48.58 144.86 3.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.412 2.285 . . . . 0.0 112.951 -171.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.7 p -129.9 161.57 30.56 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.761 1.625 . . . . 0.0 108.102 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 t -153.09 -179.55 7.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.42 0.628 . . . . 0.0 110.555 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -143.07 159.32 42.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.275 1.03 . . . . 0.0 109.758 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.7 p -155.14 142.85 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -71.26 131.54 43.62 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.62 -22.46 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.563 0.745 . . . . 0.0 112.001 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.61 21.13 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.99 1.716 . . . . 0.0 113.098 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.407 HD22 ' CE1' ' A' ' 28' ' ' HIS . 64.9 t-20 -148.51 66.24 1.07 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.975 1.71 . . . . 0.0 108.143 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.71 -24.77 58.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.513 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -62.71 -48.94 77.07 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.889 0.476 . . . . 0.0 110.105 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.62 82.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.442 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.29 -49.65 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.71 -46.2 94.69 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -56.59 -50.67 71.27 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -67.38 -33.62 75.59 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.907 -0.496 . . . . 0.0 109.665 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.53 -48.39 81.0 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.11 0.868 . . . . 0.0 110.853 170.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.38 -42.67 87.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.905 0.775 . . . . 0.0 110.499 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.53 -34.42 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.206 1.003 . . . . 0.0 111.069 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.64 9.86 1.94 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.297 169.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -77.19 155.22 32.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.737 1.769 . . . . 0.0 111.039 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.63 139.76 33.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.14 1.776 . . . . 0.0 106.58 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.487 HG22 HD22 ' A' ' 142' ' ' LEU . 21.8 t -71.73 135.42 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 123.888 0.875 . . . . 0.0 109.93 -170.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 p -124.2 -10.77 7.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.507 1.923 . . . . 0.0 111.244 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 179.16 45.02 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 118.823 0.738 . . . . 0.0 111.844 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.91 175.74 11.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.217 1.007 . . . . 0.0 108.4 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.322 -0.608 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.532 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo . . . . . 0 CA--C 1.536 0.601 0 N-CA-C 116.557 1.714 . . . . 0.0 116.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.1 tp -136.28 146.34 46.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.424 1.89 . . . . 0.0 106.368 169.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.86 149.18 39.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -126.71 137.28 53.24 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.676 1.19 . . . . 0.0 108.549 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.9 161.99 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.316 1.046 . . . . 0.0 108.583 -169.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.91 150.45 52.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 108.631 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -76.61 126.54 31.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 124.939 1.296 . . . . 0.0 110.431 -177.284 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 mm -127.74 144.16 38.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -142.13 165.38 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mm -124.1 142.71 39.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -151.84 174.24 13.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.814 0.846 . . . . 0.0 110.046 174.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -63.82 152.61 39.07 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -63.52 174.61 1.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.122 1.769 . . . . 0.0 112.326 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -132.06 142.44 49.54 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.168 1.787 . . . . 0.0 106.493 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -57.73 -40.26 79.22 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.205 0.457 . . . . 0.0 110.897 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.07 -13.43 61.58 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.74 -0.84 41.93 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.865 0.757 . . . . 0.0 110.957 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.2 -40.72 60.31 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.587 0.613 . . . . 0.0 113.182 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.82 -28.2 68.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.348 1.074 . . . . 0.0 111.685 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.485 -0.759 . . . . 0.0 109.908 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.15 -38.96 69.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.39 -47.79 83.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.82 89.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.056 0.542 . . . . 0.0 111.699 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.45 -51.25 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.825 1.25 . . . . 0.0 109.782 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -54.55 -50.17 68.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.933 0.493 . . . . 0.0 109.676 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.46 -48.63 68.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.394 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.74 -33.86 64.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.87 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -27.1 63.67 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 120.531 1.514 . . . . 0.0 111.313 172.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.26 -45.74 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 O-C-N 121.269 -0.894 . . . . 0.0 109.068 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.73 -38.01 83.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.004 0.82 . . . . 0.0 111.904 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.83 -36.59 56.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.249 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.0 p -138.94 -4.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CE1' HD22 ' A' ' 110' ' ' ASN . 20.4 m80 -126.96 25.23 6.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.9 1.227 . . . . 0.0 110.458 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.49 -15.9 31.58 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -53.03 -22.64 6.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.812 2.045 . . . . 0.0 113.155 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.94 97.54 0.36 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.876 1.27 . . . . 0.0 108.163 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -54.82 155.69 4.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 111.181 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.28 64.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.19 -48.13 68.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.85 0.75 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.44 -40.0 94.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.192 0.597 . . . . 0.0 109.872 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -55.2 -47.28 75.48 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.781 1.232 . . . . 0.0 110.195 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.5 m -64.97 -49.72 69.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.019 0.928 . . . . 0.0 110.011 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.01 -38.05 87.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.962 0.346 . . . . 0.0 110.725 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 mt -62.39 -53.67 51.6 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.519 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.16 -39.58 75.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.18 0.9 . . . . 0.0 110.54 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.42 -48.58 77.2 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.958 0.503 . . . . 0.0 111.882 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.072 0.396 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.43 -48.09 88.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 109.279 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -69.94 -10.56 58.99 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.013 -1.054 . . . . 0.0 112.498 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -98.21 5.62 48.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 110.702 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.15 -56.97 0.76 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 117.739 -1.124 . . . . 0.0 112.507 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.49 -38.95 73.55 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 120.793 1.633 . . . . 0.0 113.125 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.39 -14.38 34.39 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.266 1.977 . . . . 0.0 114.818 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -129.01 -14.03 4.47 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.862 1.665 . . . . 0.0 113.144 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.11 91.23 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.048 1.339 . . . . 0.0 111.514 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.46 60.25 7.01 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.844 3.696 . . . . 0.0 110.872 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -83.06 179.69 7.68 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.818 1.294 . . . . 0.0 110.831 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -135.38 140.66 45.17 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.58 2.752 . . . . 0.0 103.921 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.77 139.77 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 119.264 0.938 . . . . 0.0 110.063 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.8 132.66 35.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.43 141.78 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -81.74 -179.82 7.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.358 171.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.55 -25.87 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.769 2.028 . . . . 0.0 114.33 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -85.17 3.35 39.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.288 1.435 . . . . 0.0 112.175 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 51.33 59.31 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 123.761 1.743 . . . . 0.0 109.182 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -131.84 119.27 16.93 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.89 139.78 76.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.019 1.813 . . . . 0.0 109.393 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.66 -10.54 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.681 1.193 . . . . 0.0 111.977 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.12 173.03 41.63 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.86 160.94 41.08 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.615 0.722 . . . . 0.0 111.407 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -141.56 129.78 22.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.836 2.454 . . . . 0.0 105.506 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 74' ' ' ASP . 24.7 tp -109.06 124.89 51.48 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 169.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.7 tp -145.86 134.75 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m -159.72 155.61 26.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.081 2.152 . . . . 0.0 105.281 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.67 57.53 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.862 0.756 . . . . 0.0 113.881 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 58.43 21.77 8.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.992 1.717 . . . . 0.0 113.731 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -124.46 112.87 17.41 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.946 0.899 . . . . 0.0 110.079 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -85.22 85.79 7.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.535 ' HB3' HD23 ' A' ' 67' ' ' LEU . 33.0 t70 -63.76 -28.31 69.79 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.26 144.19 31.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.015 0.526 . . . . 0.0 110.094 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.8 tp -153.7 112.07 3.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -142.58 140.88 31.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.07 154.63 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -171.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -65.0 124.17 85.94 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.65 -27.59 8.1 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.147 3.231 . . . . 0.0 114.759 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.59 -24.15 66.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.978 0.911 . . . . 0.0 112.935 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.49 -2.76 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.759 0.824 . . . . 0.0 112.86 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -55.18 -42.91 73.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.553 1.07 . . . . 0.0 109.786 169.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.81 -26.73 72.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.496 -0.613 . . . . 0.0 113.132 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.9 m -74.57 -8.07 55.14 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.497 1.149 . . . . 0.0 112.419 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.02 13.93 56.98 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.399 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -56.01 -30.22 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.403 1.602 . . . . 0.0 110.293 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -46.89 -52.38 11.8 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.221 0.915 . . . . 0.0 111.883 169.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.35 -44.58 96.14 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.079 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.45 -46.96 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.835 1.198 . . . . 0.0 109.963 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.0 mt -69.3 -39.72 78.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.281 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.13 -40.27 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.817 0.735 . . . . 0.0 109.939 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.91 -34.68 78.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.375 0.989 . . . . 0.0 109.762 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -60.74 -48.51 81.49 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 122.908 0.483 . . . . 0.0 110.318 173.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.3 77.19 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.612 0.765 . . . . 0.0 110.93 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.46 -33.46 71.32 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.591 1.156 . . . . 0.0 111.546 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 m -62.92 -35.56 80.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.578 0.626 . . . . 0.0 111.547 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -85.73 -25.39 26.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.364 0.529 . . . . 0.0 112.082 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.05 94.29 7.9 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.176 1.391 . . . . 0.0 109.16 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.99 -23.31 46.88 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.24 1.293 . . . . 0.0 112.405 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.77 29.08 4.32 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.753 1.621 . . . . 0.0 110.489 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.7 tp -52.49 144.79 12.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.238 2.215 . . . . 0.0 113.248 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.9 p -129.28 164.57 23.21 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.82 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -154.86 -174.47 5.0 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.236 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -148.28 162.03 40.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 110.001 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.5 HG12 HD21 ' A' ' 142' ' ' LEU . 13.1 p -157.71 148.69 9.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -70.0 130.33 41.88 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.54 -33.23 65.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.038 1.335 . . . . 0.0 111.805 -172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.39 -27.77 68.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 0.0 111.779 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.442 HD22 ' CE1' ' A' ' 28' ' ' HIS . 57.5 t-20 -79.72 64.97 4.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.434 0.694 . . . . 0.0 109.52 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.27 -25.54 59.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.75 0.82 . . . . 0.0 111.388 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.79 -48.28 79.81 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 109.954 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.61 78.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.65 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.21 -45.35 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 119.319 0.963 . . . . 0.0 109.001 173.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.66 -49.59 71.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -54.74 -50.49 68.24 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.912 0.885 . . . . 0.0 110.44 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.02 -35.72 81.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.51 -39.75 94.36 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 120.875 -1.141 . . . . 0.0 112.552 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.18 -41.73 89.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.997 1.271 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.26 -34.18 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.307 1.043 . . . . 0.0 110.634 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.27 4.86 2.47 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.5 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -71.64 165.64 23.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.331 1.565 . . . . 0.0 111.197 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.52 140.78 33.54 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.755 2.022 . . . . 0.0 106.036 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.622 HG22 HD22 ' A' ' 142' ' ' LEU . 43.4 t -72.33 129.52 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.1 p -128.82 -7.2 5.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.012 1.725 . . . . 0.0 111.249 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.46 176.92 39.55 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 169.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -157.04 -178.81 7.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.728 0.811 . . . . 0.0 109.533 171.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 125.565 1.546 . . . . 0.0 108.073 -178.789 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_exo . . . . . 0 CA--C 1.536 0.607 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.4 147.77 27.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 106.886 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.76 148.82 32.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.546 ' C ' HD23 ' A' ' 142' ' ' LEU . 9.9 t-20 -115.11 139.2 50.1 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.622 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.07 157.97 45.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -172.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.94 150.85 52.04 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.053 1.341 . . . . 0.0 108.206 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -76.31 130.87 38.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 124.77 1.228 . . . . 0.0 109.895 -177.418 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 mm -130.95 145.67 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -140.54 162.49 35.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 55' ' ' ALA . 23.2 mm -117.76 141.7 35.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.54 177.77 10.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 109.872 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -73.63 150.3 41.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 m -72.69 -177.26 2.23 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.403 1.081 . . . . 0.0 111.154 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.87 161.45 32.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -67.34 -40.11 85.84 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.925 0.33 . . . . 0.0 110.116 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.73 -26.38 64.29 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.7 1.79 52.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.634 0.774 . . . . 0.0 111.301 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.53 -41.67 49.67 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.281 0.946 . . . . 0.0 112.837 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.03 -26.86 68.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.057 0.929 . . . . 0.0 112.228 -178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.88 -34.59 78.12 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.966 0.803 . . . . 0.0 109.598 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.46 -38.16 49.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.43 -45.45 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -45.71 91.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.074 0.55 . . . . 0.0 111.448 178.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.3 mt -59.56 -48.52 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 109.702 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.37 -51.04 66.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.619 0.767 . . . . 0.0 110.204 173.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.05 -40.83 90.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.897 -0.502 . . . . 0.0 110.367 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -66.23 -42.99 87.86 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.327 0.651 . . . . 0.0 111.216 177.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -59.05 -37.06 76.11 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.917 0.487 . . . . 0.0 111.052 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -72.2 -44.32 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.269 0.628 . . . . 0.0 109.319 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -60.27 -37.81 81.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.012 0.824 . . . . 0.0 111.721 174.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.36 61.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.855 -174.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.1 p -139.27 -3.1 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -169.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CE1' HD22 ' A' ' 110' ' ' ASN . 16.3 m80 -126.72 26.28 6.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.686 1.13 . . . . 0.0 110.456 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -13.92 28.99 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.847 -1.158 . . . . 0.0 113.053 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -57.25 -21.1 31.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.063 1.745 . . . . 0.0 112.995 170.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.05 109.69 1.9 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 m -58.05 147.53 29.25 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.533 1.533 . . . . 0.0 110.238 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.34 67.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.88 -52.48 56.35 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -70.79 -31.84 68.74 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.891 -0.506 . . . . 0.0 110.596 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 tpp85 -54.67 -46.38 74.03 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.956 0.902 . . . . 0.0 109.922 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -64.94 -50.04 67.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 109.843 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -63.4 -39.31 94.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.784 0.266 . . . . 0.0 110.545 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -62.34 -54.5 39.62 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.467 175.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -58.61 -37.81 76.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.419 1.009 . . . . 0.0 110.505 -173.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.13 -48.96 71.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.2 0.6 . . . . 0.0 111.919 175.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.47 74.92 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.282 0.492 . . . . 0.0 110.49 -176.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.71 -48.71 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.195 1.798 . . . . 0.0 108.945 171.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttp85 -70.66 -8.4 51.61 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.001 -1.062 . . . . 0.0 112.764 176.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -99.63 5.55 45.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.066 0.947 . . . . 0.0 110.801 172.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -135.45 -55.37 0.79 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.957 -169.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.72 -37.91 61.4 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.411 1.459 . . . . 0.0 112.732 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.4 -9.03 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.235 1.957 . . . . 0.0 115.437 172.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.02 -16.08 3.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.207 1.821 . . . . 0.0 113.466 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.86 152.39 96.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.794 1.238 . . . . 0.0 112.348 -172.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.24 62.38 7.54 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 125.176 3.917 . . . . 0.0 111.616 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.1 mt -83.89 172.77 11.81 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.233 1.813 . . . . 0.0 112.404 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -134.26 145.86 49.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.58 139.63 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.523 1.129 . . . . 0.0 110.262 -176.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.12 130.81 35.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -123.31 142.16 40.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.1 p30 -84.21 -173.48 4.74 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.453 174.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.64 -22.34 22.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.434 1.494 . . . . 0.0 113.657 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -81.79 -2.36 50.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 111.659 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 53.26 56.31 7.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.286 1.517 . . . . 0.0 109.142 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.61 129.19 16.31 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 127.461 2.304 . . . . 0.0 105.465 -169.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.73 136.8 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.027 1.818 . . . . 0.0 110.217 -171.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 -16.08 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.722 1.209 . . . . 0.0 111.842 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.19 173.02 39.31 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.76 161.28 42.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.707 0.753 . . . . 0.0 110.592 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 154.13 47.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.129 0.971 . . . . 0.0 108.937 168.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.78 119.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 176.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 95' ' ' ALA . 25.2 tp -146.28 134.6 21.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.275 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -159.47 156.32 28.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.358 2.263 . . . . 0.0 105.484 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.63 32.94 61.95 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.419 -0.8 . . . . 0.0 113.889 175.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 57.01 22.54 7.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.218 1.807 . . . . 0.0 114.121 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -122.69 111.02 16.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.579 0.751 . . . . 0.0 109.787 175.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 ttp -85.83 88.78 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.77 -23.95 67.4 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.14 144.88 32.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.378 0.671 . . . . 0.0 110.552 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.8 tp -156.87 117.22 3.57 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.69 1.996 . . . . 0.0 106.112 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -147.17 144.92 29.32 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.33 142.73 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -173.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.49 137.68 95.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.281 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.62 -24.53 23.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.803 3.002 . . . . 0.0 115.852 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.34 -21.1 61.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.541 1.064 . . . . 0.0 112.278 175.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.15 24.89 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.529 1.532 . . . . 0.0 110.493 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.91 132.84 54.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.778 -1.201 . . . . 0.0 108.826 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.95 2.65 53.1 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.995 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 98.7 m -70.78 169.23 15.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.654 1.727 . . . . 0.0 109.18 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.05 -28.22 16.95 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.545 1.069 . . . . 0.0 113.863 -177.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.55 -34.81 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 118.989 1.395 . . . . 0.0 112.203 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.15 -29.94 53.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.08 0.848 . . . . 0.0 112.807 175.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -91.95 -42.52 9.97 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 116.498 -1.715 . . . . 0.0 110.248 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.32 -45.56 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 121.56 1.982 . . . . 0.0 110.826 -172.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.2 -39.81 89.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.791 0.723 . . . . 0.0 111.065 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.53 -40.75 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.478 0.711 . . . . 0.0 109.798 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.54 -36.95 85.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.594 0.758 . . . . 0.0 109.544 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.52 -47.03 87.44 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.057 0.543 . . . . 0.0 110.276 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 68' ' ' LEU . . . -60.13 -49.77 76.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.06 0.544 . . . . 0.0 110.84 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -60.27 -33.72 72.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.191 0.996 . . . . 0.0 111.578 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -37.65 88.11 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.358 0.526 . . . . 0.0 111.414 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -83.92 -26.45 29.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.253 0.479 . . . . 0.0 112.117 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 91.32 10.39 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.143 1.377 . . . . 0.0 109.282 -169.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.96 -22.16 63.06 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.425 1.417 . . . . 0.0 112.822 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.86 30.92 5.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.286 1.434 . . . . 0.0 110.274 -174.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 tp -50.91 143.37 10.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.898 2.079 . . . . 0.0 112.826 -170.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 65.2 p -130.0 162.85 27.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.746 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 t -153.58 -173.58 4.63 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.014 0.526 . . . . 0.0 109.724 175.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -148.68 161.41 41.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.833 0.853 . . . . 0.0 110.631 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -156.07 147.34 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -72.56 132.16 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -58.34 -30.87 67.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.726 0.811 . . . . 0.0 112.33 -173.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.79 -33.16 72.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.506 0.594 . . . . 0.0 111.236 -177.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.445 HD22 ' CE1' ' A' ' 28' ' ' HIS . 54.5 t-20 -80.02 65.8 5.3 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.028 0.931 . . . . 0.0 110.523 176.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.11 -26.11 59.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 111.632 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.4 ' H ' ' NE2' ' A' ' 112' ' ' GLN . 2.7 mp0 -62.87 -46.97 85.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.102 0.561 . . . . 0.0 109.752 176.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.72 77.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.606 -0.711 . . . . 0.0 111.786 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.41 -46.21 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.236 0.925 . . . . 0.0 108.963 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.01 -49.59 73.79 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -55.45 -50.88 68.71 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.582 0.753 . . . . 0.0 110.755 -178.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -66.1 -34.41 78.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -174.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.15 -37.88 86.75 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.82 -1.175 . . . . 0.0 112.72 172.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.07 -42.81 91.26 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.877 1.217 . . . . 0.0 110.169 173.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.57 -35.65 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 110.788 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.72 9.08 1.82 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.418 1.008 . . . . 0.0 114.454 169.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.4 162.2 29.08 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.608 1.704 . . . . 0.0 111.107 171.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.92 140.39 25.6 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.559 HG22 HD22 ' A' ' 142' ' ' LEU . 29.9 t -72.26 129.75 35.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.907 0.883 . . . . 0.0 109.336 -174.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.6 p -123.77 -9.15 7.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.421 1.888 . . . . 0.0 111.681 -174.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.55 -179.92 41.12 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -156.36 177.87 10.96 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.804 0.841 . . . . 0.0 109.254 172.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--N 1.322 -0.609 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.53 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 CA--C 1.536 0.617 0 N-CA-C 118.449 2.442 . . . . 0.0 118.449 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.67 146.15 26.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.7 mt -117.26 145.23 44.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.451 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.1 t-20 -115.71 138.61 50.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.559 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.0 158.78 43.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -171.242 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.56 152.48 51.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.277 1.431 . . . . 0.0 108.348 176.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.5 127.36 32.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.8 t . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 125.136 1.374 . . . . 0.0 110.146 -176.644 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.267 4.3 t -74.74 155.95 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 127.702 2.401 . . . . 0.0 107.874 177.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -135.2 141.84 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.88 1.672 . . . . 0.0 106.676 172.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -136.32 166.17 24.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.7 mm -123.08 142.16 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -150.52 172.02 16.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.784 0.834 . . . . 0.0 109.76 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.47 HH12 ' HB2' ' A' ' 51' ' ' PRO . 24.6 mmt180 -61.67 148.39 42.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 121.492 -0.755 . . . . 0.0 110.488 166.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 52' ' ' LEU . 0.7 OUTLIER -70.84 160.76 32.18 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.735 1.214 . . . . 0.0 110.26 176.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -103.11 161.72 13.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.146 163.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -62.82 -51.76 65.79 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.67 -24.9 62.77 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.469 -1.696 . . . . 0.0 108.754 -162.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.35 -0.61 46.61 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.404 -0.185 . . . . 0.0 111.1 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.53 -39.43 53.22 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.137 -0.977 . . . . 0.0 112.752 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -65.56 -28.56 69.25 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 118.616 1.208 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.19 -32.78 73.25 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.209 0.528 . . . . 0.0 109.644 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.1 mt -73.88 -38.82 64.29 Favored 'General case' 0 C--N 1.334 -0.1 0 O-C-N 120.901 -1.125 . . . . 0.0 109.63 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -57.28 -46.46 85.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.77 -47.15 87.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.06 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.84 -50.36 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.996 1.319 . . . . 0.0 109.52 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -53.76 -47.15 70.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.456 -0.777 . . . . 0.0 109.737 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.0 t -59.13 -47.32 85.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.279 0.632 . . . . 0.0 110.683 -176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -72.19 -32.65 66.99 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.306 -0.871 . . . . 0.0 112.811 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.1 m -60.17 -38.06 82.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.342 0.974 . . . . 0.0 109.516 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.8 t -70.44 -42.74 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.077 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.41 -34.99 78.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.392 0.542 . . . . 0.0 111.094 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.78 -33.91 30.62 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.283 -0.886 . . . . 0.0 112.309 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.591 HG21 HH12 ' A' ' 83' ' ' ARG . 19.9 p -139.1 -5.12 1.47 Allowed 'General case' 0 C--N 1.341 0.204 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -167.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.404 ' CE1' HD22 ' A' ' 110' ' ' ASN . 57.4 m80 -126.61 30.06 5.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 120.697 1.59 . . . . 0.0 110.454 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -60.8 -18.94 58.36 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.962 0.887 . . . . 0.0 112.849 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.11 -23.52 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.212 1.405 . . . . 0.0 112.517 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -60.88 106.02 0.53 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.418 1.087 . . . . 0.0 111.591 172.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 m -56.25 151.09 13.22 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.056 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.06 -34.41 68.24 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 123.077 0.551 . . . . 0.0 112.351 -172.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -68.07 -47.91 67.01 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 122.714 1.245 . . . . 0.0 109.358 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.812 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 5.9 t80 -68.66 -34.98 76.63 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.574 -1.193 . . . . 0.0 112.02 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -53.86 -49.35 68.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.754 0.822 . . . . 0.0 110.773 170.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 m -62.91 -47.08 84.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 O-C-N 124.349 1.031 . . . . 0.0 109.16 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -70.37 -36.54 74.19 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.95 0.405 . . . . 0.0 111.457 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.54 -50.77 70.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.414 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.69 -39.06 79.64 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 119.081 0.855 . . . . 0.0 111.237 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.06 -51.07 69.46 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.06 0.544 . . . . 0.0 110.326 177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.84 -37.21 79.01 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.478 -0.764 . . . . 0.0 110.134 -175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.8 t -58.5 -46.99 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.51 1.524 . . . . 0.0 109.026 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -67.74 -18.04 64.76 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 120.913 -1.117 . . . . 0.0 113.034 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.3 m -95.02 10.61 35.0 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -140.09 -56.29 0.55 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 119.473 1.033 . . . . 0.0 111.796 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.1 mt -55.81 -40.24 83.22 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 116.888 -1.53 . . . . 0.0 112.659 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.73 -11.63 18.36 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.315 2.01 . . . . 0.0 116.209 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.99 -15.35 3.82 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.14 1.336 . . . . 0.0 112.461 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.02 148.24 98.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 C-N-CA 123.784 0.833 . . . . 0.0 110.124 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HB2' HH12 ' A' ' 7' ' ' ARG . 47.1 Cg_endo -77.84 65.23 8.25 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.347 3.365 . . . . 0.0 108.844 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.426 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 64.1 mt -83.9 170.89 13.57 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.033 0.933 . . . . 0.0 110.651 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -122.75 138.88 54.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 166.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.54 135.57 56.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.615 1.166 . . . . 0.0 108.811 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.28 133.0 41.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 160.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.4 140.65 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -79.22 -174.58 4.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.078 170.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.48 -19.53 9.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.537 1.535 . . . . 0.0 114.885 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -88.36 4.93 44.4 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 120.769 -1.207 . . . . 0.0 113.203 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.3 t0 52.24 52.45 14.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 123.27 1.509 . . . . 0.0 110.897 -169.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -131.7 124.57 19.96 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.23 137.83 45.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.113 1.875 . . . . 0.0 111.743 -169.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.86 -11.06 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.397 1.079 . . . . 0.0 111.38 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.93 171.49 41.07 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 169.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -146.66 161.96 39.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 111.704 176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.422 ' HB3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -147.31 138.92 24.05 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.674 1.59 . . . . 0.0 106.942 -175.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 73' ' ' MET . 1.1 tp -112.6 121.34 44.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 174.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.5 tp -141.56 133.25 27.13 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.573 1.171 . . . . 0.0 108.424 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 66.5 m -147.27 160.2 42.76 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.761 2.024 . . . . 0.0 106.979 164.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.0 -115.01 6.68 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -170.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -135.46 32.71 3.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.567 1.183 . . . . 0.0 109.637 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -128.2 103.13 7.02 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 124.113 0.965 . . . . 0.0 109.216 -165.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 67.1 ttp -81.08 87.14 6.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -60.26 -36.32 77.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.932 0.893 . . . . 0.0 111.181 -177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.81 146.46 41.34 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 120.546 -1.346 . . . . 0.0 110.685 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.1 tp -153.97 118.25 4.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -144.37 143.14 30.8 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.4 mt -150.74 141.23 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -53.46 122.93 34.32 Favored Pre-proline 0 C--O 1.239 0.52 0 O-C-N 125.374 1.671 . . . . 0.0 108.929 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -51.84 -27.17 26.43 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.186 1.924 . . . . 0.0 114.39 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.3 -28.28 69.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.112 1.324 . . . . 0.0 111.89 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.66 2.04 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 120.867 -1.145 . . . . 0.0 112.262 -171.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.591 HH12 HG21 ' A' ' 27' ' ' THR . 46.2 mtt180 -53.36 -44.82 68.84 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.095 -1.003 . . . . 0.0 111.958 170.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.31 -22.95 67.85 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.369 1.043 . . . . 0.0 111.596 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.0 -7.41 51.04 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 118.696 1.248 . . . . 0.0 113.084 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.21 1.25 51.08 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-O 118.699 -1.056 . . . . 0.0 112.606 172.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.6 t -55.68 -31.35 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 118.725 1.263 . . . . 0.0 110.019 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.86 -49.8 34.14 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.003 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -64.62 -47.01 80.15 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 116.792 -1.575 . . . . 0.0 110.734 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.8 t -56.86 -43.41 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.558 1.072 . . . . 0.0 110.085 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 66' ' ' MET . 29.2 mt -69.34 -42.15 75.69 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.628 -0.67 . . . . 0.0 111.017 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.51 -41.25 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.813 0.733 . . . . 0.0 110.432 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -65.38 -38.69 90.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -59.32 -46.07 89.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.381 0.537 . . . . 0.0 110.605 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.93 91.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.989 0.516 . . . . 0.0 110.609 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.808 HD21 ' HD2' ' A' ' 144' ' ' TYR . 32.6 mt -62.59 -34.58 77.29 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.9 m -62.71 -33.97 76.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 O-C-N 123.536 0.523 . . . . 0.0 110.695 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.8 mtm -87.59 -22.52 24.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.626 0.648 . . . . 0.0 112.061 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.78 93.16 6.25 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.775 1.23 . . . . 0.0 108.237 -171.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.53 -23.65 57.24 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.738 1.625 . . . . 0.0 113.266 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -104.32 31.18 4.78 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.379 1.471 . . . . 0.0 109.368 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.8 tp -49.86 144.64 6.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.529 1.932 . . . . 0.0 113.04 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 73.4 p -127.48 162.0 27.42 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.778 1.631 . . . . 0.0 108.751 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -153.35 -179.68 7.96 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -141.56 165.51 27.3 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.063 0.945 . . . . 0.0 109.856 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.5 p -156.72 145.63 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -71.29 131.85 44.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -58.35 -33.09 69.16 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.519 1.128 . . . . 0.0 111.534 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -59.76 -30.95 69.21 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 123.167 0.587 . . . . 0.0 111.523 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.404 HD22 ' CE1' ' A' ' 28' ' ' HIS . 63.4 t-20 -85.81 68.62 10.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.291 0.567 . . . . 0.0 109.886 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.35 -26.07 62.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.509 0.724 . . . . 0.0 111.018 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -61.47 -49.16 77.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.67 -0.644 . . . . 0.0 109.61 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.65 76.57 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 118.363 -0.827 . . . . 0.0 111.411 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.8 t -57.04 -48.32 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.528 1.058 . . . . 0.0 108.46 171.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.83 -47.15 92.67 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.525 0.602 . . . . 0.0 111.793 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.26 -51.04 70.96 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.91 0.884 . . . . 0.0 109.116 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -65.66 -35.39 80.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -42.69 99.12 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 119.738 1.154 . . . . 0.0 112.584 171.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt -59.57 -41.01 89.23 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 119.052 0.842 . . . . 0.0 111.306 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.2 t -67.05 -37.82 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 123.998 0.812 . . . . 0.0 109.648 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.689 ' HA3' ' HA3' ' A' ' 146' ' ' GLY . . . 141.38 5.35 0.97 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-O 122.182 0.879 . . . . 0.0 115.003 168.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -73.9 159.09 33.31 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 118.294 -2.886 . . . . 0.0 111.475 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -142.59 139.36 31.32 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.5 t -71.69 136.28 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.2 p -130.28 -8.63 4.25 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.26 1.824 . . . . 0.0 110.922 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.36 178.1 42.65 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -157.32 178.69 10.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.122 -0.634 . . . . 0.0 109.62 171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -138.09 155.06 49.15 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -91.34 -7.29 51.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.312 1.053 . . . . 0.0 112.093 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -136.18 173.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -80.9 -62.45 1.66 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.942 0.776 . . . . 0.0 109.25 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -161.16 -47.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 135' ' ' LYS . 80.5 mt -90.23 23.67 2.8 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.821 -1.174 . . . . 0.0 110.463 -173.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 4.57 89.28 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.127 -0.983 . . . . 0.0 112.476 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.812 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -67.27 137.73 94.1 Favored Pre-proline 0 CA--C 1.511 -0.528 0 CA-C-O 117.253 -1.356 . . . . 0.0 109.629 175.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.36 52.24 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.86 3.04 . . . . 0.0 112.404 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.423 ' HD2' ' CE2' ' A' ' 35' ' ' TYR . 21.9 m-85 -126.82 76.93 74.95 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.424 1.49 . . . . 0.0 108.813 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -47.84 148.14 6.6 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.705 2.27 . . . . 0.0 115.809 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.7 tp -104.39 146.77 28.36 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.8 mt -114.57 145.93 41.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.68 138.08 51.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.654 1.182 . . . . 0.0 107.986 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.87 157.85 45.8 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -169.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.24 50.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.808 ' HD2' HD21 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -73.21 116.7 14.06 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.596 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 74.7 t -109.36 -30.71 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 1 CA-C-O 100.815 -9.183 . . . . 0.0 110.44 171.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.802 ' HA3' ' HE1' ' A' ' 144' ' ' TYR . . . -35.19 -16.14 0.0 OUTLIER Glycine 2 N--CA 1.567 7.373 3 C-N-CA 151.441 13.877 . . . . 0.0 132.066 -151.649 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 145' ' ' VAL 0.265 . . . . . . . 0 C--N 1.275 -2.664 1 CA-C-N 100.476 -7.862 . . . . 0.0 117.36 125.994 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.95 149.82 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.685 0.794 . . . . 0.0 109.73 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 mm -126.76 144.45 36.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.7 m -141.65 167.59 21.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 168.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 mm -121.45 142.83 36.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 172.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -148.72 173.51 13.16 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.539 0.736 . . . . 0.0 110.214 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -66.03 147.87 52.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.573 0.701 . . . . 0.0 109.11 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -77.71 147.17 35.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.854 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -85.99 175.85 8.36 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.803 0.841 . . . . 0.0 108.746 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -82.35 -49.06 10.44 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.431 0.292 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.43 -26.54 61.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.81 0.732 . . . . 0.0 112.203 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -72.77 -5.2 36.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.031 -0.418 . . . . 0.0 111.841 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.66 -38.64 29.43 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.487 1.041 . . . . 0.0 113.178 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.78 -28.61 69.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.926 1.363 . . . . 0.0 111.795 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.71 -31.28 70.26 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.401 -0.812 . . . . 0.0 109.578 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -75.49 -39.67 58.23 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.3 t -56.29 -44.82 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.497 0.719 . . . . 0.0 109.084 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.45 96.18 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.883 -0.51 . . . . 0.0 111.436 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.0 mt -59.8 -48.89 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.512 0.725 . . . . 0.0 109.705 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.6 t90 -54.19 -45.7 72.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.269 0.628 . . . . 0.0 110.111 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 t -60.54 -44.24 96.32 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.607 -0.683 . . . . 0.0 110.518 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.3 mtp85 -63.11 -42.69 99.6 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.658 -0.651 . . . . 0.0 110.833 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.7 m -59.6 -38.09 80.33 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.514 0.726 . . . . 0.0 110.876 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.44 -45.52 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-O 118.658 -0.687 . . . . 0.0 109.273 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.02 -37.39 76.83 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.153 0.888 . . . . 0.0 111.83 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.27 -38.6 26.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.147 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 54.5 p -135.44 -5.78 2.27 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CE1' HD22 ' A' ' 110' ' ' ASN . 12.7 m80 -128.52 26.89 5.6 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.009 1.277 . . . . 0.0 110.632 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.5 -14.41 28.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.323 -0.861 . . . . 0.0 113.293 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -53.38 -22.79 8.13 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.737 2.015 . . . . 0.0 112.988 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -65.01 100.29 0.41 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.057 1.343 . . . . 0.0 108.529 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -56.32 157.33 5.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.527 1.531 . . . . 0.0 111.109 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.32 -36.98 66.81 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -67.14 -48.56 67.68 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.888 0.767 . . . . 0.0 109.783 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -63.52 -40.27 96.61 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.663 0.785 . . . . 0.0 109.796 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 -55.54 -48.45 74.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.932 1.293 . . . . 0.0 110.168 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -65.42 -49.53 68.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.0 0.92 . . . . 0.0 110.05 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.83 -38.13 88.08 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.861 0.3 . . . . 0.0 110.66 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.9 mt -62.79 -53.74 49.72 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.565 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.53 -38.22 74.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.442 1.019 . . . . 0.0 110.701 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.9 -49.09 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.221 0.609 . . . . 0.0 111.854 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -36.45 74.66 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.201 0.455 . . . . 0.0 110.296 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -59.02 -48.5 86.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 126.211 1.805 . . . . 0.0 109.038 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -70.41 -10.76 59.98 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.987 -1.071 . . . . 0.0 112.679 176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.7 m -96.05 4.7 52.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.708 0.803 . . . . 0.0 110.681 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -135.24 -56.45 0.8 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.158 -169.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.81 -38.47 68.4 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 120.466 1.485 . . . . 0.0 112.91 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -62.19 -13.01 29.5 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.945 1.764 . . . . 0.0 115.362 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -128.95 -14.7 4.41 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.63 1.559 . . . . 0.0 113.196 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.54 152.19 95.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.792 1.237 . . . . 0.0 111.999 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.19 62.71 7.61 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.98 3.787 . . . . 0.0 111.65 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.8 173.73 8.79 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.185 1.794 . . . . 0.0 112.374 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -133.07 146.15 51.41 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.45 137.87 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 124.027 0.931 . . . . 0.0 110.487 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.66 130.87 35.74 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.01 140.89 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.3 p30 -76.67 -174.83 3.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.609 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.08 -15.56 34.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.821 1.648 . . . . 0.0 113.118 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -87.74 3.73 46.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.037 1.335 . . . . 0.0 111.713 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.14 33.28 21.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.675 1.59 . . . . 0.0 111.412 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -117.79 133.49 23.33 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.26 138.18 46.04 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.703 2.268 . . . . 0.0 112.4 -169.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.76 -9.64 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.601 1.16 . . . . 0.0 112.348 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.96 170.43 37.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -147.08 158.56 43.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.882 0.841 . . . . 0.0 110.7 175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.92 153.34 48.24 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.948 0.899 . . . . 0.0 109.54 169.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -117.35 120.62 38.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.1 tp -145.45 140.26 27.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 m -154.4 155.97 35.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.985 2.114 . . . . 0.0 105.334 169.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.39 -114.56 5.63 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -169.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -130.96 13.99 5.25 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.785 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -114.74 106.21 13.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.491 1.041 . . . . 0.0 110.407 -175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.7 ttp -79.16 82.56 5.31 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.5 -19.52 62.16 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.01 148.54 30.83 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.247 0.93 . . . . 0.0 110.573 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.9 tp -156.63 119.88 4.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.525 1.93 . . . . 0.0 105.932 172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -146.03 145.08 30.46 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mt -151.34 142.07 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -169.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -55.55 120.03 28.91 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -46.03 -30.76 7.65 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 114.471 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -62.98 -24.16 67.77 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.1 m -114.9 0.33 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 118.701 0.682 . . . . 0.0 112.408 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -60.59 -38.27 84.06 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.293 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.22 -27.73 71.08 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.589 0.614 . . . . 0.0 112.742 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.6 m -75.35 -6.2 48.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.236 1.018 . . . . 0.0 112.14 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.61 16.1 64.59 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.292 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -55.38 -31.74 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 119.134 1.467 . . . . 0.0 111.094 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.86 -52.82 15.32 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-O 119.388 -0.674 . . . . 0.0 111.921 170.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.49 -42.92 98.53 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 117.327 -1.321 . . . . 0.0 110.291 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.6 t -58.1 -45.62 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 120.297 1.408 . . . . 0.0 110.011 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.3 mt -68.59 -42.23 78.53 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.855 -0.528 . . . . 0.0 110.81 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.2 t -61.65 -41.56 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.041 0.536 . . . . 0.0 110.024 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.2 -33.19 73.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.317 -0.864 . . . . 0.0 110.121 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.93 -46.55 88.85 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 118.317 0.508 . . . . 0.0 110.382 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.95 -47.89 82.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.083 0.553 . . . . 0.0 111.019 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.5 mt -58.98 -34.82 72.26 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.102 0.961 . . . . 0.0 111.303 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.81 -32.81 74.07 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.13 0.423 . . . . 0.0 111.784 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mtm -91.45 -23.21 20.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.237 0.615 . . . . 0.0 112.148 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.53 92.47 8.12 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 125.548 1.539 . . . . 0.0 108.339 -172.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.49 -22.75 65.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 121.474 1.449 . . . . 0.0 112.35 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -104.22 31.69 4.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.862 1.665 . . . . 0.0 110.039 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.8 tp -48.33 143.3 4.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.254 2.222 . . . . 0.0 112.843 -171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.1 p -130.49 159.18 37.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.56 1.544 . . . . 0.0 108.01 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.6 t -154.17 -175.41 5.38 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.157 0.503 . . . . 0.0 109.792 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -148.48 160.38 43.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.135 0.974 . . . . 0.0 110.609 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -157.11 147.94 10.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -72.51 132.57 44.02 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.98 -35.13 63.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.963 1.305 . . . . 0.0 111.939 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.11 -30.84 71.91 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.419 0.554 . . . . 0.0 111.771 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.442 HD22 ' CE1' ' A' ' 28' ' ' HIS . 58.9 t-20 -80.47 63.37 4.89 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.953 0.901 . . . . 0.0 109.374 176.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -56.27 -26.62 52.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.3 1.04 . . . . 0.0 111.151 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -47.44 83.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.688 0.795 . . . . 0.0 109.833 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.53 -35.01 75.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.856 175.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.45 -47.93 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 119.47 1.032 . . . . 0.0 108.444 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.07 -46.44 94.55 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.544 0.592 . . . . 0.0 111.817 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -55.14 -51.33 66.82 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 117.762 0.781 . . . . 0.0 110.008 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.23 -33.7 75.91 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.926 -0.484 . . . . 0.0 109.917 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -58.48 -47.48 83.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.433 1.015 . . . . 0.0 110.852 170.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.44 -42.88 88.32 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.951 0.796 . . . . 0.0 110.463 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.76 -37.76 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 123.945 0.898 . . . . 0.0 110.776 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.51 9.85 1.14 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.28 171.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -79.71 154.94 28.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.596 1.698 . . . . 0.0 111.248 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -140.79 138.51 34.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.267 1.827 . . . . 0.0 106.39 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 142' ' ' LEU . 22.0 t -71.41 134.39 30.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 123.935 0.894 . . . . 0.0 109.75 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 p -125.34 -9.99 6.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.453 1.901 . . . . 0.0 111.364 -176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.33 -177.88 42.12 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 118.822 0.737 . . . . 0.0 111.565 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -152.65 -176.43 5.72 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.124 0.969 . . . . 0.0 108.839 169.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.7 m -131.05 162.91 28.78 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.329 1.452 . . . . 0.0 108.59 174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -80.44 -12.41 59.56 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.695 0.798 . . . . 0.0 111.622 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.14 178.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.286 2.235 . . . . 0.0 106.942 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.47 -61.7 1.92 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.977 0.353 . . . . 0.0 110.175 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -161.81 -46.52 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.587 0.755 . . . . 0.0 112.482 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.72 28.77 1.26 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.661 1.184 . . . . 0.0 110.327 -173.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.12 13.65 81.0 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.786 0.707 . . . . 0.0 113.369 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -67.07 129.79 93.9 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 117.253 -1.356 . . . . 0.0 107.665 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.11 43.94 1.49 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.817 3.011 . . . . 0.0 112.564 -170.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -138.01 82.31 25.45 Favored Pre-proline 0 C--O 1.224 -0.283 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -170.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -43.4 147.58 0.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.112 3.208 . . . . 0.0 118.344 -169.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.7 148.44 23.33 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 168.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.6 mt -117.16 148.16 41.83 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -120.65 138.64 53.82 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.609 1.164 . . . . 0.0 108.131 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.88 160.75 38.44 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.343 1.057 . . . . 0.0 108.288 -169.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.26 150.1 52.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.567 1.547 . . . . 0.0 108.536 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -75.67 124.01 26.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.0 t -130.05 -17.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.468 1.107 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.04 31.56 2.02 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.0 1.286 . . . . 0.0 113.999 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.324 1.05 . . . . 0.0 109.909 174.023 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.96 153.42 8.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 169.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 mm -132.69 140.79 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.4 m -135.58 164.16 28.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 55' ' ' ALA . 15.5 mm -127.16 143.21 41.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -154.99 171.94 18.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.798 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -60.59 148.98 36.24 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.884 0.765 . . . . 0.0 109.082 169.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 p -62.84 161.62 12.41 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.764 1.626 . . . . 0.0 112.27 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -112.24 160.47 17.59 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.691 1.596 . . . . 0.0 107.251 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 -69.84 -45.46 67.75 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.094 -0.378 . . . . 0.0 111.031 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.47 -27.21 65.03 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -82.82 -2.36 54.4 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.021 0.528 . . . . 0.0 111.483 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.34 -40.19 60.46 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.201 0.909 . . . . 0.0 112.766 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.34 -28.54 69.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.551 1.175 . . . . 0.0 111.766 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.65 -32.52 69.84 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.346 -0.846 . . . . 0.0 109.711 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.6 mt -72.81 -39.44 66.65 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.728 -0.607 . . . . 0.0 109.592 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.74 -44.78 86.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.205 170.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.21 93.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.363 0.665 . . . . 0.0 112.258 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 37.3 mt -64.22 -48.94 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.398 1.079 . . . . 0.0 109.505 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 60.3 t90 -54.7 -44.92 73.84 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.885 -0.509 . . . . 0.0 110.396 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -59.84 -50.28 74.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.991 0.814 . . . . 0.0 110.832 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -68.98 -25.19 64.4 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.273 -0.892 . . . . 0.0 111.94 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.6 m -69.58 -31.89 70.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.94 0.791 . . . . 0.0 111.085 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.87 -47.16 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -58.92 -39.33 81.23 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.15 -34.23 20.62 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.706 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.0 p -138.41 -0.43 1.99 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -168.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -133.57 33.45 3.52 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.324 1.42 . . . . 0.0 110.812 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.06 -14.19 9.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 113.534 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -58.02 -27.81 63.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.222 1.809 . . . . 0.0 112.709 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.21 129.52 42.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.499 1.12 . . . . 0.0 108.917 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.6 p -61.85 161.97 9.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.375 0.67 . . . . 0.0 110.41 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.49 78.11 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.9 -0.5 . . . . 0.0 110.647 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -63.32 -50.76 68.75 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.398 0.679 . . . . 0.0 109.97 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.433 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 6.1 t80 -67.89 -36.93 81.08 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 122.145 -0.347 . . . . 0.0 110.103 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -55.25 -42.3 73.31 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.707 1.203 . . . . 0.0 110.732 171.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -72.55 -50.83 22.91 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 118.587 0.631 . . . . 0.0 109.658 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -69.34 -35.14 75.6 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.125 -174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.38 -51.47 67.43 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.121 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.48 -37.94 76.58 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 119.554 1.07 . . . . 0.0 110.843 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.49 -48.07 81.18 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.653 0.66 . . . . 0.0 111.807 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.15 -38.11 72.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -59.47 -46.37 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 126.236 1.814 . . . . 0.0 109.291 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.6 ttp85 -72.34 -10.29 59.6 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 120.753 -1.217 . . . . 0.0 112.23 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -98.0 5.71 48.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 110.696 171.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -136.09 -56.77 0.76 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.617 -1.183 . . . . 0.0 112.724 -169.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt -54.39 -38.83 69.82 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 121.019 1.736 . . . . 0.0 113.246 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -61.09 -13.55 28.48 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.409 2.072 . . . . 0.0 114.845 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.38 -12.61 3.96 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 120.772 1.624 . . . . 0.0 113.272 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 153.21 91.82 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.227 1.411 . . . . 0.0 111.626 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 66.29 7.33 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 110.136 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.3 mt -87.58 179.08 6.6 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 122.336 1.065 . . . . 0.0 109.907 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -137.37 127.67 26.36 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 m -105.63 141.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 119.026 0.83 . . . . 0.0 110.237 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -85.05 134.77 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 168.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.94 142.77 42.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.525 HD22 ' CG1' ' A' ' 63' ' ' VAL . 16.4 p30 -85.08 -178.31 6.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.251 169.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.6 -26.38 8.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.805 1.642 . . . . 0.0 114.18 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -76.64 -3.07 35.9 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.31 1.044 . . . . 0.0 111.772 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.2 t0 51.48 57.98 5.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 123.729 1.728 . . . . 0.0 109.358 -169.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -138.58 127.15 14.09 Favored Pre-proline 0 N--CA 1.447 -0.584 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 -169.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.64 142.64 49.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.634 2.222 . . . . 0.0 112.396 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' CG1' HD22 ' A' ' 57' ' ' ASN . 32.3 m -124.96 -11.92 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.111 0.964 . . . . 0.0 112.596 174.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.22 172.13 41.46 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -148.51 159.58 43.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.331 0.566 . . . . 0.0 110.479 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.18 140.47 45.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.539 1.136 . . . . 0.0 108.125 169.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.85 113.92 25.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 tp -149.9 138.57 20.82 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.571 0.7 . . . . 0.0 109.531 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.9 m -158.5 153.7 25.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 167.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.83 23.31 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -128.93 20.53 5.93 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.49 1.116 . . . . 0.0 111.382 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -123.46 103.64 8.59 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.535 0.734 . . . . 0.0 109.565 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.1 ttp -85.39 80.84 8.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.95 -32.51 63.9 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -172.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.53 157.09 43.68 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.241 0.616 . . . . 0.0 111.037 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.4 tp -155.13 123.47 5.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.064 2.146 . . . . 0.0 105.418 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -145.46 141.82 28.7 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -149.37 146.69 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -172.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -60.06 122.15 64.1 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -46.45 -29.8 7.64 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 124.069 3.18 . . . . 0.0 114.665 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.06 -23.86 67.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.998 0.919 . . . . 0.0 113.392 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 m -117.86 -0.27 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 118.716 0.689 . . . . 0.0 112.669 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -59.35 -37.03 76.83 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.918 -1.114 . . . . 0.0 110.539 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.17 -25.92 68.73 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 123.719 0.676 . . . . 0.0 113.004 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.3 m -74.96 -6.71 50.78 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.486 1.143 . . . . 0.0 112.119 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.85 14.18 63.4 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-O 118.841 -0.977 . . . . 0.0 113.345 174.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.21 -31.58 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.185 1.492 . . . . 0.0 110.996 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.12 -53.44 14.98 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.881 0.753 . . . . 0.0 111.838 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.47 -41.25 96.61 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.138 -1.41 . . . . 0.0 110.365 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.4 t -58.43 -46.52 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 120.693 1.588 . . . . 0.0 110.011 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.5 -41.91 83.72 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.963 -0.461 . . . . 0.0 110.602 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.63 -43.24 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 118.489 0.586 . . . . 0.0 110.407 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.58 -32.51 73.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.796 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -59.59 -49.07 79.19 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.131 0.423 . . . . 0.0 109.991 171.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.76 -48.21 81.74 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 122.878 0.471 . . . . 0.0 111.265 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 56.9 mt -60.67 -35.03 75.25 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.802 0.841 . . . . 0.0 111.356 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.28 -35.21 79.59 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.29 0.495 . . . . 0.0 111.523 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtm -87.78 -24.07 23.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.421 0.688 . . . . 0.0 112.062 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -144.43 96.18 5.32 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.55 1.54 . . . . 0.0 108.305 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.08 -23.72 53.11 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.198 1.265 . . . . 0.0 112.084 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -98.68 28.35 4.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.754 1.622 . . . . 0.0 110.654 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.3 tp -51.84 144.24 11.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 112.906 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.2 p -129.17 159.4 36.17 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.807 1.243 . . . . 0.0 108.811 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -153.42 -179.68 7.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.865 0.466 . . . . 0.0 110.271 175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -138.26 160.0 40.59 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.088 1.355 . . . . 0.0 109.185 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.446 HG12 HD21 ' A' ' 142' ' ' LEU . 7.3 p -155.84 145.89 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -70.66 131.51 44.02 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.49 -32.74 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.96 0.904 . . . . 0.0 111.583 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -66.88 -30.27 70.39 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.015 0.526 . . . . 0.0 111.691 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -79.65 64.19 4.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.447 1.099 . . . . 0.0 108.795 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -55.83 -25.97 44.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.565 1.146 . . . . 0.0 111.151 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -49.46 75.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.465 0.706 . . . . 0.0 109.864 176.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.81 -34.81 76.14 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.775 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.02 -49.09 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.415 1.007 . . . . 0.0 108.471 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.81 -47.44 91.19 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -54.13 -52.08 62.2 Favored 'General case' 0 C--N 1.338 0.065 0 C-N-CA 123.976 0.911 . . . . 0.0 110.124 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.65 -34.39 76.85 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.775 -0.578 . . . . 0.0 109.975 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -60.03 -46.51 89.27 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.52 1.055 . . . . 0.0 110.806 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.1 -43.05 86.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.093 0.86 . . . . 0.0 110.427 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.41 -34.4 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.15 0.98 . . . . 0.0 110.963 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.41 10.04 1.73 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.862 -0.965 . . . . 0.0 114.282 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -80.17 158.04 26.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.726 1.763 . . . . 0.0 111.28 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -143.04 136.22 28.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.868 1.667 . . . . 0.0 106.606 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.523 HG22 HD22 ' A' ' 142' ' ' LEU . 23.3 t -68.63 134.94 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.909 0.883 . . . . 0.0 110.353 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -128.17 -9.45 5.32 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.927 2.091 . . . . 0.0 111.578 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.86 174.52 42.83 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 170.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -159.68 -173.66 4.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 117.722 0.761 . . . . 0.0 110.884 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.2 m -138.15 171.78 13.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.911 2.084 . . . . 0.0 108.315 172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.77 -8.02 11.43 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.998 0.919 . . . . 0.0 111.502 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.2 m -143.88 178.08 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 127.314 2.246 . . . . 0.0 106.763 171.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -73.45 -73.39 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -165.04 -40.82 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.83 1.252 . . . . 0.0 111.273 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.69 22.7 1.06 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.978 1.311 . . . . 0.0 110.65 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.46 11.03 82.69 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.55 1.072 . . . . 0.0 113.507 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.433 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 12.4 mtpp -67.92 131.06 92.54 Favored Pre-proline 0 N--CA 1.466 0.352 0 CA-C-O 116.427 -1.749 . . . . 0.0 108.458 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -64.73 42.38 0.13 Allowed 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.986 3.79 . . . . 0.0 115.795 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.04 56.26 20.31 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.599 1.56 . . . . 0.0 110.353 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.83 161.68 24.56 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.251 2.634 . . . . 0.0 115.684 -169.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 tp -110.04 151.02 27.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.528 1.931 . . . . 0.0 107.141 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.35 151.63 32.72 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 142' ' ' LEU . 14.7 t-20 -119.86 139.62 52.1 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 124.756 1.222 . . . . 0.0 107.844 172.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.75 161.56 36.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.706 1.203 . . . . 0.0 108.529 -171.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.92 149.32 52.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 108.396 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -73.76 132.38 42.57 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.52 -23.95 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.317 1.447 . . . . 0.0 109.912 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.21 -172.92 55.09 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 C-N-CA 123.942 0.897 . . . . 0.0 110.013 176.701 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.94 -179.48 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.906 1.682 . . . . 0.0 107.092 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 mm -138.26 144.52 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.9 m -141.92 165.78 26.52 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.56 142.99 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -151.21 173.52 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.636 0.774 . . . . 0.0 110.167 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -65.73 148.75 51.25 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -73.94 146.45 43.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.242 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -89.16 131.88 35.09 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -33.32 70.78 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.399 0.545 . . . . 0.0 112.198 -174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.88 -16.66 60.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.513 0.725 . . . . 0.0 112.528 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -86.85 -2.57 58.68 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.379 0.99 . . . . 0.0 111.217 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.59 -38.28 28.23 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.79 1.185 . . . . 0.0 114.186 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.91 -28.5 68.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.769 1.285 . . . . 0.0 111.818 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -69.11 -31.53 70.29 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.465 -0.772 . . . . 0.0 109.702 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.7 -38.86 64.73 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.8 -47.16 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.42 83.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.556 0.616 . . . . 0.0 111.721 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.2 mt -65.16 -50.87 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.406 1.082 . . . . 0.0 109.449 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.6 t90 -57.13 -46.89 82.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.702 0.683 . . . . 0.0 110.49 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.3 m -55.32 -52.76 62.43 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.745 1.218 . . . . 0.0 111.005 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -69.97 -29.17 66.22 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.473 -0.767 . . . . 0.0 112.041 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -63.07 -42.46 99.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.962 0.801 . . . . 0.0 110.117 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.9 t -70.27 -42.93 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -34.49 73.78 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.902 0.773 . . . . 0.0 112.306 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.74 -34.47 21.2 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.992 -176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -137.13 -0.14 2.29 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -130.67 22.57 5.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.403 1.456 . . . . 0.0 110.63 174.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.67 -10.89 14.02 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -169.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -29.8 65.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.942 1.297 . . . . 0.0 111.618 169.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.5 tp -53.22 125.35 17.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.125 2.17 . . . . 0.0 111.362 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -53.09 140.0 26.81 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.01 1.324 . . . . 0.0 110.704 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.17 76.08 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.92 -49.87 64.18 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.48 -35.31 77.35 Favored 'General case' 0 C--N 1.341 0.217 0 O-C-N 122.081 -0.387 . . . . 0.0 110.404 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -57.19 -44.65 83.8 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 172.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.5 m -64.69 -48.64 73.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.711 0.687 . . . . 0.0 110.145 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.17 -37.3 83.51 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.009 -0.432 . . . . 0.0 110.819 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.41 -51.27 69.46 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.258 173.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.59 -41.07 76.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.688 1.131 . . . . 0.0 110.659 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.74 -47.45 81.0 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.775 0.43 . . . . 0.0 111.824 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.92 -36.59 72.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 117.949 0.34 . . . . 0.0 110.323 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 t -58.26 -48.69 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 126.257 1.823 . . . . 0.0 109.064 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -69.76 -10.33 57.95 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.095 -1.003 . . . . 0.0 112.639 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -99.5 5.94 46.02 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.987 0.915 . . . . 0.0 110.79 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -136.06 -56.28 0.77 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.451 -169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.73 -39.34 75.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 120.643 1.565 . . . . 0.0 112.844 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -61.63 -15.51 42.29 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.065 1.844 . . . . 0.0 115.073 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -127.6 -14.24 5.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.45 1.477 . . . . 0.0 112.852 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.85 153.39 88.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.128 1.371 . . . . 0.0 111.475 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -77.54 62.51 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.743 3.629 . . . . 0.0 110.972 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.18 176.74 7.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.098 1.359 . . . . 0.0 111.462 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.02 150.84 50.37 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.124 2.57 . . . . 0.0 104.868 168.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.69 140.48 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 123.942 0.897 . . . . 0.0 110.876 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.36 132.7 35.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 167.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.88 142.28 42.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -82.87 -177.26 6.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.442 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -49.74 -24.27 2.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.488 1.915 . . . . 0.0 114.488 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -84.41 2.19 41.84 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.478 1.111 . . . . 0.0 112.086 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.1 t0 50.46 58.21 5.75 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 123.512 1.625 . . . . 0.0 108.77 -169.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.08 124.52 15.35 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.48 138.63 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.65 2.233 . . . . 0.0 109.727 -170.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -127.36 -12.11 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.27 1.028 . . . . 0.0 112.289 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.03 170.15 40.61 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -141.83 159.01 43.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.533 0.733 . . . . 0.0 111.027 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.1 tmm? -140.8 126.78 19.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.302 2.241 . . . . 0.0 105.717 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 74' ' ' ASP . 25.7 tp -105.27 124.65 49.9 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -145.95 139.67 26.36 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.3 m -153.44 154.57 34.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 168.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.79 5.87 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -132.27 29.07 4.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.609 1.164 . . . . 0.0 110.455 175.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -125.5 112.03 15.75 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.425 -0.797 . . . . 0.0 110.601 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 63.5 ttp -85.09 86.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' HB3' HD23 ' A' ' 67' ' ' LEU . 31.2 t70 -63.48 -28.91 70.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.45 144.58 31.45 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.008 0.523 . . . . 0.0 110.217 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.8 tp -153.66 114.58 4.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -142.36 141.05 32.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.5 mt -148.43 145.43 18.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 -171.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -58.23 122.24 57.6 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.154 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.2 -29.81 7.05 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.192 3.262 . . . . 0.0 114.723 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.74 -23.41 67.17 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.122 0.969 . . . . 0.0 113.537 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.9 m -120.45 2.73 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 118.788 0.722 . . . . 0.0 112.827 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -58.99 -37.6 77.21 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 120.897 -1.127 . . . . 0.0 110.506 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.99 -25.59 69.51 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.71 0.671 . . . . 0.0 113.039 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 40.9 m -74.79 -7.34 53.09 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.515 1.158 . . . . 0.0 112.03 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.91 13.97 63.62 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.335 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.72 -31.69 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.288 1.544 . . . . 0.0 110.925 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.47 -52.85 18.13 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 123.819 0.723 . . . . 0.0 111.754 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -62.94 -42.38 99.79 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.356 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 t -58.55 -46.29 90.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 120.055 1.298 . . . . 0.0 109.82 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.9 mt -70.4 -39.33 74.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.215 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -63.15 -40.69 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 118.83 0.741 . . . . 0.0 109.925 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -65.04 -37.7 88.47 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 119.195 0.907 . . . . 0.0 109.71 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -61.05 -47.94 84.05 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 122.819 0.448 . . . . 0.0 110.439 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.93 -49.07 77.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.583 0.753 . . . . 0.0 110.739 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -60.09 -33.06 71.57 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.401 1.08 . . . . 0.0 111.734 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.5 -32.71 73.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.475 0.58 . . . . 0.0 111.625 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -90.06 -24.82 21.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.435 0.561 . . . . 0.0 112.074 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.06 93.35 9.29 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.287 1.435 . . . . 0.0 108.713 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.46 -23.39 50.68 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.342 1.361 . . . . 0.0 112.654 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.61 30.39 4.7 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.67 1.588 . . . . 0.0 110.219 -174.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.3 tp -51.42 145.76 8.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.195 2.198 . . . . 0.0 113.185 -169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.8 p -128.53 163.9 23.97 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.511 1.524 . . . . 0.0 108.912 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -153.75 -175.15 5.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 110.149 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -146.75 161.12 41.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.158 0.983 . . . . 0.0 109.824 172.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.431 HG12 HD21 ' A' ' 142' ' ' LEU . 10.0 p -156.21 149.06 11.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -80.04 129.72 34.71 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.2 -27.01 53.07 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.806 2.043 . . . . 0.0 111.974 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . 0.251 1.2 pt20 -51.48 -33.36 31.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.113 0.965 . . . . 0.0 112.651 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -105.71 69.51 0.83 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.132 1.373 . . . . 0.0 109.621 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -55.76 -23.99 32.73 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.894 0.877 . . . . 0.0 111.987 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -63.43 -43.93 96.04 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.454 0.702 . . . . 0.0 109.662 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.524 -0.75 . . . . 0.0 111.669 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.03 -45.81 84.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 119.206 0.912 . . . . 0.0 108.945 173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.25 59.53 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.05 -50.73 66.06 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 117.811 0.805 . . . . 0.0 110.601 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.22 -39.07 93.58 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.84 -33.94 76.29 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.631 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -61.85 -40.24 94.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.022 1.283 . . . . 0.0 110.919 174.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.8 -39.15 81.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.9 11.81 0.69 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-O 118.825 -0.986 . . . . 0.0 114.112 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -72.97 160.83 31.49 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.635 1.718 . . . . 0.0 111.189 172.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -149.72 141.18 23.34 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.884 1.674 . . . . 0.0 106.884 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.576 HG22 HD22 ' A' ' 142' ' ' LEU . 30.9 t -71.43 133.05 32.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.972 0.909 . . . . 0.0 109.436 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 p -127.11 -8.1 5.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.671 1.989 . . . . 0.0 111.492 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.82 170.71 40.73 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 111.761 171.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -142.62 164.53 29.85 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.815 1.246 . . . . 0.0 111.279 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -124.15 167.92 13.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.141 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -97.64 -10.93 24.2 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.754 -0.591 . . . . 0.0 111.296 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.6 m -149.91 177.84 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 127.794 2.438 . . . . 0.0 106.918 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.94 -60.6 2.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 119.876 -0.106 . . . . 0.0 110.938 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -160.4 -38.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 173.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 98.0 mt -109.37 32.97 4.58 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.851 1.26 . . . . 0.0 110.501 -172.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.85 11.74 84.9 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.511 0.577 . . . . 0.0 113.096 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -75.37 134.25 73.66 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-O 117.563 -1.208 . . . . 0.0 108.366 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.71 50.12 3.33 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.87 3.047 . . . . 0.0 112.342 -170.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.49 83.04 26.59 Favored Pre-proline 0 C--O 1.222 -0.361 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.58 154.96 18.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.793 1.662 . . . . 0.0 115.625 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.45 145.56 26.08 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.0 mt -114.68 144.66 43.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.511 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.8 t-20 -113.91 139.09 49.49 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 171.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.99 161.54 35.38 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -134.07 147.52 50.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.673 1.589 . . . . 0.0 108.292 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -75.8 125.91 29.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 p -133.04 -0.16 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 111.389 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.69 -25.87 71.84 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.054 0.835 . . . . 0.0 113.26 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.944 1.297 . . . . 0.0 110.532 179.094 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -61.16 152.82 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.318 0.647 . . . . 0.0 109.584 175.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 mm -136.48 141.16 41.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 124.354 1.061 . . . . 0.0 108.232 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.3 m -141.63 163.38 33.09 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -124.64 144.25 35.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -150.46 170.98 17.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.414 1.086 . . . . 0.0 109.272 171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -65.35 148.69 51.27 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 m -72.73 152.48 41.62 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.049 0.94 . . . . 0.0 111.192 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -98.24 164.09 12.46 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.465 1.506 . . . . 0.0 107.919 169.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -66.99 -39.4 87.14 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.158 -0.339 . . . . 0.0 111.048 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.99 -26.78 66.08 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.72 -0.32 56.09 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.212 0.46 . . . . 0.0 112.073 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -48.23 -45.45 27.67 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.014 0.816 . . . . 0.0 113.455 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.35 -27.18 67.68 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.261 1.031 . . . . 0.0 112.119 -178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -68.04 -33.08 73.9 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.394 -0.816 . . . . 0.0 109.572 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.3 mt -74.56 -38.54 62.68 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.03 -46.6 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.99 -40.78 98.77 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.374 0.67 . . . . 0.0 112.076 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.6 mt -65.41 -49.7 76.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.285 1.034 . . . . 0.0 109.574 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.6 t90 -52.02 -48.45 64.51 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.96 0.504 . . . . 0.0 110.004 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.0 t -61.18 -50.83 71.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.036 0.534 . . . . 0.0 110.16 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -67.63 -28.78 68.02 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.956 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -68.39 -35.87 78.31 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.511 1.05 . . . . 0.0 110.689 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.88 -43.79 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.28 -26.88 63.07 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 113.345 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.28 16.56 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.984 0.914 . . . . 0.0 111.931 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 p -133.42 -7.14 2.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -169.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -128.3 30.26 5.22 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.225 1.375 . . . . 0.0 109.512 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.51 -18.16 50.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -51.22 -27.37 8.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.306 1.842 . . . . 0.0 112.303 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 102.89 0.62 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.087 1.755 . . . . 0.0 108.912 174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -57.02 149.08 19.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.078 1.751 . . . . 0.0 112.546 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.54 70.69 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.61 -45.76 85.5 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.915 -0.491 . . . . 0.0 109.83 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.81 -32.95 62.12 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.944 -0.472 . . . . 0.0 110.241 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -53.94 -43.0 69.46 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.144 0.977 . . . . 0.0 110.235 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.6 m -62.31 -50.68 70.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.504 1.121 . . . . 0.0 110.153 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -65.03 -39.31 93.19 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.445 0.298 . . . . 0.0 110.373 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.2 mt -62.27 -53.13 59.56 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.462 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -57.08 -39.99 76.05 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.683 1.129 . . . . 0.0 110.484 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.34 -48.92 73.73 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.124 0.569 . . . . 0.0 112.012 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.1 -36.76 75.11 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.076 0.398 . . . . 0.0 110.296 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 37.7 t -58.64 -48.63 85.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 126.29 1.836 . . . . 0.0 109.023 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -69.54 -11.59 60.95 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.978 -1.076 . . . . 0.0 112.679 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -97.17 5.64 49.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.742 0.817 . . . . 0.0 110.652 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.4 -54.86 0.69 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.86 -169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.9 mt -57.61 -38.65 69.8 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 120.674 1.579 . . . . 0.0 112.938 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.23 -13.34 31.66 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.407 2.072 . . . . 0.0 115.02 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -125.82 -20.71 4.56 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.946 1.703 . . . . 0.0 112.393 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.19 148.72 97.72 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.516 1.127 . . . . 0.0 110.69 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.17 45.51 1.99 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.727 3.618 . . . . 0.0 112.091 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.81 171.05 4.65 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.457 1.503 . . . . 0.0 112.187 -171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -119.44 148.52 43.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.541 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.67 137.69 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.351 1.06 . . . . 0.0 110.122 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.41 133.99 35.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.63 145.4 35.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -88.03 -171.67 3.49 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.479 169.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -55.73 -23.57 29.84 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.926 1.29 . . . . 0.0 113.47 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -82.93 5.33 22.28 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.077 0.951 . . . . 0.0 111.679 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 53.9 30.47 11.61 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.934 1.693 . . . . 0.0 111.112 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -104.49 128.06 27.73 Favored Pre-proline 0 N--CA 1.446 -0.627 0 C-N-CA 126.927 2.091 . . . . 0.0 106.22 -169.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.62 136.19 35.44 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.727 1.618 . . . . 0.0 109.52 -171.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.15 -14.97 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.354 1.062 . . . . 0.0 111.185 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.72 170.81 42.99 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 172.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.14 160.28 40.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.741 0.816 . . . . 0.0 111.257 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -139.83 132.23 28.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.574 2.35 . . . . 0.0 105.967 -174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 74' ' ' ASP . 27.0 tp -112.19 124.2 51.93 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 169.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.0 tp -143.74 133.02 23.17 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 m -142.23 150.7 41.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 169.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.08 -113.64 4.24 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -131.4 29.75 4.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.781 1.232 . . . . 0.0 110.596 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -126.82 111.87 14.69 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.415 -0.803 . . . . 0.0 110.591 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.2 ttp -82.74 88.81 6.73 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' HB3' HD23 ' A' ' 67' ' ' LEU . 31.7 t70 -66.06 -29.52 69.87 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.68 145.43 32.44 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.851 0.46 . . . . 0.0 110.667 -172.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.1 tp -154.72 115.55 3.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.11 139.4 28.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.8 mt -150.02 144.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -170.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.29 123.61 76.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 123.833 0.853 . . . . 0.0 108.826 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.8 -19.08 66.44 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.005 2.47 . . . . 0.0 113.832 -171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.5 -21.06 63.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.801 1.182 . . . . 0.0 112.299 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.3 m -125.68 3.48 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.807 0.843 . . . . 0.0 112.841 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.24 -29.86 58.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.122 -0.986 . . . . 0.0 111.756 170.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.85 -21.0 50.62 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.316 0.96 . . . . 0.0 113.823 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 66.8 m -73.74 -3.77 30.44 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.023 1.412 . . . . 0.0 112.266 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.01 12.96 75.76 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.276 0.941 . . . . 0.0 112.869 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 t -55.85 -33.03 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 118.485 1.143 . . . . 0.0 111.579 -172.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.53 -50.52 47.96 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -38.7 88.65 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.295 1.047 . . . . 0.0 109.87 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.3 t -58.43 -49.59 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 119.624 1.102 . . . . 0.0 109.916 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.1 mt -67.76 -39.35 84.18 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 121.849 -0.532 . . . . 0.0 110.707 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.93 -39.74 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 118.933 -0.556 . . . . 0.0 109.8 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.67 -35.66 81.42 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.789 1.177 . . . . 0.0 110.388 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -61.23 -45.72 93.37 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.195 0.452 . . . . 0.0 110.3 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -49.17 74.64 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.846 0.858 . . . . 0.0 110.744 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 33.6 mt -58.3 -33.29 69.29 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.77 1.228 . . . . 0.0 111.697 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.39 -31.9 72.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.361 0.528 . . . . 0.0 111.637 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.7 mtm -90.39 -25.51 20.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.157 0.583 . . . . 0.0 112.091 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -138.97 91.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 125.276 1.43 . . . . 0.0 108.863 -173.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.09 -23.25 53.59 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.362 1.375 . . . . 0.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -101.48 29.46 4.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.595 1.558 . . . . 0.0 110.444 -174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.37 145.37 8.49 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.03 2.132 . . . . 0.0 113.327 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 66.9 p -128.03 164.77 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.545 1.538 . . . . 0.0 108.937 170.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.1 t -154.99 -174.15 4.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 110.354 177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -146.96 161.97 39.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.598 1.159 . . . . 0.0 109.799 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.497 HG12 HD21 ' A' ' 142' ' ' LEU . 8.4 p -156.13 146.22 12.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -70.59 133.93 47.16 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.0 -36.17 83.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.416 1.086 . . . . 0.0 112.514 -172.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -35.5 77.42 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.196 0.907 . . . . 0.0 110.914 -176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -80.49 70.51 7.2 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.617 0.722 . . . . 0.0 111.037 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.43 -23.04 35.89 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.756 0.822 . . . . 0.0 112.074 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -63.61 -45.66 89.31 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.794 0.724 . . . . 0.0 109.593 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.11 -34.58 75.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.878 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.26 -46.06 84.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.374 0.988 . . . . 0.0 108.895 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.4 -48.16 84.26 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.649 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -54.18 -51.94 62.77 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.128 0.971 . . . . 0.0 110.144 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -64.94 -36.67 85.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -64.36 -40.82 96.6 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.063 -1.023 . . . . 0.0 112.718 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -58.75 -42.87 89.88 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.742 1.155 . . . . 0.0 110.255 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.31 -35.19 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.086 0.954 . . . . 0.0 110.67 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.89 7.82 1.31 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.701 1.143 . . . . 0.0 114.904 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -77.1 164.78 25.38 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.132 1.966 . . . . 0.0 111.72 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -147.59 139.58 24.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.414 1.885 . . . . 0.0 106.218 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 142' ' ' LEU . 32.0 t -72.88 132.98 32.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.973 0.909 . . . . 0.0 109.688 -172.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.23 -10.05 7.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.728 2.011 . . . . 0.0 111.417 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.87 178.99 42.5 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.786 0.721 . . . . 0.0 111.44 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -155.82 -178.02 6.99 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.129 0.971 . . . . 0.0 109.214 170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -139.68 146.65 39.92 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.144 1.378 . . . . 0.0 108.892 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -73.45 -11.46 60.47 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.874 0.869 . . . . 0.0 112.226 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -137.89 178.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 126.678 1.991 . . . . 0.0 106.963 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -80.96 -65.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -161.07 -37.43 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.733 0.813 . . . . 0.0 113.024 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.4 mt -99.01 28.81 4.16 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.732 -172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.35 44.2 97.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.741 0.686 . . . . 0.0 111.737 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -126.97 121.54 22.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 125.238 1.415 . . . . 0.0 107.983 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -60.43 71.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.546 1.081 1 C-N-CA 125.471 4.114 . . . . 0.0 116.419 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -134.54 63.56 60.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -36.22 143.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.492 4.128 . . . . 0.0 118.223 -168.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.56 144.49 36.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.1 151.55 27.09 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.562 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.4 t-20 -119.63 139.52 52.07 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.608 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.23 160.78 38.04 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.852 0.861 . . . . 0.0 108.733 -172.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.7 149.95 51.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.555 1.542 . . . . 0.0 108.575 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.44 133.89 39.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.6 t -126.92 -25.69 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.912 1.685 . . . . 0.0 109.97 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.27 -178.78 38.84 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -169.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 126.299 1.84 . . . . 0.0 107.725 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.17 143.1 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -135.96 146.4 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.899 1.28 . . . . 0.0 107.603 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 m -142.92 165.03 28.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 168.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 mm -121.67 142.46 37.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.7 ptt85 -150.19 172.8 14.73 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.73 0.812 . . . . 0.0 109.876 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -65.5 147.77 52.85 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -73.89 146.74 43.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.004 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -84.8 160.21 20.28 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -66.87 -45.48 77.96 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.232 -0.293 . . . . 0.0 110.283 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.34 -28.54 68.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -83.07 0.93 42.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.915 0.486 . . . . 0.0 111.387 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.07 -45.19 33.37 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.298 0.951 . . . . 0.0 113.617 -176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.69 -21.83 63.47 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.499 1.15 . . . . 0.0 112.565 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -66.29 -33.33 75.5 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.757 1.162 . . . . 0.0 109.564 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.7 mt -75.87 -39.49 56.39 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 123.207 0.603 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.45 -45.52 85.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.54 -44.71 95.67 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.142 0.577 . . . . 0.0 111.336 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.86 -52.56 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 124.47 1.108 . . . . 0.0 108.607 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -53.03 -48.79 67.33 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.589 0.756 . . . . 0.0 110.149 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.8 t -60.16 -50.17 74.74 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.283 0.633 . . . . 0.0 110.434 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -72.85 -31.39 64.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.154 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.0 m -61.19 -43.75 98.39 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.458 1.026 . . . . 0.0 110.372 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.39 -48.48 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.901 0.88 . . . . 0.0 109.053 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -63.02 -32.94 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 112.269 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.99 58.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.29 1.036 . . . . 0.0 113.341 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -134.81 -25.55 1.42 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -169.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.449 ' CD2' HD22 ' A' ' 110' ' ' ASN . 38.5 m-70 -104.09 35.84 2.54 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.846 1.258 . . . . 0.0 108.476 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.4 -26.81 63.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.805 -1.184 . . . . 0.0 112.428 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -56.49 -24.14 44.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.288 2.235 . . . . 0.0 113.515 173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.79 109.4 1.72 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.012 1.325 . . . . 0.0 107.934 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -58.1 141.84 48.88 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 111.173 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.72 65.93 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.932 0.893 . . . . 0.0 113.006 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.57 -45.0 96.0 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.389 0.676 . . . . 0.0 109.907 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CD1' ' HE3' ' A' ' 135' ' ' LYS . 8.7 t80 -77.9 -29.09 50.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.531 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -56.74 -42.9 80.08 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 120.491 1.496 . . . . 0.0 110.318 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -63.93 -49.61 71.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.859 0.864 . . . . 0.0 109.862 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -67.33 -36.11 80.78 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.017 -0.427 . . . . 0.0 110.986 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.0 mt -63.52 -49.63 72.75 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 117.555 -1.212 . . . . 0.0 109.446 173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.91 -42.24 75.73 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 119.957 1.253 . . . . 0.0 109.769 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.85 -48.34 82.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.584 1.084 . . . . 0.0 112.446 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -38.52 74.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.81 -44.43 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.185 1.794 . . . . 0.0 110.117 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -62.94 -24.02 67.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.602 1.161 . . . . 0.0 111.134 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -97.93 7.79 45.79 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.549 1.14 . . . . 0.0 110.662 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -138.12 -59.64 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 117.359 -1.305 . . . . 0.0 112.547 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.4 mt -57.6 -36.52 46.47 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 121.228 1.831 . . . . 0.0 113.113 -175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 -15.03 34.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 121.942 1.762 . . . . 0.0 115.419 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -131.61 -11.79 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.938 1.699 . . . . 0.0 113.455 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.8 154.85 88.02 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.408 1.483 . . . . 0.0 111.988 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.86 60.67 6.84 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.961 3.774 . . . . 0.0 111.733 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.2 mt -87.24 172.99 9.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.434 1.893 . . . . 0.0 112.213 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -135.2 145.83 48.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.14 140.21 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 123.825 0.85 . . . . 0.0 110.41 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.88 134.42 35.4 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 168.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.31 144.09 38.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -83.77 -172.95 4.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -55.2 -24.36 26.8 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.033 1.333 . . . . 0.0 113.311 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -84.2 0.8 47.34 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.479 1.111 . . . . 0.0 111.831 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.4 t0 52.24 53.87 11.7 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.013 1.387 . . . . 0.0 109.524 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.05 125.28 22.75 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 -172.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -65.71 134.25 37.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.545 2.163 . . . . 0.0 110.881 -173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.39 -11.46 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.192 0.997 . . . . 0.0 111.981 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.65 169.25 41.94 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -139.79 160.92 38.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 117.709 0.754 . . . . 0.0 111.603 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -139.85 131.34 27.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.593 2.357 . . . . 0.0 105.949 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.84 116.46 28.04 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.2 tp -144.04 132.97 22.68 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.4 m -141.97 152.97 43.96 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 169.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.8 -118.62 11.23 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -129.28 30.94 4.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.159 0.984 . . . . 0.0 111.022 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -122.87 112.74 18.22 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.253 0.621 . . . . 0.0 110.153 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -85.1 90.75 7.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.68 -26.42 67.78 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.32 144.99 30.17 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.043 0.537 . . . . 0.0 110.734 -175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -153.54 119.4 5.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -145.09 143.23 30.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 mt -143.96 143.66 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 -176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -54.31 120.95 28.7 Favored Pre-proline 0 C--N 1.324 -0.519 0 C-N-CA 126.088 1.755 . . . . 0.0 109.407 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.03 -24.89 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.215 3.277 . . . . 0.0 114.919 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.11 -26.97 68.03 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.57 9.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.271 1.429 . . . . 0.0 112.54 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.88 -34.83 63.41 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.667 -1.271 . . . . 0.0 112.392 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.17 -13.59 81.73 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.165 -0.797 . . . . 0.0 113.244 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.14 173.68 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.742 1.271 . . . . 0.0 110.08 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.51 -11.09 39.78 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.959 -175.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -51.47 -34.42 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.601 1.701 . . . . 0.0 112.01 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.42 -54.64 19.59 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 172.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -65.54 -40.37 92.81 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.455 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.66 -48.39 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 121.186 1.812 . . . . 0.0 109.977 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -68.05 -40.99 82.68 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.973 -0.455 . . . . 0.0 110.701 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.44 -40.74 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.296 0.498 . . . . 0.0 110.205 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.52 -34.07 75.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.325 0.966 . . . . 0.0 110.1 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.6 -46.33 90.66 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 118.338 0.517 . . . . 0.0 110.198 173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.94 72.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 123.377 0.671 . . . . 0.0 110.822 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -58.77 -33.34 70.19 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.359 1.064 . . . . 0.0 111.734 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.1 m -62.95 -35.45 80.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.585 0.63 . . . . 0.0 111.503 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.0 mtm -85.41 -26.46 26.4 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.26 0.482 . . . . 0.0 111.86 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 89.91 12.08 Favored Pre-proline 0 CA--C 1.532 0.258 0 C-N-CA 125.101 1.36 . . . . 0.0 109.294 -170.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.47 -22.78 58.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.468 1.446 . . . . 0.0 113.059 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.02 31.49 4.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.441 1.496 . . . . 0.0 110.095 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.3 tp -50.3 143.99 7.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.232 2.213 . . . . 0.0 112.9 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.7 p -129.62 163.25 26.45 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.404 1.482 . . . . 0.0 108.778 171.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -154.78 -174.46 4.99 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.232 0.539 . . . . 0.0 110.166 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.57 161.45 41.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 110.018 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG12 HD21 ' A' ' 142' ' ' LEU . 9.7 p -157.17 145.44 10.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.0 129.29 39.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -58.39 -30.88 67.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.18 1.392 . . . . 0.0 111.941 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.51 -35.28 78.89 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.203 0.456 . . . . 0.0 111.224 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.449 HD22 ' CD2' ' A' ' 28' ' ' HIS . 61.6 t-20 -78.6 63.8 3.49 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.039 1.336 . . . . 0.0 109.882 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.74 -26.8 47.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 111.394 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.13 -45.25 94.3 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.94 73.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.034 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.88 -45.96 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 119.396 0.998 . . . . 0.0 108.828 171.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.4 -48.8 83.07 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -54.58 -51.59 64.8 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.022 0.911 . . . . 0.0 110.379 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -65.53 -35.02 79.62 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -64.91 -38.95 92.66 Favored 'General case' 0 C--N 1.341 0.205 0 O-C-N 120.916 -1.115 . . . . 0.0 112.632 172.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.28 -41.37 88.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.956 1.253 . . . . 0.0 110.329 173.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.78 -39.36 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.686 0.794 . . . . 0.0 110.309 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.41 5.18 0.98 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.753 -1.026 . . . . 0.0 114.542 170.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.99 162.92 28.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.355 1.577 . . . . 0.0 111.169 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -146.77 140.01 25.53 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 142' ' ' LEU . 41.3 t -73.11 129.31 36.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 123.984 0.914 . . . . 0.0 109.16 -173.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 p -119.54 -9.88 9.74 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 126.599 1.959 . . . . 0.0 111.397 -175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -170.87 -179.29 42.01 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 171.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -152.31 179.08 8.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.679 0.792 . . . . 0.0 109.271 170.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m -138.71 138.2 37.49 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 0.0 106.893 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -71.12 -5.77 34.14 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.213 0.605 . . . . 0.0 112.389 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.1 m -138.5 174.42 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.305 1.842 . . . . 0.0 107.836 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.1 -63.58 1.32 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 119.486 -0.292 . . . . 0.0 110.93 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -157.17 -49.26 0.07 Allowed 'General case' 0 C--N 1.341 0.232 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.18 32.6 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.353 1.061 . . . . 0.0 110.032 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.17 14.32 73.81 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.044 0.83 . . . . 0.0 113.268 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 43.2 mmtt -67.57 132.68 92.8 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-O 117.053 -1.451 . . . . 0.0 108.363 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.09 46.09 1.99 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.677 2.918 . . . . 0.0 112.195 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -131.71 71.97 80.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.564 1.545 . . . . 0.0 107.682 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -34.26 147.2 0.04 OUTLIER 'Trans proline' 0 CA--C 1.536 0.613 1 C-N-CA 125.922 4.414 . . . . 0.0 119.09 -169.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.0 tp -102.18 147.62 26.42 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 50.9 mt -110.85 150.49 29.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.537 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.5 t-20 -116.88 139.08 51.04 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.94 160.57 38.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.3 150.56 52.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.431 1.492 . . . . 0.0 108.195 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -75.12 128.26 35.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -129.85 -9.25 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.664 1.186 . . . . 0.0 109.925 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.0 37.52 92.13 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -169.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 C-N-CA 124.834 1.254 . . . . 0.0 111.011 179.487 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttp . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.924 0.392 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.36 156.88 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 mm -132.96 144.34 36.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.621 0.768 . . . . 0.0 109.348 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.8 m -141.6 164.49 30.09 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 mm -124.33 143.77 36.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -151.91 172.39 16.3 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.68 1.192 . . . . 0.0 109.162 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -66.68 149.82 49.96 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -71.34 154.11 41.83 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.482 1.113 . . . . 0.0 111.721 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -97.66 163.68 12.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.816 1.646 . . . . 0.0 108.258 169.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -69.17 -48.31 62.6 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.282 -0.261 . . . . 0.0 110.742 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.52 -28.62 67.98 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.79 -1.91 40.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.768 0.427 . . . . 0.0 111.731 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.86 -38.19 37.04 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.25 0.929 . . . . 0.0 113.503 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.76 -28.44 67.62 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.58 1.19 . . . . 0.0 111.919 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.4 -30.73 69.71 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.549 -0.719 . . . . 0.0 109.514 172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.89 -39.36 61.54 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -56.88 -45.64 83.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.04 -41.34 98.01 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 122.884 0.474 . . . . 0.0 111.884 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mt -62.41 -48.45 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.345 0.658 . . . . 0.0 109.678 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -54.49 -48.42 71.88 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 t -59.29 -42.08 90.46 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.866 -0.521 . . . . 0.0 110.596 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -62.63 -39.79 94.94 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 124.47 1.108 . . . . 0.0 111.718 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -65.78 -36.52 83.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.572 0.749 . . . . 0.0 109.969 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.59 -45.81 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.254 -0.903 . . . . 0.0 109.127 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.26 -33.8 65.8 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.948 1.299 . . . . 0.0 113.004 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.11 -29.48 12.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -139.28 0.6 1.91 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -168.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -135.17 25.79 3.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.429 1.468 . . . . 0.0 110.963 175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.58 -12.8 17.17 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.874 -1.141 . . . . 0.0 113.196 -174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -56.21 -20.34 17.74 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.325 1.85 . . . . 0.0 112.904 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.94 101.84 0.42 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.08 1.352 . . . . 0.0 108.8 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -56.69 157.71 5.18 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.342 1.457 . . . . 0.0 110.729 170.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.65 -37.9 63.59 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.88 -49.75 64.66 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.905 0.775 . . . . 0.0 109.701 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -63.72 -40.19 96.13 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.233 1.013 . . . . 0.0 109.956 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 tpp85 -55.58 -50.23 70.64 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.838 1.255 . . . . 0.0 109.614 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 78.1 m -64.1 -48.33 76.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.303 1.041 . . . . 0.0 110.274 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.46 -41.31 93.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.188 0.449 . . . . 0.0 110.723 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.99 -50.53 65.95 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.595 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.36 -41.94 76.97 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.061 0.846 . . . . 0.0 110.684 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.34 -44.51 83.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.452 0.701 . . . . 0.0 112.225 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.32 -38.24 74.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.2 t -56.8 -49.41 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.431 1.892 . . . . 0.0 109.493 171.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -58.39 -24.27 59.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.646 1.178 . . . . 0.0 111.674 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -101.46 6.49 42.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.179 0.992 . . . . 0.0 110.959 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -136.89 -52.59 0.69 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.055 -0.974 . . . . 0.0 112.306 -169.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 69.0 mt -58.36 -37.89 59.78 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 120.265 1.393 . . . . 0.0 113.001 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -63.42 -14.01 39.68 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.129 1.886 . . . . 0.0 115.426 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -127.98 -19.01 4.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.042 1.746 . . . . 0.0 112.463 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.38 148.43 96.17 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.256 1.022 . . . . 0.0 110.416 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.43 43.74 1.59 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.748 3.632 . . . . 0.0 112.102 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -66.83 169.96 7.27 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.52 1.528 . . . . 0.0 112.07 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -113.27 149.54 33.72 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.2 138.35 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 110.238 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.93 132.35 35.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.99 -2.596 . . . . 0.0 103.99 167.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.64 141.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.59 -179.51 7.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.342 169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -51.26 -25.67 6.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.594 1.558 . . . . 0.0 114.22 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -79.39 0.14 30.41 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.171 0.989 . . . . 0.0 111.773 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t0 52.01 56.97 7.0 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 123.34 1.543 . . . . 0.0 109.216 -169.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -136.95 126.75 15.72 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 104.559 -2.385 . . . . 0.0 104.559 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.8 137.3 38.0 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.904 2.403 . . . . 0.0 111.695 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.6 m -113.82 -21.36 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.115 0.966 . . . . 0.0 111.68 172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.84 170.61 39.2 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -141.44 157.43 45.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.855 0.862 . . . . 0.0 110.686 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -141.38 134.29 28.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.788 2.035 . . . . 0.0 106.668 -172.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 74' ' ' ASP . 24.0 tp -115.91 118.2 32.29 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 173.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.8 tp -142.07 133.49 26.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.215 1.006 . . . . 0.0 108.298 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -143.45 153.87 43.09 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.25 -119.48 13.58 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -169.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -128.52 37.12 4.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.194 0.998 . . . . 0.0 110.478 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -127.27 109.1 11.46 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.824 0.85 . . . . 0.0 110.066 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -85.45 97.41 10.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.437 ' HB3' HD23 ' A' ' 67' ' ' LEU . 32.3 t70 -71.47 -31.73 67.48 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.9 23.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.689 0.796 . . . . 0.0 110.282 -171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 tp -148.08 122.85 9.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 173.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.38 142.63 30.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 mt -148.55 144.37 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -61.07 115.33 13.67 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.19 -15.03 26.59 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.785 2.323 . . . . 0.0 114.364 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -62.83 -24.37 67.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.821 0.737 . . . . 0.0 112.554 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.6 m -131.32 -9.99 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.076 1.35 . . . . 0.0 112.928 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -47.24 -46.43 24.4 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.581 1.152 . . . . 0.0 111.237 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.26 -14.52 71.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.847 -0.974 . . . . 0.0 113.884 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 72.0 m -68.91 -14.39 63.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.246 1.523 . . . . 0.0 112.062 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.52 -7.76 7.9 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.309 0.956 . . . . 0.0 112.589 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.0 t -56.73 -31.52 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.744 1.272 . . . . 0.0 111.059 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -50.74 -50.45 37.2 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 123.573 0.606 . . . . 0.0 111.895 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -65.22 -46.83 79.07 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.293 -1.337 . . . . 0.0 109.842 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.71 -49.28 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 119.646 1.112 . . . . 0.0 110.288 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.24 -36.81 74.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.118 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -64.98 -40.56 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 119.03 0.832 . . . . 0.0 109.789 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.67 -36.11 83.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.409 1.004 . . . . 0.0 110.02 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -61.5 -48.24 81.97 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.871 0.469 . . . . 0.0 110.3 175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.59 76.03 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.511 0.724 . . . . 0.0 110.87 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.9 mt -58.67 -33.37 70.04 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.697 1.199 . . . . 0.0 111.696 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -62.84 -35.03 78.6 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.583 0.629 . . . . 0.0 111.465 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.8 mtm -86.13 -24.39 26.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.381 0.537 . . . . 0.0 112.013 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.77 91.05 9.42 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 124.866 1.266 . . . . 0.0 109.899 -171.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.65 -23.86 48.74 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.341 1.361 . . . . 0.0 113.273 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -103.39 30.92 4.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.428 1.491 . . . . 0.0 110.292 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.3 tp -50.86 146.57 5.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.559 2.343 . . . . 0.0 113.673 -169.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.7 p -128.32 162.23 27.55 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 108.92 169.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -155.31 -179.29 7.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.788 0.435 . . . . 0.0 111.108 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -137.19 155.14 49.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.821 1.648 . . . . 0.0 108.645 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.575 HG12 HD21 ' A' ' 142' ' ' LEU . 10.3 p -155.41 148.61 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -74.54 134.09 42.22 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.88 -35.31 68.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.682 1.193 . . . . 0.0 112.069 -174.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -64.11 -29.69 70.81 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.415 0.552 . . . . 0.0 111.873 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -79.78 65.81 5.06 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.69 -25.68 60.64 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.746 0.818 . . . . 0.0 111.342 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.58 -47.71 82.63 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.006 0.522 . . . . 0.0 109.897 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.85 80.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.592 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.0 -46.28 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 119.179 0.9 . . . . 0.0 108.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.18 -49.88 67.64 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -55.25 -49.76 71.19 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.932 0.893 . . . . 0.0 110.524 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.45 -36.1 81.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -64.56 -39.23 93.37 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.83 -1.169 . . . . 0.0 112.526 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.32 -42.94 92.6 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.863 1.21 . . . . 0.0 110.218 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.68 -34.32 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.331 1.052 . . . . 0.0 110.847 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.53 7.53 1.88 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.394 0.997 . . . . 0.0 114.361 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -73.39 166.39 23.29 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.779 1.79 . . . . 0.0 111.518 172.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -143.42 140.57 30.48 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.142 2.177 . . . . 0.0 105.969 171.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.617 HG22 HD22 ' A' ' 142' ' ' LEU . 40.3 t -72.44 129.54 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.6 p -130.85 -6.64 4.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.054 1.742 . . . . 0.0 111.338 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.34 178.57 38.08 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -157.78 -172.33 3.9 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.733 0.813 . . . . 0.0 109.918 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.1 m -138.35 166.76 23.42 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.315 1.846 . . . . 0.0 108.94 176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.16 -9.07 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.786 0.834 . . . . 0.0 111.507 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.74 178.36 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.916 2.486 . . . . 0.0 106.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.47 -66.18 0.87 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.185 0.448 . . . . 0.0 110.223 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -161.73 -45.61 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.508 0.723 . . . . 0.0 112.335 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.89 29.62 0.8 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.774 1.23 . . . . 0.0 110.093 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.0 14.65 73.62 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.484 1.04 . . . . 0.0 113.422 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -68.23 129.21 93.03 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 117.126 -1.416 . . . . 0.0 107.934 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.04 45.62 1.86 Allowed 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.777 2.985 . . . . 0.0 112.227 -172.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -139.18 79.96 24.71 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -42.31 146.92 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.698 3.599 . . . . 0.0 118.829 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.3 tp -97.45 149.42 22.17 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 71.0 mt -116.64 152.92 33.24 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.555 ' C ' HD23 ' A' ' 142' ' ' LEU . 17.4 t-20 -120.99 139.78 52.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.704 1.202 . . . . 0.0 107.874 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.35 157.71 46.16 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -170.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.34 150.87 52.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.988 1.315 . . . . 0.0 108.41 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.13 130.69 37.68 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 94.7 t -129.6 -10.98 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.486 1.515 . . . . 0.0 109.823 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.72 -27.38 70.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.216 0.912 . . . . 0.0 113.76 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 124.675 1.19 . . . . 0.0 110.527 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 ttp . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.17 159.88 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.994 0.426 . . . . 0.0 110.504 169.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.0 mm -138.63 144.98 28.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.636 1.174 . . . . 0.0 107.848 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.9 m -141.68 165.03 28.6 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.478 HD13 ' HA ' ' A' ' 55' ' ' ALA . 12.5 mm -127.06 144.06 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -154.24 169.99 22.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.13 1.372 . . . . 0.0 109.037 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -68.35 156.8 37.06 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -83.48 151.78 25.27 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.531 1.532 . . . . 0.0 112.103 -171.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -84.72 161.11 20.16 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 168.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -70.61 -43.44 69.31 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.995 -0.441 . . . . 0.0 110.739 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.87 -28.31 67.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -81.07 -0.98 42.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.872 0.469 . . . . 0.0 111.621 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.56 -38.84 52.58 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 119.02 0.827 . . . . 0.0 112.678 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -60.51 -34.04 73.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.418 1.109 . . . . 0.0 111.547 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -71.61 -32.68 68.26 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.261 0.624 . . . . 0.0 109.982 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -72.41 -39.88 67.59 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.768 -0.582 . . . . 0.0 109.437 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.62 -43.99 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.407 1.083 . . . . 0.0 109.231 172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.54 89.47 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.048 0.539 . . . . 0.0 111.298 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.9 mt -58.46 -50.3 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.485 1.114 . . . . 0.0 109.167 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.7 t90 -53.35 -47.26 69.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.307 0.643 . . . . 0.0 110.299 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.8 t -60.05 -50.81 72.26 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.534 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -69.75 -29.75 67.18 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.44 -0.788 . . . . 0.0 112.281 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -63.23 -34.95 78.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.636 0.653 . . . . 0.0 110.909 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.99 -44.21 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -58.67 -35.36 72.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.766 0.712 . . . . 0.0 112.326 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -44.88 17.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.317 -0.849 . . . . 0.0 112.787 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 p -131.79 -2.12 3.74 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.305 1.595 . . . . 0.0 115.305 -168.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -129.5 26.45 5.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.57 1.077 . . . . 0.0 110.502 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.89 -15.76 34.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.969 0.908 . . . . 0.0 113.246 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -55.51 -18.7 7.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.895 2.078 . . . . 0.0 112.955 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.09 99.54 0.67 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 169.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -53.53 152.6 4.83 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.331 1.852 . . . . 0.0 111.162 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.38 68.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.26 -49.0 68.65 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.698 -0.626 . . . . 0.0 109.513 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.449 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 15.3 t80 -66.74 -36.53 82.66 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.126 -0.359 . . . . 0.0 110.574 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.55 -47.31 73.37 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.82 1.248 . . . . 0.0 109.839 173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.4 m -65.03 -49.4 70.33 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.221 1.008 . . . . 0.0 110.053 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -65.12 -39.85 93.66 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 122.508 0.323 . . . . 0.0 110.631 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.1 mt -63.03 -52.0 64.58 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.308 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.91 -40.53 73.2 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.569 1.077 . . . . 0.0 110.592 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.59 -49.32 73.81 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.094 0.558 . . . . 0.0 111.954 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -37.44 76.75 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 117.998 0.363 . . . . 0.0 110.065 -177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.64 -48.85 84.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.412 1.885 . . . . 0.0 109.161 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -69.58 -11.67 61.02 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.241 -0.912 . . . . 0.0 112.304 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -99.03 6.09 46.78 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.098 0.959 . . . . 0.0 110.818 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.98 -53.98 0.71 Allowed 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.744 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.36 -38.03 63.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 120.73 1.605 . . . . 0.0 112.948 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.67 -14.25 34.8 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.378 2.052 . . . . 0.0 115.223 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.55 -20.01 5.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.591 1.541 . . . . 0.0 112.03 -174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.19 146.49 97.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.437 1.095 . . . . 0.0 110.107 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -80.17 46.27 2.19 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.325 3.35 . . . . 0.0 111.421 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.67 157.28 30.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.948 -1.095 . . . . 0.0 110.154 -172.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -101.06 144.35 30.08 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 168.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.84 136.7 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.684 0.794 . . . . 0.0 110.166 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.478 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 168.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.46 141.51 45.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.436 ' ND2' HH21 ' A' ' 59' ' ' ARG . 20.1 p30 -82.22 -178.12 6.91 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.135 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -54.85 -23.78 20.06 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.441 1.497 . . . . 0.0 113.712 -173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.436 HH21 ' ND2' ' A' ' 57' ' ' ASN . 84.4 mtm180 -78.14 -1.83 34.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.345 1.058 . . . . 0.0 111.685 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.0 t0 52.19 58.31 5.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 123.577 1.656 . . . . 0.0 108.967 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -139.13 127.95 13.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 140.85 47.94 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.956 2.437 . . . . 0.0 112.527 -169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 57' ' ' ASN . 27.2 m -118.94 -15.79 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.373 1.069 . . . . 0.0 112.294 171.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.71 168.81 40.38 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -141.7 156.33 45.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.347 0.659 . . . . 0.0 110.749 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.39 141.21 39.62 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.356 1.062 . . . . 0.0 108.522 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 tp -95.56 117.98 31.43 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 172.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.6 tp -148.88 134.99 19.18 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.125 0.875 . . . . 0.0 109.798 171.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.5 m -152.66 151.5 30.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 167.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.56 -122.9 26.0 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 -169.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -129.67 22.16 5.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.517 1.127 . . . . 0.0 111.482 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -123.35 104.8 9.34 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.679 0.792 . . . . 0.0 109.548 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.9 ttp -83.21 82.0 8.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -55.18 -32.6 62.3 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.98 157.06 42.41 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.848 1.259 . . . . 0.0 110.207 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 tp -154.94 126.44 7.39 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.916 2.086 . . . . 0.0 106.508 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.73 144.44 29.42 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.062 1.345 . . . . 0.0 107.959 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -149.9 146.01 17.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -53.48 116.51 9.87 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.702 1.201 . . . . 0.0 108.84 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -61.54 -18.65 60.98 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.317 2.678 . . . . 0.0 113.352 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.92 -20.86 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.222 0.919 . . . . 0.0 112.423 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.46 4.16 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.56 -45.31 66.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.065 -1.022 . . . . 0.0 110.469 171.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.49 -19.13 68.54 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.225 0.917 . . . . 0.0 113.632 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.5 m -68.81 -16.51 63.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.052 1.426 . . . . 0.0 111.749 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.99 -15.05 5.91 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 124.263 0.935 . . . . 0.0 112.637 172.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.15 -31.96 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.997 1.399 . . . . 0.0 111.656 -171.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.87 36.16 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.614 1.102 . . . . 0.0 113.693 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.72 -42.88 8.52 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 116.933 -1.508 . . . . 0.0 110.08 169.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.73 -45.13 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 120.58 1.537 . . . . 0.0 111.215 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.77 -38.53 83.54 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.94 0.791 . . . . 0.0 111.517 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.55 -42.94 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -64.39 -34.62 78.6 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 121.794 -0.566 . . . . 0.0 109.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -60.38 -49.03 79.2 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.09 0.404 . . . . 0.0 110.042 173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.71 -47.24 86.17 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 53.9 mt -61.09 -34.67 75.29 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.918 0.887 . . . . 0.0 111.404 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -63.44 -37.35 86.96 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.271 0.487 . . . . 0.0 111.331 177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.3 mtm -85.65 -24.1 27.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.101 0.56 . . . . 0.0 112.272 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.99 96.55 5.46 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 125.482 1.513 . . . . 0.0 108.342 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.77 -23.9 47.8 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.149 1.233 . . . . 0.0 112.225 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -98.77 28.49 4.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.77 1.628 . . . . 0.0 110.602 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.5 tp -52.2 145.86 10.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.155 2.182 . . . . 0.0 113.438 -169.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 40.0 p -128.11 158.0 39.21 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.069 1.348 . . . . 0.0 107.842 169.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -153.28 -173.72 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.773 0.429 . . . . 0.0 109.905 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.75 162.18 36.03 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.686 1.194 . . . . 0.0 109.552 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.527 HG12 HD21 ' A' ' 142' ' ' LEU . 10.3 p -154.55 143.55 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.69 125.58 27.23 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 172.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -58.37 -36.36 73.36 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 122.853 0.461 . . . . 0.0 111.957 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -60.47 -32.34 71.32 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.809 0.444 . . . . 0.0 110.851 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -77.3 65.98 2.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.646 1.179 . . . . 0.0 109.189 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.22 -26.49 60.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.332 1.053 . . . . 0.0 111.113 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -45.92 92.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.253 0.621 . . . . 0.0 109.791 177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.79 -34.21 73.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.936 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.69 -46.72 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 119.464 1.029 . . . . 0.0 108.791 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.04 -49.96 70.1 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -54.99 -50.57 68.65 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 123.667 0.787 . . . . 0.0 110.873 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.9 -34.92 78.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -65.84 -38.61 89.33 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 120.99 -1.068 . . . . 0.0 112.296 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -58.85 -42.84 90.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.909 1.231 . . . . 0.0 110.191 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.93 -34.27 69.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.299 1.04 . . . . 0.0 110.787 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.87 0.89 2.16 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.323 0.963 . . . . 0.0 114.853 169.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -72.93 161.76 30.31 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.466 1.633 . . . . 0.0 111.688 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 141.81 27.19 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.82 1.648 . . . . 0.0 106.609 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.538 HG22 HD22 ' A' ' 142' ' ' LEU . 32.9 t -72.02 132.47 33.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.327 1.051 . . . . 0.0 109.863 -172.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.4 p -127.58 -8.81 5.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.754 2.022 . . . . 0.0 111.707 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.62 40.78 Favored Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 170.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -161.13 -174.84 4.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.919 0.86 . . . . 0.0 111.008 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.1 m -140.02 169.32 17.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.398 2.279 . . . . 0.0 107.121 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -119.36 -1.65 10.73 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.219 -0.925 . . . . 0.0 111.133 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.17 175.33 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.608 2.363 . . . . 0.0 105.772 171.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.57 -63.65 1.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -163.48 -39.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.585 1.154 . . . . 0.0 112.081 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.6 -15.6 57.36 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.071 0.548 . . . . 0.0 111.785 -173.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 121.06 -16.67 9.3 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.254 1.407 . . . . 0.0 112.023 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.449 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 11.3 ptmt -61.51 121.96 67.48 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 124.524 1.13 . . . . 0.0 110.573 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -64.97 63.17 0.3 Allowed 'Trans proline' 0 CA--C 1.549 1.244 1 C-N-CA 125.685 4.257 . . . . 0.0 116.497 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -131.76 66.46 78.02 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.771 -1.206 . . . . 0.0 109.174 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.7 166.76 21.18 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.965 2.443 . . . . 0.0 115.71 -169.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.75 148.21 44.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.228 2.211 . . . . 0.0 106.268 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.8 mt -111.82 150.97 29.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.49 ' C ' HD23 ' A' ' 142' ' ' LEU . 15.0 t-20 -118.4 140.07 50.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.538 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.86 160.47 39.21 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.748 1.219 . . . . 0.0 108.399 -169.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.43 151.88 51.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.268 1.427 . . . . 0.0 108.781 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -80.54 72.61 7.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.832 0.825 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.1 t -70.47 -21.33 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 123.681 0.792 . . . . 0.0 110.582 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.6 42.99 7.53 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.728 1.211 . . . . 0.0 110.715 177.588 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.498 0.189 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.85 141.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 mm -133.36 144.71 35.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 171.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 m -141.34 165.04 28.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.0 mm -124.98 142.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -154.01 170.98 19.8 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.044 0.938 . . . . 0.0 109.779 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -62.24 148.68 44.02 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 170.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 p -61.29 168.18 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.461 1.904 . . . . 0.0 113.166 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -118.93 157.89 26.81 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.356 1.862 . . . . 0.0 106.792 168.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -69.16 -43.33 74.49 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.915 -0.491 . . . . 0.0 110.842 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.11 -25.73 64.56 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -169.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -85.2 0.34 52.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.264 0.625 . . . . 0.0 111.533 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.81 -41.12 57.84 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 118.931 0.787 . . . . 0.0 113.41 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.29 -24.79 64.9 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.674 1.237 . . . . 0.0 111.771 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -72.3 -30.96 65.29 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 172.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.8 mt -72.6 -38.97 67.66 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.58 -46.34 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.29 95.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.731 0.696 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.25 -50.98 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.628 0.771 . . . . 0.0 109.398 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -60.09 -46.93 87.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.715 0.406 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.38 -43.13 83.34 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.326 1.05 . . . . 0.0 111.148 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -66.29 -41.5 89.73 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.761 0.824 . . . . 0.0 111.083 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -41.53 88.48 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.267 0.627 . . . . 0.0 110.328 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -67.56 -46.15 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.702 0.801 . . . . 0.0 109.397 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.5 -37.49 81.28 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.753 0.706 . . . . 0.0 112.17 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.29 -35.24 20.05 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 123.554 0.742 . . . . 0.0 112.843 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.9 p -137.43 2.98 2.53 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -128.75 31.56 4.93 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.626 1.103 . . . . 0.0 109.239 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.44 -24.03 42.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.189 0.996 . . . . 0.0 113.314 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -24.32 58.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.973 2.109 . . . . 0.0 113.019 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.44 127.15 30.09 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.528 1.531 . . . . 0.0 111.386 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.7 m -55.83 141.59 38.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.767 1.227 . . . . 0.0 110.373 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.47 -32.38 70.2 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.588 0.355 . . . . 0.0 111.891 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.61 -47.56 75.27 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.77 -40.94 88.42 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 118.842 -0.599 . . . . 0.0 109.575 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.03 -54.5 29.26 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.493 1.117 . . . . 0.0 109.373 177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.2 m -64.95 -47.98 75.69 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.541 1.136 . . . . 0.0 111.409 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.19 -36.13 74.4 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.219 0.463 . . . . 0.0 110.654 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.0 mt -63.23 -50.78 68.88 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.065 -0.969 . . . . 0.0 108.887 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.85 -40.52 69.74 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.498 1.044 . . . . 0.0 110.64 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.56 -44.72 81.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.58 -35.79 68.02 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.084 -0.385 . . . . 0.0 110.437 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.4 t -59.65 -47.51 90.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 126.08 1.752 . . . . 0.0 109.128 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.9 ttp85 -70.01 -10.41 58.55 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.738 -1.226 . . . . 0.0 112.534 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -95.7 5.7 50.77 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.476 0.71 . . . . 0.0 110.777 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.39 -55.86 0.75 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.697 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.21 -39.1 75.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 120.635 1.561 . . . . 0.0 112.732 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -63.35 -11.57 26.27 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.423 2.082 . . . . 0.0 115.068 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -124.44 -20.55 5.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 120.704 1.593 . . . . 0.0 112.104 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.87 140.24 97.14 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.171 0.989 . . . . 0.0 110.068 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.26 50.05 3.41 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.635 3.557 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.86 164.07 4.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.364 1.466 . . . . 0.0 110.578 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -107.87 109.36 20.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.42 139.46 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 118.478 0.581 . . . . 0.0 109.946 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.98 133.28 35.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 103.714 -2.699 . . . . 0.0 103.714 167.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.54 141.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -80.56 -177.05 6.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.393 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -55.2 -23.62 22.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.299 1.439 . . . . 0.0 113.497 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.59 -0.43 42.27 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.394 1.078 . . . . 0.0 111.657 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t0 52.09 56.87 7.13 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 123.837 1.78 . . . . 0.0 109.522 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -137.09 126.15 15.2 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -171.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.36 142.53 55.01 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.592 2.195 . . . . 0.0 111.724 -169.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.51 -11.06 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 112.522 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.61 172.56 37.84 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -151.04 156.75 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.8 0.8 . . . . 0.0 110.369 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.43 162.1 36.12 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 108.758 169.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.38 130.38 52.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 tp -146.26 135.07 22.38 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 65.2 m -161.64 156.18 22.79 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 128.025 2.53 . . . . 0.0 105.298 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.28 33.6 61.77 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.425 -0.797 . . . . 0.0 113.902 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 56.0 24.56 7.85 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.167 1.787 . . . . 0.0 114.148 -175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -124.02 110.74 15.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.102 0.961 . . . . 0.0 109.707 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 65.7 ttp -85.86 89.44 7.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.58 -27.14 68.98 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.633 1.173 . . . . 0.0 113.525 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.83 150.35 31.84 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.362 1.065 . . . . 0.0 109.443 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.2 tp -157.86 120.52 3.84 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.481 1.912 . . . . 0.0 106.432 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -145.88 145.88 30.9 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.657 1.183 . . . . 0.0 108.107 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -149.98 143.6 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.81 134.01 95.1 Favored Pre-proline 0 N--CA 1.449 -0.493 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.498 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 -28.85 31.89 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.162 2.575 . . . . 0.0 114.849 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.62 -26.46 67.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.094 0.861 . . . . 0.0 112.851 -176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.1 m -111.93 -2.58 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.88 -39.71 82.22 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.252 -0.905 . . . . 0.0 110.09 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.37 -28.42 73.04 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 123.605 0.621 . . . . 0.0 112.838 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.2 m -74.01 -8.42 56.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.334 1.067 . . . . 0.0 112.293 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.49 9.38 61.63 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.783 -1.009 . . . . 0.0 113.523 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 t -56.63 -29.46 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.455 1.627 . . . . 0.0 110.68 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.97 -39.33 25.66 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.892 1.234 . . . . 0.0 113.455 170.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.42 -47.27 17.91 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.372 1.586 . . . . 0.0 109.869 169.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.4 t -52.87 -45.34 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.168 1.349 . . . . 0.0 111.428 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -68.03 -38.37 82.45 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.008 0.822 . . . . 0.0 111.422 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -41.47 90.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 CA-C-N 118.446 0.566 . . . . 0.0 109.633 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.21 -36.27 83.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.62 -0.675 . . . . 0.0 109.718 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -60.51 -47.75 84.77 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.775 0.43 . . . . 0.0 110.203 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.76 74.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 122.823 0.449 . . . . 0.0 111.159 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.26 -34.25 72.01 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.385 1.074 . . . . 0.0 111.338 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.7 m -62.44 -37.51 86.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.331 0.514 . . . . 0.0 111.434 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.1 mtm -86.57 -21.06 27.08 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.306 0.503 . . . . 0.0 112.263 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.52 93.22 5.37 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.833 1.253 . . . . 0.0 109.872 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -22.84 53.97 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.345 1.363 . . . . 0.0 113.108 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -104.39 31.01 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.403 1.481 . . . . 0.0 110.335 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.7 tp -51.68 146.11 8.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.655 2.382 . . . . 0.0 113.126 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 p -129.97 160.49 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.293 1.437 . . . . 0.0 108.63 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.0 t -155.03 -176.75 6.1 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 172.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.0 156.04 41.0 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.132 0.973 . . . . 0.0 109.588 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.9 p -150.25 149.14 14.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -70.75 123.99 23.23 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.71 -32.28 67.24 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.639 1.175 . . . . 0.0 112.638 -170.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -57.68 -34.08 69.03 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.234 0.614 . . . . 0.0 110.963 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -77.43 65.62 3.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.682 1.193 . . . . 0.0 110.465 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.86 -26.09 61.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.582 0.753 . . . . 0.0 111.448 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.48 -47.46 85.57 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.815 0.446 . . . . 0.0 110.109 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.92 -37.3 84.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.354 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.56 -46.29 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 118.9 0.773 . . . . 0.0 109.168 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.35 -50.08 68.2 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -56.28 -49.54 73.96 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.796 0.838 . . . . 0.0 110.662 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.71 -34.81 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -66.28 -38.08 86.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.931 -1.106 . . . . 0.0 112.532 172.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.66 -42.47 88.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.95 1.25 . . . . 0.0 110.142 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 66.0 t -65.97 -35.44 75.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.253 1.021 . . . . 0.0 110.741 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 137.22 4.52 1.98 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.499 -1.167 . . . . 0.0 115.067 169.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.68 161.3 31.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.584 1.692 . . . . 0.0 111.392 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -146.7 139.93 25.56 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.503 HG22 HD22 ' A' ' 142' ' ' LEU . 41.2 t -72.74 131.23 35.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.137 0.975 . . . . 0.0 109.502 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.7 p -119.99 -11.41 9.29 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.638 1.975 . . . . 0.0 111.419 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.32 173.24 41.79 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -155.3 176.59 12.38 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 122.009 -0.7 . . . . 0.0 109.82 169.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.2 m -146.92 134.33 20.77 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.278 1.831 . . . . 0.0 107.523 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.39 -23.33 67.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.997 . . . . 0.0 112.336 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.8 m -139.79 176.23 5.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.599 1.56 . . . . 0.0 107.589 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -107.3 -47.83 3.58 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -159.54 -52.1 0.06 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.49 -0.07 40.18 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.423 0.689 . . . . 0.0 112.044 -172.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.58 89.98 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -168.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -54.68 145.17 41.75 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.604 1.562 . . . . 0.0 109.633 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.51 68.8 5.26 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.241 2.627 . . . . 0.0 110.11 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -126.48 81.9 67.26 Favored Pre-proline 0 N--CA 1.457 -0.114 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.29 155.72 68.55 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 CA-C-N 119.908 1.003 . . . . 0.0 110.435 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.86 144.34 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.08 148.23 33.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.45 ' C ' HD23 ' A' ' 142' ' ' LEU . 17.1 t-20 -119.67 140.38 50.74 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.503 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.56 160.22 39.78 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.579 1.152 . . . . 0.0 108.703 -169.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.49 151.47 50.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.386 1.475 . . . . 0.0 108.208 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -76.45 127.64 33.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 85.1 t -129.58 -9.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.572 1.149 . . . . 0.0 109.959 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.72 37.91 92.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -169.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 124.819 1.248 . . . . 0.0 111.078 179.157 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.36 140.41 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -137.27 147.77 26.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 m -141.82 165.41 27.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.0 mm -123.14 142.43 39.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.3 ptt85 -151.48 174.72 13.06 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.907 0.883 . . . . 0.0 109.868 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -69.07 147.53 51.35 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.8 m -73.51 146.53 44.78 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.787 0.835 . . . . 0.0 111.91 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -81.73 158.73 24.08 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -67.77 -47.72 68.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.13 -27.43 67.31 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -169.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.03 1.8 34.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.846 0.458 . . . . 0.0 111.651 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.27 -38.71 33.96 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.962 0.792 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -62.73 -33.51 75.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.404 1.102 . . . . 0.0 111.516 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -66.94 -33.77 76.31 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 118.664 0.666 . . . . 0.0 109.583 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.47 -40.12 57.77 Favored 'General case' 0 N--CA 1.46 0.053 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.413 HG21 ' HD2' ' A' ' 44' ' ' ARG . 72.5 t -55.46 -47.35 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.76 90.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.122 0.569 . . . . 0.0 111.86 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.7 mt -59.59 -51.19 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 124.745 1.218 . . . . 0.0 108.776 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -53.07 -49.59 66.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.603 0.761 . . . . 0.0 110.079 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.4 t -59.42 -49.94 75.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.716 0.406 . . . . 0.0 110.196 -173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.8 ptt-85 -75.17 -28.16 59.98 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.46 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.9 m -60.78 -40.26 91.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 119.224 0.92 . . . . 0.0 110.779 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.3 t -70.11 -45.9 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -66.3 -24.42 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.25 -47.08 10.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.237 1.015 . . . . 0.0 112.255 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -129.37 1.54 5.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.152 1.168 . . . . 0.0 114.152 -169.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -129.54 23.17 5.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.499 1.12 . . . . 0.0 109.508 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.2 -21.51 47.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -169.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -53.03 -25.8 13.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.183 1.793 . . . . 0.0 112.254 172.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.85 103.16 0.41 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.048 1.739 . . . . 0.0 108.763 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 m -59.72 150.68 27.12 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.799 1.64 . . . . 0.0 112.444 -174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.81 -33.31 70.22 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.45 -48.17 76.32 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -74.45 -29.94 61.67 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.902 -0.499 . . . . 0.0 110.517 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -54.91 -44.75 74.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.318 0.963 . . . . 0.0 110.119 173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.0 m -64.26 -48.79 74.41 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.304 1.042 . . . . 0.0 110.022 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.14 -34.84 77.09 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.054 -0.404 . . . . 0.0 111.023 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.83 -48.29 77.42 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 117.532 -1.223 . . . . 0.0 109.462 172.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -56.57 -40.63 75.53 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 119.964 1.257 . . . . 0.0 109.813 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.82 -47.85 84.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.415 1.007 . . . . 0.0 112.37 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -37.92 75.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.848 1.659 . . . . 0.0 109.877 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HD2' HG21 ' A' ' 17' ' ' VAL . 3.0 tpt180 -61.08 -24.79 66.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.866 1.266 . . . . 0.0 111.455 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -98.21 7.37 46.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.39 1.076 . . . . 0.0 110.631 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -137.96 -59.21 0.65 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 117.576 -1.202 . . . . 0.0 112.6 -169.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.71 -36.42 45.17 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 121.01 1.732 . . . . 0.0 113.192 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -60.36 -18.49 53.33 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.899 1.733 . . . . 0.0 115.266 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -127.29 -13.78 5.49 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.313 1.415 . . . . 0.0 113.032 -171.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 153.09 90.1 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.017 1.327 . . . . 0.0 111.516 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.37 58.93 6.47 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.889 3.726 . . . . 0.0 112.064 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 mt -88.83 167.68 13.07 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.898 1.679 . . . . 0.0 112.921 -170.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -126.94 144.72 50.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.28 140.36 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.245 1.018 . . . . 0.0 110.524 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.25 134.19 35.28 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.72 142.74 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -84.64 179.24 7.41 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.43 -25.89 4.44 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.751 1.62 . . . . 0.0 114.039 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -77.0 -2.3 33.18 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.516 1.527 . . . . 0.0 112.014 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.2 t0 51.3 57.24 6.83 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 124.294 1.997 . . . . 0.0 109.855 -169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -132.31 122.57 18.18 Favored Pre-proline 0 N--CA 1.446 -0.669 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.24 141.55 82.74 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.84 1.693 . . . . 0.0 109.906 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.2 -11.32 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.042 1.337 . . . . 0.0 112.042 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.25 168.76 41.09 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -142.71 159.16 42.78 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.489 0.716 . . . . 0.0 110.99 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.77 152.47 47.95 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.173 0.989 . . . . 0.0 109.726 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.59 119.53 34.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 104.678 -2.342 . . . . 0.0 104.678 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 69' ' ' SER . 4.2 tt -143.13 137.41 29.09 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.487 ' N ' HD23 ' A' ' 68' ' ' LEU . 68.7 m -150.74 155.55 39.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.87 -108.04 1.56 Allowed Glycine 0 CA--C 1.53 0.981 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -131.48 6.52 4.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.608 1.163 . . . . 0.0 111.988 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -105.42 124.97 50.44 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.558 1.072 . . . . 0.0 109.766 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.2 ttp -93.16 86.11 5.26 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 172.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.53 -26.61 68.78 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.41 147.51 34.73 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 123.53 0.732 . . . . 0.0 110.165 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.2 tp -155.59 122.29 5.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.868 2.067 . . . . 0.0 105.501 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -144.82 142.43 29.95 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 mt -147.38 144.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -57.24 114.77 8.81 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 126.142 1.777 . . . . 0.0 110.01 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.57 -29.88 11.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 124.087 3.192 . . . . 0.0 114.492 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.38 -21.84 66.76 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.37 10.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.143 0.977 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -55.03 -35.28 64.28 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.703 -1.248 . . . . 0.0 111.085 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.94 57.09 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.256 0.931 . . . . 0.0 113.613 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -72.69 -5.0 34.65 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.949 1.375 . . . . 0.0 112.456 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.69 69.41 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 119.08 0.854 . . . . 0.0 113.053 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.5 t -55.54 -31.07 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.357 1.079 . . . . 0.0 111.169 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.8 -53.04 14.56 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.048 0.832 . . . . 0.0 111.676 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -63.93 -42.29 97.4 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 117.381 -1.295 . . . . 0.0 110.206 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -58.6 -46.28 90.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 120.251 1.387 . . . . 0.0 110.052 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.7 mt -69.23 -40.27 78.04 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.872 -0.518 . . . . 0.0 110.826 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.2 -40.44 87.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 118.632 0.651 . . . . 0.0 110.307 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.3 -33.3 72.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.037 -1.039 . . . . 0.0 109.989 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -62.3 -45.75 91.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.39 0.541 . . . . 0.0 110.383 172.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.04 83.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.286 0.634 . . . . 0.0 111.064 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.1 -34.27 73.25 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.114 0.966 . . . . 0.0 111.151 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.0 m -63.49 -37.88 88.99 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.219 0.463 . . . . 0.0 111.357 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 mtm -82.53 -28.54 30.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.371 0.532 . . . . 0.0 112.058 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.23 93.51 10.13 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 125.293 1.437 . . . . 0.0 108.613 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.85 -22.36 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 121.417 1.411 . . . . 0.0 112.202 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -103.68 31.53 4.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.054 1.741 . . . . 0.0 110.05 -175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.7 tp -48.4 141.74 6.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.073 2.149 . . . . 0.0 112.887 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -128.13 158.69 37.34 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.196 1.398 . . . . 0.0 108.163 169.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -151.96 176.82 11.09 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.872 -0.518 . . . . 0.0 110.463 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -134.86 152.11 51.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.407 1.483 . . . . 0.0 108.823 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.0 p -152.95 144.47 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.69 130.09 38.15 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -61.56 -32.59 72.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -33.94 69.91 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.139 0.881 . . . . 0.0 111.321 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -77.72 68.22 3.75 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.168 0.987 . . . . 0.0 110.557 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.79 -24.75 62.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -62.55 -46.35 88.77 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.84 -0.537 . . . . 0.0 109.878 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.39 -35.74 79.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.705 176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.44 -49.16 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.297 0.953 . . . . 0.0 108.544 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.69 -46.94 93.47 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.83 -51.54 67.13 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 123.884 0.874 . . . . 0.0 110.097 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -67.62 -33.42 74.95 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.862 -0.524 . . . . 0.0 109.716 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.7 -47.92 82.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.174 0.897 . . . . 0.0 110.802 170.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.41 -42.58 87.52 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.065 0.848 . . . . 0.0 110.552 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.56 -34.3 68.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.182 0.993 . . . . 0.0 110.92 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.26 10.48 1.92 Allowed Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.75 -1.028 . . . . 0.0 114.432 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -78.2 155.62 30.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.645 1.723 . . . . 0.0 111.53 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -141.06 138.95 33.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.362 1.865 . . . . 0.0 106.702 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.472 HG22 HD22 ' A' ' 142' ' ' LEU . 21.5 t -71.7 135.97 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.935 0.894 . . . . 0.0 110.057 -170.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.6 p -129.03 -8.72 4.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.468 1.907 . . . . 0.0 111.52 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.48 177.17 44.47 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 118.782 0.719 . . . . 0.0 111.55 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -157.46 178.0 10.79 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.066 0.946 . . . . 0.0 109.338 171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m -145.76 126.16 14.02 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.938 2.095 . . . . 0.0 105.726 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.76 1.13 18.14 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.238 0.615 . . . . 0.0 112.542 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.7 175.78 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.98 1.712 . . . . 0.0 107.244 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -91.28 -65.41 1.01 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.292 -170.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -157.15 -43.15 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.64 28.24 3.49 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.67 1.188 . . . . 0.0 110.31 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.25 12.78 81.73 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.899 0.762 . . . . 0.0 113.019 -173.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -74.84 140.53 74.44 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-O 117.719 -1.134 . . . . 0.0 108.909 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.96 55.76 5.73 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.621 2.88 . . . . 0.0 111.699 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -130.07 67.69 79.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.165 0.986 . . . . 0.0 108.803 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -40.82 147.87 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 125.105 3.87 . . . . 0.0 117.461 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp -113.18 145.1 41.54 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 49.8 mt -116.85 152.05 35.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -125.65 137.84 53.88 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.852 1.261 . . . . 0.0 108.201 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.472 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.12 161.24 36.67 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.589 1.156 . . . . 0.0 108.162 -171.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.67 149.28 52.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.667 1.587 . . . . 0.0 108.562 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -75.44 129.93 38.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 84.3 t -127.45 -20.81 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.617 1.167 . . . . 0.0 109.913 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.54 31.26 78.16 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.517 -0.739 . . . . 0.0 112.318 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 C-N-CA 126.211 1.804 . . . . 0.0 107.923 178.247 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.476 0.179 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.82 143.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 mm -132.1 144.94 35.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -140.59 165.14 28.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 55' ' ' ALA . 13.4 mm -128.07 143.22 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 -156.45 173.8 16.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.865 0.866 . . . . 0.0 110.537 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -64.54 147.01 53.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 m -73.53 145.55 45.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.607 1.163 . . . . 0.0 111.928 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -82.25 131.33 35.23 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 168.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -57.51 -39.72 77.13 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.441 1.019 . . . . 0.0 111.071 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -70.12 -20.67 63.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.955 0.902 . . . . 0.0 113.202 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -84.11 -4.96 59.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.372 0.987 . . . . 0.0 111.042 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.9 -33.25 35.64 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 124.445 1.022 . . . . 0.0 113.355 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.59 -33.33 75.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.536 1.168 . . . . 0.0 111.836 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -65.97 -30.95 71.6 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.982 -0.449 . . . . 0.0 109.884 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 24.4 mt -76.57 -37.57 56.33 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.05 0.54 . . . . 0.0 109.67 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.92 -46.06 91.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.18 -44.11 97.34 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 111.917 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.2 mt -61.88 -50.27 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 124.34 1.056 . . . . 0.0 109.134 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.7 t90 -51.31 -47.54 62.6 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.356 0.662 . . . . 0.0 110.127 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.8 t -61.5 -50.44 72.72 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.105 0.411 . . . . 0.0 110.52 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -68.78 -32.13 71.65 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.042 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.3 m -62.15 -47.61 83.76 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 119.063 0.847 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.28 -44.45 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.622 0.769 . . . . 0.0 109.519 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.2 -28.56 69.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.208 0.913 . . . . 0.0 112.064 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.69 -24.55 28.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.653 1.181 . . . . 0.0 113.939 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.8 p -137.34 -21.15 1.19 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.571 ' CE1' HD22 ' A' ' 110' ' ' ASN . 72.8 m80 -124.29 29.84 6.24 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.671 1.588 . . . . 0.0 109.28 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.28 -18.27 25.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.408 1.083 . . . . 0.0 113.589 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -51.13 -23.84 3.56 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.116 2.167 . . . . 0.0 113.162 170.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.01 97.84 0.39 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.941 1.296 . . . . 0.0 108.003 169.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.1 m -55.29 153.69 6.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.458 1.503 . . . . 0.0 110.991 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.3 -35.86 63.07 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -169.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.07 -49.11 66.15 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.941 0.792 . . . . 0.0 109.87 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -65.65 -39.04 90.97 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.001 0.521 . . . . 0.0 109.998 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -54.48 -46.49 73.4 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 124.833 1.253 . . . . 0.0 110.018 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.7 m -65.73 -48.04 73.28 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.009 0.924 . . . . 0.0 110.367 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.77 -36.93 81.37 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.911 -0.493 . . . . 0.0 110.762 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.0 mt -62.31 -51.51 67.37 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -56.85 -40.69 76.57 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.766 0.712 . . . . 0.0 110.528 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.28 -41.63 89.57 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.806 0.73 . . . . 0.0 112.597 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.45 -38.31 68.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.573 -0.705 . . . . 0.0 109.553 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.91 -47.38 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.814 1.645 . . . . 0.0 109.147 171.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -57.39 -23.95 52.4 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.36 1.464 . . . . 0.0 111.754 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -102.69 7.7 39.72 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.426 1.09 . . . . 0.0 111.187 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -136.29 -52.7 0.72 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 117.821 -1.085 . . . . 0.0 112.905 -169.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.9 mt -57.15 -37.14 54.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 120.534 1.515 . . . . 0.0 113.251 -176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.4 -16.21 33.96 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.433 2.089 . . . . 0.0 115.607 173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -126.27 -14.37 5.95 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.32 1.418 . . . . 0.0 112.527 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.75 151.54 92.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.761 1.224 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.38 63.57 7.85 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.693 3.595 . . . . 0.0 110.704 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.7 mt -86.5 177.97 7.24 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.785 1.234 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -136.47 141.58 43.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 127.547 2.339 . . . . 0.0 105.244 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.42 141.9 33.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 119.164 0.893 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.442 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -84.16 134.14 34.58 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 167.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.51 142.31 43.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -79.33 -178.85 6.44 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.563 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.13 -25.03 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.557 1.543 . . . . 0.0 113.788 -175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -84.26 3.45 35.41 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.834 1.254 . . . . 0.0 111.999 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.6 t0 52.66 58.25 5.56 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 123.384 1.564 . . . . 0.0 109.79 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -134.06 124.12 17.29 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 -170.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.49 137.13 45.55 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.975 2.45 . . . . 0.0 111.497 -171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 m -124.17 -13.63 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.282 1.033 . . . . 0.0 112.082 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.9 42.9 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 173.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -147.49 160.9 42.07 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.159 0.584 . . . . 0.0 110.925 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.56 154.07 49.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.53 1.132 . . . . 0.0 108.226 169.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 74' ' ' ASP . 13.8 tp -110.12 118.9 37.63 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -146.49 132.26 18.98 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.6 m -145.61 153.32 40.92 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 168.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.32 -123.11 32.12 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -129.21 29.05 5.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.214 1.006 . . . . 0.0 111.26 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -122.94 108.59 13.13 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 121.655 -0.653 . . . . 0.0 110.218 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.2 ttp -85.59 87.36 7.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.429 ' HB3' HD23 ' A' ' 67' ' ' LEU . 30.3 t70 -64.06 -27.82 69.37 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.26 152.79 40.51 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.716 0.689 . . . . 0.0 110.963 -173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.9 tp -158.29 119.71 3.51 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.692 1.997 . . . . 0.0 106.38 176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -147.04 141.43 26.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.561 1.144 . . . . 0.0 107.949 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.1 mt -150.95 145.71 16.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 -172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.29 126.18 77.54 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.379 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.63 -17.1 52.42 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.587 2.191 . . . . 0.0 113.834 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.18 -21.46 60.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.685 1.13 . . . . 0.0 112.018 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.49 -11.29 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -52.45 -39.71 61.41 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.892 1.224 . . . . 0.0 112.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.42 84.45 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.359 -176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.5 m -67.59 -18.64 65.07 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.175 1.488 . . . . 0.0 111.561 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.37 -23.16 1.22 Allowed Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.07 0.843 . . . . 0.0 112.198 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.7 -32.82 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 118.602 1.201 . . . . 0.0 111.812 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -52.61 -31.45 37.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.128 0.871 . . . . 0.0 113.37 173.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -87.67 -45.94 9.95 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.01 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.0 t -53.75 -43.85 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 120.364 1.438 . . . . 0.0 111.248 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -66.63 -37.02 83.96 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.872 0.76 . . . . 0.0 111.43 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.27 -42.07 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 CA-C-N 118.44 0.563 . . . . 0.0 109.524 175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.35 -35.1 79.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.554 0.615 . . . . 0.0 109.837 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -61.43 -48.43 81.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.808 0.443 . . . . 0.0 110.382 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.12 -48.31 82.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.891 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.34 -35.54 75.9 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.224 1.009 . . . . 0.0 111.458 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.9 m -62.82 -36.72 84.12 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.305 0.502 . . . . 0.0 111.408 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.3 mtm -86.16 -23.42 26.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.993 0.517 . . . . 0.0 112.218 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.15 91.45 7.05 Favored Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 125.267 1.427 . . . . 0.0 108.931 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.69 -22.93 56.92 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.413 1.408 . . . . 0.0 112.788 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -103.81 30.74 4.89 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.347 1.459 . . . . 0.0 110.258 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 40.1 tp -49.61 144.55 5.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.179 2.192 . . . . 0.0 112.961 -171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 57.9 p -129.08 161.31 30.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.02 1.328 . . . . 0.0 108.796 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -153.09 -173.8 4.71 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -149.16 161.78 41.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.992 0.917 . . . . 0.0 110.48 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.25 145.24 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -74.26 128.83 36.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -57.43 -32.37 66.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.862 0.865 . . . . 0.0 113.088 -170.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.47 -34.08 72.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.308 0.503 . . . . 0.0 111.195 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.571 HD22 ' CE1' ' A' ' 28' ' ' HIS . 64.2 t-20 -79.07 65.14 4.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.856 1.262 . . . . 0.0 109.611 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.3 -26.06 60.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.151 0.98 . . . . 0.0 111.1 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -47.12 84.83 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.959 0.503 . . . . 0.0 109.861 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.34 -35.54 77.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.395 -0.812 . . . . 0.0 111.756 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.7 t -56.84 -49.31 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.402 1.001 . . . . 0.0 108.482 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.6 -46.78 93.76 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -56.14 -50.63 70.59 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.763 0.825 . . . . 0.0 110.194 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -67.24 -33.96 76.43 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -59.46 -46.17 89.53 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.191 0.905 . . . . 0.0 110.977 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.92 -43.26 91.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.129 0.877 . . . . 0.0 110.384 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.4 t -63.13 -39.63 85.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.758 0.823 . . . . 0.0 110.365 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 138.26 11.58 0.89 Allowed Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.92 -0.933 . . . . 0.0 114.4 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -78.43 155.43 29.93 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.652 1.726 . . . . 0.0 111.479 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.01 139.22 34.12 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.103 1.761 . . . . 0.0 106.618 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.504 HG22 HD22 ' A' ' 142' ' ' LEU . 21.9 t -71.66 133.81 31.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.978 0.911 . . . . 0.0 109.8 -171.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 p -124.75 -9.66 7.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 111.459 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.09 178.31 43.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 118.849 0.75 . . . . 0.0 111.491 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -151.26 174.83 12.82 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.49 0.716 . . . . 0.0 109.572 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.1 m -147.45 139.32 24.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.267 2.227 . . . . 0.0 106.289 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -82.63 0.09 44.68 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.389 0.541 . . . . 0.0 111.832 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.3 m -137.92 173.1 13.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 126.83 2.052 . . . . 0.0 106.682 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.25 -47.69 4.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 119.07 -0.49 . . . . 0.0 112.305 -175.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -163.65 -45.91 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 78.5 mt -84.3 -1.38 55.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 112.147 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.06 -8.25 79.93 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.185 0.898 . . . . 0.0 111.709 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -51.01 123.3 18.88 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.829 1.652 . . . . 0.0 109.473 169.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -63.74 60.41 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 124.982 3.788 . . . . 0.0 115.596 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -124.02 100.42 36.65 Favored Pre-proline 0 C--O 1.226 -0.157 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 171.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.69 160.8 6.82 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.544 2.162 . . . . 0.0 114.421 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.1 tp -131.69 144.04 50.72 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 170.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 55.2 mt -113.86 141.27 47.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -113.29 138.78 49.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.504 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.07 160.07 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -171.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.64 151.37 51.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.639 1.576 . . . . 0.0 108.575 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -75.8 126.37 30.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.57 -2.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 125.272 1.429 . . . . 0.0 109.89 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.82 -23.76 65.84 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.898 -1.126 . . . . 0.0 113.856 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 125.275 1.43 . . . . 0.0 110.932 178.806 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.326 0.108 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.1 163.15 2.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.354 0.597 . . . . 0.0 110.945 170.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -137.62 144.66 30.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.961 1.304 . . . . 0.0 107.615 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.6 m -140.37 163.57 32.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.8 mm -123.78 143.06 38.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.11 170.93 18.73 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.747 1.219 . . . . 0.0 108.956 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -66.35 148.65 51.56 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -73.27 148.43 43.62 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.282 1.033 . . . . 0.0 112.237 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -79.76 155.88 27.73 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -68.63 -40.59 80.27 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.909 -0.494 . . . . 0.0 110.269 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.7 -25.82 63.14 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.82 0.6 46.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.095 0.558 . . . . 0.0 111.394 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.4 -42.91 43.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.536 1.065 . . . . 0.0 113.64 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -72.52 -18.75 61.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.732 1.266 . . . . 0.0 112.066 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.67 -31.29 68.15 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.051 -1.031 . . . . 0.0 109.33 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -73.95 -38.35 64.26 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.57 -45.47 82.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.46 98.76 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.977 -0.452 . . . . 0.0 111.505 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.52 -49.37 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.816 0.846 . . . . 0.0 109.466 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -54.26 -47.29 72.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.266 0.627 . . . . 0.0 110.298 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.5 t -60.48 -44.63 95.72 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.674 -0.642 . . . . 0.0 110.327 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -63.58 -37.04 85.82 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.677 -0.639 . . . . 0.0 110.993 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.2 m -67.87 -35.56 78.74 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.485 0.714 . . . . 0.0 110.819 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -70.9 -47.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -58.31 -33.54 69.59 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.559 0.744 . . . . 0.0 112.708 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.35 -35.63 15.11 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 118.344 -0.836 . . . . 0.0 113.17 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -138.63 2.0 2.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -136.44 26.61 3.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.942 1.246 . . . . 0.0 110.657 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.91 -13.77 28.04 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.997 -1.064 . . . . 0.0 113.565 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -52.95 -22.93 6.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.741 2.017 . . . . 0.0 112.905 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -64.21 97.21 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.36 1.464 . . . . 0.0 108.679 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -56.26 158.81 3.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.57 1.548 . . . . 0.0 111.317 174.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.41 65.03 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -169.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.37 -46.82 72.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.966 0.803 . . . . 0.0 109.98 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -64.91 -40.25 94.78 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.488 0.715 . . . . 0.0 109.748 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 tpp85 -55.57 -47.43 76.42 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.953 1.301 . . . . 0.0 110.097 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.4 m -64.94 -49.74 69.18 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.187 0.995 . . . . 0.0 110.019 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.26 -38.85 91.6 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.405 . . . . 0.0 110.785 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.86 -50.74 65.42 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.61 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.87 -38.83 79.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.734 1.152 . . . . 0.0 110.093 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.74 -48.22 82.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.98 0.809 . . . . 0.0 112.099 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -37.05 76.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.1 t -61.97 -46.37 96.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.801 1.641 . . . . 0.0 109.942 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -63.31 -20.57 65.6 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.515 1.052 . . . . 0.0 111.398 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -97.78 7.15 46.89 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.912 0.885 . . . . 0.0 110.808 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -137.4 -56.13 0.7 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.215 -169.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.99 -37.23 51.08 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 120.467 1.485 . . . . 0.0 112.708 -176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -63.94 -11.17 25.8 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.002 1.802 . . . . 0.0 115.706 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -128.06 -19.63 3.94 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.866 1.666 . . . . 0.0 112.746 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.74 149.67 97.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.408 1.083 . . . . 0.0 110.902 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.46 47.9 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.648 3.566 . . . . 0.0 112.305 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.36 165.49 16.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.038 1.735 . . . . 0.0 112.463 -171.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -115.77 147.4 40.99 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 168.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.37 138.58 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.039 0.935 . . . . 0.0 110.382 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.54 129.23 34.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 168.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.4 m -124.15 142.02 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -82.85 -179.7 7.52 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 169.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -52.05 -25.45 8.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 0.0 113.97 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -79.24 0.57 28.09 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.045 1.338 . . . . 0.0 111.955 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.5 t0 51.63 55.96 8.58 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 124.207 1.956 . . . . 0.0 109.661 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -127.41 119.09 21.71 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 128.103 2.561 . . . . 0.0 104.333 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.64 138.74 65.98 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.693 1.596 . . . . 0.0 109.924 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.34 -9.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 0.0 112.468 173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.46 168.67 40.16 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 171.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -142.46 156.34 45.16 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.813 0.806 . . . . 0.0 111.249 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -141.75 138.0 32.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.362 2.265 . . . . 0.0 106.037 -173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -124.15 119.57 29.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.7 tp -141.97 134.5 28.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.0 m -159.4 155.87 27.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.131 2.172 . . . . 0.0 105.422 168.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.14 35.46 59.9 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 121.564 -0.71 . . . . 0.0 113.774 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 58.14 22.24 8.87 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.041 1.736 . . . . 0.0 113.697 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -125.47 114.36 18.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.429 -0.795 . . . . 0.0 109.955 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.6 ttp -80.89 87.32 5.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.96 -28.09 69.84 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.619 0.768 . . . . 0.0 112.837 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.97 144.63 29.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.755 0.822 . . . . 0.0 110.407 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 48.1 tp -156.19 117.58 3.88 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.955 1.702 . . . . 0.0 106.464 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -145.31 143.14 30.01 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -149.62 144.18 17.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.08 125.33 86.63 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.52 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.73 -30.21 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.882 3.055 . . . . 0.0 114.947 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -63.72 -25.18 68.08 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.94 -3.11 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.641 0.655 . . . . 0.0 112.497 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -59.62 -37.24 78.07 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.823 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.7 -26.62 68.75 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.859 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.0 m -78.29 -3.55 43.48 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.392 1.096 . . . . 0.0 112.212 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.11 13.15 64.57 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.486 172.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.0 t -57.21 -31.03 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.294 1.547 . . . . 0.0 110.844 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -51.5 -49.85 44.12 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.634 0.635 . . . . 0.0 112.176 170.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -63.87 -46.85 83.08 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.716 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.6 t -54.03 -49.55 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 119.397 0.999 . . . . 0.0 110.152 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.95 -37.52 75.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.039 -174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.58 -39.75 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 119.088 0.858 . . . . 0.0 109.801 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -63.97 -36.11 82.9 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.74 1.154 . . . . 0.0 110.066 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -62.03 -48.33 80.78 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.872 0.469 . . . . 0.0 110.491 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.18 78.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.643 0.777 . . . . 0.0 110.753 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.2 mt -59.49 -33.66 71.62 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.702 1.201 . . . . 0.0 111.646 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -62.66 -34.11 76.41 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.5 0.591 . . . . 0.0 111.548 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -87.19 -25.38 24.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 112.091 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.08 94.96 7.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.096 1.359 . . . . 0.0 109.175 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.91 -23.42 47.3 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 121.237 1.291 . . . . 0.0 112.318 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.12 28.87 4.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.789 1.635 . . . . 0.0 110.482 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.3 tp -53.0 146.49 10.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.281 2.232 . . . . 0.0 112.819 -169.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 38.8 p -131.31 161.68 31.78 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 108.802 170.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 t -155.86 -178.37 7.24 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 122.636 0.374 . . . . 0.0 110.631 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -135.68 156.57 48.64 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.785 1.634 . . . . 0.0 108.695 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 p -154.39 145.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.53 132.48 42.91 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -58.17 -30.82 66.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.566 0.747 . . . . 0.0 112.213 -172.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -65.53 -26.73 68.02 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.367 0.53 . . . . 0.0 112.193 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -79.95 67.84 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.748 0.785 . . . . 0.0 109.806 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.41 -27.7 49.47 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.446 1.099 . . . . 0.0 111.422 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -65.25 -50.59 65.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.006 0.523 . . . . 0.0 110.149 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.77 -37.54 82.23 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.41 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 74.5 t -56.45 -49.14 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.92 -48.68 85.07 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -56.79 -50.88 70.99 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.392 0.677 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -66.94 -35.32 79.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.19 -47.37 85.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.983 0.81 . . . . 0.0 110.876 171.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -58.87 -42.03 88.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.021 0.828 . . . . 0.0 110.603 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.85 -40.28 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 123.701 0.8 . . . . 0.0 110.345 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.52 8.13 0.73 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-O 118.31 -1.272 . . . . 0.0 114.775 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.53 153.17 40.39 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.643 1.722 . . . . 0.0 111.142 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -140.5 139.49 35.11 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 126.126 1.77 . . . . 0.0 106.523 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.491 HG22 HD22 ' A' ' 142' ' ' LEU . 23.9 t -72.08 134.68 29.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.02 0.928 . . . . 0.0 109.85 -171.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.4 p -126.0 -8.6 6.58 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.789 2.036 . . . . 0.0 111.379 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.26 43.95 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 118.779 0.718 . . . . 0.0 111.467 170.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -154.44 176.91 11.77 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.83 0.852 . . . . 0.0 109.437 171.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.8 m -145.93 132.81 20.13 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.876 2.071 . . . . 0.0 105.831 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -77.37 2.04 17.13 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.17 170.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.748 1.619 . . . . 0.0 106.901 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.13 -60.77 2.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.562 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -159.08 -47.94 0.06 Allowed 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 170.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.66 33.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.564 1.146 . . . . 0.0 109.931 -173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.58 15.15 70.52 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.061 0.838 . . . . 0.0 113.221 -171.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -66.46 125.75 90.97 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 116.82 -1.562 . . . . 0.0 107.926 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -78.35 46.25 2.06 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.753 2.969 . . . . 0.0 112.465 -170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -134.62 87.31 31.84 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -44.56 148.14 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.091 3.194 . . . . 0.0 117.687 -169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 21.8 tp -103.92 148.09 26.57 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 169.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.2 mt -117.79 151.61 36.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -122.67 138.51 54.58 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.878 1.271 . . . . 0.0 107.849 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.491 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -138.03 159.79 41.08 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.435 1.094 . . . . 0.0 108.467 -170.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.18 149.66 51.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.413 1.485 . . . . 0.0 108.417 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -73.9 125.45 28.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.6 t -129.04 -7.98 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.63 1.172 . . . . 0.0 110.008 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.0 37.38 92.06 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -169.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.932 1.293 . . . . 0.0 111.127 178.833 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttp . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.87 141.52 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 mm -136.72 146.74 28.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -140.9 164.02 31.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 168.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 55' ' ' ALA . 13.8 mm -124.5 143.59 37.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ptt85 -152.3 171.3 18.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.73 1.212 . . . . 0.0 109.136 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -65.85 147.47 53.32 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -76.35 148.85 37.16 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 124.623 1.169 . . . . 0.0 111.912 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -77.33 162.07 27.57 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 168.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -70.16 -46.67 64.21 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.93 -27.61 65.91 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.72 -1.48 47.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.789 0.436 . . . . 0.0 111.334 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.12 -35.96 55.66 Favored Glycine 0 C--N 1.342 0.881 0 C-N-CA 124.14 0.876 . . . . 0.0 113.461 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.53 -28.14 69.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.979 1.39 . . . . 0.0 111.829 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -68.09 -31.73 71.56 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.364 -0.835 . . . . 0.0 109.762 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -76.13 -37.36 58.13 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.11 -46.96 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.71 97.86 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.119 0.568 . . . . 0.0 112.042 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.18 -50.6 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.24 1.016 . . . . 0.0 109.569 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 55.5 t90 -51.36 -47.51 62.77 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.282 0.633 . . . . 0.0 110.005 173.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.6 t -61.51 -49.59 76.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.901 0.48 . . . . 0.0 110.233 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.21 -30.32 68.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.179 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -62.54 -46.15 89.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.628 1.104 . . . . 0.0 109.462 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -66.57 -44.02 90.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 123.877 0.871 . . . . 0.0 109.305 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.46 -28.62 68.73 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.361 0.982 . . . . 0.0 112.326 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.71 -33.3 27.61 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.984 0.914 . . . . 0.0 113.301 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.7 p -135.17 -12.17 2.17 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -169.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.408 ' CD2' HD22 ' A' ' 110' ' ' ASN . 28.5 m-70 -118.68 24.5 10.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.347 177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.19 -19.76 35.96 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -53.41 -28.88 32.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.804 1.641 . . . . 0.0 111.927 171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.21 104.98 1.96 Allowed 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.961 2.104 . . . . 0.0 108.724 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -59.87 157.83 11.71 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.557 1.943 . . . . 0.0 113.181 -173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.15 -33.04 68.77 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -64.83 -50.18 67.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.631 0.65 . . . . 0.0 109.545 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -64.09 -38.58 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.138 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -56.18 -46.66 79.28 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.549 0.74 . . . . 0.0 109.917 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.2 m -64.81 -51.1 64.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.554 1.142 . . . . 0.0 110.105 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.37 -36.33 76.71 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.998 -0.439 . . . . 0.0 110.835 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.15 -50.97 68.3 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 117.834 -1.079 . . . . 0.0 109.276 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -55.51 -38.53 69.33 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.822 1.192 . . . . 0.0 110.501 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.9 -44.66 72.75 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.86 -36.02 70.0 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 122.123 -0.361 . . . . 0.0 110.421 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.35 -47.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 125.992 1.717 . . . . 0.0 108.949 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ttp85 -69.45 -12.1 61.37 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 120.847 -1.158 . . . . 0.0 112.819 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.2 m -95.53 6.05 49.97 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.715 0.806 . . . . 0.0 110.679 172.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -136.79 -55.32 0.73 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.58 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -57.09 -40.14 82.84 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 120.66 1.573 . . . . 0.0 112.632 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.49 -12.26 27.0 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.253 1.969 . . . . 0.0 114.853 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.85 -21.36 6.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.79 1.632 . . . . 0.0 111.937 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.55 148.65 97.98 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 110.778 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.65 48.85 3.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.653 3.569 . . . . 0.0 111.721 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.09 169.48 5.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.171 1.388 . . . . 0.0 112.272 -172.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -121.66 144.37 48.8 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.61 169.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.12 138.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.219 1.008 . . . . 0.0 110.659 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.439 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.72 129.48 34.97 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 103.617 -2.734 . . . . 0.0 103.617 167.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.3 m -126.86 144.63 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -80.47 -174.56 4.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.807 170.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -57.69 -22.43 46.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.476 1.11 . . . . 0.0 113.249 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -85.88 6.1 29.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.997 1.319 . . . . 0.0 111.682 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 53.01 41.94 32.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 122.964 1.364 . . . . 0.0 110.467 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.5 120.33 45.57 Favored Pre-proline 0 N--CA 1.451 -0.392 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -173.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.86 130.71 28.51 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.281 1.987 . . . . 0.0 110.286 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 m -118.32 -16.01 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.144 0.978 . . . . 0.0 111.637 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.97 172.72 42.16 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -147.35 161.73 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.372 0.669 . . . . 0.0 110.881 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.47 158.9 43.3 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.448 1.099 . . . . 0.0 109.717 169.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.5 tp -118.06 128.07 54.4 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 169.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -143.07 132.16 23.07 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 170.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 m -142.95 153.71 43.32 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.5 -118.44 10.54 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -169.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -129.07 30.76 5.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.181 0.992 . . . . 0.0 110.826 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -122.58 109.73 14.67 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.398 0.679 . . . . 0.0 110.452 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.1 ttp -85.78 87.85 7.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 174.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -63.37 -29.06 70.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.87 145.38 36.11 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.629 0.771 . . . . 0.0 109.815 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.7 tp -158.73 116.16 2.83 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.548 1.939 . . . . 0.0 105.958 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -145.97 143.21 29.34 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -149.91 145.44 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -171.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -60.41 121.58 61.19 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.99 -16.28 51.91 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.311 2.007 . . . . 0.0 113.704 -169.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.02 -23.29 64.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.811 1.187 . . . . 0.0 111.946 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.06 -9.37 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.438 1.095 . . . . 0.0 112.309 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -50.54 -44.18 56.35 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.341 1.056 . . . . 0.0 110.436 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.67 -18.77 66.42 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.165 0.888 . . . . 0.0 113.842 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.49 -9.11 57.68 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.108 1.454 . . . . 0.0 112.239 176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.12 7.96 34.58 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 118.988 -0.896 . . . . 0.0 113.04 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -55.33 -31.73 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.053 1.426 . . . . 0.0 110.682 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.6 -51.7 27.0 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 119.377 -0.68 . . . . 0.0 111.706 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -62.24 -42.45 99.33 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 117.583 -1.198 . . . . 0.0 110.431 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.3 t -58.76 -46.54 90.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 119.98 1.264 . . . . 0.0 109.957 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.43 -41.19 80.67 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.949 -0.469 . . . . 0.0 110.806 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.51 -41.75 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.445 0.566 . . . . 0.0 109.943 175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.3 -34.88 79.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.125 0.875 . . . . 0.0 110.14 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.38 -45.22 95.29 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 118.4 0.545 . . . . 0.0 110.424 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.31 -49.45 73.93 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.835 0.454 . . . . 0.0 111.003 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.35 -33.67 69.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.113 0.965 . . . . 0.0 111.512 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.66 -35.97 81.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.297 0.499 . . . . 0.0 111.558 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.6 mtm -88.63 -23.0 23.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.267 0.485 . . . . 0.0 112.161 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.04 90.05 9.5 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 125.137 1.375 . . . . 0.0 108.914 -170.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.27 -22.05 61.0 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.476 1.45 . . . . 0.0 112.919 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -106.45 31.93 4.85 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.535 1.534 . . . . 0.0 109.951 -175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 42.0 tp -49.2 144.81 4.8 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.238 2.215 . . . . 0.0 113.015 -171.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 p -129.23 162.25 28.3 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.186 1.395 . . . . 0.0 108.657 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -153.64 -173.72 4.68 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -148.92 161.78 41.18 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.481 0.713 . . . . 0.0 110.372 175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.3 p -155.2 149.73 11.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -78.11 136.31 37.85 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.13 -26.2 60.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.224 1.41 . . . . 0.0 112.352 -178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -48.81 -47.45 42.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.056 0.844 . . . . 0.0 111.05 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.408 HD22 ' CD2' ' A' ' 28' ' ' HIS . 59.5 t-20 -85.82 65.3 9.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.327 1.451 . . . . 0.0 110.244 -176.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.22 -29.36 46.06 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 111.441 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -43.89 97.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.409 0.684 . . . . 0.0 109.966 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.36 -33.99 72.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.148 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.9 t -56.25 -45.34 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 119.505 1.048 . . . . 0.0 108.678 171.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.39 -50.78 63.15 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -53.29 -50.54 64.68 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.869 0.868 . . . . 0.0 110.797 -178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -65.25 -38.51 90.57 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.91 -32.95 74.34 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 117.826 -1.083 . . . . 0.0 112.523 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -60.42 -40.88 92.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.353 1.433 . . . . 0.0 110.766 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.09 -39.13 80.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.05 9.32 0.82 Allowed Glycine 0 CA--C 1.526 0.767 0 CA-C-O 118.6 -1.111 . . . . 0.0 113.841 171.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -69.01 159.58 32.57 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 1.537 . . . . 0.0 111.117 173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.82 140.59 25.89 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 HD22 ' A' ' 142' ' ' LEU . 28.2 t -71.94 129.91 35.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.981 0.912 . . . . 0.0 109.324 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.4 p -124.93 -7.64 7.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.258 1.823 . . . . 0.0 111.796 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.91 173.06 42.2 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 118.82 0.737 . . . . 0.0 112.218 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -141.98 159.92 41.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.543 1.537 . . . . 0.0 111.061 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.3 m -136.69 127.7 27.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -69.88 -7.74 42.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.45 0.7 . . . . 0.0 112.827 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.41 173.06 13.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.452 1.901 . . . . 0.0 106.804 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -85.04 -55.93 3.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.817 -0.174 . . . . 0.0 111.05 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -165.05 -45.54 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.404 1.082 . . . . 0.0 112.65 176.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.51 -4.64 56.52 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.848 0.859 . . . . 0.0 112.195 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.38 -8.39 62.37 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.393 0.997 . . . . 0.0 111.817 -169.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.58 132.78 82.18 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 118.129 0.965 . . . . 0.0 109.444 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.38 55.73 5.74 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.177 3.251 . . . . 0.0 111.857 -169.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -122.38 87.83 48.77 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.7 148.41 21.68 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 121.929 1.753 . . . . 0.0 115.738 -170.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 18.0 tp -96.74 143.79 27.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.8 mt -114.73 134.72 54.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.41 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.3 t-20 -102.98 139.73 38.16 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.554 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -134.19 159.94 39.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -174.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.39 151.24 51.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.538 1.535 . . . . 0.0 107.987 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -75.8 125.7 29.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.5 t -128.73 -8.87 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.552 1.141 . . . . 0.0 110.051 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.38 37.58 90.53 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -170.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 C-N-CA 124.681 1.192 . . . . 0.0 111.046 178.444 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttp . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.57 143.54 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.9 mm -134.66 144.38 35.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -142.39 166.12 25.54 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.52 142.65 40.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.69 171.17 19.25 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 109.507 174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -64.57 147.73 52.27 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.929 0.786 . . . . 0.0 109.106 169.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.12 148.28 45.85 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.228 1.011 . . . . 0.0 112.17 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -80.49 158.57 25.82 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -66.57 -48.99 67.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -68.73 -26.71 65.39 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -169.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -80.26 -1.97 43.04 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.161 0.437 . . . . 0.0 111.635 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.53 -39.14 36.7 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 124.185 0.898 . . . . 0.0 113.385 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.77 -26.78 67.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.686 1.243 . . . . 0.0 112.078 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -68.21 -31.77 71.53 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.361 -0.837 . . . . 0.0 109.812 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.9 mt -75.15 -40.09 59.91 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.26 -46.01 81.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.603 0.761 . . . . 0.0 109.289 169.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.14 -46.92 86.88 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.932 0.493 . . . . 0.0 111.285 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.6 mt -57.35 -52.19 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.717 1.207 . . . . 0.0 108.934 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -52.94 -49.91 65.08 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.461 0.705 . . . . 0.0 109.774 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 t -59.51 -50.49 73.72 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.109 0.564 . . . . 0.0 110.655 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -68.33 -33.05 73.6 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.145 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.1 m -63.34 -46.96 84.19 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.199 0.909 . . . . 0.0 109.688 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.63 -44.14 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 123.794 0.838 . . . . 0.0 108.912 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.99 -33.58 76.4 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.998 1.272 . . . . 0.0 112.052 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.24 60.9 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.428 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.8 p -135.07 -5.66 2.37 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 -169.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -121.72 44.39 2.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.633 1.573 . . . . 0.0 108.486 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.52 -32.29 57.87 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.048 -1.033 . . . . 0.0 113.051 -173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.65 -21.72 66.59 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.745 1.218 . . . . 0.0 113.117 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -70.36 114.23 8.29 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.589 1.156 . . . . 0.0 108.367 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 p -61.06 148.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.896 1.278 . . . . 0.0 112.091 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.85 73.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.105 0.562 . . . . 0.0 112.464 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.82 -48.67 73.53 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -68.55 -35.5 77.5 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.137 -0.352 . . . . 0.0 110.381 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -54.87 -45.57 74.63 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.397 1.079 . . . . 0.0 110.313 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.4 m -65.23 -49.8 68.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.339 1.056 . . . . 0.0 110.235 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.01 -35.95 81.06 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.971 -0.456 . . . . 0.0 110.723 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.44 -52.84 62.9 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.345 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.75 -38.01 71.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.475 1.034 . . . . 0.0 110.74 -174.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.99 -48.82 72.6 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.089 0.556 . . . . 0.0 112.094 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.68 -36.03 73.11 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.974 -0.454 . . . . 0.0 110.471 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.49 -47.74 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.231 1.812 . . . . 0.0 109.098 171.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.1 ttp85 -69.85 -11.17 60.66 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 120.924 -1.11 . . . . 0.0 112.676 175.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m -95.87 5.47 51.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.691 0.796 . . . . 0.0 110.749 172.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -136.38 -56.43 0.75 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-O 117.892 -1.052 . . . . 0.0 112.628 -169.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -56.2 -38.37 67.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 120.629 1.558 . . . . 0.0 112.827 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.07 -14.86 35.72 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.8 1.666 . . . . 0.0 115.209 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.71 -13.57 4.71 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 120.741 1.61 . . . . 0.0 112.772 -173.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.23 152.34 91.94 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.957 1.303 . . . . 0.0 111.321 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.82 56.18 5.86 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.831 3.688 . . . . 0.0 111.932 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.8 mt -82.34 159.2 23.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.369 1.468 . . . . 0.0 112.009 -171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -116.24 142.45 46.82 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.0 141.22 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.259 1.024 . . . . 0.0 110.072 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.09 134.83 35.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 168.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -128.71 144.3 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -84.21 -171.77 3.79 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.39 1.076 . . . . 0.0 110.763 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -62.33 11.04 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 127.501 2.32 . . . . 0.0 114.182 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -127.97 8.99 6.26 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.354 1.862 . . . . 0.0 111.314 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.0 t0 50.25 47.26 24.0 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.187 1.47 . . . . 0.0 110.259 -173.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.41 122.99 26.59 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 -172.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.7 135.5 45.39 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.24 1.96 . . . . 0.0 110.994 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 m -119.93 -13.92 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.179 0.992 . . . . 0.0 112.136 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.8 170.86 42.61 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -140.41 159.88 41.23 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.295 1.038 . . . . 0.0 111.962 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -140.0 127.48 21.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.926 2.49 . . . . 0.0 105.999 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -111.97 116.8 31.17 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 175.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 69' ' ' SER . 2.9 tt -146.56 129.29 16.17 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.348 0.522 . . . . 0.0 109.875 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.461 ' N ' HD23 ' A' ' 68' ' ' LEU . 36.7 m -146.04 154.68 42.13 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.58 41.98 65.78 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-N 118.953 0.797 . . . . 0.0 113.996 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 59.53 21.97 10.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.811 1.644 . . . . 0.0 113.842 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -130.18 108.12 9.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.074 0.95 . . . . 0.0 108.97 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 68.2 ttp -85.9 86.14 7.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -61.13 -31.48 71.19 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.85 142.35 31.79 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.607 0.763 . . . . 0.0 110.296 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 tp -150.85 117.46 5.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -140.93 140.08 34.4 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.68 146.66 19.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 -177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -50.97 118.25 9.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.08 -18.6 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.636 2.224 . . . . 0.0 112.638 -171.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.95 -23.52 66.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.1 0.864 . . . . 0.0 112.554 174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.55 -2.6 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.939 1.295 . . . . 0.0 112.487 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -59.89 -27.64 66.89 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.678 -1.264 . . . . 0.0 111.698 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.97 -16.19 75.48 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.981 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.0 m -75.19 -175.09 2.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.713 1.256 . . . . 0.0 109.293 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.45 -31.58 36.22 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 118.632 -1.093 . . . . 0.0 113.612 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.34 -36.66 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 119.712 1.756 . . . . 0.0 112.733 -170.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -56.84 -23.04 43.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.873 0.749 . . . . 0.0 113.441 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -41.85 7.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.065 170.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.11 -45.98 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 121.605 2.002 . . . . 0.0 110.662 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.8 mt -68.9 -37.09 78.75 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.997 0.817 . . . . 0.0 111.641 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.15 -39.58 83.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 118.53 0.604 . . . . 0.0 109.674 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -66.49 -35.08 79.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.534 -0.729 . . . . 0.0 109.197 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -62.87 -48.36 79.35 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.574 0.75 . . . . 0.0 110.427 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -58.02 -47.89 81.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.584 0.753 . . . . 0.0 110.888 177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.11 -33.12 74.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 111.414 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.2 m -64.33 -39.06 93.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.491 0.587 . . . . 0.0 111.035 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.9 mtm -77.3 -29.83 53.88 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.438 0.563 . . . . 0.0 111.728 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 96.15 6.88 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 124.695 1.198 . . . . 0.0 110.13 -170.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.01 -22.83 62.01 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 121.33 1.353 . . . . 0.0 112.409 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -100.55 29.19 4.57 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.845 1.658 . . . . 0.0 110.509 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.1 tp -51.94 144.03 12.48 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.002 2.121 . . . . 0.0 113.589 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.4 p -129.87 161.3 31.13 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.47 1.508 . . . . 0.0 108.612 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 t -154.51 -179.33 7.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.918 0.487 . . . . 0.0 110.232 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.2 1.4 . . . . 0.0 109.018 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.416 HG12 HD21 ' A' ' 142' ' ' LEU . 10.5 p -153.86 145.3 14.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 172.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -75.78 137.71 40.72 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -63.89 -25.52 68.19 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.281 0.632 . . . . 0.0 111.944 -177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -71.74 31.57 0.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.152 1.381 . . . . 0.0 112.415 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -149.7 67.04 1.0 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.946 1.698 . . . . 0.0 107.685 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -57.56 -26.42 61.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.304 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.52 -49.38 75.56 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.854 0.461 . . . . 0.0 110.085 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.27 76.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.673 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.0 t -57.42 -49.74 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.52 -46.32 94.56 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 118.294 0.497 . . . . 0.0 111.914 178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -54.22 -53.17 57.25 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 125.146 1.379 . . . . 0.0 109.852 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -68.32 -33.38 74.21 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.855 -0.528 . . . . 0.0 109.852 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.26 -47.87 82.24 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.418 1.008 . . . . 0.0 110.879 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -58.64 -43.27 89.69 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.841 0.746 . . . . 0.0 110.438 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 73.7 t -64.29 -37.61 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.653 0.781 . . . . 0.0 110.607 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.59 10.07 0.83 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.618 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -81.78 155.93 25.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.635 1.717 . . . . 0.0 111.439 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.1 138.24 33.38 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.126 1.77 . . . . 0.0 106.558 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.523 HG22 HD22 ' A' ' 142' ' ' LEU . 25.2 t -70.85 133.67 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.03 0.932 . . . . 0.0 109.692 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.4 p -125.59 -9.69 6.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.588 1.955 . . . . 0.0 111.414 -175.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.61 -176.87 41.6 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.837 0.744 . . . . 0.0 111.758 171.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -151.54 -174.82 4.96 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.92 0.888 . . . . 0.0 109.338 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.3 m -133.02 150.22 52.16 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.382 1.873 . . . . 0.0 106.583 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.64 -9.84 59.08 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.827 -0.546 . . . . 0.0 112.023 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.45 178.35 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 127.43 2.292 . . . . 0.0 107.378 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -79.19 -64.79 1.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.697 -0.112 . . . . 0.0 110.697 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -159.8 -39.54 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -105.81 34.42 3.31 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.793 1.237 . . . . 0.0 110.212 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.15 9.52 86.74 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.737 0.684 . . . . 0.0 113.336 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.42 134.37 88.89 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-O 117.168 -1.396 . . . . 0.0 108.227 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.19 48.47 2.54 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.652 2.901 . . . . 0.0 111.634 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -132.17 71.26 79.93 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.275 1.83 . . . . 0.0 106.483 -172.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -42.71 142.67 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.402 2.734 . . . . 0.0 118.25 -169.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.22 145.96 24.67 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -116.36 152.86 33.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.461 ' C ' HD23 ' A' ' 142' ' ' LEU . 16.8 t-20 -124.61 138.67 54.3 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 108.206 176.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.58 161.19 37.09 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.678 1.191 . . . . 0.0 108.456 -170.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.26 150.27 52.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.67 1.588 . . . . 0.0 108.465 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -75.69 124.76 27.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 97.1 t -130.36 -17.09 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 30.91 1.98 Allowed Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.999 1.285 . . . . 0.0 114.059 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 C-N-CA 124.399 1.08 . . . . 0.0 109.957 174.229 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 120.529 0.204 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.57 162.5 2.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.668 0.747 . . . . 0.0 112.018 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.6 mm -133.25 145.83 33.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 m -137.35 164.45 28.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 55' ' ' ALA . 17.6 mm -124.99 141.8 43.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.19 170.5 21.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.075 0.95 . . . . 0.0 109.771 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -61.67 148.97 40.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.5 p -62.59 167.0 4.74 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.19 1.796 . . . . 0.0 112.858 176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -118.69 135.48 54.46 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 169.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -55.72 -39.4 71.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.94 0.791 . . . . 0.0 111.73 -173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.64 -22.46 61.68 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -85.77 -4.18 59.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.829 0.74 . . . . 0.0 110.87 176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.54 59.58 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.917 0.77 . . . . 0.0 113.107 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.65 -31.48 72.18 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.389 1.094 . . . . 0.0 111.148 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.56 -30.82 69.68 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.116 0.566 . . . . 0.0 109.631 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.2 mt -73.51 -39.47 64.8 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.689 -0.632 . . . . 0.0 109.745 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.7 -45.93 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 170.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -45.81 92.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.748 0.419 . . . . 0.0 111.129 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.66 -48.46 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.186 0.994 . . . . 0.0 109.927 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.1 t90 -53.24 -46.91 69.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.133 0.573 . . . . 0.0 110.049 173.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.4 t -60.17 -43.93 95.43 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 110.525 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -63.95 -41.63 97.54 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.521 -0.737 . . . . 0.0 111.618 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 m -59.12 -39.78 83.36 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.553 0.741 . . . . 0.0 109.722 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.54 -45.86 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 123.56 0.744 . . . . 0.0 109.567 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.5 -35.07 73.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.918 0.781 . . . . 0.0 112.11 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.31 -46.41 27.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.76 0.824 . . . . 0.0 112.076 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.3 p -137.18 3.0 2.59 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -168.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.66 23.05 5.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.656 1.116 . . . . 0.0 110.63 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.99 -14.5 35.81 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.055 -1.028 . . . . 0.0 113.42 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -55.21 -21.83 15.43 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.242 1.817 . . . . 0.0 112.787 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.56 97.98 0.16 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.524 1.53 . . . . 0.0 108.27 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.0 m -58.84 156.85 10.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.133 0.973 . . . . 0.0 110.796 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.42 -34.3 57.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -169.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.8 mp0 -65.21 -51.68 59.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.495 0.589 . . . . 0.0 109.533 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CD1' ' HE2' ' A' ' 135' ' ' LYS . 14.9 t80 -70.23 -33.7 71.97 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.864 -0.523 . . . . 0.0 110.553 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -55.14 -46.31 75.66 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.896 0.878 . . . . 0.0 109.566 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 m -64.76 -48.13 75.65 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.158 0.983 . . . . 0.0 110.187 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -62.55 -42.39 99.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.466 0.575 . . . . 0.0 110.775 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.11 -50.24 64.75 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.398 -0.81 . . . . 0.0 109.412 176.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.03 -39.27 74.49 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 119.263 0.938 . . . . 0.0 110.271 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.99 -49.89 74.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.723 0.692 . . . . 0.0 111.953 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -38.82 81.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.61 -48.15 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.009 1.723 . . . . 0.0 109.818 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 tpt85 -62.49 -22.08 65.98 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.913 0.885 . . . . 0.0 111.112 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -99.0 6.75 46.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.192 0.997 . . . . 0.0 110.941 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -136.84 -53.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.772 -169.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.8 mt -59.05 -37.01 48.45 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 120.369 1.441 . . . . 0.0 112.73 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.64 -12.62 29.26 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 0.0 115.924 172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.98 -21.19 5.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 120.602 1.546 . . . . 0.0 111.799 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.05 138.24 96.14 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 110.063 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -80.13 51.41 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.669 3.579 . . . . 0.0 110.761 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.47 164.93 3.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 125.374 1.47 . . . . 0.0 110.513 -176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -108.11 109.13 20.47 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.5 m -92.34 141.22 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 118.296 0.498 . . . . 0.0 110.015 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -85.33 133.28 34.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -128.89 143.07 42.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -86.23 -178.56 6.52 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 170.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -52.89 -23.87 8.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 113.715 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -75.32 -5.19 43.47 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.361 1.464 . . . . 0.0 111.982 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 t0 50.22 57.45 6.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 123.939 1.828 . . . . 0.0 109.64 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -139.59 128.13 13.48 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 -170.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.57 139.85 41.93 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.618 2.212 . . . . 0.0 111.576 -169.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.79 -9.45 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.078 0.951 . . . . 0.0 111.968 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 175.5 42.16 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -152.22 161.63 42.34 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.628 0.714 . . . . 0.0 111.177 171.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.51 162.89 33.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.142 1.377 . . . . 0.0 108.777 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 tp -122.99 129.09 51.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.2 tp -141.17 132.74 27.04 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.5 p -158.23 155.85 29.7 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.758 2.023 . . . . 0.0 105.837 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.11 36.18 56.07 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 121.445 -0.785 . . . . 0.0 113.896 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 58.33 21.97 8.87 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.957 1.703 . . . . 0.0 113.687 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -125.3 113.1 17.15 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.026 0.93 . . . . 0.0 110.296 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.6 ttp -85.5 90.46 7.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.65 -26.98 66.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -173.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.93 147.19 36.64 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.539 0.736 . . . . 0.0 109.67 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.8 tp -159.24 113.24 2.35 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.363 1.865 . . . . 0.0 106.137 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -144.21 140.74 29.46 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 mt -150.52 148.38 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -62.59 125.94 87.22 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.45 -27.67 19.27 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 124.018 3.145 . . . . 0.0 115.39 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.14 -22.76 67.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.316 0.962 . . . . 0.0 112.57 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.05 -1.79 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.481 0.712 . . . . 0.0 112.753 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -57.11 -43.42 82.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.276 0.943 . . . . 0.0 109.655 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.17 74.63 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.5 0.571 . . . . 0.0 112.777 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.3 m -73.44 -8.36 55.59 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.234 1.017 . . . . 0.0 112.542 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.49 19.41 52.34 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.92 -0.933 . . . . 0.0 113.339 172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.72 -30.21 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.315 1.557 . . . . 0.0 110.591 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.79 -50.42 20.24 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 123.95 0.785 . . . . 0.0 112.101 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.21 -44.17 97.18 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 118.658 1.229 . . . . 0.0 110.075 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.02 -45.8 92.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 119.924 1.238 . . . . 0.0 109.918 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -67.81 -41.46 83.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.913 -0.492 . . . . 0.0 110.687 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.4 t -63.42 -41.85 94.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 118.701 0.682 . . . . 0.0 110.234 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.07 -35.96 82.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.473 -0.767 . . . . 0.0 109.456 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.11 -45.39 94.89 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 122.719 0.408 . . . . 0.0 110.54 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.8 -48.89 75.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.713 0.405 . . . . 0.0 110.761 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.5 mt -59.98 -32.72 71.09 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.148 0.979 . . . . 0.0 111.437 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -63.12 -37.31 86.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.373 0.533 . . . . 0.0 111.565 177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.2 mtm -86.84 -24.2 25.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.38 0.537 . . . . 0.0 112.288 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.36 94.73 7.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 125.389 1.476 . . . . 0.0 108.493 -172.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.34 -23.8 51.09 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.203 1.269 . . . . 0.0 112.243 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -99.42 28.65 4.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.718 1.607 . . . . 0.0 110.537 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 34.6 tp -52.04 145.33 10.44 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.956 2.103 . . . . 0.0 113.547 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 67.7 p -129.25 163.14 26.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.479 1.511 . . . . 0.0 108.44 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.9 t -153.81 -173.5 4.6 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -147.52 161.88 40.21 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.179 0.992 . . . . 0.0 110.05 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.517 HG12 HD21 ' A' ' 142' ' ' LEU . 9.2 p -155.03 143.37 12.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -71.09 129.64 39.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.96 -37.38 74.05 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.512 0.725 . . . . 0.0 112.607 -170.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -63.23 -28.65 70.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.025 0.375 . . . . 0.0 111.476 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -78.12 66.47 3.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.72 0.772 . . . . 0.0 109.935 172.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.67 -24.87 62.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.21 -47.5 84.16 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 122.959 0.504 . . . . 0.0 109.841 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.22 79.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.595 176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 83.9 t -56.79 -46.2 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.172 0.896 . . . . 0.0 108.972 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.91 -50.59 62.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.95 -49.66 70.81 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 124.036 0.934 . . . . 0.0 110.612 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -66.81 -35.34 79.83 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -66.18 -37.92 86.79 Favored 'General case' 0 C--N 1.34 0.167 0 O-C-N 120.837 -1.164 . . . . 0.0 112.508 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.19 -43.29 92.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.932 1.242 . . . . 0.0 110.177 172.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.41 -34.7 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.317 1.047 . . . . 0.0 110.793 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.48 8.8 1.92 Allowed Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.397 0.998 . . . . 0.0 114.518 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -76.16 162.42 28.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.61 1.705 . . . . 0.0 111.407 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -147.42 140.67 25.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.221 1.808 . . . . 0.0 106.362 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.578 HG22 HD22 ' A' ' 142' ' ' LEU . 26.1 t -72.65 132.5 33.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 124.061 0.945 . . . . 0.0 109.78 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 p -127.44 -9.3 5.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.741 2.016 . . . . 0.0 111.691 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.13 177.18 41.26 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -158.46 -174.08 4.62 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 122.05 -0.677 . . . . 0.0 110.576 175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.3 m -138.91 170.68 15.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.276 2.23 . . . . 0.0 107.495 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -116.91 -3.8 11.6 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.749 0.82 . . . . 0.0 111.407 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.13 178.8 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.887 2.475 . . . . 0.0 106.401 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -85.26 -70.22 0.6 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 122.551 0.34 . . . . 0.0 110.478 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -160.56 -41.1 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.451 0.7 . . . . 0.0 112.506 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.33 16.01 2.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.529 1.132 . . . . 0.0 111.114 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.97 8.53 83.0 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.355 0.979 . . . . 0.0 112.935 -170.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' HE2' ' CD1' ' A' ' 35' ' ' TYR . 7.9 ptmt -86.53 141.36 34.22 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.486 1.143 . . . . 0.0 110.473 -177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.26 73.89 5.81 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.672 2.915 . . . . 0.0 111.718 -172.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -131.94 65.26 75.08 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -57.35 161.0 12.3 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.067 2.511 . . . . 0.0 116.16 -168.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.0 tp -116.59 147.52 41.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.769 1.628 . . . . 0.0 107.106 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.1 mt -116.01 147.74 40.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.506 ' C ' HD23 ' A' ' 142' ' ' LEU . 9.0 t-20 -118.75 139.26 51.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.96 160.25 39.46 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.111 0.964 . . . . 0.0 108.446 -170.239 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.37 151.78 51.72 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.63 1.572 . . . . 0.0 108.384 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -76.51 129.62 36.75 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 78.7 t -130.68 -10.41 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.18 1.392 . . . . 0.0 110.127 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -56.67 -27.99 55.93 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.904 1.24 . . . . 0.0 113.91 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 C-N-CA 126.849 2.059 . . . . 0.0 107.557 171.871 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 ttp . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.68 142.7 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -133.04 141.34 45.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -140.81 164.99 28.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mm -123.7 143.33 37.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -149.77 173.14 14.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 123.413 0.685 . . . . 0.0 110.376 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -65.26 147.66 53.05 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -71.99 179.36 3.28 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.863 1.265 . . . . 0.0 111.44 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -130.22 161.03 32.08 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.641 1.576 . . . . 0.0 107.131 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -69.15 -39.75 78.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.369 -0.207 . . . . 0.0 110.643 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.1 -37.2 75.31 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.679 0.392 . . . . 0.0 111.729 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -74.11 -2.95 26.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.172 0.589 . . . . 0.0 112.039 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -49.68 -39.5 31.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.267 0.937 . . . . 0.0 113.125 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.11 -28.51 68.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 111.969 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -67.07 -32.0 72.88 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 109.536 172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.7 mt -75.65 -39.22 58.02 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -56.83 -46.87 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.487 0.715 . . . . 0.0 109.203 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.29 95.33 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.95 0.5 . . . . 0.0 111.043 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.85 -54.08 36.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.077 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 38.9 t90 -51.76 -44.82 63.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.543 0.737 . . . . 0.0 110.255 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t -59.75 -42.28 92.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.635 0.374 . . . . 0.0 110.57 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -66.5 -43.23 85.9 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.611 -0.681 . . . . 0.0 111.006 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 m -58.92 -39.15 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.543 0.611 . . . . 0.0 110.305 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.61 -46.01 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.871 0.868 . . . . 0.0 109.765 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.16 -34.12 73.13 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.766 0.712 . . . . 0.0 111.968 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.36 -47.14 24.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.476 -0.773 . . . . 0.0 112.557 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.1 p -137.2 5.23 2.75 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -168.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -129.56 23.65 5.46 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.275 0.943 . . . . 0.0 110.175 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.4 -16.31 34.52 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.432 1.093 . . . . 0.0 113.624 -169.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -51.77 -23.11 4.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.034 2.133 . . . . 0.0 113.221 170.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mp -67.1 94.37 0.34 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.4 m -53.9 156.55 2.81 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.253 1.421 . . . . 0.0 111.163 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -35.59 62.39 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -169.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.68 -48.01 73.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 109.973 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -67.39 -38.52 84.83 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -54.1 -47.94 71.24 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 124.628 1.171 . . . . 0.0 109.976 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.4 m -65.06 -49.89 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.113 0.965 . . . . 0.0 110.193 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.43 -37.09 82.5 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.081 -0.387 . . . . 0.0 110.739 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.7 mt -63.95 -51.56 63.84 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.354 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.1 tm-20 -57.68 -37.58 73.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.467 1.03 . . . . 0.0 110.732 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.75 -48.37 74.83 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.139 0.575 . . . . 0.0 111.991 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.87 -36.43 72.8 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.12 -0.363 . . . . 0.0 110.24 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -59.34 -47.35 90.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 126.076 1.75 . . . . 0.0 109.123 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 ttp85 -70.36 -11.06 60.66 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.852 -1.155 . . . . 0.0 112.707 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.2 4.85 52.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.621 0.768 . . . . 0.0 110.724 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -135.26 -54.49 0.8 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-O 117.983 -1.008 . . . . 0.0 112.887 -169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.0 -39.23 74.48 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 120.764 1.62 . . . . 0.0 112.703 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -62.33 -9.91 16.86 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.421 2.081 . . . . 0.0 114.883 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.63 -22.92 4.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.562 1.528 . . . . 0.0 112.332 -175.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.83 152.06 96.67 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.117 1.367 . . . . 0.0 112.243 -171.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.62 65.91 8.07 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.887 3.724 . . . . 0.0 110.835 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.38 175.44 7.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.143 1.377 . . . . 0.0 112.023 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -133.71 151.0 51.52 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.6 2.36 . . . . 0.0 105.329 168.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.49 138.99 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.083 0.953 . . . . 0.0 110.886 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.03 132.65 35.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.72 142.81 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -83.4 -171.25 3.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.586 1.554 . . . . 0.0 110.656 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.39 8.31 0.05 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.215 2.206 . . . . 0.0 113.957 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -122.31 10.2 9.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 119.917 -1.739 . . . . 0.0 111.212 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 53.37 32.08 13.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.832 1.301 . . . . 0.0 111.127 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -116.68 132.4 23.4 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -169.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.59 138.0 44.25 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.383 2.056 . . . . 0.0 112.367 -169.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.92 -10.0 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.431 1.093 . . . . 0.0 112.091 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.35 169.76 39.99 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -142.08 159.73 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.613 0.765 . . . . 0.0 111.239 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -139.74 136.0 33.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.569 2.347 . . . . 0.0 105.862 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -117.99 122.42 43.16 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 tp -146.28 131.34 18.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 37.9 m -142.64 155.6 44.96 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.24 -114.06 4.31 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -129.11 14.82 6.25 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.791 0.836 . . . . 0.0 112.208 170.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.85 113.62 26.72 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.755 1.161 . . . . 0.0 110.735 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.621 ' HB2' HD11 ' A' ' 102' ' ' LEU . 64.8 ttp -83.23 85.41 7.21 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.07 -23.64 64.97 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.94 148.08 31.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.486 0.585 . . . . 0.0 110.606 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.3 tp -156.57 114.58 3.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -143.59 141.6 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.54 150.32 13.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.14 122.33 69.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -46.97 -27.49 5.99 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 124.334 3.356 . . . . 0.0 114.985 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.92 -23.45 65.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.597 0.759 . . . . 0.0 112.856 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.5 m -126.15 -1.27 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.699 0.8 . . . . 0.0 112.782 -178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -57.12 -39.96 76.15 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.888 -1.133 . . . . 0.0 110.328 169.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.26 -27.96 71.49 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.473 0.559 . . . . 0.0 112.917 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 58.7 m -76.22 -6.52 51.73 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 112.34 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.65 20.25 60.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.245 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.4 t -54.8 -31.81 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 119.137 1.469 . . . . 0.0 110.74 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -49.42 -48.11 34.69 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.972 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -65.7 -40.56 92.42 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.483 1.141 . . . . 0.0 110.285 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.9 t -58.86 -46.34 91.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 118.681 0.673 . . . . 0.0 109.597 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.86 -38.72 79.94 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.786 -0.571 . . . . 0.0 111.032 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.0 t -63.1 -40.13 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 118.804 0.729 . . . . 0.0 109.783 174.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -62.96 -37.31 86.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 120.058 1.299 . . . . 0.0 110.497 177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -61.52 -46.97 87.69 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.113 0.482 . . . . 0.0 110.557 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.67 78.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.685 0.794 . . . . 0.0 110.92 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 mt -58.12 -34.44 70.22 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.053 1.341 . . . . 0.0 111.44 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.4 m -62.4 -32.48 73.31 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.277 0.489 . . . . 0.0 111.68 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.1 mtm -89.93 -25.26 21.02 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.464 0.574 . . . . 0.0 112.092 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.01 89.94 12.35 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.092 1.357 . . . . 0.0 109.263 -169.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.55 -22.26 58.72 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.502 1.468 . . . . 0.0 113.192 -177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -106.38 31.55 5.1 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.492 1.517 . . . . 0.0 110.008 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 73' ' ' MET . 31.9 tp -48.16 142.68 5.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.507 2.323 . . . . 0.0 112.749 -171.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -126.15 161.05 28.56 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.334 1.453 . . . . 0.0 108.613 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -153.03 -176.23 5.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 110.723 174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -147.17 160.76 42.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.585 1.154 . . . . 0.0 110.422 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.4 144.36 7.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.8 130.24 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.88 -31.61 62.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.585 0.63 . . . . 0.0 111.943 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -60.34 -32.36 71.18 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.654 0.782 . . . . 0.0 111.857 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -80.76 67.36 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.789 0.804 . . . . 0.0 109.535 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.8 -25.22 60.28 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.78 0.832 . . . . 0.0 111.405 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.64 -49.26 73.95 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.035 0.534 . . . . 0.0 110.017 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.41 -35.25 77.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.681 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.4 t -57.03 -49.2 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.94 -47.69 90.02 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -55.85 -51.3 68.01 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.578 0.751 . . . . 0.0 109.651 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -66.59 -34.77 78.62 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.791 -0.568 . . . . 0.0 109.787 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -59.98 -45.88 91.24 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.062 -1.024 . . . . 0.0 111.167 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -59.06 -39.71 82.89 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.256 0.934 . . . . 0.0 110.881 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.08 -39.07 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.514 0.726 . . . . 0.0 110.407 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 139.15 13.21 0.69 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.501 169.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -80.93 156.06 26.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.803 1.801 . . . . 0.0 111.652 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -144.43 140.76 29.18 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 126.444 1.897 . . . . 0.0 107.261 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.506 HG22 HD22 ' A' ' 142' ' ' LEU . 21.6 t -71.12 137.94 22.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.06 0.944 . . . . 0.0 110.318 -169.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.2 p -131.12 -9.73 3.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.809 2.044 . . . . 0.0 111.59 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.23 173.27 42.41 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 170.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -158.84 -173.63 4.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.873 0.836 . . . . 0.0 111.259 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -137.11 174.22 10.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.488 1.915 . . . . 0.0 108.542 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -122.74 -7.92 8.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.936 0.894 . . . . 0.0 111.599 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.94 172.68 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.708 2.003 . . . . 0.0 106.542 170.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -78.5 -64.7 1.11 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -161.22 -43.7 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.346 1.058 . . . . 0.0 112.126 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.99 -5.17 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.528 0.731 . . . . 0.0 112.083 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.1 -14.47 21.32 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.036 1.303 . . . . 0.0 112.502 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -60.63 138.59 92.96 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.055 0.928 . . . . 0.0 110.422 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -81.13 52.56 4.38 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.224 3.282 . . . . 0.0 112.413 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -121.88 66.74 21.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.52 1.128 . . . . 0.0 108.571 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.55 156.81 54.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.773 2.315 . . . . 0.0 114.699 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.15 142.98 33.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.1 mt -109.39 149.62 29.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -123.01 137.9 54.83 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.506 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.65 161.84 35.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -133.47 146.54 51.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.662 1.585 . . . . 0.0 108.897 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -73.04 127.03 31.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.47 -12.75 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 123.466 0.706 . . . . 0.0 111.943 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.87 29.07 3.09 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.558 1.075 . . . . 0.0 113.902 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 124.396 1.078 . . . . 0.0 110.054 176.302 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.06 179.92 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 107.011 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.7 mm -137.36 145.24 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.0 m -144.15 166.01 26.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 168.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -125.66 141.85 44.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.8 ptt85 -154.78 170.31 21.92 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.746 0.818 . . . . 0.0 109.998 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmm-85 -59.07 146.94 36.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 109.818 169.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 p -62.51 157.91 19.2 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.961 1.704 . . . . 0.0 112.595 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -106.55 155.18 19.89 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -67.92 -42.09 81.59 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.711 -0.618 . . . . 0.0 110.648 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.45 -25.66 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.07 -0.06 53.23 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.059 0.544 . . . . 0.0 111.4 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.21 -41.77 47.71 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 118.998 0.817 . . . . 0.0 113.281 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.78 -26.05 65.91 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.645 1.223 . . . . 0.0 111.901 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.54 -30.73 67.55 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.281 -0.887 . . . . 0.0 109.621 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 26.0 mt -73.01 -39.9 65.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.8 t -57.18 -45.02 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.298 0.639 . . . . 0.0 109.456 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.94 98.67 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.831 0.452 . . . . 0.0 111.635 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.96 -49.56 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.589 0.756 . . . . 0.0 109.401 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -55.01 -47.79 74.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.688 0.395 . . . . 0.0 110.232 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -59.97 -44.52 94.41 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.703 -0.623 . . . . 0.0 110.249 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -64.4 -33.37 75.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 123.614 0.766 . . . . 0.0 111.813 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.4 m -68.4 -39.93 81.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.8 t -66.29 -47.25 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.07 -32.36 66.17 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.754 0.821 . . . . 0.0 112.65 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.26 -43.04 15.24 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.024 0.929 . . . . 0.0 112.482 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.7 p -138.76 -1.41 1.82 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -168.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -135.24 17.84 3.42 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.381 1.446 . . . . 0.0 112.326 -172.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -64.48 1.34 0.82 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.766 2.027 . . . . 0.0 114.368 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -59.41 -24.24 63.3 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.322 1.849 . . . . 0.0 112.523 172.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.08 112.21 2.53 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 m -56.91 154.37 9.56 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.971 1.308 . . . . 0.0 110.766 172.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.28 -36.75 71.43 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -169.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.2 -47.08 71.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.749 0.704 . . . . 0.0 109.937 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -64.72 -40.24 95.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.282 0.633 . . . . 0.0 109.821 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -55.36 -48.56 74.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.611 1.164 . . . . 0.0 110.139 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.8 m -65.08 -49.18 71.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.177 0.991 . . . . 0.0 110.041 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -65.95 -38.45 88.65 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.223 -0.298 . . . . 0.0 110.641 -176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.9 mt -62.78 -53.58 52.12 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.386 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -57.78 -38.22 75.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.244 0.929 . . . . 0.0 110.789 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.99 -48.81 72.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.196 0.598 . . . . 0.0 111.857 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.96 -36.54 75.34 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.177 0.444 . . . . 0.0 110.192 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.9 t -58.87 -48.95 84.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 126.071 1.748 . . . . 0.0 109.091 172.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -70.3 -10.56 59.31 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.001 -1.062 . . . . 0.0 112.742 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.4 m -95.46 4.2 53.5 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.625 0.77 . . . . 0.0 110.608 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -135.14 -56.58 0.81 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.805 -1.093 . . . . 0.0 112.336 -169.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.89 -38.65 70.52 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 120.644 1.565 . . . . 0.0 113.211 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -61.2 -14.8 36.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.422 2.081 . . . . 0.0 115.052 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.72 -13.82 5.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.484 1.493 . . . . 0.0 112.73 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.75 150.55 96.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.844 1.257 . . . . 0.0 111.166 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.78 55.94 5.43 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.663 3.575 . . . . 0.0 111.94 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.98 155.04 26.61 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.349 1.06 . . . . 0.0 111.146 -171.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -111.32 109.7 19.82 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -91.66 138.98 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.44 133.88 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 103.165 -2.902 . . . . 0.0 103.165 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.7 m -126.47 141.5 45.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -83.71 178.74 7.82 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.05 -23.93 0.95 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.869 2.068 . . . . 0.0 114.661 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -79.27 -3.34 45.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.669 1.588 . . . . 0.0 112.274 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 t0 50.76 57.69 6.36 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 123.929 1.823 . . . . 0.0 109.69 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -140.63 126.35 11.43 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 141.95 54.02 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.445 2.097 . . . . 0.0 111.468 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.05 -8.67 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.372 1.069 . . . . 0.0 112.304 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.75 171.55 39.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.42 153.06 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 117.81 0.805 . . . . 0.0 110.667 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -136.91 132.02 33.89 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 127.539 2.336 . . . . 0.0 105.667 -175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.75 117.37 31.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 104.714 -2.328 . . . . 0.0 104.714 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.2 tp -142.78 133.47 25.27 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 m -143.04 152.74 42.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.76 -114.89 5.3 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -170.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -130.68 27.66 4.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 110.679 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -125.58 111.47 15.05 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.53 -0.731 . . . . 0.0 110.458 -177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -79.39 89.02 4.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -62.23 -29.26 70.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.924 0.89 . . . . 0.0 112.979 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.95 148.81 29.54 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.826 0.851 . . . . 0.0 110.488 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.0 tp -155.36 119.37 4.58 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.0 1.72 . . . . 0.0 106.463 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.12 144.31 30.85 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 mt -151.43 142.93 16.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -169.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.9 133.81 95.7 Favored Pre-proline 0 C--O 1.238 0.461 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.547 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.67 -24.31 70.14 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.755 2.303 . . . . 0.0 113.729 -176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.59 -24.2 67.51 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.416 1.007 . . . . 0.0 112.902 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.4 m -115.42 -1.22 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -59.91 -38.49 82.49 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.978 -1.076 . . . . 0.0 110.223 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.02 72.09 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.563 0.601 . . . . 0.0 112.776 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.1 m -75.03 -6.5 49.75 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.229 1.014 . . . . 0.0 112.214 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.39 13.73 65.1 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.377 174.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.64 -31.2 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 119.255 1.527 . . . . 0.0 111.088 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.27 -54.38 10.23 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.947 0.784 . . . . 0.0 111.95 169.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -64.32 -43.76 93.66 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.031 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.3 t -56.78 -46.66 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 120.453 1.479 . . . . 0.0 110.179 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.3 mt -69.15 -40.33 78.29 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.349 0.522 . . . . 0.0 111.147 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.55 -40.94 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.713 0.688 . . . . 0.0 109.883 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.71 -34.45 77.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.21 0.914 . . . . 0.0 109.87 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -61.2 -46.79 88.99 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 118.186 0.448 . . . . 0.0 110.404 173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -47.73 80.34 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.268 0.627 . . . . 0.0 110.583 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.97 -33.18 71.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.488 1.115 . . . . 0.0 111.459 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -63.18 -36.61 84.19 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.486 0.584 . . . . 0.0 111.392 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 46.4 mtm -85.17 -23.95 28.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.32 0.509 . . . . 0.0 112.117 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.42 95.19 6.63 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 125.123 1.369 . . . . 0.0 109.184 -173.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.16 -25.99 50.19 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 121.29 1.326 . . . . 0.0 112.554 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -102.03 31.52 3.89 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.822 1.649 . . . . 0.0 110.369 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.9 tp -49.63 146.37 4.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.662 2.385 . . . . 0.0 113.118 -172.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.9 p -129.94 162.91 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.558 1.543 . . . . 0.0 108.969 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 t -155.76 -178.05 7.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 122.736 0.414 . . . . 0.0 110.548 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -136.13 155.39 50.24 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.621 1.569 . . . . 0.0 108.782 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.63 146.44 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -77.52 138.9 39.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -63.13 -24.19 67.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.637 0.375 . . . . 0.0 111.932 -176.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -54.97 -40.46 70.04 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.398 0.679 . . . . 0.0 111.538 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -86.15 63.81 8.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.551 1.141 . . . . 0.0 109.331 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.73 -28.27 47.04 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.207 1.003 . . . . 0.0 111.316 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -47.04 83.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.718 0.807 . . . . 0.0 109.802 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.84 -35.17 78.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.907 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.14 -49.46 79.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 119.57 1.077 . . . . 0.0 108.476 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.84 93.59 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -56.2 -50.6 70.78 Favored 'General case' 0 CA--C 1.524 -0.047 0 C-N-CA 123.536 0.735 . . . . 0.0 110.147 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -67.13 -33.88 76.39 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.88 -0.513 . . . . 0.0 109.822 -174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -59.29 -47.09 86.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.144 0.884 . . . . 0.0 110.901 170.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -58.81 -42.68 89.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.986 0.812 . . . . 0.0 110.429 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.03 -36.61 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.932 0.893 . . . . 0.0 110.737 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 136.02 9.86 1.42 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.8 -1.0 . . . . 0.0 114.638 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.38 155.49 30.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.87 1.835 . . . . 0.0 111.252 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -141.49 138.99 33.21 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.147 1.779 . . . . 0.0 106.574 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.492 HG22 HD22 ' A' ' 142' ' ' LEU . 25.9 t -71.73 135.03 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.17 0.988 . . . . 0.0 109.995 -171.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.1 p -126.77 -8.69 6.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.951 2.1 . . . . 0.0 111.481 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.55 178.3 43.94 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 118.901 0.773 . . . . 0.0 111.735 171.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -154.66 176.1 12.85 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.653 0.781 . . . . 0.0 110.185 171.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.2 m -147.11 136.95 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.679 2.392 . . . . 0.0 106.089 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -81.51 0.41 38.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.477 0.581 . . . . 0.0 112.371 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.27 172.32 16.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.948 1.699 . . . . 0.0 107.245 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.98 -65.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.22 -171.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -158.3 -48.45 0.06 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.67 27.06 1.18 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.352 1.061 . . . . 0.0 110.194 -177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.93 18.99 71.26 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.318 0.961 . . . . 0.0 113.127 -170.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -65.53 133.65 95.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -78.59 45.21 1.81 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.883 3.056 . . . . 0.0 112.438 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -131.57 112.82 15.29 Favored Pre-proline 0 N--CA 1.455 -0.189 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.0 162.93 8.33 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.09 1.86 . . . . 0.0 115.547 -173.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -126.42 145.64 50.39 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 57.2 mt -116.69 150.1 38.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.429 ' C ' HD23 ' A' ' 142' ' ' LEU . 16.6 t-20 -120.16 138.87 53.35 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.492 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.89 160.83 38.25 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.398 1.079 . . . . 0.0 108.591 -170.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.9 150.97 52.11 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.706 1.602 . . . . 0.0 108.569 176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -76.46 124.84 28.18 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 99.6 t -130.53 -18.62 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.407 1.083 . . . . 0.0 110.434 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.99 29.52 2.42 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.787 1.184 . . . . 0.0 114.106 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.403 1.081 . . . . 0.0 110.004 175.019 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.94 158.82 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.458 0.647 . . . . 0.0 111.464 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.3 mm -138.14 144.77 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -140.78 165.35 27.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 168.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.0 mm -127.12 143.18 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -155.02 170.63 21.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.041 0.937 . . . . 0.0 109.822 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -59.02 147.8 33.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.489 0.586 . . . . 0.0 109.905 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p -63.4 154.41 32.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 125.584 1.553 . . . . 0.0 112.6 174.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -100.16 155.28 17.83 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -65.48 -48.51 72.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.852 -0.53 . . . . 0.0 110.278 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.24 -27.33 64.37 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -169.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.5 -5.76 51.18 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.141 0.428 . . . . 0.0 111.497 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.37 -35.64 36.01 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 124.184 0.897 . . . . 0.0 113.355 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -66.72 -31.51 72.21 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.293 1.047 . . . . 0.0 111.281 -177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.96 -31.32 70.97 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.402 0.681 . . . . 0.0 109.587 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.2 mt -73.38 -39.74 64.88 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.792 -0.567 . . . . 0.0 109.774 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -57.89 -46.11 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 171.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.13 99.34 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.108 0.563 . . . . 0.0 111.688 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.3 mt -62.11 -50.27 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 109.432 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t90 -51.98 -47.88 64.66 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.534 . . . . 0.0 110.269 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 t -58.62 -50.39 74.03 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.153 0.433 . . . . 0.0 110.747 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -70.74 -28.18 64.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.504 -0.748 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 m -63.16 -44.92 94.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.081 0.855 . . . . 0.0 109.435 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.89 -42.54 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.772 0.829 . . . . 0.0 109.425 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.37 -35.05 73.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.021 0.828 . . . . 0.0 111.888 177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.47 -36.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.111 -0.947 . . . . 0.0 113.1 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -136.58 -13.41 1.74 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 -169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -129.76 29.64 4.98 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.129 0.971 . . . . 0.0 110.572 -169.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -60.7 -12.76 11.4 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.289 1.436 . . . . 0.0 113.495 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -51.61 -23.0 3.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.333 1.853 . . . . 0.0 113.203 169.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.34 97.78 0.43 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.667 1.187 . . . . 0.0 108.741 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -54.35 157.82 2.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.999 1.319 . . . . 0.0 110.712 170.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.42 64.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -46.81 72.37 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.901 0.773 . . . . 0.0 110.246 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.16 -40.89 97.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.632 0.773 . . . . 0.0 109.715 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -56.65 -47.28 80.09 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 124.256 1.022 . . . . 0.0 109.992 175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 m -65.78 -47.03 76.52 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.242 1.017 . . . . 0.0 110.393 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.0 -36.97 83.35 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.228 0.467 . . . . 0.0 110.712 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.91 -49.92 66.3 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.68 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -56.09 -39.45 72.14 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 119.126 0.875 . . . . 0.0 110.27 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.92 -48.33 80.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 118.809 0.731 . . . . 0.0 112.198 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.69 -38.9 77.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -58.88 -47.55 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.979 1.711 . . . . 0.0 109.781 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.3 tpt85 -60.82 -24.22 65.68 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.367 1.067 . . . . 0.0 111.121 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m -99.66 7.13 45.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.316 1.046 . . . . 0.0 110.969 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -136.96 -54.08 0.71 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 117.776 -1.107 . . . . 0.0 112.81 -169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.26 -37.76 60.75 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 120.642 1.565 . . . . 0.0 113.048 -176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -61.84 -14.15 34.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.337 2.025 . . . . 0.0 115.479 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.32 -14.6 5.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.645 1.566 . . . . 0.0 112.48 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.28 150.15 93.28 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.835 1.254 . . . . 0.0 110.834 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.28 50.83 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.56 3.506 . . . . 0.0 111.675 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.36 162.05 29.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 124.461 1.104 . . . . 0.0 110.993 -171.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -118.06 117.03 28.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 171.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -99.06 140.08 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.24 0.616 . . . . 0.0 109.992 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.88 137.83 34.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.92 144.52 37.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -85.43 -175.62 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.586 170.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.79 -25.3 40.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.335 1.454 . . . . 0.0 113.415 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -79.75 -1.66 39.6 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.04 0.936 . . . . 0.0 111.498 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.4 t0 51.98 57.43 6.5 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.558 1.647 . . . . 0.0 109.238 -169.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? -136.35 127.59 16.85 Favored Pre-proline 0 N--CA 1.446 -0.643 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.26 141.34 47.01 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.498 2.132 . . . . 0.0 111.681 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.17 -11.74 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.387 1.075 . . . . 0.0 112.103 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.25 172.69 41.64 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -145.5 160.96 40.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.545 0.688 . . . . 0.0 111.494 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -140.29 137.1 33.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.068 2.547 . . . . 0.0 106.1 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.2 tp -115.48 127.52 55.37 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 169.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 tp -144.36 140.87 29.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 170.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -154.21 155.81 35.96 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 168.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.19 -114.24 4.85 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -169.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -133.98 36.81 3.25 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.641 1.177 . . . . 0.0 110.043 175.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -134.05 115.38 14.24 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 121.212 -0.93 . . . . 0.0 111.34 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 56.1 ttp -86.2 90.41 8.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.95 -29.31 67.52 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.75 144.69 35.66 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.218 0.607 . . . . 0.0 110.799 -169.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.0 tp -157.12 115.47 3.24 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.451 1.901 . . . . 0.0 106.14 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -145.69 141.35 27.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -151.4 146.21 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -169.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -59.24 122.13 61.19 Favored Pre-proline 0 N--CA 1.448 -0.54 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.27 -24.47 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.815 3.01 . . . . 0.0 115.36 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -64.43 -25.14 67.88 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.244 0.929 . . . . 0.0 112.75 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.45 -8.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -46.99 -41.61 16.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.005 1.322 . . . . 0.0 111.799 171.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.43 -12.22 65.33 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.866 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.9 -22.18 62.3 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.317 1.558 . . . . 0.0 112.109 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 137.18 -9.17 3.83 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.031 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.66 -32.17 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 119.161 1.48 . . . . 0.0 111.278 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -48.92 -53.92 16.31 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 123.538 0.589 . . . . 0.0 111.656 170.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -63.57 -42.4 98.32 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 117.141 -1.409 . . . . 0.0 110.262 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -58.72 -46.46 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.593 1.542 . . . . 0.0 109.932 -176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.4 mt -68.28 -41.81 80.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.982 -0.448 . . . . 0.0 110.77 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.74 -42.87 96.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.535 0.607 . . . . 0.0 110.181 176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -66.52 -36.22 82.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.561 0.745 . . . . 0.0 109.59 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -59.82 -44.97 93.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.884 0.474 . . . . 0.0 110.443 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.37 -50.34 63.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.323 0.649 . . . . 0.0 110.158 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.72 -31.13 67.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.393 1.077 . . . . 0.0 111.782 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.3 m -62.82 -31.79 72.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.759 0.709 . . . . 0.0 111.969 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.0 mtm -91.77 -20.79 21.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.286 0.635 . . . . 0.0 112.208 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 94.88 6.1 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.532 1.533 . . . . 0.0 108.175 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.99 -21.83 36.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 CA-C-N 120.738 1.299 . . . . 0.0 112.887 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -104.52 30.28 5.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.721 1.608 . . . . 0.0 110.182 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.93 149.16 12.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.477 2.311 . . . . 0.0 113.56 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p -128.04 162.1 27.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.188 1.395 . . . . 0.0 109.811 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 t -152.72 -174.12 4.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.261 0.553 . . . . 0.0 109.75 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -147.85 162.59 38.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.231 1.012 . . . . 0.0 109.994 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -157.0 143.49 9.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -71.04 133.74 46.55 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.88 -31.73 70.06 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.396 1.078 . . . . 0.0 111.782 -172.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.17 -32.2 73.77 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.848 0.459 . . . . 0.0 111.465 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -80.58 61.56 4.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.865 1.266 . . . . 0.0 109.143 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.92 -26.37 47.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.479 1.112 . . . . 0.0 111.381 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.09 -47.65 81.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.6 75.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.338 -0.839 . . . . 0.0 111.83 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.0 t -57.02 -48.53 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 119.578 1.081 . . . . 0.0 108.484 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.06 -46.76 93.9 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -54.92 -51.11 67.09 Favored 'General case' 0 CA--C 1.523 -0.061 0 C-N-CA 123.633 0.773 . . . . 0.0 110.02 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -66.76 -34.53 78.04 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.027 -0.42 . . . . 0.0 109.956 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.28 -47.91 82.13 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.246 0.93 . . . . 0.0 110.778 170.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -58.85 -41.6 87.35 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.051 0.841 . . . . 0.0 110.757 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.77 -36.07 75.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.091 0.957 . . . . 0.0 110.478 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.91 9.51 1.7 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.338 0.97 . . . . 0.0 114.272 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.92 154.84 35.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.222 1.511 . . . . 0.0 111.449 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -139.62 138.66 36.33 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.637 1.575 . . . . 0.0 106.759 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 142' ' ' LEU . 25.6 t -72.64 135.28 28.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.214 1.006 . . . . 0.0 109.86 -171.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.2 p -125.12 -9.75 7.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.714 2.006 . . . . 0.0 111.327 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.17 179.77 43.57 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 118.755 0.707 . . . . 0.0 111.43 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -154.8 179.0 9.51 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 109.246 169.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -145.44 141.64 28.56 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 107.96 -178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -72.48 -3.58 25.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.736 0.814 . . . . 0.0 112.693 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 m -134.67 171.51 17.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.559 1.544 . . . . 0.0 107.602 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -82.98 -57.31 3.35 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -163.48 -41.22 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.811 0.845 . . . . 0.0 112.745 174.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.0 mt -89.04 9.67 24.42 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.072 0.949 . . . . 0.0 111.691 -171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.53 -9.21 77.71 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.512 1.054 . . . . 0.0 112.742 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -63.17 132.41 95.08 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.184 0.993 . . . . 0.0 110.44 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.75 62.64 8.57 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.236 3.291 . . . . 0.0 112.131 -170.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -128.84 74.68 80.71 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -36.82 147.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 125.074 3.849 . . . . 0.0 118.902 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.22 148.27 32.18 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.661 1.584 . . . . 0.0 107.255 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 60.9 mt -113.77 148.33 36.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 170.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.443 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.2 t-20 -119.09 138.27 53.0 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.756 1.223 . . . . 0.0 107.753 175.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.517 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.14 162.47 33.32 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.028 0.931 . . . . 0.0 108.525 -171.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.02 51.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.792 1.637 . . . . 0.0 108.134 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -72.48 127.2 31.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.2 -9.98 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 124.437 1.095 . . . . 0.0 110.191 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.72 38.14 89.54 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -169.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 124.907 1.283 . . . . 0.0 111.033 178.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.401 0.143 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.5 t -60.05 151.22 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.54 0.736 . . . . 0.0 109.499 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 mm -128.46 146.22 34.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 m -143.61 167.14 22.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 168.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 HD12 ' CD2' ' A' ' 91' ' ' LEU . 13.5 mm -126.22 142.87 41.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.1 ptt85 -154.53 171.56 19.23 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.881 0.872 . . . . 0.0 109.955 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -61.31 150.31 35.34 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.544 0.611 . . . . 0.0 109.781 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 p -60.11 162.56 5.66 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.037 1.335 . . . . 0.0 112.046 171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -120.82 139.18 53.5 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.489 1.916 . . . . 0.0 106.131 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -57.44 -41.45 80.51 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.474 0.579 . . . . 0.0 111.563 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.53 -19.3 62.91 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -88.56 -2.59 58.68 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.863 0.756 . . . . 0.0 111.33 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.52 -39.17 44.53 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 118.92 0.782 . . . . 0.0 113.467 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.88 -28.94 70.18 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.195 0.998 . . . . 0.0 112.13 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -65.33 -35.6 81.48 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 118.868 0.758 . . . . 0.0 109.647 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.3 -39.31 59.75 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.6 t -58.46 -45.58 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.284 0.634 . . . . 0.0 109.411 169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.59 91.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.339 0.656 . . . . 0.0 112.176 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.0 mt -63.36 -49.79 81.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.695 1.198 . . . . 0.0 109.258 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.0 t90 -55.87 -45.72 78.46 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.864 -0.523 . . . . 0.0 110.319 174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.3 t -59.91 -49.74 76.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.739 0.816 . . . . 0.0 110.903 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.52 -25.72 64.17 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.018 -1.051 . . . . 0.0 111.976 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 60.0 m -68.6 -34.32 75.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.049 0.841 . . . . 0.0 110.595 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.1 -46.48 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.5 -40.67 92.23 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.82 -34.38 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.448 -173.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.5 p -137.9 3.14 2.44 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -168.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' CE1' HD22 ' A' ' 110' ' ' ASN . 15.9 m80 -126.99 37.53 4.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.324 1.42 . . . . 0.0 109.305 172.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.25 -27.47 55.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.353 1.061 . . . . 0.0 113.784 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.09 -17.19 64.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.534 0.734 . . . . 0.0 112.957 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.4 tp -58.9 127.14 30.69 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.531 1.132 . . . . 0.0 110.783 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -56.48 138.08 52.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.096 1.358 . . . . 0.0 110.055 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.57 80.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.078 0.399 . . . . 0.0 112.024 -175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -66.17 -42.86 88.34 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.783 -0.573 . . . . 0.0 109.696 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.66 -38.89 84.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.37 -52.93 57.69 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.887 0.875 . . . . 0.0 109.329 172.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.9 m -59.39 -49.07 79.23 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 110.321 -174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.12 -35.37 71.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.29 -0.256 . . . . 0.0 111.18 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.81 -49.7 73.9 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 172.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.14 -36.59 77.86 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.052 0.842 . . . . 0.0 110.441 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.08 -47.89 80.97 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.014 0.525 . . . . 0.0 111.907 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -36.56 71.16 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.122 -0.361 . . . . 0.0 110.104 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.46 -46.99 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.111 1.765 . . . . 0.0 109.229 172.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -70.25 -9.05 54.77 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.797 -1.19 . . . . 0.0 112.555 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -101.28 6.68 42.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.174 0.99 . . . . 0.0 110.891 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.99 -55.1 0.72 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.653 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -56.45 -38.4 68.03 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 120.57 1.532 . . . . 0.0 112.932 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -61.46 -14.18 33.51 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.323 2.015 . . . . 0.0 114.94 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.63 -17.45 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.596 1.544 . . . . 0.0 112.38 -174.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.34 148.37 98.03 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 124.585 1.154 . . . . 0.0 110.826 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.39 51.48 3.89 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.942 3.762 . . . . 0.0 111.373 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.34 165.48 20.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.595 1.158 . . . . 0.0 110.691 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -118.38 109.77 16.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -90.04 138.82 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 123.191 0.596 . . . . 0.0 109.663 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.9 134.27 35.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 167.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.3 m -126.35 143.86 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -77.04 -177.32 4.4 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.172 0.987 . . . . 0.0 110.12 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.0 -17.86 20.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.446 1.898 . . . . 0.0 113.552 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.71 4.56 53.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.383 1.473 . . . . 0.0 112.046 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.6 t0 53.27 46.25 26.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.716 1.246 . . . . 0.0 110.235 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 129.19 24.21 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.86 138.96 71.59 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.85 1.7 . . . . 0.0 110.282 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.7 -8.89 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.714 1.205 . . . . 0.0 112.233 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.83 174.2 40.78 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -148.16 159.49 43.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.804 0.802 . . . . 0.0 111.517 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.3 tmm? -136.97 141.25 42.59 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.329 2.652 . . . . 0.0 105.826 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.7 tp -122.9 127.34 48.82 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 tp -145.37 139.85 27.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.7 m -153.25 156.3 38.21 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.2 -116.12 7.0 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -169.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.0 25.78 4.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.874 0.87 . . . . 0.0 111.51 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -110.9 112.36 24.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.306 1.042 . . . . 0.0 110.685 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 64.6 ttp -80.04 87.27 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 169.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -67.1 -23.02 65.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.12 146.55 30.92 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.447 0.567 . . . . 0.0 110.263 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.9 tp -156.08 116.05 3.64 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.74 141.4 30.45 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -148.11 146.93 17.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -59.64 122.76 67.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.06 -29.59 6.46 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.049 3.166 . . . . 0.0 114.638 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.38 -24.53 67.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.187 0.995 . . . . 0.0 113.563 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.77 -1.51 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 118.828 0.74 . . . . 0.0 112.741 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -58.16 -37.4 74.61 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.905 -1.122 . . . . 0.0 110.67 175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.27 -21.58 68.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.824 0.726 . . . . 0.0 113.394 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.7 m -79.36 -3.35 45.84 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.635 1.217 . . . . 0.0 111.846 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.59 12.97 68.44 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.359 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -55.7 -31.42 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.196 1.498 . . . . 0.0 110.994 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -47.9 -53.52 13.9 Favored Glycine 0 C--N 1.339 0.73 0 C-N-CA 123.831 0.729 . . . . 0.0 111.722 170.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -63.25 -43.24 98.57 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 117.213 -1.375 . . . . 0.0 110.19 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -57.83 -46.27 87.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 120.356 1.435 . . . . 0.0 110.076 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.411 ' CD2' HD12 ' A' ' 5' ' ' ILE . 24.7 mt -69.36 -40.59 77.39 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.803 -0.561 . . . . 0.0 111.144 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.2 t -62.69 -41.24 91.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.646 0.657 . . . . 0.0 109.991 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -67.91 -34.13 76.04 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.124 0.875 . . . . 0.0 109.876 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -60.1 -47.04 87.56 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.231 0.469 . . . . 0.0 110.261 172.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -48.64 75.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.419 0.688 . . . . 0.0 110.785 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.17 -34.07 69.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.532 1.133 . . . . 0.0 111.458 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.9 m -62.72 -34.11 76.5 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.447 0.567 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 43.5 mtm -90.2 -21.88 21.96 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.363 0.529 . . . . 0.0 112.124 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.12 90.63 9.18 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 -172.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.43 -21.99 59.93 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.513 1.475 . . . . 0.0 113.134 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -107.34 33.02 4.23 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.606 1.562 . . . . 0.0 109.808 -175.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 38.5 tp -48.58 144.86 3.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.412 2.285 . . . . 0.0 112.951 -171.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.7 p -129.9 161.57 30.56 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 125.761 1.625 . . . . 0.0 108.102 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 t -153.09 -179.55 7.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.42 0.628 . . . . 0.0 110.555 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -143.07 159.32 42.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.275 1.03 . . . . 0.0 109.758 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.7 p -155.14 142.85 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -71.26 131.54 43.62 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -60.62 -22.46 63.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.563 0.745 . . . . 0.0 112.001 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.61 21.13 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.99 1.716 . . . . 0.0 113.098 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.407 HD22 ' CE1' ' A' ' 28' ' ' HIS . 64.9 t-20 -148.51 66.24 1.07 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.975 1.71 . . . . 0.0 108.143 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.71 -24.77 58.54 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.513 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -62.71 -48.94 77.07 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.889 0.476 . . . . 0.0 110.105 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.62 82.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.442 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.29 -49.65 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.71 -46.2 94.69 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -56.59 -50.67 71.27 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -67.38 -33.62 75.59 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.907 -0.496 . . . . 0.0 109.665 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mptm? -58.53 -48.39 81.0 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.11 0.868 . . . . 0.0 110.853 170.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -58.38 -42.67 87.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.905 0.775 . . . . 0.0 110.499 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.53 -34.42 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.206 1.003 . . . . 0.0 111.069 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.64 9.86 1.94 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.856 -0.969 . . . . 0.0 114.297 169.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -77.19 155.22 32.38 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.737 1.769 . . . . 0.0 111.039 173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -141.63 139.76 33.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.14 1.776 . . . . 0.0 106.58 178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.487 HG22 HD22 ' A' ' 142' ' ' LEU . 21.8 t -71.73 135.42 27.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 123.888 0.875 . . . . 0.0 109.93 -170.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 p -124.2 -10.77 7.55 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.507 1.923 . . . . 0.0 111.244 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 179.16 45.02 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 118.823 0.738 . . . . 0.0 111.844 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.91 175.74 11.76 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.217 1.007 . . . . 0.0 108.4 169.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.0 m -145.65 135.89 23.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -79.92 1.64 26.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.059 0.39 . . . . 0.0 111.629 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.61 170.71 19.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 126.208 1.803 . . . . 0.0 107.781 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -100.85 -58.3 1.92 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.337 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -161.68 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.47 10.62 5.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.595 1.158 . . . . 0.0 111.218 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.82 1.7 62.96 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.833 1.206 . . . . 0.0 112.472 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -70.5 138.2 86.22 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.768 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -77.55 62.95 7.86 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.21 3.273 . . . . 0.0 112.194 -171.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -123.79 101.48 36.2 Favored Pre-proline 0 C--O 1.224 -0.28 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -57.36 165.06 6.11 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.37 2.047 . . . . 0.0 116.557 -169.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.1 tp -136.28 146.34 46.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.424 1.89 . . . . 0.0 106.368 169.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.5 mt -115.86 149.18 39.05 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -126.71 137.28 53.24 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 124.676 1.19 . . . . 0.0 108.549 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -137.9 161.99 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.316 1.046 . . . . 0.0 108.583 -169.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.91 150.45 52.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 108.631 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -76.61 126.54 31.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.92 -14.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.939 1.296 . . . . 0.0 110.431 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -54.08 143.47 29.67 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.511 1.053 . . . . 0.0 112.278 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.722 2.009 . . . . 0.0 107.86 175.195 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.29 169.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 171.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 mm -127.74 144.16 38.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.8 m -142.13 165.38 27.61 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mm -124.1 142.71 39.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -151.84 174.24 13.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.814 0.846 . . . . 0.0 110.046 174.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -63.82 152.61 39.07 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 p -63.52 174.61 1.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.122 1.769 . . . . 0.0 112.326 174.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -132.06 142.44 49.54 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.168 1.787 . . . . 0.0 106.493 169.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -57.73 -40.26 79.22 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.205 0.457 . . . . 0.0 110.897 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.07 -13.43 61.58 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.74 -0.84 41.93 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.865 0.757 . . . . 0.0 110.957 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -53.2 -40.72 60.31 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.587 0.613 . . . . 0.0 113.182 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.82 -28.2 68.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.348 1.074 . . . . 0.0 111.685 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.71 -33.04 71.96 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.485 -0.759 . . . . 0.0 109.908 173.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.5 mt -72.15 -38.96 69.07 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.39 -47.79 83.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.82 89.22 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.056 0.542 . . . . 0.0 111.699 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.45 -51.25 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.825 1.25 . . . . 0.0 109.782 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.3 t90 -54.55 -50.17 68.55 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.933 0.493 . . . . 0.0 109.676 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.3 m -53.46 -48.63 68.66 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.955 1.302 . . . . 0.0 111.394 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -73.74 -33.86 64.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.042 -0.98 . . . . 0.0 112.87 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.78 -27.1 63.67 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 120.531 1.514 . . . . 0.0 111.313 172.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.26 -45.74 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 O-C-N 121.269 -0.894 . . . . 0.0 109.068 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -60.73 -38.01 83.67 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.004 0.82 . . . . 0.0 111.904 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.83 -36.59 56.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.249 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.0 p -138.94 -4.56 1.54 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -169.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' CE1' HD22 ' A' ' 110' ' ' ASN . 20.4 m80 -126.96 25.23 6.3 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.9 1.227 . . . . 0.0 110.458 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.49 -15.9 31.58 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -170.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -53.03 -22.64 6.09 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.812 2.045 . . . . 0.0 113.155 170.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.94 97.54 0.36 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.876 1.27 . . . . 0.0 108.163 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.7 m -54.82 155.69 4.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 111.181 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.28 64.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.19 -48.13 68.86 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.85 0.75 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.44 -40.0 94.91 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.192 0.597 . . . . 0.0 109.872 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -55.2 -47.28 75.48 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.781 1.232 . . . . 0.0 110.195 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.5 m -64.97 -49.72 69.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.019 0.928 . . . . 0.0 110.011 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.01 -38.05 87.48 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.962 0.346 . . . . 0.0 110.725 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 mt -62.39 -53.67 51.6 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-O 118.5 -0.762 . . . . 0.0 109.519 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -57.16 -39.58 75.55 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.18 0.9 . . . . 0.0 110.54 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.42 -48.58 77.2 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.958 0.503 . . . . 0.0 111.882 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.072 0.396 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.7 t -59.43 -48.09 88.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.079 1.752 . . . . 0.0 109.279 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -69.94 -10.56 58.99 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.013 -1.054 . . . . 0.0 112.498 176.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -98.21 5.62 48.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 110.702 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -136.15 -56.97 0.76 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 117.739 -1.124 . . . . 0.0 112.507 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.0 mt -55.49 -38.95 73.55 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 120.793 1.633 . . . . 0.0 113.125 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.39 -14.38 34.39 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.266 1.977 . . . . 0.0 114.818 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -129.01 -14.03 4.47 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 120.862 1.665 . . . . 0.0 113.144 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.11 91.23 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.048 1.339 . . . . 0.0 111.514 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.46 60.25 7.01 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 124.844 3.696 . . . . 0.0 110.872 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.8 mt -83.06 179.69 7.68 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.818 1.294 . . . . 0.0 110.831 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -135.38 140.66 45.17 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.58 2.752 . . . . 0.0 103.921 168.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.6 m -116.77 139.77 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 119.264 0.938 . . . . 0.0 110.063 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.8 132.66 35.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 167.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.9 m -125.43 141.78 44.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -81.74 -179.82 7.53 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.358 171.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.55 -25.87 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.769 2.028 . . . . 0.0 114.33 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -85.17 3.35 39.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.288 1.435 . . . . 0.0 112.175 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.2 t0 51.33 59.31 4.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 123.761 1.743 . . . . 0.0 109.182 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -131.84 119.27 16.93 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 -169.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.89 139.78 76.03 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.019 1.813 . . . . 0.0 109.393 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.66 -10.54 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.681 1.193 . . . . 0.0 111.977 174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.12 173.03 41.63 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -145.86 160.94 41.08 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.615 0.722 . . . . 0.0 111.407 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.6 tmm? -141.56 129.78 22.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.836 2.454 . . . . 0.0 105.506 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 74' ' ' ASP . 24.7 tp -109.06 124.89 51.48 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 169.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.7 tp -145.86 134.75 22.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.5 m -159.72 155.61 26.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.081 2.152 . . . . 0.0 105.281 168.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.67 57.53 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.862 0.756 . . . . 0.0 113.881 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 58.43 21.77 8.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.992 1.717 . . . . 0.0 113.731 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -124.46 112.87 17.41 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.946 0.899 . . . . 0.0 110.079 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.1 ttp -85.22 85.79 7.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.535 ' HB3' HD23 ' A' ' 67' ' ' LEU . 33.0 t70 -63.76 -28.31 69.79 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.26 144.19 31.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.015 0.526 . . . . 0.0 110.094 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.8 tp -153.7 112.07 3.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -142.58 140.88 31.87 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.07 154.63 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 -171.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -65.0 124.17 85.94 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.65 -27.59 8.1 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.147 3.231 . . . . 0.0 114.759 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.59 -24.15 66.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.978 0.911 . . . . 0.0 112.935 176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.5 m -124.49 -2.76 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.759 0.824 . . . . 0.0 112.86 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -55.18 -42.91 73.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.553 1.07 . . . . 0.0 109.786 169.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.81 -26.73 72.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.496 -0.613 . . . . 0.0 113.132 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.9 m -74.57 -8.07 55.14 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.497 1.149 . . . . 0.0 112.419 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.02 13.93 56.98 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.399 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.9 t -56.01 -30.22 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 119.403 1.602 . . . . 0.0 110.293 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -46.89 -52.38 11.8 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 124.221 0.915 . . . . 0.0 111.883 169.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -62.35 -44.58 96.14 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.079 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.45 -46.96 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 119.835 1.198 . . . . 0.0 109.963 -176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.0 mt -69.3 -39.72 78.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.281 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.13 -40.27 88.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.817 0.735 . . . . 0.0 109.939 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.91 -34.68 78.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.375 0.989 . . . . 0.0 109.762 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -60.74 -48.51 81.49 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 122.908 0.483 . . . . 0.0 110.318 173.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.58 -49.3 77.19 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.612 0.765 . . . . 0.0 110.93 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.46 -33.46 71.32 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.591 1.156 . . . . 0.0 111.546 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.7 m -62.92 -35.56 80.51 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.578 0.626 . . . . 0.0 111.547 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.7 mtm -85.73 -25.39 26.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.364 0.529 . . . . 0.0 112.082 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.05 94.29 7.9 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 125.176 1.391 . . . . 0.0 109.16 -172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.99 -23.31 46.88 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 121.24 1.293 . . . . 0.0 112.405 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.77 29.08 4.32 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.753 1.621 . . . . 0.0 110.489 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.7 tp -52.49 144.79 12.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.238 2.215 . . . . 0.0 113.248 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.9 p -129.28 164.57 23.21 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.53 1.532 . . . . 0.0 108.82 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -154.86 -174.47 5.0 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.149 0.5 . . . . 0.0 110.236 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -148.28 162.03 40.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 110.001 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.5 HG12 HD21 ' A' ' 142' ' ' LEU . 13.1 p -157.71 148.69 9.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -70.0 130.33 41.88 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -56.54 -33.23 65.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.038 1.335 . . . . 0.0 111.805 -172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -66.39 -27.77 68.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.0 0.52 . . . . 0.0 111.779 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.442 HD22 ' CE1' ' A' ' 28' ' ' HIS . 57.5 t-20 -79.72 64.97 4.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.434 0.694 . . . . 0.0 109.52 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.27 -25.54 59.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.75 0.82 . . . . 0.0 111.388 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -62.79 -48.28 79.81 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 109.954 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.69 -36.61 78.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.65 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.21 -45.35 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 119.319 0.963 . . . . 0.0 109.001 173.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.66 -49.59 71.83 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -54.74 -50.49 68.24 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.912 0.885 . . . . 0.0 110.44 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -66.02 -35.72 81.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -64.51 -39.75 94.36 Favored 'General case' 0 C--N 1.341 0.209 0 O-C-N 120.875 -1.141 . . . . 0.0 112.552 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -59.18 -41.73 89.14 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.997 1.271 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.26 -34.18 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.307 1.043 . . . . 0.0 110.634 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 135.27 4.86 2.47 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.5 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -71.64 165.64 23.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.331 1.565 . . . . 0.0 111.197 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.52 140.78 33.54 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 126.755 2.022 . . . . 0.0 106.036 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.622 HG22 HD22 ' A' ' 142' ' ' LEU . 43.4 t -72.33 129.52 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.1 p -128.82 -7.2 5.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.012 1.725 . . . . 0.0 111.249 -173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.46 176.92 39.55 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 169.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -157.04 -178.81 7.64 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.728 0.811 . . . . 0.0 109.533 171.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.6 m -143.61 143.99 31.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.565 1.546 . . . . 0.0 108.073 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.23 -8.17 51.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.648 0.779 . . . . 0.0 112.494 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.66 174.76 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 126.138 1.775 . . . . 0.0 107.481 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.5 -61.91 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -160.82 -46.86 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.288 0.635 . . . . 0.0 112.684 171.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.36 27.7 1.39 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.372 1.069 . . . . 0.0 110.387 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.29 14.8 79.02 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 123.898 0.761 . . . . 0.0 113.21 -170.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -67.6 129.1 93.59 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.017 -1.468 . . . . 0.0 107.596 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.41 47.15 2.32 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.828 3.019 . . . . 0.0 112.388 -171.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -137.45 78.28 38.65 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 125.533 1.533 . . . . 0.0 107.152 -171.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_exo -37.49 146.98 0.09 OUTLIER 'Trans proline' 0 CA--C 1.536 0.607 1 C-N-CA 125.467 4.111 . . . . 0.0 118.74 -169.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.9 tp -104.4 147.77 27.17 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.592 1.557 . . . . 0.0 106.886 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.76 148.82 32.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.546 ' C ' HD23 ' A' ' 142' ' ' LEU . 9.9 t-20 -115.11 139.2 50.1 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.622 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -135.07 157.97 45.55 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -172.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -131.94 150.85 52.04 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.053 1.341 . . . . 0.0 108.206 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -76.31 130.87 38.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 89.6 t -130.25 -11.04 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.77 1.228 . . . . 0.0 109.895 -177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 66.34 36.51 91.75 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.843 1.257 . . . . 0.0 111.061 -179.777 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.04 168.15 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 mm -130.95 145.67 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -140.54 162.49 35.24 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 55' ' ' ALA . 23.2 mm -117.76 141.7 35.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 172.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.54 177.77 10.83 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.253 1.021 . . . . 0.0 109.872 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -73.63 150.3 41.45 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 m -72.69 -177.26 2.23 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.403 1.081 . . . . 0.0 111.154 173.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.87 161.45 32.97 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -67.34 -40.11 85.84 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 117.925 0.33 . . . . 0.0 110.116 176.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.73 -26.38 64.29 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -171.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.7 1.79 52.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.634 0.774 . . . . 0.0 111.301 175.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.53 -41.67 49.67 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 119.281 0.946 . . . . 0.0 112.837 -175.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.03 -26.86 68.45 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.057 0.929 . . . . 0.0 112.228 -178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -66.88 -34.59 78.12 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.966 0.803 . . . . 0.0 109.598 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.46 -38.16 49.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.43 -45.45 81.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -45.71 91.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.074 0.55 . . . . 0.0 111.448 178.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.3 mt -59.56 -48.52 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.161 0.985 . . . . 0.0 109.702 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.37 -51.04 66.05 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.619 0.767 . . . . 0.0 110.204 173.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.8 t -60.05 -40.83 90.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.897 -0.502 . . . . 0.0 110.367 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -66.23 -42.99 87.86 Favored 'General case' 0 C--O 1.228 -0.054 0 C-N-CA 123.327 0.651 . . . . 0.0 111.216 177.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -59.05 -37.06 76.11 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.917 0.487 . . . . 0.0 111.052 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -72.2 -44.32 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 123.269 0.628 . . . . 0.0 109.319 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -60.27 -37.81 81.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.012 0.824 . . . . 0.0 111.721 174.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.36 61.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.855 -174.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.1 p -139.27 -3.1 1.57 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -169.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.445 ' CE1' HD22 ' A' ' 110' ' ' ASN . 16.3 m80 -126.72 26.28 6.26 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.686 1.13 . . . . 0.0 110.456 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -13.92 28.99 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.847 -1.158 . . . . 0.0 113.053 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -57.25 -21.1 31.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.063 1.745 . . . . 0.0 112.995 170.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.05 109.69 1.9 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 173.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.3 m -58.05 147.53 29.25 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.533 1.533 . . . . 0.0 110.238 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.34 67.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.88 -52.48 56.35 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.503 ' CD1' ' HE3' ' A' ' 135' ' ' LYS . 4.3 t80 -70.79 -31.84 68.74 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.891 -0.506 . . . . 0.0 110.596 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 tpp85 -54.67 -46.38 74.03 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.956 0.902 . . . . 0.0 109.922 173.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.1 m -64.94 -50.04 67.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 109.843 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -63.4 -39.31 94.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.784 0.266 . . . . 0.0 110.545 -177.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.3 mt -62.34 -54.5 39.62 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 118.247 -0.882 . . . . 0.0 109.467 175.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -58.61 -37.81 76.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.419 1.009 . . . . 0.0 110.505 -173.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.13 -48.96 71.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.2 0.6 . . . . 0.0 111.919 175.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.09 -36.47 74.92 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.282 0.492 . . . . 0.0 110.49 -176.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.71 -48.71 85.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.195 1.798 . . . . 0.0 108.945 171.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.2 ttp85 -70.66 -8.4 51.61 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.001 -1.062 . . . . 0.0 112.764 176.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 m -99.63 5.55 45.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.066 0.947 . . . . 0.0 110.801 172.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -135.45 -55.37 0.79 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.075 -0.964 . . . . 0.0 111.957 -169.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.72 -37.91 61.4 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.411 1.459 . . . . 0.0 112.732 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -61.4 -9.03 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.235 1.957 . . . . 0.0 115.437 172.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.02 -16.08 3.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.207 1.821 . . . . 0.0 113.466 -178.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.86 152.39 96.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.794 1.238 . . . . 0.0 112.348 -172.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.24 62.38 7.54 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 125.176 3.917 . . . . 0.0 111.616 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.1 mt -83.89 172.77 11.81 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.233 1.813 . . . . 0.0 112.404 -172.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -134.26 145.86 49.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.58 139.63 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.523 1.129 . . . . 0.0 110.262 -176.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 5' ' ' ILE . . . -82.12 130.81 35.19 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -123.31 142.16 40.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 47.1 p30 -84.21 -173.48 4.74 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.453 174.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.64 -22.34 22.2 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.434 1.494 . . . . 0.0 113.657 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -81.79 -2.36 50.55 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 111.659 178.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t0 53.26 56.31 7.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 123.286 1.517 . . . . 0.0 109.142 -169.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.61 129.19 16.31 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 127.461 2.304 . . . . 0.0 105.465 -169.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.73 136.8 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.027 1.818 . . . . 0.0 110.217 -171.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 -16.08 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.722 1.209 . . . . 0.0 111.842 174.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.19 173.02 39.31 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 173.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -149.76 161.28 42.55 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.707 0.753 . . . . 0.0 110.592 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.21 154.13 47.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.129 0.971 . . . . 0.0 108.937 168.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.78 119.59 33.16 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 176.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 95' ' ' ALA . 25.2 tp -146.28 134.6 21.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.275 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.4 m -159.47 156.32 28.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.358 2.263 . . . . 0.0 105.484 168.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.63 32.94 61.95 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.419 -0.8 . . . . 0.0 113.889 175.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 57.01 22.54 7.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.218 1.807 . . . . 0.0 114.121 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -122.69 111.02 16.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.579 0.751 . . . . 0.0 109.787 175.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 67.0 ttp -85.83 88.78 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -64.77 -23.95 67.4 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.14 144.88 32.39 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.378 0.671 . . . . 0.0 110.552 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.8 tp -156.87 117.22 3.57 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.69 1.996 . . . . 0.0 106.112 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -147.17 144.92 29.32 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -149.33 142.73 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -173.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.49 137.68 95.38 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.281 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.62 -24.53 23.05 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.803 3.002 . . . . 0.0 115.852 178.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.34 -21.1 61.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.541 1.064 . . . . 0.0 112.278 175.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.15 24.89 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.529 1.532 . . . . 0.0 110.493 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -57.91 132.84 54.59 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.778 -1.201 . . . . 0.0 108.826 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.95 2.65 53.1 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.995 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 98.7 m -70.78 169.23 15.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.654 1.727 . . . . 0.0 109.18 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -51.05 -28.22 16.95 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.545 1.069 . . . . 0.0 113.863 -177.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -50.55 -34.81 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 118.989 1.395 . . . . 0.0 112.203 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -55.15 -29.94 53.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.08 0.848 . . . . 0.0 112.807 175.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -91.95 -42.52 9.97 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 116.498 -1.715 . . . . 0.0 110.248 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.1 t -54.32 -45.56 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 121.56 1.982 . . . . 0.0 110.826 -172.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.6 mt -66.2 -39.81 89.91 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.791 0.723 . . . . 0.0 111.065 -178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.53 -40.75 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 123.478 0.711 . . . . 0.0 109.798 178.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.54 -36.95 85.31 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.594 0.758 . . . . 0.0 109.544 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.52 -47.03 87.44 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.057 0.543 . . . . 0.0 110.276 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 68' ' ' LEU . . . -60.13 -49.77 76.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.06 0.544 . . . . 0.0 110.84 177.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.9 mt -60.27 -33.72 72.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.191 0.996 . . . . 0.0 111.578 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -63.41 -37.65 88.11 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.358 0.526 . . . . 0.0 111.414 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.9 mtm -83.92 -26.45 29.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.253 0.479 . . . . 0.0 112.117 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 91.32 10.39 Favored Pre-proline 0 N--CA 1.453 -0.31 0 C-N-CA 125.143 1.377 . . . . 0.0 109.282 -169.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.96 -22.16 63.06 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.425 1.417 . . . . 0.0 112.822 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -104.86 30.92 5.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.286 1.434 . . . . 0.0 110.274 -174.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.6 tp -50.91 143.37 10.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.898 2.079 . . . . 0.0 112.826 -170.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 65.2 p -130.0 162.85 27.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.746 169.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.2 t -153.58 -173.58 4.63 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.014 0.526 . . . . 0.0 109.724 175.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -148.68 161.41 41.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.833 0.853 . . . . 0.0 110.631 177.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 p -156.07 147.34 12.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -72.56 132.16 43.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 174.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -58.34 -30.87 67.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.726 0.811 . . . . 0.0 112.33 -173.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -60.79 -33.16 72.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.506 0.594 . . . . 0.0 111.236 -177.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.445 HD22 ' CE1' ' A' ' 28' ' ' HIS . 54.5 t-20 -80.02 65.8 5.3 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.028 0.931 . . . . 0.0 110.523 176.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -57.11 -26.11 59.92 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.608 0.763 . . . . 0.0 111.632 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.4 ' H ' ' NE2' ' A' ' 112' ' ' GLN . 2.7 mp0 -62.87 -46.97 85.36 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.102 0.561 . . . . 0.0 109.752 176.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.72 77.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.606 -0.711 . . . . 0.0 111.786 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.41 -46.21 81.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.236 0.925 . . . . 0.0 108.963 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.01 -49.59 73.79 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 175.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -55.45 -50.88 68.71 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.582 0.753 . . . . 0.0 110.755 -178.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -66.1 -34.41 78.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -174.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.15 -37.88 86.75 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 120.82 -1.175 . . . . 0.0 112.72 172.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.07 -42.81 91.26 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.877 1.217 . . . . 0.0 110.169 173.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.57 -35.65 75.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 110.788 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.72 9.08 1.82 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.418 1.008 . . . . 0.0 114.454 169.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.4 162.2 29.08 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.608 1.704 . . . . 0.0 111.107 171.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -146.92 140.39 25.6 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.559 HG22 HD22 ' A' ' 142' ' ' LEU . 29.9 t -72.26 129.75 35.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 123.907 0.883 . . . . 0.0 109.336 -174.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.6 p -123.77 -9.15 7.84 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.421 1.888 . . . . 0.0 111.681 -174.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.55 -179.92 41.12 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 172.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -156.36 177.87 10.96 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.804 0.841 . . . . 0.0 109.254 172.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.0 m -145.69 129.98 17.66 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -76.4 2.66 12.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.3 m -132.26 169.79 21.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.177 1.391 . . . . 0.0 107.513 169.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.44 -59.63 2.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.394 -177.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -157.24 -43.35 0.07 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.18 31.97 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.435 1.094 . . . . 0.0 110.28 -173.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.15 11.44 84.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 123.554 0.597 . . . . 0.0 112.966 -173.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.503 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 39.1 mmtt -68.39 129.26 92.87 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 116.953 -1.499 . . . . 0.0 108.129 -179.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.63 47.7 2.52 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.762 2.975 . . . . 0.0 112.425 -171.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -130.68 79.46 71.92 Favored Pre-proline 0 C--O 1.222 -0.379 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -41.12 145.73 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.168 3.246 . . . . 0.0 118.449 -169.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.67 146.15 26.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.7 mt -117.26 145.23 44.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.451 ' C ' HD23 ' A' ' 142' ' ' LEU . 10.1 t-20 -115.71 138.61 50.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.559 HD22 HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -136.0 158.78 43.57 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -171.242 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.56 152.48 51.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.277 1.431 . . . . 0.0 108.348 176.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.5 127.36 32.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 92.8 t -130.24 -9.48 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.136 1.374 . . . . 0.0 110.146 -176.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.06 -27.01 69.77 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.108 -0.995 . . . . 0.0 113.75 177.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 C-N-CA 124.746 1.218 . . . . 0.0 110.629 179.874 . . . . . . . . 0 0 . 1 stop_ save_